data_2mqm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mqm _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.737 0.303 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.0 p -94.87 10.75 34.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.173 0.589 . . . . 0.0 111.258 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.35 139.47 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.683 0.793 . . . . 0.0 110.664 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 99.1 mt -128.52 160.35 32.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.386 0.612 . . . . 0.0 111.255 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.4 tp -120.65 133.36 55.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.99 1.316 . . . . 0.0 108.042 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -119.75 144.71 47.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.652 0.781 . . . . 0.0 109.912 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 99.0 m -139.52 142.83 37.24 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.4 mp -105.38 135.78 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.86 -35.79 12.54 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -130.79 62.84 67.58 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.429 0.692 . . . . 0.0 110.329 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.45 103.25 1.08 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.795 2.33 . . . . 0.0 110.989 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.8 pt -128.83 2.71 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.742 0.417 . . . . 0.0 111.614 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -132.31 167.47 19.81 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.737 0.815 . . . . 0.0 109.628 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.5 m -74.68 146.73 42.08 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.65 0.262 . . . . 0.0 111.133 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mm -138.11 136.02 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.5 p -144.05 174.21 11.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.463 0.705 . . . . 0.0 109.538 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.2 p -63.51 -19.16 64.54 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.507 0.323 . . . . 0.0 111.153 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -83.4 -25.96 30.84 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.745 0.248 . . . . 0.0 111.042 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.4 t -81.67 -36.58 14.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.76 -26.32 57.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.217 -0.302 . . . . 0.0 110.295 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -75.63 -36.64 60.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.868 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.1 t -77.13 -17.69 58.45 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.312 0.505 . . . . 0.0 111.647 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.77 -13.9 7.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.148 0.431 . . . . 0.0 111.877 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 83.6 m -99.31 -24.97 14.64 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.765 0.711 . . . . 0.0 112.139 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.426 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 47.9 t30 -63.93 -39.16 42.75 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 95.1 Cg_endo -72.89 -5.81 17.87 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.437 1.425 . . . . 0.0 111.729 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 73.0 m -102.54 -10.52 19.25 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.806 0.442 . . . . 0.0 111.105 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 156.89 166.01 15.81 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.71 112.75 2.97 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.61 2.873 . . . . 0.0 110.658 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.25 152.33 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -117.18 -37.82 3.48 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.617 0.367 . . . . 0.0 110.95 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -163.16 157.32 20.37 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.2 0.455 . . . . 0.0 112.186 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.6 mt -143.67 146.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.315 1.046 . . . . 0.0 109.913 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.17 150.9 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--O 1.231 0.116 0 C-N-CA 122.966 0.506 . . . . 0.0 110.742 -173.806 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.808 0.337 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -154.24 171.6 18.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.556 0.342 . . . . 0.0 110.418 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.4 mtp -138.45 147.73 43.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.2 t -137.81 151.75 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 123.149 0.58 . . . . 0.0 109.786 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -141.2 141.49 34.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.297 0.639 . . . . 0.0 109.88 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -118.0 168.73 10.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.95 0.9 . . . . 0.0 110.981 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.01 -14.41 60.22 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.979 0.512 . . . . 0.0 111.357 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.4 t -150.75 152.15 33.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.939 0.496 . . . . 0.0 109.998 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.52 -23.68 30.22 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.85 -29.09 70.03 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 27.3 m -83.87 -28.0 28.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.573 0.349 . . . . 0.0 110.391 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.23 -27.02 47.61 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -69.96 -38.92 76.25 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -76.55 -27.95 56.1 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.15 -53.83 39.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.399 -0.188 . . . . 0.0 110.968 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -14.38 60.01 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.999 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.05 -12.58 57.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.014 0.37 . . . . 0.0 111.947 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -128.75 2.31 5.44 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 76.5 mt -128.45 -4.94 5.37 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.472 0.578 . . . . 0.0 112.363 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.4 132.85 37.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.97 7.94 72.08 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.69 174.17 11.62 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.574 0.687 . . . . 0.0 111.018 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -132.15 148.62 52.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 49.9 mt . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -178.479 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.605 0.24 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.94 140.53 56.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.28 0.632 . . . . 0.0 110.051 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.2 154.86 16.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.007 0.523 . . . . 0.0 111.661 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -143.24 124.9 14.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 71.6 mt -126.44 146.2 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.147 0.499 . . . . 0.0 111.715 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -156.35 170.73 21.63 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.952 1.301 . . . . 0.0 108.656 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.48 145.74 33.09 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 121.798 -0.564 . . . . 0.0 110.427 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -89.68 166.41 13.61 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.2 pttt -79.02 -28.32 0.55 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.4 Cg_endo -82.01 163.2 18.05 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 121.95 1.732 . . . . 0.0 110.442 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.5 p -97.24 -7.48 32.16 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 122.275 0.23 . . . . 0.0 110.992 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -152.82 148.88 27.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.818 0.847 . . . . 0.0 110.187 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 67.9 mt -107.48 172.26 6.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.586 0.754 . . . . 0.0 109.638 173.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -141.36 157.0 45.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.711 0.404 . . . . 0.0 110.22 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 79.9 t -135.59 152.36 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -119.93 -22.85 6.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.386 0.274 . . . . 0.0 111.148 -174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -165.38 173.52 11.05 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.712 0.805 . . . . 0.0 109.971 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -117.16 111.45 19.49 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.764 0.316 . . . . 0.0 110.463 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -156.24 -171.69 3.81 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.98 1.312 . . . . 0.0 109.56 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -73.95 -0.49 16.33 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -109.69 -27.35 9.39 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.45 0.568 . . . . 0.0 111.05 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.9 t -156.09 144.33 19.9 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.155 0.582 . . . . 0.0 109.584 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -150.31 150.73 31.88 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.657 0.265 . . . . 0.0 110.634 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -126.5 137.55 53.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.071 0.549 . . . . 0.0 109.765 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.96 11.76 13.51 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.594 0.758 . . . . 0.0 112.351 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.533 0.296 0 CA-C-N 117.983 0.356 . . . . 0.0 111.942 -179.031 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 32.7 p30 . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.4 p -92.77 15.79 13.83 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.595 0.758 . . . . 0.0 112.472 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.47 145.9 24.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 122.884 0.474 . . . . 0.0 110.893 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.64 165.02 23.71 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.29 0.567 . . . . 0.0 111.29 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.1 tp -127.69 131.26 49.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -117.0 144.31 44.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.826 0.851 . . . . 0.0 109.443 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.1 m -135.91 141.72 44.59 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.91 136.19 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.6 mt -92.86 -36.55 12.76 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -131.67 64.87 74.39 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.467 0.707 . . . . 0.0 110.096 -177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.85 104.2 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.571 2.181 . . . . 0.0 111.075 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.2 pt -130.13 1.44 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.073 0.549 . . . . 0.0 111.457 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -131.5 167.32 19.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.849 0.86 . . . . 0.0 109.197 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 27.0 t -76.53 149.48 36.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.416 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.3 mm -138.8 133.3 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.6 p -145.07 176.17 9.7 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 123.388 0.675 . . . . 0.0 110.136 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 35.5 p -61.33 -28.15 69.01 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.383 -0.198 . . . . 0.0 110.936 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.08 -22.35 58.36 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.699 0.399 . . . . 0.0 111.631 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.0 t -89.62 -38.0 10.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 84.3 mt -77.76 -23.39 49.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.96 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -78.3 -34.54 48.71 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.017 -0.427 . . . . 0.0 110.711 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.9 t -75.59 -23.23 56.45 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.217 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.1 pt -88.91 -22.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.203 0.456 . . . . 0.0 111.755 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.9 m -96.21 -20.12 18.81 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.779 0.718 . . . . 0.0 112.507 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.451 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.84 -43.5 87.54 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 95.8 Cg_endo -72.13 -11.04 26.74 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.874 1.716 . . . . 0.0 111.594 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.1 m -90.56 -23.04 21.0 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.232 0.469 . . . . 0.0 111.121 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.26 170.97 28.91 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -68.38 111.03 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.766 2.978 . . . . 0.0 110.71 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -83.49 152.37 3.86 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -115.52 -35.53 4.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.815 0.446 . . . . 0.0 110.693 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -164.31 160.35 20.85 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.129 0.422 . . . . 0.0 111.772 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.1 mt -144.35 146.89 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.074 0.95 . . . . 0.0 109.986 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.1 144.61 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 123.528 0.731 . . . . 0.0 109.408 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.527 0.084 0 C-N-CA 123.767 0.827 . . . . 0.0 110.386 -176.502 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 . . . . . 0 N--CA 1.457 -0.087 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.15 168.65 26.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.418 0.287 . . . . 0.0 110.416 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 87.8 mtp -138.43 151.43 47.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.31 150.15 21.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 122.829 0.452 . . . . 0.0 109.898 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -132.44 141.78 48.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.746 0.818 . . . . 0.0 108.794 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -118.02 167.98 10.96 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.907 0.883 . . . . 0.0 110.916 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.24 -15.5 60.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.738 0.415 . . . . 0.0 111.135 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 93.4 p -152.08 158.34 42.87 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.039 0.447 . . . . 0.0 110.459 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.94 -26.68 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.388 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -72.63 -22.2 60.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.335 0.516 . . . . 0.0 110.534 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.8 m -80.56 -28.3 37.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.02 -26.19 39.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.354 0.262 . . . . 0.0 110.469 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -69.71 -36.91 76.32 Favored 'General case' 0 N--CA 1.458 -0.05 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -79.67 -24.94 41.46 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.16 0.184 . . . . 0.0 110.762 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.68 -52.79 33.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.975 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -16.08 60.08 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.795 0.725 . . . . 0.0 111.662 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.8 58.74 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.702 0.228 . . . . 0.0 111.6 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.8 t -126.73 0.52 6.75 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.0 mt -130.68 -4.27 4.14 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -78.14 130.91 36.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.884 0.765 . . . . 0.0 109.083 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.38 8.66 76.02 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.25 175.38 9.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.666 0.733 . . . . 0.0 111.284 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -139.8 149.14 43.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.569 0.748 . . . . 0.0 109.01 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.4 mt . . . . . 0 CA--C 1.532 0.253 0 C-N-CA 122.491 0.317 . . . . 0.0 111.243 -176.051 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.39 142.69 51.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.385 0.674 . . . . 0.0 109.987 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 53.9 mt -97.76 154.99 17.24 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.15 0.5 . . . . 0.0 111.87 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -146.25 132.55 19.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 76.6 mt -129.58 149.12 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 121.338 0.589 . . . . 0.0 112.012 -172.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.74 172.3 16.89 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.356 1.462 . . . . 0.0 108.428 174.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -83.75 143.92 29.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.948 -0.47 . . . . 0.0 110.445 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.68 170.29 12.65 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.41 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.441 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -84.82 -26.35 0.37 Allowed Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 49.4 Cg_endo -82.5 -177.84 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.023 1.815 . . . . 0.0 110.033 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.0 p -108.23 -7.43 15.98 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 122.196 -0.315 . . . . 0.0 111.422 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.75 168.47 27.07 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.138 0.975 . . . . 0.0 109.665 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 90.4 mt -124.73 174.37 7.94 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.475 0.71 . . . . 0.0 109.739 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -140.79 159.77 41.49 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.835 0.35 . . . . 0.0 110.929 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.8 t -135.69 153.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 124.277 1.031 . . . . 0.0 108.744 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -120.58 -26.38 5.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.614 0.366 . . . . 0.0 111.493 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.12 169.89 18.71 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.729 1.212 . . . . 0.0 108.865 176.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -107.08 117.43 34.04 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.782 0.325 . . . . 0.0 110.616 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -158.25 -172.57 3.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.624 1.169 . . . . 0.0 109.755 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -71.49 -4.94 29.46 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -114.16 -18.9 11.53 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.664 0.665 . . . . 0.0 111.728 -178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.0 t -156.63 139.38 15.14 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -152.49 149.56 28.67 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.703 0.287 . . . . 0.0 110.666 -176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -124.95 138.2 54.24 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.176 0.59 . . . . 0.0 109.479 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -118.37 11.17 12.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.3 0.64 . . . . 0.0 112.253 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 CA--C 1.53 0.178 0 CA-C-N 118.231 0.469 . . . . 0.0 112.22 -178.006 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.5 p30 . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.659 0.266 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.5 p -100.3 15.59 27.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.686 0.795 . . . . 0.0 111.788 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.11 143.94 27.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.011 0.524 . . . . 0.0 110.858 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.3 mt -128.79 164.92 21.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.212 0.53 . . . . 0.0 111.783 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.1 tp -123.87 134.43 53.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.783 1.233 . . . . 0.0 107.939 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -121.75 150.85 41.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.029 0.932 . . . . 0.0 109.618 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 94.6 m -142.63 146.71 34.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 42.9 mt -119.26 136.99 54.65 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.05 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 50.2 mt -102.91 -23.69 13.72 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -131.7 62.19 62.91 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.39 0.676 . . . . 0.0 110.102 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.31 40.27 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 125.073 3.849 . . . . 0.0 112.632 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 38.0 pt -77.08 -0.7 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.887 -0.508 . . . . 0.0 111.888 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -130.16 166.05 21.05 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.729 0.812 . . . . 0.0 109.655 176.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.2 m -70.57 146.56 50.04 Favored 'General case' 0 C--N 1.335 -0.048 0 CA-C-O 120.73 0.3 . . . . 0.0 111.526 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.8 mm -137.33 134.6 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.9 p -146.87 173.88 12.01 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.368 0.667 . . . . 0.0 109.236 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.3 p -63.74 -19.56 65.06 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 122.333 0.253 . . . . 0.0 111.529 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.15 -24.37 37.65 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.843 0.292 . . . . 0.0 110.849 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.0 t -82.48 -37.62 14.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.58 -24.25 58.88 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.212 -0.305 . . . . 0.0 110.614 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -78.31 -36.23 46.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.229 -0.294 . . . . 0.0 111.177 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.7 t -74.97 -21.32 59.23 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.145 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 39.5 pt -91.73 -21.9 6.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 CA-C-N 118.136 0.425 . . . . 0.0 112.058 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.2 m -95.67 -24.2 16.66 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.444 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 50.4 t30 -63.88 -40.57 56.49 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 89.4 Cg_endo -73.14 -4.5 15.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.754 1.636 . . . . 0.0 111.821 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.5 m -101.67 -10.42 20.03 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.868 0.467 . . . . 0.0 111.199 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 155.53 164.66 13.38 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.86 109.59 1.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.729 2.953 . . . . 0.0 111.016 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.96 151.88 4.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -117.39 -38.37 3.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.612 0.365 . . . . 0.0 111.086 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -162.98 157.95 21.62 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.01 0.368 . . . . 0.0 111.424 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 54.1 mt -143.15 141.93 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.762 0.825 . . . . 0.0 109.419 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 20.3 m -136.2 151.66 29.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 56.3 mt . . . . . 0 N--CA 1.455 -0.182 0 C-N-CA 122.796 0.438 . . . . 0.0 110.138 -175.435 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 N--CA 1.457 -0.125 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.83 171.4 18.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.843 0.457 . . . . 0.0 109.985 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.0 mtp -141.47 150.53 42.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.2 t -136.71 152.41 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 C-N-CA 122.928 0.491 . . . . 0.0 109.829 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -137.42 140.84 41.55 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.461 0.704 . . . . 0.0 109.577 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -120.97 169.24 10.66 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 123.879 0.871 . . . . 0.0 111.079 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.04 -16.07 61.06 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.852 0.461 . . . . 0.0 111.362 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 90.7 p -153.02 159.71 42.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.974 0.416 . . . . 0.0 110.664 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.38 -26.62 31.84 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 O-C-N 122.269 -0.269 . . . . 0.0 110.365 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -65.49 -29.33 69.97 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 122.077 -0.39 . . . . 0.0 110.083 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.7 m -80.14 -27.33 39.08 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.704 0.402 . . . . 0.0 110.641 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.14 -25.27 37.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.276 -0.265 . . . . 0.0 110.527 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -70.89 -35.99 72.56 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -77.05 -27.79 54.54 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.335 -0.228 . . . . 0.0 110.487 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.12 -51.5 57.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.361 -0.212 . . . . 0.0 111.056 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -13.32 59.92 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.863 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -84.89 -10.79 56.76 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.924 0.329 . . . . 0.0 111.591 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.6 m -124.73 -2.47 7.84 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.51 -7.4 4.67 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -78.34 133.02 37.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.889 0.768 . . . . 0.0 109.099 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.16 4.78 64.3 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.79 179.67 7.41 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 117.641 0.72 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.48 161.45 37.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.723 0.809 . . . . 0.0 108.995 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.9 mt . . . . . 0 CA--C 1.531 0.226 0 CA-C-O 119.783 -0.151 . . . . 0.0 111.337 -177.718 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.5 m . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.703 0.287 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.9 m -56.27 138.17 50.95 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.919 0.487 . . . . 0.0 109.901 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.3 mt -105.21 153.44 21.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.043 0.537 . . . . 0.0 112.069 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -141.59 125.12 16.72 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 77.4 mt -124.25 147.6 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-O 121.136 0.494 . . . . 0.0 111.498 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -155.89 170.55 21.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.054 1.342 . . . . 0.0 108.427 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -80.39 146.35 31.54 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.861 -0.524 . . . . 0.0 110.51 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.26 165.92 15.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.489 0.316 . . . . 0.0 110.272 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -82.9 -26.55 0.4 Allowed Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 43.2 Cg_endo -81.7 177.74 7.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.848 1.696 . . . . 0.0 109.593 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 59.2 p -106.38 -5.17 19.2 Favored 'General case' 0 CA--C 1.527 0.084 0 O-C-N 122.285 -0.26 . . . . 0.0 110.985 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.0 mmm-85 -154.48 155.86 35.66 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.118 0.967 . . . . 0.0 110.235 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -118.47 168.64 10.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.173 0.989 . . . . 0.0 109.716 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -140.79 161.38 37.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.329 0.252 . . . . 0.0 110.878 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.15 153.92 36.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 124.164 0.986 . . . . 0.0 109.111 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -123.83 -21.28 5.19 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.447 ' HE3' ' CG2' ' A' ' 279' ' ' THR . 0.3 OUTLIER -164.95 173.08 12.0 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.678 1.191 . . . . 0.0 109.021 176.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -113.05 113.64 25.73 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -154.93 -172.13 4.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.944 1.297 . . . . 0.0 109.387 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -71.65 -4.97 30.24 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -115.86 -14.5 11.32 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.649 0.659 . . . . 0.0 111.899 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' THR . . . . . 0.447 ' CG2' ' HE3' ' A' ' 274' ' ' LYS . 5.0 t -157.09 138.58 13.94 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -152.91 150.24 29.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.252 -0.28 . . . . 0.0 110.894 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -125.43 137.52 54.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.133 0.573 . . . . 0.0 109.556 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -117.15 7.27 12.97 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.312 0.645 . . . . 0.0 112.084 -175.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.533 0.297 0 C-N-CA 122.569 0.348 . . . . 0.0 111.837 179.215 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.701 0.286 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.1 p -87.17 15.44 6.21 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.248 0.619 . . . . 0.0 111.606 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.71 137.92 45.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 123.158 0.583 . . . . 0.0 111.073 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.06 163.31 24.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.376 0.607 . . . . 0.0 111.266 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.1 tp -125.09 132.41 53.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.871 1.268 . . . . 0.0 108.191 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -117.84 146.96 43.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.667 0.787 . . . . 0.0 109.845 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 72.9 m -136.59 144.39 44.1 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.43 136.62 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 63.3 mt -99.71 -26.42 14.06 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -174.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -135.88 66.77 62.93 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 123.67 0.788 . . . . 0.0 109.687 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -75.11 52.64 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 125.133 3.889 . . . . 0.0 112.398 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.4 pt -78.79 -1.75 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 121.724 -0.61 . . . . 0.0 111.641 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -136.54 168.85 18.7 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.268 1.027 . . . . 0.0 109.36 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.9 m -79.12 150.5 31.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.853 0.359 . . . . 0.0 111.483 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.4 mm -134.31 138.73 49.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.4 p -142.18 174.53 10.52 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 122.934 0.493 . . . . 0.0 110.018 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 38.5 p -63.19 -21.45 66.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.203 0.201 . . . . 0.0 111.109 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.81 -27.91 33.4 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.38 0.272 . . . . 0.0 111.222 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.9 t -78.96 -37.8 20.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 89.2 mt -76.79 -22.49 53.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.274 -0.266 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -77.88 -34.32 51.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.973 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -76.88 -21.71 54.53 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.386 0.539 . . . . 0.0 111.294 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 44.8 pt -90.62 -21.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.969 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.7 m -96.58 -21.66 17.53 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.507 0.594 . . . . 0.0 112.257 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.447 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.1 t-20 -60.26 -44.3 95.79 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.434 -0.793 . . . . 0.0 113.111 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 97.8 Cg_endo -72.39 -9.43 24.2 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.039 1.826 . . . . 0.0 112.103 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 76.9 m -94.67 -20.5 19.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.99 0.359 . . . . 0.0 111.217 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.54 167.32 23.82 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.44 113.27 3.07 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.799 2.999 . . . . 0.0 110.886 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.7 t -87.21 150.45 3.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -112.35 -36.73 5.2 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.159 0.584 . . . . 0.0 110.796 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -164.35 159.17 19.46 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 117.993 0.36 . . . . 0.0 111.882 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 42.4 mt -144.34 142.35 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.01 0.924 . . . . 0.0 109.354 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 m -138.4 154.63 27.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 122.72 0.408 . . . . 0.0 110.239 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 CA--C 1.528 0.122 0 C-N-CA 123.604 0.762 . . . . 0.0 111.062 -175.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.995 0.426 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.57 166.47 31.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.409 0.683 . . . . 0.0 109.339 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 87.4 mtp -135.94 150.26 49.22 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.05 148.23 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 122.918 0.487 . . . . 0.0 109.881 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.9 138.91 48.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -115.24 169.33 9.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.922 0.889 . . . . 0.0 111.065 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.79 -16.64 61.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.574 0.35 . . . . 0.0 111.549 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.5 p -152.57 159.9 43.24 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.612 0.365 . . . . 0.0 110.684 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.39 -25.75 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -70.72 -25.2 62.83 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.305 -0.247 . . . . 0.0 110.405 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.9 m -80.37 -28.53 37.97 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.64 -25.78 41.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.381 -0.2 . . . . 0.0 110.528 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -69.68 -37.02 76.5 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 48.4 ttt-85 -78.92 -26.66 43.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 121.897 0.079 . . . . 0.0 110.936 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.25 -48.89 66.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.036 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -14.41 59.27 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 118.57 0.623 . . . . 0.0 111.663 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -84.67 -9.92 57.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.653 -0.213 . . . . 0.0 111.191 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -124.71 -1.44 7.94 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.0 mt -132.07 -5.52 3.49 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -77.21 131.24 38.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.021 0.828 . . . . 0.0 109.244 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.25 5.76 67.45 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.29 179.28 7.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.609 0.704 . . . . 0.0 111.281 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -139.43 157.98 44.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.853 0.861 . . . . 0.0 108.807 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 57.1 mt . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -174.044 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.783 0.325 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.4 m -60.38 137.93 58.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.692 0.397 . . . . 0.0 109.955 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.3 mt -98.85 156.17 17.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.206 0.602 . . . . 0.0 112.314 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -144.09 134.11 24.1 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 81.2 mt -128.53 148.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-O 121.217 0.532 . . . . 0.0 111.562 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -154.3 169.49 23.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.075 1.35 . . . . 0.0 108.488 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -83.37 143.08 30.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.831 -0.543 . . . . 0.0 110.449 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.84 169.38 11.65 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -85.07 -26.51 0.37 Allowed Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.6 Cg_endo -82.03 165.26 17.31 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 CA-C-N 122.069 1.775 . . . . 0.0 109.927 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.9 p -94.3 -7.79 40.86 Favored 'General case' 0 CA--C 1.527 0.073 0 O-C-N 122.245 -0.284 . . . . 0.0 111.419 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.88 169.53 24.57 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.806 0.842 . . . . 0.0 109.939 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 84.1 mt -121.05 167.75 12.28 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.501 0.72 . . . . 0.0 109.565 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -129.85 154.13 47.59 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.681 0.277 . . . . 0.0 110.374 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 87.6 t -136.86 151.14 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.221 1.008 . . . . 0.0 108.866 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -123.43 -19.99 5.73 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.856 0.463 . . . . 0.0 111.324 -174.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -164.7 168.29 18.15 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.891 1.276 . . . . 0.0 108.7 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -116.96 109.27 16.81 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 121.016 0.436 . . . . 0.0 110.648 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -154.51 -172.14 4.1 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.789 1.236 . . . . 0.0 109.506 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -69.88 -4.85 22.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -114.1 -15.46 12.25 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 118.732 0.696 . . . . 0.0 111.826 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.2 t -159.43 134.75 8.32 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -152.23 148.31 27.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.121 -0.362 . . . . 0.0 111.153 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -125.64 132.5 52.45 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.44 0.696 . . . . 0.0 109.436 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -109.38 2.19 20.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.628 0.771 . . . . 0.0 112.137 -173.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.532 0.269 0 C-N-CA 122.947 0.499 . . . . 0.0 110.499 177.367 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.774 0.321 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.8 p -89.68 13.68 13.59 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.194 0.597 . . . . 0.0 112.127 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.56 145.62 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 122.6 0.36 . . . . 0.0 110.721 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.3 mt -130.34 165.06 23.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.266 0.626 . . . . 0.0 111.586 -174.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 63.8 tp -123.89 133.01 53.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.565 1.146 . . . . 0.0 108.432 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -119.95 144.98 47.18 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.76 0.824 . . . . 0.0 109.994 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.1 m -138.1 142.93 40.21 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.54 136.53 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.9 mt -92.4 -34.58 14.1 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -134.35 67.42 72.4 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 123.634 0.773 . . . . 0.0 109.34 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.13 64.59 4.26 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.666 3.577 . . . . 0.0 112.113 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 45.6 pt -83.84 -4.5 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.993 -0.442 . . . . 0.0 111.202 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -129.38 166.24 19.93 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 109.379 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 77.9 p -80.54 156.61 26.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.642 0.258 . . . . 0.0 111.121 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mm -136.21 139.96 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 70.7 p -143.25 172.36 12.85 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.066 0.546 . . . . 0.0 110.007 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.6 p -62.04 -24.97 67.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.24 0.216 . . . . 0.0 110.991 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -78.92 -27.57 43.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.346 0.258 . . . . 0.0 111.352 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.15 -38.58 18.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.878 0.37 . . . . 0.0 110.025 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.35 -22.97 54.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.218 -0.301 . . . . 0.0 110.561 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -78.65 -35.22 45.69 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.914 0.324 . . . . 0.0 110.879 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.2 t -74.73 -23.56 58.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.242 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 pt -89.05 -21.41 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 118.379 0.536 . . . . 0.0 111.955 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 87.6 m -95.74 -19.3 19.78 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.302 0.501 . . . . 0.0 112.182 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.43 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.6 t-20 -60.39 -44.08 94.87 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 92.7 Cg_endo -73.06 -10.81 24.89 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.706 1.604 . . . . 0.0 111.995 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 77.5 m -89.4 -23.7 22.1 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.161 0.437 . . . . 0.0 111.249 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.86 171.78 30.52 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.1 111.43 2.68 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.553 2.835 . . . . 0.0 110.556 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.47 151.45 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -116.06 -39.1 3.49 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.064 0.546 . . . . 0.0 110.907 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -161.67 158.48 26.08 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.402 0.546 . . . . 0.0 112.062 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 41.2 mt -144.89 143.93 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 124.364 1.066 . . . . 0.0 109.721 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.4 m -141.69 149.52 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 123.288 0.635 . . . . 0.0 109.857 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.529 0.17 0 C-N-CA 123.765 0.826 . . . . 0.0 109.81 -178.394 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 N--CA 1.455 -0.183 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.05 171.64 20.1 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.528 0.331 . . . . 0.0 110.218 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.8 mtp -138.78 149.95 45.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.28 151.37 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -135.5 140.74 45.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.564 0.746 . . . . 0.0 109.818 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -120.03 167.74 11.87 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.851 0.861 . . . . 0.0 110.854 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.51 -11.21 59.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.616 0.366 . . . . 0.0 111.349 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 42.9 t -152.18 151.45 31.03 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.151 0.581 . . . . 0.0 110.088 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.11 -25.71 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.54 -24.38 62.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.009 -0.432 . . . . 0.0 110.14 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 41.2 m -80.35 -27.2 38.35 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.75 -26.42 37.32 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.243 0.217 . . . . 0.0 110.424 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -68.46 -37.64 80.36 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -78.68 -24.79 44.86 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.99 -50.63 54.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.319 -0.238 . . . . 0.0 111.197 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -14.57 59.45 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.626 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.22 -8.54 58.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.835 0.289 . . . . 0.0 111.555 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.8 t -125.6 -6.79 6.88 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.3 mt -124.49 -5.33 7.67 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -77.71 131.36 37.66 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.82 5.05 73.41 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.563 -0.576 . . . . 0.0 111.827 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.86 177.57 8.95 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.833 0.816 . . . . 0.0 111.093 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -138.64 160.38 39.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.758 0.823 . . . . 0.0 109.371 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.4 mt . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.294 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.3 m . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.49 0.186 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.0 m -60.56 139.59 57.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.937 0.495 . . . . 0.0 110.041 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.0 mt -95.24 154.51 17.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.372 0.669 . . . . 0.0 111.756 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -145.56 129.15 17.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 81.0 mt -129.29 147.69 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 CA-C-O 121.171 0.51 . . . . 0.0 112.216 -171.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.36 173.56 15.47 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.679 1.191 . . . . 0.0 108.547 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -83.23 143.56 30.36 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.976 -0.452 . . . . 0.0 110.675 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.18 167.33 17.84 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.068 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -74.64 -46.88 5.43 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 118.298 -0.858 . . . . 0.0 113.273 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -74.9 177.53 8.43 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.353 2.035 . . . . 0.0 110.539 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.2 p -108.49 -7.79 15.69 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.592 0.357 . . . . 0.0 111.534 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.77 136.49 14.4 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 56.4 mt -88.05 171.09 10.53 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 122.731 0.412 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -131.93 151.7 51.55 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.549 0.34 . . . . 0.0 110.369 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.3 153.69 24.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 124.171 0.988 . . . . 0.0 108.786 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -126.94 -19.62 4.39 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.57 0.348 . . . . 0.0 111.437 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -165.56 170.46 14.27 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 124.505 1.122 . . . . 0.0 109.011 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -117.06 109.42 16.94 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.619 0.368 . . . . 0.0 110.411 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -154.93 -172.13 4.08 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.585 1.154 . . . . 0.0 109.627 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -69.75 -4.86 21.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -115.2 -17.29 11.41 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.121 0.873 . . . . 0.0 111.779 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.6 t -156.68 134.81 11.2 Favored 'General case' 0 N--CA 1.458 -0.055 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -152.61 147.36 26.06 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.758 0.314 . . . . 0.0 111.212 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -124.43 119.76 30.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -95.66 -4.68 43.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.281 0.632 . . . . 0.0 111.568 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 121.335 0.588 . . . . 0.0 110.124 176.698 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.3 p30 . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 120.988 0.423 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.0 p -82.96 10.13 8.59 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.5 t -109.43 136.56 44.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 122.815 0.446 . . . . 0.0 110.611 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.5 mt -125.1 161.43 26.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.754 0.788 . . . . 0.0 111.373 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.0 tp -126.17 131.44 52.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.035 1.334 . . . . 0.0 107.51 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -118.09 145.16 45.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.69 0.796 . . . . 0.0 109.406 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.3 m -139.49 141.54 37.34 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.2 mp -105.7 135.3 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.4 mt -94.02 -36.55 12.08 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -173.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -129.87 62.78 65.68 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 123.368 0.667 . . . . 0.0 110.082 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.45 101.96 0.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.947 2.431 . . . . 0.0 110.717 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.0 pt -128.26 3.07 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.788 0.435 . . . . 0.0 111.402 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -131.67 166.47 21.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.855 0.862 . . . . 0.0 109.457 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.5 m -73.91 145.8 44.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.787 0.327 . . . . 0.0 111.32 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.5 mm -137.49 136.79 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.6 p -145.04 172.27 13.3 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.529 0.732 . . . . 0.0 109.636 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.9 p -63.77 -20.76 66.02 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 122.327 -0.233 . . . . 0.0 110.931 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -79.7 -27.37 40.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.326 0.25 . . . . 0.0 110.888 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.2 t -81.51 -37.64 15.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.66 -28.54 62.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.185 -0.322 . . . . 0.0 110.599 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -74.28 -37.96 63.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.991 -0.443 . . . . 0.0 111.044 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.7 t -74.11 -20.99 60.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.555 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.3 pt -88.85 -23.55 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.184 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 16.6 p -109.69 -6.83 15.2 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.44 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.16 -42.79 87.82 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.562 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 94.4 Cg_endo -72.85 -7.02 20.07 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.805 1.67 . . . . 0.0 112.089 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 65.7 m -86.02 -21.86 27.57 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.062 0.392 . . . . 0.0 111.213 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.8 176.7 32.17 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.77 107.83 1.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.975 3.117 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.09 149.47 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -112.61 -39.05 4.44 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.474 0.31 . . . . 0.0 111.003 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -167.18 161.75 14.72 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 117.967 0.349 . . . . 0.0 111.911 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.4 mt -143.07 139.76 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.205 1.002 . . . . 0.0 109.145 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.17 157.8 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.8 mt . . . . . 0 C--N 1.335 -0.053 0 C-N-CA 122.875 0.47 . . . . 0.0 111.014 -175.274 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.785 0.326 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.55 172.14 17.04 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.418 0.287 . . . . 0.0 110.58 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 85.0 mtp -141.39 152.41 44.31 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 46.5 t -139.73 149.86 22.36 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.032 0 C-N-CA 123.02 0.528 . . . . 0.0 109.607 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -132.91 140.48 47.89 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -117.33 169.07 9.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.045 0.938 . . . . 0.0 110.974 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.56 -11.15 59.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.061 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.9 t -150.59 149.65 30.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.211 0.604 . . . . 0.0 110.111 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.45 -26.37 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -70.94 -23.63 62.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.961 -0.462 . . . . 0.0 110.316 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.9 m -80.11 -28.31 39.02 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.22 -27.86 42.5 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.519 0.199 . . . . 0.0 110.793 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -67.26 -36.02 80.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -82.47 -27.09 32.06 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.73 0.412 . . . . 0.0 111.698 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.16 -44.16 72.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.06 -0.4 . . . . 0.0 110.399 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -27.94 64.81 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -77.66 -8.53 58.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.819 -0.551 . . . . 0.0 111.712 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.6 m -121.07 -5.5 9.51 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.45 -8.75 2.53 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -74.57 131.15 40.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.735 1.152 . . . . 0.0 108.845 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 71.88 6.17 63.05 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.386 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.33 -179.06 7.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.83 0.815 . . . . 0.0 111.387 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -140.28 163.15 33.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.897 0.879 . . . . 0.0 109.456 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.0 mt . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -175.519 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 79.8 m . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.638 0.256 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.7 m -59.94 139.22 57.54 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.044 0.538 . . . . 0.0 109.896 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 64.9 mt -93.71 154.64 17.68 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.433 0.693 . . . . 0.0 111.799 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -144.06 123.1 12.83 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.6 mt -123.82 145.53 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-O 120.98 0.419 . . . . 0.0 111.575 -173.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -155.02 172.68 17.71 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.818 1.247 . . . . 0.0 108.498 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -85.81 147.25 26.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.11 -0.369 . . . . 0.0 110.858 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -95.7 165.74 12.16 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.657 0.383 . . . . 0.0 110.816 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -80.72 -27.17 0.45 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 47.6 Cg_endo -80.66 160.44 21.91 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 CA-C-N 121.965 1.738 . . . . 0.0 110.047 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 43.0 p -89.87 -10.44 45.29 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.6 0.36 . . . . 0.0 111.257 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 168.73 26.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.612 0.765 . . . . 0.0 110.074 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -119.93 172.69 7.55 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.093 0.957 . . . . 0.0 109.691 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -134.28 154.64 51.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.292 -0.255 . . . . 0.0 110.404 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 70.7 t -136.77 150.52 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.747 0.819 . . . . 0.0 108.885 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -122.75 -20.56 5.87 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.482 0.313 . . . . 0.0 111.358 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -165.23 169.98 15.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.176 0.99 . . . . 0.0 109.414 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -116.47 116.37 27.54 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.023 0.44 . . . . 0.0 110.519 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -159.87 -172.54 3.69 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.338 1.455 . . . . 0.0 109.384 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.75 -1.32 11.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.46 -19.93 8.64 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.622 0.646 . . . . 0.0 111.944 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 2.8 t -153.68 137.11 15.84 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -153.84 149.44 27.37 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.221 -0.299 . . . . 0.0 111.394 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -128.34 138.07 52.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.275 0.63 . . . . 0.0 109.62 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -115.9 6.93 14.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.582 0.753 . . . . 0.0 112.461 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.532 0.264 0 C-N-CA 122.843 0.457 . . . . 0.0 111.163 179.051 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.2 p30 . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.628 0.251 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.2 p -99.61 18.87 16.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.483 0.713 . . . . 0.0 111.955 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.6 143.92 33.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 C-N-CA 123.003 0.521 . . . . 0.0 110.696 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.5 mt -129.68 163.24 26.55 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.149 0.58 . . . . 0.0 111.365 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.3 tp -121.2 133.68 55.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.989 1.316 . . . . 0.0 108.054 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -119.61 145.58 46.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.521 0.728 . . . . 0.0 109.738 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.6 m -140.62 144.49 35.8 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.68 135.25 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.1 mt -91.77 -35.67 13.99 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -130.79 61.71 61.0 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 123.575 0.75 . . . . 0.0 110.184 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.98 101.79 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.78 2.32 . . . . 0.0 110.784 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.0 pt -125.72 0.22 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.95 0.5 . . . . 0.0 111.339 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.13 166.47 21.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.711 0.804 . . . . 0.0 109.264 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.5 m -73.53 151.68 40.9 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.81 0.338 . . . . 0.0 111.563 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.5 mm -138.71 135.24 43.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 68.4 p -146.46 176.35 9.87 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.149 0.58 . . . . 0.0 110.1 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.2 p -62.38 -25.55 67.98 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 122.435 0.294 . . . . 0.0 111.209 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -80.54 -20.61 43.08 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.545 0.338 . . . . 0.0 111.461 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 88.6 t -90.56 -37.82 9.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.4 mt -77.31 -22.53 51.81 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.254 -0.279 . . . . 0.0 110.715 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -78.8 -36.1 43.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.924 0.329 . . . . 0.0 110.903 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.9 t -77.0 -17.31 58.93 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.996 -0.44 . . . . 0.0 111.395 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.41 -17.57 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.913 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 88.8 m -95.7 -25.3 16.16 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.91 0.777 . . . . 0.0 111.859 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.453 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.2 t-20 -59.71 -42.2 90.1 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 83.6 Cg_endo -71.1 -4.54 15.1 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.962 1.775 . . . . 0.0 112.1 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 72.4 m -107.52 -11.68 15.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.223 0.465 . . . . 0.0 111.335 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.7 165.05 15.87 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.42 114.39 3.79 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.897 3.064 . . . . 0.0 110.67 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.2 t -86.56 151.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -113.34 -36.39 5.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.162 0.585 . . . . 0.0 110.554 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -164.04 159.88 21.08 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.8 mt -144.49 145.79 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.361 1.064 . . . . 0.0 109.92 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.476 HG13 ' HG1' ' A' ' 279' ' ' THR . 34.3 m -138.37 150.39 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 C-N-CA 123.265 0.626 . . . . 0.0 109.45 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.231 0.104 0 C-N-CA 123.077 0.551 . . . . 0.0 110.872 -175.785 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.77 170.15 23.11 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.9 mtp -138.49 151.52 47.45 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 43.7 t -138.4 149.49 24.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 C-N-CA 122.645 0.378 . . . . 0.0 110.424 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -132.43 138.88 47.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.728 0.811 . . . . 0.0 109.147 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -117.04 167.85 10.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.445 0.698 . . . . 0.0 110.797 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -75.99 -15.37 60.16 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.237 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.6 t -152.23 153.49 33.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.241 0.616 . . . . 0.0 110.057 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.89 -27.08 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -68.17 -24.13 64.94 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.926 -0.484 . . . . 0.0 109.854 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.9 m -81.47 -27.9 34.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.424 0.29 . . . . 0.0 110.395 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.15 -25.21 37.03 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -70.02 -37.5 75.64 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -77.49 -26.6 51.41 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 122.277 -0.265 . . . . 0.0 110.494 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.55 -53.59 39.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.951 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -14.34 60.13 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.622 0.647 . . . . 0.0 111.976 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.85 -12.67 55.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.1 -0.375 . . . . 0.0 111.855 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.0 m -129.67 1.72 4.95 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 77.0 mt -128.46 -4.27 5.41 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.65 0.659 . . . . 0.0 112.717 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -78.78 132.04 36.75 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.6 4.51 70.51 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.016 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.74 177.59 8.54 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.634 0.717 . . . . 0.0 110.866 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -140.39 161.18 38.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.466 0.706 . . . . 0.0 109.287 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.8 mt . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.851 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.4 m . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.471 0.177 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 16.7 m -59.55 138.22 57.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.78 0.432 . . . . 0.0 110.081 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 62.6 mt -91.68 156.78 17.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.322 0.649 . . . . 0.0 112.053 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -140.76 137.91 33.75 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 77.7 mt -133.82 141.62 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.135 0.493 . . . . 0.0 111.489 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.75 167.94 27.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.782 1.233 . . . . 0.0 108.232 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -78.41 144.55 35.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.808 -0.558 . . . . 0.0 110.812 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.87 165.68 17.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.508 0.323 . . . . 0.0 110.265 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -81.06 -27.24 0.45 Allowed Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -176.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 46.2 Cg_endo -81.67 178.34 6.67 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.838 1.692 . . . . 0.0 109.913 177.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 69.2 p -105.09 -9.0 18.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.432 0.293 . . . . 0.0 111.089 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.92 168.03 27.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.835 0.854 . . . . 0.0 109.976 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 94.4 mt -127.11 170.43 12.36 Favored 'General case' 0 N--CA 1.459 0.014 0 C-N-CA 123.659 0.784 . . . . 0.0 109.817 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -138.76 163.85 31.1 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.397 0.618 . . . . 0.0 111.673 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 38.7 t -140.51 156.2 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 124.695 1.198 . . . . 0.0 108.555 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -125.61 -21.92 4.37 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.504 0.322 . . . . 0.0 111.678 -174.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -163.6 169.1 19.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.381 1.072 . . . . 0.0 108.91 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -115.71 110.01 18.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.121 0.486 . . . . 0.0 110.438 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -155.32 -170.24 3.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.009 1.323 . . . . 0.0 109.335 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -72.67 -2.51 20.44 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -119.6 -15.82 8.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.893 0.77 . . . . 0.0 112.006 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' THR . . . . . 0.476 ' HG1' HG13 ' A' ' 222' ' ' VAL . 3.7 t -154.76 135.01 13.2 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -157.96 145.25 18.18 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.266 -0.271 . . . . 0.0 110.871 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -129.19 141.14 51.24 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.575 0.703 . . . . 0.0 111.311 171.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -108.58 -9.81 15.29 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.558 0.743 . . . . 0.0 111.816 -174.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 CA--C 1.532 0.26 0 C-N-CA 123.089 0.556 . . . . 0.0 110.23 176.026 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.6 p30 . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 121.112 0.482 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.7 p -97.76 15.89 22.3 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.809 0.843 . . . . 0.0 111.021 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.08 138.74 38.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 C-N-CA 123.615 0.766 . . . . 0.0 110.703 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.0 mt -127.35 159.91 32.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.298 0.57 . . . . 0.0 111.54 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.9 tp -124.2 130.51 52.66 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.017 1.327 . . . . 0.0 107.764 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -115.1 145.03 42.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.401 0.68 . . . . 0.0 109.684 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.9 m -139.44 144.38 38.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.17 136.94 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 75.4 mt -93.77 -34.87 13.03 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -130.09 63.15 67.83 Favored Pre-proline 0 CA--C 1.528 0.114 0 C-N-CA 123.162 0.585 . . . . 0.0 109.951 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.58 101.71 0.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.766 2.31 . . . . 0.0 110.881 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.58 2.5 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 122.774 0.429 . . . . 0.0 111.29 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -134.98 166.89 21.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.814 0.845 . . . . 0.0 109.314 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 33.1 t -78.54 151.44 32.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.794 0.331 . . . . 0.0 110.975 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.1 mm -136.83 137.16 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.6 p -143.52 176.72 8.97 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 123.148 0.579 . . . . 0.0 110.053 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.1 p -62.34 -23.25 66.66 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.696 0.399 . . . . 0.0 111.195 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -82.2 -23.75 35.27 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.84 0.291 . . . . 0.0 111.274 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 83.6 t -83.97 -37.64 13.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.84 -21.52 47.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.039 -0.413 . . . . 0.0 110.848 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -77.6 -34.39 53.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.171 0.441 . . . . 0.0 110.848 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.3 t -76.91 -22.34 53.51 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.268 0.485 . . . . 0.0 111.354 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.2 pt -90.18 -22.44 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.491 0.587 . . . . 0.0 111.791 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.4 m -94.66 -23.07 17.76 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.439 0.563 . . . . 0.0 112.013 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.438 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.3 t-20 -59.75 -44.57 97.54 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 97.2 Cg_endo -72.77 -10.11 24.59 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.863 1.708 . . . . 0.0 111.803 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 74.6 m -93.73 -20.92 19.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.32 0.509 . . . . 0.0 110.95 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 166.35 167.38 26.91 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.12 104.77 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.93 3.087 . . . . 0.0 110.763 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.4 t -78.42 152.0 5.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -115.0 -40.85 3.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.011 0.525 . . . . 0.0 110.828 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.403 HH22 ' CG1' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -163.96 159.51 20.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.53 0.605 . . . . 0.0 112.495 177.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 42.0 mt -142.07 150.64 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 124.104 0.962 . . . . 0.0 110.45 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.403 ' CG1' HH22 ' A' ' 220' ' ' ARG . 7.3 p -141.53 148.62 20.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 C-N-CA 123.739 0.816 . . . . 0.0 109.202 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 38.6 mm . . . . . 0 N--CA 1.456 -0.148 0 C-N-CA 124.035 0.934 . . . . 0.0 110.418 -174.587 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.83 0.348 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.8 167.73 29.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.026 0.531 . . . . 0.0 109.957 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.2 mtp -134.98 142.69 46.53 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.64 151.25 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.16 0.584 . . . . 0.0 110.237 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -135.17 140.79 45.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.44 0.696 . . . . 0.0 109.225 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -118.73 168.02 11.12 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.722 0.809 . . . . 0.0 110.996 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.47 -17.85 61.73 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.88 0.472 . . . . 0.0 111.564 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.0 p -152.37 160.08 43.34 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.626 0.371 . . . . 0.0 110.422 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.74 -28.26 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -64.83 -30.07 71.06 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.925 -0.485 . . . . 0.0 109.877 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 45.0 m -78.24 -28.77 47.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.211 0.204 . . . . 0.0 110.571 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.49 -26.03 38.45 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.212 -0.305 . . . . 0.0 110.639 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -70.56 -36.13 73.46 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -79.77 -24.98 41.15 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.278 -0.264 . . . . 0.0 110.497 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.84 -52.66 40.97 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.162 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -15.49 59.68 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.755 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -80.72 -13.95 58.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.912 0.324 . . . . 0.0 111.721 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.7 m -125.05 1.44 7.95 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.0 mt -129.18 -4.82 4.94 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -77.74 132.73 38.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.8 5.55 64.88 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.218 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.15 179.56 7.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.679 0.74 . . . . 0.0 111.007 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -139.64 163.08 33.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.278 0.631 . . . . 0.0 109.515 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.6 mt . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -176.485 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.927 0.394 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 14.6 m -59.67 138.81 57.63 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.746 0.418 . . . . 0.0 109.917 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 58.4 mt -92.62 155.47 17.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.276 0.631 . . . . 0.0 112.179 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -143.63 123.62 13.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 74.1 mt -123.78 146.3 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.248 0.547 . . . . 0.0 111.682 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.44 169.27 24.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.677 1.191 . . . . 0.0 108.732 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -78.44 145.53 35.01 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.008 -0.433 . . . . 0.0 110.599 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.86 167.85 15.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.328 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -80.06 -29.27 0.55 Allowed Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.8 Cg_endo -82.68 169.44 13.56 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 121.73 1.653 . . . . 0.0 110.093 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.0 p -99.57 -5.93 28.28 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 122.388 -0.195 . . . . 0.0 110.998 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -152.85 157.04 40.13 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 123.836 0.854 . . . . 0.0 110.634 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 80.2 mt -121.99 175.37 6.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.186 0.994 . . . . 0.0 109.308 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -143.95 165.14 28.57 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.483 0.313 . . . . 0.0 110.926 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.2 t -137.6 157.98 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 124.398 1.079 . . . . 0.0 108.925 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -125.03 -31.36 3.12 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 122.263 -0.273 . . . . 0.0 110.923 -174.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.09 167.78 28.34 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.264 1.025 . . . . 0.0 109.291 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -107.66 118.59 37.15 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.121 0.486 . . . . 0.0 111.148 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.97 -171.64 3.47 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.063 1.345 . . . . 0.0 109.251 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -74.5 -3.69 32.3 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -107.67 -23.68 12.02 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.409 0.55 . . . . 0.0 111.115 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.1 t -158.07 141.08 14.95 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -150.71 151.26 32.16 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.304 -0.248 . . . . 0.0 110.873 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -129.18 135.99 49.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.222 0.609 . . . . 0.0 109.403 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.2 6.03 14.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.549 0.74 . . . . 0.0 112.211 -174.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.531 0.224 0 C-N-CA 122.993 0.517 . . . . 0.0 111.211 179.23 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.7 p -88.58 7.6 32.46 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.835 0.454 . . . . 0.0 111.415 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -104.54 138.51 28.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.552 0.741 . . . . 0.0 111.297 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.09 160.64 32.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.544 0.737 . . . . 0.0 111.507 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 64.4 tp -119.71 133.89 55.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.036 1.334 . . . . 0.0 107.862 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -120.12 147.33 45.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.492 0.717 . . . . 0.0 109.861 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 81.5 m -142.09 145.36 34.2 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.4 mp -109.51 135.91 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 64.8 mt -94.85 -28.73 15.07 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -136.15 68.17 62.62 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 123.911 0.884 . . . . 0.0 109.587 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.55 57.41 4.26 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.704 3.603 . . . . 0.0 112.425 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.87 -3.12 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 O-C-N 121.958 -0.464 . . . . 0.0 111.616 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -130.13 166.59 19.91 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.924 0.89 . . . . 0.0 109.442 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 m -74.8 148.52 40.26 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.939 0.399 . . . . 0.0 111.604 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.9 mm -137.73 138.3 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.3 p -145.47 174.98 10.67 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.208 0.603 . . . . 0.0 109.893 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 38.0 p -63.14 -21.24 66.06 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 122.314 -0.241 . . . . 0.0 111.099 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -81.94 -26.18 34.25 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.024 0.375 . . . . 0.0 111.048 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.06 -38.59 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 86.3 mt -76.95 -22.92 52.52 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.921 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -76.3 -36.14 58.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 117.96 0.346 . . . . 0.0 110.785 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.1 t -78.11 -18.68 55.36 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.14 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -95.84 -14.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 118.348 0.522 . . . . 0.0 112.028 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 78.3 m -98.21 -24.36 15.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.869 0.758 . . . . 0.0 112.25 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.422 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 48.6 t30 -64.18 -38.87 38.34 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 86.1 Cg_endo -73.66 -0.05 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.635 1.557 . . . . 0.0 112.159 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 80.6 m -112.62 -5.69 13.97 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.609 0.364 . . . . 0.0 111.625 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 158.8 164.39 14.26 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.98 106.39 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.852 3.035 . . . . 0.0 110.638 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.7 t -78.49 150.63 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -117.03 -36.5 3.79 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.643 0.377 . . . . 0.0 111.279 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -164.12 156.43 17.05 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.101 0.41 . . . . 0.0 111.792 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 40.5 mt -144.77 143.75 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.751 0.821 . . . . 0.0 109.761 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.7 m -138.76 155.97 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 123.359 0.663 . . . . 0.0 109.756 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.7 mm . . . . . 0 C--O 1.231 0.101 0 C-N-CA 123.569 0.747 . . . . 0.0 111.096 -176.293 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.01 171.18 20.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.388 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.6 mtp -135.77 149.38 49.13 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 55.2 t -136.63 150.77 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -139.85 141.33 36.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -118.27 170.47 8.87 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.834 0.853 . . . . 0.0 110.849 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.63 -13.16 59.98 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.549 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 46.1 t -150.53 153.56 36.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.677 0.391 . . . . 0.0 110.416 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.17 -26.5 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -71.04 -24.04 62.27 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 22.5 m -81.34 -27.43 34.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.22 -25.1 36.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.416 0.286 . . . . 0.0 110.457 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -70.56 -37.49 74.01 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -74.93 -29.33 60.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.315 0.246 . . . . 0.0 110.689 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.49 -52.44 45.97 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 119.733 -0.175 . . . . 0.0 111.268 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -12.6 59.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.845 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.52 -10.22 52.32 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.822 0.283 . . . . 0.0 111.601 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 21.4 m -126.33 -1.78 6.93 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.7 mt -130.62 -5.36 4.14 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -78.14 132.71 37.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.38 6.9 71.39 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.46 174.94 11.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.672 0.736 . . . . 0.0 111.061 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -132.65 149.75 52.26 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.1 0.96 . . . . 0.0 108.763 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.4 mt . . . . . 0 CA--C 1.533 0.3 0 CA-C-N 117.433 0.106 . . . . 0.0 111.219 -177.942 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.601 0.239 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.7 m -60.13 139.8 57.29 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.991 0.516 . . . . 0.0 110.223 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 54.3 mt -96.79 156.9 16.15 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.111 0.564 . . . . 0.0 112.282 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -140.52 137.71 34.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 171.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 71.7 mt -136.0 142.33 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.082 0.467 . . . . 0.0 111.308 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.72 167.3 30.07 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.563 1.145 . . . . 0.0 108.54 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -79.01 141.49 37.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.803 -0.561 . . . . 0.0 110.684 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.67 167.9 14.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.423 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -81.26 -27.89 0.46 Allowed Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.2 Cg_endo -82.15 166.86 16.26 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 CA-C-N 121.913 1.719 . . . . 0.0 110.138 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.1 p -99.87 -5.32 28.62 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 122.332 0.253 . . . . 0.0 111.025 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -154.76 151.95 29.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.088 0.955 . . . . 0.0 109.92 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.46 171.41 7.53 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.779 0.832 . . . . 0.0 109.398 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -138.92 159.3 42.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.961 0.504 . . . . 0.0 109.893 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.94 154.02 35.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.912 0.885 . . . . 0.0 109.006 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -123.15 -21.71 5.35 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.672 0.389 . . . . 0.0 111.771 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -166.93 173.11 9.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.311 1.044 . . . . 0.0 109.695 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -116.48 113.51 22.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.073 0.463 . . . . 0.0 110.473 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -157.53 -174.38 4.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.204 1.401 . . . . 0.0 109.243 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -69.79 -4.15 18.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -117.24 -11.76 10.61 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.713 0.688 . . . . 0.0 112.031 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.2 t -158.55 134.25 8.88 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -152.65 150.73 29.79 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 122.087 -0.383 . . . . 0.0 111.055 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -123.24 137.45 54.87 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.247 0.619 . . . . 0.0 109.743 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -119.33 15.95 13.05 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.487 0.715 . . . . 0.0 112.091 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.669 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.8 p30 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.992 0.425 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -90.12 18.08 6.29 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.565 0.746 . . . . 0.0 111.243 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.1 t -116.62 139.62 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.423 0.689 . . . . 0.0 110.325 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.2 mt -128.59 161.86 28.62 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.353 0.597 . . . . 0.0 110.621 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 tt -129.68 136.35 49.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -117.02 148.49 41.44 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.191 0.996 . . . . 0.0 109.903 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 89.8 m -133.28 141.16 47.86 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.21 138.84 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 53.3 mt -108.06 -22.59 12.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -131.47 63.27 69.01 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 123.499 0.719 . . . . 0.0 109.777 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.92 40.04 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 125.104 3.869 . . . . 0.0 112.87 -173.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.4 pt -75.95 -2.91 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.6 -0.688 . . . . 0.0 111.531 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -130.4 165.22 23.02 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.987 0.915 . . . . 0.0 109.516 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 32.4 t -74.74 148.77 40.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.623 0.249 . . . . 0.0 111.487 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.7 mm -137.28 136.48 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 124.462 1.105 . . . . 0.0 108.175 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.0 p -143.97 176.88 8.95 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.138 0.575 . . . . 0.0 109.967 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.2 p -61.92 -22.68 65.8 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.569 0.348 . . . . 0.0 111.011 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.95 -24.61 35.45 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.48 0.312 . . . . 0.0 110.793 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.5 t -83.99 -37.6 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.95 -22.55 53.1 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.656 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -75.8 -36.92 59.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.196 0.453 . . . . 0.0 110.675 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 t -77.93 -18.7 55.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.396 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.94 -15.15 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.894 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.6 m -96.91 -25.42 15.43 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.741 0.701 . . . . 0.0 111.826 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 25.5 t-20 -58.75 -42.57 94.95 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 79.9 Cg_endo -71.26 -2.42 11.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.183 1.922 . . . . 0.0 112.379 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 83.7 m -115.03 -4.75 12.5 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.153 0.433 . . . . 0.0 111.642 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 158.86 158.68 9.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.76 114.59 3.75 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.674 2.916 . . . . 0.0 110.634 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.7 t -85.68 149.39 4.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -112.58 -34.74 5.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.893 0.477 . . . . 0.0 110.943 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -165.36 160.41 18.11 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 111.945 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 41.6 mt -143.48 147.43 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 124.256 1.023 . . . . 0.0 109.487 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.98 145.04 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.062 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.5 mm . . . . . 0 N--CA 1.455 -0.194 0 C-N-CA 123.754 0.822 . . . . 0.0 110.291 -174.137 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.826 0.346 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.65 168.56 26.76 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.62 0.768 . . . . 0.0 109.914 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 85.2 mtp -136.89 151.65 49.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.74 150.27 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.048 0.539 . . . . 0.0 110.062 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -133.08 139.53 47.19 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -114.04 167.38 10.71 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.777 0.831 . . . . 0.0 111.299 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -75.2 -14.13 60.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.9 t -152.06 151.49 31.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.017 0.527 . . . . 0.0 110.08 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.4 p -69.12 -24.05 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.41 -24.81 62.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 26.3 m -81.54 -25.38 35.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.738 0.415 . . . . 0.0 110.612 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.46 -26.4 35.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.64 -36.9 76.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -77.64 -29.33 51.66 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.31 -52.24 55.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 119.647 -0.216 . . . . 0.0 110.97 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -15.07 59.75 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.628 0.649 . . . . 0.0 112.209 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -82.53 -12.7 57.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.986 0.357 . . . . 0.0 111.814 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -128.51 2.53 5.59 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 73.2 mt -129.59 -3.61 4.78 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.791 0.723 . . . . 0.0 112.491 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -78.5 131.53 36.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.24 3.63 76.85 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.75 179.95 5.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.762 0.781 . . . . 0.0 110.7 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.78 162.34 35.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.434 0.694 . . . . 0.0 109.181 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 38.3 mt . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 111.227 0.084 . . . . 0.0 111.227 -176.74 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.512 0.196 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.1 m -55.35 142.12 33.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.41 0.684 . . . . 0.0 109.795 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.0 mt -108.62 153.76 22.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.374 0.669 . . . . 0.0 112.022 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -140.26 135.0 31.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 171.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 79.4 mt -125.81 148.99 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.048 0.451 . . . . 0.0 111.435 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.86 165.97 34.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.034 1.333 . . . . 0.0 108.421 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.73 139.95 38.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.834 -0.541 . . . . 0.0 110.231 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -75.36 167.18 22.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.897 0.479 . . . . 0.0 111.427 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -71.72 -54.78 6.09 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.164 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.66 164.59 31.88 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.336 2.024 . . . . 0.0 111.123 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.0 p -91.74 -6.47 51.86 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.712 0.405 . . . . 0.0 111.576 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.62 167.06 30.81 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.732 0.813 . . . . 0.0 109.878 176.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 86.2 mt -123.54 173.15 8.23 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.517 0.727 . . . . 0.0 109.863 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -136.19 154.53 50.92 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 91.9 t -136.37 153.12 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.876 0.871 . . . . 0.0 108.65 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.72 -18.78 5.09 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -166.06 172.56 11.24 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.931 1.292 . . . . 0.0 109.296 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -119.06 110.63 17.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.01 0.434 . . . . 0.0 110.46 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -154.62 -169.85 3.34 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.796 1.238 . . . . 0.0 109.773 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -70.18 -6.66 35.93 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -114.42 -15.25 12.1 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.782 0.719 . . . . 0.0 112.209 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.2 t -159.02 140.17 12.97 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -154.88 148.32 25.14 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.997 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -128.03 135.7 50.23 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -112.87 5.12 17.26 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.612 0.765 . . . . 0.0 112.031 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 CA--C 1.53 0.19 0 C-N-CA 122.907 0.483 . . . . 0.0 111.55 -179.503 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.846 0.355 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 82.3 p -87.12 13.59 9.13 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.245 0.618 . . . . 0.0 111.842 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.4 t -109.01 138.63 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 122.91 0.484 . . . . 0.0 110.885 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.67 160.83 31.24 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 121.427 0.632 . . . . 0.0 111.459 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.7 tp -125.7 130.29 51.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.94 1.296 . . . . 0.0 108.222 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -115.56 146.91 41.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.566 0.746 . . . . 0.0 109.985 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.4 m -138.43 142.63 39.52 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.7 mp -106.8 136.46 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 73.1 mt -92.4 -34.46 14.14 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -134.02 68.25 74.35 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 123.406 0.682 . . . . 0.0 109.543 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -74.41 62.92 5.4 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.555 3.503 . . . . 0.0 112.427 -174.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 44.8 pt -84.66 -4.85 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 122.024 -0.422 . . . . 0.0 111.289 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -126.85 167.88 15.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.945 0.898 . . . . 0.0 109.27 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 78.1 p -83.26 154.15 24.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.015 0.436 . . . . 0.0 111.21 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.0 mm -136.91 138.3 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.1 p -143.97 176.1 9.54 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.044 0.538 . . . . 0.0 110.018 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.9 p -62.12 -27.47 68.95 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 122.542 0.337 . . . . 0.0 110.966 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -78.03 -20.34 52.65 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.431 0.292 . . . . 0.0 111.495 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.42 -40.68 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 88.5 mt -73.56 -30.67 63.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.175 -0.328 . . . . 0.0 110.924 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -68.87 -37.82 79.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.217 0.462 . . . . 0.0 110.921 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 t -78.58 -17.43 56.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.481 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.35 -9.73 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 18.2 p -119.69 -6.23 10.16 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.347 0.976 . . . . 0.0 113.136 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.461 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.6 t-20 -63.06 -41.12 68.24 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.496 -0.764 . . . . 0.0 113.054 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 96.3 Cg_endo -71.7 -3.03 12.32 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.794 1.663 . . . . 0.0 111.982 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.2 m -93.58 -8.47 41.11 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.096 0.407 . . . . 0.0 111.41 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 144.91 174.58 17.29 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.38 114.91 3.42 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.672 2.915 . . . . 0.0 110.953 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 96.9 t -87.06 150.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -113.9 -37.61 4.45 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -165.17 159.16 17.29 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.518 0.599 . . . . 0.0 112.287 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 48.7 mt -142.83 144.36 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.081 0.953 . . . . 0.0 109.677 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.4 p -143.85 142.71 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 123.486 0.714 . . . . 0.0 109.487 176.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.529 0.143 0 C-N-CA 123.799 0.84 . . . . 0.0 109.649 -177.93 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.913 0.387 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.35 169.28 24.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.024 0.53 . . . . 0.0 109.731 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.0 mtp -137.96 151.71 48.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.1 t -139.3 151.1 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 C-N-CA 122.904 0.482 . . . . 0.0 109.884 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -135.41 141.65 45.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.457 0.703 . . . . 0.0 109.192 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -117.37 168.45 10.34 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.087 0.955 . . . . 0.0 110.761 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.88 -9.98 59.77 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.791 0.437 . . . . 0.0 110.889 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.1 t -150.17 147.67 28.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.103 0.561 . . . . 0.0 109.935 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 -23.3 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -73.2 -23.23 60.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.082 -0.386 . . . . 0.0 110.235 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 42.2 m -80.85 -28.12 36.2 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.82 -25.43 44.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -70.92 -37.96 72.93 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -74.96 -27.61 60.24 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.247 0.619 . . . . 0.0 110.965 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.32 -54.98 10.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.125 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -14.77 60.35 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.356 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -81.52 -16.62 51.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.118 0.417 . . . . 0.0 111.568 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -123.44 4.38 9.04 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.7 mt -121.65 -5.69 9.19 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.856 0.753 . . . . 0.0 112.559 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -74.79 129.93 38.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.943 0.792 . . . . 0.0 109.149 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.43 8.78 76.56 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.13 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.93 174.15 10.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.85 0.825 . . . . 0.0 111.333 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -137.71 145.26 42.33 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.66 0.784 . . . . 0.0 109.185 -177.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 51.8 mt . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -176.534 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 26.9 m -58.61 140.61 54.14 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.738 0.415 . . . . 0.0 109.948 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.4 mt -95.07 154.99 16.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.023 0.44 . . . . 0.0 112.014 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -145.65 134.7 22.67 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.34 150.42 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-O 120.993 0.425 . . . . 0.0 111.247 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -153.75 168.05 27.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.194 1.398 . . . . 0.0 108.364 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.85 144.0 32.33 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 121.74 -0.6 . . . . 0.0 110.994 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.03 170.3 10.46 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.413 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.7 pttt -86.0 -26.21 0.36 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -177.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.4 Cg_endo -82.23 164.63 17.11 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 121.881 1.707 . . . . 0.0 110.406 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 58.4 p -93.45 -9.04 39.88 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 122.265 -0.272 . . . . 0.0 111.564 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.39 168.48 27.21 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.746 0.818 . . . . 0.0 109.711 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 87.7 mt -120.6 170.74 9.13 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.369 0.668 . . . . 0.0 109.685 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -131.1 157.47 43.02 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.449 0.166 . . . . 0.0 110.667 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 87.0 t -137.85 153.93 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 124.08 0.952 . . . . 0.0 108.958 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -128.06 -14.66 4.91 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.294 0.238 . . . . 0.0 111.627 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.466 ' HZ1' HG23 ' A' ' 279' ' ' THR . 21.7 pttp -163.54 170.32 17.43 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.048 0.939 . . . . 0.0 109.237 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.33 99.65 6.83 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -152.96 -169.14 3.25 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.103 0.961 . . . . 0.0 110.102 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -72.27 -1.81 16.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.53 -31.39 8.54 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.183 0.593 . . . . 0.0 110.8 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' THR . . . . . 0.466 HG23 ' HZ1' ' A' ' 274' ' ' LYS . 11.3 t -159.28 147.02 17.43 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 173.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -152.48 146.68 25.46 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.721 0.296 . . . . 0.0 110.705 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -121.28 134.3 55.16 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.956 0.502 . . . . 0.0 109.646 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.99 6.48 19.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.554 0.742 . . . . 0.0 112.449 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 123.15 0.58 . . . . 0.0 110.552 177.691 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.5 p30 . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.9 p -97.46 8.62 44.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.372 0.669 . . . . 0.0 111.975 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.96 143.37 18.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 123.055 0.542 . . . . 0.0 110.86 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.0 mt -129.0 163.54 25.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.073 0.549 . . . . 0.0 111.663 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.7 tp -123.24 133.38 54.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.654 1.182 . . . . 0.0 108.179 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -120.24 143.62 48.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.675 0.79 . . . . 0.0 109.383 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 97.4 m -139.51 143.55 37.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.35 135.38 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.8 mt -90.39 -36.52 14.56 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -131.93 64.27 71.84 Favored Pre-proline 0 CA--C 1.529 0.135 0 C-N-CA 123.379 0.672 . . . . 0.0 109.922 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.6 102.91 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.608 2.205 . . . . 0.0 111.135 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.4 pt -129.58 2.7 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 122.996 0.518 . . . . 0.0 111.401 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -130.6 169.58 15.42 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.791 0.836 . . . . 0.0 109.492 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.5 m -77.58 145.86 36.58 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.5 mm -137.18 133.89 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 61.7 p -142.58 175.55 9.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.8 p -64.37 -20.48 66.15 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 122.296 0.239 . . . . 0.0 111.206 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.7 -25.34 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 122.283 0.233 . . . . 0.0 110.587 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.7 t -82.42 -36.87 13.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.7 -25.43 53.59 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.122 -0.362 . . . . 0.0 110.781 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -78.39 -34.5 48.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.023 -0.423 . . . . 0.0 111.057 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -74.9 -23.46 58.37 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.563 0.62 . . . . 0.0 111.389 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.6 pt -88.73 -23.17 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.176 0.444 . . . . 0.0 111.723 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.9 m -95.58 -20.15 19.22 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.618 0.645 . . . . 0.0 112.483 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.43 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.41 -43.79 90.48 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 87.8 Cg_endo -73.94 -9.63 22.4 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.887 1.724 . . . . 0.0 111.651 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 82.3 m -91.98 -21.56 20.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.023 0.374 . . . . 0.0 111.207 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.15 172.45 30.65 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.57 105.14 1.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 124.122 3.215 . . . . 0.0 110.549 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 94.0 t -78.32 150.14 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -113.53 -41.09 3.69 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.778 0.431 . . . . 0.0 110.876 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.73 163.34 32.4 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.177 0.444 . . . . 0.0 111.472 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.43 146.9 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.534 0.734 . . . . 0.0 109.903 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.24 147.6 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 54.3 mt . . . . . 0 N--CA 1.456 -0.172 0 C-N-CA 123.348 0.659 . . . . 0.0 110.085 -174.208 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--O 1.23 0.061 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.4 171.9 19.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.552 0.215 . . . . 0.0 110.876 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.1 mtp -142.28 150.38 40.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 49.0 t -139.25 151.37 23.04 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.987 0.515 . . . . 0.0 109.719 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -136.2 141.32 44.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.144 0.577 . . . . 0.0 109.497 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -116.31 168.84 9.78 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.905 0.882 . . . . 0.0 110.983 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.55 -14.16 60.76 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.831 0.452 . . . . 0.0 111.22 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 48.4 t -152.7 153.54 33.47 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.878 0.471 . . . . 0.0 110.378 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.09 -25.71 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.57 -29.4 68.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.012 0.369 . . . . 0.0 110.056 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 20.8 m -79.24 -27.58 42.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.541 0.336 . . . . 0.0 110.65 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.4 -27.45 38.1 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -68.01 -37.24 81.2 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -78.46 -25.68 45.9 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.344 0.257 . . . . 0.0 110.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.93 -55.39 17.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.343 0.257 . . . . 0.0 110.807 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -16.36 60.51 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.566 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -78.43 -14.65 59.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.189 0.45 . . . . 0.0 111.643 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 55.6 m -125.07 1.56 7.94 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.56 -5.17 4.72 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -78.22 132.79 37.7 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.917 0.781 . . . . 0.0 109.124 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.33 6.66 70.42 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.48 176.6 7.39 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.715 0.758 . . . . 0.0 111.343 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -139.6 151.07 45.72 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.707 0.803 . . . . 0.0 109.13 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.1 mt . . . . . 0 CA--C 1.535 0.368 0 C-N-CA 122.405 0.282 . . . . 0.0 111.296 -175.688 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.7 m -60.27 141.68 55.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.244 0.618 . . . . 0.0 109.87 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.42 155.41 16.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -144.51 124.78 13.76 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.41 147.38 28.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 CA-C-O 121.163 0.506 . . . . 0.0 111.542 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.56 171.01 20.66 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.718 1.207 . . . . 0.0 108.762 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -80.99 143.98 32.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 122.051 -0.405 . . . . 0.0 110.45 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.3 167.2 15.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.319 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.44 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -83.46 -26.56 0.4 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -176.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 48.2 Cg_endo -80.95 -176.7 3.29 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.952 1.768 . . . . 0.0 109.9 176.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 67.2 p -117.77 -0.75 11.71 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.749 0.42 . . . . 0.0 110.89 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -155.16 146.05 22.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.912 0.885 . . . . 0.0 109.255 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.9 mt -112.35 167.55 10.34 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.246 0.619 . . . . 0.0 110.01 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -129.62 166.74 19.15 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.49 0.316 . . . . 0.0 110.813 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.73 155.71 22.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.223 1.009 . . . . 0.0 109.023 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -130.47 -16.74 3.41 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.368 0.267 . . . . 0.0 111.563 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -165.84 174.38 9.66 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.182 0.993 . . . . 0.0 109.516 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -120.35 96.69 5.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -148.35 -166.01 2.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.929 0.892 . . . . 0.0 110.126 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -73.36 -3.0 24.51 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -112.48 -21.88 11.11 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.813 0.733 . . . . 0.0 111.749 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.2 t -159.9 144.97 15.17 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -151.86 153.3 33.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.91 138.75 51.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 110.393 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -116.4 7.19 13.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.556 0.742 . . . . 0.0 112.331 -174.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 CA--C 1.531 0.225 0 C-N-CA 122.875 0.47 . . . . 0.0 110.517 176.393 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 85.8 p -86.31 13.97 7.29 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.147 0.579 . . . . 0.0 112.264 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.75 138.91 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 123.002 0.521 . . . . 0.0 110.712 -176.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.8 mt -129.56 162.45 28.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.416 0.627 . . . . 0.0 111.246 -177.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.1 tp -122.43 133.09 54.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.935 1.294 . . . . 0.0 107.994 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -118.8 145.42 45.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.677 0.791 . . . . 0.0 109.827 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 96.2 m -136.19 141.75 44.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.9 mp -107.27 133.23 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 66.3 mt -92.69 -29.51 16.04 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -137.89 69.35 50.7 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 123.557 0.743 . . . . 0.0 109.586 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.4 56.16 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.529 3.486 . . . . 0.0 112.047 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.8 pt -81.04 -1.53 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 122.03 -0.419 . . . . 0.0 111.603 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -128.85 167.24 17.64 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.683 0.793 . . . . 0.0 109.685 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.1 m -75.84 149.78 37.8 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 111.539 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.4 mm -137.49 137.57 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 81.0 p -145.27 175.49 10.24 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.385 0.674 . . . . 0.0 109.782 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.2 p -63.64 -22.82 67.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 119.673 -0.203 . . . . 0.0 111.049 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -79.0 -23.87 44.09 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.298 0.239 . . . . 0.0 111.129 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 88.1 t -86.33 -39.11 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.92 -22.8 58.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.11 -0.369 . . . . 0.0 110.94 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -78.89 -36.11 42.6 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.885 0.311 . . . . 0.0 111.144 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.9 t -74.94 -20.47 59.67 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.89 -0.506 . . . . 0.0 111.327 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.2 pt -92.04 -21.54 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.7 m -97.85 -23.67 15.76 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.798 0.726 . . . . 0.0 112.899 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.44 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 51.1 t30 -65.21 -40.78 47.5 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 98.3 Cg_endo -72.91 -8.96 23.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.424 1.416 . . . . 0.0 111.684 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 77.5 m -97.81 -12.69 21.91 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.707 0.403 . . . . 0.0 111.17 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 161.65 162.06 12.57 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.28 110.73 2.09 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.654 2.903 . . . . 0.0 110.581 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.7 149.79 4.37 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -115.0 -34.75 4.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.847 0.459 . . . . 0.0 110.901 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -164.32 159.49 19.9 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.3 144.65 23.42 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 124.098 0.959 . . . . 0.0 109.644 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.02 142.96 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.288 0.635 . . . . 0.0 109.472 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.53 0.205 0 C-N-CA 123.905 0.882 . . . . 0.0 109.756 -179.372 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.957 0.408 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.53 167.05 31.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.6 mtp -134.38 150.94 50.94 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.35 149.36 22.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.643 0.377 . . . . 0.0 110.194 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -131.52 140.73 49.58 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -116.27 167.91 10.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.872 0.869 . . . . 0.0 110.648 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -72.31 -18.84 61.75 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.686 0.394 . . . . 0.0 111.611 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 85.1 p -151.64 159.86 43.87 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.913 0.485 . . . . 0.0 110.473 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.7 -28.78 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 O-C-N 122.18 -0.325 . . . . 0.0 110.386 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -69.3 -25.07 64.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.035 0.38 . . . . 0.0 110.394 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 59.6 m -78.37 -29.39 47.39 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.45 -24.5 42.38 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.396 -0.19 . . . . 0.0 110.941 176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -70.86 -36.63 72.93 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -78.51 -27.16 46.04 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 122.153 -0.342 . . . . 0.0 110.578 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.39 -52.71 51.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.174 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -17.37 60.0 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.838 0.744 . . . . 0.0 111.74 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -82.46 -9.61 59.36 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.934 0.334 . . . . 0.0 111.547 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.2 m -124.93 -2.3 7.75 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 79.9 mt -131.11 -4.58 3.91 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.697 0.68 . . . . 0.0 112.823 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -75.76 132.81 40.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 118.953 0.797 . . . . 0.0 109.13 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.78 5.24 68.68 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 119.794 -0.448 . . . . 0.0 112.331 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.93 175.44 10.04 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.712 0.756 . . . . 0.0 111.506 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -132.64 145.07 50.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.2 mt . . . . . 0 CA--C 1.531 0.221 0 O-C-N 122.491 -0.131 . . . . 0.0 111.348 -177.166 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.534 0.207 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.2 m -59.89 142.95 52.66 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 122.821 0.448 . . . . 0.0 110.043 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 56.1 mt -103.53 157.33 17.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.259 0.552 . . . . 0.0 112.232 -174.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -144.36 134.68 24.42 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 88.0 mt -127.96 148.96 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.306 0.574 . . . . 0.0 111.543 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.08 171.37 20.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.969 1.308 . . . . 0.0 108.374 172.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -84.14 144.35 29.07 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.943 -0.473 . . . . 0.0 110.775 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.06 168.43 11.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.345 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -84.26 -27.35 0.4 Allowed Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -176.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 44.9 Cg_endo -81.91 167.38 16.39 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 CA-C-N 121.752 1.661 . . . . 0.0 110.4 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 45.3 p -96.68 -9.11 29.83 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.28 0.232 . . . . 0.0 111.286 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 170.29 22.31 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.711 0.804 . . . . 0.0 109.617 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 91.6 mt -124.23 167.93 13.63 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.924 0.49 . . . . 0.0 110.758 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -123.58 158.55 31.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 5.6 t -131.87 -24.78 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 122.309 0.244 . . . . 0.0 111.518 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 62.89 -37.05 0.14 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.185 1.794 . . . . 0.0 115.055 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -164.64 177.87 7.74 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.787 0.835 . . . . 0.0 110.446 -174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -118.85 113.14 20.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -155.2 -174.66 5.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.699 1.199 . . . . 0.0 109.87 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -70.94 -3.82 21.32 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -113.17 -16.88 12.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.619 0.645 . . . . 0.0 111.438 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 14.6 t -156.98 132.42 9.23 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 12.6 t-105 -147.01 149.82 33.89 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 122.071 -0.393 . . . . 0.0 111.299 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -126.22 137.65 53.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.3 0.64 . . . . 0.0 109.677 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -115.87 4.28 13.87 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.619 0.768 . . . . 0.0 112.464 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 CA--C 1.531 0.239 0 C-N-CA 123.013 0.525 . . . . 0.0 111.707 -179.092 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.4 p -89.16 13.3 13.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.431 0.693 . . . . 0.0 111.607 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 31.3 t -112.73 139.92 35.26 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 123.271 0.628 . . . . 0.0 110.962 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.0 mt -130.32 163.63 26.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.375 0.607 . . . . 0.0 111.279 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.2 tp -124.98 133.47 53.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.842 1.257 . . . . 0.0 107.962 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -119.37 142.95 47.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.743 0.817 . . . . 0.0 110.106 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 88.4 m -137.67 143.85 41.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.51 137.99 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.8 mt -92.09 -35.46 13.89 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -133.0 68.73 78.81 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.801 0.84 . . . . 0.0 109.428 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.29 67.62 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.321 3.347 . . . . 0.0 112.109 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.1 pt -88.07 -4.34 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 122.079 -0.388 . . . . 0.0 111.128 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -128.18 169.27 14.32 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.02 0.928 . . . . 0.0 109.239 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 79.8 p -85.04 155.26 21.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.832 0.349 . . . . 0.0 111.487 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mm -135.66 138.18 48.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.3 p -143.27 174.39 10.76 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.956 0.502 . . . . 0.0 110.146 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 39.6 p -62.24 -25.2 67.69 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.415 0.286 . . . . 0.0 111.061 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -78.71 -24.36 45.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.349 0.26 . . . . 0.0 111.185 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.6 t -84.29 -38.34 13.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.83 -23.39 52.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.226 -0.296 . . . . 0.0 110.977 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -79.39 -33.85 42.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.271 0.487 . . . . 0.0 111.079 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -76.64 -20.92 56.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.219 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.3 pt -91.58 -22.35 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 118.251 0.478 . . . . 0.0 111.707 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.5 m -94.83 -19.53 20.24 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.39 0.541 . . . . 0.0 112.271 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.429 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.8 t-20 -59.8 -43.69 95.54 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 90.6 Cg_endo -71.56 -5.98 18.19 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.875 1.717 . . . . 0.0 112.22 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 86.1 m -96.13 -5.89 39.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.079 0.399 . . . . 0.0 111.134 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 137.44 174.24 13.26 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.8 119.25 6.26 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.711 2.941 . . . . 0.0 111.263 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.16 151.85 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -113.29 -36.46 5.0 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.101 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -165.3 160.24 18.08 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.198 0.453 . . . . 0.0 111.966 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 48.7 mt -143.0 147.54 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.971 0.908 . . . . 0.0 109.321 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.24 144.47 18.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 123.103 0.561 . . . . 0.0 109.795 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.53 0.209 0 C-N-CA 123.797 0.839 . . . . 0.0 109.969 -178.24 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.955 0.407 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -158.32 169.09 25.26 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.125 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.8 mtp -137.12 150.77 48.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.02 149.83 24.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -132.23 140.84 48.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -117.04 169.05 9.72 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.907 0.883 . . . . 0.0 110.849 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -77.81 -13.85 59.76 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.059 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 95.6 p -151.93 157.33 41.64 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.986 0.422 . . . . 0.0 110.839 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.72 -25.03 27.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.159 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -67.3 -29.99 69.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.124 -0.36 . . . . 0.0 110.344 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 50.2 m -79.41 -28.14 41.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.34 -26.68 42.09 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -70.05 -36.43 74.99 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -77.39 -27.47 52.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.457 -0.152 . . . . 0.0 110.631 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.02 -51.82 50.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.279 -0.263 . . . . 0.0 111.277 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -13.93 60.13 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.516 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -86.78 -10.05 54.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.889 0.313 . . . . 0.0 111.495 176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.3 m -124.48 -2.05 8.0 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 88.1 mt -129.85 -5.22 4.56 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -77.35 130.69 37.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.975 0.807 . . . . 0.0 109.058 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.29 7.38 72.17 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.57 175.57 9.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.727 0.764 . . . . 0.0 111.568 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -137.3 144.88 42.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.96 0.904 . . . . 0.0 108.963 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.5 mt . . . . . 0 CA--C 1.534 0.329 0 C-N-CA 122.546 0.338 . . . . 0.0 111.603 -175.814 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.6 m -59.12 140.49 55.79 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.852 0.461 . . . . 0.0 109.849 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.3 mt -94.31 154.79 17.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.202 0.525 . . . . 0.0 112.162 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -145.14 132.76 20.93 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 84.4 mt -132.7 147.94 31.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.247 0.546 . . . . 0.0 112.29 -172.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.36 172.87 15.8 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.869 1.268 . . . . 0.0 108.8 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -84.41 142.28 30.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.22 -0.3 . . . . 0.0 110.598 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.87 169.59 12.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.44 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -85.78 -26.97 0.37 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.0 Cg_endo -82.62 164.91 16.16 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.01 1.807 . . . . 0.0 110.261 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.5 p -94.1 -7.84 41.33 Favored 'General case' 0 CA--C 1.527 0.065 0 O-C-N 122.325 -0.234 . . . . 0.0 111.396 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.85 169.13 25.47 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.835 0.854 . . . . 0.0 109.809 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 85.9 mt -121.06 173.18 7.43 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.461 0.705 . . . . 0.0 110.08 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -129.42 157.37 42.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.601 0.36 . . . . 0.0 110.485 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.9 t -138.36 152.33 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 C-N-CA 124.118 0.967 . . . . 0.0 108.866 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -125.84 -14.8 6.09 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.394 0.278 . . . . 0.0 111.627 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -164.68 173.92 11.35 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.286 1.034 . . . . 0.0 109.885 -176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -119.95 98.24 6.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -150.58 -168.79 3.21 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.868 0.867 . . . . 0.0 110.311 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -71.77 -4.11 25.9 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -110.88 -24.65 10.28 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.673 0.67 . . . . 0.0 111.753 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.8 t -157.63 144.57 18.15 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 173.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -152.76 147.99 26.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.172 0.189 . . . . 0.0 110.522 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -122.17 134.84 54.72 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.73 8.53 17.51 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.702 0.801 . . . . 0.0 112.17 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 123.289 0.636 . . . . 0.0 110.532 178.001 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 44.3 p30 . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.7 p -96.64 15.39 21.87 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.216 0.606 . . . . 0.0 112.082 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.34 143.53 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 123.038 0.535 . . . . 0.0 111.022 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.7 mt -129.13 166.13 19.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.182 0.593 . . . . 0.0 111.325 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.6 tp -124.95 133.95 52.83 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.823 1.249 . . . . 0.0 107.999 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -120.12 147.71 44.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.832 0.853 . . . . 0.0 109.889 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.8 m -136.82 139.11 41.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.5 mp -103.47 135.69 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 50.4 mt -102.5 -17.07 15.93 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -139.13 66.55 38.69 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 123.657 0.783 . . . . 0.0 109.362 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.24 40.58 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 124.903 3.735 . . . . 0.0 112.069 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 32.9 pt -77.66 -1.58 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 O-C-N 121.944 -0.473 . . . . 0.0 111.791 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -132.11 165.89 23.01 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.131 0.972 . . . . 0.0 109.216 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.9 m -73.98 149.6 41.22 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.758 0.313 . . . . 0.0 111.303 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.5 mm -136.54 137.98 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.7 p -145.33 175.33 10.38 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.287 0.635 . . . . 0.0 109.77 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.0 p -63.0 -23.1 67.3 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 122.423 0.289 . . . . 0.0 111.199 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.24 -26.68 35.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.311 -0.243 . . . . 0.0 111.205 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 89.8 t -81.86 -36.78 14.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.8 mt -76.9 -24.16 52.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 122.378 -0.201 . . . . 0.0 110.528 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -76.83 -36.15 57.06 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.851 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -77.52 -20.06 54.83 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.344 0.52 . . . . 0.0 111.544 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -93.27 -15.47 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 118.331 0.514 . . . . 0.0 111.653 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 67.5 m -98.52 -21.68 16.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.642 0.655 . . . . 0.0 111.924 176.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.439 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.9 t-20 -58.82 -43.4 97.69 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 96.6 Cg_endo -72.31 -8.83 23.39 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.004 1.803 . . . . 0.0 112.012 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 70.7 m -96.21 -21.0 18.15 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.912 0.324 . . . . 0.0 111.151 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.63 168.09 25.1 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.91 112.58 3.14 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.757 2.971 . . . . 0.0 110.895 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.99 151.48 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 123.286 0.634 . . . . 0.0 109.395 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -116.42 -36.05 4.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.0 0.52 . . . . 0.0 110.788 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -163.17 157.81 20.97 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 112.413 0.524 . . . . 0.0 112.413 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.7 mt -143.67 146.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.243 1.017 . . . . 0.0 109.443 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.0 p -146.4 143.59 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.307 0.643 . . . . 0.0 109.61 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.529 0.166 0 C-N-CA 123.743 0.817 . . . . 0.0 110.016 -178.286 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.805 0.336 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.98 169.5 24.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.865 0.466 . . . . 0.0 109.95 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.4 mtp -134.65 149.85 50.58 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.41 149.84 25.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -135.72 140.16 44.19 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.594 0.757 . . . . 0.0 109.434 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -118.58 167.97 11.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.897 0.879 . . . . 0.0 110.837 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -14.35 60.08 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.722 0.409 . . . . 0.0 111.493 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.1 t -149.97 150.39 31.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.061 0.544 . . . . 0.0 109.72 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.56 -25.93 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -66.77 -26.99 67.23 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.7 m -82.43 -25.49 33.59 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.82 -26.81 40.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -69.72 -36.46 75.9 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -79.14 -24.54 43.24 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.332 -0.23 . . . . 0.0 110.849 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.25 -53.38 30.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.305 -0.247 . . . . 0.0 111.06 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -16.05 59.95 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.734 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.37 -9.89 58.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.032 0.378 . . . . 0.0 111.781 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 16.7 t -124.61 -5.38 7.61 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.6 mt -126.95 -4.96 6.27 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -76.88 131.25 38.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.94 4.76 78.26 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.15 -178.41 5.6 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.398 0.599 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -141.55 163.57 32.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.988 0.915 . . . . 0.0 109.145 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 39.1 mt . . . . . 0 CA--C 1.532 0.28 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.214 -178.877 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 96.2 m . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.972 0.415 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 8.7 m -55.62 138.2 47.54 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.396 0.679 . . . . 0.0 109.936 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 64.6 mt -102.65 154.0 19.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.073 0.549 . . . . 0.0 111.872 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -144.81 129.93 18.54 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 78.7 mt -128.87 147.08 33.31 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-O 121.347 0.594 . . . . 0.0 112.175 -170.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.51 173.41 15.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.891 1.277 . . . . 0.0 108.74 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -84.33 145.25 28.35 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 121.61 -0.681 . . . . 0.0 110.749 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.3 167.57 13.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.685 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 22.0 ptmt -82.38 -27.09 0.42 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 47.2 Cg_endo -84.31 -177.84 3.16 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.959 1.772 . . . . 0.0 110.065 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.9 p -111.36 -9.79 14.25 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.494 0.318 . . . . 0.0 111.337 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.36 137.35 13.56 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 63.5 mt -88.02 172.79 9.29 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 123.088 0.555 . . . . 0.0 110.726 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -132.34 149.36 52.37 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.324 -0.235 . . . . 0.0 111.008 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 72.5 t -138.6 151.34 24.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 124.298 1.039 . . . . 0.0 108.484 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -124.44 -23.67 4.4 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 177.21 9.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.575 1.15 . . . . 0.0 108.834 176.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -110.76 110.16 20.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.651 0.381 . . . . 0.0 110.113 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -152.79 -175.02 5.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.237 1.015 . . . . 0.0 109.545 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -72.53 -1.72 17.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -117.38 -20.42 9.13 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 118.503 0.592 . . . . 0.0 111.775 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.9 t -154.13 137.87 16.14 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -159.25 146.67 17.26 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 122.381 -0.199 . . . . 0.0 110.517 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -129.79 139.23 51.3 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.628 0.728 . . . . 0.0 111.38 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -104.69 -6.94 19.94 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.741 0.816 . . . . 0.0 111.526 -173.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 123.217 0.607 . . . . 0.0 109.857 173.207 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 35.6 p30 . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.6 p -93.44 18.63 9.49 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.659 0.783 . . . . 0.0 112.048 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.17 145.09 30.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 122.939 0.496 . . . . 0.0 110.817 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.6 mt -131.08 163.24 28.08 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.305 0.574 . . . . 0.0 111.5 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 62.3 tp -122.73 132.36 54.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.663 1.185 . . . . 0.0 108.302 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -117.75 146.33 43.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.587 0.755 . . . . 0.0 109.685 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 97.0 m -138.2 143.34 40.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.67 137.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.22 -35.91 10.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -173.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -129.9 63.94 70.32 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.997 0.519 . . . . 0.0 110.346 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.47 100.41 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.167 2.578 . . . . 0.0 111.152 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.2 pt -122.17 3.11 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 122.874 0.469 . . . . 0.0 110.878 173.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -138.24 164.85 28.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.21 1.004 . . . . 0.0 109.097 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 80.3 p -79.21 156.6 28.09 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.902 0.382 . . . . 0.0 111.324 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.5 mm -135.86 137.95 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.1 p -144.44 175.41 10.14 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.137 0.575 . . . . 0.0 110.285 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.4 p -60.36 -26.45 66.63 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.973 0.509 . . . . 0.0 111.092 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.75 -21.3 44.63 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.506 0.322 . . . . 0.0 111.175 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.77 -37.86 10.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.21 -24.03 54.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.128 -0.357 . . . . 0.0 110.906 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -79.64 -33.06 41.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.95 -0.469 . . . . 0.0 111.111 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -77.09 -23.63 51.89 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-N 118.451 0.569 . . . . 0.0 111.369 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 39.1 pt -88.51 -22.25 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 118.258 0.481 . . . . 0.0 111.732 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 93.7 m -95.55 -21.94 17.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.546 0.612 . . . . 0.0 112.414 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.442 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.3 t-20 -60.33 -44.49 96.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 93.2 Cg_endo -72.89 -10.83 25.22 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.181 1.921 . . . . 0.0 111.727 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.7 m -94.04 -20.65 19.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.14 0.427 . . . . 0.0 110.931 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.67 168.36 27.7 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.08 105.84 1.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.659 2.906 . . . . 0.0 110.685 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.9 t -78.51 151.3 5.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -116.14 -37.66 3.77 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.705 0.402 . . . . 0.0 110.728 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -162.74 159.49 24.27 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 117.804 0.275 . . . . 0.0 111.474 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 50.5 mt -143.07 145.07 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 124.099 0.959 . . . . 0.0 110.319 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.483 HG13 ' HG1' ' A' ' 279' ' ' THR . 33.4 m -137.83 149.69 25.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 123.587 0.755 . . . . 0.0 109.33 173.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 123.259 0.624 . . . . 0.0 109.789 -178.227 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 . . . . . 0 N--CA 1.458 -0.041 0 CA-C-O 120.678 0.275 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.64 169.82 21.75 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.993 0.517 . . . . 0.0 110.446 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.1 mtp -140.09 150.46 44.34 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.9 t -137.88 150.97 25.21 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 122.64 0.376 . . . . 0.0 110.04 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -133.4 140.85 47.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.366 0.667 . . . . 0.0 109.572 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.11 171.29 8.38 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.873 0.869 . . . . 0.0 110.774 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.14 -16.56 61.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.763 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 60.0 p -154.02 163.31 40.29 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.219 0.533 . . . . 0.0 110.829 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.72 -25.52 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.354 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -71.1 -27.58 63.71 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.199 0.454 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 m -77.81 -28.98 50.51 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.76 -24.69 41.37 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.446 -0.159 . . . . 0.0 110.759 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -70.35 -36.51 74.25 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -80.24 -25.69 39.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.439 -0.163 . . . . 0.0 110.732 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.52 -50.32 63.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.038 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.27 -15.74 59.31 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.693 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.21 -10.42 58.59 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.905 0.32 . . . . 0.0 111.401 176.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.6 m -123.2 -3.22 8.51 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.58 -4.26 4.2 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -79.03 131.51 36.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.42 5.46 63.29 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.586 -0.605 . . . . 0.0 111.586 -176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.44 178.64 8.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.863 0.832 . . . . 0.0 111.093 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -141.17 160.05 40.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.613 0.765 . . . . 0.0 109.372 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.8 mt . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.071 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.362 0.125 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.9 m -58.44 140.41 53.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.321 0.648 . . . . 0.0 110.335 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 56.9 mt -98.0 155.17 17.23 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.115 0.566 . . . . 0.0 111.712 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -142.15 132.52 25.04 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 83.2 mt -129.38 145.67 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-O 121.17 0.51 . . . . 0.0 111.849 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.27 168.21 26.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.94 1.296 . . . . 0.0 108.3 173.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -78.01 141.54 38.85 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.868 -0.52 . . . . 0.0 110.497 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -80.8 166.24 21.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.6 pttt -81.72 -27.42 0.44 Allowed Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 49.1 Cg_endo -81.33 178.48 6.7 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.891 1.727 . . . . 0.0 109.797 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 63.5 p -104.51 -7.65 19.62 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 122.109 0.164 . . . . 0.0 111.18 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 167.72 28.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.319 0.647 . . . . 0.0 110.449 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.59 170.18 12.33 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.942 0.897 . . . . 0.0 109.425 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -143.13 163.21 33.49 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.502 0.191 . . . . 0.0 110.788 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.6 156.42 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 124.214 1.006 . . . . 0.0 109.103 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -126.1 -18.88 4.9 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.775 0.43 . . . . 0.0 111.621 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -166.09 169.24 14.71 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.042 0.937 . . . . 0.0 109.297 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -117.56 109.36 16.61 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.055 0.455 . . . . 0.0 110.54 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -155.47 -167.21 2.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.718 1.207 . . . . 0.0 109.898 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -73.44 -5.72 41.74 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.47 -15.98 12.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.672 0.669 . . . . 0.0 111.54 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' THR . . . . . 0.483 ' HG1' HG13 ' A' ' 222' ' ' VAL . 3.0 t -159.08 139.44 12.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -154.07 148.03 25.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.139 -0.351 . . . . 0.0 110.792 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.86 135.39 54.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.903 0.481 . . . . 0.0 110.017 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -115.73 9.1 15.09 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.56 0.744 . . . . 0.0 112.132 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.533 0.319 0 C-N-CA 123.234 0.614 . . . . 0.0 110.765 177.721 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.7 p30 . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.545 0.212 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -91.51 10.09 29.3 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.222 0.609 . . . . 0.0 111.587 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.5 t -106.04 137.94 33.78 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 C-N-CA 123.248 0.619 . . . . 0.0 110.589 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.3 mt -126.47 159.96 31.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.623 0.725 . . . . 0.0 111.572 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.0 tp -118.7 132.39 56.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.037 1.335 . . . . 0.0 108.15 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -118.37 141.66 48.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.302 0.641 . . . . 0.0 109.713 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 92.5 m -137.21 141.1 42.1 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.6 mp -104.26 136.21 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.46 -34.61 12.66 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -130.4 62.27 63.62 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.492 0.717 . . . . 0.0 110.041 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.33 101.79 0.89 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.781 2.32 . . . . 0.0 111.021 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.4 pt -127.0 2.31 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 122.878 0.471 . . . . 0.0 111.227 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -132.11 166.58 21.46 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.879 0.872 . . . . 0.0 109.405 177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.9 m -75.11 150.6 38.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.367 0.267 . . . . 0.0 111.346 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.6 mm -138.37 136.67 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 80.7 p -144.94 174.27 11.16 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.435 0.694 . . . . 0.0 109.853 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.7 p -62.17 -24.85 67.44 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.191 0.196 . . . . 0.0 111.142 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.16 -24.9 47.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.789 0.268 . . . . 0.0 111.154 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.77 -37.48 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.92 -23.45 52.48 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.381 -0.199 . . . . 0.0 110.753 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -79.87 -33.96 39.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.887 0.312 . . . . 0.0 110.957 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 t -75.54 -22.47 57.04 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 118.467 0.576 . . . . 0.0 110.935 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.9 pt -89.7 -22.09 6.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.157 0.435 . . . . 0.0 111.899 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.4 m -95.72 -20.13 19.14 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.403 0.547 . . . . 0.0 112.355 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.45 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.8 t-20 -60.88 -42.76 88.83 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 84.4 Cg_endo -72.1 -10.71 26.33 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.876 1.717 . . . . 0.0 111.795 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.8 m -91.22 -20.68 21.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.933 0.333 . . . . 0.0 110.888 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.52 171.35 25.25 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.74 111.95 2.94 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.676 2.917 . . . . 0.0 110.948 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.8 t -84.41 150.6 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -113.89 -37.3 4.54 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.119 0.567 . . . . 0.0 111.125 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -164.08 158.37 19.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.723 0.692 . . . . 0.0 112.351 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.2 mt -144.32 147.28 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.956 0.902 . . . . 0.0 109.529 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.04 144.02 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.262 0.625 . . . . 0.0 109.503 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.529 0.159 0 C-N-CA 123.861 0.864 . . . . 0.0 109.907 -178.05 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.872 0.368 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.44 173.24 17.2 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.669 0.388 . . . . 0.0 110.278 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.5 mtp -137.51 150.25 47.4 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.92 151.34 25.44 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -138.73 141.75 38.89 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.195 0.598 . . . . 0.0 109.407 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -118.26 168.15 10.87 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.808 0.843 . . . . 0.0 110.805 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -76.67 -11.12 59.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.94 0.496 . . . . 0.0 111.527 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.0 t -151.67 150.18 29.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.157 0.583 . . . . 0.0 109.745 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.03 -23.64 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.05 -25.23 62.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 38.2 m -80.59 -26.31 37.94 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.09 -26.99 35.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.168 0.187 . . . . 0.0 110.521 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -68.06 -36.89 80.6 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.3 ttt-85 -78.62 -25.98 45.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.406 -0.184 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -68.4 -48.42 64.71 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.419 -0.324 . . . . 0.0 111.262 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -13.26 59.92 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.534 0.606 . . . . 0.0 111.532 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.42 -9.67 54.05 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.543 -0.265 . . . . 0.0 111.6 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -123.87 -3.46 8.17 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.7 mt -129.99 -4.31 4.52 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -76.52 133.17 39.83 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 119.072 0.851 . . . . 0.0 109.134 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.59 5.89 69.65 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.803 -0.443 . . . . 0.0 112.327 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.31 174.74 11.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.689 0.744 . . . . 0.0 111.134 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -132.67 144.32 50.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.9 mt . . . . . 0 CA--C 1.53 0.208 0 O-C-N 122.293 -0.254 . . . . 0.0 111.052 -177.269 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.543 0.211 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.8 m -59.82 142.58 53.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.939 0.495 . . . . 0.0 110.117 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 55.0 mt -100.58 154.56 18.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.365 0.602 . . . . 0.0 112.608 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -139.02 137.56 36.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 74.8 mt -134.5 142.68 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 111.382 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.07 167.83 28.49 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.468 1.107 . . . . 0.0 108.526 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.0 144.0 37.07 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.883 -0.511 . . . . 0.0 110.613 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.95 169.79 10.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.659 0.384 . . . . 0.0 110.926 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.1 pttt -84.55 -26.97 0.39 Allowed Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -176.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 52.2 Cg_endo -80.25 166.47 20.44 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 CA-C-N 121.82 1.686 . . . . 0.0 109.784 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.6 p -100.58 -10.88 20.55 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 122.314 -0.241 . . . . 0.0 111.154 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.65 137.07 11.96 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 85.7 mt -85.42 169.77 13.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.728 0.411 . . . . 0.0 110.74 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -132.3 151.14 51.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 93.8 t -138.3 154.01 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 124.072 0.949 . . . . 0.0 108.65 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.81 -23.75 4.99 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -173.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.2 171.07 12.63 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.542 1.137 . . . . 0.0 109.082 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -107.79 117.92 35.37 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.91 0.386 . . . . 0.0 110.593 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -157.99 -172.45 3.92 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.69 1.196 . . . . 0.0 109.309 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -73.59 -5.07 38.01 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -112.15 -20.0 12.07 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.801 0.728 . . . . 0.0 111.671 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.1 t -156.33 139.99 16.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 173.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -149.88 147.78 28.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 110.696 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -123.7 113.03 18.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -91.09 3.25 55.25 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.898 0.879 . . . . 0.0 111.709 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.3 t . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 123.555 0.742 . . . . 0.0 109.904 177.202 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 43.0 p30 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.696 0.284 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.8 p -94.96 16.15 16.9 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.29 0.636 . . . . 0.0 111.953 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.59 146.13 25.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 123.042 0.537 . . . . 0.0 111.108 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.55 164.0 25.85 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.682 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.4 tp -122.98 133.29 54.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.874 1.27 . . . . 0.0 108.099 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -120.74 144.47 48.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.657 0.783 . . . . 0.0 110.168 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 96.4 m -136.61 141.01 43.25 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.65 136.77 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.09 -26.95 13.51 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -134.22 62.51 56.68 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 123.618 0.767 . . . . 0.0 109.812 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.72 59.7 5.03 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 124.241 3.294 . . . . 0.0 111.477 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 43.8 pt -82.22 -0.83 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 O-C-N 121.884 -0.51 . . . . 0.0 111.565 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -134.79 167.97 19.89 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.061 0.944 . . . . 0.0 109.382 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.2 m -79.72 151.17 30.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.6 mm -133.64 138.66 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.1 p -141.81 174.78 10.26 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.101 0.56 . . . . 0.0 109.598 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.9 p -63.26 -21.69 66.4 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.48 0.312 . . . . 0.0 110.959 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.17 -24.53 40.28 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.488 0.315 . . . . 0.0 110.798 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 87.3 t -82.99 -37.4 13.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.4 mt -76.82 -22.75 53.16 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.155 -0.341 . . . . 0.0 110.75 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -79.17 -34.89 42.73 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.905 -0.497 . . . . 0.0 110.788 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.3 t -75.43 -23.1 56.91 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.114 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.0 pt -90.48 -20.89 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.53 0.605 . . . . 0.0 112.28 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.1 m -98.43 -19.87 17.45 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.866 0.757 . . . . 0.0 112.975 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.446 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 47.6 t30 -64.47 -40.49 51.05 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 90.5 Cg_endo -71.68 -3.36 12.96 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.576 1.517 . . . . 0.0 111.932 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 73.1 m -99.96 -4.5 29.99 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.702 0.401 . . . . 0.0 111.295 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 142.11 174.44 14.76 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.06 109.34 2.15 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.765 2.976 . . . . 0.0 110.981 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.2 t -80.98 149.71 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -115.67 -39.99 3.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.927 0.491 . . . . 0.0 111.337 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -161.27 158.15 26.71 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.1 mt -141.42 145.71 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.269 1.028 . . . . 0.0 109.582 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.68 147.91 20.41 Favored 'Isoleucine or valine' 0 C--O 1.23 0.052 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.0 mt . . . . . 0 N--CA 1.456 -0.14 0 C-N-CA 123.05 0.54 . . . . 0.0 110.515 -173.591 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -153.63 171.49 18.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.694 0.398 . . . . 0.0 110.478 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 81.3 mtp -141.32 150.13 42.1 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 52.0 t -137.97 152.7 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.036 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -137.02 140.99 42.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.406 0.682 . . . . 0.0 109.755 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.66 168.39 10.76 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.006 0.922 . . . . 0.0 110.816 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.49 -10.38 59.69 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.213 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 40.7 t -153.21 151.66 30.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.034 0.534 . . . . 0.0 110.067 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.55 -22.67 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -66.67 -28.5 68.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.993 0.36 . . . . 0.0 110.642 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 75.4 m -87.21 -23.97 24.58 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.358 -0.214 . . . . 0.0 110.757 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.53 -28.86 59.25 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -70.72 -36.91 73.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 40.3 ttm105 -74.89 -32.79 61.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.341 0.256 . . . . 0.0 111.041 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.82 66.04 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.189 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -11.83 59.94 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.972 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.43 -12.4 46.28 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.603 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 58.7 m -127.57 2.57 6.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 91.1 mt -130.86 -4.99 4.02 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.642 0.655 . . . . 0.0 112.488 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -79.05 131.14 36.17 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.75 7.54 70.03 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.32 177.99 8.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.428 0.691 . . . . 0.0 111.467 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.23 143.99 50.32 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.259 1.023 . . . . 0.0 108.357 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 59.7 mt . . . . . 0 CA--C 1.53 0.196 0 O-C-N 122.403 -0.186 . . . . 0.0 111.272 -177.627 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 76.4 m . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.565 0.222 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 8.9 m -58.12 139.18 55.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.114 0.565 . . . . 0.0 110.105 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 51.1 mt -102.11 155.73 18.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.219 0.533 . . . . 0.0 112.212 -175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -143.4 134.74 26.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 74.2 mt -129.24 149.87 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 121.135 0.493 . . . . 0.0 111.436 -176.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.75 170.27 22.44 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.984 1.314 . . . . 0.0 108.029 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -79.69 144.45 33.69 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 121.865 -0.522 . . . . 0.0 110.337 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.23 164.91 19.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.141 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 40.0 ttpt -72.27 -45.76 10.71 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 79.6 Cg_endo -75.59 176.79 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.605 2.203 . . . . 0.0 110.503 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 63.6 p -106.56 -8.66 16.91 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 122.595 0.358 . . . . 0.0 111.61 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.34 137.42 15.56 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 58.5 mt -90.18 177.64 6.38 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.105 0.562 . . . . 0.0 110.608 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -137.37 154.17 50.06 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.156 -0.34 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.2 t -138.29 153.07 26.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.948 0.899 . . . . 0.0 109.166 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.22 -15.24 4.72 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.617 0.367 . . . . 0.0 111.777 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -166.65 175.82 7.66 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.031 0.933 . . . . 0.0 109.911 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -119.6 101.19 7.75 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -150.47 -169.63 3.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.946 0.898 . . . . 0.0 110.341 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -71.13 -1.38 12.18 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -116.1 -21.25 9.52 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.917 0.781 . . . . 0.0 111.856 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.8 t -157.95 145.69 18.51 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 118.296 0.498 . . . . 0.0 109.999 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -153.15 151.05 29.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.657 0.265 . . . . 0.0 110.697 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.54 139.56 53.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.6 15.72 12.82 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.354 0.661 . . . . 0.0 112.171 -174.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 CA--C 1.533 0.289 0 O-C-N 122.1 -0.375 . . . . 0.0 111.863 -178.737 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 45.9 p30 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 81.2 p -101.18 16.73 24.52 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.536 0.734 . . . . 0.0 111.845 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.6 m -119.7 144.38 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 C-N-CA 123.008 0.523 . . . . 0.0 111.083 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.1 mt -130.94 164.64 24.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.168 0.508 . . . . 0.0 111.384 -174.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 62.8 tp -123.28 134.03 54.12 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.824 1.249 . . . . 0.0 108.316 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -120.52 146.71 46.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.678 0.791 . . . . 0.0 109.816 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 87.3 m -136.53 144.36 44.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.42 136.43 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.5 mt -98.93 -32.79 11.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -172.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -133.42 69.38 77.22 Favored Pre-proline 0 CA--C 1.532 0.25 0 C-N-CA 123.572 0.749 . . . . 0.0 109.507 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.57 55.7 3.79 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 125.007 3.805 . . . . 0.0 112.26 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.1 -3.68 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 121.753 -0.592 . . . . 0.0 111.38 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -129.86 168.16 17.04 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.703 0.801 . . . . 0.0 109.378 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 82.0 p -80.87 153.01 27.86 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.947 0.403 . . . . 0.0 111.504 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.0 mm -138.68 139.48 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.9 p -144.04 173.14 11.98 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.528 0.731 . . . . 0.0 109.56 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.1 p -63.63 -19.13 64.62 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.355 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -83.24 -26.06 31.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 117.805 0.275 . . . . 0.0 110.591 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.2 t -81.51 -36.24 14.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.37 -25.19 57.47 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.275 -0.266 . . . . 0.0 110.333 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -77.05 -36.32 56.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.086 -0.384 . . . . 0.0 110.966 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -76.46 -20.27 57.19 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.471 0.578 . . . . 0.0 111.336 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.16 -16.69 7.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-N 118.244 0.474 . . . . 0.0 111.78 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.3 m -97.31 -20.92 17.53 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.761 0.71 . . . . 0.0 112.155 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.435 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.2 t-20 -61.41 -43.73 90.26 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 98.7 Cg_endo -72.43 -10.59 25.65 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.633 1.555 . . . . 0.0 111.633 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 74.7 m -94.42 -21.59 18.83 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.797 0.271 . . . . 0.0 111.397 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 167.8 168.54 30.09 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.98 99.47 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.297 3.331 . . . . 0.0 110.902 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.3 t -75.52 144.21 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -113.02 -33.65 5.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.456 0.302 . . . . 0.0 111.075 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -163.73 157.87 19.6 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 117.966 0.348 . . . . 0.0 111.574 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.0 mt -143.37 142.74 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.289 1.036 . . . . 0.0 109.715 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.1 m -138.43 156.61 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.055 0.542 . . . . 0.0 109.588 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 66.0 mt . . . . . 0 C--O 1.231 0.098 0 C-N-CA 122.89 0.476 . . . . 0.0 110.403 -175.739 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.996 0.427 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.44 169.64 20.4 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.139 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 78.2 mtp -138.86 148.98 44.37 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.7 t -136.37 151.42 28.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 122.878 0.471 . . . . 0.0 109.842 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -137.08 138.58 40.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.25 0.62 . . . . 0.0 109.745 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.07 170.36 8.92 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.141 0.976 . . . . 0.0 110.497 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.05 -16.24 59.97 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.565 0.346 . . . . 0.0 111.528 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.7 t -150.99 154.46 37.12 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.729 0.412 . . . . 0.0 110.579 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.24 -26.94 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.022 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -67.08 -29.9 69.79 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.059 -0.401 . . . . 0.0 110.079 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.2 m -79.29 -26.68 42.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.411 0.285 . . . . 0.0 110.501 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.52 -26.29 38.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.396 -0.19 . . . . 0.0 110.685 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -69.54 -36.62 76.53 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -77.82 -26.6 49.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.307 0.243 . . . . 0.0 110.798 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.5 -53.82 30.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.141 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -14.42 60.38 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.814 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.53 -10.65 55.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.096 -0.378 . . . . 0.0 111.45 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.6 m -123.78 -0.35 8.55 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 94.0 mt -131.1 -6.2 3.89 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -76.35 131.24 39.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.917 0.78 . . . . 0.0 109.274 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.42 7.51 73.21 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.121 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.99 174.05 12.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.864 0.832 . . . . 0.0 111.337 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -132.62 145.65 51.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.8 mt . . . . . 0 CA--C 1.531 0.244 0 C-N-CA 122.097 0.159 . . . . 0.0 111.124 -177.246 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 120.586 0.232 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.8 m -59.21 140.57 55.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.978 0.511 . . . . 0.0 110.09 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 47.4 mt -98.9 153.62 18.67 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.126 0.571 . . . . 0.0 111.94 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -140.43 134.8 31.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 171.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 81.6 mt -129.19 149.34 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.209 0.528 . . . . 0.0 111.286 -175.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.74 169.16 24.99 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.865 1.266 . . . . 0.0 108.199 173.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -79.57 142.01 36.08 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.756 -0.59 . . . . 0.0 110.542 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.43 164.11 20.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -81.78 -26.12 0.41 Allowed Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -175.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 44.0 Cg_endo -81.51 177.69 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 121.767 1.667 . . . . 0.0 109.876 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 68.5 p -106.53 -5.56 18.71 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.611 0.364 . . . . 0.0 110.902 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.9 mmm-85 -153.81 154.81 34.67 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.901 0.88 . . . . 0.0 110.295 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.68 168.56 10.32 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.644 0.778 . . . . 0.0 109.47 173.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -140.16 166.63 24.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.935 0.398 . . . . 0.0 111.494 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.5 t -138.09 155.27 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.144 0.978 . . . . 0.0 108.723 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.81 -26.3 4.87 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.299 0.24 . . . . 0.0 111.392 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.76 168.87 17.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.451 1.101 . . . . 0.0 109.08 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -106.44 117.34 33.78 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.931 0.396 . . . . 0.0 110.963 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -157.41 -175.17 5.25 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.713 1.205 . . . . 0.0 109.496 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -71.24 -3.42 20.23 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -173.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -118.08 -14.3 9.94 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.711 0.687 . . . . 0.0 111.968 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.9 t -155.98 135.2 12.18 Favored 'General case' 0 C--O 1.228 -0.043 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -153.2 147.75 26.09 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.872 0.368 . . . . 0.0 111.359 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.68 135.57 55.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.452 0.701 . . . . 0.0 109.509 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -116.9 13.66 14.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.4 0.68 . . . . 0.0 112.503 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.53 0.2 0 CA-C-N 118.315 0.507 . . . . 0.0 112.342 -177.544 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.2 p30 . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.6 p -96.51 12.25 32.15 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.138 0.575 . . . . 0.0 111.826 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.72 142.46 25.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 122.874 0.469 . . . . 0.0 111.194 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.3 mt -129.19 164.0 24.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.113 0.565 . . . . 0.0 111.454 -175.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.7 tp -123.89 132.69 53.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.716 1.206 . . . . 0.0 108.171 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -119.43 144.25 47.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.729 0.811 . . . . 0.0 109.805 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 91.7 m -139.06 144.3 38.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.9 mp -106.85 134.36 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.66 -36.55 15.18 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -173.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -131.54 63.5 69.72 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 123.606 0.762 . . . . 0.0 109.948 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.84 103.24 1.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.849 2.366 . . . . 0.0 110.88 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.9 pt -128.65 0.94 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 122.879 0.472 . . . . 0.0 111.384 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.42 ' HB2' ' HG ' ' A' ' 258' ' ' CYS . 38.0 m-85 -130.1 166.52 20.02 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.954 0.902 . . . . 0.0 109.191 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.2 m -74.98 147.8 40.5 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.719 0.295 . . . . 0.0 111.56 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.1 mm -137.55 132.88 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.3 p -142.87 176.36 9.13 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 122.896 0.479 . . . . 0.0 110.299 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 41.5 p -63.31 -22.8 67.1 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.193 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -80.5 -26.14 38.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.295 0.238 . . . . 0.0 110.821 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 87.6 t -84.41 -37.59 12.9 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.17 -24.93 54.81 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.294 -0.254 . . . . 0.0 111.093 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -77.62 -37.26 50.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.815 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.4 t -75.74 -19.58 58.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.219 0.463 . . . . 0.0 111.374 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -94.92 -15.67 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.339 0.518 . . . . 0.0 111.858 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.5 m -97.41 -22.78 16.4 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.697 0.68 . . . . 0.0 111.864 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.433 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 26.9 t-20 -59.82 -43.04 94.07 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 93.9 Cg_endo -72.22 -9.19 24.05 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.985 1.79 . . . . 0.0 111.928 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.4 m -96.09 -20.75 18.41 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 122.063 -0.398 . . . . 0.0 111.317 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 162.94 169.75 26.82 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.84 115.76 3.76 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.571 2.847 . . . . 0.0 111.039 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.96 147.34 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -111.63 -39.56 4.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.986 0.514 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -160.83 159.08 29.46 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.56 0.618 . . . . 0.0 112.177 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.6 mt -142.53 146.96 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.623 0.769 . . . . 0.0 110.377 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.61 144.25 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 123.372 0.669 . . . . 0.0 109.587 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 123.493 0.717 . . . . 0.0 109.727 -178.967 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 . . . . . 0 CA--C 1.528 0.134 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.13 171.04 21.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.796 0.439 . . . . 0.0 110.071 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.2 mtp -138.24 151.29 47.51 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.1 t -141.13 151.93 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 122.847 0.459 . . . . 0.0 109.846 -175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -136.94 141.45 42.65 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -115.8 168.32 10.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.471 0.709 . . . . 0.0 110.802 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -74.51 -13.83 60.73 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.761 0.425 . . . . 0.0 111.341 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 37.7 t -152.31 153.82 34.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.839 0.456 . . . . 0.0 109.938 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.8 -25.19 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -65.39 -27.59 68.66 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.908 -0.495 . . . . 0.0 109.742 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 40.4 m -82.51 -26.85 32.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.2 0.2 . . . . 0.0 110.712 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.76 -25.4 41.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -70.73 -37.53 73.51 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -77.88 -24.83 48.35 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 122.076 0.15 . . . . 0.0 110.779 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.43 -54.6 18.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.325 -0.234 . . . . 0.0 110.935 -178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -15.82 60.26 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.708 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.14 -11.11 58.24 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.115 -0.366 . . . . 0.0 111.563 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.0 m -124.45 -0.71 8.14 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 87.2 mt -130.17 -4.82 4.4 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -77.0 130.24 37.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.461 -0.774 . . . . 0.0 109.176 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.68 6.2 76.51 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.805 -0.442 . . . . 0.0 112.052 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.26 176.29 7.52 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.673 0.737 . . . . 0.0 111.488 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -140.11 150.96 44.93 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.57 0.748 . . . . 0.0 109.364 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.3 mt . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 122.407 0.283 . . . . 0.0 111.442 -176.106 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . 0.42 ' HG ' ' HB2' ' A' ' 201' ' ' TYR . 79.6 m . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.68 140.72 56.21 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.962 0.505 . . . . 0.0 109.777 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 62.2 mt -93.52 155.2 17.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.206 0.527 . . . . 0.0 111.786 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -144.3 135.6 25.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 172.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 85.2 mt -130.17 149.7 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 121.0 0.428 . . . . 0.0 111.174 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.35 168.77 26.0 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.934 1.294 . . . . 0.0 108.211 173.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -80.39 144.05 33.0 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.679 -0.638 . . . . 0.0 110.578 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.66 165.46 16.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.669 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -83.18 -25.79 0.38 Allowed Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 43.7 Cg_endo -81.43 179.46 5.79 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.836 1.691 . . . . 0.0 109.858 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 65.1 p -108.57 -4.65 17.0 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.734 0.414 . . . . 0.0 110.728 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.3 mmm-85 -153.8 153.94 33.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.039 0.936 . . . . 0.0 110.099 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 83.9 mt -115.21 168.91 9.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.298 0.639 . . . . 0.0 109.514 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -141.13 158.49 43.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.286 0.234 . . . . 0.0 110.813 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.37 156.22 29.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 124.215 1.006 . . . . 0.0 109.097 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -124.61 -15.73 6.47 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -173.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -162.49 175.16 11.77 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.698 0.799 . . . . 0.0 110.293 -176.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -121.09 95.88 4.87 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.38 0.672 . . . . 0.0 109.577 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -149.42 -170.69 3.7 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.726 0.81 . . . . 0.0 110.649 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -70.91 -5.04 27.73 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -109.0 -24.21 11.32 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.649 0.658 . . . . 0.0 111.392 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.2 t -159.26 143.33 15.11 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -150.91 150.23 30.6 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.25 137.57 52.06 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -113.81 5.17 16.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.379 0.671 . . . . 0.0 112.519 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.531 0.235 0 C-N-CA 122.755 0.422 . . . . 0.0 110.921 178.693 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 119.901 -0.095 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -148.01 159.44 43.89 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.28 153.19 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 122.991 0.516 . . . . 0.0 110.584 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.5 p -78.39 1.84 20.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.016 0.526 . . . . 0.0 112.21 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -139.2 68.73 40.83 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 123.8 0.84 . . . . 0.0 109.02 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.1 171.39 17.67 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.108 3.205 . . . . 0.0 111.127 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -70.45 173.97 39.29 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 112.363 -0.295 . . . . 0.0 112.363 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -146.39 170.23 17.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.195 0.598 . . . . 0.0 109.727 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 29.2 m 54.95 21.45 3.72 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.658 0.783 . . . . 0.0 112.819 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.0 t0 50.68 32.2 6.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.921 0.888 . . . . 0.0 111.983 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 26.3 t70 53.38 23.93 3.62 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.389 1.076 . . . . 0.0 112.825 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 38.5 m 56.46 13.74 1.42 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.451 1.1 . . . . 0.0 113.184 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 54.16 -173.32 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.861 1.264 . . . . 0.0 113.037 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 47.3 t -147.76 158.35 43.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.459 0.704 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.1 p -147.16 -54.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.542 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -166.21 166.13 17.09 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.395 0.678 . . . . 0.0 110.447 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.0 p -94.87 10.75 34.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.173 0.589 . . . . 0.0 111.258 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.35 139.47 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.683 0.793 . . . . 0.0 110.664 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 99.1 mt -128.52 160.35 32.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.386 0.612 . . . . 0.0 111.255 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.4 tp -120.65 133.36 55.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.99 1.316 . . . . 0.0 108.042 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -119.75 144.71 47.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.652 0.781 . . . . 0.0 109.912 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 99.0 m -139.52 142.83 37.24 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.4 mp -105.38 135.78 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.86 -35.79 12.54 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -130.79 62.84 67.58 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.429 0.692 . . . . 0.0 110.329 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.45 103.25 1.08 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.795 2.33 . . . . 0.0 110.989 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.8 pt -128.83 2.71 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.742 0.417 . . . . 0.0 111.614 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -132.31 167.47 19.81 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.737 0.815 . . . . 0.0 109.628 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.5 m -74.68 146.73 42.08 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.65 0.262 . . . . 0.0 111.133 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mm -138.11 136.02 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.5 p -144.05 174.21 11.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.463 0.705 . . . . 0.0 109.538 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.2 p -63.51 -19.16 64.54 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.507 0.323 . . . . 0.0 111.153 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -83.4 -25.96 30.84 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.745 0.248 . . . . 0.0 111.042 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.4 t -81.67 -36.58 14.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.76 -26.32 57.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.217 -0.302 . . . . 0.0 110.295 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -75.63 -36.64 60.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.868 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.1 t -77.13 -17.69 58.45 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.312 0.505 . . . . 0.0 111.647 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.77 -13.9 7.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.148 0.431 . . . . 0.0 111.877 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 83.6 m -99.31 -24.97 14.64 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.765 0.711 . . . . 0.0 112.139 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.426 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 47.9 t30 -63.93 -39.16 42.75 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 95.1 Cg_endo -72.89 -5.81 17.87 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.437 1.425 . . . . 0.0 111.729 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 73.0 m -102.54 -10.52 19.25 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.806 0.442 . . . . 0.0 111.105 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 156.89 166.01 15.81 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.71 112.75 2.97 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.61 2.873 . . . . 0.0 110.658 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.25 152.33 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -117.18 -37.82 3.48 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.617 0.367 . . . . 0.0 110.95 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -163.16 157.32 20.37 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.2 0.455 . . . . 0.0 112.186 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.6 mt -143.67 146.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.315 1.046 . . . . 0.0 109.913 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.17 150.9 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.2 mt -130.55 149.35 33.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.966 0.506 . . . . 0.0 110.742 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -138.51 134.57 34.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.737 0.815 . . . . 0.0 109.441 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.25 24.95 1.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.29 -20.13 63.9 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -152.18 120.63 6.4 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 61.96 -154.67 39.69 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.0 t -139.16 125.99 24.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -145.85 164.44 31.92 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.324 0.649 . . . . 0.0 110.236 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -154.24 171.6 18.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.556 0.342 . . . . 0.0 110.418 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.4 mtp -138.45 147.73 43.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.2 t -137.81 151.75 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 123.149 0.58 . . . . 0.0 109.786 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -141.2 141.49 34.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.297 0.639 . . . . 0.0 109.88 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -118.0 168.73 10.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.95 0.9 . . . . 0.0 110.981 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.01 -14.41 60.22 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.979 0.512 . . . . 0.0 111.357 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.4 t -150.75 152.15 33.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.939 0.496 . . . . 0.0 109.998 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.52 -23.68 30.22 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.85 -29.09 70.03 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 27.3 m -83.87 -28.0 28.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.573 0.349 . . . . 0.0 110.391 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.23 -27.02 47.61 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -69.96 -38.92 76.25 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -76.55 -27.95 56.1 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.15 -53.83 39.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.399 -0.188 . . . . 0.0 110.968 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -14.38 60.01 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.999 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.05 -12.58 57.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.014 0.37 . . . . 0.0 111.947 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -128.75 2.31 5.44 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 76.5 mt -128.45 -4.94 5.37 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.472 0.578 . . . . 0.0 112.363 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.4 132.85 37.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.97 7.94 72.08 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.69 174.17 11.62 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.574 0.687 . . . . 0.0 111.018 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -132.15 148.62 52.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 49.9 mt -100.62 -16.05 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.91 24.32 9.05 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.998 0.519 . . . . 0.0 111.551 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 24.7 m 57.52 15.23 2.66 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.077 0.951 . . . . 0.0 112.209 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 173.38 143.67 4.36 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 68.3 m 56.19 179.38 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.736 0.814 . . . . 0.0 111.906 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.0 m 49.94 33.85 7.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.85 0.46 . . . . 0.0 110.971 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.94 140.53 56.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.28 0.632 . . . . 0.0 110.051 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.2 154.86 16.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.007 0.523 . . . . 0.0 111.661 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -143.24 124.9 14.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 71.6 mt -126.44 146.2 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.147 0.499 . . . . 0.0 111.715 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -156.35 170.73 21.63 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.952 1.301 . . . . 0.0 108.656 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.48 145.74 33.09 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 121.798 -0.564 . . . . 0.0 110.427 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -89.68 166.41 13.61 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.2 pttt -79.02 -28.32 0.55 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.4 Cg_endo -82.01 163.2 18.05 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 121.95 1.732 . . . . 0.0 110.442 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.5 p -97.24 -7.48 32.16 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 122.275 0.23 . . . . 0.0 110.992 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -152.82 148.88 27.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.818 0.847 . . . . 0.0 110.187 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 67.9 mt -107.48 172.26 6.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.586 0.754 . . . . 0.0 109.638 173.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -141.36 157.0 45.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.711 0.404 . . . . 0.0 110.22 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 79.9 t -135.59 152.36 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -119.93 -22.85 6.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.386 0.274 . . . . 0.0 111.148 -174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -165.38 173.52 11.05 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.712 0.805 . . . . 0.0 109.971 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -117.16 111.45 19.49 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.764 0.316 . . . . 0.0 110.463 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -156.24 -171.69 3.81 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.98 1.312 . . . . 0.0 109.56 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -73.95 -0.49 16.33 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -109.69 -27.35 9.39 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.45 0.568 . . . . 0.0 111.05 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.9 t -156.09 144.33 19.9 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.155 0.582 . . . . 0.0 109.584 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -150.31 150.73 31.88 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.657 0.265 . . . . 0.0 110.634 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -126.5 137.55 53.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.071 0.549 . . . . 0.0 109.765 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.96 11.76 13.51 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.594 0.758 . . . . 0.0 112.351 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.0 t -130.87 -7.32 3.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.983 0.356 . . . . 0.0 111.942 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -64.87 150.79 94.33 Favored Pre-proline 0 CA--C 1.532 0.265 0 O-C-N 121.685 -0.634 . . . . 0.0 109.926 174.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.2 0.36 10.08 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.916 3.077 . . . . 0.0 111.3 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -137.79 39.38 2.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.059 0.944 . . . . 0.0 110.127 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -73.68 0.36 13.13 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 26.8 p 56.82 178.23 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.539 1.536 . . . . 0.0 113.559 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -177.89 -174.92 44.64 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -137.24 8.61 2.93 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.861 0.464 . . . . 0.0 111.772 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 117.476 -1.736 . . . . 0.0 110.861 -179.797 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -137.76 164.27 29.3 Favored 'General case' 0 C--N 1.338 0.066 0 C-N-CA 123.466 0.706 . . . . 0.0 111.032 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 19.3 tt -130.43 10.64 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.268 1.027 . . . . 0.0 110.848 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.3 m 59.53 9.64 1.61 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.007 1.323 . . . . 0.0 114.2 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' ' 179' ' ' PRO . 33.6 ptt-85 -149.77 43.54 0.28 Allowed Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 123.462 0.705 . . . . 0.0 112.027 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 178' ' ' ARG . 90.0 Cg_endo -72.02 -17.31 28.52 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.93 2.42 . . . . 0.0 111.588 -176.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 151.25 -164.72 30.19 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -81.37 160.45 24.1 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.572 0.349 . . . . 0.0 110.551 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 t 57.35 -166.49 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.607 0.763 . . . . 0.0 112.095 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 185' ' ' SER . 27.1 t0 62.62 163.96 0.1 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.48 1.512 . . . . 0.0 112.653 -175.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 61.08 -22.35 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.334 1.854 . . . . 0.0 114.003 -173.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 183' ' ' ASP . 26.5 m 48.38 23.99 0.66 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.859 1.263 . . . . 0.0 113.801 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 50.76 27.11 2.87 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.981 0.912 . . . . 0.0 112.218 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.3 t -66.95 149.51 50.52 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.573 0.749 . . . . 0.0 112.029 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 65.3 t -140.98 -67.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -162.1 164.36 28.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.857 0.863 . . . . 0.0 110.12 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.4 p -92.77 15.79 13.83 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.595 0.758 . . . . 0.0 112.472 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.47 145.9 24.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 122.884 0.474 . . . . 0.0 110.893 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.64 165.02 23.71 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.29 0.567 . . . . 0.0 111.29 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.1 tp -127.69 131.26 49.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -117.0 144.31 44.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.826 0.851 . . . . 0.0 109.443 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.1 m -135.91 141.72 44.59 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.91 136.19 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.6 mt -92.86 -36.55 12.76 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -131.67 64.87 74.39 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.467 0.707 . . . . 0.0 110.096 -177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.85 104.2 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.571 2.181 . . . . 0.0 111.075 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.2 pt -130.13 1.44 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.073 0.549 . . . . 0.0 111.457 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -131.5 167.32 19.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.849 0.86 . . . . 0.0 109.197 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 27.0 t -76.53 149.48 36.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.416 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.3 mm -138.8 133.3 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.6 p -145.07 176.17 9.7 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 123.388 0.675 . . . . 0.0 110.136 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 35.5 p -61.33 -28.15 69.01 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.383 -0.198 . . . . 0.0 110.936 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.08 -22.35 58.36 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.699 0.399 . . . . 0.0 111.631 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.0 t -89.62 -38.0 10.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 84.3 mt -77.76 -23.39 49.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.96 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -78.3 -34.54 48.71 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.017 -0.427 . . . . 0.0 110.711 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.9 t -75.59 -23.23 56.45 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.217 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.1 pt -88.91 -22.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.203 0.456 . . . . 0.0 111.755 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.9 m -96.21 -20.12 18.81 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.779 0.718 . . . . 0.0 112.507 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.451 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.84 -43.5 87.54 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 95.8 Cg_endo -72.13 -11.04 26.74 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.874 1.716 . . . . 0.0 111.594 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.1 m -90.56 -23.04 21.0 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.232 0.469 . . . . 0.0 111.121 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.26 170.97 28.91 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -68.38 111.03 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.766 2.978 . . . . 0.0 110.71 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -83.49 152.37 3.86 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -115.52 -35.53 4.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.815 0.446 . . . . 0.0 110.693 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -164.31 160.35 20.85 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.129 0.422 . . . . 0.0 111.772 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.1 mt -144.35 146.89 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.074 0.95 . . . . 0.0 109.986 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.1 144.61 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 123.528 0.731 . . . . 0.0 109.408 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.0 mp -120.91 151.01 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 C-N-CA 123.767 0.827 . . . . 0.0 110.386 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.65 138.56 51.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 173.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -140.86 21.9 2.29 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -115.84 140.56 49.11 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 53.98 18.68 1.74 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.014 0.926 . . . . 0.0 112.266 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 149.51 -173.36 29.33 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.2 t -135.45 124.59 40.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 CA-C-N 117.505 0.652 . . . . 0.0 109.605 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -148.31 168.96 21.21 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 124.026 0.931 . . . . 0.0 109.463 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.15 168.65 26.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.418 0.287 . . . . 0.0 110.416 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 87.8 mtp -138.43 151.43 47.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.31 150.15 21.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 122.829 0.452 . . . . 0.0 109.898 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -132.44 141.78 48.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.746 0.818 . . . . 0.0 108.794 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -118.02 167.98 10.96 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.907 0.883 . . . . 0.0 110.916 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.24 -15.5 60.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.738 0.415 . . . . 0.0 111.135 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 93.4 p -152.08 158.34 42.87 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.039 0.447 . . . . 0.0 110.459 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.94 -26.68 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.388 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -72.63 -22.2 60.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.335 0.516 . . . . 0.0 110.534 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.8 m -80.56 -28.3 37.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.02 -26.19 39.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.354 0.262 . . . . 0.0 110.469 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -69.71 -36.91 76.32 Favored 'General case' 0 N--CA 1.458 -0.05 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -79.67 -24.94 41.46 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.16 0.184 . . . . 0.0 110.762 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.68 -52.79 33.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.975 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.92 -16.08 60.08 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.795 0.725 . . . . 0.0 111.662 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.8 58.74 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.702 0.228 . . . . 0.0 111.6 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.8 t -126.73 0.52 6.75 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.0 mt -130.68 -4.27 4.14 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -78.14 130.91 36.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.884 0.765 . . . . 0.0 109.083 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.38 8.66 76.02 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.25 175.38 9.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.666 0.733 . . . . 0.0 111.284 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -139.8 149.14 43.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.569 0.748 . . . . 0.0 109.01 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.4 mt -111.13 -19.02 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 122.491 0.317 . . . . 0.0 111.243 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -125.91 23.14 7.28 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.72 0.408 . . . . 0.0 111.66 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.2 m 55.38 20.12 3.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.618 0.767 . . . . 0.0 112.41 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 169.17 136.57 2.09 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 71.9 m 57.27 178.81 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.865 0.866 . . . . 0.0 111.941 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.8 m 53.02 29.8 8.53 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.924 0.489 . . . . 0.0 111.639 -174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.39 142.69 51.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.385 0.674 . . . . 0.0 109.987 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 53.9 mt -97.76 154.99 17.24 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.15 0.5 . . . . 0.0 111.87 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -146.25 132.55 19.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 76.6 mt -129.58 149.12 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 121.338 0.589 . . . . 0.0 112.012 -172.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.74 172.3 16.89 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.356 1.462 . . . . 0.0 108.428 174.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -83.75 143.92 29.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.948 -0.47 . . . . 0.0 110.445 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.68 170.29 12.65 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.41 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.441 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -84.82 -26.35 0.37 Allowed Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 49.4 Cg_endo -82.5 -177.84 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.023 1.815 . . . . 0.0 110.033 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.0 p -108.23 -7.43 15.98 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 122.196 -0.315 . . . . 0.0 111.422 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.75 168.47 27.07 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.138 0.975 . . . . 0.0 109.665 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 90.4 mt -124.73 174.37 7.94 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.475 0.71 . . . . 0.0 109.739 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -140.79 159.77 41.49 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.835 0.35 . . . . 0.0 110.929 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.8 t -135.69 153.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 124.277 1.031 . . . . 0.0 108.744 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -120.58 -26.38 5.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.614 0.366 . . . . 0.0 111.493 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.12 169.89 18.71 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.729 1.212 . . . . 0.0 108.865 176.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -107.08 117.43 34.04 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.782 0.325 . . . . 0.0 110.616 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -158.25 -172.57 3.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.624 1.169 . . . . 0.0 109.755 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -71.49 -4.94 29.46 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -114.16 -18.9 11.53 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.664 0.665 . . . . 0.0 111.728 -178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.0 t -156.63 139.38 15.14 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -152.49 149.56 28.67 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.703 0.287 . . . . 0.0 110.666 -176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -124.95 138.2 54.24 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.176 0.59 . . . . 0.0 109.479 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -118.37 11.17 12.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.3 0.64 . . . . 0.0 112.253 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.7 t -132.41 -7.82 3.31 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.231 0.469 . . . . 0.0 112.22 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -79.79 155.68 75.47 Favored Pre-proline 0 CA--C 1.533 0.315 0 O-C-N 121.8 -0.563 . . . . 0.0 110.792 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.84 -5.13 16.63 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.213 2.609 . . . . 0.0 112.201 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -77.82 -10.22 59.45 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.106 -0.371 . . . . 0.0 111.239 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 44.0 tp -90.67 -12.34 37.06 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.509 0.324 . . . . 0.0 110.688 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 35.1 m -67.57 -9.78 45.87 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.94 -0.475 . . . . 0.0 111.686 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -80.62 -5.18 90.08 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -134.99 -14.81 2.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.493 0.646 . . . . 0.0 111.445 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.368 -1.795 . . . . 0.0 111.017 179.489 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -141.1 172.75 12.25 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 123.555 0.742 . . . . 0.0 110.79 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.9 6.58 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.626 1.17 . . . . 0.0 111.271 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.5 m 59.1 7.99 0.95 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.887 1.275 . . . . 0.0 113.49 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 -152.91 61.91 4.01 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 123.407 0.683 . . . . 0.0 109.202 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -69.56 170.05 17.24 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.826 3.017 . . . . 0.0 111.336 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 100.3 -164.23 19.14 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -124.05 157.85 33.55 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.144 0.578 . . . . 0.0 110.881 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 20.3 m 56.63 -174.79 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.491 1.117 . . . . 0.0 113.251 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 29.9 t70 61.91 137.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.071 1.748 . . . . 0.0 114.15 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 t70 51.13 16.94 0.41 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.949 1.299 . . . . 0.0 113.359 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 54.0 m 53.81 14.16 0.62 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.121 0.968 . . . . 0.0 112.831 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 48.6 -156.25 0.07 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.352 1.061 . . . . 0.0 111.776 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.6 t -147.43 151.76 36.99 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.063 0.545 . . . . 0.0 109.58 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.8 p -152.69 -51.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.294 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -165.87 170.23 14.04 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.012 0.525 . . . . 0.0 110.598 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.5 p -100.3 15.59 27.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.686 0.795 . . . . 0.0 111.788 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.11 143.94 27.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.011 0.524 . . . . 0.0 110.858 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.3 mt -128.79 164.92 21.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.212 0.53 . . . . 0.0 111.783 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.1 tp -123.87 134.43 53.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.783 1.233 . . . . 0.0 107.939 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -121.75 150.85 41.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.029 0.932 . . . . 0.0 109.618 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 94.6 m -142.63 146.71 34.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 42.9 mt -119.26 136.99 54.65 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.05 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 50.2 mt -102.91 -23.69 13.72 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -131.7 62.19 62.91 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.39 0.676 . . . . 0.0 110.102 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.31 40.27 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 125.073 3.849 . . . . 0.0 112.632 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 38.0 pt -77.08 -0.7 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.887 -0.508 . . . . 0.0 111.888 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -130.16 166.05 21.05 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.729 0.812 . . . . 0.0 109.655 176.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.2 m -70.57 146.56 50.04 Favored 'General case' 0 C--N 1.335 -0.048 0 CA-C-O 120.73 0.3 . . . . 0.0 111.526 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.8 mm -137.33 134.6 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.9 p -146.87 173.88 12.01 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.368 0.667 . . . . 0.0 109.236 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.3 p -63.74 -19.56 65.06 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 122.333 0.253 . . . . 0.0 111.529 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.15 -24.37 37.65 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.843 0.292 . . . . 0.0 110.849 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.0 t -82.48 -37.62 14.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.58 -24.25 58.88 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.212 -0.305 . . . . 0.0 110.614 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -78.31 -36.23 46.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.229 -0.294 . . . . 0.0 111.177 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.7 t -74.97 -21.32 59.23 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.145 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 39.5 pt -91.73 -21.9 6.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 CA-C-N 118.136 0.425 . . . . 0.0 112.058 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.2 m -95.67 -24.2 16.66 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.444 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 50.4 t30 -63.88 -40.57 56.49 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 89.4 Cg_endo -73.14 -4.5 15.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.754 1.636 . . . . 0.0 111.821 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.5 m -101.67 -10.42 20.03 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.868 0.467 . . . . 0.0 111.199 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 155.53 164.66 13.38 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.86 109.59 1.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.729 2.953 . . . . 0.0 111.016 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.96 151.88 4.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -117.39 -38.37 3.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.612 0.365 . . . . 0.0 111.086 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -162.98 157.95 21.62 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.01 0.368 . . . . 0.0 111.424 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 54.1 mt -143.15 141.93 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.762 0.825 . . . . 0.0 109.419 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 20.3 m -136.2 151.66 29.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 56.3 mt -133.91 150.24 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 122.796 0.438 . . . . 0.0 110.138 -175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.2 121.72 22.93 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -142.63 18.3 2.01 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 122.798 0.439 . . . . 0.0 111.984 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.596 ' HA ' ' HE2' ' A' ' 226' ' ' LYS . 0.7 OUTLIER -76.84 -24.2 52.71 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -150.97 125.56 9.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 61.61 -157.43 33.85 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.94 118.85 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 117.475 0.637 . . . . 0.0 110.674 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -148.4 165.15 31.98 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 123.395 0.678 . . . . 0.0 110.188 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.83 171.4 18.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.843 0.457 . . . . 0.0 109.985 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.0 mtp -141.47 150.53 42.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.2 t -136.71 152.41 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 C-N-CA 122.928 0.491 . . . . 0.0 109.829 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -137.42 140.84 41.55 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.461 0.704 . . . . 0.0 109.577 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -120.97 169.24 10.66 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 123.879 0.871 . . . . 0.0 111.079 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.04 -16.07 61.06 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.852 0.461 . . . . 0.0 111.362 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 90.7 p -153.02 159.71 42.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.974 0.416 . . . . 0.0 110.664 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.38 -26.62 31.84 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 O-C-N 122.269 -0.269 . . . . 0.0 110.365 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -65.49 -29.33 69.97 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 122.077 -0.39 . . . . 0.0 110.083 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.7 m -80.14 -27.33 39.08 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.704 0.402 . . . . 0.0 110.641 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.14 -25.27 37.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.276 -0.265 . . . . 0.0 110.527 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -70.89 -35.99 72.56 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -77.05 -27.79 54.54 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.335 -0.228 . . . . 0.0 110.487 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.12 -51.5 57.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.361 -0.212 . . . . 0.0 111.056 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -13.32 59.92 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.863 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -84.89 -10.79 56.76 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.924 0.329 . . . . 0.0 111.591 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.6 m -124.73 -2.47 7.84 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.51 -7.4 4.67 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -78.34 133.02 37.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.889 0.768 . . . . 0.0 109.099 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.16 4.78 64.3 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.79 179.67 7.41 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 117.641 0.72 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.48 161.45 37.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.723 0.809 . . . . 0.0 108.995 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.9 mt -113.01 -23.28 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 119.783 -0.151 . . . . 0.0 111.337 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -137.75 82.55 1.93 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.191 0.45 . . . . 0.0 111.674 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.9 m 49.26 45.71 23.29 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 94.19 -0.64 66.54 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.591 -0.561 . . . . 0.0 112.464 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 60.9 m -102.66 166.81 10.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.802 0.801 . . . . 0.0 109.802 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.5 m 52.55 43.13 31.44 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.558 0.343 . . . . 0.0 110.778 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.9 m -56.27 138.17 50.95 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.919 0.487 . . . . 0.0 109.901 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.3 mt -105.21 153.44 21.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.043 0.537 . . . . 0.0 112.069 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -141.59 125.12 16.72 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 77.4 mt -124.25 147.6 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-O 121.136 0.494 . . . . 0.0 111.498 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -155.89 170.55 21.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.054 1.342 . . . . 0.0 108.427 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -80.39 146.35 31.54 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.861 -0.524 . . . . 0.0 110.51 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.26 165.92 15.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.489 0.316 . . . . 0.0 110.272 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -82.9 -26.55 0.4 Allowed Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 43.2 Cg_endo -81.7 177.74 7.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.848 1.696 . . . . 0.0 109.593 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 59.2 p -106.38 -5.17 19.2 Favored 'General case' 0 CA--C 1.527 0.084 0 O-C-N 122.285 -0.26 . . . . 0.0 110.985 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.0 mmm-85 -154.48 155.86 35.66 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.118 0.967 . . . . 0.0 110.235 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -118.47 168.64 10.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.173 0.989 . . . . 0.0 109.716 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -140.79 161.38 37.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.329 0.252 . . . . 0.0 110.878 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.15 153.92 36.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 124.164 0.986 . . . . 0.0 109.111 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -123.83 -21.28 5.19 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.447 ' HE3' ' CG2' ' A' ' 279' ' ' THR . 0.3 OUTLIER -164.95 173.08 12.0 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.678 1.191 . . . . 0.0 109.021 176.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -113.05 113.64 25.73 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -154.93 -172.13 4.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.944 1.297 . . . . 0.0 109.387 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -71.65 -4.97 30.24 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -115.86 -14.5 11.32 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.649 0.659 . . . . 0.0 111.899 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' THR . . . . . 0.447 ' CG2' ' HE3' ' A' ' 274' ' ' LYS . 5.0 t -157.09 138.58 13.94 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -152.91 150.24 29.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.252 -0.28 . . . . 0.0 110.894 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -125.43 137.52 54.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.133 0.573 . . . . 0.0 109.556 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -117.15 7.27 12.97 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.312 0.645 . . . . 0.0 112.084 -175.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t -132.1 -7.13 3.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.569 0.348 . . . . 0.0 111.837 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -68.9 121.6 82.08 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.06 -11.27 28.88 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.226 2.617 . . . . 0.0 112.163 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -99.44 5.09 46.36 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.087 0.555 . . . . 0.0 110.955 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 16.4 tp 51.49 25.19 2.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.951 0.9 . . . . 0.0 111.935 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 17.1 m 54.47 18.44 1.96 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.72 1.208 . . . . 0.0 113.449 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 68.77 -169.71 41.39 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 122.879 0.276 . . . . 0.0 112.418 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -140.81 9.92 2.19 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.98 0.512 . . . . 0.0 111.6 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.325 -1.819 . . . . 0.0 111.087 -178.177 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -148.18 -61.46 0.25 Allowed 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.563 0.345 . . . . 0.0 110.241 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.2 tp -159.76 167.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 108.279 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 78.6 p -88.78 2.04 54.19 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -136.34 45.63 1.33 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.502 0.721 . . . . 0.0 112.507 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.75 -15.24 30.12 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.607 2.205 . . . . 0.0 111.576 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.9 7.92 80.94 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.781 -0.527 . . . . 0.0 111.781 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -140.62 167.91 21.05 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.511 0.725 . . . . 0.0 110.366 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.7 t 57.99 -172.65 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.678 0.791 . . . . 0.0 112.015 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.9 t0 52.97 30.52 9.49 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.026 0.93 . . . . 0.0 111.845 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.98 24.76 3.58 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.436 1.094 . . . . 0.0 112.52 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 33.3 m 54.11 15.14 0.83 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.391 1.077 . . . . 0.0 113.118 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 50.81 25.61 2.22 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.616 1.166 . . . . 0.0 113.101 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 80.7 p -79.82 152.46 29.71 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.616 0.367 . . . . 0.0 110.831 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 61.1 t -140.31 -64.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -161.26 163.62 30.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.604 0.762 . . . . 0.0 110.279 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.1 p -87.17 15.44 6.21 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.248 0.619 . . . . 0.0 111.606 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.71 137.92 45.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 123.158 0.583 . . . . 0.0 111.073 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.06 163.31 24.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.376 0.607 . . . . 0.0 111.266 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.1 tp -125.09 132.41 53.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.871 1.268 . . . . 0.0 108.191 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -117.84 146.96 43.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.667 0.787 . . . . 0.0 109.845 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 72.9 m -136.59 144.39 44.1 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.43 136.62 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 63.3 mt -99.71 -26.42 14.06 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -174.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -135.88 66.77 62.93 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 123.67 0.788 . . . . 0.0 109.687 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -75.11 52.64 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 125.133 3.889 . . . . 0.0 112.398 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.4 pt -78.79 -1.75 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 121.724 -0.61 . . . . 0.0 111.641 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -136.54 168.85 18.7 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.268 1.027 . . . . 0.0 109.36 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.9 m -79.12 150.5 31.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.853 0.359 . . . . 0.0 111.483 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.4 mm -134.31 138.73 49.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.4 p -142.18 174.53 10.52 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 122.934 0.493 . . . . 0.0 110.018 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 38.5 p -63.19 -21.45 66.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.203 0.201 . . . . 0.0 111.109 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.81 -27.91 33.4 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.38 0.272 . . . . 0.0 111.222 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.9 t -78.96 -37.8 20.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 89.2 mt -76.79 -22.49 53.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.274 -0.266 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -77.88 -34.32 51.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.973 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -76.88 -21.71 54.53 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.386 0.539 . . . . 0.0 111.294 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 44.8 pt -90.62 -21.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.969 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.7 m -96.58 -21.66 17.53 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.507 0.594 . . . . 0.0 112.257 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.447 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.1 t-20 -60.26 -44.3 95.79 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.434 -0.793 . . . . 0.0 113.111 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 97.8 Cg_endo -72.39 -9.43 24.2 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.039 1.826 . . . . 0.0 112.103 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 76.9 m -94.67 -20.5 19.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.99 0.359 . . . . 0.0 111.217 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.54 167.32 23.82 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.44 113.27 3.07 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.799 2.999 . . . . 0.0 110.886 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.7 t -87.21 150.45 3.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -112.35 -36.73 5.2 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.159 0.584 . . . . 0.0 110.796 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -164.35 159.17 19.46 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 117.993 0.36 . . . . 0.0 111.882 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 42.4 mt -144.34 142.35 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.01 0.924 . . . . 0.0 109.354 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 m -138.4 154.63 27.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 122.72 0.408 . . . . 0.0 110.239 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.4 mm -114.27 152.07 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.604 0.762 . . . . 0.0 111.062 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -136.01 140.96 44.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.973 0.909 . . . . 0.0 108.775 173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -142.85 23.43 1.9 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -108.47 139.54 43.07 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.18 0.592 . . . . 0.0 109.804 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 62.1 t30 51.04 22.29 1.2 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.459 1.104 . . . . 0.0 112.6 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 149.57 -161.47 28.82 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -141.47 126.48 17.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.292 0.568 . . . . 0.0 109.768 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -150.74 171.91 16.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.071 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.57 166.47 31.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.409 0.683 . . . . 0.0 109.339 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 87.4 mtp -135.94 150.26 49.22 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.05 148.23 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 122.918 0.487 . . . . 0.0 109.881 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.9 138.91 48.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -115.24 169.33 9.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.922 0.889 . . . . 0.0 111.065 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.79 -16.64 61.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.574 0.35 . . . . 0.0 111.549 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.5 p -152.57 159.9 43.24 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.612 0.365 . . . . 0.0 110.684 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.39 -25.75 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -70.72 -25.2 62.83 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.305 -0.247 . . . . 0.0 110.405 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.9 m -80.37 -28.53 37.97 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.64 -25.78 41.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.381 -0.2 . . . . 0.0 110.528 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -69.68 -37.02 76.5 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 48.4 ttt-85 -78.92 -26.66 43.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 121.897 0.079 . . . . 0.0 110.936 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.25 -48.89 66.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.036 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -14.41 59.27 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 118.57 0.623 . . . . 0.0 111.663 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -84.67 -9.92 57.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.653 -0.213 . . . . 0.0 111.191 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -124.71 -1.44 7.94 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.0 mt -132.07 -5.52 3.49 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -77.21 131.24 38.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.021 0.828 . . . . 0.0 109.244 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.25 5.76 67.45 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.29 179.28 7.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.609 0.704 . . . . 0.0 111.281 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -139.43 157.98 44.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.853 0.861 . . . . 0.0 108.807 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 57.1 mt -106.46 -21.92 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -122.35 35.07 4.97 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.192 0.451 . . . . 0.0 112.057 -174.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.5 m 57.41 19.11 4.89 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.799 0.84 . . . . 0.0 111.637 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 163.89 162.03 14.09 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 9.1 p 47.61 -172.99 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.333 1.453 . . . . 0.0 113.092 -176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.0 m 46.68 36.09 3.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.109 0.564 . . . . 0.0 111.384 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.4 m -60.38 137.93 58.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.692 0.397 . . . . 0.0 109.955 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.3 mt -98.85 156.17 17.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.206 0.602 . . . . 0.0 112.314 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -144.09 134.11 24.1 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 81.2 mt -128.53 148.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-O 121.217 0.532 . . . . 0.0 111.562 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -154.3 169.49 23.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.075 1.35 . . . . 0.0 108.488 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -83.37 143.08 30.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.831 -0.543 . . . . 0.0 110.449 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.84 169.38 11.65 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -85.07 -26.51 0.37 Allowed Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.6 Cg_endo -82.03 165.26 17.31 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 CA-C-N 122.069 1.775 . . . . 0.0 109.927 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.9 p -94.3 -7.79 40.86 Favored 'General case' 0 CA--C 1.527 0.073 0 O-C-N 122.245 -0.284 . . . . 0.0 111.419 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.88 169.53 24.57 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.806 0.842 . . . . 0.0 109.939 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 84.1 mt -121.05 167.75 12.28 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.501 0.72 . . . . 0.0 109.565 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -129.85 154.13 47.59 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.681 0.277 . . . . 0.0 110.374 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 87.6 t -136.86 151.14 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.221 1.008 . . . . 0.0 108.866 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -123.43 -19.99 5.73 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.856 0.463 . . . . 0.0 111.324 -174.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -164.7 168.29 18.15 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.891 1.276 . . . . 0.0 108.7 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -116.96 109.27 16.81 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 121.016 0.436 . . . . 0.0 110.648 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -154.51 -172.14 4.1 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.789 1.236 . . . . 0.0 109.506 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -69.88 -4.85 22.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -114.1 -15.46 12.25 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 118.732 0.696 . . . . 0.0 111.826 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.2 t -159.43 134.75 8.32 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -152.23 148.31 27.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.121 -0.362 . . . . 0.0 111.153 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -125.64 132.5 52.45 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.44 0.696 . . . . 0.0 109.436 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -109.38 2.19 20.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.628 0.771 . . . . 0.0 112.137 -173.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t -117.84 -2.79 11.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.947 0.499 . . . . 0.0 110.499 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -67.61 123.5 86.96 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.626 1.17 . . . . 0.0 109.585 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.67 -16.67 25.6 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.816 3.011 . . . . 0.0 113.875 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -93.81 -28.89 15.63 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.159 0.436 . . . . 0.0 111.172 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 21.3 tp 55.35 -2.86 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.803 1.641 . . . . 0.0 114.882 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 89.5 p -152.46 11.83 0.53 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.943 0.792 . . . . 0.0 112.36 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -168.33 -176.05 38.41 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.43 5.64 3.22 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.222 0.609 . . . . 0.0 112.156 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 117.433 -1.76 . . . . 0.0 110.751 -179.899 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -148.87 174.8 11.85 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.177 0.591 . . . . 0.0 110.399 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.35 156.32 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.332 0.653 . . . . 0.0 110.117 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 81.0 p -80.1 1.01 29.6 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -139.37 62.08 22.98 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.9 0.88 . . . . 0.0 110.413 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.88 141.78 66.45 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.823 2.349 . . . . 0.0 110.677 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.77 8.5 72.77 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.499 -0.611 . . . . 0.0 112.826 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -144.7 153.4 41.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.251 1.026 . . . . 0.0 111.468 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.9 t -158.64 177.77 10.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.636 0.374 . . . . 0.0 110.916 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 61.1 165.42 0.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.898 1.679 . . . . 0.0 114.265 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 186' ' ' ARG . 49.9 m-20 57.74 -3.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.262 1.825 . . . . 0.0 114.623 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 37.3 m 55.35 -0.53 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.759 1.624 . . . . 0.0 114.294 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.432 ' H ' ' C ' ' A' ' 184' ' ' ASP . 29.9 mmt180 52.11 -173.47 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.315 1.446 . . . . 0.0 113.206 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.4 m -71.86 158.24 36.42 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.332 0.653 . . . . 0.0 111.023 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.01 -65.88 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.337 0.065 0 C-N-CA 122.57 0.348 . . . . 0.0 110.542 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -158.78 160.46 36.31 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.124 0.57 . . . . 0.0 110.482 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.8 p -89.68 13.68 13.59 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.194 0.597 . . . . 0.0 112.127 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.56 145.62 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 122.6 0.36 . . . . 0.0 110.721 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.3 mt -130.34 165.06 23.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.266 0.626 . . . . 0.0 111.586 -174.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 63.8 tp -123.89 133.01 53.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.565 1.146 . . . . 0.0 108.432 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -119.95 144.98 47.18 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.76 0.824 . . . . 0.0 109.994 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.1 m -138.1 142.93 40.21 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.54 136.53 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.9 mt -92.4 -34.58 14.1 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -134.35 67.42 72.4 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 123.634 0.773 . . . . 0.0 109.34 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.13 64.59 4.26 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.666 3.577 . . . . 0.0 112.113 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 45.6 pt -83.84 -4.5 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.993 -0.442 . . . . 0.0 111.202 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -129.38 166.24 19.93 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 109.379 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 77.9 p -80.54 156.61 26.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.642 0.258 . . . . 0.0 111.121 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mm -136.21 139.96 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 70.7 p -143.25 172.36 12.85 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.066 0.546 . . . . 0.0 110.007 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.6 p -62.04 -24.97 67.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.24 0.216 . . . . 0.0 110.991 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -78.92 -27.57 43.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.346 0.258 . . . . 0.0 111.352 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.15 -38.58 18.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.878 0.37 . . . . 0.0 110.025 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.35 -22.97 54.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.218 -0.301 . . . . 0.0 110.561 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -78.65 -35.22 45.69 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.914 0.324 . . . . 0.0 110.879 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.2 t -74.73 -23.56 58.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.242 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 pt -89.05 -21.41 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 118.379 0.536 . . . . 0.0 111.955 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 87.6 m -95.74 -19.3 19.78 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.302 0.501 . . . . 0.0 112.182 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.43 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.6 t-20 -60.39 -44.08 94.87 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 92.7 Cg_endo -73.06 -10.81 24.89 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.706 1.604 . . . . 0.0 111.995 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 77.5 m -89.4 -23.7 22.1 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.161 0.437 . . . . 0.0 111.249 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.86 171.78 30.52 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.1 111.43 2.68 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.553 2.835 . . . . 0.0 110.556 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.47 151.45 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -116.06 -39.1 3.49 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.064 0.546 . . . . 0.0 110.907 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -161.67 158.48 26.08 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.402 0.546 . . . . 0.0 112.062 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 41.2 mt -144.89 143.93 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 124.364 1.066 . . . . 0.0 109.721 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.4 m -141.69 149.52 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 123.288 0.635 . . . . 0.0 109.857 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.41 151.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.765 0.826 . . . . 0.0 109.81 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -137.07 150.47 48.06 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.977 0.911 . . . . 0.0 109.9 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.34 16.24 1.86 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.0 -29.46 68.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.623 0.369 . . . . 0.0 110.497 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -151.8 123.94 8.18 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 58.13 -143.25 43.65 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.3 t -131.39 130.86 63.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -143.69 166.08 25.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.346 0.658 . . . . 0.0 109.891 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.05 171.64 20.1 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.528 0.331 . . . . 0.0 110.218 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.8 mtp -138.78 149.95 45.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.28 151.37 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -135.5 140.74 45.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.564 0.746 . . . . 0.0 109.818 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -120.03 167.74 11.87 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.851 0.861 . . . . 0.0 110.854 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.51 -11.21 59.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.616 0.366 . . . . 0.0 111.349 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 42.9 t -152.18 151.45 31.03 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.151 0.581 . . . . 0.0 110.088 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.11 -25.71 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.54 -24.38 62.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.009 -0.432 . . . . 0.0 110.14 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 41.2 m -80.35 -27.2 38.35 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.75 -26.42 37.32 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.243 0.217 . . . . 0.0 110.424 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -68.46 -37.64 80.36 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -78.68 -24.79 44.86 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.99 -50.63 54.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.319 -0.238 . . . . 0.0 111.197 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -14.57 59.45 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.626 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.22 -8.54 58.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.835 0.289 . . . . 0.0 111.555 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.8 t -125.6 -6.79 6.88 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.3 mt -124.49 -5.33 7.67 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -77.71 131.36 37.66 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.82 5.05 73.41 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.563 -0.576 . . . . 0.0 111.827 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.86 177.57 8.95 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.833 0.816 . . . . 0.0 111.093 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -138.64 160.38 39.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.758 0.823 . . . . 0.0 109.371 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.4 mt -112.37 -20.89 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -120.95 28.82 7.69 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.6 t 58.14 15.44 3.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.973 0.909 . . . . 0.0 112.05 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 170.4 145.48 4.75 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 75.2 m 53.83 -172.58 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.754 0.822 . . . . 0.0 111.852 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.3 m 50.3 33.48 7.5 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.198 0.599 . . . . 0.0 111.222 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.0 m -60.56 139.59 57.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.937 0.495 . . . . 0.0 110.041 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.0 mt -95.24 154.51 17.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.372 0.669 . . . . 0.0 111.756 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -145.56 129.15 17.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 81.0 mt -129.29 147.69 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 CA-C-O 121.171 0.51 . . . . 0.0 112.216 -171.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.36 173.56 15.47 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.679 1.191 . . . . 0.0 108.547 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -83.23 143.56 30.36 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.976 -0.452 . . . . 0.0 110.675 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.18 167.33 17.84 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.068 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -74.64 -46.88 5.43 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 118.298 -0.858 . . . . 0.0 113.273 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -74.9 177.53 8.43 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.353 2.035 . . . . 0.0 110.539 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.2 p -108.49 -7.79 15.69 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.592 0.357 . . . . 0.0 111.534 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.77 136.49 14.4 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 56.4 mt -88.05 171.09 10.53 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 122.731 0.412 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -131.93 151.7 51.55 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.549 0.34 . . . . 0.0 110.369 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.3 153.69 24.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 124.171 0.988 . . . . 0.0 108.786 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -126.94 -19.62 4.39 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.57 0.348 . . . . 0.0 111.437 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -165.56 170.46 14.27 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 124.505 1.122 . . . . 0.0 109.011 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -117.06 109.42 16.94 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.619 0.368 . . . . 0.0 110.411 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -154.93 -172.13 4.08 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.585 1.154 . . . . 0.0 109.627 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -69.75 -4.86 21.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -115.2 -17.29 11.41 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.121 0.873 . . . . 0.0 111.779 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.6 t -156.68 134.81 11.2 Favored 'General case' 0 N--CA 1.458 -0.055 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -152.61 147.36 26.06 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.758 0.314 . . . . 0.0 111.212 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -124.43 119.76 30.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -95.66 -4.68 43.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.281 0.632 . . . . 0.0 111.568 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.5 t -111.89 15.51 20.76 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.335 0.588 . . . . 0.0 110.124 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -68.89 124.81 91.09 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 123.765 0.826 . . . . 0.0 109.755 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.08 -17.89 26.76 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.272 2.648 . . . . 0.0 113.197 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -89.12 -0.29 57.31 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.538 0.335 . . . . 0.0 111.591 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 56.9 tp -117.34 -19.56 9.51 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.366 0.666 . . . . 0.0 110.515 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.6 p -96.73 -4.14 41.21 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.016 0.526 . . . . 0.0 111.441 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.41 171.07 54.88 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -141.32 10.04 2.09 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.065 0.546 . . . . 0.0 111.927 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.305 -1.831 . . . . 0.0 110.824 -179.189 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -143.47 159.44 42.4 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.007 0.523 . . . . 0.0 110.229 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.3 tp -64.31 155.81 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.324 0.65 . . . . 0.0 110.659 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.0 p -68.88 159.25 32.92 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.695 0.398 . . . . 0.0 111.001 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 45.69 55.21 14.74 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.606 0.762 . . . . 0.0 110.843 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.0 164.8 34.5 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.335 2.69 . . . . 0.0 111.46 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.69 5.35 0.02 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.743 -0.476 . . . . 0.0 112.286 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -148.0 153.94 39.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.891 0.845 . . . . 0.0 110.467 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.1 t 61.97 151.31 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.658 1.583 . . . . 0.0 113.409 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.4 p30 45.64 22.88 0.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.818 1.647 . . . . 0.0 113.764 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.4 t70 57.05 13.05 1.41 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.472 1.109 . . . . 0.0 113.251 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 50.0 m 53.24 20.27 1.81 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.902 1.281 . . . . 0.0 114.078 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.401 ' HG3' ' H ' ' A' ' 187' ' ' SER . 0.0 OUTLIER 61.31 164.63 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.021 1.329 . . . . 0.0 113.668 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.401 ' H ' ' HG3' ' A' ' 186' ' ' ARG . 8.6 t 57.42 -178.29 0.06 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.758 1.223 . . . . 0.0 112.582 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.7 t -136.68 -93.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 122.621 0.368 . . . . 0.0 110.518 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -154.65 169.82 22.98 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.293 0.637 . . . . 0.0 110.76 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.0 p -82.96 10.13 8.59 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.5 t -109.43 136.56 44.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 122.815 0.446 . . . . 0.0 110.611 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.5 mt -125.1 161.43 26.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.754 0.788 . . . . 0.0 111.373 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.0 tp -126.17 131.44 52.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.035 1.334 . . . . 0.0 107.51 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -118.09 145.16 45.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.69 0.796 . . . . 0.0 109.406 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.3 m -139.49 141.54 37.34 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.2 mp -105.7 135.3 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.4 mt -94.02 -36.55 12.08 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -173.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -129.87 62.78 65.68 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 123.368 0.667 . . . . 0.0 110.082 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.45 101.96 0.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.947 2.431 . . . . 0.0 110.717 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.0 pt -128.26 3.07 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.788 0.435 . . . . 0.0 111.402 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -131.67 166.47 21.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.855 0.862 . . . . 0.0 109.457 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.5 m -73.91 145.8 44.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.787 0.327 . . . . 0.0 111.32 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.5 mm -137.49 136.79 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.6 p -145.04 172.27 13.3 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.529 0.732 . . . . 0.0 109.636 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.9 p -63.77 -20.76 66.02 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 122.327 -0.233 . . . . 0.0 110.931 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -79.7 -27.37 40.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.326 0.25 . . . . 0.0 110.888 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.2 t -81.51 -37.64 15.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.66 -28.54 62.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.185 -0.322 . . . . 0.0 110.599 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -74.28 -37.96 63.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.991 -0.443 . . . . 0.0 111.044 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.7 t -74.11 -20.99 60.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.555 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.3 pt -88.85 -23.55 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.184 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 16.6 p -109.69 -6.83 15.2 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.44 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.16 -42.79 87.82 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.562 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 94.4 Cg_endo -72.85 -7.02 20.07 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.805 1.67 . . . . 0.0 112.089 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 65.7 m -86.02 -21.86 27.57 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.062 0.392 . . . . 0.0 111.213 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.8 176.7 32.17 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.77 107.83 1.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.975 3.117 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.09 149.47 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -112.61 -39.05 4.44 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.474 0.31 . . . . 0.0 111.003 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -167.18 161.75 14.72 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 117.967 0.349 . . . . 0.0 111.911 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.4 mt -143.07 139.76 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.205 1.002 . . . . 0.0 109.145 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.17 157.8 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.8 mt -128.92 151.78 36.17 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.053 0 C-N-CA 122.875 0.47 . . . . 0.0 111.014 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -138.97 145.1 39.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.781 0.833 . . . . 0.0 109.574 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.85 15.48 2.3 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -79.22 -9.21 59.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.067 0.547 . . . . 0.0 111.613 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -135.06 12.75 3.6 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.219 0.608 . . . . 0.0 112.125 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 137.71 -128.99 4.47 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 108.926 -1.669 . . . . 0.0 108.926 -174.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.5 t -133.87 112.79 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -144.84 163.69 33.32 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 122.832 0.453 . . . . 0.0 110.303 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.55 172.14 17.04 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.418 0.287 . . . . 0.0 110.58 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 85.0 mtp -141.39 152.41 44.31 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 46.5 t -139.73 149.86 22.36 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.032 0 C-N-CA 123.02 0.528 . . . . 0.0 109.607 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -132.91 140.48 47.89 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -117.33 169.07 9.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.045 0.938 . . . . 0.0 110.974 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.56 -11.15 59.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.061 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.9 t -150.59 149.65 30.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.211 0.604 . . . . 0.0 110.111 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.45 -26.37 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -70.94 -23.63 62.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.961 -0.462 . . . . 0.0 110.316 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.9 m -80.11 -28.31 39.02 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.22 -27.86 42.5 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.519 0.199 . . . . 0.0 110.793 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -67.26 -36.02 80.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -82.47 -27.09 32.06 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.73 0.412 . . . . 0.0 111.698 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.16 -44.16 72.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.06 -0.4 . . . . 0.0 110.399 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -27.94 64.81 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -77.66 -8.53 58.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.819 -0.551 . . . . 0.0 111.712 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.6 m -121.07 -5.5 9.51 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.45 -8.75 2.53 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -74.57 131.15 40.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.735 1.152 . . . . 0.0 108.845 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 71.88 6.17 63.05 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.386 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.33 -179.06 7.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.83 0.815 . . . . 0.0 111.387 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -140.28 163.15 33.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.897 0.879 . . . . 0.0 109.456 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.0 mt -114.89 -17.4 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -125.24 31.14 5.65 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.022 -0.424 . . . . 0.0 112.051 -175.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.0 m 56.69 16.66 2.73 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.808 0.843 . . . . 0.0 112.346 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 165.77 148.77 5.64 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 82.7 m 54.72 -177.42 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.922 0.889 . . . . 0.0 111.922 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 79.8 m 49.36 32.71 4.73 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.094 0.558 . . . . 0.0 111.182 -174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.7 m -59.94 139.22 57.54 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.044 0.538 . . . . 0.0 109.896 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 64.9 mt -93.71 154.64 17.68 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.433 0.693 . . . . 0.0 111.799 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -144.06 123.1 12.83 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.6 mt -123.82 145.53 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-O 120.98 0.419 . . . . 0.0 111.575 -173.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -155.02 172.68 17.71 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.818 1.247 . . . . 0.0 108.498 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -85.81 147.25 26.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.11 -0.369 . . . . 0.0 110.858 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -95.7 165.74 12.16 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.657 0.383 . . . . 0.0 110.816 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -80.72 -27.17 0.45 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 47.6 Cg_endo -80.66 160.44 21.91 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 CA-C-N 121.965 1.738 . . . . 0.0 110.047 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 43.0 p -89.87 -10.44 45.29 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.6 0.36 . . . . 0.0 111.257 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 168.73 26.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.612 0.765 . . . . 0.0 110.074 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -119.93 172.69 7.55 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.093 0.957 . . . . 0.0 109.691 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -134.28 154.64 51.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.292 -0.255 . . . . 0.0 110.404 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 70.7 t -136.77 150.52 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.747 0.819 . . . . 0.0 108.885 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -122.75 -20.56 5.87 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.482 0.313 . . . . 0.0 111.358 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -165.23 169.98 15.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.176 0.99 . . . . 0.0 109.414 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -116.47 116.37 27.54 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.023 0.44 . . . . 0.0 110.519 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -159.87 -172.54 3.69 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.338 1.455 . . . . 0.0 109.384 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.75 -1.32 11.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.46 -19.93 8.64 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.622 0.646 . . . . 0.0 111.944 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 2.8 t -153.68 137.11 15.84 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -153.84 149.44 27.37 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.221 -0.299 . . . . 0.0 111.394 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -128.34 138.07 52.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.275 0.63 . . . . 0.0 109.62 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -115.9 6.93 14.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.582 0.753 . . . . 0.0 112.461 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t -122.7 -9.55 8.38 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.843 0.457 . . . . 0.0 111.163 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -70.13 126.14 92.27 Favored Pre-proline 0 N--CA 1.452 -0.336 0 C-N-CA 123.895 0.878 . . . . 0.0 109.089 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.99 -6.09 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.859 3.04 . . . . 0.0 113.578 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -114.4 19.92 15.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.704 0.802 . . . . 0.0 111.567 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -63.82 -6.27 5.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -134.67 17.18 3.6 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.589 0.756 . . . . 0.0 110.961 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 78.07 -170.38 54.88 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -129.06 6.48 5.42 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.596 0.758 . . . . 0.0 111.14 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.21 0 CA-C-O 117.372 -1.793 . . . . 0.0 110.883 -179.721 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 120.392 0.139 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -85.23 162.16 19.28 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.755 0.422 . . . . 0.0 109.98 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.25 151.61 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 122.396 0.278 . . . . 0.0 110.61 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.3 m -76.62 -2.35 32.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.003 0.521 . . . . 0.0 112.396 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -139.74 76.26 29.63 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.92 -5.3 16.62 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.733 2.955 . . . . 0.0 112.041 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.52 -5.9 86.29 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -148.85 150.15 32.52 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.697 0.749 . . . . 0.0 110.045 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 42.3 m 53.78 -167.94 0.07 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.451 0.701 . . . . 0.0 112.326 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.5 t0 59.64 172.4 0.08 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.275 1.03 . . . . 0.0 112.253 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.4 t70 51.75 35.34 14.99 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.07 0.548 . . . . 0.0 111.422 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 66.7 p 53.06 20.81 1.86 Allowed 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.937 1.295 . . . . 0.0 113.214 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 53.03 29.96 8.79 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.409 1.083 . . . . 0.0 111.652 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 44.9 t -63.33 143.89 57.42 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.136 0.574 . . . . 0.0 111.349 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.07 -45.81 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.783 0.433 . . . . 0.0 110.329 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -164.49 166.21 20.65 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.429 0.692 . . . . 0.0 110.486 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.2 p -99.61 18.87 16.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.483 0.713 . . . . 0.0 111.955 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.6 143.92 33.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 C-N-CA 123.003 0.521 . . . . 0.0 110.696 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.5 mt -129.68 163.24 26.55 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.149 0.58 . . . . 0.0 111.365 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.3 tp -121.2 133.68 55.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.989 1.316 . . . . 0.0 108.054 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -119.61 145.58 46.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.521 0.728 . . . . 0.0 109.738 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.6 m -140.62 144.49 35.8 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.68 135.25 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.1 mt -91.77 -35.67 13.99 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -130.79 61.71 61.0 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 123.575 0.75 . . . . 0.0 110.184 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.98 101.79 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.78 2.32 . . . . 0.0 110.784 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.0 pt -125.72 0.22 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.95 0.5 . . . . 0.0 111.339 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.13 166.47 21.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.711 0.804 . . . . 0.0 109.264 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.5 m -73.53 151.68 40.9 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.81 0.338 . . . . 0.0 111.563 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.5 mm -138.71 135.24 43.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 68.4 p -146.46 176.35 9.87 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.149 0.58 . . . . 0.0 110.1 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.2 p -62.38 -25.55 67.98 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 122.435 0.294 . . . . 0.0 111.209 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -80.54 -20.61 43.08 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.545 0.338 . . . . 0.0 111.461 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 88.6 t -90.56 -37.82 9.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.4 mt -77.31 -22.53 51.81 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.254 -0.279 . . . . 0.0 110.715 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -78.8 -36.1 43.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.924 0.329 . . . . 0.0 110.903 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.9 t -77.0 -17.31 58.93 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.996 -0.44 . . . . 0.0 111.395 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.41 -17.57 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.913 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 88.8 m -95.7 -25.3 16.16 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.91 0.777 . . . . 0.0 111.859 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.453 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.2 t-20 -59.71 -42.2 90.1 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 83.6 Cg_endo -71.1 -4.54 15.1 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.962 1.775 . . . . 0.0 112.1 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 72.4 m -107.52 -11.68 15.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.223 0.465 . . . . 0.0 111.335 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.7 165.05 15.87 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.42 114.39 3.79 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.897 3.064 . . . . 0.0 110.67 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.2 t -86.56 151.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -113.34 -36.39 5.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.162 0.585 . . . . 0.0 110.554 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -164.04 159.88 21.08 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.8 mt -144.49 145.79 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.361 1.064 . . . . 0.0 109.92 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.476 HG13 ' HG1' ' A' ' 279' ' ' THR . 34.3 m -138.37 150.39 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 C-N-CA 123.265 0.626 . . . . 0.0 109.45 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.28 151.06 32.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 C-N-CA 123.077 0.551 . . . . 0.0 110.872 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -128.93 137.65 51.53 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -140.05 23.41 2.4 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -118.77 142.32 47.81 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 35.7 m120 53.05 20.29 1.67 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.924 0.89 . . . . 0.0 112.474 -174.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 145.89 -171.88 26.72 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.45 125.06 42.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 117.348 0.574 . . . . 0.0 109.517 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -148.58 168.97 21.38 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.932 0.893 . . . . 0.0 109.529 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.77 170.15 23.11 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.9 mtp -138.49 151.52 47.45 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 43.7 t -138.4 149.49 24.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 C-N-CA 122.645 0.378 . . . . 0.0 110.424 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -132.43 138.88 47.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.728 0.811 . . . . 0.0 109.147 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -117.04 167.85 10.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.445 0.698 . . . . 0.0 110.797 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -75.99 -15.37 60.16 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.237 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.6 t -152.23 153.49 33.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.241 0.616 . . . . 0.0 110.057 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.89 -27.08 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -68.17 -24.13 64.94 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.926 -0.484 . . . . 0.0 109.854 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.9 m -81.47 -27.9 34.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.424 0.29 . . . . 0.0 110.395 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.15 -25.21 37.03 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -70.02 -37.5 75.64 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -77.49 -26.6 51.41 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 122.277 -0.265 . . . . 0.0 110.494 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.55 -53.59 39.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.951 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -14.34 60.13 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.622 0.647 . . . . 0.0 111.976 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.85 -12.67 55.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.1 -0.375 . . . . 0.0 111.855 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.0 m -129.67 1.72 4.95 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 77.0 mt -128.46 -4.27 5.41 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.65 0.659 . . . . 0.0 112.717 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -78.78 132.04 36.75 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.6 4.51 70.51 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.016 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.74 177.59 8.54 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.634 0.717 . . . . 0.0 110.866 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -140.39 161.18 38.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.466 0.706 . . . . 0.0 109.287 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.8 mt -115.81 -15.57 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -122.24 28.32 7.53 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.898 -0.501 . . . . 0.0 112.222 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 25.5 m 57.64 14.75 2.52 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.043 0.937 . . . . 0.0 112.247 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 168.44 148.79 5.87 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 65.0 m 54.63 -176.31 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.665 0.786 . . . . 0.0 111.862 -176.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.4 m 50.09 31.74 5.22 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.915 0.486 . . . . 0.0 111.438 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 16.7 m -59.55 138.22 57.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.78 0.432 . . . . 0.0 110.081 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 62.6 mt -91.68 156.78 17.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.322 0.649 . . . . 0.0 112.053 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -140.76 137.91 33.75 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 77.7 mt -133.82 141.62 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.135 0.493 . . . . 0.0 111.489 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.75 167.94 27.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.782 1.233 . . . . 0.0 108.232 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -78.41 144.55 35.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.808 -0.558 . . . . 0.0 110.812 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.87 165.68 17.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.508 0.323 . . . . 0.0 110.265 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -81.06 -27.24 0.45 Allowed Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -176.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 46.2 Cg_endo -81.67 178.34 6.67 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.838 1.692 . . . . 0.0 109.913 177.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 69.2 p -105.09 -9.0 18.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.432 0.293 . . . . 0.0 111.089 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.92 168.03 27.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.835 0.854 . . . . 0.0 109.976 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 94.4 mt -127.11 170.43 12.36 Favored 'General case' 0 N--CA 1.459 0.014 0 C-N-CA 123.659 0.784 . . . . 0.0 109.817 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -138.76 163.85 31.1 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.397 0.618 . . . . 0.0 111.673 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 38.7 t -140.51 156.2 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 124.695 1.198 . . . . 0.0 108.555 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -125.61 -21.92 4.37 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.504 0.322 . . . . 0.0 111.678 -174.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -163.6 169.1 19.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.381 1.072 . . . . 0.0 108.91 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -115.71 110.01 18.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.121 0.486 . . . . 0.0 110.438 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -155.32 -170.24 3.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.009 1.323 . . . . 0.0 109.335 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -72.67 -2.51 20.44 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -119.6 -15.82 8.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.893 0.77 . . . . 0.0 112.006 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' THR . . . . . 0.476 ' HG1' HG13 ' A' ' 222' ' ' VAL . 3.7 t -154.76 135.01 13.2 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -157.96 145.25 18.18 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.266 -0.271 . . . . 0.0 110.871 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -129.19 141.14 51.24 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.575 0.703 . . . . 0.0 111.311 171.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -108.58 -9.81 15.29 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.558 0.743 . . . . 0.0 111.816 -174.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.3 t -89.82 1.9 55.59 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.089 0.556 . . . . 0.0 110.23 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -78.99 123.03 85.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.57 1.148 . . . . 0.0 110.083 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.67 -14.56 24.53 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.486 2.791 . . . . 0.0 112.27 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -107.82 -8.86 15.88 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.815 0.446 . . . . 0.0 110.99 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 14.8 tp 49.12 26.94 1.58 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.459 1.104 . . . . 0.0 111.979 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.6 m -138.63 162.72 33.92 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.526 0.73 . . . . 0.0 110.898 -176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.07 175.88 47.51 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 116.609 -0.269 . . . . 0.0 112.554 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -87.04 1.44 52.9 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.824 0.449 . . . . 0.0 112.09 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 CA-C-O 117.195 -1.892 . . . . 0.0 110.617 -179.223 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -147.29 165.02 31.37 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.2 tp -60.57 153.63 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.317 0.647 . . . . 0.0 110.412 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 76.9 p -71.97 -7.32 48.01 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.428 0.691 . . . . 0.0 112.701 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -144.07 85.38 9.0 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.557 0.743 . . . . 0.0 109.477 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.49 -13.38 18.42 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.485 2.79 . . . . 0.0 111.219 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.78 178.65 53.91 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.336 -0.705 . . . . 0.0 111.336 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -148.0 155.49 41.59 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 122.851 0.46 . . . . 0.0 110.31 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 184' ' ' ASP . 47.3 p 54.9 -178.57 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.668 1.587 . . . . 0.0 113.564 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.6 t70 62.92 -23.07 0.05 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.197 1.799 . . . . 0.0 114.775 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 182' ' ' SER . 25.0 t0 48.8 27.65 1.64 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.576 1.15 . . . . 0.0 113.125 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 31.7 m 56.55 11.93 0.97 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.478 1.111 . . . . 0.0 113.299 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 54.66 -177.42 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 125.207 1.403 . . . . 0.0 113.361 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 47.5 t -151.97 149.63 29.12 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 123.944 0.898 . . . . 0.0 108.963 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.83 -44.93 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -164.25 169.65 17.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.392 0.542 . . . . 0.0 111.214 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.7 p -97.76 15.89 22.3 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.809 0.843 . . . . 0.0 111.021 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.08 138.74 38.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 C-N-CA 123.615 0.766 . . . . 0.0 110.703 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.0 mt -127.35 159.91 32.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.298 0.57 . . . . 0.0 111.54 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.9 tp -124.2 130.51 52.66 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.017 1.327 . . . . 0.0 107.764 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -115.1 145.03 42.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.401 0.68 . . . . 0.0 109.684 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.9 m -139.44 144.38 38.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.17 136.94 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 75.4 mt -93.77 -34.87 13.03 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -130.09 63.15 67.83 Favored Pre-proline 0 CA--C 1.528 0.114 0 C-N-CA 123.162 0.585 . . . . 0.0 109.951 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.58 101.71 0.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.766 2.31 . . . . 0.0 110.881 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.58 2.5 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 122.774 0.429 . . . . 0.0 111.29 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -134.98 166.89 21.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.814 0.845 . . . . 0.0 109.314 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 33.1 t -78.54 151.44 32.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.794 0.331 . . . . 0.0 110.975 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.1 mm -136.83 137.16 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.6 p -143.52 176.72 8.97 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 123.148 0.579 . . . . 0.0 110.053 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.1 p -62.34 -23.25 66.66 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.696 0.399 . . . . 0.0 111.195 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -82.2 -23.75 35.27 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.84 0.291 . . . . 0.0 111.274 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 83.6 t -83.97 -37.64 13.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.84 -21.52 47.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.039 -0.413 . . . . 0.0 110.848 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -77.6 -34.39 53.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.171 0.441 . . . . 0.0 110.848 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.3 t -76.91 -22.34 53.51 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.268 0.485 . . . . 0.0 111.354 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.2 pt -90.18 -22.44 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.491 0.587 . . . . 0.0 111.791 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.4 m -94.66 -23.07 17.76 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.439 0.563 . . . . 0.0 112.013 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.438 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.3 t-20 -59.75 -44.57 97.54 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 97.2 Cg_endo -72.77 -10.11 24.59 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.863 1.708 . . . . 0.0 111.803 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 74.6 m -93.73 -20.92 19.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.32 0.509 . . . . 0.0 110.95 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 166.35 167.38 26.91 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.12 104.77 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.93 3.087 . . . . 0.0 110.763 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.4 t -78.42 152.0 5.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -115.0 -40.85 3.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.011 0.525 . . . . 0.0 110.828 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.403 HH22 ' CG1' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -163.96 159.51 20.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.53 0.605 . . . . 0.0 112.495 177.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 42.0 mt -142.07 150.64 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 124.104 0.962 . . . . 0.0 110.45 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.403 ' CG1' HH22 ' A' ' 220' ' ' ARG . 7.3 p -141.53 148.62 20.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 C-N-CA 123.739 0.816 . . . . 0.0 109.202 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 38.6 mm -115.54 148.67 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 124.035 0.934 . . . . 0.0 110.418 -174.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -139.09 132.39 29.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.46 21.92 0.93 Allowed 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -68.77 -20.11 64.35 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.186 -0.321 . . . . 0.0 110.607 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -154.81 121.57 5.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 61.73 -154.15 39.68 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.6 t -140.28 127.86 24.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -149.0 168.57 22.76 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.779 0.831 . . . . 0.0 110.094 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.8 167.73 29.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.026 0.531 . . . . 0.0 109.957 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.2 mtp -134.98 142.69 46.53 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.64 151.25 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.16 0.584 . . . . 0.0 110.237 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -135.17 140.79 45.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.44 0.696 . . . . 0.0 109.225 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -118.73 168.02 11.12 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.722 0.809 . . . . 0.0 110.996 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.47 -17.85 61.73 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.88 0.472 . . . . 0.0 111.564 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.0 p -152.37 160.08 43.34 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.626 0.371 . . . . 0.0 110.422 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.74 -28.26 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -64.83 -30.07 71.06 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.925 -0.485 . . . . 0.0 109.877 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 45.0 m -78.24 -28.77 47.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.211 0.204 . . . . 0.0 110.571 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.49 -26.03 38.45 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.212 -0.305 . . . . 0.0 110.639 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -70.56 -36.13 73.46 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -79.77 -24.98 41.15 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.278 -0.264 . . . . 0.0 110.497 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.84 -52.66 40.97 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.162 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -15.49 59.68 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.755 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -80.72 -13.95 58.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.912 0.324 . . . . 0.0 111.721 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.7 m -125.05 1.44 7.95 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.0 mt -129.18 -4.82 4.94 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -77.74 132.73 38.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.8 5.55 64.88 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.218 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.15 179.56 7.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.679 0.74 . . . . 0.0 111.007 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -139.64 163.08 33.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.278 0.631 . . . . 0.0 109.515 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.6 mt -115.69 -18.81 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -120.92 30.96 6.61 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 122.03 -0.419 . . . . 0.0 111.716 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.4 m 57.41 15.73 2.84 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.802 0.841 . . . . 0.0 112.139 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 165.58 150.0 6.09 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 81.9 m 55.02 -176.97 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.61 0.764 . . . . 0.0 111.854 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.8 m 49.93 32.75 5.83 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.973 0.509 . . . . 0.0 111.663 -175.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 14.6 m -59.67 138.81 57.63 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.746 0.418 . . . . 0.0 109.917 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 58.4 mt -92.62 155.47 17.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.276 0.631 . . . . 0.0 112.179 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -143.63 123.62 13.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 74.1 mt -123.78 146.3 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.248 0.547 . . . . 0.0 111.682 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.44 169.27 24.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.677 1.191 . . . . 0.0 108.732 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -78.44 145.53 35.01 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.008 -0.433 . . . . 0.0 110.599 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.86 167.85 15.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.328 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -80.06 -29.27 0.55 Allowed Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.8 Cg_endo -82.68 169.44 13.56 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 121.73 1.653 . . . . 0.0 110.093 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.0 p -99.57 -5.93 28.28 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 122.388 -0.195 . . . . 0.0 110.998 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -152.85 157.04 40.13 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 123.836 0.854 . . . . 0.0 110.634 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 80.2 mt -121.99 175.37 6.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.186 0.994 . . . . 0.0 109.308 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -143.95 165.14 28.57 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.483 0.313 . . . . 0.0 110.926 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.2 t -137.6 157.98 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 124.398 1.079 . . . . 0.0 108.925 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -125.03 -31.36 3.12 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 122.263 -0.273 . . . . 0.0 110.923 -174.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.09 167.78 28.34 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.264 1.025 . . . . 0.0 109.291 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -107.66 118.59 37.15 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.121 0.486 . . . . 0.0 111.148 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.97 -171.64 3.47 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.063 1.345 . . . . 0.0 109.251 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -74.5 -3.69 32.3 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -107.67 -23.68 12.02 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.409 0.55 . . . . 0.0 111.115 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.1 t -158.07 141.08 14.95 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -150.71 151.26 32.16 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.304 -0.248 . . . . 0.0 110.873 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -129.18 135.99 49.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.222 0.609 . . . . 0.0 109.403 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.2 6.03 14.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.549 0.74 . . . . 0.0 112.211 -174.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.0 t -124.42 -9.44 7.47 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.993 0.517 . . . . 0.0 111.211 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -66.87 123.79 86.97 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 123.92 0.888 . . . . 0.0 109.445 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.3 -19.51 35.24 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.733 2.955 . . . . 0.0 113.424 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -84.95 -22.92 29.01 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.985 0.357 . . . . 0.0 111.01 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 17.0 tp 50.11 23.27 1.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.482 1.113 . . . . 0.0 112.517 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.1 p -146.02 -22.52 0.45 Allowed 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.616 -0.677 . . . . 0.0 112.568 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 154.85 176.68 27.36 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.255 0.479 . . . . 0.0 112.252 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -151.36 5.51 0.47 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.903 0.481 . . . . 0.0 112.007 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 CA-C-O 117.575 -1.68 . . . . 0.0 111.326 -179.873 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -145.97 159.42 43.28 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.364 0.666 . . . . 0.0 109.412 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 tt -69.01 153.12 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.1 m -75.95 -1.14 24.17 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -136.5 65.76 56.15 Favored Pre-proline 0 C--N 1.339 0.123 0 C-N-CA 123.944 0.898 . . . . 0.0 109.479 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.29 -18.44 26.63 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.763 2.975 . . . . 0.0 111.658 -175.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 75.13 -18.81 2.43 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.799 0.714 . . . . 0.0 113.051 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -155.27 159.69 40.22 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.002 0.901 . . . . 0.0 110.477 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 t 59.41 167.83 0.06 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.866 1.267 . . . . 0.0 113.696 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.6 p30 47.99 16.0 0.08 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.236 1.815 . . . . 0.0 114.463 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 186' ' ' ARG . 51.5 m-20 51.33 25.3 2.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.298 1.039 . . . . 0.0 112.513 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.0 m 61.87 -19.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.949 1.699 . . . . 0.0 113.993 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -162.58 145.55 11.15 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.706 0.684 . . . . 0.0 110.073 173.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 83.4 p -159.52 153.12 22.69 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.615 0.366 . . . . 0.0 110.301 176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 55.0 t -142.72 -67.45 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -163.99 165.0 22.97 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.11 0.964 . . . . 0.0 109.934 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.7 p -88.58 7.6 32.46 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.835 0.454 . . . . 0.0 111.415 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -104.54 138.51 28.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.552 0.741 . . . . 0.0 111.297 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.09 160.64 32.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.544 0.737 . . . . 0.0 111.507 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 64.4 tp -119.71 133.89 55.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.036 1.334 . . . . 0.0 107.862 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -120.12 147.33 45.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.492 0.717 . . . . 0.0 109.861 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 81.5 m -142.09 145.36 34.2 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.4 mp -109.51 135.91 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 64.8 mt -94.85 -28.73 15.07 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -136.15 68.17 62.62 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 123.911 0.884 . . . . 0.0 109.587 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.55 57.41 4.26 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.704 3.603 . . . . 0.0 112.425 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.87 -3.12 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 O-C-N 121.958 -0.464 . . . . 0.0 111.616 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -130.13 166.59 19.91 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.924 0.89 . . . . 0.0 109.442 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 m -74.8 148.52 40.26 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.939 0.399 . . . . 0.0 111.604 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.9 mm -137.73 138.3 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.3 p -145.47 174.98 10.67 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.208 0.603 . . . . 0.0 109.893 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 38.0 p -63.14 -21.24 66.06 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 122.314 -0.241 . . . . 0.0 111.099 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -81.94 -26.18 34.25 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.024 0.375 . . . . 0.0 111.048 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.06 -38.59 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 86.3 mt -76.95 -22.92 52.52 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.921 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -76.3 -36.14 58.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 117.96 0.346 . . . . 0.0 110.785 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.1 t -78.11 -18.68 55.36 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.14 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -95.84 -14.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 118.348 0.522 . . . . 0.0 112.028 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 78.3 m -98.21 -24.36 15.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.869 0.758 . . . . 0.0 112.25 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.422 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 48.6 t30 -64.18 -38.87 38.34 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 86.1 Cg_endo -73.66 -0.05 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.635 1.557 . . . . 0.0 112.159 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 80.6 m -112.62 -5.69 13.97 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.609 0.364 . . . . 0.0 111.625 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 158.8 164.39 14.26 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.98 106.39 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.852 3.035 . . . . 0.0 110.638 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.7 t -78.49 150.63 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -117.03 -36.5 3.79 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.643 0.377 . . . . 0.0 111.279 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -164.12 156.43 17.05 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.101 0.41 . . . . 0.0 111.792 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 40.5 mt -144.77 143.75 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.751 0.821 . . . . 0.0 109.761 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.7 m -138.76 155.97 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 123.359 0.663 . . . . 0.0 109.756 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.7 mm -116.55 153.28 18.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 123.569 0.747 . . . . 0.0 111.096 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -138.8 145.81 40.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.009 0.924 . . . . 0.0 109.533 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 19.07 1.84 Allowed 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -177.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -64.44 -27.05 68.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.485 0.314 . . . . 0.0 110.446 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -153.44 123.86 7.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 58.44 -144.9 42.71 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.0 t -130.74 129.32 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -142.91 166.62 24.15 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.374 0.67 . . . . 0.0 109.878 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.01 171.18 20.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.388 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.6 mtp -135.77 149.38 49.13 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 55.2 t -136.63 150.77 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -139.85 141.33 36.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -118.27 170.47 8.87 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.834 0.853 . . . . 0.0 110.849 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.63 -13.16 59.98 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.549 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 46.1 t -150.53 153.56 36.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.677 0.391 . . . . 0.0 110.416 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.17 -26.5 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -71.04 -24.04 62.27 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 22.5 m -81.34 -27.43 34.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.22 -25.1 36.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.416 0.286 . . . . 0.0 110.457 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -70.56 -37.49 74.01 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -74.93 -29.33 60.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.315 0.246 . . . . 0.0 110.689 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.49 -52.44 45.97 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 119.733 -0.175 . . . . 0.0 111.268 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -12.6 59.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.845 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.52 -10.22 52.32 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.822 0.283 . . . . 0.0 111.601 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 21.4 m -126.33 -1.78 6.93 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.7 mt -130.62 -5.36 4.14 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -78.14 132.71 37.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.38 6.9 71.39 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.46 174.94 11.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.672 0.736 . . . . 0.0 111.061 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -132.65 149.75 52.26 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.1 0.96 . . . . 0.0 108.763 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.4 mt -102.0 -17.63 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 117.433 0.106 . . . . 0.0 111.219 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.74 25.63 8.01 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.025 -0.422 . . . . 0.0 111.447 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 31.8 m 56.0 16.51 2.2 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.095 0.958 . . . . 0.0 112.476 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.98 141.56 3.88 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 85.2 m 54.13 -176.56 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.914 0.885 . . . . 0.0 112.014 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.1 m 51.01 33.08 8.37 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.977 0.511 . . . . 0.0 111.133 -174.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.7 m -60.13 139.8 57.29 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.991 0.516 . . . . 0.0 110.223 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 54.3 mt -96.79 156.9 16.15 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.111 0.564 . . . . 0.0 112.282 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -140.52 137.71 34.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 171.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 71.7 mt -136.0 142.33 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.082 0.467 . . . . 0.0 111.308 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.72 167.3 30.07 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.563 1.145 . . . . 0.0 108.54 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -79.01 141.49 37.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.803 -0.561 . . . . 0.0 110.684 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.67 167.9 14.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.423 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -81.26 -27.89 0.46 Allowed Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.2 Cg_endo -82.15 166.86 16.26 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 CA-C-N 121.913 1.719 . . . . 0.0 110.138 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.1 p -99.87 -5.32 28.62 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 122.332 0.253 . . . . 0.0 111.025 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -154.76 151.95 29.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.088 0.955 . . . . 0.0 109.92 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.46 171.41 7.53 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.779 0.832 . . . . 0.0 109.398 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -138.92 159.3 42.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.961 0.504 . . . . 0.0 109.893 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.94 154.02 35.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.912 0.885 . . . . 0.0 109.006 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -123.15 -21.71 5.35 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.672 0.389 . . . . 0.0 111.771 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -166.93 173.11 9.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.311 1.044 . . . . 0.0 109.695 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -116.48 113.51 22.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.073 0.463 . . . . 0.0 110.473 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -157.53 -174.38 4.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.204 1.401 . . . . 0.0 109.243 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -69.79 -4.15 18.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -117.24 -11.76 10.61 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.713 0.688 . . . . 0.0 112.031 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.2 t -158.55 134.25 8.88 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -152.65 150.73 29.79 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 122.087 -0.383 . . . . 0.0 111.055 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -123.24 137.45 54.87 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.247 0.619 . . . . 0.0 109.743 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -119.33 15.95 13.05 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.487 0.715 . . . . 0.0 112.091 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t -135.6 -10.69 2.12 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -77.45 162.0 70.36 Favored Pre-proline 0 CA--C 1.535 0.369 0 O-C-N 121.803 -0.561 . . . . 0.0 110.36 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.37 -7.32 10.15 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.58 2.853 . . . . 0.0 113.714 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -115.92 23.9 11.89 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.755 0.822 . . . . 0.0 111.451 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.08 -4.9 5.36 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 45.4 m -118.13 13.09 13.75 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.628 0.771 . . . . 0.0 110.716 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -135.53 -164.47 10.38 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -76.46 2.24 14.26 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 116.991 -2.005 . . . . 0.0 111.473 -179.764 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 110.71 -0.107 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -142.0 166.76 23.82 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.484 0.714 . . . . 0.0 111.078 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 19.5 tt -141.83 165.89 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.865 1.266 . . . . 0.0 108.86 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 80.8 p -75.91 -1.28 24.72 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -142.57 64.87 16.41 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.355 0.662 . . . . 0.0 109.762 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.96 -15.39 18.72 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.683 2.922 . . . . 0.0 111.893 -174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.58 -155.46 26.78 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -75.77 176.36 7.84 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.296 0.638 . . . . 0.0 110.932 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.0 m 61.07 178.26 0.11 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.174 0.989 . . . . 0.0 112.828 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 55.74 15.52 1.64 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.401 1.08 . . . . 0.0 112.907 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.2 t70 54.35 12.11 0.47 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.13 1.372 . . . . 0.0 113.722 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 93.8 p 40.97 -127.85 0.47 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.401 1.08 . . . . 0.0 111.977 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -139.99 138.21 35.3 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.5 0.72 . . . . 0.0 109.419 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 63.6 m 57.86 169.71 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.808 1.243 . . . . 0.0 113.521 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.31 -41.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 119.251 -0.404 . . . . 0.0 111.527 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -164.21 163.15 22.91 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.565 0.62 . . . . 0.0 111.194 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -90.12 18.08 6.29 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.565 0.746 . . . . 0.0 111.243 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.1 t -116.62 139.62 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.423 0.689 . . . . 0.0 110.325 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.2 mt -128.59 161.86 28.62 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.353 0.597 . . . . 0.0 110.621 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 tt -129.68 136.35 49.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -117.02 148.49 41.44 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.191 0.996 . . . . 0.0 109.903 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 89.8 m -133.28 141.16 47.86 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.21 138.84 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 53.3 mt -108.06 -22.59 12.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -131.47 63.27 69.01 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 123.499 0.719 . . . . 0.0 109.777 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.92 40.04 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 125.104 3.869 . . . . 0.0 112.87 -173.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.4 pt -75.95 -2.91 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.6 -0.688 . . . . 0.0 111.531 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -130.4 165.22 23.02 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.987 0.915 . . . . 0.0 109.516 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 32.4 t -74.74 148.77 40.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.623 0.249 . . . . 0.0 111.487 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.7 mm -137.28 136.48 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 124.462 1.105 . . . . 0.0 108.175 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.0 p -143.97 176.88 8.95 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.138 0.575 . . . . 0.0 109.967 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.2 p -61.92 -22.68 65.8 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.569 0.348 . . . . 0.0 111.011 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.95 -24.61 35.45 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.48 0.312 . . . . 0.0 110.793 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.5 t -83.99 -37.6 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.95 -22.55 53.1 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.656 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -75.8 -36.92 59.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.196 0.453 . . . . 0.0 110.675 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 t -77.93 -18.7 55.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.396 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.94 -15.15 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.894 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.6 m -96.91 -25.42 15.43 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.741 0.701 . . . . 0.0 111.826 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 25.5 t-20 -58.75 -42.57 94.95 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 79.9 Cg_endo -71.26 -2.42 11.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.183 1.922 . . . . 0.0 112.379 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 83.7 m -115.03 -4.75 12.5 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.153 0.433 . . . . 0.0 111.642 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 158.86 158.68 9.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.76 114.59 3.75 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.674 2.916 . . . . 0.0 110.634 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.7 t -85.68 149.39 4.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -112.58 -34.74 5.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.893 0.477 . . . . 0.0 110.943 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -165.36 160.41 18.11 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 111.945 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 41.6 mt -143.48 147.43 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 124.256 1.023 . . . . 0.0 109.487 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.98 145.04 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.062 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.5 mm -112.76 151.61 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 123.754 0.822 . . . . 0.0 110.291 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -133.58 109.65 9.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -139.78 16.8 2.5 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.1 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -76.47 -27.78 56.27 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -150.68 136.81 18.47 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 59.61 -157.99 24.25 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.58 114.83 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 O-C-N 122.172 -0.605 . . . . 0.0 110.172 175.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -149.67 172.6 14.8 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.264 0.626 . . . . 0.0 110.611 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.65 168.56 26.76 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.62 0.768 . . . . 0.0 109.914 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 85.2 mtp -136.89 151.65 49.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.74 150.27 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.048 0.539 . . . . 0.0 110.062 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -133.08 139.53 47.19 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -114.04 167.38 10.71 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.777 0.831 . . . . 0.0 111.299 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -75.2 -14.13 60.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.9 t -152.06 151.49 31.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.017 0.527 . . . . 0.0 110.08 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.4 p -69.12 -24.05 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.41 -24.81 62.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 26.3 m -81.54 -25.38 35.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.738 0.415 . . . . 0.0 110.612 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.46 -26.4 35.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.64 -36.9 76.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -77.64 -29.33 51.66 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.31 -52.24 55.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 119.647 -0.216 . . . . 0.0 110.97 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -15.07 59.75 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.628 0.649 . . . . 0.0 112.209 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -82.53 -12.7 57.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.986 0.357 . . . . 0.0 111.814 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -128.51 2.53 5.59 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 73.2 mt -129.59 -3.61 4.78 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.791 0.723 . . . . 0.0 112.491 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -78.5 131.53 36.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.24 3.63 76.85 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.75 179.95 5.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.762 0.781 . . . . 0.0 110.7 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.78 162.34 35.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.434 0.694 . . . . 0.0 109.181 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 38.3 mt -114.77 -20.09 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 111.227 0.084 . . . . 0.0 111.227 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -137.6 73.99 1.46 Allowed 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.048 -0.407 . . . . 0.0 111.498 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 25.0 m 49.2 48.37 21.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 95.28 0.07 63.47 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.257 0.456 . . . . 0.0 112.497 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 58.5 m -106.44 163.53 12.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 117.388 0.594 . . . . 0.0 109.67 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.8 m 51.94 41.45 29.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.022 0.529 . . . . 0.0 110.688 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.1 m -55.35 142.12 33.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.41 0.684 . . . . 0.0 109.795 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.0 mt -108.62 153.76 22.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.374 0.669 . . . . 0.0 112.022 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -140.26 135.0 31.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 171.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 79.4 mt -125.81 148.99 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.048 0.451 . . . . 0.0 111.435 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.86 165.97 34.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.034 1.333 . . . . 0.0 108.421 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.73 139.95 38.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.834 -0.541 . . . . 0.0 110.231 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -75.36 167.18 22.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.897 0.479 . . . . 0.0 111.427 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -71.72 -54.78 6.09 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.164 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.66 164.59 31.88 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.336 2.024 . . . . 0.0 111.123 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.0 p -91.74 -6.47 51.86 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.712 0.405 . . . . 0.0 111.576 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.62 167.06 30.81 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.732 0.813 . . . . 0.0 109.878 176.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 86.2 mt -123.54 173.15 8.23 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.517 0.727 . . . . 0.0 109.863 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -136.19 154.53 50.92 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 91.9 t -136.37 153.12 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.876 0.871 . . . . 0.0 108.65 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.72 -18.78 5.09 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -166.06 172.56 11.24 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.931 1.292 . . . . 0.0 109.296 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -119.06 110.63 17.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.01 0.434 . . . . 0.0 110.46 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -154.62 -169.85 3.34 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.796 1.238 . . . . 0.0 109.773 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -70.18 -6.66 35.93 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -114.42 -15.25 12.1 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.782 0.719 . . . . 0.0 112.209 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.2 t -159.02 140.17 12.97 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -154.88 148.32 25.14 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.997 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -128.03 135.7 50.23 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -112.87 5.12 17.26 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.612 0.765 . . . . 0.0 112.031 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.0 t -125.63 -4.64 7.1 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.907 0.483 . . . . 0.0 111.55 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -65.92 120.56 70.13 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.613 0.765 . . . . 0.0 109.467 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.15 -17.34 38.23 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.583 2.855 . . . . 0.0 113.682 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -104.54 3.52 31.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.085 0.554 . . . . 0.0 111.573 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 18.4 tp 50.98 28.62 3.93 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.774 0.83 . . . . 0.0 111.339 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 17.3 m 54.98 20.03 2.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.208 1.003 . . . . 0.0 113.21 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -77.31 174.93 54.43 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -82.14 -15.19 54.21 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.499 -0.412 . . . . 0.0 110.688 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-O 117.139 -1.923 . . . . 0.0 111.695 179.676 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -145.9 162.11 38.49 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.131 0.573 . . . . 0.0 109.658 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.9 tp -61.7 157.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.049 0.54 . . . . 0.0 110.595 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 78.5 p -82.85 1.27 40.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.392 0.677 . . . . 0.0 112.753 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -133.37 56.98 23.58 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 123.496 0.718 . . . . 0.0 111.063 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.01 159.14 45.1 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.628 2.886 . . . . 0.0 110.582 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.29 1.01 84.11 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.858 -0.412 . . . . 0.0 112.133 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -153.53 176.6 11.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.646 0.723 . . . . 0.0 110.721 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 39.5 m 58.61 18.78 6.1 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.591 1.157 . . . . 0.0 114.079 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 47.04 79.14 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.593 1.157 . . . . 0.0 112.867 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 60.97 -0.74 0.29 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 51.0 m 48.82 -154.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.049 0.94 . . . . 0.0 112.342 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 60.48 -175.95 0.11 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.45 1.1 . . . . 0.0 112.177 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 83.4 p -141.49 173.53 11.41 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.799 0.839 . . . . 0.0 110.177 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.0 t -118.66 -77.44 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 O-C-N 122.143 -0.348 . . . . 0.0 111.314 -176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -156.33 163.48 39.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.126 0.57 . . . . 0.0 110.685 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 82.3 p -87.12 13.59 9.13 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.245 0.618 . . . . 0.0 111.842 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.4 t -109.01 138.63 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 122.91 0.484 . . . . 0.0 110.885 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.67 160.83 31.24 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 121.427 0.632 . . . . 0.0 111.459 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.7 tp -125.7 130.29 51.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.94 1.296 . . . . 0.0 108.222 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -115.56 146.91 41.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.566 0.746 . . . . 0.0 109.985 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.4 m -138.43 142.63 39.52 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.7 mp -106.8 136.46 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 73.1 mt -92.4 -34.46 14.14 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -134.02 68.25 74.35 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 123.406 0.682 . . . . 0.0 109.543 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -74.41 62.92 5.4 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.555 3.503 . . . . 0.0 112.427 -174.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 44.8 pt -84.66 -4.85 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 122.024 -0.422 . . . . 0.0 111.289 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -126.85 167.88 15.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.945 0.898 . . . . 0.0 109.27 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 78.1 p -83.26 154.15 24.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.015 0.436 . . . . 0.0 111.21 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.0 mm -136.91 138.3 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.1 p -143.97 176.1 9.54 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.044 0.538 . . . . 0.0 110.018 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.9 p -62.12 -27.47 68.95 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 122.542 0.337 . . . . 0.0 110.966 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -78.03 -20.34 52.65 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.431 0.292 . . . . 0.0 111.495 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.42 -40.68 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 88.5 mt -73.56 -30.67 63.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.175 -0.328 . . . . 0.0 110.924 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -68.87 -37.82 79.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.217 0.462 . . . . 0.0 110.921 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 t -78.58 -17.43 56.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.481 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.35 -9.73 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 18.2 p -119.69 -6.23 10.16 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.347 0.976 . . . . 0.0 113.136 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.461 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.6 t-20 -63.06 -41.12 68.24 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.496 -0.764 . . . . 0.0 113.054 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 96.3 Cg_endo -71.7 -3.03 12.32 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.794 1.663 . . . . 0.0 111.982 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.2 m -93.58 -8.47 41.11 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.096 0.407 . . . . 0.0 111.41 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 144.91 174.58 17.29 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.38 114.91 3.42 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.672 2.915 . . . . 0.0 110.953 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 96.9 t -87.06 150.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -113.9 -37.61 4.45 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -165.17 159.16 17.29 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.518 0.599 . . . . 0.0 112.287 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 48.7 mt -142.83 144.36 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.081 0.953 . . . . 0.0 109.677 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.4 p -143.85 142.71 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 123.486 0.714 . . . . 0.0 109.487 176.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.83 150.37 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 123.799 0.84 . . . . 0.0 109.649 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -136.35 138.79 42.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.619 0.767 . . . . 0.0 109.905 176.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.25 22.76 0.84 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -73.66 -20.13 60.64 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.997 -0.439 . . . . 0.0 110.281 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -154.56 122.09 5.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 60.43 -153.7 35.61 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -173.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.0 t -138.08 124.38 26.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -147.23 169.79 18.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.473 0.709 . . . . 0.0 110.636 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.35 169.28 24.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.024 0.53 . . . . 0.0 109.731 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.0 mtp -137.96 151.71 48.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.1 t -139.3 151.1 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 C-N-CA 122.904 0.482 . . . . 0.0 109.884 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -135.41 141.65 45.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.457 0.703 . . . . 0.0 109.192 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -117.37 168.45 10.34 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.087 0.955 . . . . 0.0 110.761 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.88 -9.98 59.77 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.791 0.437 . . . . 0.0 110.889 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.1 t -150.17 147.67 28.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.103 0.561 . . . . 0.0 109.935 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 -23.3 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -73.2 -23.23 60.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.082 -0.386 . . . . 0.0 110.235 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 42.2 m -80.85 -28.12 36.2 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.82 -25.43 44.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -70.92 -37.96 72.93 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -74.96 -27.61 60.24 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.247 0.619 . . . . 0.0 110.965 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.32 -54.98 10.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.125 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -14.77 60.35 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.356 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -81.52 -16.62 51.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.118 0.417 . . . . 0.0 111.568 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -123.44 4.38 9.04 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.7 mt -121.65 -5.69 9.19 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.856 0.753 . . . . 0.0 112.559 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -74.79 129.93 38.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.943 0.792 . . . . 0.0 109.149 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.43 8.78 76.56 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.13 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.93 174.15 10.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.85 0.825 . . . . 0.0 111.333 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -137.71 145.26 42.33 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.66 0.784 . . . . 0.0 109.185 -177.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 51.8 mt -108.29 -19.11 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -126.11 22.34 7.28 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.91 -0.494 . . . . 0.0 111.776 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 25.6 m 55.95 20.88 4.52 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.509 0.724 . . . . 0.0 111.91 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 173.44 135.07 1.93 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 76.6 m 54.73 -173.36 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.232 1.013 . . . . 0.0 112.129 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m 52.58 31.62 10.35 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.815 0.446 . . . . 0.0 111.673 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 26.9 m -58.61 140.61 54.14 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.738 0.415 . . . . 0.0 109.948 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.4 mt -95.07 154.99 16.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.023 0.44 . . . . 0.0 112.014 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -145.65 134.7 22.67 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.34 150.42 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-O 120.993 0.425 . . . . 0.0 111.247 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -153.75 168.05 27.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.194 1.398 . . . . 0.0 108.364 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.85 144.0 32.33 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 121.74 -0.6 . . . . 0.0 110.994 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.03 170.3 10.46 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.413 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.7 pttt -86.0 -26.21 0.36 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -177.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.4 Cg_endo -82.23 164.63 17.11 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 121.881 1.707 . . . . 0.0 110.406 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 58.4 p -93.45 -9.04 39.88 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 122.265 -0.272 . . . . 0.0 111.564 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.39 168.48 27.21 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.746 0.818 . . . . 0.0 109.711 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 87.7 mt -120.6 170.74 9.13 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.369 0.668 . . . . 0.0 109.685 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -131.1 157.47 43.02 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.449 0.166 . . . . 0.0 110.667 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 87.0 t -137.85 153.93 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 124.08 0.952 . . . . 0.0 108.958 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -128.06 -14.66 4.91 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.294 0.238 . . . . 0.0 111.627 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.466 ' HZ1' HG23 ' A' ' 279' ' ' THR . 21.7 pttp -163.54 170.32 17.43 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.048 0.939 . . . . 0.0 109.237 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.33 99.65 6.83 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -152.96 -169.14 3.25 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.103 0.961 . . . . 0.0 110.102 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -72.27 -1.81 16.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.53 -31.39 8.54 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.183 0.593 . . . . 0.0 110.8 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' THR . . . . . 0.466 HG23 ' HZ1' ' A' ' 274' ' ' LYS . 11.3 t -159.28 147.02 17.43 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 173.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -152.48 146.68 25.46 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.721 0.296 . . . . 0.0 110.705 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -121.28 134.3 55.16 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.956 0.502 . . . . 0.0 109.646 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.99 6.48 19.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.554 0.742 . . . . 0.0 112.449 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.9 t -125.8 0.27 7.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.15 0.58 . . . . 0.0 110.552 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -66.89 123.63 86.59 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.146 0.978 . . . . 0.0 109.661 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.69 -13.97 19.84 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.411 2.741 . . . . 0.0 113.727 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -87.67 0.15 56.08 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.0 tp -79.68 -22.7 43.14 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.929 0.331 . . . . 0.0 111.052 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.2 p -148.09 3.88 0.71 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.651 0.38 . . . . 0.0 111.992 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 78.81 170.36 38.03 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -142.82 8.17 1.69 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.758 0.423 . . . . 0.0 111.887 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 117.308 -1.829 . . . . 0.0 111.217 -179.51 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -138.07 168.9 18.75 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.274 0.63 . . . . 0.0 110.521 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 tt -69.27 162.12 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.396 0.678 . . . . 0.0 109.98 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.8 m -70.77 -1.52 11.81 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.0 ttp-105 -147.17 70.59 11.97 Favored Pre-proline 0 CA--C 1.53 0.184 0 C-N-CA 123.595 0.758 . . . . 0.0 109.05 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.13 -16.98 15.42 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.664 2.909 . . . . 0.0 112.301 -172.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.78 -5.33 24.61 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.887 -0.396 . . . . 0.0 112.958 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -152.29 150.31 29.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 117.749 0.774 . . . . 0.0 109.692 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.2 t 58.55 166.45 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.363 1.065 . . . . 0.0 111.974 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 48.97 37.13 9.64 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.288 0.635 . . . . 0.0 111.903 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 54.43 28.85 10.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.654 0.782 . . . . 0.0 112.246 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 55.5 p 57.41 11.84 1.29 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.858 1.663 . . . . 0.0 113.944 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 55.83 -177.92 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.976 1.31 . . . . 0.0 112.886 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 43.0 t -147.14 159.69 43.31 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.414 0.685 . . . . 0.0 109.881 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.54 -72.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.5 p30 -162.62 166.17 24.92 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.338 0.655 . . . . 0.0 110.28 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.9 p -97.46 8.62 44.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.372 0.669 . . . . 0.0 111.975 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.96 143.37 18.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 123.055 0.542 . . . . 0.0 110.86 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.0 mt -129.0 163.54 25.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.073 0.549 . . . . 0.0 111.663 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.7 tp -123.24 133.38 54.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.654 1.182 . . . . 0.0 108.179 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -120.24 143.62 48.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.675 0.79 . . . . 0.0 109.383 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 97.4 m -139.51 143.55 37.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.35 135.38 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.8 mt -90.39 -36.52 14.56 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -131.93 64.27 71.84 Favored Pre-proline 0 CA--C 1.529 0.135 0 C-N-CA 123.379 0.672 . . . . 0.0 109.922 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.6 102.91 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.608 2.205 . . . . 0.0 111.135 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.4 pt -129.58 2.7 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 122.996 0.518 . . . . 0.0 111.401 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -130.6 169.58 15.42 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.791 0.836 . . . . 0.0 109.492 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.5 m -77.58 145.86 36.58 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.5 mm -137.18 133.89 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 61.7 p -142.58 175.55 9.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.8 p -64.37 -20.48 66.15 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 122.296 0.239 . . . . 0.0 111.206 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.7 -25.34 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 122.283 0.233 . . . . 0.0 110.587 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.7 t -82.42 -36.87 13.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.7 -25.43 53.59 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.122 -0.362 . . . . 0.0 110.781 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -78.39 -34.5 48.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.023 -0.423 . . . . 0.0 111.057 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -74.9 -23.46 58.37 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.563 0.62 . . . . 0.0 111.389 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.6 pt -88.73 -23.17 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.176 0.444 . . . . 0.0 111.723 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.9 m -95.58 -20.15 19.22 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.618 0.645 . . . . 0.0 112.483 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.43 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.41 -43.79 90.48 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 87.8 Cg_endo -73.94 -9.63 22.4 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.887 1.724 . . . . 0.0 111.651 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 82.3 m -91.98 -21.56 20.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.023 0.374 . . . . 0.0 111.207 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.15 172.45 30.65 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.57 105.14 1.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 124.122 3.215 . . . . 0.0 110.549 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 94.0 t -78.32 150.14 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -113.53 -41.09 3.69 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.778 0.431 . . . . 0.0 110.876 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.73 163.34 32.4 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.177 0.444 . . . . 0.0 111.472 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.43 146.9 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.534 0.734 . . . . 0.0 109.903 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.24 147.6 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 54.3 mt -133.15 151.44 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.348 0.659 . . . . 0.0 110.085 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -131.77 128.92 39.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -146.14 23.78 1.33 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -72.91 -29.36 63.08 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -151.62 127.97 10.62 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 60.57 -159.67 25.56 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -172.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.1 t -140.81 128.42 22.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.304 0.552 . . . . 0.0 109.627 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -146.38 163.26 36.16 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 123.608 0.763 . . . . 0.0 109.424 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.4 171.9 19.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.552 0.215 . . . . 0.0 110.876 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.1 mtp -142.28 150.38 40.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 49.0 t -139.25 151.37 23.04 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.987 0.515 . . . . 0.0 109.719 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -136.2 141.32 44.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.144 0.577 . . . . 0.0 109.497 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -116.31 168.84 9.78 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.905 0.882 . . . . 0.0 110.983 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.55 -14.16 60.76 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.831 0.452 . . . . 0.0 111.22 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 48.4 t -152.7 153.54 33.47 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.878 0.471 . . . . 0.0 110.378 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.09 -25.71 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.57 -29.4 68.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.012 0.369 . . . . 0.0 110.056 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 20.8 m -79.24 -27.58 42.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.541 0.336 . . . . 0.0 110.65 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.4 -27.45 38.1 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -68.01 -37.24 81.2 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -78.46 -25.68 45.9 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.344 0.257 . . . . 0.0 110.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.93 -55.39 17.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.343 0.257 . . . . 0.0 110.807 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -16.36 60.51 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.566 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -78.43 -14.65 59.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.189 0.45 . . . . 0.0 111.643 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 55.6 m -125.07 1.56 7.94 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.56 -5.17 4.72 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -78.22 132.79 37.7 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.917 0.781 . . . . 0.0 109.124 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.33 6.66 70.42 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.48 176.6 7.39 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.715 0.758 . . . . 0.0 111.343 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -139.6 151.07 45.72 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.707 0.803 . . . . 0.0 109.13 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.1 mt -114.63 -17.8 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 122.405 0.282 . . . . 0.0 111.296 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -127.96 25.1 5.96 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.059 -0.401 . . . . 0.0 111.567 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.3 p 53.3 19.41 1.55 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.119 1.368 . . . . 0.0 112.592 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 170.9 138.78 2.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 69.6 m 56.91 179.6 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.26 1.024 . . . . 0.0 112.107 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.3 m 52.94 30.36 9.18 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.772 0.429 . . . . 0.0 111.735 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.7 m -60.27 141.68 55.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.244 0.618 . . . . 0.0 109.87 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.42 155.41 16.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -144.51 124.78 13.76 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.41 147.38 28.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 CA-C-O 121.163 0.506 . . . . 0.0 111.542 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.56 171.01 20.66 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.718 1.207 . . . . 0.0 108.762 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -80.99 143.98 32.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 122.051 -0.405 . . . . 0.0 110.45 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.3 167.2 15.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.319 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.44 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -83.46 -26.56 0.4 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -176.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 48.2 Cg_endo -80.95 -176.7 3.29 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.952 1.768 . . . . 0.0 109.9 176.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 67.2 p -117.77 -0.75 11.71 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.749 0.42 . . . . 0.0 110.89 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -155.16 146.05 22.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.912 0.885 . . . . 0.0 109.255 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.9 mt -112.35 167.55 10.34 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.246 0.619 . . . . 0.0 110.01 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -129.62 166.74 19.15 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.49 0.316 . . . . 0.0 110.813 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.73 155.71 22.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.223 1.009 . . . . 0.0 109.023 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -130.47 -16.74 3.41 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.368 0.267 . . . . 0.0 111.563 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -165.84 174.38 9.66 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.182 0.993 . . . . 0.0 109.516 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -120.35 96.69 5.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -148.35 -166.01 2.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.929 0.892 . . . . 0.0 110.126 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -73.36 -3.0 24.51 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -112.48 -21.88 11.11 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.813 0.733 . . . . 0.0 111.749 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.2 t -159.9 144.97 15.17 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -151.86 153.3 33.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.91 138.75 51.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 110.393 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -116.4 7.19 13.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.556 0.742 . . . . 0.0 112.331 -174.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.4 t -125.61 -4.04 7.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.875 0.47 . . . . 0.0 110.517 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -57.75 135.15 82.96 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 124.862 1.265 . . . . 0.0 108.878 174.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -62.15 -9.38 14.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.767 2.978 . . . . 0.0 114.289 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.93 11.03 30.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.151 0.887 . . . . 0.0 111.486 175.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.88 14.36 2.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.883 0.873 . . . . 0.0 110.204 178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 32.7 t -150.59 160.55 43.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.118 0.567 . . . . 0.0 110.082 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 67.83 -155.9 52.83 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.39 -13.97 60.43 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.863 0.465 . . . . 0.0 111.318 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.454 -1.748 . . . . 0.0 111.325 -179.51 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -83.88 -60.61 2.05 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.398 0.279 . . . . 0.0 110.509 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 32.6 pt -150.47 -177.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.416 1.486 . . . . 0.0 108.724 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 39.7 m -84.51 -3.13 58.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -149.45 52.2 1.07 Allowed Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.35 168.59 23.03 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.348 2.699 . . . . 0.0 111.074 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.35 -173.77 30.36 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -131.5 157.18 44.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.079 0.552 . . . . 0.0 110.734 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.9 p 58.85 159.26 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.043 1.737 . . . . 0.0 113.656 -175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 184' ' ' ASP . 8.0 t70 48.92 -152.13 0.13 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.032 0.933 . . . . 0.0 110.938 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.407 ' H ' ' CG ' ' A' ' 183' ' ' ASP . 25.6 t0 59.56 172.34 0.08 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.722 1.209 . . . . 0.0 113.655 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 94.1 p 48.62 28.48 1.81 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.466 1.506 . . . . 0.0 113.609 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -141.03 151.69 44.27 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.793 0.437 . . . . 0.0 110.962 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 40.7 t -155.08 149.52 26.22 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.153 0.581 . . . . 0.0 110.21 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 52.3 t -142.14 -75.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.048 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 -161.07 166.09 28.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.19 0.996 . . . . 0.0 110.081 176.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 85.8 p -86.31 13.97 7.29 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.147 0.579 . . . . 0.0 112.264 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.75 138.91 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 123.002 0.521 . . . . 0.0 110.712 -176.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.8 mt -129.56 162.45 28.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.416 0.627 . . . . 0.0 111.246 -177.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.1 tp -122.43 133.09 54.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.935 1.294 . . . . 0.0 107.994 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -118.8 145.42 45.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.677 0.791 . . . . 0.0 109.827 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 96.2 m -136.19 141.75 44.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.9 mp -107.27 133.23 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 66.3 mt -92.69 -29.51 16.04 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -137.89 69.35 50.7 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 123.557 0.743 . . . . 0.0 109.586 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.4 56.16 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.529 3.486 . . . . 0.0 112.047 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.8 pt -81.04 -1.53 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 122.03 -0.419 . . . . 0.0 111.603 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -128.85 167.24 17.64 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.683 0.793 . . . . 0.0 109.685 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.1 m -75.84 149.78 37.8 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 111.539 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.4 mm -137.49 137.57 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 81.0 p -145.27 175.49 10.24 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.385 0.674 . . . . 0.0 109.782 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.2 p -63.64 -22.82 67.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 119.673 -0.203 . . . . 0.0 111.049 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -79.0 -23.87 44.09 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.298 0.239 . . . . 0.0 111.129 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 88.1 t -86.33 -39.11 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.92 -22.8 58.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.11 -0.369 . . . . 0.0 110.94 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -78.89 -36.11 42.6 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.885 0.311 . . . . 0.0 111.144 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.9 t -74.94 -20.47 59.67 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.89 -0.506 . . . . 0.0 111.327 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.2 pt -92.04 -21.54 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.7 m -97.85 -23.67 15.76 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.798 0.726 . . . . 0.0 112.899 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.44 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 51.1 t30 -65.21 -40.78 47.5 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 98.3 Cg_endo -72.91 -8.96 23.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.424 1.416 . . . . 0.0 111.684 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 77.5 m -97.81 -12.69 21.91 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.707 0.403 . . . . 0.0 111.17 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 161.65 162.06 12.57 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.28 110.73 2.09 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.654 2.903 . . . . 0.0 110.581 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.7 149.79 4.37 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -115.0 -34.75 4.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.847 0.459 . . . . 0.0 110.901 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -164.32 159.49 19.9 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.3 144.65 23.42 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 124.098 0.959 . . . . 0.0 109.644 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.02 142.96 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.288 0.635 . . . . 0.0 109.472 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.03 150.58 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.905 0.882 . . . . 0.0 109.756 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -136.64 147.88 47.14 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.019 0.928 . . . . 0.0 109.878 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.78 17.94 1.98 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.997 0.519 . . . . 0.0 112.28 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.62 -24.45 67.05 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 122.232 -0.292 . . . . 0.0 110.825 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -154.47 123.73 6.44 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 59.4 -144.1 45.82 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.7 t -134.31 127.32 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -145.81 168.23 21.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.99 0.516 . . . . 0.0 110.547 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.53 167.05 31.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.6 mtp -134.38 150.94 50.94 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.35 149.36 22.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.643 0.377 . . . . 0.0 110.194 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -131.52 140.73 49.58 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -116.27 167.91 10.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.872 0.869 . . . . 0.0 110.648 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -72.31 -18.84 61.75 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.686 0.394 . . . . 0.0 111.611 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 85.1 p -151.64 159.86 43.87 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.913 0.485 . . . . 0.0 110.473 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.7 -28.78 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 O-C-N 122.18 -0.325 . . . . 0.0 110.386 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -69.3 -25.07 64.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.035 0.38 . . . . 0.0 110.394 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 59.6 m -78.37 -29.39 47.39 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.45 -24.5 42.38 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.396 -0.19 . . . . 0.0 110.941 176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -70.86 -36.63 72.93 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -78.51 -27.16 46.04 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 122.153 -0.342 . . . . 0.0 110.578 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.39 -52.71 51.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.174 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -17.37 60.0 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.838 0.744 . . . . 0.0 111.74 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -82.46 -9.61 59.36 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.934 0.334 . . . . 0.0 111.547 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.2 m -124.93 -2.3 7.75 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 79.9 mt -131.11 -4.58 3.91 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.697 0.68 . . . . 0.0 112.823 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -75.76 132.81 40.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 118.953 0.797 . . . . 0.0 109.13 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.78 5.24 68.68 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 119.794 -0.448 . . . . 0.0 112.331 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.93 175.44 10.04 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.712 0.756 . . . . 0.0 111.506 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -132.64 145.07 50.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.2 mt -92.12 -22.17 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 O-C-N 122.491 -0.131 . . . . 0.0 111.348 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -123.64 25.49 8.13 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.729 0.412 . . . . 0.0 111.591 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 37.9 m 55.98 17.27 2.52 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.938 0.895 . . . . 0.0 112.222 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.96 139.2 3.32 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 67.9 m 54.24 -177.16 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.691 0.796 . . . . 0.0 111.804 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m 51.07 33.79 9.77 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.002 -0.436 . . . . 0.0 111.183 -174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.2 m -59.89 142.95 52.66 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 122.821 0.448 . . . . 0.0 110.043 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 56.1 mt -103.53 157.33 17.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.259 0.552 . . . . 0.0 112.232 -174.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -144.36 134.68 24.42 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 88.0 mt -127.96 148.96 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.306 0.574 . . . . 0.0 111.543 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.08 171.37 20.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.969 1.308 . . . . 0.0 108.374 172.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -84.14 144.35 29.07 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.943 -0.473 . . . . 0.0 110.775 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.06 168.43 11.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.345 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -84.26 -27.35 0.4 Allowed Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -176.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 44.9 Cg_endo -81.91 167.38 16.39 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 CA-C-N 121.752 1.661 . . . . 0.0 110.4 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 45.3 p -96.68 -9.11 29.83 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.28 0.232 . . . . 0.0 111.286 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 170.29 22.31 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.711 0.804 . . . . 0.0 109.617 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 91.6 mt -124.23 167.93 13.63 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.924 0.49 . . . . 0.0 110.758 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -123.58 158.55 31.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 5.6 t -131.87 -24.78 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 122.309 0.244 . . . . 0.0 111.518 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 62.89 -37.05 0.14 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.185 1.794 . . . . 0.0 115.055 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -164.64 177.87 7.74 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.787 0.835 . . . . 0.0 110.446 -174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -118.85 113.14 20.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -155.2 -174.66 5.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.699 1.199 . . . . 0.0 109.87 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -70.94 -3.82 21.32 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -113.17 -16.88 12.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.619 0.645 . . . . 0.0 111.438 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 14.6 t -156.98 132.42 9.23 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 12.6 t-105 -147.01 149.82 33.89 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 122.071 -0.393 . . . . 0.0 111.299 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -126.22 137.65 53.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.3 0.64 . . . . 0.0 109.677 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -115.87 4.28 13.87 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.619 0.768 . . . . 0.0 112.464 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 11.8 t -119.22 -12.2 9.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.013 0.525 . . . . 0.0 111.707 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -71.72 158.09 88.48 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.119 0.568 . . . . 0.0 110.538 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -61.37 -11.34 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.158 3.238 . . . . 0.0 113.426 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -88.74 3.19 51.75 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.643 0.377 . . . . 0.0 111.937 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -140.36 -44.61 0.41 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.8 p 43.82 39.11 2.39 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.695 1.198 . . . . 0.0 113.028 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.33 -2.23 18.79 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.362 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -137.88 13.74 2.9 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.808 0.804 . . . . 0.0 111.493 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 117.387 -1.785 . . . . 0.0 111.675 -179.316 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 120.535 0.207 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -146.19 -63.4 0.31 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 122.85 0.46 . . . . 0.0 110.298 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 178' ' ' ARG . 19.4 tt -160.66 158.21 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.508 0.723 . . . . 0.0 109.173 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 80.9 p -83.81 -6.64 59.47 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.416 ' H ' HG12 ' A' ' 176' ' ' ILE . 55.8 ttm-85 -150.05 73.39 9.37 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 122.933 0.493 . . . . 0.0 110.117 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.44 -11.36 24.53 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.894 3.062 . . . . 0.0 111.526 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.2 178.1 49.79 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 183' ' ' ASP . 5.0 p-10 -143.13 157.08 44.84 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.653 0.381 . . . . 0.0 110.524 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.0 t 59.3 -9.64 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.147 1.379 . . . . 0.0 114.167 -177.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 181' ' ' ASP . 40.1 m-20 49.6 26.39 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.653 1.181 . . . . 0.0 112.999 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t70 53.04 26.18 4.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.84 0.856 . . . . 0.0 112.247 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 25.9 m 57.14 11.8 1.13 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.788 1.235 . . . . 0.0 113.421 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 59.08 147.22 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.095 1.758 . . . . 0.0 113.856 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 81.7 p -155.37 155.63 33.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.734 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.1 t -141.48 -75.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.458 -0.056 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -159.95 168.49 25.56 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.895 0.878 . . . . 0.0 110.082 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.4 p -89.16 13.3 13.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.431 0.693 . . . . 0.0 111.607 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 31.3 t -112.73 139.92 35.26 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 123.271 0.628 . . . . 0.0 110.962 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.0 mt -130.32 163.63 26.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.375 0.607 . . . . 0.0 111.279 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.2 tp -124.98 133.47 53.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.842 1.257 . . . . 0.0 107.962 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -119.37 142.95 47.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.743 0.817 . . . . 0.0 110.106 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 88.4 m -137.67 143.85 41.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.51 137.99 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.8 mt -92.09 -35.46 13.89 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -133.0 68.73 78.81 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.801 0.84 . . . . 0.0 109.428 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.29 67.62 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.321 3.347 . . . . 0.0 112.109 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.1 pt -88.07 -4.34 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 122.079 -0.388 . . . . 0.0 111.128 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -128.18 169.27 14.32 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.02 0.928 . . . . 0.0 109.239 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 79.8 p -85.04 155.26 21.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.832 0.349 . . . . 0.0 111.487 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mm -135.66 138.18 48.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.3 p -143.27 174.39 10.76 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.956 0.502 . . . . 0.0 110.146 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 39.6 p -62.24 -25.2 67.69 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.415 0.286 . . . . 0.0 111.061 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -78.71 -24.36 45.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.349 0.26 . . . . 0.0 111.185 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.6 t -84.29 -38.34 13.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.83 -23.39 52.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.226 -0.296 . . . . 0.0 110.977 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -79.39 -33.85 42.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.271 0.487 . . . . 0.0 111.079 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -76.64 -20.92 56.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.219 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.3 pt -91.58 -22.35 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 118.251 0.478 . . . . 0.0 111.707 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.5 m -94.83 -19.53 20.24 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.39 0.541 . . . . 0.0 112.271 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.429 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.8 t-20 -59.8 -43.69 95.54 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 90.6 Cg_endo -71.56 -5.98 18.19 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.875 1.717 . . . . 0.0 112.22 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 86.1 m -96.13 -5.89 39.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.079 0.399 . . . . 0.0 111.134 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 137.44 174.24 13.26 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.8 119.25 6.26 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.711 2.941 . . . . 0.0 111.263 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.16 151.85 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -113.29 -36.46 5.0 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.101 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -165.3 160.24 18.08 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.198 0.453 . . . . 0.0 111.966 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 48.7 mt -143.0 147.54 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.971 0.908 . . . . 0.0 109.321 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.24 144.47 18.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 123.103 0.561 . . . . 0.0 109.795 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.51 150.9 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.797 0.839 . . . . 0.0 109.969 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -136.2 144.79 45.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.705 0.802 . . . . 0.0 109.073 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -146.13 20.46 1.41 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -68.78 -19.05 64.29 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.373 -0.205 . . . . 0.0 111.108 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -156.3 120.77 4.54 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 58.92 -145.98 42.95 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.3 t -132.59 132.3 59.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -145.48 168.5 20.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.633 0.773 . . . . 0.0 109.99 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -158.32 169.09 25.26 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.125 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.8 mtp -137.12 150.77 48.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.02 149.83 24.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -132.23 140.84 48.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -117.04 169.05 9.72 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.907 0.883 . . . . 0.0 110.849 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -77.81 -13.85 59.76 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.059 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 95.6 p -151.93 157.33 41.64 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.986 0.422 . . . . 0.0 110.839 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.72 -25.03 27.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.159 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -67.3 -29.99 69.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.124 -0.36 . . . . 0.0 110.344 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 50.2 m -79.41 -28.14 41.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.34 -26.68 42.09 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -70.05 -36.43 74.99 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -77.39 -27.47 52.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.457 -0.152 . . . . 0.0 110.631 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.02 -51.82 50.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.279 -0.263 . . . . 0.0 111.277 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -13.93 60.13 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.516 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -86.78 -10.05 54.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.889 0.313 . . . . 0.0 111.495 176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.3 m -124.48 -2.05 8.0 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 88.1 mt -129.85 -5.22 4.56 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -77.35 130.69 37.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.975 0.807 . . . . 0.0 109.058 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.29 7.38 72.17 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.57 175.57 9.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.727 0.764 . . . . 0.0 111.568 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -137.3 144.88 42.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.96 0.904 . . . . 0.0 108.963 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.5 mt -109.34 -20.12 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 122.546 0.338 . . . . 0.0 111.603 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -127.37 28.52 5.69 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.973 -0.454 . . . . 0.0 111.43 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 96.2 p 49.79 22.66 0.86 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.046 1.338 . . . . 0.0 112.727 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 171.57 136.28 2.09 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 81.1 m 55.48 -172.62 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.924 0.89 . . . . 0.0 112.15 -176.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.4 m 51.69 31.45 7.96 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.151 0.58 . . . . 0.0 112.003 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.6 m -59.12 140.49 55.79 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.852 0.461 . . . . 0.0 109.849 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.3 mt -94.31 154.79 17.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.202 0.525 . . . . 0.0 112.162 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -145.14 132.76 20.93 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 84.4 mt -132.7 147.94 31.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.247 0.546 . . . . 0.0 112.29 -172.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.36 172.87 15.8 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.869 1.268 . . . . 0.0 108.8 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -84.41 142.28 30.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.22 -0.3 . . . . 0.0 110.598 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.87 169.59 12.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.44 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -85.78 -26.97 0.37 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.0 Cg_endo -82.62 164.91 16.16 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.01 1.807 . . . . 0.0 110.261 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.5 p -94.1 -7.84 41.33 Favored 'General case' 0 CA--C 1.527 0.065 0 O-C-N 122.325 -0.234 . . . . 0.0 111.396 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.85 169.13 25.47 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.835 0.854 . . . . 0.0 109.809 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 85.9 mt -121.06 173.18 7.43 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.461 0.705 . . . . 0.0 110.08 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -129.42 157.37 42.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.601 0.36 . . . . 0.0 110.485 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.9 t -138.36 152.33 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 C-N-CA 124.118 0.967 . . . . 0.0 108.866 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -125.84 -14.8 6.09 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.394 0.278 . . . . 0.0 111.627 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -164.68 173.92 11.35 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.286 1.034 . . . . 0.0 109.885 -176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -119.95 98.24 6.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -150.58 -168.79 3.21 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.868 0.867 . . . . 0.0 110.311 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -71.77 -4.11 25.9 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -110.88 -24.65 10.28 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.673 0.67 . . . . 0.0 111.753 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.8 t -157.63 144.57 18.15 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 173.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -152.76 147.99 26.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.172 0.189 . . . . 0.0 110.522 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -122.17 134.84 54.72 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.73 8.53 17.51 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.702 0.801 . . . . 0.0 112.17 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.7 t -128.5 2.4 5.6 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.289 0.636 . . . . 0.0 110.532 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -66.2 129.04 94.18 Favored Pre-proline 0 N--CA 1.453 -0.312 0 C-N-CA 124.455 1.102 . . . . 0.0 109.455 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.04 -6.83 13.69 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.44 2.76 . . . . 0.0 112.853 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -89.55 1.41 55.97 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.824 0.45 . . . . 0.0 111.139 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 61.8 tp -138.48 -29.73 0.79 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.137 0.575 . . . . 0.0 111.041 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 48.7 m -82.21 166.13 19.87 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.896 0.479 . . . . 0.0 110.394 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.4 158.26 51.14 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -131.97 7.63 4.37 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.655 0.782 . . . . 0.0 110.781 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.325 -1.82 . . . . 0.0 110.763 -179.523 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.624 0.25 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -146.25 160.14 42.39 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.561 0.744 . . . . 0.0 109.489 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.3 tp -63.92 153.54 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.356 0.662 . . . . 0.0 110.598 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.3 p -80.36 4.8 16.75 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.616 0.767 . . . . 0.0 112.52 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -134.85 59.39 34.44 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 123.88 0.872 . . . . 0.0 109.523 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -76.2 -11.5 19.34 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.807 3.004 . . . . 0.0 112.252 -172.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.33 8.6 0.03 OUTLIER Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.509 -0.606 . . . . 0.0 113.207 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -71.09 140.69 50.74 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.488 1.144 . . . . 0.0 110.433 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.4 t 54.98 -173.43 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.288 1.035 . . . . 0.0 112.196 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 51.51 25.66 2.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.974 0.91 . . . . 0.0 112.778 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.5 t70 52.49 23.35 2.5 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.016 0.927 . . . . 0.0 112.032 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.8 t 57.79 9.16 0.81 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.728 1.211 . . . . 0.0 113.518 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -155.25 125.58 6.77 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.863 -0.523 . . . . 0.0 109.708 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 61.4 p -156.22 154.57 30.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.691 0.281 . . . . 0.0 111.453 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 6.9 p -151.43 -46.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.051 0.54 . . . . 0.0 109.942 173.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -164.01 164.07 23.2 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.035 0.934 . . . . 0.0 109.461 172.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.7 p -96.64 15.39 21.87 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.216 0.606 . . . . 0.0 112.082 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.34 143.53 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 123.038 0.535 . . . . 0.0 111.022 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.7 mt -129.13 166.13 19.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.182 0.593 . . . . 0.0 111.325 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.6 tp -124.95 133.95 52.83 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.823 1.249 . . . . 0.0 107.999 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -120.12 147.71 44.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.832 0.853 . . . . 0.0 109.889 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.8 m -136.82 139.11 41.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.5 mp -103.47 135.69 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 50.4 mt -102.5 -17.07 15.93 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -139.13 66.55 38.69 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 123.657 0.783 . . . . 0.0 109.362 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.24 40.58 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 124.903 3.735 . . . . 0.0 112.069 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 32.9 pt -77.66 -1.58 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 O-C-N 121.944 -0.473 . . . . 0.0 111.791 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -132.11 165.89 23.01 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.131 0.972 . . . . 0.0 109.216 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.9 m -73.98 149.6 41.22 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.758 0.313 . . . . 0.0 111.303 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.5 mm -136.54 137.98 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.7 p -145.33 175.33 10.38 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.287 0.635 . . . . 0.0 109.77 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.0 p -63.0 -23.1 67.3 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 122.423 0.289 . . . . 0.0 111.199 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.24 -26.68 35.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.311 -0.243 . . . . 0.0 111.205 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 89.8 t -81.86 -36.78 14.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.8 mt -76.9 -24.16 52.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 122.378 -0.201 . . . . 0.0 110.528 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -76.83 -36.15 57.06 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.851 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -77.52 -20.06 54.83 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.344 0.52 . . . . 0.0 111.544 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -93.27 -15.47 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 118.331 0.514 . . . . 0.0 111.653 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 67.5 m -98.52 -21.68 16.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.642 0.655 . . . . 0.0 111.924 176.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.439 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.9 t-20 -58.82 -43.4 97.69 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 96.6 Cg_endo -72.31 -8.83 23.39 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.004 1.803 . . . . 0.0 112.012 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 70.7 m -96.21 -21.0 18.15 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.912 0.324 . . . . 0.0 111.151 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.63 168.09 25.1 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.91 112.58 3.14 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.757 2.971 . . . . 0.0 110.895 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.99 151.48 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 123.286 0.634 . . . . 0.0 109.395 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -116.42 -36.05 4.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.0 0.52 . . . . 0.0 110.788 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -163.17 157.81 20.97 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 112.413 0.524 . . . . 0.0 112.413 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.7 mt -143.67 146.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.243 1.017 . . . . 0.0 109.443 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.0 p -146.4 143.59 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.307 0.643 . . . . 0.0 109.61 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.71 151.39 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.743 0.817 . . . . 0.0 110.016 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -136.5 149.36 48.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.724 0.81 . . . . 0.0 109.862 175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.4 18.37 2.05 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.31 -27.46 69.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.539 0.336 . . . . 0.0 110.396 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -151.11 121.84 7.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 58.24 -145.1 41.87 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.4 t -129.67 128.0 65.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -143.1 166.91 23.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.43 0.692 . . . . 0.0 110.396 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.98 169.5 24.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.865 0.466 . . . . 0.0 109.95 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.4 mtp -134.65 149.85 50.58 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.41 149.84 25.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -135.72 140.16 44.19 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.594 0.757 . . . . 0.0 109.434 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -118.58 167.97 11.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.897 0.879 . . . . 0.0 110.837 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -14.35 60.08 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.722 0.409 . . . . 0.0 111.493 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.1 t -149.97 150.39 31.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.061 0.544 . . . . 0.0 109.72 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.56 -25.93 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -66.77 -26.99 67.23 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.7 m -82.43 -25.49 33.59 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.82 -26.81 40.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -69.72 -36.46 75.9 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -79.14 -24.54 43.24 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.332 -0.23 . . . . 0.0 110.849 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.25 -53.38 30.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.305 -0.247 . . . . 0.0 111.06 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -16.05 59.95 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.734 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.37 -9.89 58.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.032 0.378 . . . . 0.0 111.781 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 16.7 t -124.61 -5.38 7.61 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.6 mt -126.95 -4.96 6.27 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -76.88 131.25 38.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.94 4.76 78.26 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.15 -178.41 5.6 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.398 0.599 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -141.55 163.57 32.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.988 0.915 . . . . 0.0 109.145 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 39.1 mt -117.79 -20.5 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.214 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -138.32 80.69 1.81 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.843 -0.535 . . . . 0.0 111.183 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.8 m 50.74 42.05 26.99 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.522 0.729 . . . . 0.0 112.926 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 96.83 -4.61 63.44 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.743 -0.476 . . . . 0.0 112.934 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 58.8 m -97.03 167.58 10.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.834 0.817 . . . . 0.0 110.101 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 96.2 m 52.35 42.98 31.25 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.972 0.415 . . . . 0.0 110.66 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 8.7 m -55.62 138.2 47.54 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.396 0.679 . . . . 0.0 109.936 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 64.6 mt -102.65 154.0 19.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.073 0.549 . . . . 0.0 111.872 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -144.81 129.93 18.54 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 78.7 mt -128.87 147.08 33.31 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-O 121.347 0.594 . . . . 0.0 112.175 -170.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.51 173.41 15.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.891 1.277 . . . . 0.0 108.74 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -84.33 145.25 28.35 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 121.61 -0.681 . . . . 0.0 110.749 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.3 167.57 13.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.685 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 22.0 ptmt -82.38 -27.09 0.42 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 47.2 Cg_endo -84.31 -177.84 3.16 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.959 1.772 . . . . 0.0 110.065 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.9 p -111.36 -9.79 14.25 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.494 0.318 . . . . 0.0 111.337 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.36 137.35 13.56 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 63.5 mt -88.02 172.79 9.29 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 123.088 0.555 . . . . 0.0 110.726 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -132.34 149.36 52.37 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.324 -0.235 . . . . 0.0 111.008 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 72.5 t -138.6 151.34 24.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 124.298 1.039 . . . . 0.0 108.484 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -124.44 -23.67 4.4 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 177.21 9.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.575 1.15 . . . . 0.0 108.834 176.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -110.76 110.16 20.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.651 0.381 . . . . 0.0 110.113 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -152.79 -175.02 5.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.237 1.015 . . . . 0.0 109.545 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -72.53 -1.72 17.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -117.38 -20.42 9.13 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 118.503 0.592 . . . . 0.0 111.775 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.9 t -154.13 137.87 16.14 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -159.25 146.67 17.26 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 122.381 -0.199 . . . . 0.0 110.517 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -129.79 139.23 51.3 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.628 0.728 . . . . 0.0 111.38 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -104.69 -6.94 19.94 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.741 0.816 . . . . 0.0 111.526 -173.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 12.3 t -88.13 7.52 31.25 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.217 0.607 . . . . 0.0 109.857 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -111.83 131.01 22.62 Favored Pre-proline 0 N--CA 1.452 -0.33 0 C-N-CA 125.103 1.361 . . . . 0.0 109.455 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.94 64.06 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.077 3.185 . . . . 0.0 111.471 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 53.52 23.0 3.22 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.711 1.204 . . . . 0.0 113.503 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 17.1 tp 54.93 23.36 4.97 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.052 0.941 . . . . 0.0 111.91 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.4 p -139.07 -4.51 1.52 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 76.81 4.47 82.23 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -88.53 2.04 53.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.629 0.714 . . . . 0.0 112.067 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 CA-C-O 117.271 -1.849 . . . . 0.0 111.349 178.525 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -144.52 172.93 12.28 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 123.238 0.615 . . . . 0.0 111.121 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.3 tt -64.78 154.59 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.345 0.658 . . . . 0.0 110.607 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.3 p -81.0 1.51 30.95 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.984 0.514 . . . . 0.0 112.383 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -136.81 64.43 49.87 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 123.747 0.819 . . . . 0.0 109.821 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.48 160.05 49.61 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.725 2.95 . . . . 0.0 111.219 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.68 -5.29 89.98 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.94 -0.367 . . . . 0.0 112.635 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -149.28 158.06 43.86 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.138 0.575 . . . . 0.0 110.163 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.0 t 56.43 -172.38 0.07 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.024 0.929 . . . . 0.0 111.868 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 184' ' ' ASP . 25.8 t0 58.53 178.39 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.614 1.166 . . . . 0.0 112.369 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.428 ' H ' ' CG ' ' A' ' 183' ' ' ASP . 28.8 t70 62.37 162.98 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.038 1.335 . . . . 0.0 113.259 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 46.7 m 57.63 4.13 0.23 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.159 1.384 . . . . 0.0 114.093 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.539 ' HG2' ' H ' ' A' ' 187' ' ' SER . 50.9 ttt-85 45.49 -144.39 0.2 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.357 1.063 . . . . 0.0 111.06 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.539 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 57.8 p -151.75 150.38 30.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.515 1.126 . . . . 0.0 108.966 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 56.4 t -141.99 -63.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -161.34 164.99 29.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.235 0.614 . . . . 0.0 110.415 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.6 p -93.44 18.63 9.49 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.659 0.783 . . . . 0.0 112.048 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.17 145.09 30.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 122.939 0.496 . . . . 0.0 110.817 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.6 mt -131.08 163.24 28.08 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.305 0.574 . . . . 0.0 111.5 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 62.3 tp -122.73 132.36 54.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.663 1.185 . . . . 0.0 108.302 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -117.75 146.33 43.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.587 0.755 . . . . 0.0 109.685 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 97.0 m -138.2 143.34 40.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.67 137.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.22 -35.91 10.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -173.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -129.9 63.94 70.32 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.997 0.519 . . . . 0.0 110.346 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.47 100.41 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.167 2.578 . . . . 0.0 111.152 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.2 pt -122.17 3.11 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 122.874 0.469 . . . . 0.0 110.878 173.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -138.24 164.85 28.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.21 1.004 . . . . 0.0 109.097 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 80.3 p -79.21 156.6 28.09 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.902 0.382 . . . . 0.0 111.324 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.5 mm -135.86 137.95 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.1 p -144.44 175.41 10.14 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.137 0.575 . . . . 0.0 110.285 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.4 p -60.36 -26.45 66.63 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.973 0.509 . . . . 0.0 111.092 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.75 -21.3 44.63 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.506 0.322 . . . . 0.0 111.175 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.77 -37.86 10.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.21 -24.03 54.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.128 -0.357 . . . . 0.0 110.906 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -79.64 -33.06 41.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.95 -0.469 . . . . 0.0 111.111 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -77.09 -23.63 51.89 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-N 118.451 0.569 . . . . 0.0 111.369 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 39.1 pt -88.51 -22.25 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 118.258 0.481 . . . . 0.0 111.732 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 93.7 m -95.55 -21.94 17.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.546 0.612 . . . . 0.0 112.414 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.442 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.3 t-20 -60.33 -44.49 96.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 93.2 Cg_endo -72.89 -10.83 25.22 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.181 1.921 . . . . 0.0 111.727 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.7 m -94.04 -20.65 19.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.14 0.427 . . . . 0.0 110.931 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.67 168.36 27.7 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.08 105.84 1.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.659 2.906 . . . . 0.0 110.685 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.9 t -78.51 151.3 5.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -116.14 -37.66 3.77 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.705 0.402 . . . . 0.0 110.728 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -162.74 159.49 24.27 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 117.804 0.275 . . . . 0.0 111.474 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 50.5 mt -143.07 145.07 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 124.099 0.959 . . . . 0.0 110.319 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.483 HG13 ' HG1' ' A' ' 279' ' ' THR . 33.4 m -137.83 149.69 25.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 123.587 0.755 . . . . 0.0 109.33 173.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.46 149.02 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.259 0.624 . . . . 0.0 109.789 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -130.4 122.85 28.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.3 ppt_? -144.77 17.77 1.63 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -84.74 -19.09 33.23 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -153.21 122.18 6.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 62.48 -159.37 34.22 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -172.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.4 p -149.04 116.68 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 121.421 0.629 . . . . 0.0 110.426 175.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -149.88 169.5 20.99 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.344 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.64 169.82 21.75 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.993 0.517 . . . . 0.0 110.446 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.1 mtp -140.09 150.46 44.34 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.9 t -137.88 150.97 25.21 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 122.64 0.376 . . . . 0.0 110.04 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -133.4 140.85 47.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.366 0.667 . . . . 0.0 109.572 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.11 171.29 8.38 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.873 0.869 . . . . 0.0 110.774 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.14 -16.56 61.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.763 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 60.0 p -154.02 163.31 40.29 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.219 0.533 . . . . 0.0 110.829 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.72 -25.52 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.354 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -71.1 -27.58 63.71 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.199 0.454 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 m -77.81 -28.98 50.51 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.76 -24.69 41.37 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.446 -0.159 . . . . 0.0 110.759 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -70.35 -36.51 74.25 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -80.24 -25.69 39.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.439 -0.163 . . . . 0.0 110.732 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.52 -50.32 63.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.038 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.27 -15.74 59.31 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.693 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.21 -10.42 58.59 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.905 0.32 . . . . 0.0 111.401 176.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.6 m -123.2 -3.22 8.51 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.58 -4.26 4.2 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -79.03 131.51 36.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.42 5.46 63.29 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.586 -0.605 . . . . 0.0 111.586 -176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.44 178.64 8.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.863 0.832 . . . . 0.0 111.093 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -141.17 160.05 40.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.613 0.765 . . . . 0.0 109.372 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.8 mt -111.66 -19.88 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -121.32 32.58 5.86 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.971 -0.455 . . . . 0.0 112.132 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 52.3 p 56.31 13.07 1.15 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.84 1.256 . . . . 0.0 112.766 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 169.85 150.15 6.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 79.4 m 55.06 -174.85 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.54 0.736 . . . . 0.0 111.927 -175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.7 m 48.52 32.56 3.46 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.139 0.575 . . . . 0.0 111.307 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.9 m -58.44 140.41 53.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.321 0.648 . . . . 0.0 110.335 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 56.9 mt -98.0 155.17 17.23 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.115 0.566 . . . . 0.0 111.712 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -142.15 132.52 25.04 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 83.2 mt -129.38 145.67 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-O 121.17 0.51 . . . . 0.0 111.849 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.27 168.21 26.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.94 1.296 . . . . 0.0 108.3 173.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -78.01 141.54 38.85 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.868 -0.52 . . . . 0.0 110.497 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -80.8 166.24 21.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.6 pttt -81.72 -27.42 0.44 Allowed Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 49.1 Cg_endo -81.33 178.48 6.7 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.891 1.727 . . . . 0.0 109.797 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 63.5 p -104.51 -7.65 19.62 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 122.109 0.164 . . . . 0.0 111.18 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 167.72 28.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.319 0.647 . . . . 0.0 110.449 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.59 170.18 12.33 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.942 0.897 . . . . 0.0 109.425 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -143.13 163.21 33.49 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.502 0.191 . . . . 0.0 110.788 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.6 156.42 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 124.214 1.006 . . . . 0.0 109.103 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -126.1 -18.88 4.9 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.775 0.43 . . . . 0.0 111.621 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -166.09 169.24 14.71 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.042 0.937 . . . . 0.0 109.297 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -117.56 109.36 16.61 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.055 0.455 . . . . 0.0 110.54 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -155.47 -167.21 2.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.718 1.207 . . . . 0.0 109.898 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -73.44 -5.72 41.74 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.47 -15.98 12.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.672 0.669 . . . . 0.0 111.54 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' THR . . . . . 0.483 ' HG1' HG13 ' A' ' 222' ' ' VAL . 3.0 t -159.08 139.44 12.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -154.07 148.03 25.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.139 -0.351 . . . . 0.0 110.792 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.86 135.39 54.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.903 0.481 . . . . 0.0 110.017 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -115.73 9.1 15.09 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.56 0.744 . . . . 0.0 112.132 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t -129.99 1.22 4.78 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.234 0.614 . . . . 0.0 110.765 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -66.13 125.36 90.02 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 124.096 0.958 . . . . 0.0 109.672 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -56.82 -17.64 24.24 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.505 2.803 . . . . 0.0 113.57 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -81.85 -1.22 46.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.023 0.374 . . . . 0.0 111.807 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 60.0 tp -135.29 -25.0 1.37 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.597 0.359 . . . . 0.0 110.666 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 42.4 m -75.15 -12.48 60.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.987 -0.446 . . . . 0.0 111.055 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -77.94 -5.92 87.03 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -82.0 -14.76 55.52 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.484 0.642 . . . . 0.0 110.912 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 117.392 -1.782 . . . . 0.0 111.262 -179.174 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -113.8 -55.86 2.46 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.374 0.67 . . . . 0.0 111.469 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 17.9 tt -157.35 3.37 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.318 0.247 . . . . 0.0 111.001 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 20.4 m 56.92 8.66 0.52 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.62 1.168 . . . . 0.0 113.795 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -155.13 52.69 0.74 Allowed Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.239 0.615 . . . . 0.0 110.951 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.52 -14.44 30.61 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.941 2.427 . . . . 0.0 111.06 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 168.74 165.06 25.5 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -153.32 166.02 33.93 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 122.958 0.503 . . . . 0.0 110.829 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.5 m 60.57 151.25 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.343 1.457 . . . . 0.0 113.776 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.6 t70 50.43 23.43 1.27 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.213 1.005 . . . . 0.0 112.814 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 53.75 19.7 1.96 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.186 0.994 . . . . 0.0 112.846 -176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 84.1 p 55.15 -57.83 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.527 2.731 . . . . 0.0 114.835 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 58.26 171.4 0.06 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.697 1.599 . . . . 0.0 112.862 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.3 m 57.9 168.37 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.803 1.241 . . . . 0.0 113.615 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.46 -42.81 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.819 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -164.85 166.1 19.94 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.314 0.646 . . . . 0.0 110.506 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -91.51 10.09 29.3 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.222 0.609 . . . . 0.0 111.587 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.5 t -106.04 137.94 33.78 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 C-N-CA 123.248 0.619 . . . . 0.0 110.589 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.3 mt -126.47 159.96 31.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.623 0.725 . . . . 0.0 111.572 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.0 tp -118.7 132.39 56.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.037 1.335 . . . . 0.0 108.15 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -118.37 141.66 48.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.302 0.641 . . . . 0.0 109.713 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 92.5 m -137.21 141.1 42.1 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.6 mp -104.26 136.21 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.46 -34.61 12.66 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -130.4 62.27 63.62 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.492 0.717 . . . . 0.0 110.041 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.33 101.79 0.89 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.781 2.32 . . . . 0.0 111.021 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.4 pt -127.0 2.31 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 122.878 0.471 . . . . 0.0 111.227 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -132.11 166.58 21.46 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.879 0.872 . . . . 0.0 109.405 177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.9 m -75.11 150.6 38.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.367 0.267 . . . . 0.0 111.346 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.6 mm -138.37 136.67 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 80.7 p -144.94 174.27 11.16 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.435 0.694 . . . . 0.0 109.853 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.7 p -62.17 -24.85 67.44 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.191 0.196 . . . . 0.0 111.142 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.16 -24.9 47.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.789 0.268 . . . . 0.0 111.154 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.77 -37.48 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.92 -23.45 52.48 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.381 -0.199 . . . . 0.0 110.753 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -79.87 -33.96 39.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.887 0.312 . . . . 0.0 110.957 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 t -75.54 -22.47 57.04 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 118.467 0.576 . . . . 0.0 110.935 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.9 pt -89.7 -22.09 6.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.157 0.435 . . . . 0.0 111.899 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.4 m -95.72 -20.13 19.14 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.403 0.547 . . . . 0.0 112.355 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.45 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.8 t-20 -60.88 -42.76 88.83 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 84.4 Cg_endo -72.1 -10.71 26.33 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.876 1.717 . . . . 0.0 111.795 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.8 m -91.22 -20.68 21.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.933 0.333 . . . . 0.0 110.888 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.52 171.35 25.25 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.74 111.95 2.94 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.676 2.917 . . . . 0.0 110.948 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.8 t -84.41 150.6 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -113.89 -37.3 4.54 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.119 0.567 . . . . 0.0 111.125 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -164.08 158.37 19.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.723 0.692 . . . . 0.0 112.351 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.2 mt -144.32 147.28 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.956 0.902 . . . . 0.0 109.529 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.04 144.02 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.262 0.625 . . . . 0.0 109.503 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.8 151.43 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.861 0.864 . . . . 0.0 109.907 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -136.65 143.05 43.26 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.984 0.913 . . . . 0.0 108.939 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.98 16.0 1.38 Allowed 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -174.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.49 -18.79 65.56 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.006 -0.433 . . . . 0.0 111.137 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -154.88 124.23 6.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 57.26 -147.31 35.31 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.6 t -133.96 129.51 54.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -146.24 167.18 24.13 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.242 0.617 . . . . 0.0 110.276 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.44 173.24 17.2 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.669 0.388 . . . . 0.0 110.278 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.5 mtp -137.51 150.25 47.4 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.92 151.34 25.44 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -138.73 141.75 38.89 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.195 0.598 . . . . 0.0 109.407 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -118.26 168.15 10.87 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.808 0.843 . . . . 0.0 110.805 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -76.67 -11.12 59.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.94 0.496 . . . . 0.0 111.527 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.0 t -151.67 150.18 29.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.157 0.583 . . . . 0.0 109.745 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.03 -23.64 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.05 -25.23 62.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 38.2 m -80.59 -26.31 37.94 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.09 -26.99 35.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.168 0.187 . . . . 0.0 110.521 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -68.06 -36.89 80.6 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.3 ttt-85 -78.62 -25.98 45.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.406 -0.184 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -68.4 -48.42 64.71 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.419 -0.324 . . . . 0.0 111.262 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -13.26 59.92 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.534 0.606 . . . . 0.0 111.532 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.42 -9.67 54.05 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.543 -0.265 . . . . 0.0 111.6 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -123.87 -3.46 8.17 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.7 mt -129.99 -4.31 4.52 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -76.52 133.17 39.83 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 119.072 0.851 . . . . 0.0 109.134 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.59 5.89 69.65 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.803 -0.443 . . . . 0.0 112.327 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.31 174.74 11.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.689 0.744 . . . . 0.0 111.134 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -132.67 144.32 50.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.9 mt -92.43 -20.22 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 O-C-N 122.293 -0.254 . . . . 0.0 111.052 -177.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -122.11 25.56 8.97 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.177 0.591 . . . . 0.0 111.226 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.1 m 56.78 16.01 2.49 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.204 1.002 . . . . 0.0 112.416 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.78 142.57 4.26 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 64.6 m 55.19 -179.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.859 0.864 . . . . 0.0 112.008 -174.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.7 m 50.17 34.98 9.33 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.068 -0.395 . . . . 0.0 111.071 -173.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.8 m -59.82 142.58 53.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.939 0.495 . . . . 0.0 110.117 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 55.0 mt -100.58 154.56 18.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.365 0.602 . . . . 0.0 112.608 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -139.02 137.56 36.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 74.8 mt -134.5 142.68 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 111.382 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.07 167.83 28.49 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.468 1.107 . . . . 0.0 108.526 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.0 144.0 37.07 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.883 -0.511 . . . . 0.0 110.613 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.95 169.79 10.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.659 0.384 . . . . 0.0 110.926 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.1 pttt -84.55 -26.97 0.39 Allowed Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -176.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 52.2 Cg_endo -80.25 166.47 20.44 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 CA-C-N 121.82 1.686 . . . . 0.0 109.784 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.6 p -100.58 -10.88 20.55 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 122.314 -0.241 . . . . 0.0 111.154 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.65 137.07 11.96 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 85.7 mt -85.42 169.77 13.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.728 0.411 . . . . 0.0 110.74 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -132.3 151.14 51.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 93.8 t -138.3 154.01 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 124.072 0.949 . . . . 0.0 108.65 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.81 -23.75 4.99 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -173.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.2 171.07 12.63 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.542 1.137 . . . . 0.0 109.082 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -107.79 117.92 35.37 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.91 0.386 . . . . 0.0 110.593 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -157.99 -172.45 3.92 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.69 1.196 . . . . 0.0 109.309 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -73.59 -5.07 38.01 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -112.15 -20.0 12.07 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.801 0.728 . . . . 0.0 111.671 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.1 t -156.33 139.99 16.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 173.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -149.88 147.78 28.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 110.696 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -123.7 113.03 18.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -91.09 3.25 55.25 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.898 0.879 . . . . 0.0 111.709 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.3 t -124.85 20.04 8.46 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.555 0.742 . . . . 0.0 109.904 177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -69.85 143.33 91.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.227 0.611 . . . . 0.0 110.922 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.05 -16.92 35.26 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.237 2.625 . . . . 0.0 113.283 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -99.93 4.08 44.77 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.816 0.447 . . . . 0.0 111.731 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 40.2 tp -128.39 -14.89 4.69 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.862 0.465 . . . . 0.0 110.955 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 49.3 m -125.6 7.27 7.56 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.307 0.643 . . . . 0.0 111.55 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -77.17 177.04 52.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -139.87 10.51 2.41 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.002 0.521 . . . . 0.0 111.657 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.568 -1.684 . . . . 0.0 111.04 -179.782 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -139.16 167.89 21.05 Favored 'General case' 0 C--N 1.338 0.066 0 C-N-CA 123.699 0.8 . . . . 0.0 110.892 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.4 tt -142.91 163.91 16.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 124.152 0.981 . . . . 0.0 109.175 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 m -63.17 -14.02 44.02 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -148.48 94.47 4.17 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.4 -14.78 25.21 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.064 2.509 . . . . 0.0 111.823 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.53 155.53 21.32 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -147.18 159.17 43.94 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.002 0.521 . . . . 0.0 110.087 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.1 m 56.63 177.34 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.824 1.25 . . . . 0.0 113.036 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 52.04 24.99 2.91 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.003 0.921 . . . . 0.0 113.073 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.5 t70 54.91 25.19 6.51 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.947 0.899 . . . . 0.0 112.529 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.6 t 59.51 178.99 0.08 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.446 1.099 . . . . 0.0 112.734 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -68.11 150.75 47.99 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.903 0.481 . . . . 0.0 111.468 -176.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.9 t -157.79 170.63 21.93 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.982 0.913 . . . . 0.0 109.471 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.13 -96.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -157.46 163.49 38.43 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.273 0.629 . . . . 0.0 110.353 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.8 p -94.96 16.15 16.9 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.29 0.636 . . . . 0.0 111.953 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.59 146.13 25.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 123.042 0.537 . . . . 0.0 111.108 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.55 164.0 25.85 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.682 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.4 tp -122.98 133.29 54.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.874 1.27 . . . . 0.0 108.099 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -120.74 144.47 48.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.657 0.783 . . . . 0.0 110.168 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 96.4 m -136.61 141.01 43.25 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.65 136.77 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.09 -26.95 13.51 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -134.22 62.51 56.68 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 123.618 0.767 . . . . 0.0 109.812 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.72 59.7 5.03 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 124.241 3.294 . . . . 0.0 111.477 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 43.8 pt -82.22 -0.83 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 O-C-N 121.884 -0.51 . . . . 0.0 111.565 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -134.79 167.97 19.89 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.061 0.944 . . . . 0.0 109.382 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.2 m -79.72 151.17 30.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.6 mm -133.64 138.66 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.1 p -141.81 174.78 10.26 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.101 0.56 . . . . 0.0 109.598 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.9 p -63.26 -21.69 66.4 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.48 0.312 . . . . 0.0 110.959 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.17 -24.53 40.28 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.488 0.315 . . . . 0.0 110.798 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 87.3 t -82.99 -37.4 13.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.4 mt -76.82 -22.75 53.16 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.155 -0.341 . . . . 0.0 110.75 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -79.17 -34.89 42.73 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.905 -0.497 . . . . 0.0 110.788 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.3 t -75.43 -23.1 56.91 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.114 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.0 pt -90.48 -20.89 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.53 0.605 . . . . 0.0 112.28 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.1 m -98.43 -19.87 17.45 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.866 0.757 . . . . 0.0 112.975 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.446 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 47.6 t30 -64.47 -40.49 51.05 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 90.5 Cg_endo -71.68 -3.36 12.96 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.576 1.517 . . . . 0.0 111.932 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 73.1 m -99.96 -4.5 29.99 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.702 0.401 . . . . 0.0 111.295 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 142.11 174.44 14.76 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.06 109.34 2.15 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.765 2.976 . . . . 0.0 110.981 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.2 t -80.98 149.71 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -115.67 -39.99 3.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.927 0.491 . . . . 0.0 111.337 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -161.27 158.15 26.71 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.1 mt -141.42 145.71 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.269 1.028 . . . . 0.0 109.582 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.68 147.91 20.41 Favored 'Isoleucine or valine' 0 C--O 1.23 0.052 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.92 149.24 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.05 0.54 . . . . 0.0 110.515 -173.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -128.78 123.66 33.48 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -145.27 28.47 1.21 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -76.38 -18.0 59.09 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -156.73 -54.65 0.08 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.36 -164.68 39.96 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.3 t -138.72 108.03 4.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -145.26 164.9 29.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.352 0.661 . . . . 0.0 109.952 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -153.63 171.49 18.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.694 0.398 . . . . 0.0 110.478 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 81.3 mtp -141.32 150.13 42.1 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 52.0 t -137.97 152.7 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.036 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -137.02 140.99 42.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.406 0.682 . . . . 0.0 109.755 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.66 168.39 10.76 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.006 0.922 . . . . 0.0 110.816 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.49 -10.38 59.69 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.213 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 40.7 t -153.21 151.66 30.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.034 0.534 . . . . 0.0 110.067 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.55 -22.67 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -66.67 -28.5 68.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.993 0.36 . . . . 0.0 110.642 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 75.4 m -87.21 -23.97 24.58 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.358 -0.214 . . . . 0.0 110.757 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.53 -28.86 59.25 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -70.72 -36.91 73.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 40.3 ttm105 -74.89 -32.79 61.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.341 0.256 . . . . 0.0 111.041 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.82 66.04 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.189 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -11.83 59.94 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.972 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.43 -12.4 46.28 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.603 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 58.7 m -127.57 2.57 6.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 91.1 mt -130.86 -4.99 4.02 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.642 0.655 . . . . 0.0 112.488 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -79.05 131.14 36.17 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.75 7.54 70.03 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.32 177.99 8.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.428 0.691 . . . . 0.0 111.467 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.23 143.99 50.32 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.259 1.023 . . . . 0.0 108.357 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 59.7 mt -90.55 -22.45 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 O-C-N 122.403 -0.186 . . . . 0.0 111.272 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -122.7 30.43 6.46 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.838 0.455 . . . . 0.0 111.333 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.2 m 56.2 19.53 3.92 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.351 0.66 . . . . 0.0 111.828 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 172.07 155.53 11.18 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 6.7 p 48.97 -175.52 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.916 1.286 . . . . 0.0 113.112 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 76.4 m 47.38 37.77 6.51 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.132 0.573 . . . . 0.0 111.162 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 8.9 m -58.12 139.18 55.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.114 0.565 . . . . 0.0 110.105 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 51.1 mt -102.11 155.73 18.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.219 0.533 . . . . 0.0 112.212 -175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -143.4 134.74 26.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 74.2 mt -129.24 149.87 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 121.135 0.493 . . . . 0.0 111.436 -176.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.75 170.27 22.44 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.984 1.314 . . . . 0.0 108.029 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -79.69 144.45 33.69 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 121.865 -0.522 . . . . 0.0 110.337 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.23 164.91 19.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.141 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 40.0 ttpt -72.27 -45.76 10.71 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 79.6 Cg_endo -75.59 176.79 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.605 2.203 . . . . 0.0 110.503 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 63.6 p -106.56 -8.66 16.91 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 122.595 0.358 . . . . 0.0 111.61 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.34 137.42 15.56 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 58.5 mt -90.18 177.64 6.38 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.105 0.562 . . . . 0.0 110.608 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -137.37 154.17 50.06 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.156 -0.34 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.2 t -138.29 153.07 26.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.948 0.899 . . . . 0.0 109.166 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.22 -15.24 4.72 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.617 0.367 . . . . 0.0 111.777 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -166.65 175.82 7.66 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.031 0.933 . . . . 0.0 109.911 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -119.6 101.19 7.75 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -150.47 -169.63 3.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.946 0.898 . . . . 0.0 110.341 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -71.13 -1.38 12.18 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -116.1 -21.25 9.52 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.917 0.781 . . . . 0.0 111.856 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.8 t -157.95 145.69 18.51 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 118.296 0.498 . . . . 0.0 109.999 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -153.15 151.05 29.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.657 0.265 . . . . 0.0 110.697 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.54 139.56 53.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.6 15.72 12.82 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.354 0.661 . . . . 0.0 112.171 -174.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.1 t -131.27 -3.39 3.88 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.1 -0.375 . . . . 0.0 111.863 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -81.9 154.73 70.46 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.175 0.59 . . . . 0.0 110.613 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.23 -6.34 18.27 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.447 2.765 . . . . 0.0 111.697 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -78.87 -4.42 49.58 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.769 0.428 . . . . 0.0 111.892 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 36.6 tp -94.97 -10.22 31.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.898 0.479 . . . . 0.0 110.909 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 50.5 m -134.84 11.49 3.66 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.006 0.522 . . . . 0.0 111.448 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 179.67 -169.11 39.92 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -90.0 -0.46 57.59 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.548 -0.384 . . . . 0.0 111.007 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.089 0 CA-C-O 117.361 -1.8 . . . . 0.0 111.087 -179.641 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -146.72 163.51 35.7 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.176 0.591 . . . . 0.0 109.763 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.83 154.34 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.587 0.355 . . . . 0.0 110.546 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 78.5 p -78.55 0.57 25.68 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.261 0.624 . . . . 0.0 112.285 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -139.37 68.54 39.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.601 0.761 . . . . 0.0 109.394 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.98 162.33 39.32 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.497 2.798 . . . . 0.0 110.96 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.89 175.18 53.94 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 183' ' ' ASP . 26.6 t70 -144.39 142.83 30.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.625 -0.338 . . . . 0.0 110.346 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.0 m 58.54 -19.28 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.77 2.028 . . . . 0.0 115.151 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 184' ' ' ASP . 38.2 t0 52.67 -171.69 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.757 1.223 . . . . 0.0 112.518 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.483 ' H ' ' CG ' ' A' ' 183' ' ' ASP . 8.6 t70 53.94 -158.42 0.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.139 0.975 . . . . 0.0 111.628 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.472 ' H ' ' CG ' ' A' ' 184' ' ' ASP . 19.4 t 60.5 -67.67 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.114 1.765 . . . . 0.0 113.781 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 54.54 -171.56 0.05 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.18 0.992 . . . . 0.0 111.711 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 60.6 m -145.32 152.26 39.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.945 0.498 . . . . 0.0 110.483 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.19 -50.19 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 122.246 0.218 . . . . 0.0 110.79 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -164.04 168.24 19.42 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.296 0.638 . . . . 0.0 110.069 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 81.2 p -101.18 16.73 24.52 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.536 0.734 . . . . 0.0 111.845 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.6 m -119.7 144.38 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 C-N-CA 123.008 0.523 . . . . 0.0 111.083 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.1 mt -130.94 164.64 24.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.168 0.508 . . . . 0.0 111.384 -174.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 62.8 tp -123.28 134.03 54.12 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.824 1.249 . . . . 0.0 108.316 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -120.52 146.71 46.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.678 0.791 . . . . 0.0 109.816 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 87.3 m -136.53 144.36 44.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.42 136.43 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.5 mt -98.93 -32.79 11.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -172.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -133.42 69.38 77.22 Favored Pre-proline 0 CA--C 1.532 0.25 0 C-N-CA 123.572 0.749 . . . . 0.0 109.507 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.57 55.7 3.79 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 125.007 3.805 . . . . 0.0 112.26 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.1 -3.68 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 121.753 -0.592 . . . . 0.0 111.38 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -129.86 168.16 17.04 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.703 0.801 . . . . 0.0 109.378 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 82.0 p -80.87 153.01 27.86 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.947 0.403 . . . . 0.0 111.504 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.0 mm -138.68 139.48 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.9 p -144.04 173.14 11.98 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.528 0.731 . . . . 0.0 109.56 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.1 p -63.63 -19.13 64.62 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.355 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -83.24 -26.06 31.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 117.805 0.275 . . . . 0.0 110.591 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.2 t -81.51 -36.24 14.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.37 -25.19 57.47 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.275 -0.266 . . . . 0.0 110.333 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -77.05 -36.32 56.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.086 -0.384 . . . . 0.0 110.966 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -76.46 -20.27 57.19 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.471 0.578 . . . . 0.0 111.336 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.16 -16.69 7.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-N 118.244 0.474 . . . . 0.0 111.78 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.3 m -97.31 -20.92 17.53 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.761 0.71 . . . . 0.0 112.155 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.435 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.2 t-20 -61.41 -43.73 90.26 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 98.7 Cg_endo -72.43 -10.59 25.65 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.633 1.555 . . . . 0.0 111.633 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 74.7 m -94.42 -21.59 18.83 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.797 0.271 . . . . 0.0 111.397 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 167.8 168.54 30.09 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.98 99.47 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.297 3.331 . . . . 0.0 110.902 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.3 t -75.52 144.21 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -113.02 -33.65 5.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.456 0.302 . . . . 0.0 111.075 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -163.73 157.87 19.6 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 117.966 0.348 . . . . 0.0 111.574 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.0 mt -143.37 142.74 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.289 1.036 . . . . 0.0 109.715 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.1 m -138.43 156.61 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.055 0.542 . . . . 0.0 109.588 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 66.0 mt -132.14 149.87 33.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 122.89 0.476 . . . . 0.0 110.403 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -138.14 143.36 40.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.566 0.746 . . . . 0.0 109.599 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.96 14.96 1.72 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.708 0.403 . . . . 0.0 112.058 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -82.3 -2.27 52.17 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -145.74 11.1 1.24 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.127 0.571 . . . . 0.0 111.448 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 152.14 -134.26 4.48 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -173.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.52 116.36 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -149.3 165.7 31.15 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.556 0.742 . . . . 0.0 110.582 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.44 169.64 20.4 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.139 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 78.2 mtp -138.86 148.98 44.37 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.7 t -136.37 151.42 28.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 122.878 0.471 . . . . 0.0 109.842 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -137.08 138.58 40.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.25 0.62 . . . . 0.0 109.745 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.07 170.36 8.92 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.141 0.976 . . . . 0.0 110.497 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.05 -16.24 59.97 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.565 0.346 . . . . 0.0 111.528 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.7 t -150.99 154.46 37.12 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.729 0.412 . . . . 0.0 110.579 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.24 -26.94 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.022 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -67.08 -29.9 69.79 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.059 -0.401 . . . . 0.0 110.079 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.2 m -79.29 -26.68 42.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.411 0.285 . . . . 0.0 110.501 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.52 -26.29 38.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.396 -0.19 . . . . 0.0 110.685 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -69.54 -36.62 76.53 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -77.82 -26.6 49.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.307 0.243 . . . . 0.0 110.798 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.5 -53.82 30.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.141 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -14.42 60.38 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.814 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.53 -10.65 55.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.096 -0.378 . . . . 0.0 111.45 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.6 m -123.78 -0.35 8.55 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 94.0 mt -131.1 -6.2 3.89 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -76.35 131.24 39.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.917 0.78 . . . . 0.0 109.274 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.42 7.51 73.21 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.121 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.99 174.05 12.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.864 0.832 . . . . 0.0 111.337 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -132.62 145.65 51.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.8 mt -95.68 -17.37 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 122.097 0.159 . . . . 0.0 111.124 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.23 27.07 7.21 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.04 0.536 . . . . 0.0 111.137 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.7 m 56.49 17.64 3.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.953 0.901 . . . . 0.0 112.244 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 172.54 143.36 4.12 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 84.7 m 54.91 -178.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.89 0.876 . . . . 0.0 112.04 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.8 m 50.82 33.7 9.0 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.916 0.486 . . . . 0.0 110.936 -173.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.8 m -59.21 140.57 55.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.978 0.511 . . . . 0.0 110.09 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 47.4 mt -98.9 153.62 18.67 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.126 0.571 . . . . 0.0 111.94 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -140.43 134.8 31.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 171.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 81.6 mt -129.19 149.34 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.209 0.528 . . . . 0.0 111.286 -175.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.74 169.16 24.99 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.865 1.266 . . . . 0.0 108.199 173.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -79.57 142.01 36.08 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.756 -0.59 . . . . 0.0 110.542 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.43 164.11 20.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -81.78 -26.12 0.41 Allowed Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -175.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 44.0 Cg_endo -81.51 177.69 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 121.767 1.667 . . . . 0.0 109.876 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 68.5 p -106.53 -5.56 18.71 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.611 0.364 . . . . 0.0 110.902 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.9 mmm-85 -153.81 154.81 34.67 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.901 0.88 . . . . 0.0 110.295 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.68 168.56 10.32 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.644 0.778 . . . . 0.0 109.47 173.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -140.16 166.63 24.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.935 0.398 . . . . 0.0 111.494 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.5 t -138.09 155.27 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.144 0.978 . . . . 0.0 108.723 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.81 -26.3 4.87 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.299 0.24 . . . . 0.0 111.392 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.76 168.87 17.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.451 1.101 . . . . 0.0 109.08 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -106.44 117.34 33.78 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.931 0.396 . . . . 0.0 110.963 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -157.41 -175.17 5.25 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.713 1.205 . . . . 0.0 109.496 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -71.24 -3.42 20.23 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -173.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -118.08 -14.3 9.94 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.711 0.687 . . . . 0.0 111.968 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.9 t -155.98 135.2 12.18 Favored 'General case' 0 C--O 1.228 -0.043 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -153.2 147.75 26.09 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.872 0.368 . . . . 0.0 111.359 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.68 135.57 55.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.452 0.701 . . . . 0.0 109.509 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -116.9 13.66 14.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.4 0.68 . . . . 0.0 112.503 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.1 t -135.98 -5.53 2.15 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.315 0.507 . . . . 0.0 112.342 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -80.33 160.79 67.0 Favored Pre-proline 0 CA--C 1.535 0.374 0 O-C-N 121.834 -0.542 . . . . 0.0 111.36 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -61.66 -10.07 15.64 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.203 3.268 . . . . 0.0 113.37 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -81.75 -5.66 58.35 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.738 0.415 . . . . 0.0 111.72 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 23.3 tp -138.19 0.72 2.15 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.82 0.448 . . . . 0.0 111.093 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 26.3 m 55.66 31.3 17.06 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.699 0.799 . . . . 0.0 112.822 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 84.53 -164.93 40.16 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 112.308 -0.317 . . . . 0.0 112.308 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -73.78 -13.13 60.9 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.43 -0.453 . . . . 0.0 110.81 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 CA-C-O 117.346 -1.808 . . . . 0.0 110.744 -179.861 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -143.42 155.87 44.51 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.096 0.559 . . . . 0.0 110.004 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 17.9 tt -69.11 156.17 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 122.861 0.464 . . . . 0.0 110.415 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 78.4 p -81.09 -1.64 45.07 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -140.46 62.15 18.38 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 123.607 0.763 . . . . 0.0 110.764 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.07 -9.31 23.34 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.08 3.187 . . . . 0.0 112.291 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.21 153.81 51.28 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -152.95 158.19 41.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.587 0.355 . . . . 0.0 110.943 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 58.1 p 53.19 175.11 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.659 1.984 . . . . 0.0 114.759 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.7 t0 53.32 17.79 1.13 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.898 1.279 . . . . 0.0 113.363 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.9 t0 51.57 29.59 5.65 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.021 0.928 . . . . 0.0 112.488 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 26.1 m 57.8 9.52 0.89 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.103 0.961 . . . . 0.0 112.952 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 59.32 140.86 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.111 2.165 . . . . 0.0 114.899 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.0 m 58.55 144.61 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.438 1.895 . . . . 0.0 114.983 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.5 p -156.06 -40.72 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.304 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -163.92 165.78 22.36 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.881 0.872 . . . . 0.0 109.935 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.6 p -96.51 12.25 32.15 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.138 0.575 . . . . 0.0 111.826 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.72 142.46 25.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 122.874 0.469 . . . . 0.0 111.194 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.3 mt -129.19 164.0 24.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.113 0.565 . . . . 0.0 111.454 -175.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.7 tp -123.89 132.69 53.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.716 1.206 . . . . 0.0 108.171 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -119.43 144.25 47.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.729 0.811 . . . . 0.0 109.805 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 91.7 m -139.06 144.3 38.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.9 mp -106.85 134.36 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.66 -36.55 15.18 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -173.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -131.54 63.5 69.72 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 123.606 0.762 . . . . 0.0 109.948 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.84 103.24 1.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.849 2.366 . . . . 0.0 110.88 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.9 pt -128.65 0.94 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 122.879 0.472 . . . . 0.0 111.384 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.42 ' HB2' ' HG ' ' A' ' 258' ' ' CYS . 38.0 m-85 -130.1 166.52 20.02 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.954 0.902 . . . . 0.0 109.191 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.2 m -74.98 147.8 40.5 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.719 0.295 . . . . 0.0 111.56 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.1 mm -137.55 132.88 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.3 p -142.87 176.36 9.13 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 122.896 0.479 . . . . 0.0 110.299 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 41.5 p -63.31 -22.8 67.1 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.193 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -80.5 -26.14 38.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.295 0.238 . . . . 0.0 110.821 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 87.6 t -84.41 -37.59 12.9 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.17 -24.93 54.81 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.294 -0.254 . . . . 0.0 111.093 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -77.62 -37.26 50.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.815 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.4 t -75.74 -19.58 58.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.219 0.463 . . . . 0.0 111.374 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -94.92 -15.67 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.339 0.518 . . . . 0.0 111.858 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.5 m -97.41 -22.78 16.4 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.697 0.68 . . . . 0.0 111.864 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.433 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 26.9 t-20 -59.82 -43.04 94.07 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 93.9 Cg_endo -72.22 -9.19 24.05 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.985 1.79 . . . . 0.0 111.928 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.4 m -96.09 -20.75 18.41 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 122.063 -0.398 . . . . 0.0 111.317 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 162.94 169.75 26.82 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.84 115.76 3.76 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.571 2.847 . . . . 0.0 111.039 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.96 147.34 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -111.63 -39.56 4.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.986 0.514 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -160.83 159.08 29.46 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.56 0.618 . . . . 0.0 112.177 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.6 mt -142.53 146.96 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.623 0.769 . . . . 0.0 110.377 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.61 144.25 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 123.372 0.669 . . . . 0.0 109.587 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp -109.12 150.95 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.493 0.717 . . . . 0.0 109.727 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -136.9 149.2 47.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.741 0.816 . . . . 0.0 109.959 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.53 16.75 2.37 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.51 -26.84 68.76 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.441 0.296 . . . . 0.0 110.794 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -151.19 120.05 6.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 57.78 -141.38 44.89 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.5 t -129.12 131.44 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -145.23 166.97 23.95 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.3 0.64 . . . . 0.0 110.067 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.13 171.04 21.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.796 0.439 . . . . 0.0 110.071 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.2 mtp -138.24 151.29 47.51 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.1 t -141.13 151.93 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 122.847 0.459 . . . . 0.0 109.846 -175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -136.94 141.45 42.65 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -115.8 168.32 10.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.471 0.709 . . . . 0.0 110.802 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -74.51 -13.83 60.73 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.761 0.425 . . . . 0.0 111.341 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 37.7 t -152.31 153.82 34.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.839 0.456 . . . . 0.0 109.938 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.8 -25.19 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -65.39 -27.59 68.66 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.908 -0.495 . . . . 0.0 109.742 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 40.4 m -82.51 -26.85 32.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.2 0.2 . . . . 0.0 110.712 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.76 -25.4 41.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -70.73 -37.53 73.51 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -77.88 -24.83 48.35 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 122.076 0.15 . . . . 0.0 110.779 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.43 -54.6 18.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.325 -0.234 . . . . 0.0 110.935 -178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -15.82 60.26 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.708 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.14 -11.11 58.24 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.115 -0.366 . . . . 0.0 111.563 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.0 m -124.45 -0.71 8.14 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 87.2 mt -130.17 -4.82 4.4 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -77.0 130.24 37.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.461 -0.774 . . . . 0.0 109.176 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.68 6.2 76.51 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.805 -0.442 . . . . 0.0 112.052 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.26 176.29 7.52 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.673 0.737 . . . . 0.0 111.488 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -140.11 150.96 44.93 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.57 0.748 . . . . 0.0 109.364 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.3 mt -114.58 -18.01 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 122.407 0.283 . . . . 0.0 111.442 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.18 22.01 8.72 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.045 -0.409 . . . . 0.0 111.231 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.8 m 55.77 21.03 4.4 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.524 0.73 . . . . 0.0 112.096 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 168.95 137.65 2.3 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 85.5 m 55.69 -178.73 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.132 0.973 . . . . 0.0 112.243 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . 0.42 ' HG ' ' HB2' ' A' ' 201' ' ' TYR . 79.6 m 51.81 30.53 7.1 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.062 -0.399 . . . . 0.0 111.878 -174.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.68 140.72 56.21 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.962 0.505 . . . . 0.0 109.777 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 62.2 mt -93.52 155.2 17.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.206 0.527 . . . . 0.0 111.786 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -144.3 135.6 25.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 172.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 85.2 mt -130.17 149.7 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 121.0 0.428 . . . . 0.0 111.174 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.35 168.77 26.0 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.934 1.294 . . . . 0.0 108.211 173.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -80.39 144.05 33.0 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.679 -0.638 . . . . 0.0 110.578 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.66 165.46 16.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.669 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -83.18 -25.79 0.38 Allowed Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 43.7 Cg_endo -81.43 179.46 5.79 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.836 1.691 . . . . 0.0 109.858 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 65.1 p -108.57 -4.65 17.0 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.734 0.414 . . . . 0.0 110.728 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.3 mmm-85 -153.8 153.94 33.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.039 0.936 . . . . 0.0 110.099 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 83.9 mt -115.21 168.91 9.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.298 0.639 . . . . 0.0 109.514 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -141.13 158.49 43.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.286 0.234 . . . . 0.0 110.813 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.37 156.22 29.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 124.215 1.006 . . . . 0.0 109.097 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -124.61 -15.73 6.47 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -173.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -162.49 175.16 11.77 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.698 0.799 . . . . 0.0 110.293 -176.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -121.09 95.88 4.87 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.38 0.672 . . . . 0.0 109.577 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -149.42 -170.69 3.7 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.726 0.81 . . . . 0.0 110.649 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -70.91 -5.04 27.73 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -109.0 -24.21 11.32 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.649 0.658 . . . . 0.0 111.392 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.2 t -159.26 143.33 15.11 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -150.91 150.23 30.6 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.25 137.57 52.06 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -113.81 5.17 16.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.379 0.671 . . . . 0.0 112.519 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t -128.25 -5.22 5.47 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.755 0.422 . . . . 0.0 110.921 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -79.91 126.54 79.72 Favored Pre-proline 0 N--CA 1.453 -0.312 0 C-N-CA 124.167 0.987 . . . . 0.0 109.907 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.16 -16.3 32.93 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.615 2.877 . . . . 0.0 113.782 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -67.11 121.65 16.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 56.93 23.9 8.77 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.109 0.964 . . . . 0.0 111.123 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 10.2 t 52.29 15.52 0.47 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.792 1.237 . . . . 0.0 112.846 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 67.92 11.84 61.42 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.658 -0.523 . . . . 0.0 112.693 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -139.56 -4.37 1.44 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.125 0.962 . . . . 0.0 113.022 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.132 -1.927 . . . . 0.0 111.434 179.706 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.737 0.303 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.0 p -94.87 10.75 34.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.173 0.589 . . . . 0.0 111.258 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.35 139.47 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.683 0.793 . . . . 0.0 110.664 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 99.1 mt -128.52 160.35 32.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.386 0.612 . . . . 0.0 111.255 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.4 tp -120.65 133.36 55.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.99 1.316 . . . . 0.0 108.042 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -119.75 144.71 47.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.652 0.781 . . . . 0.0 109.912 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 99.0 m -139.52 142.83 37.24 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.4 mp -105.38 135.78 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.86 -35.79 12.54 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -130.79 62.84 67.58 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.429 0.692 . . . . 0.0 110.329 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.45 103.25 1.08 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.795 2.33 . . . . 0.0 110.989 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.8 pt -128.83 2.71 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.742 0.417 . . . . 0.0 111.614 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -132.31 167.47 19.81 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.737 0.815 . . . . 0.0 109.628 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.5 m -74.68 146.73 42.08 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.65 0.262 . . . . 0.0 111.133 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mm -138.11 136.02 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.5 p -144.05 174.21 11.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.463 0.705 . . . . 0.0 109.538 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.2 p -63.51 -19.16 64.54 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.507 0.323 . . . . 0.0 111.153 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -83.4 -25.96 30.84 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.745 0.248 . . . . 0.0 111.042 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.4 t -81.67 -36.58 14.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.76 -26.32 57.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.217 -0.302 . . . . 0.0 110.295 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -75.63 -36.64 60.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.868 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.1 t -77.13 -17.69 58.45 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.312 0.505 . . . . 0.0 111.647 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.77 -13.9 7.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.148 0.431 . . . . 0.0 111.877 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 83.6 m -99.31 -24.97 14.64 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.765 0.711 . . . . 0.0 112.139 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.471 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 47.9 t30 -63.93 -39.16 42.75 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 95.1 Cg_endo -72.89 -5.81 17.87 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.437 1.425 . . . . 0.0 111.729 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 73.0 m -102.54 -10.52 19.25 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.806 0.442 . . . . 0.0 111.105 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 156.89 166.01 15.81 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.71 112.75 2.97 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.61 2.873 . . . . 0.0 110.658 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.25 152.33 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -117.18 -37.82 3.48 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.617 0.367 . . . . 0.0 110.95 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -163.16 157.32 20.37 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.2 0.455 . . . . 0.0 112.186 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.6 mt -143.67 146.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.315 1.046 . . . . 0.0 109.913 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.17 150.9 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--O 1.231 0.116 0 C-N-CA 122.966 0.506 . . . . 0.0 110.742 -173.806 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.808 0.337 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -154.24 171.6 18.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.556 0.342 . . . . 0.0 110.418 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.4 mtp -138.45 147.73 43.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.2 t -137.81 151.75 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 123.149 0.58 . . . . 0.0 109.786 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -141.2 141.49 34.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.297 0.639 . . . . 0.0 109.88 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -118.0 168.73 10.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.95 0.9 . . . . 0.0 110.981 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.01 -14.41 60.22 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.979 0.512 . . . . 0.0 111.357 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.4 t -150.75 152.15 33.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.939 0.496 . . . . 0.0 109.998 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.52 -23.68 30.22 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.85 -29.09 70.03 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 27.3 m -83.87 -28.0 28.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.573 0.349 . . . . 0.0 110.391 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.23 -27.02 47.61 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -69.96 -38.92 76.25 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -76.55 -27.95 56.1 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.15 -53.83 39.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.399 -0.188 . . . . 0.0 110.968 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.433 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.57 -14.38 60.01 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.999 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.05 -12.58 57.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.014 0.37 . . . . 0.0 111.947 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -128.75 2.31 5.44 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 76.5 mt -128.45 -4.94 5.37 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.472 0.578 . . . . 0.0 112.363 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.4 132.85 37.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.97 7.94 72.08 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.69 174.17 11.62 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.574 0.687 . . . . 0.0 111.018 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -132.15 148.62 52.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 49.9 mt . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -178.479 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.605 0.24 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.94 140.53 56.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.28 0.632 . . . . 0.0 110.051 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.2 154.86 16.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.007 0.523 . . . . 0.0 111.661 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -143.24 124.9 14.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.433 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 71.6 mt -126.44 146.2 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.147 0.499 . . . . 0.0 111.715 -173.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -156.35 170.73 21.63 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.952 1.301 . . . . 0.0 108.656 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.48 145.74 33.09 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 121.798 -0.564 . . . . 0.0 110.427 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -89.68 166.41 13.61 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.2 pttt -79.02 -28.32 0.55 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.4 Cg_endo -82.01 163.2 18.05 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 121.95 1.732 . . . . 0.0 110.442 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.5 p -97.24 -7.48 32.16 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 122.275 0.23 . . . . 0.0 110.992 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -152.82 148.88 27.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.818 0.847 . . . . 0.0 110.187 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 67.9 mt -107.48 172.26 6.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.586 0.754 . . . . 0.0 109.638 173.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -141.36 157.0 45.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.711 0.404 . . . . 0.0 110.22 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 79.9 t -135.59 152.36 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -119.93 -22.85 6.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.386 0.274 . . . . 0.0 111.148 -174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -165.38 173.52 11.05 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.712 0.805 . . . . 0.0 109.971 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -117.16 111.45 19.49 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.764 0.316 . . . . 0.0 110.463 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -156.24 -171.69 3.81 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.98 1.312 . . . . 0.0 109.56 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -73.95 -0.49 16.33 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -109.69 -27.35 9.39 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.45 0.568 . . . . 0.0 111.05 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.9 t -156.09 144.33 19.9 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.155 0.582 . . . . 0.0 109.584 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -150.31 150.73 31.88 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.657 0.265 . . . . 0.0 110.634 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -126.5 137.55 53.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.071 0.549 . . . . 0.0 109.765 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.96 11.76 13.51 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.594 0.758 . . . . 0.0 112.351 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.533 0.296 0 CA-C-N 117.983 0.356 . . . . 0.0 111.942 -179.031 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 32.7 p30 . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.4 p -92.77 15.79 13.83 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.595 0.758 . . . . 0.0 112.472 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.47 145.9 24.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 122.884 0.474 . . . . 0.0 110.893 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.64 165.02 23.71 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.29 0.567 . . . . 0.0 111.29 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.1 tp -127.69 131.26 49.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -117.0 144.31 44.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.826 0.851 . . . . 0.0 109.443 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.1 m -135.91 141.72 44.59 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 196' ' ' ILE . 1.9 mp -103.91 136.19 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.6 mt -92.86 -36.55 12.76 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -131.67 64.87 74.39 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.467 0.707 . . . . 0.0 110.096 -177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.85 104.2 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.571 2.181 . . . . 0.0 111.075 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.2 pt -130.13 1.44 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.073 0.549 . . . . 0.0 111.457 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -131.5 167.32 19.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.849 0.86 . . . . 0.0 109.197 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 27.0 t -76.53 149.48 36.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.416 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.3 mm -138.8 133.3 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.6 p -145.07 176.17 9.7 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 123.388 0.675 . . . . 0.0 110.136 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 35.5 p -61.33 -28.15 69.01 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.383 -0.198 . . . . 0.0 110.936 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.08 -22.35 58.36 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.699 0.399 . . . . 0.0 111.631 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.0 t -89.62 -38.0 10.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 84.3 mt -77.76 -23.39 49.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.96 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -78.3 -34.54 48.71 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.017 -0.427 . . . . 0.0 110.711 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.9 t -75.59 -23.23 56.45 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.217 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.1 pt -88.91 -22.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.203 0.456 . . . . 0.0 111.755 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.9 m -96.21 -20.12 18.81 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.779 0.718 . . . . 0.0 112.507 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.482 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.84 -43.5 87.54 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 95.8 Cg_endo -72.13 -11.04 26.74 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.874 1.716 . . . . 0.0 111.594 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.1 m -90.56 -23.04 21.0 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.232 0.469 . . . . 0.0 111.121 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.26 170.97 28.91 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -68.38 111.03 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.766 2.978 . . . . 0.0 110.71 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -83.49 152.37 3.86 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -115.52 -35.53 4.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.815 0.446 . . . . 0.0 110.693 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -164.31 160.35 20.85 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.129 0.422 . . . . 0.0 111.772 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.1 mt -144.35 146.89 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.074 0.95 . . . . 0.0 109.986 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.1 144.61 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 123.528 0.731 . . . . 0.0 109.408 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.527 0.084 0 C-N-CA 123.767 0.827 . . . . 0.0 110.386 -176.502 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 . . . . . 0 N--CA 1.457 -0.087 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.15 168.65 26.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.418 0.287 . . . . 0.0 110.416 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 87.8 mtp -138.43 151.43 47.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.31 150.15 21.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 122.829 0.452 . . . . 0.0 109.898 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -132.44 141.78 48.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.746 0.818 . . . . 0.0 108.794 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -118.02 167.98 10.96 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.907 0.883 . . . . 0.0 110.916 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.24 -15.5 60.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.738 0.415 . . . . 0.0 111.135 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 93.4 p -152.08 158.34 42.87 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.039 0.447 . . . . 0.0 110.459 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.94 -26.68 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.388 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -72.63 -22.2 60.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.335 0.516 . . . . 0.0 110.534 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.8 m -80.56 -28.3 37.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.02 -26.19 39.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.354 0.262 . . . . 0.0 110.469 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -69.71 -36.91 76.32 Favored 'General case' 0 N--CA 1.458 -0.05 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -79.67 -24.94 41.46 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.16 0.184 . . . . 0.0 110.762 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.68 -52.79 33.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.975 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.412 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.92 -16.08 60.08 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.795 0.725 . . . . 0.0 111.662 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.8 58.74 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.702 0.228 . . . . 0.0 111.6 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.8 t -126.73 0.52 6.75 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.0 mt -130.68 -4.27 4.14 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -78.14 130.91 36.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.884 0.765 . . . . 0.0 109.083 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.38 8.66 76.02 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.25 175.38 9.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.666 0.733 . . . . 0.0 111.284 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -139.8 149.14 43.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.569 0.748 . . . . 0.0 109.01 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.4 mt . . . . . 0 CA--C 1.532 0.253 0 C-N-CA 122.491 0.317 . . . . 0.0 111.243 -176.051 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.39 142.69 51.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.385 0.674 . . . . 0.0 109.987 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 53.9 mt -97.76 154.99 17.24 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.15 0.5 . . . . 0.0 111.87 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -146.25 132.55 19.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.412 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 76.6 mt -129.58 149.12 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 121.338 0.589 . . . . 0.0 112.012 -172.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.74 172.3 16.89 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.356 1.462 . . . . 0.0 108.428 174.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -83.75 143.92 29.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.948 -0.47 . . . . 0.0 110.445 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.68 170.29 12.65 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.41 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.441 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -84.82 -26.35 0.37 Allowed Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 49.4 Cg_endo -82.5 -177.84 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.023 1.815 . . . . 0.0 110.033 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.0 p -108.23 -7.43 15.98 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 122.196 -0.315 . . . . 0.0 111.422 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.75 168.47 27.07 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.138 0.975 . . . . 0.0 109.665 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 90.4 mt -124.73 174.37 7.94 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.475 0.71 . . . . 0.0 109.739 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -140.79 159.77 41.49 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.835 0.35 . . . . 0.0 110.929 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.8 t -135.69 153.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 124.277 1.031 . . . . 0.0 108.744 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -120.58 -26.38 5.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.614 0.366 . . . . 0.0 111.493 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.12 169.89 18.71 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.729 1.212 . . . . 0.0 108.865 176.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -107.08 117.43 34.04 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.782 0.325 . . . . 0.0 110.616 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -158.25 -172.57 3.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.624 1.169 . . . . 0.0 109.755 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -71.49 -4.94 29.46 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -114.16 -18.9 11.53 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.664 0.665 . . . . 0.0 111.728 -178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.0 t -156.63 139.38 15.14 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -152.49 149.56 28.67 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.703 0.287 . . . . 0.0 110.666 -176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -124.95 138.2 54.24 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.176 0.59 . . . . 0.0 109.479 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -118.37 11.17 12.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.3 0.64 . . . . 0.0 112.253 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 CA--C 1.53 0.178 0 CA-C-N 118.231 0.469 . . . . 0.0 112.22 -178.006 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.5 p30 . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.659 0.266 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.5 p -100.3 15.59 27.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.686 0.795 . . . . 0.0 111.788 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.11 143.94 27.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.011 0.524 . . . . 0.0 110.858 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.3 mt -128.79 164.92 21.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.212 0.53 . . . . 0.0 111.783 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.1 tp -123.87 134.43 53.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.783 1.233 . . . . 0.0 107.939 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -121.75 150.85 41.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.029 0.932 . . . . 0.0 109.618 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 94.6 m -142.63 146.71 34.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 42.9 mt -119.26 136.99 54.65 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.05 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 50.2 mt -102.91 -23.69 13.72 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -173.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -131.7 62.19 62.91 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.39 0.676 . . . . 0.0 110.102 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.31 40.27 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 125.073 3.849 . . . . 0.0 112.632 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 38.0 pt -77.08 -0.7 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.887 -0.508 . . . . 0.0 111.888 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -130.16 166.05 21.05 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.729 0.812 . . . . 0.0 109.655 176.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.2 m -70.57 146.56 50.04 Favored 'General case' 0 C--N 1.335 -0.048 0 CA-C-O 120.73 0.3 . . . . 0.0 111.526 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.8 mm -137.33 134.6 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.9 p -146.87 173.88 12.01 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.368 0.667 . . . . 0.0 109.236 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.3 p -63.74 -19.56 65.06 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 122.333 0.253 . . . . 0.0 111.529 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.15 -24.37 37.65 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.843 0.292 . . . . 0.0 110.849 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.0 t -82.48 -37.62 14.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.58 -24.25 58.88 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.212 -0.305 . . . . 0.0 110.614 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -78.31 -36.23 46.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.229 -0.294 . . . . 0.0 111.177 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.7 t -74.97 -21.32 59.23 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.145 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 39.5 pt -91.73 -21.9 6.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 CA-C-N 118.136 0.425 . . . . 0.0 112.058 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.2 m -95.67 -24.2 16.66 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 50.4 t30 -63.88 -40.57 56.49 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 89.4 Cg_endo -73.14 -4.5 15.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.754 1.636 . . . . 0.0 111.821 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.5 m -101.67 -10.42 20.03 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.868 0.467 . . . . 0.0 111.199 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 155.53 164.66 13.38 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.86 109.59 1.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.729 2.953 . . . . 0.0 111.016 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.96 151.88 4.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -117.39 -38.37 3.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.612 0.365 . . . . 0.0 111.086 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -162.98 157.95 21.62 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.01 0.368 . . . . 0.0 111.424 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 54.1 mt -143.15 141.93 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.762 0.825 . . . . 0.0 109.419 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 20.3 m -136.2 151.66 29.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 56.3 mt . . . . . 0 N--CA 1.455 -0.182 0 C-N-CA 122.796 0.438 . . . . 0.0 110.138 -175.435 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 N--CA 1.457 -0.125 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.83 171.4 18.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.843 0.457 . . . . 0.0 109.985 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.0 mtp -141.47 150.53 42.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.2 t -136.71 152.41 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 C-N-CA 122.928 0.491 . . . . 0.0 109.829 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -137.42 140.84 41.55 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.461 0.704 . . . . 0.0 109.577 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -120.97 169.24 10.66 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 123.879 0.871 . . . . 0.0 111.079 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.04 -16.07 61.06 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.852 0.461 . . . . 0.0 111.362 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 90.7 p -153.02 159.71 42.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.974 0.416 . . . . 0.0 110.664 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.38 -26.62 31.84 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 O-C-N 122.269 -0.269 . . . . 0.0 110.365 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -65.49 -29.33 69.97 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 122.077 -0.39 . . . . 0.0 110.083 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.7 m -80.14 -27.33 39.08 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.704 0.402 . . . . 0.0 110.641 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.14 -25.27 37.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.276 -0.265 . . . . 0.0 110.527 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -70.89 -35.99 72.56 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -77.05 -27.79 54.54 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.335 -0.228 . . . . 0.0 110.487 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.12 -51.5 57.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.361 -0.212 . . . . 0.0 111.056 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -13.32 59.92 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.863 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -84.89 -10.79 56.76 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.924 0.329 . . . . 0.0 111.591 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.6 m -124.73 -2.47 7.84 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.51 -7.4 4.67 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -78.34 133.02 37.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.889 0.768 . . . . 0.0 109.099 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.16 4.78 64.3 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.79 179.67 7.41 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 117.641 0.72 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.48 161.45 37.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.723 0.809 . . . . 0.0 108.995 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.9 mt . . . . . 0 CA--C 1.531 0.226 0 CA-C-O 119.783 -0.151 . . . . 0.0 111.337 -177.718 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.5 m . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.703 0.287 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.9 m -56.27 138.17 50.95 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.919 0.487 . . . . 0.0 109.901 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.3 mt -105.21 153.44 21.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.043 0.537 . . . . 0.0 112.069 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -141.59 125.12 16.72 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 77.4 mt -124.25 147.6 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-O 121.136 0.494 . . . . 0.0 111.498 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -155.89 170.55 21.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.054 1.342 . . . . 0.0 108.427 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -80.39 146.35 31.54 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.861 -0.524 . . . . 0.0 110.51 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.26 165.92 15.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.489 0.316 . . . . 0.0 110.272 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -82.9 -26.55 0.4 Allowed Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 43.2 Cg_endo -81.7 177.74 7.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.848 1.696 . . . . 0.0 109.593 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 59.2 p -106.38 -5.17 19.2 Favored 'General case' 0 CA--C 1.527 0.084 0 O-C-N 122.285 -0.26 . . . . 0.0 110.985 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.0 mmm-85 -154.48 155.86 35.66 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.118 0.967 . . . . 0.0 110.235 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -118.47 168.64 10.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.173 0.989 . . . . 0.0 109.716 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -140.79 161.38 37.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.329 0.252 . . . . 0.0 110.878 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.15 153.92 36.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 124.164 0.986 . . . . 0.0 109.111 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -123.83 -21.28 5.19 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.453 ' HE3' ' CG2' ' A' ' 279' ' ' THR . 0.3 OUTLIER -164.95 173.08 12.0 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.678 1.191 . . . . 0.0 109.021 176.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -113.05 113.64 25.73 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -154.93 -172.13 4.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.944 1.297 . . . . 0.0 109.387 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -71.65 -4.97 30.24 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -115.86 -14.5 11.32 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.649 0.659 . . . . 0.0 111.899 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' THR . . . . . 0.453 ' CG2' ' HE3' ' A' ' 274' ' ' LYS . 5.0 t -157.09 138.58 13.94 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -152.91 150.24 29.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.252 -0.28 . . . . 0.0 110.894 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -125.43 137.52 54.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.133 0.573 . . . . 0.0 109.556 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -117.15 7.27 12.97 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.312 0.645 . . . . 0.0 112.084 -175.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.533 0.297 0 C-N-CA 122.569 0.348 . . . . 0.0 111.837 179.215 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.701 0.286 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.1 p -87.17 15.44 6.21 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.248 0.619 . . . . 0.0 111.606 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.71 137.92 45.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 123.158 0.583 . . . . 0.0 111.073 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.06 163.31 24.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.376 0.607 . . . . 0.0 111.266 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.1 tp -125.09 132.41 53.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.871 1.268 . . . . 0.0 108.191 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -117.84 146.96 43.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.667 0.787 . . . . 0.0 109.845 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 72.9 m -136.59 144.39 44.1 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.6 mp -109.43 136.62 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 63.3 mt -99.71 -26.42 14.06 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -174.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -135.88 66.77 62.93 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 123.67 0.788 . . . . 0.0 109.687 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -75.11 52.64 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 125.133 3.889 . . . . 0.0 112.398 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.4 pt -78.79 -1.75 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 121.724 -0.61 . . . . 0.0 111.641 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -136.54 168.85 18.7 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.268 1.027 . . . . 0.0 109.36 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.9 m -79.12 150.5 31.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.853 0.359 . . . . 0.0 111.483 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.4 mm -134.31 138.73 49.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.4 p -142.18 174.53 10.52 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 122.934 0.493 . . . . 0.0 110.018 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 38.5 p -63.19 -21.45 66.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.203 0.201 . . . . 0.0 111.109 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.81 -27.91 33.4 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.38 0.272 . . . . 0.0 111.222 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.9 t -78.96 -37.8 20.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 89.2 mt -76.79 -22.49 53.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.274 -0.266 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -77.88 -34.32 51.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.973 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -76.88 -21.71 54.53 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.386 0.539 . . . . 0.0 111.294 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 44.8 pt -90.62 -21.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.969 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.7 m -96.58 -21.66 17.53 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.507 0.594 . . . . 0.0 112.257 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.476 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.1 t-20 -60.26 -44.3 95.79 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.434 -0.793 . . . . 0.0 113.111 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 97.8 Cg_endo -72.39 -9.43 24.2 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.039 1.826 . . . . 0.0 112.103 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 76.9 m -94.67 -20.5 19.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.99 0.359 . . . . 0.0 111.217 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.54 167.32 23.82 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.44 113.27 3.07 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.799 2.999 . . . . 0.0 110.886 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.7 t -87.21 150.45 3.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -112.35 -36.73 5.2 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.159 0.584 . . . . 0.0 110.796 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -164.35 159.17 19.46 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 117.993 0.36 . . . . 0.0 111.882 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 42.4 mt -144.34 142.35 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.01 0.924 . . . . 0.0 109.354 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 m -138.4 154.63 27.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 122.72 0.408 . . . . 0.0 110.239 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 CA--C 1.528 0.122 0 C-N-CA 123.604 0.762 . . . . 0.0 111.062 -175.972 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.995 0.426 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.57 166.47 31.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.409 0.683 . . . . 0.0 109.339 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 87.4 mtp -135.94 150.26 49.22 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.05 148.23 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 122.918 0.487 . . . . 0.0 109.881 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.9 138.91 48.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -115.24 169.33 9.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.922 0.889 . . . . 0.0 111.065 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.79 -16.64 61.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.574 0.35 . . . . 0.0 111.549 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.5 p -152.57 159.9 43.24 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.612 0.365 . . . . 0.0 110.684 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.39 -25.75 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -70.72 -25.2 62.83 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.305 -0.247 . . . . 0.0 110.405 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.9 m -80.37 -28.53 37.97 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.64 -25.78 41.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.381 -0.2 . . . . 0.0 110.528 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -69.68 -37.02 76.5 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 48.4 ttt-85 -78.92 -26.66 43.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 121.897 0.079 . . . . 0.0 110.936 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.25 -48.89 66.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.036 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -14.41 59.27 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 118.57 0.623 . . . . 0.0 111.663 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -84.67 -9.92 57.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.653 -0.213 . . . . 0.0 111.191 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -124.71 -1.44 7.94 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.0 mt -132.07 -5.52 3.49 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -77.21 131.24 38.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.021 0.828 . . . . 0.0 109.244 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.25 5.76 67.45 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.29 179.28 7.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.609 0.704 . . . . 0.0 111.281 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -139.43 157.98 44.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.853 0.861 . . . . 0.0 108.807 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 57.1 mt . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -174.044 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.783 0.325 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.4 m -60.38 137.93 58.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.692 0.397 . . . . 0.0 109.955 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.3 mt -98.85 156.17 17.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.206 0.602 . . . . 0.0 112.314 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -144.09 134.11 24.1 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 81.2 mt -128.53 148.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-O 121.217 0.532 . . . . 0.0 111.562 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -154.3 169.49 23.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.075 1.35 . . . . 0.0 108.488 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -83.37 143.08 30.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.831 -0.543 . . . . 0.0 110.449 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.84 169.38 11.65 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -85.07 -26.51 0.37 Allowed Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.6 Cg_endo -82.03 165.26 17.31 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 CA-C-N 122.069 1.775 . . . . 0.0 109.927 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.9 p -94.3 -7.79 40.86 Favored 'General case' 0 CA--C 1.527 0.073 0 O-C-N 122.245 -0.284 . . . . 0.0 111.419 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.88 169.53 24.57 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.806 0.842 . . . . 0.0 109.939 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 84.1 mt -121.05 167.75 12.28 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.501 0.72 . . . . 0.0 109.565 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -129.85 154.13 47.59 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.681 0.277 . . . . 0.0 110.374 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 87.6 t -136.86 151.14 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.221 1.008 . . . . 0.0 108.866 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -123.43 -19.99 5.73 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.856 0.463 . . . . 0.0 111.324 -174.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -164.7 168.29 18.15 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.891 1.276 . . . . 0.0 108.7 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -116.96 109.27 16.81 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 121.016 0.436 . . . . 0.0 110.648 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -154.51 -172.14 4.1 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.789 1.236 . . . . 0.0 109.506 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -69.88 -4.85 22.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -114.1 -15.46 12.25 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 118.732 0.696 . . . . 0.0 111.826 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.2 t -159.43 134.75 8.32 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -152.23 148.31 27.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.121 -0.362 . . . . 0.0 111.153 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -125.64 132.5 52.45 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.44 0.696 . . . . 0.0 109.436 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -109.38 2.19 20.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.628 0.771 . . . . 0.0 112.137 -173.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.532 0.269 0 C-N-CA 122.947 0.499 . . . . 0.0 110.499 177.367 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.774 0.321 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.8 p -89.68 13.68 13.59 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.194 0.597 . . . . 0.0 112.127 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.56 145.62 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 122.6 0.36 . . . . 0.0 110.721 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.3 mt -130.34 165.06 23.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.266 0.626 . . . . 0.0 111.586 -174.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 63.8 tp -123.89 133.01 53.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.565 1.146 . . . . 0.0 108.432 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -119.95 144.98 47.18 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.76 0.824 . . . . 0.0 109.994 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.1 m -138.1 142.93 40.21 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.2 mp -106.54 136.53 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.9 mt -92.4 -34.58 14.1 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -134.35 67.42 72.4 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 123.634 0.773 . . . . 0.0 109.34 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.13 64.59 4.26 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.666 3.577 . . . . 0.0 112.113 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 45.6 pt -83.84 -4.5 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.993 -0.442 . . . . 0.0 111.202 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -129.38 166.24 19.93 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 109.379 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 77.9 p -80.54 156.61 26.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.642 0.258 . . . . 0.0 111.121 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mm -136.21 139.96 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 70.7 p -143.25 172.36 12.85 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.066 0.546 . . . . 0.0 110.007 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.6 p -62.04 -24.97 67.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.24 0.216 . . . . 0.0 110.991 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -78.92 -27.57 43.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.346 0.258 . . . . 0.0 111.352 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.15 -38.58 18.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.878 0.37 . . . . 0.0 110.025 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.35 -22.97 54.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.218 -0.301 . . . . 0.0 110.561 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -78.65 -35.22 45.69 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.914 0.324 . . . . 0.0 110.879 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.2 t -74.73 -23.56 58.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.242 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 pt -89.05 -21.41 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 118.379 0.536 . . . . 0.0 111.955 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 87.6 m -95.74 -19.3 19.78 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.302 0.501 . . . . 0.0 112.182 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.458 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.6 t-20 -60.39 -44.08 94.87 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 92.7 Cg_endo -73.06 -10.81 24.89 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.706 1.604 . . . . 0.0 111.995 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 77.5 m -89.4 -23.7 22.1 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.161 0.437 . . . . 0.0 111.249 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.86 171.78 30.52 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.1 111.43 2.68 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.553 2.835 . . . . 0.0 110.556 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.47 151.45 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -116.06 -39.1 3.49 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.064 0.546 . . . . 0.0 110.907 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -161.67 158.48 26.08 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.402 0.546 . . . . 0.0 112.062 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 41.2 mt -144.89 143.93 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 124.364 1.066 . . . . 0.0 109.721 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.427 ' C ' HD12 ' A' ' 223' ' ' ILE . 22.4 m -141.69 149.52 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 123.288 0.635 . . . . 0.0 109.857 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.427 HD12 ' C ' ' A' ' 222' ' ' VAL . 1.8 mp . . . . . 0 CA--C 1.529 0.17 0 C-N-CA 123.765 0.826 . . . . 0.0 109.81 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 N--CA 1.455 -0.183 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.05 171.64 20.1 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.528 0.331 . . . . 0.0 110.218 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.8 mtp -138.78 149.95 45.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.28 151.37 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -135.5 140.74 45.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.564 0.746 . . . . 0.0 109.818 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -120.03 167.74 11.87 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.851 0.861 . . . . 0.0 110.854 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.51 -11.21 59.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.616 0.366 . . . . 0.0 111.349 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 42.9 t -152.18 151.45 31.03 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.151 0.581 . . . . 0.0 110.088 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.11 -25.71 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.54 -24.38 62.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.009 -0.432 . . . . 0.0 110.14 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 41.2 m -80.35 -27.2 38.35 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.75 -26.42 37.32 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.243 0.217 . . . . 0.0 110.424 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -68.46 -37.64 80.36 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -78.68 -24.79 44.86 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.99 -50.63 54.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.319 -0.238 . . . . 0.0 111.197 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.404 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.06 -14.57 59.45 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.626 179.07 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.22 -8.54 58.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.835 0.289 . . . . 0.0 111.555 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.8 t -125.6 -6.79 6.88 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.3 mt -124.49 -5.33 7.67 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -77.71 131.36 37.66 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.82 5.05 73.41 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.563 -0.576 . . . . 0.0 111.827 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.86 177.57 8.95 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.833 0.816 . . . . 0.0 111.093 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -138.64 160.38 39.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.758 0.823 . . . . 0.0 109.371 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.4 mt . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.294 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.3 m . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.49 0.186 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.0 m -60.56 139.59 57.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.937 0.495 . . . . 0.0 110.041 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.0 mt -95.24 154.51 17.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.372 0.669 . . . . 0.0 111.756 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -145.56 129.15 17.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.404 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 81.0 mt -129.29 147.69 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 CA-C-O 121.171 0.51 . . . . 0.0 112.216 -171.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.36 173.56 15.47 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.679 1.191 . . . . 0.0 108.547 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -83.23 143.56 30.36 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.976 -0.452 . . . . 0.0 110.675 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.18 167.33 17.84 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.068 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 39.7 ttpt -74.64 -46.88 5.43 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 118.298 -0.858 . . . . 0.0 113.273 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 74.8 Cg_endo -74.9 177.53 8.43 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.353 2.035 . . . . 0.0 110.539 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.2 p -108.49 -7.79 15.69 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.592 0.357 . . . . 0.0 111.534 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.77 136.49 14.4 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 56.4 mt -88.05 171.09 10.53 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 122.731 0.412 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -131.93 151.7 51.55 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.549 0.34 . . . . 0.0 110.369 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.3 153.69 24.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 124.171 0.988 . . . . 0.0 108.786 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -126.94 -19.62 4.39 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.57 0.348 . . . . 0.0 111.437 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -165.56 170.46 14.27 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 124.505 1.122 . . . . 0.0 109.011 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -117.06 109.42 16.94 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.619 0.368 . . . . 0.0 110.411 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -154.93 -172.13 4.08 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.585 1.154 . . . . 0.0 109.627 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -69.75 -4.86 21.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -115.2 -17.29 11.41 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.121 0.873 . . . . 0.0 111.779 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.6 t -156.68 134.81 11.2 Favored 'General case' 0 N--CA 1.458 -0.055 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -152.61 147.36 26.06 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.758 0.314 . . . . 0.0 111.212 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -124.43 119.76 30.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -95.66 -4.68 43.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.281 0.632 . . . . 0.0 111.568 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 121.335 0.588 . . . . 0.0 110.124 176.698 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.3 p30 . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 120.988 0.423 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.0 p -82.96 10.13 8.59 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.5 t -109.43 136.56 44.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 122.815 0.446 . . . . 0.0 110.611 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.5 mt -125.1 161.43 26.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.754 0.788 . . . . 0.0 111.373 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.0 tp -126.17 131.44 52.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.035 1.334 . . . . 0.0 107.51 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -118.09 145.16 45.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.69 0.796 . . . . 0.0 109.406 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.3 m -139.49 141.54 37.34 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.2 mp -105.7 135.3 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.4 mt -94.02 -36.55 12.08 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -173.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -129.87 62.78 65.68 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 123.368 0.667 . . . . 0.0 110.082 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.45 101.96 0.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.947 2.431 . . . . 0.0 110.717 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.0 pt -128.26 3.07 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.788 0.435 . . . . 0.0 111.402 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -131.67 166.47 21.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.855 0.862 . . . . 0.0 109.457 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.5 m -73.91 145.8 44.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.787 0.327 . . . . 0.0 111.32 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.5 mm -137.49 136.79 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.6 p -145.04 172.27 13.3 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.529 0.732 . . . . 0.0 109.636 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.9 p -63.77 -20.76 66.02 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 122.327 -0.233 . . . . 0.0 110.931 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -79.7 -27.37 40.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.326 0.25 . . . . 0.0 110.888 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.2 t -81.51 -37.64 15.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.66 -28.54 62.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.185 -0.322 . . . . 0.0 110.599 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -74.28 -37.96 63.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.991 -0.443 . . . . 0.0 111.044 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.7 t -74.11 -20.99 60.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.555 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.3 pt -88.85 -23.55 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.184 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 16.6 p -109.69 -6.83 15.2 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.16 -42.79 87.82 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.562 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 94.4 Cg_endo -72.85 -7.02 20.07 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.805 1.67 . . . . 0.0 112.089 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 65.7 m -86.02 -21.86 27.57 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.062 0.392 . . . . 0.0 111.213 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.8 176.7 32.17 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.77 107.83 1.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.975 3.117 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.09 149.47 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -112.61 -39.05 4.44 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.474 0.31 . . . . 0.0 111.003 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -167.18 161.75 14.72 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 117.967 0.349 . . . . 0.0 111.911 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.4 mt -143.07 139.76 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.205 1.002 . . . . 0.0 109.145 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.17 157.8 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.8 mt . . . . . 0 C--N 1.335 -0.053 0 C-N-CA 122.875 0.47 . . . . 0.0 111.014 -175.274 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.785 0.326 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.55 172.14 17.04 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.418 0.287 . . . . 0.0 110.58 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 85.0 mtp -141.39 152.41 44.31 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 46.5 t -139.73 149.86 22.36 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.032 0 C-N-CA 123.02 0.528 . . . . 0.0 109.607 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -132.91 140.48 47.89 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -117.33 169.07 9.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.045 0.938 . . . . 0.0 110.974 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.56 -11.15 59.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.061 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.9 t -150.59 149.65 30.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.211 0.604 . . . . 0.0 110.111 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.45 -26.37 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -70.94 -23.63 62.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.961 -0.462 . . . . 0.0 110.316 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.9 m -80.11 -28.31 39.02 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.22 -27.86 42.5 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.519 0.199 . . . . 0.0 110.793 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -67.26 -36.02 80.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -82.47 -27.09 32.06 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.73 0.412 . . . . 0.0 111.698 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.16 -44.16 72.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.06 -0.4 . . . . 0.0 110.399 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -27.94 64.81 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -77.66 -8.53 58.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.819 -0.551 . . . . 0.0 111.712 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.6 m -121.07 -5.5 9.51 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.45 -8.75 2.53 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -74.57 131.15 40.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.735 1.152 . . . . 0.0 108.845 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 71.88 6.17 63.05 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.386 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.33 -179.06 7.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.83 0.815 . . . . 0.0 111.387 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -140.28 163.15 33.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.897 0.879 . . . . 0.0 109.456 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.0 mt . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -175.519 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 79.8 m . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.638 0.256 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.7 m -59.94 139.22 57.54 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.044 0.538 . . . . 0.0 109.896 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 64.9 mt -93.71 154.64 17.68 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.433 0.693 . . . . 0.0 111.799 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -144.06 123.1 12.83 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.6 mt -123.82 145.53 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-O 120.98 0.419 . . . . 0.0 111.575 -173.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -155.02 172.68 17.71 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.818 1.247 . . . . 0.0 108.498 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -85.81 147.25 26.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.11 -0.369 . . . . 0.0 110.858 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -95.7 165.74 12.16 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.657 0.383 . . . . 0.0 110.816 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -80.72 -27.17 0.45 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 47.6 Cg_endo -80.66 160.44 21.91 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 CA-C-N 121.965 1.738 . . . . 0.0 110.047 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 43.0 p -89.87 -10.44 45.29 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.6 0.36 . . . . 0.0 111.257 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 168.73 26.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.612 0.765 . . . . 0.0 110.074 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -119.93 172.69 7.55 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.093 0.957 . . . . 0.0 109.691 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -134.28 154.64 51.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.292 -0.255 . . . . 0.0 110.404 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 70.7 t -136.77 150.52 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.747 0.819 . . . . 0.0 108.885 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -122.75 -20.56 5.87 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.482 0.313 . . . . 0.0 111.358 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -165.23 169.98 15.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.176 0.99 . . . . 0.0 109.414 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -116.47 116.37 27.54 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.023 0.44 . . . . 0.0 110.519 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -159.87 -172.54 3.69 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.338 1.455 . . . . 0.0 109.384 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.75 -1.32 11.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.46 -19.93 8.64 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.622 0.646 . . . . 0.0 111.944 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 2.8 t -153.68 137.11 15.84 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -153.84 149.44 27.37 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.221 -0.299 . . . . 0.0 111.394 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -128.34 138.07 52.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.275 0.63 . . . . 0.0 109.62 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -115.9 6.93 14.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.582 0.753 . . . . 0.0 112.461 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.532 0.264 0 C-N-CA 122.843 0.457 . . . . 0.0 111.163 179.051 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.2 p30 . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.628 0.251 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.2 p -99.61 18.87 16.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.483 0.713 . . . . 0.0 111.955 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.6 143.92 33.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 C-N-CA 123.003 0.521 . . . . 0.0 110.696 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.5 mt -129.68 163.24 26.55 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.149 0.58 . . . . 0.0 111.365 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.3 tp -121.2 133.68 55.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.989 1.316 . . . . 0.0 108.054 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -119.61 145.58 46.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.521 0.728 . . . . 0.0 109.738 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.6 m -140.62 144.49 35.8 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.5 mp -107.68 135.25 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.1 mt -91.77 -35.67 13.99 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -130.79 61.71 61.0 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 123.575 0.75 . . . . 0.0 110.184 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.98 101.79 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.78 2.32 . . . . 0.0 110.784 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.0 pt -125.72 0.22 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.95 0.5 . . . . 0.0 111.339 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.13 166.47 21.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.711 0.804 . . . . 0.0 109.264 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.5 m -73.53 151.68 40.9 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.81 0.338 . . . . 0.0 111.563 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.5 mm -138.71 135.24 43.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 68.4 p -146.46 176.35 9.87 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.149 0.58 . . . . 0.0 110.1 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.2 p -62.38 -25.55 67.98 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 122.435 0.294 . . . . 0.0 111.209 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -80.54 -20.61 43.08 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.545 0.338 . . . . 0.0 111.461 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 88.6 t -90.56 -37.82 9.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.4 mt -77.31 -22.53 51.81 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.254 -0.279 . . . . 0.0 110.715 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -78.8 -36.1 43.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.924 0.329 . . . . 0.0 110.903 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.9 t -77.0 -17.31 58.93 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.996 -0.44 . . . . 0.0 111.395 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.41 -17.57 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.913 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 88.8 m -95.7 -25.3 16.16 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.91 0.777 . . . . 0.0 111.859 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.487 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.2 t-20 -59.71 -42.2 90.1 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 83.6 Cg_endo -71.1 -4.54 15.1 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.962 1.775 . . . . 0.0 112.1 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 72.4 m -107.52 -11.68 15.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.223 0.465 . . . . 0.0 111.335 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.7 165.05 15.87 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.42 114.39 3.79 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.897 3.064 . . . . 0.0 110.67 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.2 t -86.56 151.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -113.34 -36.39 5.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.162 0.585 . . . . 0.0 110.554 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -164.04 159.88 21.08 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.8 mt -144.49 145.79 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.361 1.064 . . . . 0.0 109.92 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.37 150.39 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 C-N-CA 123.265 0.626 . . . . 0.0 109.45 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.231 0.104 0 C-N-CA 123.077 0.551 . . . . 0.0 110.872 -175.785 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.77 170.15 23.11 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.9 mtp -138.49 151.52 47.45 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 43.7 t -138.4 149.49 24.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 C-N-CA 122.645 0.378 . . . . 0.0 110.424 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -132.43 138.88 47.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.728 0.811 . . . . 0.0 109.147 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -117.04 167.85 10.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.445 0.698 . . . . 0.0 110.797 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -75.99 -15.37 60.16 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.237 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.6 t -152.23 153.49 33.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.241 0.616 . . . . 0.0 110.057 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.89 -27.08 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -68.17 -24.13 64.94 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.926 -0.484 . . . . 0.0 109.854 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.9 m -81.47 -27.9 34.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.424 0.29 . . . . 0.0 110.395 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.15 -25.21 37.03 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -70.02 -37.5 75.64 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -77.49 -26.6 51.41 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 122.277 -0.265 . . . . 0.0 110.494 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.55 -53.59 39.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.951 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.26 -14.34 60.13 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.622 0.647 . . . . 0.0 111.976 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.85 -12.67 55.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.1 -0.375 . . . . 0.0 111.855 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.0 m -129.67 1.72 4.95 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 77.0 mt -128.46 -4.27 5.41 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.65 0.659 . . . . 0.0 112.717 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -78.78 132.04 36.75 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.6 4.51 70.51 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.016 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.74 177.59 8.54 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.634 0.717 . . . . 0.0 110.866 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -140.39 161.18 38.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.466 0.706 . . . . 0.0 109.287 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.8 mt . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.851 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.4 m . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.471 0.177 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 16.7 m -59.55 138.22 57.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.78 0.432 . . . . 0.0 110.081 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 62.6 mt -91.68 156.78 17.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.322 0.649 . . . . 0.0 112.053 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -140.76 137.91 33.75 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 77.7 mt -133.82 141.62 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.135 0.493 . . . . 0.0 111.489 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.75 167.94 27.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.782 1.233 . . . . 0.0 108.232 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -78.41 144.55 35.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.808 -0.558 . . . . 0.0 110.812 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.87 165.68 17.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.508 0.323 . . . . 0.0 110.265 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -81.06 -27.24 0.45 Allowed Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -176.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 46.2 Cg_endo -81.67 178.34 6.67 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.838 1.692 . . . . 0.0 109.913 177.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 69.2 p -105.09 -9.0 18.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.432 0.293 . . . . 0.0 111.089 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.92 168.03 27.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.835 0.854 . . . . 0.0 109.976 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 94.4 mt -127.11 170.43 12.36 Favored 'General case' 0 N--CA 1.459 0.014 0 C-N-CA 123.659 0.784 . . . . 0.0 109.817 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -138.76 163.85 31.1 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.397 0.618 . . . . 0.0 111.673 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 38.7 t -140.51 156.2 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 124.695 1.198 . . . . 0.0 108.555 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -125.61 -21.92 4.37 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.504 0.322 . . . . 0.0 111.678 -174.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -163.6 169.1 19.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.381 1.072 . . . . 0.0 108.91 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -115.71 110.01 18.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.121 0.486 . . . . 0.0 110.438 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -155.32 -170.24 3.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.009 1.323 . . . . 0.0 109.335 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -72.67 -2.51 20.44 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -119.6 -15.82 8.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.893 0.77 . . . . 0.0 112.006 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.7 t -154.76 135.01 13.2 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -157.96 145.25 18.18 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.266 -0.271 . . . . 0.0 110.871 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -129.19 141.14 51.24 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.575 0.703 . . . . 0.0 111.311 171.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -108.58 -9.81 15.29 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.558 0.743 . . . . 0.0 111.816 -174.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 CA--C 1.532 0.26 0 C-N-CA 123.089 0.556 . . . . 0.0 110.23 176.026 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.6 p30 . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 121.112 0.482 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.7 p -97.76 15.89 22.3 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.809 0.843 . . . . 0.0 111.021 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.08 138.74 38.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 C-N-CA 123.615 0.766 . . . . 0.0 110.703 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.0 mt -127.35 159.91 32.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.298 0.57 . . . . 0.0 111.54 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.9 tp -124.2 130.51 52.66 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.017 1.327 . . . . 0.0 107.764 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -115.1 145.03 42.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.401 0.68 . . . . 0.0 109.684 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.9 m -139.44 144.38 38.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.4 mp -107.17 136.94 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 75.4 mt -93.77 -34.87 13.03 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -130.09 63.15 67.83 Favored Pre-proline 0 CA--C 1.528 0.114 0 C-N-CA 123.162 0.585 . . . . 0.0 109.951 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.58 101.71 0.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.766 2.31 . . . . 0.0 110.881 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.58 2.5 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 122.774 0.429 . . . . 0.0 111.29 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -134.98 166.89 21.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.814 0.845 . . . . 0.0 109.314 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 33.1 t -78.54 151.44 32.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.794 0.331 . . . . 0.0 110.975 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.1 mm -136.83 137.16 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.6 p -143.52 176.72 8.97 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 123.148 0.579 . . . . 0.0 110.053 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.1 p -62.34 -23.25 66.66 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.696 0.399 . . . . 0.0 111.195 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -82.2 -23.75 35.27 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.84 0.291 . . . . 0.0 111.274 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 83.6 t -83.97 -37.64 13.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.84 -21.52 47.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.039 -0.413 . . . . 0.0 110.848 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -77.6 -34.39 53.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.171 0.441 . . . . 0.0 110.848 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.3 t -76.91 -22.34 53.51 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.268 0.485 . . . . 0.0 111.354 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.2 pt -90.18 -22.44 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.491 0.587 . . . . 0.0 111.791 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.4 m -94.66 -23.07 17.76 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.439 0.563 . . . . 0.0 112.013 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.3 t-20 -59.75 -44.57 97.54 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 97.2 Cg_endo -72.77 -10.11 24.59 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.863 1.708 . . . . 0.0 111.803 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 74.6 m -93.73 -20.92 19.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.32 0.509 . . . . 0.0 110.95 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 166.35 167.38 26.91 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.12 104.77 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.93 3.087 . . . . 0.0 110.763 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.4 t -78.42 152.0 5.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -115.0 -40.85 3.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.011 0.525 . . . . 0.0 110.828 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.412 HH22 ' CG1' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -163.96 159.51 20.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.53 0.605 . . . . 0.0 112.495 177.413 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 42.0 mt -142.07 150.64 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 124.104 0.962 . . . . 0.0 110.45 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.412 ' CG1' HH22 ' A' ' 220' ' ' ARG . 7.3 p -141.53 148.62 20.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 C-N-CA 123.739 0.816 . . . . 0.0 109.202 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 38.6 mm . . . . . 0 N--CA 1.456 -0.148 0 C-N-CA 124.035 0.934 . . . . 0.0 110.418 -174.587 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.83 0.348 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.8 167.73 29.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.026 0.531 . . . . 0.0 109.957 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.2 mtp -134.98 142.69 46.53 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.64 151.25 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.16 0.584 . . . . 0.0 110.237 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -135.17 140.79 45.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.44 0.696 . . . . 0.0 109.225 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -118.73 168.02 11.12 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.722 0.809 . . . . 0.0 110.996 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.47 -17.85 61.73 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.88 0.472 . . . . 0.0 111.564 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.0 p -152.37 160.08 43.34 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.626 0.371 . . . . 0.0 110.422 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.74 -28.26 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -64.83 -30.07 71.06 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.925 -0.485 . . . . 0.0 109.877 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 45.0 m -78.24 -28.77 47.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.211 0.204 . . . . 0.0 110.571 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.49 -26.03 38.45 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.212 -0.305 . . . . 0.0 110.639 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -70.56 -36.13 73.46 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -79.77 -24.98 41.15 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.278 -0.264 . . . . 0.0 110.497 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.84 -52.66 40.97 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.162 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -15.49 59.68 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.755 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -80.72 -13.95 58.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.912 0.324 . . . . 0.0 111.721 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.7 m -125.05 1.44 7.95 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.0 mt -129.18 -4.82 4.94 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -77.74 132.73 38.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.8 5.55 64.88 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.218 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.15 179.56 7.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.679 0.74 . . . . 0.0 111.007 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -139.64 163.08 33.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.278 0.631 . . . . 0.0 109.515 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.6 mt . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -176.485 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.927 0.394 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 14.6 m -59.67 138.81 57.63 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.746 0.418 . . . . 0.0 109.917 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 58.4 mt -92.62 155.47 17.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.276 0.631 . . . . 0.0 112.179 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -143.63 123.62 13.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 74.1 mt -123.78 146.3 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.248 0.547 . . . . 0.0 111.682 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.44 169.27 24.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.677 1.191 . . . . 0.0 108.732 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -78.44 145.53 35.01 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.008 -0.433 . . . . 0.0 110.599 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.86 167.85 15.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.328 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -80.06 -29.27 0.55 Allowed Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.8 Cg_endo -82.68 169.44 13.56 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 121.73 1.653 . . . . 0.0 110.093 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.0 p -99.57 -5.93 28.28 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 122.388 -0.195 . . . . 0.0 110.998 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -152.85 157.04 40.13 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 123.836 0.854 . . . . 0.0 110.634 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 80.2 mt -121.99 175.37 6.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.186 0.994 . . . . 0.0 109.308 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -143.95 165.14 28.57 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.483 0.313 . . . . 0.0 110.926 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.2 t -137.6 157.98 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 124.398 1.079 . . . . 0.0 108.925 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -125.03 -31.36 3.12 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 122.263 -0.273 . . . . 0.0 110.923 -174.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.09 167.78 28.34 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.264 1.025 . . . . 0.0 109.291 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -107.66 118.59 37.15 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.121 0.486 . . . . 0.0 111.148 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.97 -171.64 3.47 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.063 1.345 . . . . 0.0 109.251 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -74.5 -3.69 32.3 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -107.67 -23.68 12.02 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.409 0.55 . . . . 0.0 111.115 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.1 t -158.07 141.08 14.95 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -150.71 151.26 32.16 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.304 -0.248 . . . . 0.0 110.873 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -129.18 135.99 49.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.222 0.609 . . . . 0.0 109.403 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.2 6.03 14.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.549 0.74 . . . . 0.0 112.211 -174.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.531 0.224 0 C-N-CA 122.993 0.517 . . . . 0.0 111.211 179.23 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.7 p -88.58 7.6 32.46 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.835 0.454 . . . . 0.0 111.415 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -104.54 138.51 28.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.552 0.741 . . . . 0.0 111.297 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.09 160.64 32.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.544 0.737 . . . . 0.0 111.507 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 64.4 tp -119.71 133.89 55.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.036 1.334 . . . . 0.0 107.862 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -120.12 147.33 45.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.492 0.717 . . . . 0.0 109.861 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 81.5 m -142.09 145.36 34.2 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.4 mp -109.51 135.91 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 64.8 mt -94.85 -28.73 15.07 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -136.15 68.17 62.62 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 123.911 0.884 . . . . 0.0 109.587 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.55 57.41 4.26 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.704 3.603 . . . . 0.0 112.425 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.87 -3.12 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 O-C-N 121.958 -0.464 . . . . 0.0 111.616 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -130.13 166.59 19.91 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.924 0.89 . . . . 0.0 109.442 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 m -74.8 148.52 40.26 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.939 0.399 . . . . 0.0 111.604 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.9 mm -137.73 138.3 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.3 p -145.47 174.98 10.67 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.208 0.603 . . . . 0.0 109.893 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 38.0 p -63.14 -21.24 66.06 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 122.314 -0.241 . . . . 0.0 111.099 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -81.94 -26.18 34.25 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.024 0.375 . . . . 0.0 111.048 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.06 -38.59 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 86.3 mt -76.95 -22.92 52.52 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.921 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -76.3 -36.14 58.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 117.96 0.346 . . . . 0.0 110.785 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.1 t -78.11 -18.68 55.36 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.14 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -95.84 -14.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 118.348 0.522 . . . . 0.0 112.028 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 78.3 m -98.21 -24.36 15.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.869 0.758 . . . . 0.0 112.25 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.469 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 48.6 t30 -64.18 -38.87 38.34 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 86.1 Cg_endo -73.66 -0.05 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.635 1.557 . . . . 0.0 112.159 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 80.6 m -112.62 -5.69 13.97 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.609 0.364 . . . . 0.0 111.625 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 158.8 164.39 14.26 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.98 106.39 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.852 3.035 . . . . 0.0 110.638 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.7 t -78.49 150.63 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -117.03 -36.5 3.79 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.643 0.377 . . . . 0.0 111.279 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -164.12 156.43 17.05 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.101 0.41 . . . . 0.0 111.792 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 40.5 mt -144.77 143.75 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.751 0.821 . . . . 0.0 109.761 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.7 m -138.76 155.97 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 123.359 0.663 . . . . 0.0 109.756 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.7 mm . . . . . 0 C--O 1.231 0.101 0 C-N-CA 123.569 0.747 . . . . 0.0 111.096 -176.293 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.01 171.18 20.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.388 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.6 mtp -135.77 149.38 49.13 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 55.2 t -136.63 150.77 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -139.85 141.33 36.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -118.27 170.47 8.87 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.834 0.853 . . . . 0.0 110.849 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.63 -13.16 59.98 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.549 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 46.1 t -150.53 153.56 36.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.677 0.391 . . . . 0.0 110.416 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.17 -26.5 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -71.04 -24.04 62.27 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 22.5 m -81.34 -27.43 34.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.22 -25.1 36.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.416 0.286 . . . . 0.0 110.457 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -70.56 -37.49 74.01 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -74.93 -29.33 60.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.315 0.246 . . . . 0.0 110.689 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.49 -52.44 45.97 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 119.733 -0.175 . . . . 0.0 111.268 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.41 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.76 -12.6 59.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.845 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.52 -10.22 52.32 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.822 0.283 . . . . 0.0 111.601 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 21.4 m -126.33 -1.78 6.93 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.7 mt -130.62 -5.36 4.14 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -78.14 132.71 37.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.38 6.9 71.39 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.46 174.94 11.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.672 0.736 . . . . 0.0 111.061 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -132.65 149.75 52.26 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.1 0.96 . . . . 0.0 108.763 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.4 mt . . . . . 0 CA--C 1.533 0.3 0 CA-C-N 117.433 0.106 . . . . 0.0 111.219 -177.942 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.601 0.239 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.7 m -60.13 139.8 57.29 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.991 0.516 . . . . 0.0 110.223 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 54.3 mt -96.79 156.9 16.15 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.111 0.564 . . . . 0.0 112.282 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -140.52 137.71 34.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 171.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 71.7 mt -136.0 142.33 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.082 0.467 . . . . 0.0 111.308 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.72 167.3 30.07 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.563 1.145 . . . . 0.0 108.54 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -79.01 141.49 37.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.803 -0.561 . . . . 0.0 110.684 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.67 167.9 14.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.423 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -81.26 -27.89 0.46 Allowed Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.2 Cg_endo -82.15 166.86 16.26 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 CA-C-N 121.913 1.719 . . . . 0.0 110.138 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.1 p -99.87 -5.32 28.62 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 122.332 0.253 . . . . 0.0 111.025 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -154.76 151.95 29.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.088 0.955 . . . . 0.0 109.92 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.46 171.41 7.53 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.779 0.832 . . . . 0.0 109.398 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -138.92 159.3 42.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.961 0.504 . . . . 0.0 109.893 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.94 154.02 35.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.912 0.885 . . . . 0.0 109.006 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -123.15 -21.71 5.35 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.672 0.389 . . . . 0.0 111.771 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -166.93 173.11 9.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.311 1.044 . . . . 0.0 109.695 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -116.48 113.51 22.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.073 0.463 . . . . 0.0 110.473 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -157.53 -174.38 4.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.204 1.401 . . . . 0.0 109.243 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -69.79 -4.15 18.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -117.24 -11.76 10.61 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.713 0.688 . . . . 0.0 112.031 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.2 t -158.55 134.25 8.88 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -152.65 150.73 29.79 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 122.087 -0.383 . . . . 0.0 111.055 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -123.24 137.45 54.87 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.247 0.619 . . . . 0.0 109.743 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -119.33 15.95 13.05 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.487 0.715 . . . . 0.0 112.091 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.669 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.8 p30 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.992 0.425 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -90.12 18.08 6.29 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.565 0.746 . . . . 0.0 111.243 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.1 t -116.62 139.62 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.423 0.689 . . . . 0.0 110.325 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.2 mt -128.59 161.86 28.62 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.353 0.597 . . . . 0.0 110.621 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 tt -129.68 136.35 49.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -117.02 148.49 41.44 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.191 0.996 . . . . 0.0 109.903 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 89.8 m -133.28 141.16 47.86 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.4 mp -107.21 138.84 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 53.3 mt -108.06 -22.59 12.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -131.47 63.27 69.01 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 123.499 0.719 . . . . 0.0 109.777 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.92 40.04 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 125.104 3.869 . . . . 0.0 112.87 -173.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.4 pt -75.95 -2.91 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.6 -0.688 . . . . 0.0 111.531 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -130.4 165.22 23.02 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.987 0.915 . . . . 0.0 109.516 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 32.4 t -74.74 148.77 40.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.623 0.249 . . . . 0.0 111.487 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.7 mm -137.28 136.48 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 124.462 1.105 . . . . 0.0 108.175 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.0 p -143.97 176.88 8.95 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.138 0.575 . . . . 0.0 109.967 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.2 p -61.92 -22.68 65.8 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.569 0.348 . . . . 0.0 111.011 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.95 -24.61 35.45 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.48 0.312 . . . . 0.0 110.793 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.5 t -83.99 -37.6 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.95 -22.55 53.1 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.656 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -75.8 -36.92 59.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.196 0.453 . . . . 0.0 110.675 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 t -77.93 -18.7 55.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.396 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.94 -15.15 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.894 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.6 m -96.91 -25.42 15.43 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.741 0.701 . . . . 0.0 111.826 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.499 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 25.5 t-20 -58.75 -42.57 94.95 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 79.9 Cg_endo -71.26 -2.42 11.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.183 1.922 . . . . 0.0 112.379 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 83.7 m -115.03 -4.75 12.5 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.153 0.433 . . . . 0.0 111.642 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 158.86 158.68 9.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.76 114.59 3.75 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.674 2.916 . . . . 0.0 110.634 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.7 t -85.68 149.39 4.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -112.58 -34.74 5.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.893 0.477 . . . . 0.0 110.943 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -165.36 160.41 18.11 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 111.945 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 41.6 mt -143.48 147.43 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 124.256 1.023 . . . . 0.0 109.487 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.98 145.04 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.062 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.5 mm . . . . . 0 N--CA 1.455 -0.194 0 C-N-CA 123.754 0.822 . . . . 0.0 110.291 -174.137 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.826 0.346 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.65 168.56 26.76 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.62 0.768 . . . . 0.0 109.914 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 85.2 mtp -136.89 151.65 49.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.74 150.27 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.048 0.539 . . . . 0.0 110.062 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -133.08 139.53 47.19 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -114.04 167.38 10.71 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.777 0.831 . . . . 0.0 111.299 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -75.2 -14.13 60.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.9 t -152.06 151.49 31.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.017 0.527 . . . . 0.0 110.08 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.4 p -69.12 -24.05 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.41 -24.81 62.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 26.3 m -81.54 -25.38 35.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.738 0.415 . . . . 0.0 110.612 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.46 -26.4 35.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.64 -36.9 76.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -77.64 -29.33 51.66 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.31 -52.24 55.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 119.647 -0.216 . . . . 0.0 110.97 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.422 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.99 -15.07 59.75 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.628 0.649 . . . . 0.0 112.209 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -82.53 -12.7 57.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.986 0.357 . . . . 0.0 111.814 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -128.51 2.53 5.59 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 73.2 mt -129.59 -3.61 4.78 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.791 0.723 . . . . 0.0 112.491 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -78.5 131.53 36.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.24 3.63 76.85 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.75 179.95 5.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.762 0.781 . . . . 0.0 110.7 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.78 162.34 35.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.434 0.694 . . . . 0.0 109.181 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 38.3 mt . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 111.227 0.084 . . . . 0.0 111.227 -176.74 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.512 0.196 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.1 m -55.35 142.12 33.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.41 0.684 . . . . 0.0 109.795 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.0 mt -108.62 153.76 22.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.374 0.669 . . . . 0.0 112.022 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -140.26 135.0 31.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 171.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.422 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 79.4 mt -125.81 148.99 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.048 0.451 . . . . 0.0 111.435 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.86 165.97 34.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.034 1.333 . . . . 0.0 108.421 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.73 139.95 38.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.834 -0.541 . . . . 0.0 110.231 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -75.36 167.18 22.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.897 0.479 . . . . 0.0 111.427 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -71.72 -54.78 6.09 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.164 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.66 164.59 31.88 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.336 2.024 . . . . 0.0 111.123 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.0 p -91.74 -6.47 51.86 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.712 0.405 . . . . 0.0 111.576 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.62 167.06 30.81 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.732 0.813 . . . . 0.0 109.878 176.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 86.2 mt -123.54 173.15 8.23 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.517 0.727 . . . . 0.0 109.863 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -136.19 154.53 50.92 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 91.9 t -136.37 153.12 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.876 0.871 . . . . 0.0 108.65 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.72 -18.78 5.09 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -166.06 172.56 11.24 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.931 1.292 . . . . 0.0 109.296 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -119.06 110.63 17.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.01 0.434 . . . . 0.0 110.46 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -154.62 -169.85 3.34 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.796 1.238 . . . . 0.0 109.773 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -70.18 -6.66 35.93 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -114.42 -15.25 12.1 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.782 0.719 . . . . 0.0 112.209 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.2 t -159.02 140.17 12.97 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -154.88 148.32 25.14 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.997 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -128.03 135.7 50.23 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -112.87 5.12 17.26 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.612 0.765 . . . . 0.0 112.031 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 CA--C 1.53 0.19 0 C-N-CA 122.907 0.483 . . . . 0.0 111.55 -179.503 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.846 0.355 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 82.3 p -87.12 13.59 9.13 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.245 0.618 . . . . 0.0 111.842 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.4 t -109.01 138.63 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 122.91 0.484 . . . . 0.0 110.885 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.67 160.83 31.24 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 121.427 0.632 . . . . 0.0 111.459 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.7 tp -125.7 130.29 51.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.94 1.296 . . . . 0.0 108.222 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -115.56 146.91 41.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.566 0.746 . . . . 0.0 109.985 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.4 m -138.43 142.63 39.52 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.7 mp -106.8 136.46 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 73.1 mt -92.4 -34.46 14.14 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -134.02 68.25 74.35 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 123.406 0.682 . . . . 0.0 109.543 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -74.41 62.92 5.4 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.555 3.503 . . . . 0.0 112.427 -174.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 44.8 pt -84.66 -4.85 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 122.024 -0.422 . . . . 0.0 111.289 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -126.85 167.88 15.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.945 0.898 . . . . 0.0 109.27 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 78.1 p -83.26 154.15 24.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.015 0.436 . . . . 0.0 111.21 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.0 mm -136.91 138.3 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.1 p -143.97 176.1 9.54 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.044 0.538 . . . . 0.0 110.018 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.9 p -62.12 -27.47 68.95 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 122.542 0.337 . . . . 0.0 110.966 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -78.03 -20.34 52.65 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.431 0.292 . . . . 0.0 111.495 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.42 -40.68 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 88.5 mt -73.56 -30.67 63.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.175 -0.328 . . . . 0.0 110.924 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -68.87 -37.82 79.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.217 0.462 . . . . 0.0 110.921 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 t -78.58 -17.43 56.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.481 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.35 -9.73 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 18.2 p -119.69 -6.23 10.16 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.347 0.976 . . . . 0.0 113.136 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.498 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.6 t-20 -63.06 -41.12 68.24 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.496 -0.764 . . . . 0.0 113.054 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 96.3 Cg_endo -71.7 -3.03 12.32 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.794 1.663 . . . . 0.0 111.982 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.2 m -93.58 -8.47 41.11 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.096 0.407 . . . . 0.0 111.41 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 144.91 174.58 17.29 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.38 114.91 3.42 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.672 2.915 . . . . 0.0 110.953 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 96.9 t -87.06 150.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -113.9 -37.61 4.45 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -165.17 159.16 17.29 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.518 0.599 . . . . 0.0 112.287 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 48.7 mt -142.83 144.36 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.081 0.953 . . . . 0.0 109.677 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.408 ' C ' HD12 ' A' ' 223' ' ' ILE . 6.4 p -143.85 142.71 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 123.486 0.714 . . . . 0.0 109.487 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 222' ' ' VAL . 1.8 mp . . . . . 0 CA--C 1.529 0.143 0 C-N-CA 123.799 0.84 . . . . 0.0 109.649 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.913 0.387 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.35 169.28 24.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.024 0.53 . . . . 0.0 109.731 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.0 mtp -137.96 151.71 48.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.1 t -139.3 151.1 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 C-N-CA 122.904 0.482 . . . . 0.0 109.884 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -135.41 141.65 45.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.457 0.703 . . . . 0.0 109.192 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -117.37 168.45 10.34 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.087 0.955 . . . . 0.0 110.761 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.88 -9.98 59.77 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.791 0.437 . . . . 0.0 110.889 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.1 t -150.17 147.67 28.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.103 0.561 . . . . 0.0 109.935 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 -23.3 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -73.2 -23.23 60.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.082 -0.386 . . . . 0.0 110.235 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 42.2 m -80.85 -28.12 36.2 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.82 -25.43 44.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -70.92 -37.96 72.93 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -74.96 -27.61 60.24 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.247 0.619 . . . . 0.0 110.965 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.32 -54.98 10.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.125 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -14.77 60.35 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.356 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -81.52 -16.62 51.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.118 0.417 . . . . 0.0 111.568 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -123.44 4.38 9.04 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.7 mt -121.65 -5.69 9.19 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.856 0.753 . . . . 0.0 112.559 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -74.79 129.93 38.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.943 0.792 . . . . 0.0 109.149 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.43 8.78 76.56 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.13 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.93 174.15 10.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.85 0.825 . . . . 0.0 111.333 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -137.71 145.26 42.33 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.66 0.784 . . . . 0.0 109.185 -177.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 51.8 mt . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -176.534 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 26.9 m -58.61 140.61 54.14 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.738 0.415 . . . . 0.0 109.948 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.4 mt -95.07 154.99 16.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.023 0.44 . . . . 0.0 112.014 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -145.65 134.7 22.67 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.34 150.42 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-O 120.993 0.425 . . . . 0.0 111.247 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -153.75 168.05 27.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.194 1.398 . . . . 0.0 108.364 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.85 144.0 32.33 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 121.74 -0.6 . . . . 0.0 110.994 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.03 170.3 10.46 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.413 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.7 pttt -86.0 -26.21 0.36 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -177.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.4 Cg_endo -82.23 164.63 17.11 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 121.881 1.707 . . . . 0.0 110.406 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 58.4 p -93.45 -9.04 39.88 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 122.265 -0.272 . . . . 0.0 111.564 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.39 168.48 27.21 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.746 0.818 . . . . 0.0 109.711 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 87.7 mt -120.6 170.74 9.13 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.369 0.668 . . . . 0.0 109.685 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -131.1 157.47 43.02 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.449 0.166 . . . . 0.0 110.667 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 87.0 t -137.85 153.93 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 124.08 0.952 . . . . 0.0 108.958 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -128.06 -14.66 4.91 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.294 0.238 . . . . 0.0 111.627 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -163.54 170.32 17.43 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.048 0.939 . . . . 0.0 109.237 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.33 99.65 6.83 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -152.96 -169.14 3.25 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.103 0.961 . . . . 0.0 110.102 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -72.27 -1.81 16.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.53 -31.39 8.54 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.183 0.593 . . . . 0.0 110.8 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.3 t -159.28 147.02 17.43 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -152.48 146.68 25.46 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.721 0.296 . . . . 0.0 110.705 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -121.28 134.3 55.16 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.956 0.502 . . . . 0.0 109.646 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.99 6.48 19.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.554 0.742 . . . . 0.0 112.449 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 123.15 0.58 . . . . 0.0 110.552 177.691 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.5 p30 . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.9 p -97.46 8.62 44.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.372 0.669 . . . . 0.0 111.975 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.96 143.37 18.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 123.055 0.542 . . . . 0.0 110.86 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.0 mt -129.0 163.54 25.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.073 0.549 . . . . 0.0 111.663 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.7 tp -123.24 133.38 54.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.654 1.182 . . . . 0.0 108.179 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -120.24 143.62 48.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.675 0.79 . . . . 0.0 109.383 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 97.4 m -139.51 143.55 37.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.0 mp -106.35 135.38 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.8 mt -90.39 -36.52 14.56 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -131.93 64.27 71.84 Favored Pre-proline 0 CA--C 1.529 0.135 0 C-N-CA 123.379 0.672 . . . . 0.0 109.922 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.6 102.91 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.608 2.205 . . . . 0.0 111.135 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.4 pt -129.58 2.7 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 122.996 0.518 . . . . 0.0 111.401 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -130.6 169.58 15.42 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.791 0.836 . . . . 0.0 109.492 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.5 m -77.58 145.86 36.58 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.5 mm -137.18 133.89 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 61.7 p -142.58 175.55 9.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.8 p -64.37 -20.48 66.15 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 122.296 0.239 . . . . 0.0 111.206 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.7 -25.34 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 122.283 0.233 . . . . 0.0 110.587 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.7 t -82.42 -36.87 13.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.7 -25.43 53.59 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.122 -0.362 . . . . 0.0 110.781 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -78.39 -34.5 48.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.023 -0.423 . . . . 0.0 111.057 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -74.9 -23.46 58.37 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.563 0.62 . . . . 0.0 111.389 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.6 pt -88.73 -23.17 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.176 0.444 . . . . 0.0 111.723 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.9 m -95.58 -20.15 19.22 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.618 0.645 . . . . 0.0 112.483 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.459 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.41 -43.79 90.48 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 87.8 Cg_endo -73.94 -9.63 22.4 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.887 1.724 . . . . 0.0 111.651 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 82.3 m -91.98 -21.56 20.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.023 0.374 . . . . 0.0 111.207 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.15 172.45 30.65 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.57 105.14 1.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 124.122 3.215 . . . . 0.0 110.549 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 94.0 t -78.32 150.14 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -113.53 -41.09 3.69 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.778 0.431 . . . . 0.0 110.876 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.73 163.34 32.4 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.177 0.444 . . . . 0.0 111.472 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.43 146.9 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.534 0.734 . . . . 0.0 109.903 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.24 147.6 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 54.3 mt . . . . . 0 N--CA 1.456 -0.172 0 C-N-CA 123.348 0.659 . . . . 0.0 110.085 -174.208 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--O 1.23 0.061 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.4 171.9 19.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.552 0.215 . . . . 0.0 110.876 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.1 mtp -142.28 150.38 40.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 49.0 t -139.25 151.37 23.04 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.987 0.515 . . . . 0.0 109.719 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -136.2 141.32 44.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.144 0.577 . . . . 0.0 109.497 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -116.31 168.84 9.78 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.905 0.882 . . . . 0.0 110.983 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.55 -14.16 60.76 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.831 0.452 . . . . 0.0 111.22 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 48.4 t -152.7 153.54 33.47 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.878 0.471 . . . . 0.0 110.378 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.09 -25.71 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.57 -29.4 68.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.012 0.369 . . . . 0.0 110.056 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 20.8 m -79.24 -27.58 42.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.541 0.336 . . . . 0.0 110.65 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.4 -27.45 38.1 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -68.01 -37.24 81.2 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -78.46 -25.68 45.9 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.344 0.257 . . . . 0.0 110.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.93 -55.39 17.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.343 0.257 . . . . 0.0 110.807 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -16.36 60.51 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.566 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -78.43 -14.65 59.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.189 0.45 . . . . 0.0 111.643 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 55.6 m -125.07 1.56 7.94 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.56 -5.17 4.72 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -78.22 132.79 37.7 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.917 0.781 . . . . 0.0 109.124 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.33 6.66 70.42 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.48 176.6 7.39 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.715 0.758 . . . . 0.0 111.343 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -139.6 151.07 45.72 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.707 0.803 . . . . 0.0 109.13 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.1 mt . . . . . 0 CA--C 1.535 0.368 0 C-N-CA 122.405 0.282 . . . . 0.0 111.296 -175.688 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.7 m -60.27 141.68 55.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.244 0.618 . . . . 0.0 109.87 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.42 155.41 16.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -144.51 124.78 13.76 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.41 147.38 28.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 CA-C-O 121.163 0.506 . . . . 0.0 111.542 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.56 171.01 20.66 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.718 1.207 . . . . 0.0 108.762 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -80.99 143.98 32.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 122.051 -0.405 . . . . 0.0 110.45 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.3 167.2 15.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.319 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.44 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -83.46 -26.56 0.4 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -176.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 48.2 Cg_endo -80.95 -176.7 3.29 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.952 1.768 . . . . 0.0 109.9 176.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 67.2 p -117.77 -0.75 11.71 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.749 0.42 . . . . 0.0 110.89 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -155.16 146.05 22.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.912 0.885 . . . . 0.0 109.255 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.9 mt -112.35 167.55 10.34 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.246 0.619 . . . . 0.0 110.01 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -129.62 166.74 19.15 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.49 0.316 . . . . 0.0 110.813 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.73 155.71 22.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.223 1.009 . . . . 0.0 109.023 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -130.47 -16.74 3.41 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.368 0.267 . . . . 0.0 111.563 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -165.84 174.38 9.66 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.182 0.993 . . . . 0.0 109.516 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -120.35 96.69 5.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -148.35 -166.01 2.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.929 0.892 . . . . 0.0 110.126 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -73.36 -3.0 24.51 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -112.48 -21.88 11.11 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.813 0.733 . . . . 0.0 111.749 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.2 t -159.9 144.97 15.17 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -151.86 153.3 33.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.91 138.75 51.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 110.393 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -116.4 7.19 13.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.556 0.742 . . . . 0.0 112.331 -174.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 CA--C 1.531 0.225 0 C-N-CA 122.875 0.47 . . . . 0.0 110.517 176.393 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 85.8 p -86.31 13.97 7.29 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.147 0.579 . . . . 0.0 112.264 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.75 138.91 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 123.002 0.521 . . . . 0.0 110.712 -176.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.8 mt -129.56 162.45 28.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.416 0.627 . . . . 0.0 111.246 -177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.1 tp -122.43 133.09 54.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.935 1.294 . . . . 0.0 107.994 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -118.8 145.42 45.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.677 0.791 . . . . 0.0 109.827 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 96.2 m -136.19 141.75 44.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.9 mp -107.27 133.23 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 66.3 mt -92.69 -29.51 16.04 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -137.89 69.35 50.7 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 123.557 0.743 . . . . 0.0 109.586 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.4 56.16 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.529 3.486 . . . . 0.0 112.047 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.8 pt -81.04 -1.53 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 122.03 -0.419 . . . . 0.0 111.603 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -128.85 167.24 17.64 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.683 0.793 . . . . 0.0 109.685 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.1 m -75.84 149.78 37.8 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 111.539 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.4 mm -137.49 137.57 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 81.0 p -145.27 175.49 10.24 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.385 0.674 . . . . 0.0 109.782 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.2 p -63.64 -22.82 67.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 119.673 -0.203 . . . . 0.0 111.049 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -79.0 -23.87 44.09 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.298 0.239 . . . . 0.0 111.129 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 88.1 t -86.33 -39.11 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.92 -22.8 58.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.11 -0.369 . . . . 0.0 110.94 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -78.89 -36.11 42.6 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.885 0.311 . . . . 0.0 111.144 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.9 t -74.94 -20.47 59.67 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.89 -0.506 . . . . 0.0 111.327 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.2 pt -92.04 -21.54 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.7 m -97.85 -23.67 15.76 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.798 0.726 . . . . 0.0 112.899 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.48 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 51.1 t30 -65.21 -40.78 47.5 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 98.3 Cg_endo -72.91 -8.96 23.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.424 1.416 . . . . 0.0 111.684 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 77.5 m -97.81 -12.69 21.91 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.707 0.403 . . . . 0.0 111.17 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 161.65 162.06 12.57 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.28 110.73 2.09 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.654 2.903 . . . . 0.0 110.581 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.7 149.79 4.37 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -115.0 -34.75 4.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.847 0.459 . . . . 0.0 110.901 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -164.32 159.49 19.9 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.3 144.65 23.42 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 124.098 0.959 . . . . 0.0 109.644 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.02 142.96 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.288 0.635 . . . . 0.0 109.472 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.53 0.205 0 C-N-CA 123.905 0.882 . . . . 0.0 109.756 -179.372 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.957 0.408 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.53 167.05 31.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.6 mtp -134.38 150.94 50.94 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.35 149.36 22.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.643 0.377 . . . . 0.0 110.194 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -131.52 140.73 49.58 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -116.27 167.91 10.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.872 0.869 . . . . 0.0 110.648 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -72.31 -18.84 61.75 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.686 0.394 . . . . 0.0 111.611 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 85.1 p -151.64 159.86 43.87 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.913 0.485 . . . . 0.0 110.473 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.7 -28.78 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 O-C-N 122.18 -0.325 . . . . 0.0 110.386 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -69.3 -25.07 64.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.035 0.38 . . . . 0.0 110.394 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 59.6 m -78.37 -29.39 47.39 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.45 -24.5 42.38 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.396 -0.19 . . . . 0.0 110.941 176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -70.86 -36.63 72.93 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -78.51 -27.16 46.04 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 122.153 -0.342 . . . . 0.0 110.578 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.39 -52.71 51.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.174 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.421 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.66 -17.37 60.0 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.838 0.744 . . . . 0.0 111.74 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -82.46 -9.61 59.36 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.934 0.334 . . . . 0.0 111.547 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.2 m -124.93 -2.3 7.75 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 79.9 mt -131.11 -4.58 3.91 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.697 0.68 . . . . 0.0 112.823 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -75.76 132.81 40.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 118.953 0.797 . . . . 0.0 109.13 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.78 5.24 68.68 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 119.794 -0.448 . . . . 0.0 112.331 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.93 175.44 10.04 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.712 0.756 . . . . 0.0 111.506 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -132.64 145.07 50.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.2 mt . . . . . 0 CA--C 1.531 0.221 0 O-C-N 122.491 -0.131 . . . . 0.0 111.348 -177.166 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.534 0.207 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.2 m -59.89 142.95 52.66 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 122.821 0.448 . . . . 0.0 110.043 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 56.1 mt -103.53 157.33 17.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.259 0.552 . . . . 0.0 112.232 -174.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -144.36 134.68 24.42 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.421 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 88.0 mt -127.96 148.96 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.306 0.574 . . . . 0.0 111.543 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.08 171.37 20.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.969 1.308 . . . . 0.0 108.374 172.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -84.14 144.35 29.07 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.943 -0.473 . . . . 0.0 110.775 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.06 168.43 11.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.345 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -84.26 -27.35 0.4 Allowed Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -176.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 44.9 Cg_endo -81.91 167.38 16.39 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 CA-C-N 121.752 1.661 . . . . 0.0 110.4 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 45.3 p -96.68 -9.11 29.83 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.28 0.232 . . . . 0.0 111.286 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 170.29 22.31 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.711 0.804 . . . . 0.0 109.617 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 91.6 mt -124.23 167.93 13.63 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.924 0.49 . . . . 0.0 110.758 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -123.58 158.55 31.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.434 HG11 ' C ' ' A' ' 280' ' ' TRP . 5.6 t -131.87 -24.78 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 122.309 0.244 . . . . 0.0 111.518 -171.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 62.89 -37.05 0.14 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.185 1.794 . . . . 0.0 115.055 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -164.64 177.87 7.74 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.787 0.835 . . . . 0.0 110.446 -174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -118.85 113.14 20.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -155.2 -174.66 5.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.699 1.199 . . . . 0.0 109.87 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -70.94 -3.82 21.32 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -113.17 -16.88 12.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.619 0.645 . . . . 0.0 111.438 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 14.6 t -156.98 132.42 9.23 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' TRP . . . . . 0.434 ' C ' HG11 ' A' ' 272' ' ' VAL . 12.6 t-105 -147.01 149.82 33.89 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 122.071 -0.393 . . . . 0.0 111.299 -175.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -126.22 137.65 53.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.3 0.64 . . . . 0.0 109.677 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -115.87 4.28 13.87 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.619 0.768 . . . . 0.0 112.464 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 CA--C 1.531 0.239 0 C-N-CA 123.013 0.525 . . . . 0.0 111.707 -179.092 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.4 p -89.16 13.3 13.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.431 0.693 . . . . 0.0 111.607 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 31.3 t -112.73 139.92 35.26 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 123.271 0.628 . . . . 0.0 110.962 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.0 mt -130.32 163.63 26.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.375 0.607 . . . . 0.0 111.279 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.2 tp -124.98 133.47 53.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.842 1.257 . . . . 0.0 107.962 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -119.37 142.95 47.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.743 0.817 . . . . 0.0 110.106 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 88.4 m -137.67 143.85 41.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.4 mp -108.51 137.99 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.8 mt -92.09 -35.46 13.89 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -133.0 68.73 78.81 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.801 0.84 . . . . 0.0 109.428 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.29 67.62 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.321 3.347 . . . . 0.0 112.109 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.1 pt -88.07 -4.34 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 122.079 -0.388 . . . . 0.0 111.128 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -128.18 169.27 14.32 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.02 0.928 . . . . 0.0 109.239 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 79.8 p -85.04 155.26 21.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.832 0.349 . . . . 0.0 111.487 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mm -135.66 138.18 48.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.3 p -143.27 174.39 10.76 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.956 0.502 . . . . 0.0 110.146 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 39.6 p -62.24 -25.2 67.69 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.415 0.286 . . . . 0.0 111.061 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -78.71 -24.36 45.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.349 0.26 . . . . 0.0 111.185 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.6 t -84.29 -38.34 13.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.83 -23.39 52.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.226 -0.296 . . . . 0.0 110.977 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -79.39 -33.85 42.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.271 0.487 . . . . 0.0 111.079 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -76.64 -20.92 56.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.219 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.3 pt -91.58 -22.35 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 118.251 0.478 . . . . 0.0 111.707 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.5 m -94.83 -19.53 20.24 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.39 0.541 . . . . 0.0 112.271 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.8 t-20 -59.8 -43.69 95.54 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 90.6 Cg_endo -71.56 -5.98 18.19 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.875 1.717 . . . . 0.0 112.22 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 86.1 m -96.13 -5.89 39.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.079 0.399 . . . . 0.0 111.134 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 137.44 174.24 13.26 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.8 119.25 6.26 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.711 2.941 . . . . 0.0 111.263 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.16 151.85 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -113.29 -36.46 5.0 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.101 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -165.3 160.24 18.08 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.198 0.453 . . . . 0.0 111.966 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 48.7 mt -143.0 147.54 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.971 0.908 . . . . 0.0 109.321 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.24 144.47 18.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 123.103 0.561 . . . . 0.0 109.795 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.53 0.209 0 C-N-CA 123.797 0.839 . . . . 0.0 109.969 -178.24 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.955 0.407 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -158.32 169.09 25.26 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.125 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.8 mtp -137.12 150.77 48.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.02 149.83 24.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -132.23 140.84 48.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -117.04 169.05 9.72 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.907 0.883 . . . . 0.0 110.849 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -77.81 -13.85 59.76 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.059 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 95.6 p -151.93 157.33 41.64 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.986 0.422 . . . . 0.0 110.839 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.72 -25.03 27.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.159 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -67.3 -29.99 69.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.124 -0.36 . . . . 0.0 110.344 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 50.2 m -79.41 -28.14 41.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.34 -26.68 42.09 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -70.05 -36.43 74.99 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -77.39 -27.47 52.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.457 -0.152 . . . . 0.0 110.631 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.02 -51.82 50.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.279 -0.263 . . . . 0.0 111.277 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.408 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.31 -13.93 60.13 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.516 179.531 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -86.78 -10.05 54.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.889 0.313 . . . . 0.0 111.495 176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.3 m -124.48 -2.05 8.0 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 88.1 mt -129.85 -5.22 4.56 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -77.35 130.69 37.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.975 0.807 . . . . 0.0 109.058 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.29 7.38 72.17 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.57 175.57 9.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.727 0.764 . . . . 0.0 111.568 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -137.3 144.88 42.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.96 0.904 . . . . 0.0 108.963 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.5 mt . . . . . 0 CA--C 1.534 0.329 0 C-N-CA 122.546 0.338 . . . . 0.0 111.603 -175.814 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.6 m -59.12 140.49 55.79 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.852 0.461 . . . . 0.0 109.849 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.3 mt -94.31 154.79 17.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.202 0.525 . . . . 0.0 112.162 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -145.14 132.76 20.93 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 84.4 mt -132.7 147.94 31.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.247 0.546 . . . . 0.0 112.29 -172.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.36 172.87 15.8 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.869 1.268 . . . . 0.0 108.8 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -84.41 142.28 30.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.22 -0.3 . . . . 0.0 110.598 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.87 169.59 12.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.44 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -85.78 -26.97 0.37 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.0 Cg_endo -82.62 164.91 16.16 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.01 1.807 . . . . 0.0 110.261 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.5 p -94.1 -7.84 41.33 Favored 'General case' 0 CA--C 1.527 0.065 0 O-C-N 122.325 -0.234 . . . . 0.0 111.396 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.85 169.13 25.47 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.835 0.854 . . . . 0.0 109.809 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 85.9 mt -121.06 173.18 7.43 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.461 0.705 . . . . 0.0 110.08 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -129.42 157.37 42.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.601 0.36 . . . . 0.0 110.485 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.9 t -138.36 152.33 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 C-N-CA 124.118 0.967 . . . . 0.0 108.866 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -125.84 -14.8 6.09 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.394 0.278 . . . . 0.0 111.627 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -164.68 173.92 11.35 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.286 1.034 . . . . 0.0 109.885 -176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -119.95 98.24 6.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -150.58 -168.79 3.21 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.868 0.867 . . . . 0.0 110.311 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -71.77 -4.11 25.9 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -110.88 -24.65 10.28 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.673 0.67 . . . . 0.0 111.753 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.8 t -157.63 144.57 18.15 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 173.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -152.76 147.99 26.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.172 0.189 . . . . 0.0 110.522 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -122.17 134.84 54.72 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.73 8.53 17.51 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.702 0.801 . . . . 0.0 112.17 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 123.289 0.636 . . . . 0.0 110.532 178.001 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 44.3 p30 . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.7 p -96.64 15.39 21.87 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.216 0.606 . . . . 0.0 112.082 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.34 143.53 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 123.038 0.535 . . . . 0.0 111.022 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.7 mt -129.13 166.13 19.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.182 0.593 . . . . 0.0 111.325 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.6 tp -124.95 133.95 52.83 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.823 1.249 . . . . 0.0 107.999 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -120.12 147.71 44.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.832 0.853 . . . . 0.0 109.889 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.8 m -136.82 139.11 41.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.5 mp -103.47 135.69 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 50.4 mt -102.5 -17.07 15.93 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -139.13 66.55 38.69 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 123.657 0.783 . . . . 0.0 109.362 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.24 40.58 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 124.903 3.735 . . . . 0.0 112.069 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 32.9 pt -77.66 -1.58 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 O-C-N 121.944 -0.473 . . . . 0.0 111.791 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -132.11 165.89 23.01 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.131 0.972 . . . . 0.0 109.216 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.9 m -73.98 149.6 41.22 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.758 0.313 . . . . 0.0 111.303 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.5 mm -136.54 137.98 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.7 p -145.33 175.33 10.38 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.287 0.635 . . . . 0.0 109.77 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.0 p -63.0 -23.1 67.3 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 122.423 0.289 . . . . 0.0 111.199 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.24 -26.68 35.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.311 -0.243 . . . . 0.0 111.205 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 89.8 t -81.86 -36.78 14.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.8 mt -76.9 -24.16 52.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 122.378 -0.201 . . . . 0.0 110.528 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -76.83 -36.15 57.06 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.851 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -77.52 -20.06 54.83 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.344 0.52 . . . . 0.0 111.544 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -93.27 -15.47 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 118.331 0.514 . . . . 0.0 111.653 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 67.5 m -98.52 -21.68 16.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.642 0.655 . . . . 0.0 111.924 176.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.47 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.9 t-20 -58.82 -43.4 97.69 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 96.6 Cg_endo -72.31 -8.83 23.39 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.004 1.803 . . . . 0.0 112.012 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 70.7 m -96.21 -21.0 18.15 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.912 0.324 . . . . 0.0 111.151 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.63 168.09 25.1 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.91 112.58 3.14 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.757 2.971 . . . . 0.0 110.895 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.99 151.48 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 123.286 0.634 . . . . 0.0 109.395 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -116.42 -36.05 4.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.0 0.52 . . . . 0.0 110.788 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -163.17 157.81 20.97 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 112.413 0.524 . . . . 0.0 112.413 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.7 mt -143.67 146.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.243 1.017 . . . . 0.0 109.443 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.0 p -146.4 143.59 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.307 0.643 . . . . 0.0 109.61 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.529 0.166 0 C-N-CA 123.743 0.817 . . . . 0.0 110.016 -178.286 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.805 0.336 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.98 169.5 24.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.865 0.466 . . . . 0.0 109.95 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.4 mtp -134.65 149.85 50.58 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.41 149.84 25.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -135.72 140.16 44.19 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.594 0.757 . . . . 0.0 109.434 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -118.58 167.97 11.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.897 0.879 . . . . 0.0 110.837 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -14.35 60.08 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.722 0.409 . . . . 0.0 111.493 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.1 t -149.97 150.39 31.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.061 0.544 . . . . 0.0 109.72 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.56 -25.93 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -66.77 -26.99 67.23 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.7 m -82.43 -25.49 33.59 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.82 -26.81 40.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -69.72 -36.46 75.9 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -79.14 -24.54 43.24 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.332 -0.23 . . . . 0.0 110.849 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.25 -53.38 30.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.305 -0.247 . . . . 0.0 111.06 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.15 -16.05 59.95 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.734 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.37 -9.89 58.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.032 0.378 . . . . 0.0 111.781 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 16.7 t -124.61 -5.38 7.61 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.6 mt -126.95 -4.96 6.27 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -176.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -76.88 131.25 38.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.94 4.76 78.26 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.15 -178.41 5.6 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.398 0.599 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -141.55 163.57 32.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.988 0.915 . . . . 0.0 109.145 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 39.1 mt . . . . . 0 CA--C 1.532 0.28 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.214 -178.877 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 96.2 m . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.972 0.415 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 8.7 m -55.62 138.2 47.54 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.396 0.679 . . . . 0.0 109.936 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 64.6 mt -102.65 154.0 19.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.073 0.549 . . . . 0.0 111.872 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -144.81 129.93 18.54 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 78.7 mt -128.87 147.08 33.31 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-O 121.347 0.594 . . . . 0.0 112.175 -170.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.51 173.41 15.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.891 1.277 . . . . 0.0 108.74 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -84.33 145.25 28.35 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 121.61 -0.681 . . . . 0.0 110.749 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.3 167.57 13.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.685 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 22.0 ptmt -82.38 -27.09 0.42 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 47.2 Cg_endo -84.31 -177.84 3.16 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.959 1.772 . . . . 0.0 110.065 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.9 p -111.36 -9.79 14.25 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.494 0.318 . . . . 0.0 111.337 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.401 ' HD3' ' N ' ' A' ' 270' ' ' LEU . 0.0 OUTLIER -156.36 137.35 13.56 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.401 ' N ' ' HD3' ' A' ' 269' ' ' ARG . 63.5 mt -88.02 172.79 9.29 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 123.088 0.555 . . . . 0.0 110.726 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -132.34 149.36 52.37 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.324 -0.235 . . . . 0.0 111.008 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 72.5 t -138.6 151.34 24.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 124.298 1.039 . . . . 0.0 108.484 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -124.44 -23.67 4.4 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 177.21 9.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.575 1.15 . . . . 0.0 108.834 176.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -110.76 110.16 20.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.651 0.381 . . . . 0.0 110.113 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -152.79 -175.02 5.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.237 1.015 . . . . 0.0 109.545 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -72.53 -1.72 17.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -117.38 -20.42 9.13 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 118.503 0.592 . . . . 0.0 111.775 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.9 t -154.13 137.87 16.14 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -159.25 146.67 17.26 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 122.381 -0.199 . . . . 0.0 110.517 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -129.79 139.23 51.3 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.628 0.728 . . . . 0.0 111.38 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -104.69 -6.94 19.94 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.741 0.816 . . . . 0.0 111.526 -173.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 123.217 0.607 . . . . 0.0 109.857 173.207 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 35.6 p30 . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.6 p -93.44 18.63 9.49 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.659 0.783 . . . . 0.0 112.048 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.17 145.09 30.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 122.939 0.496 . . . . 0.0 110.817 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.6 mt -131.08 163.24 28.08 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.305 0.574 . . . . 0.0 111.5 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 62.3 tp -122.73 132.36 54.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.663 1.185 . . . . 0.0 108.302 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -117.75 146.33 43.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.587 0.755 . . . . 0.0 109.685 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 97.0 m -138.2 143.34 40.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 196' ' ' ILE . 1.9 mp -106.67 137.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.22 -35.91 10.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -173.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -129.9 63.94 70.32 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.997 0.519 . . . . 0.0 110.346 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.47 100.41 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.167 2.578 . . . . 0.0 111.152 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.2 pt -122.17 3.11 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 122.874 0.469 . . . . 0.0 110.878 173.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -138.24 164.85 28.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.21 1.004 . . . . 0.0 109.097 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 80.3 p -79.21 156.6 28.09 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.902 0.382 . . . . 0.0 111.324 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.5 mm -135.86 137.95 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.1 p -144.44 175.41 10.14 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.137 0.575 . . . . 0.0 110.285 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.4 p -60.36 -26.45 66.63 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.973 0.509 . . . . 0.0 111.092 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.75 -21.3 44.63 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.506 0.322 . . . . 0.0 111.175 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.77 -37.86 10.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.21 -24.03 54.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.128 -0.357 . . . . 0.0 110.906 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -79.64 -33.06 41.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.95 -0.469 . . . . 0.0 111.111 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -77.09 -23.63 51.89 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-N 118.451 0.569 . . . . 0.0 111.369 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 39.1 pt -88.51 -22.25 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 118.258 0.481 . . . . 0.0 111.732 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 93.7 m -95.55 -21.94 17.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.546 0.612 . . . . 0.0 112.414 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.474 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.3 t-20 -60.33 -44.49 96.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 93.2 Cg_endo -72.89 -10.83 25.22 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.181 1.921 . . . . 0.0 111.727 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.7 m -94.04 -20.65 19.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.14 0.427 . . . . 0.0 110.931 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.67 168.36 27.7 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.08 105.84 1.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.659 2.906 . . . . 0.0 110.685 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.9 t -78.51 151.3 5.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -116.14 -37.66 3.77 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.705 0.402 . . . . 0.0 110.728 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -162.74 159.49 24.27 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 117.804 0.275 . . . . 0.0 111.474 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 50.5 mt -143.07 145.07 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 124.099 0.959 . . . . 0.0 110.319 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.4 m -137.83 149.69 25.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 123.587 0.755 . . . . 0.0 109.33 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 123.259 0.624 . . . . 0.0 109.789 -178.227 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 . . . . . 0 N--CA 1.458 -0.041 0 CA-C-O 120.678 0.275 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.64 169.82 21.75 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.993 0.517 . . . . 0.0 110.446 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.1 mtp -140.09 150.46 44.34 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.9 t -137.88 150.97 25.21 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 122.64 0.376 . . . . 0.0 110.04 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -133.4 140.85 47.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.366 0.667 . . . . 0.0 109.572 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.11 171.29 8.38 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.873 0.869 . . . . 0.0 110.774 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.14 -16.56 61.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.763 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 60.0 p -154.02 163.31 40.29 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.219 0.533 . . . . 0.0 110.829 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.72 -25.52 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.354 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -71.1 -27.58 63.71 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.199 0.454 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 m -77.81 -28.98 50.51 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.76 -24.69 41.37 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.446 -0.159 . . . . 0.0 110.759 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -70.35 -36.51 74.25 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -80.24 -25.69 39.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.439 -0.163 . . . . 0.0 110.732 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.52 -50.32 63.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.038 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.409 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.27 -15.74 59.31 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.693 179.222 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.21 -10.42 58.59 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.905 0.32 . . . . 0.0 111.401 176.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.6 m -123.2 -3.22 8.51 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.58 -4.26 4.2 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -79.03 131.51 36.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.42 5.46 63.29 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.586 -0.605 . . . . 0.0 111.586 -176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.44 178.64 8.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.863 0.832 . . . . 0.0 111.093 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -141.17 160.05 40.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.613 0.765 . . . . 0.0 109.372 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.8 mt . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.071 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.362 0.125 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.9 m -58.44 140.41 53.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.321 0.648 . . . . 0.0 110.335 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 56.9 mt -98.0 155.17 17.23 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.115 0.566 . . . . 0.0 111.712 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -142.15 132.52 25.04 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.409 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 83.2 mt -129.38 145.67 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-O 121.17 0.51 . . . . 0.0 111.849 -174.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.27 168.21 26.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.94 1.296 . . . . 0.0 108.3 173.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -78.01 141.54 38.85 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.868 -0.52 . . . . 0.0 110.497 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -80.8 166.24 21.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.6 pttt -81.72 -27.42 0.44 Allowed Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 49.1 Cg_endo -81.33 178.48 6.7 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.891 1.727 . . . . 0.0 109.797 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 63.5 p -104.51 -7.65 19.62 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 122.109 0.164 . . . . 0.0 111.18 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 167.72 28.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.319 0.647 . . . . 0.0 110.449 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.59 170.18 12.33 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.942 0.897 . . . . 0.0 109.425 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -143.13 163.21 33.49 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.502 0.191 . . . . 0.0 110.788 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.6 156.42 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 124.214 1.006 . . . . 0.0 109.103 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -126.1 -18.88 4.9 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.775 0.43 . . . . 0.0 111.621 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -166.09 169.24 14.71 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.042 0.937 . . . . 0.0 109.297 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -117.56 109.36 16.61 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.055 0.455 . . . . 0.0 110.54 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -155.47 -167.21 2.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.718 1.207 . . . . 0.0 109.898 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -73.44 -5.72 41.74 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.47 -15.98 12.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.672 0.669 . . . . 0.0 111.54 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.0 t -159.08 139.44 12.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -154.07 148.03 25.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.139 -0.351 . . . . 0.0 110.792 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.86 135.39 54.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.903 0.481 . . . . 0.0 110.017 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -115.73 9.1 15.09 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.56 0.744 . . . . 0.0 112.132 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.533 0.319 0 C-N-CA 123.234 0.614 . . . . 0.0 110.765 177.721 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.7 p30 . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.545 0.212 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -91.51 10.09 29.3 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.222 0.609 . . . . 0.0 111.587 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.5 t -106.04 137.94 33.78 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 C-N-CA 123.248 0.619 . . . . 0.0 110.589 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.3 mt -126.47 159.96 31.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.623 0.725 . . . . 0.0 111.572 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.0 tp -118.7 132.39 56.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.037 1.335 . . . . 0.0 108.15 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -118.37 141.66 48.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.302 0.641 . . . . 0.0 109.713 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 92.5 m -137.21 141.1 42.1 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.6 mp -104.26 136.21 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.46 -34.61 12.66 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -130.4 62.27 63.62 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.492 0.717 . . . . 0.0 110.041 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.33 101.79 0.89 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.781 2.32 . . . . 0.0 111.021 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.4 pt -127.0 2.31 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 122.878 0.471 . . . . 0.0 111.227 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -132.11 166.58 21.46 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.879 0.872 . . . . 0.0 109.405 177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.9 m -75.11 150.6 38.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.367 0.267 . . . . 0.0 111.346 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.6 mm -138.37 136.67 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 80.7 p -144.94 174.27 11.16 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.435 0.694 . . . . 0.0 109.853 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.7 p -62.17 -24.85 67.44 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.191 0.196 . . . . 0.0 111.142 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.16 -24.9 47.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.789 0.268 . . . . 0.0 111.154 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.77 -37.48 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.92 -23.45 52.48 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.381 -0.199 . . . . 0.0 110.753 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -79.87 -33.96 39.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.887 0.312 . . . . 0.0 110.957 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 t -75.54 -22.47 57.04 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 118.467 0.576 . . . . 0.0 110.935 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.9 pt -89.7 -22.09 6.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.157 0.435 . . . . 0.0 111.899 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.4 m -95.72 -20.13 19.14 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.403 0.547 . . . . 0.0 112.355 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.8 t-20 -60.88 -42.76 88.83 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 84.4 Cg_endo -72.1 -10.71 26.33 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.876 1.717 . . . . 0.0 111.795 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.8 m -91.22 -20.68 21.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.933 0.333 . . . . 0.0 110.888 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.52 171.35 25.25 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.74 111.95 2.94 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.676 2.917 . . . . 0.0 110.948 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.8 t -84.41 150.6 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -113.89 -37.3 4.54 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.119 0.567 . . . . 0.0 111.125 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -164.08 158.37 19.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.723 0.692 . . . . 0.0 112.351 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.2 mt -144.32 147.28 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.956 0.902 . . . . 0.0 109.529 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.04 144.02 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.262 0.625 . . . . 0.0 109.503 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.529 0.159 0 C-N-CA 123.861 0.864 . . . . 0.0 109.907 -178.05 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.872 0.368 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.44 173.24 17.2 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.669 0.388 . . . . 0.0 110.278 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.5 mtp -137.51 150.25 47.4 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.92 151.34 25.44 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -138.73 141.75 38.89 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.195 0.598 . . . . 0.0 109.407 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -118.26 168.15 10.87 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.808 0.843 . . . . 0.0 110.805 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -76.67 -11.12 59.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.94 0.496 . . . . 0.0 111.527 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.0 t -151.67 150.18 29.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.157 0.583 . . . . 0.0 109.745 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.03 -23.64 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.05 -25.23 62.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 38.2 m -80.59 -26.31 37.94 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.09 -26.99 35.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.168 0.187 . . . . 0.0 110.521 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -68.06 -36.89 80.6 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.3 ttt-85 -78.62 -25.98 45.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.406 -0.184 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -68.4 -48.42 64.71 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.419 -0.324 . . . . 0.0 111.262 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.39 -13.26 59.92 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.534 0.606 . . . . 0.0 111.532 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.42 -9.67 54.05 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.543 -0.265 . . . . 0.0 111.6 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -123.87 -3.46 8.17 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.7 mt -129.99 -4.31 4.52 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -76.52 133.17 39.83 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 119.072 0.851 . . . . 0.0 109.134 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.59 5.89 69.65 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.803 -0.443 . . . . 0.0 112.327 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.31 174.74 11.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.689 0.744 . . . . 0.0 111.134 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -132.67 144.32 50.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.9 mt . . . . . 0 CA--C 1.53 0.208 0 O-C-N 122.293 -0.254 . . . . 0.0 111.052 -177.269 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.543 0.211 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.8 m -59.82 142.58 53.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.939 0.495 . . . . 0.0 110.117 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 55.0 mt -100.58 154.56 18.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.365 0.602 . . . . 0.0 112.608 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -139.02 137.56 36.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 74.8 mt -134.5 142.68 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 111.382 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.07 167.83 28.49 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.468 1.107 . . . . 0.0 108.526 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.0 144.0 37.07 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.883 -0.511 . . . . 0.0 110.613 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.95 169.79 10.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.659 0.384 . . . . 0.0 110.926 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.1 pttt -84.55 -26.97 0.39 Allowed Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -176.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 52.2 Cg_endo -80.25 166.47 20.44 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 CA-C-N 121.82 1.686 . . . . 0.0 109.784 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.6 p -100.58 -10.88 20.55 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 122.314 -0.241 . . . . 0.0 111.154 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.65 137.07 11.96 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 85.7 mt -85.42 169.77 13.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.728 0.411 . . . . 0.0 110.74 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -132.3 151.14 51.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 93.8 t -138.3 154.01 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 124.072 0.949 . . . . 0.0 108.65 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.81 -23.75 4.99 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -173.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.2 171.07 12.63 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.542 1.137 . . . . 0.0 109.082 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -107.79 117.92 35.37 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.91 0.386 . . . . 0.0 110.593 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -157.99 -172.45 3.92 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.69 1.196 . . . . 0.0 109.309 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -73.59 -5.07 38.01 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -112.15 -20.0 12.07 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.801 0.728 . . . . 0.0 111.671 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.1 t -156.33 139.99 16.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 173.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -149.88 147.78 28.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 110.696 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -123.7 113.03 18.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -91.09 3.25 55.25 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.898 0.879 . . . . 0.0 111.709 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.3 t . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 123.555 0.742 . . . . 0.0 109.904 177.202 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 43.0 p30 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.696 0.284 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.8 p -94.96 16.15 16.9 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.29 0.636 . . . . 0.0 111.953 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.59 146.13 25.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 123.042 0.537 . . . . 0.0 111.108 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.55 164.0 25.85 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.682 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.4 tp -122.98 133.29 54.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.874 1.27 . . . . 0.0 108.099 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -120.74 144.47 48.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.657 0.783 . . . . 0.0 110.168 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 96.4 m -136.61 141.01 43.25 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.3 mp -107.65 136.77 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.09 -26.95 13.51 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -134.22 62.51 56.68 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 123.618 0.767 . . . . 0.0 109.812 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.72 59.7 5.03 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 124.241 3.294 . . . . 0.0 111.477 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 43.8 pt -82.22 -0.83 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 O-C-N 121.884 -0.51 . . . . 0.0 111.565 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -134.79 167.97 19.89 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.061 0.944 . . . . 0.0 109.382 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.2 m -79.72 151.17 30.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.6 mm -133.64 138.66 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.1 p -141.81 174.78 10.26 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.101 0.56 . . . . 0.0 109.598 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.9 p -63.26 -21.69 66.4 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.48 0.312 . . . . 0.0 110.959 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.17 -24.53 40.28 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.488 0.315 . . . . 0.0 110.798 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 87.3 t -82.99 -37.4 13.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.4 mt -76.82 -22.75 53.16 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.155 -0.341 . . . . 0.0 110.75 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -79.17 -34.89 42.73 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.905 -0.497 . . . . 0.0 110.788 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.3 t -75.43 -23.1 56.91 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.114 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.0 pt -90.48 -20.89 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.53 0.605 . . . . 0.0 112.28 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.1 m -98.43 -19.87 17.45 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.866 0.757 . . . . 0.0 112.975 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.486 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 47.6 t30 -64.47 -40.49 51.05 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 90.5 Cg_endo -71.68 -3.36 12.96 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.576 1.517 . . . . 0.0 111.932 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 73.1 m -99.96 -4.5 29.99 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.702 0.401 . . . . 0.0 111.295 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 142.11 174.44 14.76 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.06 109.34 2.15 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.765 2.976 . . . . 0.0 110.981 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.2 t -80.98 149.71 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -115.67 -39.99 3.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.927 0.491 . . . . 0.0 111.337 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -161.27 158.15 26.71 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.1 mt -141.42 145.71 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.269 1.028 . . . . 0.0 109.582 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.68 147.91 20.41 Favored 'Isoleucine or valine' 0 C--O 1.23 0.052 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.0 mt . . . . . 0 N--CA 1.456 -0.14 0 C-N-CA 123.05 0.54 . . . . 0.0 110.515 -173.591 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -153.63 171.49 18.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.694 0.398 . . . . 0.0 110.478 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 81.3 mtp -141.32 150.13 42.1 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 52.0 t -137.97 152.7 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.036 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -137.02 140.99 42.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.406 0.682 . . . . 0.0 109.755 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.66 168.39 10.76 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.006 0.922 . . . . 0.0 110.816 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.49 -10.38 59.69 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.213 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 40.7 t -153.21 151.66 30.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.034 0.534 . . . . 0.0 110.067 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.55 -22.67 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -66.67 -28.5 68.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.993 0.36 . . . . 0.0 110.642 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 75.4 m -87.21 -23.97 24.58 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.358 -0.214 . . . . 0.0 110.757 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.53 -28.86 59.25 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -70.72 -36.91 73.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 40.3 ttm105 -74.89 -32.79 61.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.341 0.256 . . . . 0.0 111.041 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.82 66.04 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.189 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.423 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.5 -11.83 59.94 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.972 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.43 -12.4 46.28 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.603 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 58.7 m -127.57 2.57 6.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 91.1 mt -130.86 -4.99 4.02 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.642 0.655 . . . . 0.0 112.488 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -79.05 131.14 36.17 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.75 7.54 70.03 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.32 177.99 8.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.428 0.691 . . . . 0.0 111.467 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.23 143.99 50.32 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.259 1.023 . . . . 0.0 108.357 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 59.7 mt . . . . . 0 CA--C 1.53 0.196 0 O-C-N 122.403 -0.186 . . . . 0.0 111.272 -177.627 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 76.4 m . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.565 0.222 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 8.9 m -58.12 139.18 55.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.114 0.565 . . . . 0.0 110.105 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 51.1 mt -102.11 155.73 18.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.219 0.533 . . . . 0.0 112.212 -175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -143.4 134.74 26.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 74.2 mt -129.24 149.87 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 121.135 0.493 . . . . 0.0 111.436 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.75 170.27 22.44 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.984 1.314 . . . . 0.0 108.029 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -79.69 144.45 33.69 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 121.865 -0.522 . . . . 0.0 110.337 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.23 164.91 19.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.141 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 40.0 ttpt -72.27 -45.76 10.71 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 79.6 Cg_endo -75.59 176.79 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.605 2.203 . . . . 0.0 110.503 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 63.6 p -106.56 -8.66 16.91 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 122.595 0.358 . . . . 0.0 111.61 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.34 137.42 15.56 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 58.5 mt -90.18 177.64 6.38 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.105 0.562 . . . . 0.0 110.608 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -137.37 154.17 50.06 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.156 -0.34 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.2 t -138.29 153.07 26.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.948 0.899 . . . . 0.0 109.166 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.22 -15.24 4.72 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.617 0.367 . . . . 0.0 111.777 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -166.65 175.82 7.66 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.031 0.933 . . . . 0.0 109.911 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -119.6 101.19 7.75 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -150.47 -169.63 3.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.946 0.898 . . . . 0.0 110.341 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -71.13 -1.38 12.18 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -116.1 -21.25 9.52 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.917 0.781 . . . . 0.0 111.856 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.8 t -157.95 145.69 18.51 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 118.296 0.498 . . . . 0.0 109.999 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -153.15 151.05 29.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.657 0.265 . . . . 0.0 110.697 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.54 139.56 53.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.6 15.72 12.82 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.354 0.661 . . . . 0.0 112.171 -174.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 CA--C 1.533 0.289 0 O-C-N 122.1 -0.375 . . . . 0.0 111.863 -178.737 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 45.9 p30 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 81.2 p -101.18 16.73 24.52 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.536 0.734 . . . . 0.0 111.845 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.6 m -119.7 144.38 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 C-N-CA 123.008 0.523 . . . . 0.0 111.083 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.1 mt -130.94 164.64 24.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.168 0.508 . . . . 0.0 111.384 -174.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 62.8 tp -123.28 134.03 54.12 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.824 1.249 . . . . 0.0 108.316 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -120.52 146.71 46.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.678 0.791 . . . . 0.0 109.816 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 87.3 m -136.53 144.36 44.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.3 mp -110.42 136.43 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.5 mt -98.93 -32.79 11.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -172.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -133.42 69.38 77.22 Favored Pre-proline 0 CA--C 1.532 0.25 0 C-N-CA 123.572 0.749 . . . . 0.0 109.507 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.57 55.7 3.79 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 125.007 3.805 . . . . 0.0 112.26 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.1 -3.68 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 121.753 -0.592 . . . . 0.0 111.38 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -129.86 168.16 17.04 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.703 0.801 . . . . 0.0 109.378 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 82.0 p -80.87 153.01 27.86 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.947 0.403 . . . . 0.0 111.504 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.0 mm -138.68 139.48 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.9 p -144.04 173.14 11.98 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.528 0.731 . . . . 0.0 109.56 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.1 p -63.63 -19.13 64.62 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.355 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -83.24 -26.06 31.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 117.805 0.275 . . . . 0.0 110.591 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.2 t -81.51 -36.24 14.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.37 -25.19 57.47 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.275 -0.266 . . . . 0.0 110.333 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -77.05 -36.32 56.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.086 -0.384 . . . . 0.0 110.966 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -76.46 -20.27 57.19 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.471 0.578 . . . . 0.0 111.336 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.16 -16.69 7.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-N 118.244 0.474 . . . . 0.0 111.78 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.3 m -97.31 -20.92 17.53 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.761 0.71 . . . . 0.0 112.155 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.2 t-20 -61.41 -43.73 90.26 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 98.7 Cg_endo -72.43 -10.59 25.65 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.633 1.555 . . . . 0.0 111.633 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 74.7 m -94.42 -21.59 18.83 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.797 0.271 . . . . 0.0 111.397 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 167.8 168.54 30.09 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.98 99.47 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.297 3.331 . . . . 0.0 110.902 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.3 t -75.52 144.21 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -113.02 -33.65 5.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.456 0.302 . . . . 0.0 111.075 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -163.73 157.87 19.6 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 117.966 0.348 . . . . 0.0 111.574 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.0 mt -143.37 142.74 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.289 1.036 . . . . 0.0 109.715 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.1 m -138.43 156.61 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.055 0.542 . . . . 0.0 109.588 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 66.0 mt . . . . . 0 C--O 1.231 0.098 0 C-N-CA 122.89 0.476 . . . . 0.0 110.403 -175.739 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.996 0.427 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.44 169.64 20.4 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.139 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 78.2 mtp -138.86 148.98 44.37 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.7 t -136.37 151.42 28.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 122.878 0.471 . . . . 0.0 109.842 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -137.08 138.58 40.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.25 0.62 . . . . 0.0 109.745 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.07 170.36 8.92 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.141 0.976 . . . . 0.0 110.497 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.05 -16.24 59.97 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.565 0.346 . . . . 0.0 111.528 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.7 t -150.99 154.46 37.12 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.729 0.412 . . . . 0.0 110.579 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.24 -26.94 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.022 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -67.08 -29.9 69.79 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.059 -0.401 . . . . 0.0 110.079 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.2 m -79.29 -26.68 42.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.411 0.285 . . . . 0.0 110.501 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.52 -26.29 38.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.396 -0.19 . . . . 0.0 110.685 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -69.54 -36.62 76.53 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -77.82 -26.6 49.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.307 0.243 . . . . 0.0 110.798 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.5 -53.82 30.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.141 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.61 -14.42 60.38 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.814 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.53 -10.65 55.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.096 -0.378 . . . . 0.0 111.45 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.6 m -123.78 -0.35 8.55 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 94.0 mt -131.1 -6.2 3.89 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -76.35 131.24 39.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.917 0.78 . . . . 0.0 109.274 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.42 7.51 73.21 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.121 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.99 174.05 12.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.864 0.832 . . . . 0.0 111.337 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -132.62 145.65 51.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.8 mt . . . . . 0 CA--C 1.531 0.244 0 C-N-CA 122.097 0.159 . . . . 0.0 111.124 -177.246 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 120.586 0.232 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.8 m -59.21 140.57 55.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.978 0.511 . . . . 0.0 110.09 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 47.4 mt -98.9 153.62 18.67 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.126 0.571 . . . . 0.0 111.94 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -140.43 134.8 31.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 171.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.424 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 81.6 mt -129.19 149.34 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.209 0.528 . . . . 0.0 111.286 -175.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.74 169.16 24.99 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.865 1.266 . . . . 0.0 108.199 173.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -79.57 142.01 36.08 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.756 -0.59 . . . . 0.0 110.542 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.43 164.11 20.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -81.78 -26.12 0.41 Allowed Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -175.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 44.0 Cg_endo -81.51 177.69 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 121.767 1.667 . . . . 0.0 109.876 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 68.5 p -106.53 -5.56 18.71 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.611 0.364 . . . . 0.0 110.902 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.9 mmm-85 -153.81 154.81 34.67 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.901 0.88 . . . . 0.0 110.295 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.68 168.56 10.32 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.644 0.778 . . . . 0.0 109.47 173.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -140.16 166.63 24.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.935 0.398 . . . . 0.0 111.494 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.5 t -138.09 155.27 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.144 0.978 . . . . 0.0 108.723 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.81 -26.3 4.87 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.299 0.24 . . . . 0.0 111.392 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.76 168.87 17.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.451 1.101 . . . . 0.0 109.08 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -106.44 117.34 33.78 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.931 0.396 . . . . 0.0 110.963 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -157.41 -175.17 5.25 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.713 1.205 . . . . 0.0 109.496 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -71.24 -3.42 20.23 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -173.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -118.08 -14.3 9.94 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.711 0.687 . . . . 0.0 111.968 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.9 t -155.98 135.2 12.18 Favored 'General case' 0 C--O 1.228 -0.043 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -153.2 147.75 26.09 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.872 0.368 . . . . 0.0 111.359 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.68 135.57 55.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.452 0.701 . . . . 0.0 109.509 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -116.9 13.66 14.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.4 0.68 . . . . 0.0 112.503 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.53 0.2 0 CA-C-N 118.315 0.507 . . . . 0.0 112.342 -177.544 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.2 p30 . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.6 p -96.51 12.25 32.15 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.138 0.575 . . . . 0.0 111.826 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.72 142.46 25.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 122.874 0.469 . . . . 0.0 111.194 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.3 mt -129.19 164.0 24.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.113 0.565 . . . . 0.0 111.454 -175.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.7 tp -123.89 132.69 53.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.716 1.206 . . . . 0.0 108.171 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -119.43 144.25 47.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.729 0.811 . . . . 0.0 109.805 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 91.7 m -139.06 144.3 38.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.9 mp -106.85 134.36 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.66 -36.55 15.18 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -173.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -131.54 63.5 69.72 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 123.606 0.762 . . . . 0.0 109.948 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.84 103.24 1.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.849 2.366 . . . . 0.0 110.88 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.9 pt -128.65 0.94 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 122.879 0.472 . . . . 0.0 111.384 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -130.1 166.52 20.02 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.954 0.902 . . . . 0.0 109.191 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.2 m -74.98 147.8 40.5 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.719 0.295 . . . . 0.0 111.56 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.1 mm -137.55 132.88 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.3 p -142.87 176.36 9.13 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 122.896 0.479 . . . . 0.0 110.299 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 41.5 p -63.31 -22.8 67.1 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.193 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -80.5 -26.14 38.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.295 0.238 . . . . 0.0 110.821 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 87.6 t -84.41 -37.59 12.9 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.17 -24.93 54.81 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.294 -0.254 . . . . 0.0 111.093 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -77.62 -37.26 50.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.815 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.4 t -75.74 -19.58 58.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.219 0.463 . . . . 0.0 111.374 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -94.92 -15.67 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.339 0.518 . . . . 0.0 111.858 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.5 m -97.41 -22.78 16.4 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.697 0.68 . . . . 0.0 111.864 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 26.9 t-20 -59.82 -43.04 94.07 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 93.9 Cg_endo -72.22 -9.19 24.05 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.985 1.79 . . . . 0.0 111.928 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.4 m -96.09 -20.75 18.41 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 122.063 -0.398 . . . . 0.0 111.317 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 162.94 169.75 26.82 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.84 115.76 3.76 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.571 2.847 . . . . 0.0 111.039 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.96 147.34 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -111.63 -39.56 4.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.986 0.514 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -160.83 159.08 29.46 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.56 0.618 . . . . 0.0 112.177 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.6 mt -142.53 146.96 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.623 0.769 . . . . 0.0 110.377 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.61 144.25 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 123.372 0.669 . . . . 0.0 109.587 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 123.493 0.717 . . . . 0.0 109.727 -178.967 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 . . . . . 0 CA--C 1.528 0.134 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.13 171.04 21.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.796 0.439 . . . . 0.0 110.071 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.2 mtp -138.24 151.29 47.51 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.1 t -141.13 151.93 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 122.847 0.459 . . . . 0.0 109.846 -175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -136.94 141.45 42.65 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -115.8 168.32 10.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.471 0.709 . . . . 0.0 110.802 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -74.51 -13.83 60.73 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.761 0.425 . . . . 0.0 111.341 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 37.7 t -152.31 153.82 34.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.839 0.456 . . . . 0.0 109.938 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.8 -25.19 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -65.39 -27.59 68.66 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.908 -0.495 . . . . 0.0 109.742 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 40.4 m -82.51 -26.85 32.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.2 0.2 . . . . 0.0 110.712 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.76 -25.4 41.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -70.73 -37.53 73.51 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -77.88 -24.83 48.35 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 122.076 0.15 . . . . 0.0 110.779 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.43 -54.6 18.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.325 -0.234 . . . . 0.0 110.935 -178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.68 -15.82 60.26 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.708 -179.383 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.14 -11.11 58.24 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.115 -0.366 . . . . 0.0 111.563 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.0 m -124.45 -0.71 8.14 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 87.2 mt -130.17 -4.82 4.4 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -77.0 130.24 37.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.461 -0.774 . . . . 0.0 109.176 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.68 6.2 76.51 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.805 -0.442 . . . . 0.0 112.052 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.26 176.29 7.52 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.673 0.737 . . . . 0.0 111.488 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -140.11 150.96 44.93 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.57 0.748 . . . . 0.0 109.364 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.3 mt . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 122.407 0.283 . . . . 0.0 111.442 -176.106 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 79.6 m . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.68 140.72 56.21 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.962 0.505 . . . . 0.0 109.777 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 62.2 mt -93.52 155.2 17.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.206 0.527 . . . . 0.0 111.786 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -144.3 135.6 25.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 172.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 85.2 mt -130.17 149.7 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 121.0 0.428 . . . . 0.0 111.174 -175.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.35 168.77 26.0 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.934 1.294 . . . . 0.0 108.211 173.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -80.39 144.05 33.0 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.679 -0.638 . . . . 0.0 110.578 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.66 165.46 16.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.669 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -83.18 -25.79 0.38 Allowed Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 43.7 Cg_endo -81.43 179.46 5.79 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.836 1.691 . . . . 0.0 109.858 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 65.1 p -108.57 -4.65 17.0 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.734 0.414 . . . . 0.0 110.728 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.3 mmm-85 -153.8 153.94 33.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.039 0.936 . . . . 0.0 110.099 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 83.9 mt -115.21 168.91 9.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.298 0.639 . . . . 0.0 109.514 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -141.13 158.49 43.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.286 0.234 . . . . 0.0 110.813 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.37 156.22 29.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 124.215 1.006 . . . . 0.0 109.097 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -124.61 -15.73 6.47 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -173.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -162.49 175.16 11.77 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.698 0.799 . . . . 0.0 110.293 -176.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -121.09 95.88 4.87 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.38 0.672 . . . . 0.0 109.577 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -149.42 -170.69 3.7 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.726 0.81 . . . . 0.0 110.649 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -70.91 -5.04 27.73 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -109.0 -24.21 11.32 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.649 0.658 . . . . 0.0 111.392 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.2 t -159.26 143.33 15.11 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -150.91 150.23 30.6 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.25 137.57 52.06 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -113.81 5.17 16.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.379 0.671 . . . . 0.0 112.519 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.531 0.235 0 C-N-CA 122.755 0.422 . . . . 0.0 110.921 178.693 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 119.901 -0.095 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -148.01 159.44 43.89 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.28 153.19 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 122.991 0.516 . . . . 0.0 110.584 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.5 p -78.39 1.84 20.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.016 0.526 . . . . 0.0 112.21 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -139.2 68.73 40.83 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 123.8 0.84 . . . . 0.0 109.02 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.1 171.39 17.67 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.108 3.205 . . . . 0.0 111.127 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -70.45 173.97 39.29 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 112.363 -0.295 . . . . 0.0 112.363 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -146.39 170.23 17.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.195 0.598 . . . . 0.0 109.727 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 29.2 m 54.95 21.45 3.72 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.658 0.783 . . . . 0.0 112.819 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.0 t0 50.68 32.2 6.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.921 0.888 . . . . 0.0 111.983 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 26.3 t70 53.38 23.93 3.62 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.389 1.076 . . . . 0.0 112.825 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 38.5 m 56.46 13.74 1.42 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.451 1.1 . . . . 0.0 113.184 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 54.16 -173.32 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.861 1.264 . . . . 0.0 113.037 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 47.3 t -147.76 158.35 43.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.459 0.704 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.1 p -147.16 -54.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.542 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -166.21 166.13 17.09 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.395 0.678 . . . . 0.0 110.447 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.0 p -94.87 10.75 34.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.173 0.589 . . . . 0.0 111.258 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.35 139.47 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.683 0.793 . . . . 0.0 110.664 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 99.1 mt -128.52 160.35 32.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.386 0.612 . . . . 0.0 111.255 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.4 tp -120.65 133.36 55.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.99 1.316 . . . . 0.0 108.042 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -119.75 144.71 47.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.652 0.781 . . . . 0.0 109.912 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 99.0 m -139.52 142.83 37.24 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.4 mp -105.38 135.78 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.86 -35.79 12.54 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -130.79 62.84 67.58 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.429 0.692 . . . . 0.0 110.329 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.45 103.25 1.08 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.795 2.33 . . . . 0.0 110.989 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.8 pt -128.83 2.71 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.742 0.417 . . . . 0.0 111.614 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -132.31 167.47 19.81 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.737 0.815 . . . . 0.0 109.628 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.5 m -74.68 146.73 42.08 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.65 0.262 . . . . 0.0 111.133 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mm -138.11 136.02 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.5 p -144.05 174.21 11.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.463 0.705 . . . . 0.0 109.538 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.2 p -63.51 -19.16 64.54 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.507 0.323 . . . . 0.0 111.153 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -83.4 -25.96 30.84 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.745 0.248 . . . . 0.0 111.042 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.4 t -81.67 -36.58 14.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.76 -26.32 57.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.217 -0.302 . . . . 0.0 110.295 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -75.63 -36.64 60.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.868 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.1 t -77.13 -17.69 58.45 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.312 0.505 . . . . 0.0 111.647 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.77 -13.9 7.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.148 0.431 . . . . 0.0 111.877 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 83.6 m -99.31 -24.97 14.64 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.765 0.711 . . . . 0.0 112.139 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.471 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 47.9 t30 -63.93 -39.16 42.75 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 95.1 Cg_endo -72.89 -5.81 17.87 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.437 1.425 . . . . 0.0 111.729 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 73.0 m -102.54 -10.52 19.25 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.806 0.442 . . . . 0.0 111.105 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 156.89 166.01 15.81 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.71 112.75 2.97 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.61 2.873 . . . . 0.0 110.658 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.25 152.33 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -117.18 -37.82 3.48 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.617 0.367 . . . . 0.0 110.95 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -163.16 157.32 20.37 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.2 0.455 . . . . 0.0 112.186 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.6 mt -143.67 146.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.315 1.046 . . . . 0.0 109.913 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.17 150.9 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.2 mt -130.55 149.35 33.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.966 0.506 . . . . 0.0 110.742 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -138.51 134.57 34.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.737 0.815 . . . . 0.0 109.441 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.25 24.95 1.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.29 -20.13 63.9 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -152.18 120.63 6.4 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 61.96 -154.67 39.69 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.0 t -139.16 125.99 24.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -145.85 164.44 31.92 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.324 0.649 . . . . 0.0 110.236 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -154.24 171.6 18.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.556 0.342 . . . . 0.0 110.418 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.4 mtp -138.45 147.73 43.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.2 t -137.81 151.75 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 123.149 0.58 . . . . 0.0 109.786 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -141.2 141.49 34.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.297 0.639 . . . . 0.0 109.88 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -118.0 168.73 10.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.95 0.9 . . . . 0.0 110.981 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.01 -14.41 60.22 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.979 0.512 . . . . 0.0 111.357 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.4 t -150.75 152.15 33.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.939 0.496 . . . . 0.0 109.998 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.52 -23.68 30.22 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.85 -29.09 70.03 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 27.3 m -83.87 -28.0 28.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.573 0.349 . . . . 0.0 110.391 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.23 -27.02 47.61 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -69.96 -38.92 76.25 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -76.55 -27.95 56.1 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.15 -53.83 39.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.399 -0.188 . . . . 0.0 110.968 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.433 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.57 -14.38 60.01 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.999 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.05 -12.58 57.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.014 0.37 . . . . 0.0 111.947 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -128.75 2.31 5.44 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 76.5 mt -128.45 -4.94 5.37 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.472 0.578 . . . . 0.0 112.363 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.4 132.85 37.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.97 7.94 72.08 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.69 174.17 11.62 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.574 0.687 . . . . 0.0 111.018 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -132.15 148.62 52.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 49.9 mt -100.62 -16.05 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.91 24.32 9.05 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.998 0.519 . . . . 0.0 111.551 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 24.7 m 57.52 15.23 2.66 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.077 0.951 . . . . 0.0 112.209 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 173.38 143.67 4.36 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 68.3 m 56.19 179.38 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.736 0.814 . . . . 0.0 111.906 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.0 m 49.94 33.85 7.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.85 0.46 . . . . 0.0 110.971 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.94 140.53 56.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.28 0.632 . . . . 0.0 110.051 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.2 154.86 16.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.007 0.523 . . . . 0.0 111.661 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -143.24 124.9 14.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.433 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 71.6 mt -126.44 146.2 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.147 0.499 . . . . 0.0 111.715 -173.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -156.35 170.73 21.63 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.952 1.301 . . . . 0.0 108.656 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.48 145.74 33.09 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 121.798 -0.564 . . . . 0.0 110.427 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -89.68 166.41 13.61 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.2 pttt -79.02 -28.32 0.55 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.4 Cg_endo -82.01 163.2 18.05 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 121.95 1.732 . . . . 0.0 110.442 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.5 p -97.24 -7.48 32.16 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 122.275 0.23 . . . . 0.0 110.992 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -152.82 148.88 27.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.818 0.847 . . . . 0.0 110.187 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 67.9 mt -107.48 172.26 6.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.586 0.754 . . . . 0.0 109.638 173.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -141.36 157.0 45.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.711 0.404 . . . . 0.0 110.22 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 79.9 t -135.59 152.36 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -119.93 -22.85 6.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.386 0.274 . . . . 0.0 111.148 -174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -165.38 173.52 11.05 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.712 0.805 . . . . 0.0 109.971 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -117.16 111.45 19.49 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.764 0.316 . . . . 0.0 110.463 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -156.24 -171.69 3.81 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.98 1.312 . . . . 0.0 109.56 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -73.95 -0.49 16.33 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -109.69 -27.35 9.39 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.45 0.568 . . . . 0.0 111.05 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.9 t -156.09 144.33 19.9 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.155 0.582 . . . . 0.0 109.584 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -150.31 150.73 31.88 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.657 0.265 . . . . 0.0 110.634 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -126.5 137.55 53.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.071 0.549 . . . . 0.0 109.765 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.96 11.76 13.51 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.594 0.758 . . . . 0.0 112.351 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.0 t -130.87 -7.32 3.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.983 0.356 . . . . 0.0 111.942 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -64.87 150.79 94.33 Favored Pre-proline 0 CA--C 1.532 0.265 0 O-C-N 121.685 -0.634 . . . . 0.0 109.926 174.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.2 0.36 10.08 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.916 3.077 . . . . 0.0 111.3 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -137.79 39.38 2.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.059 0.944 . . . . 0.0 110.127 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -73.68 0.36 13.13 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 26.8 p 56.82 178.23 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.539 1.536 . . . . 0.0 113.559 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -177.89 -174.92 44.64 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -137.24 8.61 2.93 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.861 0.464 . . . . 0.0 111.772 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 117.476 -1.736 . . . . 0.0 110.861 -179.797 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -137.76 164.27 29.3 Favored 'General case' 0 C--N 1.338 0.066 0 C-N-CA 123.466 0.706 . . . . 0.0 111.032 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 19.3 tt -130.43 10.64 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.268 1.027 . . . . 0.0 110.848 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.3 m 59.53 9.64 1.61 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.007 1.323 . . . . 0.0 114.2 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' ' 179' ' ' PRO . 33.6 ptt-85 -149.77 43.54 0.28 Allowed Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 123.462 0.705 . . . . 0.0 112.027 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 178' ' ' ARG . 90.0 Cg_endo -72.02 -17.31 28.52 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.93 2.42 . . . . 0.0 111.588 -176.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 151.25 -164.72 30.19 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -81.37 160.45 24.1 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.572 0.349 . . . . 0.0 110.551 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 t 57.35 -166.49 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.607 0.763 . . . . 0.0 112.095 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 185' ' ' SER . 27.1 t0 62.62 163.96 0.1 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.48 1.512 . . . . 0.0 112.653 -175.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 61.08 -22.35 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.334 1.854 . . . . 0.0 114.003 -173.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.446 ' H ' ' C ' ' A' ' 183' ' ' ASP . 26.5 m 48.38 23.99 0.66 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.859 1.263 . . . . 0.0 113.801 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 50.76 27.11 2.87 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.981 0.912 . . . . 0.0 112.218 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.3 t -66.95 149.51 50.52 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.573 0.749 . . . . 0.0 112.029 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 65.3 t -140.98 -67.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -162.1 164.36 28.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.857 0.863 . . . . 0.0 110.12 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.4 p -92.77 15.79 13.83 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.595 0.758 . . . . 0.0 112.472 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.47 145.9 24.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 122.884 0.474 . . . . 0.0 110.893 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.64 165.02 23.71 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.29 0.567 . . . . 0.0 111.29 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.1 tp -127.69 131.26 49.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -117.0 144.31 44.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.826 0.851 . . . . 0.0 109.443 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.1 m -135.91 141.72 44.59 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 196' ' ' ILE . 1.9 mp -103.91 136.19 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.6 mt -92.86 -36.55 12.76 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -131.67 64.87 74.39 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.467 0.707 . . . . 0.0 110.096 -177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.85 104.2 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.571 2.181 . . . . 0.0 111.075 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.2 pt -130.13 1.44 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.073 0.549 . . . . 0.0 111.457 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -131.5 167.32 19.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.849 0.86 . . . . 0.0 109.197 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 27.0 t -76.53 149.48 36.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.416 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.3 mm -138.8 133.3 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.6 p -145.07 176.17 9.7 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 123.388 0.675 . . . . 0.0 110.136 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 35.5 p -61.33 -28.15 69.01 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.383 -0.198 . . . . 0.0 110.936 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.08 -22.35 58.36 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.699 0.399 . . . . 0.0 111.631 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.0 t -89.62 -38.0 10.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 84.3 mt -77.76 -23.39 49.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.96 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -78.3 -34.54 48.71 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.017 -0.427 . . . . 0.0 110.711 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.9 t -75.59 -23.23 56.45 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.217 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.1 pt -88.91 -22.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.203 0.456 . . . . 0.0 111.755 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.9 m -96.21 -20.12 18.81 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.779 0.718 . . . . 0.0 112.507 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.482 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.84 -43.5 87.54 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 95.8 Cg_endo -72.13 -11.04 26.74 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.874 1.716 . . . . 0.0 111.594 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.1 m -90.56 -23.04 21.0 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.232 0.469 . . . . 0.0 111.121 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.26 170.97 28.91 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -68.38 111.03 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.766 2.978 . . . . 0.0 110.71 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -83.49 152.37 3.86 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -115.52 -35.53 4.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.815 0.446 . . . . 0.0 110.693 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -164.31 160.35 20.85 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.129 0.422 . . . . 0.0 111.772 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.1 mt -144.35 146.89 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.074 0.95 . . . . 0.0 109.986 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.1 144.61 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 123.528 0.731 . . . . 0.0 109.408 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.0 mp -120.91 151.01 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 C-N-CA 123.767 0.827 . . . . 0.0 110.386 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.65 138.56 51.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 173.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -140.86 21.9 2.29 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -115.84 140.56 49.11 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 53.98 18.68 1.74 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.014 0.926 . . . . 0.0 112.266 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 149.51 -173.36 29.33 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.2 t -135.45 124.59 40.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 CA-C-N 117.505 0.652 . . . . 0.0 109.605 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -148.31 168.96 21.21 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 124.026 0.931 . . . . 0.0 109.463 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.15 168.65 26.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.418 0.287 . . . . 0.0 110.416 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 87.8 mtp -138.43 151.43 47.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.31 150.15 21.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 122.829 0.452 . . . . 0.0 109.898 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -132.44 141.78 48.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.746 0.818 . . . . 0.0 108.794 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -118.02 167.98 10.96 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.907 0.883 . . . . 0.0 110.916 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.24 -15.5 60.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.738 0.415 . . . . 0.0 111.135 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 93.4 p -152.08 158.34 42.87 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.039 0.447 . . . . 0.0 110.459 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.94 -26.68 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.388 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -72.63 -22.2 60.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.335 0.516 . . . . 0.0 110.534 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.8 m -80.56 -28.3 37.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.02 -26.19 39.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.354 0.262 . . . . 0.0 110.469 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -69.71 -36.91 76.32 Favored 'General case' 0 N--CA 1.458 -0.05 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -79.67 -24.94 41.46 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.16 0.184 . . . . 0.0 110.762 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.68 -52.79 33.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.975 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.412 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.92 -16.08 60.08 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.795 0.725 . . . . 0.0 111.662 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.8 58.74 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.702 0.228 . . . . 0.0 111.6 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.8 t -126.73 0.52 6.75 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.0 mt -130.68 -4.27 4.14 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -78.14 130.91 36.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.884 0.765 . . . . 0.0 109.083 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.38 8.66 76.02 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.25 175.38 9.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.666 0.733 . . . . 0.0 111.284 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -139.8 149.14 43.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.569 0.748 . . . . 0.0 109.01 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.4 mt -111.13 -19.02 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 122.491 0.317 . . . . 0.0 111.243 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -125.91 23.14 7.28 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.72 0.408 . . . . 0.0 111.66 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.2 m 55.38 20.12 3.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.618 0.767 . . . . 0.0 112.41 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 169.17 136.57 2.09 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 71.9 m 57.27 178.81 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.865 0.866 . . . . 0.0 111.941 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.8 m 53.02 29.8 8.53 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.924 0.489 . . . . 0.0 111.639 -174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.39 142.69 51.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.385 0.674 . . . . 0.0 109.987 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 53.9 mt -97.76 154.99 17.24 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.15 0.5 . . . . 0.0 111.87 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -146.25 132.55 19.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.412 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 76.6 mt -129.58 149.12 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 121.338 0.589 . . . . 0.0 112.012 -172.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.74 172.3 16.89 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.356 1.462 . . . . 0.0 108.428 174.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -83.75 143.92 29.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.948 -0.47 . . . . 0.0 110.445 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.68 170.29 12.65 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.41 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.441 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -84.82 -26.35 0.37 Allowed Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 49.4 Cg_endo -82.5 -177.84 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.023 1.815 . . . . 0.0 110.033 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.0 p -108.23 -7.43 15.98 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 122.196 -0.315 . . . . 0.0 111.422 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.75 168.47 27.07 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.138 0.975 . . . . 0.0 109.665 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 90.4 mt -124.73 174.37 7.94 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.475 0.71 . . . . 0.0 109.739 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -140.79 159.77 41.49 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.835 0.35 . . . . 0.0 110.929 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.8 t -135.69 153.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 124.277 1.031 . . . . 0.0 108.744 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -120.58 -26.38 5.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.614 0.366 . . . . 0.0 111.493 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.12 169.89 18.71 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.729 1.212 . . . . 0.0 108.865 176.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -107.08 117.43 34.04 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.782 0.325 . . . . 0.0 110.616 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -158.25 -172.57 3.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.624 1.169 . . . . 0.0 109.755 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -71.49 -4.94 29.46 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -114.16 -18.9 11.53 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.664 0.665 . . . . 0.0 111.728 -178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.0 t -156.63 139.38 15.14 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -152.49 149.56 28.67 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.703 0.287 . . . . 0.0 110.666 -176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -124.95 138.2 54.24 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.176 0.59 . . . . 0.0 109.479 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -118.37 11.17 12.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.3 0.64 . . . . 0.0 112.253 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.7 t -132.41 -7.82 3.31 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.231 0.469 . . . . 0.0 112.22 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -79.79 155.68 75.47 Favored Pre-proline 0 CA--C 1.533 0.315 0 O-C-N 121.8 -0.563 . . . . 0.0 110.792 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.84 -5.13 16.63 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.213 2.609 . . . . 0.0 112.201 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -77.82 -10.22 59.45 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.106 -0.371 . . . . 0.0 111.239 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 44.0 tp -90.67 -12.34 37.06 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.509 0.324 . . . . 0.0 110.688 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 35.1 m -67.57 -9.78 45.87 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.94 -0.475 . . . . 0.0 111.686 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -80.62 -5.18 90.08 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -134.99 -14.81 2.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.493 0.646 . . . . 0.0 111.445 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.368 -1.795 . . . . 0.0 111.017 179.489 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -141.1 172.75 12.25 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 123.555 0.742 . . . . 0.0 110.79 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.423 HG23 ' H ' ' A' ' 178' ' ' ARG . 8.6 tp -78.9 6.58 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.626 1.17 . . . . 0.0 111.271 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.5 m 59.1 7.99 0.95 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.887 1.275 . . . . 0.0 113.49 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.423 ' H ' HG23 ' A' ' 176' ' ' ILE . 43.3 ttt85 -152.91 61.91 4.01 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 123.407 0.683 . . . . 0.0 109.202 174.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -69.56 170.05 17.24 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.826 3.017 . . . . 0.0 111.336 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 100.3 -164.23 19.14 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -124.05 157.85 33.55 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.144 0.578 . . . . 0.0 110.881 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 20.3 m 56.63 -174.79 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.491 1.117 . . . . 0.0 113.251 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 29.9 t70 61.91 137.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.071 1.748 . . . . 0.0 114.15 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 t70 51.13 16.94 0.41 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.949 1.299 . . . . 0.0 113.359 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 54.0 m 53.81 14.16 0.62 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.121 0.968 . . . . 0.0 112.831 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 48.6 -156.25 0.07 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.352 1.061 . . . . 0.0 111.776 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.6 t -147.43 151.76 36.99 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.063 0.545 . . . . 0.0 109.58 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.8 p -152.69 -51.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.294 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -165.87 170.23 14.04 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.012 0.525 . . . . 0.0 110.598 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.5 p -100.3 15.59 27.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.686 0.795 . . . . 0.0 111.788 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.11 143.94 27.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.011 0.524 . . . . 0.0 110.858 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.3 mt -128.79 164.92 21.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.212 0.53 . . . . 0.0 111.783 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.1 tp -123.87 134.43 53.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.783 1.233 . . . . 0.0 107.939 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -121.75 150.85 41.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.029 0.932 . . . . 0.0 109.618 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 94.6 m -142.63 146.71 34.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 42.9 mt -119.26 136.99 54.65 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.05 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 50.2 mt -102.91 -23.69 13.72 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -173.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -131.7 62.19 62.91 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.39 0.676 . . . . 0.0 110.102 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.31 40.27 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 125.073 3.849 . . . . 0.0 112.632 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 38.0 pt -77.08 -0.7 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.887 -0.508 . . . . 0.0 111.888 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -130.16 166.05 21.05 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.729 0.812 . . . . 0.0 109.655 176.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.2 m -70.57 146.56 50.04 Favored 'General case' 0 C--N 1.335 -0.048 0 CA-C-O 120.73 0.3 . . . . 0.0 111.526 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.8 mm -137.33 134.6 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.9 p -146.87 173.88 12.01 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.368 0.667 . . . . 0.0 109.236 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.3 p -63.74 -19.56 65.06 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 122.333 0.253 . . . . 0.0 111.529 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.15 -24.37 37.65 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.843 0.292 . . . . 0.0 110.849 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.0 t -82.48 -37.62 14.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.58 -24.25 58.88 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.212 -0.305 . . . . 0.0 110.614 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -78.31 -36.23 46.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.229 -0.294 . . . . 0.0 111.177 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.7 t -74.97 -21.32 59.23 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.145 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 39.5 pt -91.73 -21.9 6.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 CA-C-N 118.136 0.425 . . . . 0.0 112.058 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.2 m -95.67 -24.2 16.66 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 50.4 t30 -63.88 -40.57 56.49 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 89.4 Cg_endo -73.14 -4.5 15.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.754 1.636 . . . . 0.0 111.821 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.5 m -101.67 -10.42 20.03 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.868 0.467 . . . . 0.0 111.199 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 155.53 164.66 13.38 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.86 109.59 1.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.729 2.953 . . . . 0.0 111.016 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.96 151.88 4.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -117.39 -38.37 3.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.612 0.365 . . . . 0.0 111.086 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -162.98 157.95 21.62 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.01 0.368 . . . . 0.0 111.424 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 54.1 mt -143.15 141.93 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.762 0.825 . . . . 0.0 109.419 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 20.3 m -136.2 151.66 29.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 56.3 mt -133.91 150.24 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 122.796 0.438 . . . . 0.0 110.138 -175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.2 121.72 22.93 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -142.63 18.3 2.01 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 122.798 0.439 . . . . 0.0 111.984 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.644 ' HE2' ' HA ' ' A' ' 226' ' ' LYS . 0.7 OUTLIER -76.84 -24.2 52.71 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -150.97 125.56 9.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 61.61 -157.43 33.85 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.94 118.85 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 117.475 0.637 . . . . 0.0 110.674 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -148.4 165.15 31.98 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 123.395 0.678 . . . . 0.0 110.188 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.83 171.4 18.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.843 0.457 . . . . 0.0 109.985 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.0 mtp -141.47 150.53 42.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.2 t -136.71 152.41 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 C-N-CA 122.928 0.491 . . . . 0.0 109.829 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -137.42 140.84 41.55 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.461 0.704 . . . . 0.0 109.577 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -120.97 169.24 10.66 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 123.879 0.871 . . . . 0.0 111.079 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.04 -16.07 61.06 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.852 0.461 . . . . 0.0 111.362 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 90.7 p -153.02 159.71 42.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.974 0.416 . . . . 0.0 110.664 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.38 -26.62 31.84 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 O-C-N 122.269 -0.269 . . . . 0.0 110.365 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -65.49 -29.33 69.97 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 122.077 -0.39 . . . . 0.0 110.083 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.7 m -80.14 -27.33 39.08 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.704 0.402 . . . . 0.0 110.641 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.14 -25.27 37.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.276 -0.265 . . . . 0.0 110.527 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -70.89 -35.99 72.56 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -77.05 -27.79 54.54 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.335 -0.228 . . . . 0.0 110.487 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.12 -51.5 57.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.361 -0.212 . . . . 0.0 111.056 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -13.32 59.92 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.863 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -84.89 -10.79 56.76 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.924 0.329 . . . . 0.0 111.591 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.6 m -124.73 -2.47 7.84 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.51 -7.4 4.67 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -78.34 133.02 37.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.889 0.768 . . . . 0.0 109.099 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.16 4.78 64.3 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.79 179.67 7.41 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 117.641 0.72 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.48 161.45 37.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.723 0.809 . . . . 0.0 108.995 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.9 mt -113.01 -23.28 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 119.783 -0.151 . . . . 0.0 111.337 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -137.75 82.55 1.93 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.191 0.45 . . . . 0.0 111.674 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.9 m 49.26 45.71 23.29 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 94.19 -0.64 66.54 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.591 -0.561 . . . . 0.0 112.464 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 60.9 m -102.66 166.81 10.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.802 0.801 . . . . 0.0 109.802 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.5 m 52.55 43.13 31.44 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.558 0.343 . . . . 0.0 110.778 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.9 m -56.27 138.17 50.95 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.919 0.487 . . . . 0.0 109.901 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.3 mt -105.21 153.44 21.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.043 0.537 . . . . 0.0 112.069 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -141.59 125.12 16.72 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 77.4 mt -124.25 147.6 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-O 121.136 0.494 . . . . 0.0 111.498 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -155.89 170.55 21.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.054 1.342 . . . . 0.0 108.427 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -80.39 146.35 31.54 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.861 -0.524 . . . . 0.0 110.51 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.26 165.92 15.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.489 0.316 . . . . 0.0 110.272 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -82.9 -26.55 0.4 Allowed Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 43.2 Cg_endo -81.7 177.74 7.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.848 1.696 . . . . 0.0 109.593 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 59.2 p -106.38 -5.17 19.2 Favored 'General case' 0 CA--C 1.527 0.084 0 O-C-N 122.285 -0.26 . . . . 0.0 110.985 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.0 mmm-85 -154.48 155.86 35.66 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.118 0.967 . . . . 0.0 110.235 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -118.47 168.64 10.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.173 0.989 . . . . 0.0 109.716 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -140.79 161.38 37.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.329 0.252 . . . . 0.0 110.878 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.15 153.92 36.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 124.164 0.986 . . . . 0.0 109.111 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -123.83 -21.28 5.19 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.453 ' HE3' ' CG2' ' A' ' 279' ' ' THR . 0.3 OUTLIER -164.95 173.08 12.0 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.678 1.191 . . . . 0.0 109.021 176.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -113.05 113.64 25.73 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -154.93 -172.13 4.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.944 1.297 . . . . 0.0 109.387 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -71.65 -4.97 30.24 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -115.86 -14.5 11.32 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.649 0.659 . . . . 0.0 111.899 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' THR . . . . . 0.453 ' CG2' ' HE3' ' A' ' 274' ' ' LYS . 5.0 t -157.09 138.58 13.94 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -152.91 150.24 29.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.252 -0.28 . . . . 0.0 110.894 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -125.43 137.52 54.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.133 0.573 . . . . 0.0 109.556 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -117.15 7.27 12.97 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.312 0.645 . . . . 0.0 112.084 -175.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t -132.1 -7.13 3.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.569 0.348 . . . . 0.0 111.837 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -68.9 121.6 82.08 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.06 -11.27 28.88 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.226 2.617 . . . . 0.0 112.163 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -99.44 5.09 46.36 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.087 0.555 . . . . 0.0 110.955 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 16.4 tp 51.49 25.19 2.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.951 0.9 . . . . 0.0 111.935 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 17.1 m 54.47 18.44 1.96 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.72 1.208 . . . . 0.0 113.449 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 68.77 -169.71 41.39 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 122.879 0.276 . . . . 0.0 112.418 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -140.81 9.92 2.19 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.98 0.512 . . . . 0.0 111.6 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.325 -1.819 . . . . 0.0 111.087 -178.177 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -148.18 -61.46 0.25 Allowed 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.563 0.345 . . . . 0.0 110.241 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.2 tp -159.76 167.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 108.279 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 78.6 p -88.78 2.04 54.19 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -136.34 45.63 1.33 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.502 0.721 . . . . 0.0 112.507 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.75 -15.24 30.12 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.607 2.205 . . . . 0.0 111.576 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.9 7.92 80.94 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.781 -0.527 . . . . 0.0 111.781 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -140.62 167.91 21.05 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.511 0.725 . . . . 0.0 110.366 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.7 t 57.99 -172.65 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.678 0.791 . . . . 0.0 112.015 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.9 t0 52.97 30.52 9.49 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.026 0.93 . . . . 0.0 111.845 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.98 24.76 3.58 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.436 1.094 . . . . 0.0 112.52 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 33.3 m 54.11 15.14 0.83 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.391 1.077 . . . . 0.0 113.118 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 50.81 25.61 2.22 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.616 1.166 . . . . 0.0 113.101 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 80.7 p -79.82 152.46 29.71 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.616 0.367 . . . . 0.0 110.831 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 61.1 t -140.31 -64.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -161.26 163.62 30.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.604 0.762 . . . . 0.0 110.279 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.1 p -87.17 15.44 6.21 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.248 0.619 . . . . 0.0 111.606 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.71 137.92 45.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 123.158 0.583 . . . . 0.0 111.073 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.06 163.31 24.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.376 0.607 . . . . 0.0 111.266 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.1 tp -125.09 132.41 53.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.871 1.268 . . . . 0.0 108.191 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -117.84 146.96 43.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.667 0.787 . . . . 0.0 109.845 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 72.9 m -136.59 144.39 44.1 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.6 mp -109.43 136.62 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 63.3 mt -99.71 -26.42 14.06 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -174.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -135.88 66.77 62.93 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 123.67 0.788 . . . . 0.0 109.687 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -75.11 52.64 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 125.133 3.889 . . . . 0.0 112.398 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.4 pt -78.79 -1.75 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 121.724 -0.61 . . . . 0.0 111.641 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -136.54 168.85 18.7 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.268 1.027 . . . . 0.0 109.36 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.9 m -79.12 150.5 31.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.853 0.359 . . . . 0.0 111.483 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.4 mm -134.31 138.73 49.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.4 p -142.18 174.53 10.52 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 122.934 0.493 . . . . 0.0 110.018 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 38.5 p -63.19 -21.45 66.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.203 0.201 . . . . 0.0 111.109 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.81 -27.91 33.4 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.38 0.272 . . . . 0.0 111.222 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.9 t -78.96 -37.8 20.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 89.2 mt -76.79 -22.49 53.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.274 -0.266 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -77.88 -34.32 51.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.973 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -76.88 -21.71 54.53 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.386 0.539 . . . . 0.0 111.294 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 44.8 pt -90.62 -21.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.969 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.7 m -96.58 -21.66 17.53 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.507 0.594 . . . . 0.0 112.257 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.476 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.1 t-20 -60.26 -44.3 95.79 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.434 -0.793 . . . . 0.0 113.111 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 97.8 Cg_endo -72.39 -9.43 24.2 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.039 1.826 . . . . 0.0 112.103 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 76.9 m -94.67 -20.5 19.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.99 0.359 . . . . 0.0 111.217 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.54 167.32 23.82 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.44 113.27 3.07 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.799 2.999 . . . . 0.0 110.886 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.7 t -87.21 150.45 3.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -112.35 -36.73 5.2 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.159 0.584 . . . . 0.0 110.796 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -164.35 159.17 19.46 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 117.993 0.36 . . . . 0.0 111.882 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 42.4 mt -144.34 142.35 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.01 0.924 . . . . 0.0 109.354 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 m -138.4 154.63 27.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 122.72 0.408 . . . . 0.0 110.239 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.4 mm -114.27 152.07 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.604 0.762 . . . . 0.0 111.062 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -136.01 140.96 44.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.973 0.909 . . . . 0.0 108.775 173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -142.85 23.43 1.9 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -108.47 139.54 43.07 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.18 0.592 . . . . 0.0 109.804 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 62.1 t30 51.04 22.29 1.2 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.459 1.104 . . . . 0.0 112.6 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 149.57 -161.47 28.82 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -141.47 126.48 17.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.292 0.568 . . . . 0.0 109.768 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -150.74 171.91 16.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.071 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.57 166.47 31.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.409 0.683 . . . . 0.0 109.339 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 87.4 mtp -135.94 150.26 49.22 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.05 148.23 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 122.918 0.487 . . . . 0.0 109.881 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.9 138.91 48.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -115.24 169.33 9.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.922 0.889 . . . . 0.0 111.065 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.79 -16.64 61.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.574 0.35 . . . . 0.0 111.549 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.5 p -152.57 159.9 43.24 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.612 0.365 . . . . 0.0 110.684 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.39 -25.75 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -70.72 -25.2 62.83 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.305 -0.247 . . . . 0.0 110.405 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.9 m -80.37 -28.53 37.97 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.64 -25.78 41.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.381 -0.2 . . . . 0.0 110.528 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -69.68 -37.02 76.5 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 48.4 ttt-85 -78.92 -26.66 43.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 121.897 0.079 . . . . 0.0 110.936 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.25 -48.89 66.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.036 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -14.41 59.27 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 118.57 0.623 . . . . 0.0 111.663 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -84.67 -9.92 57.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.653 -0.213 . . . . 0.0 111.191 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -124.71 -1.44 7.94 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.0 mt -132.07 -5.52 3.49 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -77.21 131.24 38.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.021 0.828 . . . . 0.0 109.244 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.25 5.76 67.45 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.29 179.28 7.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.609 0.704 . . . . 0.0 111.281 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -139.43 157.98 44.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.853 0.861 . . . . 0.0 108.807 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 57.1 mt -106.46 -21.92 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -122.35 35.07 4.97 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.192 0.451 . . . . 0.0 112.057 -174.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.5 m 57.41 19.11 4.89 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.799 0.84 . . . . 0.0 111.637 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 163.89 162.03 14.09 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 9.1 p 47.61 -172.99 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.333 1.453 . . . . 0.0 113.092 -176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.0 m 46.68 36.09 3.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.109 0.564 . . . . 0.0 111.384 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.4 m -60.38 137.93 58.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.692 0.397 . . . . 0.0 109.955 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.3 mt -98.85 156.17 17.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.206 0.602 . . . . 0.0 112.314 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -144.09 134.11 24.1 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 81.2 mt -128.53 148.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-O 121.217 0.532 . . . . 0.0 111.562 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -154.3 169.49 23.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.075 1.35 . . . . 0.0 108.488 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -83.37 143.08 30.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.831 -0.543 . . . . 0.0 110.449 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.84 169.38 11.65 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -85.07 -26.51 0.37 Allowed Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.6 Cg_endo -82.03 165.26 17.31 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 CA-C-N 122.069 1.775 . . . . 0.0 109.927 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.9 p -94.3 -7.79 40.86 Favored 'General case' 0 CA--C 1.527 0.073 0 O-C-N 122.245 -0.284 . . . . 0.0 111.419 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.88 169.53 24.57 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.806 0.842 . . . . 0.0 109.939 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 84.1 mt -121.05 167.75 12.28 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.501 0.72 . . . . 0.0 109.565 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -129.85 154.13 47.59 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.681 0.277 . . . . 0.0 110.374 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 87.6 t -136.86 151.14 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.221 1.008 . . . . 0.0 108.866 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -123.43 -19.99 5.73 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.856 0.463 . . . . 0.0 111.324 -174.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -164.7 168.29 18.15 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.891 1.276 . . . . 0.0 108.7 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -116.96 109.27 16.81 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 121.016 0.436 . . . . 0.0 110.648 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -154.51 -172.14 4.1 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.789 1.236 . . . . 0.0 109.506 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -69.88 -4.85 22.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -114.1 -15.46 12.25 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 118.732 0.696 . . . . 0.0 111.826 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.2 t -159.43 134.75 8.32 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -152.23 148.31 27.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.121 -0.362 . . . . 0.0 111.153 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -125.64 132.5 52.45 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.44 0.696 . . . . 0.0 109.436 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -109.38 2.19 20.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.628 0.771 . . . . 0.0 112.137 -173.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t -117.84 -2.79 11.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.947 0.499 . . . . 0.0 110.499 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -67.61 123.5 86.96 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.626 1.17 . . . . 0.0 109.585 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.67 -16.67 25.6 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.816 3.011 . . . . 0.0 113.875 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -93.81 -28.89 15.63 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.159 0.436 . . . . 0.0 111.172 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 21.3 tp 55.35 -2.86 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.803 1.641 . . . . 0.0 114.882 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 89.5 p -152.46 11.83 0.53 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.943 0.792 . . . . 0.0 112.36 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -168.33 -176.05 38.41 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.43 5.64 3.22 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.222 0.609 . . . . 0.0 112.156 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 117.433 -1.76 . . . . 0.0 110.751 -179.899 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -148.87 174.8 11.85 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.177 0.591 . . . . 0.0 110.399 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.35 156.32 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.332 0.653 . . . . 0.0 110.117 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 81.0 p -80.1 1.01 29.6 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -139.37 62.08 22.98 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.9 0.88 . . . . 0.0 110.413 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.88 141.78 66.45 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.823 2.349 . . . . 0.0 110.677 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.77 8.5 72.77 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.499 -0.611 . . . . 0.0 112.826 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -144.7 153.4 41.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.251 1.026 . . . . 0.0 111.468 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.9 t -158.64 177.77 10.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.636 0.374 . . . . 0.0 110.916 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 61.1 165.42 0.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.898 1.679 . . . . 0.0 114.265 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 57.74 -3.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.262 1.825 . . . . 0.0 114.623 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 37.3 m 55.35 -0.53 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.759 1.624 . . . . 0.0 114.294 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 52.11 -173.47 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.315 1.446 . . . . 0.0 113.206 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.4 m -71.86 158.24 36.42 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.332 0.653 . . . . 0.0 111.023 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.01 -65.88 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.337 0.065 0 C-N-CA 122.57 0.348 . . . . 0.0 110.542 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -158.78 160.46 36.31 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.124 0.57 . . . . 0.0 110.482 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.8 p -89.68 13.68 13.59 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.194 0.597 . . . . 0.0 112.127 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.56 145.62 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 122.6 0.36 . . . . 0.0 110.721 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.3 mt -130.34 165.06 23.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.266 0.626 . . . . 0.0 111.586 -174.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 63.8 tp -123.89 133.01 53.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.565 1.146 . . . . 0.0 108.432 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -119.95 144.98 47.18 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.76 0.824 . . . . 0.0 109.994 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.1 m -138.1 142.93 40.21 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.2 mp -106.54 136.53 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.9 mt -92.4 -34.58 14.1 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -134.35 67.42 72.4 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 123.634 0.773 . . . . 0.0 109.34 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.13 64.59 4.26 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.666 3.577 . . . . 0.0 112.113 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 45.6 pt -83.84 -4.5 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.993 -0.442 . . . . 0.0 111.202 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -129.38 166.24 19.93 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 109.379 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 77.9 p -80.54 156.61 26.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.642 0.258 . . . . 0.0 111.121 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mm -136.21 139.96 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 70.7 p -143.25 172.36 12.85 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.066 0.546 . . . . 0.0 110.007 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.6 p -62.04 -24.97 67.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.24 0.216 . . . . 0.0 110.991 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -78.92 -27.57 43.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.346 0.258 . . . . 0.0 111.352 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.15 -38.58 18.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.878 0.37 . . . . 0.0 110.025 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.35 -22.97 54.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.218 -0.301 . . . . 0.0 110.561 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -78.65 -35.22 45.69 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.914 0.324 . . . . 0.0 110.879 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.2 t -74.73 -23.56 58.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.242 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 pt -89.05 -21.41 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 118.379 0.536 . . . . 0.0 111.955 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 87.6 m -95.74 -19.3 19.78 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.302 0.501 . . . . 0.0 112.182 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.458 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.6 t-20 -60.39 -44.08 94.87 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 92.7 Cg_endo -73.06 -10.81 24.89 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.706 1.604 . . . . 0.0 111.995 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 77.5 m -89.4 -23.7 22.1 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.161 0.437 . . . . 0.0 111.249 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.86 171.78 30.52 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.1 111.43 2.68 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.553 2.835 . . . . 0.0 110.556 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.47 151.45 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -116.06 -39.1 3.49 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.064 0.546 . . . . 0.0 110.907 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -161.67 158.48 26.08 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.402 0.546 . . . . 0.0 112.062 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 41.2 mt -144.89 143.93 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 124.364 1.066 . . . . 0.0 109.721 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.427 ' C ' HD12 ' A' ' 223' ' ' ILE . 22.4 m -141.69 149.52 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 123.288 0.635 . . . . 0.0 109.857 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.427 HD12 ' C ' ' A' ' 222' ' ' VAL . 1.8 mp -113.41 151.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.765 0.826 . . . . 0.0 109.81 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -137.07 150.47 48.06 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.977 0.911 . . . . 0.0 109.9 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.34 16.24 1.86 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.0 -29.46 68.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.623 0.369 . . . . 0.0 110.497 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -151.8 123.94 8.18 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 58.13 -143.25 43.65 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.3 t -131.39 130.86 63.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -143.69 166.08 25.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.346 0.658 . . . . 0.0 109.891 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.05 171.64 20.1 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.528 0.331 . . . . 0.0 110.218 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.8 mtp -138.78 149.95 45.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.28 151.37 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -135.5 140.74 45.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.564 0.746 . . . . 0.0 109.818 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -120.03 167.74 11.87 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.851 0.861 . . . . 0.0 110.854 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.51 -11.21 59.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.616 0.366 . . . . 0.0 111.349 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 42.9 t -152.18 151.45 31.03 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.151 0.581 . . . . 0.0 110.088 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.11 -25.71 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.54 -24.38 62.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.009 -0.432 . . . . 0.0 110.14 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 41.2 m -80.35 -27.2 38.35 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.75 -26.42 37.32 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.243 0.217 . . . . 0.0 110.424 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -68.46 -37.64 80.36 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -78.68 -24.79 44.86 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.99 -50.63 54.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.319 -0.238 . . . . 0.0 111.197 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.404 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.06 -14.57 59.45 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.626 179.07 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.22 -8.54 58.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.835 0.289 . . . . 0.0 111.555 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.8 t -125.6 -6.79 6.88 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.3 mt -124.49 -5.33 7.67 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -77.71 131.36 37.66 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.82 5.05 73.41 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.563 -0.576 . . . . 0.0 111.827 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.86 177.57 8.95 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.833 0.816 . . . . 0.0 111.093 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -138.64 160.38 39.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.758 0.823 . . . . 0.0 109.371 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.4 mt -112.37 -20.89 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -120.95 28.82 7.69 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.6 t 58.14 15.44 3.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.973 0.909 . . . . 0.0 112.05 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 170.4 145.48 4.75 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 75.2 m 53.83 -172.58 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.754 0.822 . . . . 0.0 111.852 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.3 m 50.3 33.48 7.5 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.198 0.599 . . . . 0.0 111.222 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.0 m -60.56 139.59 57.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.937 0.495 . . . . 0.0 110.041 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.0 mt -95.24 154.51 17.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.372 0.669 . . . . 0.0 111.756 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -145.56 129.15 17.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.404 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 81.0 mt -129.29 147.69 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 CA-C-O 121.171 0.51 . . . . 0.0 112.216 -171.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.36 173.56 15.47 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.679 1.191 . . . . 0.0 108.547 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -83.23 143.56 30.36 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.976 -0.452 . . . . 0.0 110.675 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.18 167.33 17.84 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.068 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 39.7 ttpt -74.64 -46.88 5.43 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 118.298 -0.858 . . . . 0.0 113.273 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 74.8 Cg_endo -74.9 177.53 8.43 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.353 2.035 . . . . 0.0 110.539 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.2 p -108.49 -7.79 15.69 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.592 0.357 . . . . 0.0 111.534 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.77 136.49 14.4 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 56.4 mt -88.05 171.09 10.53 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 122.731 0.412 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -131.93 151.7 51.55 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.549 0.34 . . . . 0.0 110.369 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.3 153.69 24.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 124.171 0.988 . . . . 0.0 108.786 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -126.94 -19.62 4.39 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.57 0.348 . . . . 0.0 111.437 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -165.56 170.46 14.27 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 124.505 1.122 . . . . 0.0 109.011 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -117.06 109.42 16.94 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.619 0.368 . . . . 0.0 110.411 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -154.93 -172.13 4.08 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.585 1.154 . . . . 0.0 109.627 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -69.75 -4.86 21.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -115.2 -17.29 11.41 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.121 0.873 . . . . 0.0 111.779 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.6 t -156.68 134.81 11.2 Favored 'General case' 0 N--CA 1.458 -0.055 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -152.61 147.36 26.06 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.758 0.314 . . . . 0.0 111.212 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -124.43 119.76 30.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -95.66 -4.68 43.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.281 0.632 . . . . 0.0 111.568 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.5 t -111.89 15.51 20.76 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.335 0.588 . . . . 0.0 110.124 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -68.89 124.81 91.09 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 123.765 0.826 . . . . 0.0 109.755 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.08 -17.89 26.76 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.272 2.648 . . . . 0.0 113.197 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -89.12 -0.29 57.31 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.538 0.335 . . . . 0.0 111.591 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 56.9 tp -117.34 -19.56 9.51 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.366 0.666 . . . . 0.0 110.515 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.6 p -96.73 -4.14 41.21 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.016 0.526 . . . . 0.0 111.441 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.41 171.07 54.88 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -141.32 10.04 2.09 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.065 0.546 . . . . 0.0 111.927 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.305 -1.831 . . . . 0.0 110.824 -179.189 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -143.47 159.44 42.4 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.007 0.523 . . . . 0.0 110.229 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.3 tp -64.31 155.81 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.324 0.65 . . . . 0.0 110.659 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.0 p -68.88 159.25 32.92 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.695 0.398 . . . . 0.0 111.001 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 45.69 55.21 14.74 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.606 0.762 . . . . 0.0 110.843 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.0 164.8 34.5 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.335 2.69 . . . . 0.0 111.46 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.69 5.35 0.02 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.743 -0.476 . . . . 0.0 112.286 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -148.0 153.94 39.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.891 0.845 . . . . 0.0 110.467 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.1 t 61.97 151.31 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.658 1.583 . . . . 0.0 113.409 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.4 p30 45.64 22.88 0.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.818 1.647 . . . . 0.0 113.764 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.4 t70 57.05 13.05 1.41 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.472 1.109 . . . . 0.0 113.251 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 50.0 m 53.24 20.27 1.81 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.902 1.281 . . . . 0.0 114.078 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.31 164.63 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.021 1.329 . . . . 0.0 113.668 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 57.42 -178.29 0.06 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.758 1.223 . . . . 0.0 112.582 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.7 t -136.68 -93.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 122.621 0.368 . . . . 0.0 110.518 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -154.65 169.82 22.98 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.293 0.637 . . . . 0.0 110.76 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.0 p -82.96 10.13 8.59 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.5 t -109.43 136.56 44.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 122.815 0.446 . . . . 0.0 110.611 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.5 mt -125.1 161.43 26.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.754 0.788 . . . . 0.0 111.373 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.0 tp -126.17 131.44 52.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.035 1.334 . . . . 0.0 107.51 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -118.09 145.16 45.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.69 0.796 . . . . 0.0 109.406 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.3 m -139.49 141.54 37.34 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.2 mp -105.7 135.3 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.4 mt -94.02 -36.55 12.08 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -173.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -129.87 62.78 65.68 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 123.368 0.667 . . . . 0.0 110.082 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.45 101.96 0.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.947 2.431 . . . . 0.0 110.717 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.0 pt -128.26 3.07 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.788 0.435 . . . . 0.0 111.402 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -131.67 166.47 21.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.855 0.862 . . . . 0.0 109.457 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.5 m -73.91 145.8 44.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.787 0.327 . . . . 0.0 111.32 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.5 mm -137.49 136.79 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.6 p -145.04 172.27 13.3 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.529 0.732 . . . . 0.0 109.636 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.9 p -63.77 -20.76 66.02 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 122.327 -0.233 . . . . 0.0 110.931 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -79.7 -27.37 40.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.326 0.25 . . . . 0.0 110.888 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.2 t -81.51 -37.64 15.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.66 -28.54 62.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.185 -0.322 . . . . 0.0 110.599 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -74.28 -37.96 63.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.991 -0.443 . . . . 0.0 111.044 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.7 t -74.11 -20.99 60.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.555 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.3 pt -88.85 -23.55 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.184 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 16.6 p -109.69 -6.83 15.2 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.16 -42.79 87.82 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.562 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 94.4 Cg_endo -72.85 -7.02 20.07 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.805 1.67 . . . . 0.0 112.089 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 65.7 m -86.02 -21.86 27.57 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.062 0.392 . . . . 0.0 111.213 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.8 176.7 32.17 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.77 107.83 1.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.975 3.117 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.09 149.47 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -112.61 -39.05 4.44 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.474 0.31 . . . . 0.0 111.003 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -167.18 161.75 14.72 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 117.967 0.349 . . . . 0.0 111.911 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.4 mt -143.07 139.76 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.205 1.002 . . . . 0.0 109.145 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.17 157.8 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.8 mt -128.92 151.78 36.17 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.053 0 C-N-CA 122.875 0.47 . . . . 0.0 111.014 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -138.97 145.1 39.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.781 0.833 . . . . 0.0 109.574 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.85 15.48 2.3 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -79.22 -9.21 59.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.067 0.547 . . . . 0.0 111.613 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -135.06 12.75 3.6 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.219 0.608 . . . . 0.0 112.125 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 137.71 -128.99 4.47 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 108.926 -1.669 . . . . 0.0 108.926 -174.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.5 t -133.87 112.79 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -144.84 163.69 33.32 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 122.832 0.453 . . . . 0.0 110.303 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.55 172.14 17.04 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.418 0.287 . . . . 0.0 110.58 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 85.0 mtp -141.39 152.41 44.31 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 46.5 t -139.73 149.86 22.36 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.032 0 C-N-CA 123.02 0.528 . . . . 0.0 109.607 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -132.91 140.48 47.89 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -117.33 169.07 9.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.045 0.938 . . . . 0.0 110.974 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.56 -11.15 59.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.061 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.9 t -150.59 149.65 30.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.211 0.604 . . . . 0.0 110.111 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.45 -26.37 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -70.94 -23.63 62.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.961 -0.462 . . . . 0.0 110.316 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.9 m -80.11 -28.31 39.02 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.22 -27.86 42.5 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.519 0.199 . . . . 0.0 110.793 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -67.26 -36.02 80.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -82.47 -27.09 32.06 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.73 0.412 . . . . 0.0 111.698 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.16 -44.16 72.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.06 -0.4 . . . . 0.0 110.399 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -27.94 64.81 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -77.66 -8.53 58.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.819 -0.551 . . . . 0.0 111.712 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.6 m -121.07 -5.5 9.51 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.45 -8.75 2.53 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -74.57 131.15 40.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.735 1.152 . . . . 0.0 108.845 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 71.88 6.17 63.05 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.386 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.33 -179.06 7.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.83 0.815 . . . . 0.0 111.387 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -140.28 163.15 33.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.897 0.879 . . . . 0.0 109.456 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.0 mt -114.89 -17.4 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -125.24 31.14 5.65 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.022 -0.424 . . . . 0.0 112.051 -175.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.0 m 56.69 16.66 2.73 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.808 0.843 . . . . 0.0 112.346 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 165.77 148.77 5.64 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 82.7 m 54.72 -177.42 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.922 0.889 . . . . 0.0 111.922 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 79.8 m 49.36 32.71 4.73 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.094 0.558 . . . . 0.0 111.182 -174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.7 m -59.94 139.22 57.54 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.044 0.538 . . . . 0.0 109.896 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 64.9 mt -93.71 154.64 17.68 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.433 0.693 . . . . 0.0 111.799 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -144.06 123.1 12.83 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.6 mt -123.82 145.53 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-O 120.98 0.419 . . . . 0.0 111.575 -173.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -155.02 172.68 17.71 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.818 1.247 . . . . 0.0 108.498 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -85.81 147.25 26.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.11 -0.369 . . . . 0.0 110.858 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -95.7 165.74 12.16 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.657 0.383 . . . . 0.0 110.816 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -80.72 -27.17 0.45 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 47.6 Cg_endo -80.66 160.44 21.91 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 CA-C-N 121.965 1.738 . . . . 0.0 110.047 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 43.0 p -89.87 -10.44 45.29 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.6 0.36 . . . . 0.0 111.257 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 168.73 26.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.612 0.765 . . . . 0.0 110.074 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -119.93 172.69 7.55 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.093 0.957 . . . . 0.0 109.691 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -134.28 154.64 51.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.292 -0.255 . . . . 0.0 110.404 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 70.7 t -136.77 150.52 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.747 0.819 . . . . 0.0 108.885 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -122.75 -20.56 5.87 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.482 0.313 . . . . 0.0 111.358 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -165.23 169.98 15.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.176 0.99 . . . . 0.0 109.414 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -116.47 116.37 27.54 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.023 0.44 . . . . 0.0 110.519 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -159.87 -172.54 3.69 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.338 1.455 . . . . 0.0 109.384 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.75 -1.32 11.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.46 -19.93 8.64 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.622 0.646 . . . . 0.0 111.944 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 2.8 t -153.68 137.11 15.84 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -153.84 149.44 27.37 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.221 -0.299 . . . . 0.0 111.394 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -128.34 138.07 52.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.275 0.63 . . . . 0.0 109.62 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -115.9 6.93 14.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.582 0.753 . . . . 0.0 112.461 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t -122.7 -9.55 8.38 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.843 0.457 . . . . 0.0 111.163 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -70.13 126.14 92.27 Favored Pre-proline 0 N--CA 1.452 -0.336 0 C-N-CA 123.895 0.878 . . . . 0.0 109.089 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.99 -6.09 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.859 3.04 . . . . 0.0 113.578 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -114.4 19.92 15.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.704 0.802 . . . . 0.0 111.567 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -63.82 -6.27 5.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -134.67 17.18 3.6 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.589 0.756 . . . . 0.0 110.961 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 78.07 -170.38 54.88 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -129.06 6.48 5.42 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.596 0.758 . . . . 0.0 111.14 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.21 0 CA-C-O 117.372 -1.793 . . . . 0.0 110.883 -179.721 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 120.392 0.139 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -85.23 162.16 19.28 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.755 0.422 . . . . 0.0 109.98 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.25 151.61 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 122.396 0.278 . . . . 0.0 110.61 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.3 m -76.62 -2.35 32.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.003 0.521 . . . . 0.0 112.396 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -139.74 76.26 29.63 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.92 -5.3 16.62 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.733 2.955 . . . . 0.0 112.041 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.52 -5.9 86.29 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -148.85 150.15 32.52 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.697 0.749 . . . . 0.0 110.045 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 42.3 m 53.78 -167.94 0.07 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.451 0.701 . . . . 0.0 112.326 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.5 t0 59.64 172.4 0.08 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.275 1.03 . . . . 0.0 112.253 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.4 t70 51.75 35.34 14.99 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.07 0.548 . . . . 0.0 111.422 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 66.7 p 53.06 20.81 1.86 Allowed 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.937 1.295 . . . . 0.0 113.214 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 53.03 29.96 8.79 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.409 1.083 . . . . 0.0 111.652 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 44.9 t -63.33 143.89 57.42 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.136 0.574 . . . . 0.0 111.349 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.07 -45.81 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.783 0.433 . . . . 0.0 110.329 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -164.49 166.21 20.65 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.429 0.692 . . . . 0.0 110.486 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.2 p -99.61 18.87 16.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.483 0.713 . . . . 0.0 111.955 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.6 143.92 33.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 C-N-CA 123.003 0.521 . . . . 0.0 110.696 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.5 mt -129.68 163.24 26.55 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.149 0.58 . . . . 0.0 111.365 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.3 tp -121.2 133.68 55.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.989 1.316 . . . . 0.0 108.054 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -119.61 145.58 46.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.521 0.728 . . . . 0.0 109.738 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.6 m -140.62 144.49 35.8 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.5 mp -107.68 135.25 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.1 mt -91.77 -35.67 13.99 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -130.79 61.71 61.0 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 123.575 0.75 . . . . 0.0 110.184 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.98 101.79 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.78 2.32 . . . . 0.0 110.784 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.0 pt -125.72 0.22 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.95 0.5 . . . . 0.0 111.339 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.13 166.47 21.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.711 0.804 . . . . 0.0 109.264 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.5 m -73.53 151.68 40.9 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.81 0.338 . . . . 0.0 111.563 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.5 mm -138.71 135.24 43.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 68.4 p -146.46 176.35 9.87 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.149 0.58 . . . . 0.0 110.1 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.2 p -62.38 -25.55 67.98 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 122.435 0.294 . . . . 0.0 111.209 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -80.54 -20.61 43.08 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.545 0.338 . . . . 0.0 111.461 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 88.6 t -90.56 -37.82 9.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.4 mt -77.31 -22.53 51.81 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.254 -0.279 . . . . 0.0 110.715 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -78.8 -36.1 43.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.924 0.329 . . . . 0.0 110.903 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.9 t -77.0 -17.31 58.93 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.996 -0.44 . . . . 0.0 111.395 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.41 -17.57 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.913 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 88.8 m -95.7 -25.3 16.16 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.91 0.777 . . . . 0.0 111.859 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.487 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.2 t-20 -59.71 -42.2 90.1 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 83.6 Cg_endo -71.1 -4.54 15.1 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.962 1.775 . . . . 0.0 112.1 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 72.4 m -107.52 -11.68 15.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.223 0.465 . . . . 0.0 111.335 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.7 165.05 15.87 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.42 114.39 3.79 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.897 3.064 . . . . 0.0 110.67 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.2 t -86.56 151.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -113.34 -36.39 5.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.162 0.585 . . . . 0.0 110.554 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -164.04 159.88 21.08 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.8 mt -144.49 145.79 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.361 1.064 . . . . 0.0 109.92 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.37 150.39 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 C-N-CA 123.265 0.626 . . . . 0.0 109.45 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.28 151.06 32.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 C-N-CA 123.077 0.551 . . . . 0.0 110.872 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -128.93 137.65 51.53 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -140.05 23.41 2.4 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -118.77 142.32 47.81 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 35.7 m120 53.05 20.29 1.67 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.924 0.89 . . . . 0.0 112.474 -174.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 145.89 -171.88 26.72 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.45 125.06 42.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 117.348 0.574 . . . . 0.0 109.517 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -148.58 168.97 21.38 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.932 0.893 . . . . 0.0 109.529 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.77 170.15 23.11 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.9 mtp -138.49 151.52 47.45 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 43.7 t -138.4 149.49 24.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 C-N-CA 122.645 0.378 . . . . 0.0 110.424 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -132.43 138.88 47.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.728 0.811 . . . . 0.0 109.147 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -117.04 167.85 10.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.445 0.698 . . . . 0.0 110.797 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -75.99 -15.37 60.16 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.237 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.6 t -152.23 153.49 33.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.241 0.616 . . . . 0.0 110.057 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.89 -27.08 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -68.17 -24.13 64.94 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.926 -0.484 . . . . 0.0 109.854 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.9 m -81.47 -27.9 34.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.424 0.29 . . . . 0.0 110.395 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.15 -25.21 37.03 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -70.02 -37.5 75.64 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -77.49 -26.6 51.41 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 122.277 -0.265 . . . . 0.0 110.494 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.55 -53.59 39.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.951 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.26 -14.34 60.13 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.622 0.647 . . . . 0.0 111.976 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.85 -12.67 55.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.1 -0.375 . . . . 0.0 111.855 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.0 m -129.67 1.72 4.95 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 77.0 mt -128.46 -4.27 5.41 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.65 0.659 . . . . 0.0 112.717 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -78.78 132.04 36.75 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.6 4.51 70.51 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.016 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.74 177.59 8.54 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.634 0.717 . . . . 0.0 110.866 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -140.39 161.18 38.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.466 0.706 . . . . 0.0 109.287 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.8 mt -115.81 -15.57 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -122.24 28.32 7.53 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.898 -0.501 . . . . 0.0 112.222 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 25.5 m 57.64 14.75 2.52 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.043 0.937 . . . . 0.0 112.247 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 168.44 148.79 5.87 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 65.0 m 54.63 -176.31 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.665 0.786 . . . . 0.0 111.862 -176.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.4 m 50.09 31.74 5.22 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.915 0.486 . . . . 0.0 111.438 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 16.7 m -59.55 138.22 57.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.78 0.432 . . . . 0.0 110.081 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 62.6 mt -91.68 156.78 17.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.322 0.649 . . . . 0.0 112.053 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -140.76 137.91 33.75 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 77.7 mt -133.82 141.62 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.135 0.493 . . . . 0.0 111.489 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.75 167.94 27.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.782 1.233 . . . . 0.0 108.232 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -78.41 144.55 35.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.808 -0.558 . . . . 0.0 110.812 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.87 165.68 17.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.508 0.323 . . . . 0.0 110.265 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -81.06 -27.24 0.45 Allowed Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -176.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 46.2 Cg_endo -81.67 178.34 6.67 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.838 1.692 . . . . 0.0 109.913 177.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 69.2 p -105.09 -9.0 18.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.432 0.293 . . . . 0.0 111.089 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.92 168.03 27.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.835 0.854 . . . . 0.0 109.976 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 94.4 mt -127.11 170.43 12.36 Favored 'General case' 0 N--CA 1.459 0.014 0 C-N-CA 123.659 0.784 . . . . 0.0 109.817 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -138.76 163.85 31.1 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.397 0.618 . . . . 0.0 111.673 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 38.7 t -140.51 156.2 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 124.695 1.198 . . . . 0.0 108.555 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -125.61 -21.92 4.37 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.504 0.322 . . . . 0.0 111.678 -174.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -163.6 169.1 19.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.381 1.072 . . . . 0.0 108.91 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -115.71 110.01 18.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.121 0.486 . . . . 0.0 110.438 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -155.32 -170.24 3.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.009 1.323 . . . . 0.0 109.335 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -72.67 -2.51 20.44 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -119.6 -15.82 8.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.893 0.77 . . . . 0.0 112.006 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.7 t -154.76 135.01 13.2 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -157.96 145.25 18.18 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.266 -0.271 . . . . 0.0 110.871 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -129.19 141.14 51.24 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.575 0.703 . . . . 0.0 111.311 171.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -108.58 -9.81 15.29 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.558 0.743 . . . . 0.0 111.816 -174.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.3 t -89.82 1.9 55.59 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.089 0.556 . . . . 0.0 110.23 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -78.99 123.03 85.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.57 1.148 . . . . 0.0 110.083 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.67 -14.56 24.53 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.486 2.791 . . . . 0.0 112.27 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -107.82 -8.86 15.88 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.815 0.446 . . . . 0.0 110.99 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 14.8 tp 49.12 26.94 1.58 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.459 1.104 . . . . 0.0 111.979 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.6 m -138.63 162.72 33.92 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.526 0.73 . . . . 0.0 110.898 -176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.07 175.88 47.51 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 116.609 -0.269 . . . . 0.0 112.554 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -87.04 1.44 52.9 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.824 0.449 . . . . 0.0 112.09 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 CA-C-O 117.195 -1.892 . . . . 0.0 110.617 -179.223 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -147.29 165.02 31.37 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.2 tp -60.57 153.63 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.317 0.647 . . . . 0.0 110.412 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 76.9 p -71.97 -7.32 48.01 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.428 0.691 . . . . 0.0 112.701 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -144.07 85.38 9.0 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.557 0.743 . . . . 0.0 109.477 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.49 -13.38 18.42 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.485 2.79 . . . . 0.0 111.219 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.78 178.65 53.91 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.336 -0.705 . . . . 0.0 111.336 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -148.0 155.49 41.59 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 122.851 0.46 . . . . 0.0 110.31 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.3 p 54.9 -178.57 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.668 1.587 . . . . 0.0 113.564 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.6 t70 62.92 -23.07 0.05 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.197 1.799 . . . . 0.0 114.775 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.0 t0 48.8 27.65 1.64 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.576 1.15 . . . . 0.0 113.125 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 31.7 m 56.55 11.93 0.97 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.478 1.111 . . . . 0.0 113.299 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 54.66 -177.42 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 125.207 1.403 . . . . 0.0 113.361 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 47.5 t -151.97 149.63 29.12 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 123.944 0.898 . . . . 0.0 108.963 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.83 -44.93 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -164.25 169.65 17.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.392 0.542 . . . . 0.0 111.214 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.7 p -97.76 15.89 22.3 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.809 0.843 . . . . 0.0 111.021 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.08 138.74 38.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 C-N-CA 123.615 0.766 . . . . 0.0 110.703 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.0 mt -127.35 159.91 32.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.298 0.57 . . . . 0.0 111.54 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.9 tp -124.2 130.51 52.66 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.017 1.327 . . . . 0.0 107.764 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -115.1 145.03 42.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.401 0.68 . . . . 0.0 109.684 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.9 m -139.44 144.38 38.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.4 mp -107.17 136.94 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 75.4 mt -93.77 -34.87 13.03 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -130.09 63.15 67.83 Favored Pre-proline 0 CA--C 1.528 0.114 0 C-N-CA 123.162 0.585 . . . . 0.0 109.951 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.58 101.71 0.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.766 2.31 . . . . 0.0 110.881 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.58 2.5 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 122.774 0.429 . . . . 0.0 111.29 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -134.98 166.89 21.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.814 0.845 . . . . 0.0 109.314 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 33.1 t -78.54 151.44 32.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.794 0.331 . . . . 0.0 110.975 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.1 mm -136.83 137.16 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.6 p -143.52 176.72 8.97 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 123.148 0.579 . . . . 0.0 110.053 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.1 p -62.34 -23.25 66.66 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.696 0.399 . . . . 0.0 111.195 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -82.2 -23.75 35.27 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.84 0.291 . . . . 0.0 111.274 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 83.6 t -83.97 -37.64 13.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.84 -21.52 47.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.039 -0.413 . . . . 0.0 110.848 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -77.6 -34.39 53.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.171 0.441 . . . . 0.0 110.848 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.3 t -76.91 -22.34 53.51 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.268 0.485 . . . . 0.0 111.354 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.2 pt -90.18 -22.44 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.491 0.587 . . . . 0.0 111.791 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.4 m -94.66 -23.07 17.76 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.439 0.563 . . . . 0.0 112.013 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.3 t-20 -59.75 -44.57 97.54 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 97.2 Cg_endo -72.77 -10.11 24.59 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.863 1.708 . . . . 0.0 111.803 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 74.6 m -93.73 -20.92 19.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.32 0.509 . . . . 0.0 110.95 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 166.35 167.38 26.91 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.12 104.77 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.93 3.087 . . . . 0.0 110.763 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.4 t -78.42 152.0 5.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -115.0 -40.85 3.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.011 0.525 . . . . 0.0 110.828 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.412 HH22 ' CG1' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -163.96 159.51 20.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.53 0.605 . . . . 0.0 112.495 177.413 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 42.0 mt -142.07 150.64 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 124.104 0.962 . . . . 0.0 110.45 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.412 ' CG1' HH22 ' A' ' 220' ' ' ARG . 7.3 p -141.53 148.62 20.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 C-N-CA 123.739 0.816 . . . . 0.0 109.202 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 38.6 mm -115.54 148.67 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 124.035 0.934 . . . . 0.0 110.418 -174.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -139.09 132.39 29.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.46 21.92 0.93 Allowed 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -68.77 -20.11 64.35 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.186 -0.321 . . . . 0.0 110.607 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -154.81 121.57 5.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 61.73 -154.15 39.68 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.6 t -140.28 127.86 24.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -149.0 168.57 22.76 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.779 0.831 . . . . 0.0 110.094 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.8 167.73 29.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.026 0.531 . . . . 0.0 109.957 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.2 mtp -134.98 142.69 46.53 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.64 151.25 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.16 0.584 . . . . 0.0 110.237 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -135.17 140.79 45.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.44 0.696 . . . . 0.0 109.225 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -118.73 168.02 11.12 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.722 0.809 . . . . 0.0 110.996 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.47 -17.85 61.73 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.88 0.472 . . . . 0.0 111.564 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.0 p -152.37 160.08 43.34 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.626 0.371 . . . . 0.0 110.422 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.74 -28.26 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -64.83 -30.07 71.06 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.925 -0.485 . . . . 0.0 109.877 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 45.0 m -78.24 -28.77 47.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.211 0.204 . . . . 0.0 110.571 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.49 -26.03 38.45 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.212 -0.305 . . . . 0.0 110.639 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -70.56 -36.13 73.46 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -79.77 -24.98 41.15 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.278 -0.264 . . . . 0.0 110.497 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.84 -52.66 40.97 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.162 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -15.49 59.68 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.755 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -80.72 -13.95 58.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.912 0.324 . . . . 0.0 111.721 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.7 m -125.05 1.44 7.95 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.0 mt -129.18 -4.82 4.94 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -77.74 132.73 38.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.8 5.55 64.88 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.218 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.15 179.56 7.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.679 0.74 . . . . 0.0 111.007 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -139.64 163.08 33.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.278 0.631 . . . . 0.0 109.515 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.6 mt -115.69 -18.81 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -120.92 30.96 6.61 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 122.03 -0.419 . . . . 0.0 111.716 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.4 m 57.41 15.73 2.84 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.802 0.841 . . . . 0.0 112.139 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 165.58 150.0 6.09 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 81.9 m 55.02 -176.97 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.61 0.764 . . . . 0.0 111.854 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.8 m 49.93 32.75 5.83 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.973 0.509 . . . . 0.0 111.663 -175.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 14.6 m -59.67 138.81 57.63 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.746 0.418 . . . . 0.0 109.917 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 58.4 mt -92.62 155.47 17.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.276 0.631 . . . . 0.0 112.179 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -143.63 123.62 13.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 74.1 mt -123.78 146.3 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.248 0.547 . . . . 0.0 111.682 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.44 169.27 24.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.677 1.191 . . . . 0.0 108.732 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -78.44 145.53 35.01 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.008 -0.433 . . . . 0.0 110.599 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.86 167.85 15.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.328 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -80.06 -29.27 0.55 Allowed Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.8 Cg_endo -82.68 169.44 13.56 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 121.73 1.653 . . . . 0.0 110.093 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.0 p -99.57 -5.93 28.28 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 122.388 -0.195 . . . . 0.0 110.998 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -152.85 157.04 40.13 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 123.836 0.854 . . . . 0.0 110.634 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 80.2 mt -121.99 175.37 6.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.186 0.994 . . . . 0.0 109.308 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -143.95 165.14 28.57 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.483 0.313 . . . . 0.0 110.926 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.2 t -137.6 157.98 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 124.398 1.079 . . . . 0.0 108.925 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -125.03 -31.36 3.12 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 122.263 -0.273 . . . . 0.0 110.923 -174.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.09 167.78 28.34 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.264 1.025 . . . . 0.0 109.291 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -107.66 118.59 37.15 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.121 0.486 . . . . 0.0 111.148 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.97 -171.64 3.47 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.063 1.345 . . . . 0.0 109.251 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -74.5 -3.69 32.3 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -107.67 -23.68 12.02 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.409 0.55 . . . . 0.0 111.115 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.1 t -158.07 141.08 14.95 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -150.71 151.26 32.16 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.304 -0.248 . . . . 0.0 110.873 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -129.18 135.99 49.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.222 0.609 . . . . 0.0 109.403 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.2 6.03 14.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.549 0.74 . . . . 0.0 112.211 -174.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.0 t -124.42 -9.44 7.47 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.993 0.517 . . . . 0.0 111.211 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 285' ' ' PRO . 56.0 t-20 -66.87 123.79 86.97 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 123.92 0.888 . . . . 0.0 109.445 176.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 284' ' ' ASN . 54.0 Cg_exo -57.3 -19.51 35.24 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.733 2.955 . . . . 0.0 113.424 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -84.95 -22.92 29.01 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.985 0.357 . . . . 0.0 111.01 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 17.0 tp 50.11 23.27 1.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.482 1.113 . . . . 0.0 112.517 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.1 p -146.02 -22.52 0.45 Allowed 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.616 -0.677 . . . . 0.0 112.568 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 154.85 176.68 27.36 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.255 0.479 . . . . 0.0 112.252 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -151.36 5.51 0.47 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.903 0.481 . . . . 0.0 112.007 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 CA-C-O 117.575 -1.68 . . . . 0.0 111.326 -179.873 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 179' ' ' PRO . 76.2 tttt -145.97 159.42 43.28 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.364 0.666 . . . . 0.0 109.412 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 tt -69.01 153.12 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.1 m -75.95 -1.14 24.17 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -136.5 65.76 56.15 Favored Pre-proline 0 C--N 1.339 0.123 0 C-N-CA 123.944 0.898 . . . . 0.0 109.479 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.457 ' HB3' ' HE2' ' A' ' 175' ' ' LYS . 87.4 Cg_endo -72.29 -18.44 26.63 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.763 2.975 . . . . 0.0 111.658 -175.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 75.13 -18.81 2.43 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.799 0.714 . . . . 0.0 113.051 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -155.27 159.69 40.22 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.002 0.901 . . . . 0.0 110.477 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 t 59.41 167.83 0.06 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.866 1.267 . . . . 0.0 113.696 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.6 p30 47.99 16.0 0.08 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.236 1.815 . . . . 0.0 114.463 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 186' ' ' ARG . 51.5 m-20 51.33 25.3 2.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.298 1.039 . . . . 0.0 112.513 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.0 m 61.87 -19.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.949 1.699 . . . . 0.0 113.993 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.408 ' H ' ' C ' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -162.58 145.55 11.15 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.706 0.684 . . . . 0.0 110.073 173.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 83.4 p -159.52 153.12 22.69 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.615 0.366 . . . . 0.0 110.301 176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 55.0 t -142.72 -67.45 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -163.99 165.0 22.97 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.11 0.964 . . . . 0.0 109.934 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.7 p -88.58 7.6 32.46 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.835 0.454 . . . . 0.0 111.415 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -104.54 138.51 28.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.552 0.741 . . . . 0.0 111.297 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.09 160.64 32.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.544 0.737 . . . . 0.0 111.507 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 64.4 tp -119.71 133.89 55.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.036 1.334 . . . . 0.0 107.862 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -120.12 147.33 45.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.492 0.717 . . . . 0.0 109.861 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 81.5 m -142.09 145.36 34.2 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.4 mp -109.51 135.91 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 64.8 mt -94.85 -28.73 15.07 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -136.15 68.17 62.62 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 123.911 0.884 . . . . 0.0 109.587 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.55 57.41 4.26 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.704 3.603 . . . . 0.0 112.425 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.87 -3.12 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 O-C-N 121.958 -0.464 . . . . 0.0 111.616 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -130.13 166.59 19.91 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.924 0.89 . . . . 0.0 109.442 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 m -74.8 148.52 40.26 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.939 0.399 . . . . 0.0 111.604 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.9 mm -137.73 138.3 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.3 p -145.47 174.98 10.67 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.208 0.603 . . . . 0.0 109.893 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 38.0 p -63.14 -21.24 66.06 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 122.314 -0.241 . . . . 0.0 111.099 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -81.94 -26.18 34.25 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.024 0.375 . . . . 0.0 111.048 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.06 -38.59 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 86.3 mt -76.95 -22.92 52.52 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.921 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -76.3 -36.14 58.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 117.96 0.346 . . . . 0.0 110.785 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.1 t -78.11 -18.68 55.36 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.14 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -95.84 -14.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 118.348 0.522 . . . . 0.0 112.028 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 78.3 m -98.21 -24.36 15.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.869 0.758 . . . . 0.0 112.25 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.469 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 48.6 t30 -64.18 -38.87 38.34 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 86.1 Cg_endo -73.66 -0.05 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.635 1.557 . . . . 0.0 112.159 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 80.6 m -112.62 -5.69 13.97 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.609 0.364 . . . . 0.0 111.625 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 158.8 164.39 14.26 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.98 106.39 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.852 3.035 . . . . 0.0 110.638 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.7 t -78.49 150.63 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -117.03 -36.5 3.79 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.643 0.377 . . . . 0.0 111.279 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -164.12 156.43 17.05 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.101 0.41 . . . . 0.0 111.792 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 40.5 mt -144.77 143.75 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.751 0.821 . . . . 0.0 109.761 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.7 m -138.76 155.97 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 123.359 0.663 . . . . 0.0 109.756 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.7 mm -116.55 153.28 18.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 123.569 0.747 . . . . 0.0 111.096 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -138.8 145.81 40.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.009 0.924 . . . . 0.0 109.533 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 19.07 1.84 Allowed 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -177.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -64.44 -27.05 68.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.485 0.314 . . . . 0.0 110.446 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -153.44 123.86 7.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 58.44 -144.9 42.71 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.0 t -130.74 129.32 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -142.91 166.62 24.15 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.374 0.67 . . . . 0.0 109.878 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.01 171.18 20.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.388 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.6 mtp -135.77 149.38 49.13 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 55.2 t -136.63 150.77 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -139.85 141.33 36.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -118.27 170.47 8.87 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.834 0.853 . . . . 0.0 110.849 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.63 -13.16 59.98 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.549 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 46.1 t -150.53 153.56 36.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.677 0.391 . . . . 0.0 110.416 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.17 -26.5 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -71.04 -24.04 62.27 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 22.5 m -81.34 -27.43 34.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.22 -25.1 36.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.416 0.286 . . . . 0.0 110.457 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -70.56 -37.49 74.01 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -74.93 -29.33 60.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.315 0.246 . . . . 0.0 110.689 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.49 -52.44 45.97 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 119.733 -0.175 . . . . 0.0 111.268 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.41 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.76 -12.6 59.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.845 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.52 -10.22 52.32 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.822 0.283 . . . . 0.0 111.601 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 21.4 m -126.33 -1.78 6.93 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.7 mt -130.62 -5.36 4.14 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -78.14 132.71 37.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.38 6.9 71.39 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.46 174.94 11.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.672 0.736 . . . . 0.0 111.061 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -132.65 149.75 52.26 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.1 0.96 . . . . 0.0 108.763 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.4 mt -102.0 -17.63 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 117.433 0.106 . . . . 0.0 111.219 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.74 25.63 8.01 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.025 -0.422 . . . . 0.0 111.447 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 31.8 m 56.0 16.51 2.2 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.095 0.958 . . . . 0.0 112.476 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.98 141.56 3.88 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 85.2 m 54.13 -176.56 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.914 0.885 . . . . 0.0 112.014 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.1 m 51.01 33.08 8.37 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.977 0.511 . . . . 0.0 111.133 -174.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.7 m -60.13 139.8 57.29 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.991 0.516 . . . . 0.0 110.223 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 54.3 mt -96.79 156.9 16.15 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.111 0.564 . . . . 0.0 112.282 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -140.52 137.71 34.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 171.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 71.7 mt -136.0 142.33 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.082 0.467 . . . . 0.0 111.308 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.72 167.3 30.07 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.563 1.145 . . . . 0.0 108.54 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -79.01 141.49 37.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.803 -0.561 . . . . 0.0 110.684 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.67 167.9 14.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.423 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -81.26 -27.89 0.46 Allowed Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.2 Cg_endo -82.15 166.86 16.26 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 CA-C-N 121.913 1.719 . . . . 0.0 110.138 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.1 p -99.87 -5.32 28.62 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 122.332 0.253 . . . . 0.0 111.025 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -154.76 151.95 29.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.088 0.955 . . . . 0.0 109.92 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.46 171.41 7.53 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.779 0.832 . . . . 0.0 109.398 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -138.92 159.3 42.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.961 0.504 . . . . 0.0 109.893 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.94 154.02 35.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.912 0.885 . . . . 0.0 109.006 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -123.15 -21.71 5.35 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.672 0.389 . . . . 0.0 111.771 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -166.93 173.11 9.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.311 1.044 . . . . 0.0 109.695 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -116.48 113.51 22.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.073 0.463 . . . . 0.0 110.473 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -157.53 -174.38 4.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.204 1.401 . . . . 0.0 109.243 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -69.79 -4.15 18.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -117.24 -11.76 10.61 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.713 0.688 . . . . 0.0 112.031 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.2 t -158.55 134.25 8.88 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -152.65 150.73 29.79 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 122.087 -0.383 . . . . 0.0 111.055 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -123.24 137.45 54.87 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.247 0.619 . . . . 0.0 109.743 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -119.33 15.95 13.05 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.487 0.715 . . . . 0.0 112.091 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t -135.6 -10.69 2.12 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -77.45 162.0 70.36 Favored Pre-proline 0 CA--C 1.535 0.369 0 O-C-N 121.803 -0.561 . . . . 0.0 110.36 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.37 -7.32 10.15 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.58 2.853 . . . . 0.0 113.714 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -115.92 23.9 11.89 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.755 0.822 . . . . 0.0 111.451 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.08 -4.9 5.36 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 45.4 m -118.13 13.09 13.75 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.628 0.771 . . . . 0.0 110.716 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -135.53 -164.47 10.38 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -76.46 2.24 14.26 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 116.991 -2.005 . . . . 0.0 111.473 -179.764 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 110.71 -0.107 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -142.0 166.76 23.82 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.484 0.714 . . . . 0.0 111.078 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 19.5 tt -141.83 165.89 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.865 1.266 . . . . 0.0 108.86 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 80.8 p -75.91 -1.28 24.72 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -142.57 64.87 16.41 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.355 0.662 . . . . 0.0 109.762 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.96 -15.39 18.72 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.683 2.922 . . . . 0.0 111.893 -174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.58 -155.46 26.78 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -75.77 176.36 7.84 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.296 0.638 . . . . 0.0 110.932 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.0 m 61.07 178.26 0.11 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.174 0.989 . . . . 0.0 112.828 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 55.74 15.52 1.64 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.401 1.08 . . . . 0.0 112.907 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.2 t70 54.35 12.11 0.47 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.13 1.372 . . . . 0.0 113.722 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 93.8 p 40.97 -127.85 0.47 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.401 1.08 . . . . 0.0 111.977 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -139.99 138.21 35.3 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.5 0.72 . . . . 0.0 109.419 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 63.6 m 57.86 169.71 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.808 1.243 . . . . 0.0 113.521 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.31 -41.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 119.251 -0.404 . . . . 0.0 111.527 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -164.21 163.15 22.91 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.565 0.62 . . . . 0.0 111.194 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -90.12 18.08 6.29 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.565 0.746 . . . . 0.0 111.243 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.1 t -116.62 139.62 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.423 0.689 . . . . 0.0 110.325 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.2 mt -128.59 161.86 28.62 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.353 0.597 . . . . 0.0 110.621 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 tt -129.68 136.35 49.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -117.02 148.49 41.44 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.191 0.996 . . . . 0.0 109.903 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 89.8 m -133.28 141.16 47.86 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.4 mp -107.21 138.84 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 53.3 mt -108.06 -22.59 12.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -131.47 63.27 69.01 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 123.499 0.719 . . . . 0.0 109.777 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.92 40.04 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 125.104 3.869 . . . . 0.0 112.87 -173.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.4 pt -75.95 -2.91 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.6 -0.688 . . . . 0.0 111.531 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -130.4 165.22 23.02 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.987 0.915 . . . . 0.0 109.516 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 32.4 t -74.74 148.77 40.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.623 0.249 . . . . 0.0 111.487 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.7 mm -137.28 136.48 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 124.462 1.105 . . . . 0.0 108.175 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.0 p -143.97 176.88 8.95 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.138 0.575 . . . . 0.0 109.967 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.2 p -61.92 -22.68 65.8 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.569 0.348 . . . . 0.0 111.011 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.95 -24.61 35.45 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.48 0.312 . . . . 0.0 110.793 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.5 t -83.99 -37.6 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.95 -22.55 53.1 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.656 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -75.8 -36.92 59.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.196 0.453 . . . . 0.0 110.675 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 t -77.93 -18.7 55.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.396 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.94 -15.15 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.894 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.6 m -96.91 -25.42 15.43 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.741 0.701 . . . . 0.0 111.826 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.499 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 25.5 t-20 -58.75 -42.57 94.95 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 79.9 Cg_endo -71.26 -2.42 11.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.183 1.922 . . . . 0.0 112.379 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 83.7 m -115.03 -4.75 12.5 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.153 0.433 . . . . 0.0 111.642 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 158.86 158.68 9.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.76 114.59 3.75 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.674 2.916 . . . . 0.0 110.634 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.7 t -85.68 149.39 4.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -112.58 -34.74 5.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.893 0.477 . . . . 0.0 110.943 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -165.36 160.41 18.11 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 111.945 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 41.6 mt -143.48 147.43 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 124.256 1.023 . . . . 0.0 109.487 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.98 145.04 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.062 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.5 mm -112.76 151.61 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 123.754 0.822 . . . . 0.0 110.291 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -133.58 109.65 9.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -139.78 16.8 2.5 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.1 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -76.47 -27.78 56.27 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -150.68 136.81 18.47 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 59.61 -157.99 24.25 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.58 114.83 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 O-C-N 122.172 -0.605 . . . . 0.0 110.172 175.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -149.67 172.6 14.8 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.264 0.626 . . . . 0.0 110.611 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.65 168.56 26.76 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.62 0.768 . . . . 0.0 109.914 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 85.2 mtp -136.89 151.65 49.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.74 150.27 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.048 0.539 . . . . 0.0 110.062 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -133.08 139.53 47.19 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -114.04 167.38 10.71 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.777 0.831 . . . . 0.0 111.299 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -75.2 -14.13 60.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.9 t -152.06 151.49 31.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.017 0.527 . . . . 0.0 110.08 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.4 p -69.12 -24.05 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.41 -24.81 62.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 26.3 m -81.54 -25.38 35.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.738 0.415 . . . . 0.0 110.612 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.46 -26.4 35.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.64 -36.9 76.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -77.64 -29.33 51.66 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.31 -52.24 55.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 119.647 -0.216 . . . . 0.0 110.97 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.422 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.99 -15.07 59.75 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.628 0.649 . . . . 0.0 112.209 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -82.53 -12.7 57.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.986 0.357 . . . . 0.0 111.814 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -128.51 2.53 5.59 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 73.2 mt -129.59 -3.61 4.78 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.791 0.723 . . . . 0.0 112.491 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -78.5 131.53 36.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.24 3.63 76.85 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.75 179.95 5.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.762 0.781 . . . . 0.0 110.7 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.78 162.34 35.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.434 0.694 . . . . 0.0 109.181 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 38.3 mt -114.77 -20.09 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 111.227 0.084 . . . . 0.0 111.227 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -137.6 73.99 1.46 Allowed 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.048 -0.407 . . . . 0.0 111.498 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 25.0 m 49.2 48.37 21.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 95.28 0.07 63.47 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.257 0.456 . . . . 0.0 112.497 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 58.5 m -106.44 163.53 12.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 117.388 0.594 . . . . 0.0 109.67 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.8 m 51.94 41.45 29.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.022 0.529 . . . . 0.0 110.688 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.1 m -55.35 142.12 33.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.41 0.684 . . . . 0.0 109.795 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.0 mt -108.62 153.76 22.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.374 0.669 . . . . 0.0 112.022 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -140.26 135.0 31.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 171.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.422 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 79.4 mt -125.81 148.99 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.048 0.451 . . . . 0.0 111.435 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.86 165.97 34.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.034 1.333 . . . . 0.0 108.421 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.73 139.95 38.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.834 -0.541 . . . . 0.0 110.231 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -75.36 167.18 22.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.897 0.479 . . . . 0.0 111.427 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -71.72 -54.78 6.09 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.164 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.66 164.59 31.88 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.336 2.024 . . . . 0.0 111.123 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.0 p -91.74 -6.47 51.86 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.712 0.405 . . . . 0.0 111.576 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.62 167.06 30.81 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.732 0.813 . . . . 0.0 109.878 176.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 86.2 mt -123.54 173.15 8.23 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.517 0.727 . . . . 0.0 109.863 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -136.19 154.53 50.92 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 91.9 t -136.37 153.12 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.876 0.871 . . . . 0.0 108.65 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.72 -18.78 5.09 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -166.06 172.56 11.24 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.931 1.292 . . . . 0.0 109.296 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -119.06 110.63 17.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.01 0.434 . . . . 0.0 110.46 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -154.62 -169.85 3.34 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.796 1.238 . . . . 0.0 109.773 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -70.18 -6.66 35.93 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -114.42 -15.25 12.1 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.782 0.719 . . . . 0.0 112.209 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.2 t -159.02 140.17 12.97 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -154.88 148.32 25.14 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.997 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -128.03 135.7 50.23 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -112.87 5.12 17.26 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.612 0.765 . . . . 0.0 112.031 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.0 t -125.63 -4.64 7.1 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.907 0.483 . . . . 0.0 111.55 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -65.92 120.56 70.13 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.613 0.765 . . . . 0.0 109.467 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.15 -17.34 38.23 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.583 2.855 . . . . 0.0 113.682 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -104.54 3.52 31.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.085 0.554 . . . . 0.0 111.573 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 18.4 tp 50.98 28.62 3.93 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.774 0.83 . . . . 0.0 111.339 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 17.3 m 54.98 20.03 2.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.208 1.003 . . . . 0.0 113.21 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -77.31 174.93 54.43 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -82.14 -15.19 54.21 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.499 -0.412 . . . . 0.0 110.688 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-O 117.139 -1.923 . . . . 0.0 111.695 179.676 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -145.9 162.11 38.49 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.131 0.573 . . . . 0.0 109.658 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.9 tp -61.7 157.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.049 0.54 . . . . 0.0 110.595 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 78.5 p -82.85 1.27 40.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.392 0.677 . . . . 0.0 112.753 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -133.37 56.98 23.58 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 123.496 0.718 . . . . 0.0 111.063 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.01 159.14 45.1 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.628 2.886 . . . . 0.0 110.582 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.29 1.01 84.11 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.858 -0.412 . . . . 0.0 112.133 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -153.53 176.6 11.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.646 0.723 . . . . 0.0 110.721 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 39.5 m 58.61 18.78 6.1 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.591 1.157 . . . . 0.0 114.079 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 47.04 79.14 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.593 1.157 . . . . 0.0 112.867 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 60.97 -0.74 0.29 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 51.0 m 48.82 -154.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.049 0.94 . . . . 0.0 112.342 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 60.48 -175.95 0.11 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.45 1.1 . . . . 0.0 112.177 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 83.4 p -141.49 173.53 11.41 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.799 0.839 . . . . 0.0 110.177 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.0 t -118.66 -77.44 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 O-C-N 122.143 -0.348 . . . . 0.0 111.314 -176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -156.33 163.48 39.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.126 0.57 . . . . 0.0 110.685 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 82.3 p -87.12 13.59 9.13 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.245 0.618 . . . . 0.0 111.842 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.4 t -109.01 138.63 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 122.91 0.484 . . . . 0.0 110.885 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.67 160.83 31.24 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 121.427 0.632 . . . . 0.0 111.459 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.7 tp -125.7 130.29 51.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.94 1.296 . . . . 0.0 108.222 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -115.56 146.91 41.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.566 0.746 . . . . 0.0 109.985 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.4 m -138.43 142.63 39.52 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.7 mp -106.8 136.46 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 73.1 mt -92.4 -34.46 14.14 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -134.02 68.25 74.35 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 123.406 0.682 . . . . 0.0 109.543 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -74.41 62.92 5.4 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.555 3.503 . . . . 0.0 112.427 -174.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 44.8 pt -84.66 -4.85 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 122.024 -0.422 . . . . 0.0 111.289 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -126.85 167.88 15.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.945 0.898 . . . . 0.0 109.27 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 78.1 p -83.26 154.15 24.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.015 0.436 . . . . 0.0 111.21 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.0 mm -136.91 138.3 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.1 p -143.97 176.1 9.54 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.044 0.538 . . . . 0.0 110.018 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.9 p -62.12 -27.47 68.95 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 122.542 0.337 . . . . 0.0 110.966 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -78.03 -20.34 52.65 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.431 0.292 . . . . 0.0 111.495 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.42 -40.68 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 88.5 mt -73.56 -30.67 63.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.175 -0.328 . . . . 0.0 110.924 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -68.87 -37.82 79.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.217 0.462 . . . . 0.0 110.921 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 t -78.58 -17.43 56.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.481 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.35 -9.73 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 18.2 p -119.69 -6.23 10.16 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.347 0.976 . . . . 0.0 113.136 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.498 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.6 t-20 -63.06 -41.12 68.24 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.496 -0.764 . . . . 0.0 113.054 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 96.3 Cg_endo -71.7 -3.03 12.32 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.794 1.663 . . . . 0.0 111.982 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.2 m -93.58 -8.47 41.11 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.096 0.407 . . . . 0.0 111.41 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 144.91 174.58 17.29 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.38 114.91 3.42 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.672 2.915 . . . . 0.0 110.953 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 96.9 t -87.06 150.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -113.9 -37.61 4.45 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -165.17 159.16 17.29 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.518 0.599 . . . . 0.0 112.287 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 48.7 mt -142.83 144.36 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.081 0.953 . . . . 0.0 109.677 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.408 ' C ' HD12 ' A' ' 223' ' ' ILE . 6.4 p -143.85 142.71 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 123.486 0.714 . . . . 0.0 109.487 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 222' ' ' VAL . 1.8 mp -109.83 150.37 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 123.799 0.84 . . . . 0.0 109.649 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -136.35 138.79 42.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.619 0.767 . . . . 0.0 109.905 176.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.25 22.76 0.84 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -73.66 -20.13 60.64 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.997 -0.439 . . . . 0.0 110.281 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -154.56 122.09 5.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 60.43 -153.7 35.61 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -173.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.0 t -138.08 124.38 26.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -147.23 169.79 18.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.473 0.709 . . . . 0.0 110.636 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.35 169.28 24.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.024 0.53 . . . . 0.0 109.731 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.0 mtp -137.96 151.71 48.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.1 t -139.3 151.1 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 C-N-CA 122.904 0.482 . . . . 0.0 109.884 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -135.41 141.65 45.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.457 0.703 . . . . 0.0 109.192 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -117.37 168.45 10.34 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.087 0.955 . . . . 0.0 110.761 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.88 -9.98 59.77 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.791 0.437 . . . . 0.0 110.889 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.1 t -150.17 147.67 28.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.103 0.561 . . . . 0.0 109.935 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 -23.3 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -73.2 -23.23 60.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.082 -0.386 . . . . 0.0 110.235 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 42.2 m -80.85 -28.12 36.2 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.82 -25.43 44.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -70.92 -37.96 72.93 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -74.96 -27.61 60.24 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.247 0.619 . . . . 0.0 110.965 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.32 -54.98 10.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.125 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -14.77 60.35 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.356 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -81.52 -16.62 51.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.118 0.417 . . . . 0.0 111.568 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -123.44 4.38 9.04 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.7 mt -121.65 -5.69 9.19 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.856 0.753 . . . . 0.0 112.559 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -74.79 129.93 38.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.943 0.792 . . . . 0.0 109.149 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.43 8.78 76.56 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.13 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.93 174.15 10.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.85 0.825 . . . . 0.0 111.333 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -137.71 145.26 42.33 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.66 0.784 . . . . 0.0 109.185 -177.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 51.8 mt -108.29 -19.11 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -126.11 22.34 7.28 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.91 -0.494 . . . . 0.0 111.776 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 25.6 m 55.95 20.88 4.52 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.509 0.724 . . . . 0.0 111.91 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 173.44 135.07 1.93 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 76.6 m 54.73 -173.36 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.232 1.013 . . . . 0.0 112.129 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m 52.58 31.62 10.35 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.815 0.446 . . . . 0.0 111.673 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 26.9 m -58.61 140.61 54.14 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.738 0.415 . . . . 0.0 109.948 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.4 mt -95.07 154.99 16.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.023 0.44 . . . . 0.0 112.014 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -145.65 134.7 22.67 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.34 150.42 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-O 120.993 0.425 . . . . 0.0 111.247 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -153.75 168.05 27.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.194 1.398 . . . . 0.0 108.364 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.85 144.0 32.33 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 121.74 -0.6 . . . . 0.0 110.994 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.03 170.3 10.46 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.413 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.7 pttt -86.0 -26.21 0.36 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -177.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.4 Cg_endo -82.23 164.63 17.11 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 121.881 1.707 . . . . 0.0 110.406 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 58.4 p -93.45 -9.04 39.88 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 122.265 -0.272 . . . . 0.0 111.564 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.39 168.48 27.21 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.746 0.818 . . . . 0.0 109.711 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 87.7 mt -120.6 170.74 9.13 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.369 0.668 . . . . 0.0 109.685 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -131.1 157.47 43.02 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.449 0.166 . . . . 0.0 110.667 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 87.0 t -137.85 153.93 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 124.08 0.952 . . . . 0.0 108.958 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -128.06 -14.66 4.91 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.294 0.238 . . . . 0.0 111.627 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -163.54 170.32 17.43 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.048 0.939 . . . . 0.0 109.237 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.33 99.65 6.83 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -152.96 -169.14 3.25 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.103 0.961 . . . . 0.0 110.102 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -72.27 -1.81 16.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.53 -31.39 8.54 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.183 0.593 . . . . 0.0 110.8 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.3 t -159.28 147.02 17.43 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -152.48 146.68 25.46 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.721 0.296 . . . . 0.0 110.705 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -121.28 134.3 55.16 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.956 0.502 . . . . 0.0 109.646 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.99 6.48 19.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.554 0.742 . . . . 0.0 112.449 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.9 t -125.8 0.27 7.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.15 0.58 . . . . 0.0 110.552 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 285' ' ' PRO . 60.8 t-20 -66.89 123.63 86.59 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.146 0.978 . . . . 0.0 109.661 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 284' ' ' ASN . 51.9 Cg_exo -58.69 -13.97 19.84 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.411 2.741 . . . . 0.0 113.727 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -87.67 0.15 56.08 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.0 tp -79.68 -22.7 43.14 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.929 0.331 . . . . 0.0 111.052 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.2 p -148.09 3.88 0.71 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.651 0.38 . . . . 0.0 111.992 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 78.81 170.36 38.03 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -142.82 8.17 1.69 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.758 0.423 . . . . 0.0 111.887 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 117.308 -1.829 . . . . 0.0 111.217 -179.51 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -138.07 168.9 18.75 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.274 0.63 . . . . 0.0 110.521 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 tt -69.27 162.12 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.396 0.678 . . . . 0.0 109.98 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.8 m -70.77 -1.52 11.81 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.0 ttp-105 -147.17 70.59 11.97 Favored Pre-proline 0 CA--C 1.53 0.184 0 C-N-CA 123.595 0.758 . . . . 0.0 109.05 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.13 -16.98 15.42 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.664 2.909 . . . . 0.0 112.301 -172.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.78 -5.33 24.61 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.887 -0.396 . . . . 0.0 112.958 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -152.29 150.31 29.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 117.749 0.774 . . . . 0.0 109.692 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.2 t 58.55 166.45 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.363 1.065 . . . . 0.0 111.974 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 48.97 37.13 9.64 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.288 0.635 . . . . 0.0 111.903 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 54.43 28.85 10.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.654 0.782 . . . . 0.0 112.246 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 55.5 p 57.41 11.84 1.29 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.858 1.663 . . . . 0.0 113.944 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 55.83 -177.92 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.976 1.31 . . . . 0.0 112.886 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 43.0 t -147.14 159.69 43.31 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.414 0.685 . . . . 0.0 109.881 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.54 -72.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.5 p30 -162.62 166.17 24.92 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.338 0.655 . . . . 0.0 110.28 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.9 p -97.46 8.62 44.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.372 0.669 . . . . 0.0 111.975 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.96 143.37 18.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 123.055 0.542 . . . . 0.0 110.86 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.0 mt -129.0 163.54 25.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.073 0.549 . . . . 0.0 111.663 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.7 tp -123.24 133.38 54.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.654 1.182 . . . . 0.0 108.179 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -120.24 143.62 48.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.675 0.79 . . . . 0.0 109.383 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 97.4 m -139.51 143.55 37.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.0 mp -106.35 135.38 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.8 mt -90.39 -36.52 14.56 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -131.93 64.27 71.84 Favored Pre-proline 0 CA--C 1.529 0.135 0 C-N-CA 123.379 0.672 . . . . 0.0 109.922 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.6 102.91 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.608 2.205 . . . . 0.0 111.135 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.4 pt -129.58 2.7 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 122.996 0.518 . . . . 0.0 111.401 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -130.6 169.58 15.42 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.791 0.836 . . . . 0.0 109.492 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.5 m -77.58 145.86 36.58 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.5 mm -137.18 133.89 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 61.7 p -142.58 175.55 9.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.8 p -64.37 -20.48 66.15 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 122.296 0.239 . . . . 0.0 111.206 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.7 -25.34 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 122.283 0.233 . . . . 0.0 110.587 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.7 t -82.42 -36.87 13.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.7 -25.43 53.59 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.122 -0.362 . . . . 0.0 110.781 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -78.39 -34.5 48.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.023 -0.423 . . . . 0.0 111.057 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -74.9 -23.46 58.37 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.563 0.62 . . . . 0.0 111.389 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.6 pt -88.73 -23.17 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.176 0.444 . . . . 0.0 111.723 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.9 m -95.58 -20.15 19.22 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.618 0.645 . . . . 0.0 112.483 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.459 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.41 -43.79 90.48 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 87.8 Cg_endo -73.94 -9.63 22.4 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.887 1.724 . . . . 0.0 111.651 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 82.3 m -91.98 -21.56 20.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.023 0.374 . . . . 0.0 111.207 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.15 172.45 30.65 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.57 105.14 1.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 124.122 3.215 . . . . 0.0 110.549 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 94.0 t -78.32 150.14 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -113.53 -41.09 3.69 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.778 0.431 . . . . 0.0 110.876 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.73 163.34 32.4 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.177 0.444 . . . . 0.0 111.472 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.43 146.9 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.534 0.734 . . . . 0.0 109.903 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.24 147.6 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 54.3 mt -133.15 151.44 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.348 0.659 . . . . 0.0 110.085 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -131.77 128.92 39.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -146.14 23.78 1.33 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -72.91 -29.36 63.08 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -151.62 127.97 10.62 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 60.57 -159.67 25.56 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -172.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.1 t -140.81 128.42 22.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.304 0.552 . . . . 0.0 109.627 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -146.38 163.26 36.16 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 123.608 0.763 . . . . 0.0 109.424 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.4 171.9 19.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.552 0.215 . . . . 0.0 110.876 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.1 mtp -142.28 150.38 40.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 49.0 t -139.25 151.37 23.04 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.987 0.515 . . . . 0.0 109.719 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -136.2 141.32 44.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.144 0.577 . . . . 0.0 109.497 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -116.31 168.84 9.78 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.905 0.882 . . . . 0.0 110.983 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.55 -14.16 60.76 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.831 0.452 . . . . 0.0 111.22 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 48.4 t -152.7 153.54 33.47 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.878 0.471 . . . . 0.0 110.378 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.09 -25.71 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.57 -29.4 68.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.012 0.369 . . . . 0.0 110.056 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 20.8 m -79.24 -27.58 42.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.541 0.336 . . . . 0.0 110.65 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.4 -27.45 38.1 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -68.01 -37.24 81.2 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -78.46 -25.68 45.9 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.344 0.257 . . . . 0.0 110.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.93 -55.39 17.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.343 0.257 . . . . 0.0 110.807 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -16.36 60.51 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.566 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -78.43 -14.65 59.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.189 0.45 . . . . 0.0 111.643 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 55.6 m -125.07 1.56 7.94 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.56 -5.17 4.72 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -78.22 132.79 37.7 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.917 0.781 . . . . 0.0 109.124 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.33 6.66 70.42 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.48 176.6 7.39 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.715 0.758 . . . . 0.0 111.343 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -139.6 151.07 45.72 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.707 0.803 . . . . 0.0 109.13 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.1 mt -114.63 -17.8 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 122.405 0.282 . . . . 0.0 111.296 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -127.96 25.1 5.96 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.059 -0.401 . . . . 0.0 111.567 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.3 p 53.3 19.41 1.55 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.119 1.368 . . . . 0.0 112.592 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 170.9 138.78 2.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 69.6 m 56.91 179.6 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.26 1.024 . . . . 0.0 112.107 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.3 m 52.94 30.36 9.18 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.772 0.429 . . . . 0.0 111.735 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.7 m -60.27 141.68 55.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.244 0.618 . . . . 0.0 109.87 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.42 155.41 16.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -144.51 124.78 13.76 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.41 147.38 28.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 CA-C-O 121.163 0.506 . . . . 0.0 111.542 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.56 171.01 20.66 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.718 1.207 . . . . 0.0 108.762 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -80.99 143.98 32.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 122.051 -0.405 . . . . 0.0 110.45 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.3 167.2 15.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.319 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.44 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -83.46 -26.56 0.4 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -176.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 48.2 Cg_endo -80.95 -176.7 3.29 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.952 1.768 . . . . 0.0 109.9 176.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 67.2 p -117.77 -0.75 11.71 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.749 0.42 . . . . 0.0 110.89 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -155.16 146.05 22.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.912 0.885 . . . . 0.0 109.255 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.9 mt -112.35 167.55 10.34 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.246 0.619 . . . . 0.0 110.01 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -129.62 166.74 19.15 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.49 0.316 . . . . 0.0 110.813 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.73 155.71 22.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.223 1.009 . . . . 0.0 109.023 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -130.47 -16.74 3.41 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.368 0.267 . . . . 0.0 111.563 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -165.84 174.38 9.66 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.182 0.993 . . . . 0.0 109.516 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -120.35 96.69 5.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -148.35 -166.01 2.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.929 0.892 . . . . 0.0 110.126 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -73.36 -3.0 24.51 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -112.48 -21.88 11.11 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.813 0.733 . . . . 0.0 111.749 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.2 t -159.9 144.97 15.17 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -151.86 153.3 33.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.91 138.75 51.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 110.393 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -116.4 7.19 13.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.556 0.742 . . . . 0.0 112.331 -174.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.4 t -125.61 -4.04 7.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.875 0.47 . . . . 0.0 110.517 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -57.75 135.15 82.96 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 124.862 1.265 . . . . 0.0 108.878 174.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -62.15 -9.38 14.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.767 2.978 . . . . 0.0 114.289 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.93 11.03 30.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.151 0.887 . . . . 0.0 111.486 175.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.88 14.36 2.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.883 0.873 . . . . 0.0 110.204 178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 32.7 t -150.59 160.55 43.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.118 0.567 . . . . 0.0 110.082 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 67.83 -155.9 52.83 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.39 -13.97 60.43 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.863 0.465 . . . . 0.0 111.318 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.454 -1.748 . . . . 0.0 111.325 -179.51 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -83.88 -60.61 2.05 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.398 0.279 . . . . 0.0 110.509 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 32.6 pt -150.47 -177.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.416 1.486 . . . . 0.0 108.724 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 39.7 m -84.51 -3.13 58.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -149.45 52.2 1.07 Allowed Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.35 168.59 23.03 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.348 2.699 . . . . 0.0 111.074 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.35 -173.77 30.36 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -131.5 157.18 44.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.079 0.552 . . . . 0.0 110.734 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.9 p 58.85 159.26 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.043 1.737 . . . . 0.0 113.656 -175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.0 t70 48.92 -152.13 0.13 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.032 0.933 . . . . 0.0 110.938 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.6 t0 59.56 172.34 0.08 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.722 1.209 . . . . 0.0 113.655 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 94.1 p 48.62 28.48 1.81 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.466 1.506 . . . . 0.0 113.609 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -141.03 151.69 44.27 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.793 0.437 . . . . 0.0 110.962 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 40.7 t -155.08 149.52 26.22 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.153 0.581 . . . . 0.0 110.21 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 52.3 t -142.14 -75.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.048 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 -161.07 166.09 28.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.19 0.996 . . . . 0.0 110.081 176.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 85.8 p -86.31 13.97 7.29 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.147 0.579 . . . . 0.0 112.264 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.75 138.91 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 123.002 0.521 . . . . 0.0 110.712 -176.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.8 mt -129.56 162.45 28.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.416 0.627 . . . . 0.0 111.246 -177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.1 tp -122.43 133.09 54.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.935 1.294 . . . . 0.0 107.994 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -118.8 145.42 45.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.677 0.791 . . . . 0.0 109.827 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 96.2 m -136.19 141.75 44.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.9 mp -107.27 133.23 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 66.3 mt -92.69 -29.51 16.04 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -137.89 69.35 50.7 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 123.557 0.743 . . . . 0.0 109.586 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.4 56.16 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.529 3.486 . . . . 0.0 112.047 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.8 pt -81.04 -1.53 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 122.03 -0.419 . . . . 0.0 111.603 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -128.85 167.24 17.64 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.683 0.793 . . . . 0.0 109.685 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.1 m -75.84 149.78 37.8 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 111.539 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.4 mm -137.49 137.57 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 81.0 p -145.27 175.49 10.24 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.385 0.674 . . . . 0.0 109.782 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.2 p -63.64 -22.82 67.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 119.673 -0.203 . . . . 0.0 111.049 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -79.0 -23.87 44.09 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.298 0.239 . . . . 0.0 111.129 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 88.1 t -86.33 -39.11 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.92 -22.8 58.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.11 -0.369 . . . . 0.0 110.94 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -78.89 -36.11 42.6 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.885 0.311 . . . . 0.0 111.144 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.9 t -74.94 -20.47 59.67 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.89 -0.506 . . . . 0.0 111.327 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.2 pt -92.04 -21.54 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.7 m -97.85 -23.67 15.76 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.798 0.726 . . . . 0.0 112.899 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.48 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 51.1 t30 -65.21 -40.78 47.5 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 98.3 Cg_endo -72.91 -8.96 23.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.424 1.416 . . . . 0.0 111.684 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 77.5 m -97.81 -12.69 21.91 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.707 0.403 . . . . 0.0 111.17 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 161.65 162.06 12.57 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.28 110.73 2.09 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.654 2.903 . . . . 0.0 110.581 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.7 149.79 4.37 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -115.0 -34.75 4.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.847 0.459 . . . . 0.0 110.901 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -164.32 159.49 19.9 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.3 144.65 23.42 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 124.098 0.959 . . . . 0.0 109.644 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.02 142.96 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.288 0.635 . . . . 0.0 109.472 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.03 150.58 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.905 0.882 . . . . 0.0 109.756 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -136.64 147.88 47.14 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.019 0.928 . . . . 0.0 109.878 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.78 17.94 1.98 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.997 0.519 . . . . 0.0 112.28 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.62 -24.45 67.05 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 122.232 -0.292 . . . . 0.0 110.825 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -154.47 123.73 6.44 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 59.4 -144.1 45.82 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.7 t -134.31 127.32 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -145.81 168.23 21.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.99 0.516 . . . . 0.0 110.547 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.53 167.05 31.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.6 mtp -134.38 150.94 50.94 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.35 149.36 22.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.643 0.377 . . . . 0.0 110.194 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -131.52 140.73 49.58 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -116.27 167.91 10.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.872 0.869 . . . . 0.0 110.648 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -72.31 -18.84 61.75 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.686 0.394 . . . . 0.0 111.611 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 85.1 p -151.64 159.86 43.87 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.913 0.485 . . . . 0.0 110.473 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.7 -28.78 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 O-C-N 122.18 -0.325 . . . . 0.0 110.386 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -69.3 -25.07 64.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.035 0.38 . . . . 0.0 110.394 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 59.6 m -78.37 -29.39 47.39 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.45 -24.5 42.38 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.396 -0.19 . . . . 0.0 110.941 176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -70.86 -36.63 72.93 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -78.51 -27.16 46.04 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 122.153 -0.342 . . . . 0.0 110.578 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.39 -52.71 51.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.174 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.421 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.66 -17.37 60.0 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.838 0.744 . . . . 0.0 111.74 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -82.46 -9.61 59.36 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.934 0.334 . . . . 0.0 111.547 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.2 m -124.93 -2.3 7.75 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 79.9 mt -131.11 -4.58 3.91 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.697 0.68 . . . . 0.0 112.823 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -75.76 132.81 40.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 118.953 0.797 . . . . 0.0 109.13 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.78 5.24 68.68 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 119.794 -0.448 . . . . 0.0 112.331 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.93 175.44 10.04 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.712 0.756 . . . . 0.0 111.506 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -132.64 145.07 50.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.2 mt -92.12 -22.17 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 O-C-N 122.491 -0.131 . . . . 0.0 111.348 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -123.64 25.49 8.13 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.729 0.412 . . . . 0.0 111.591 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 37.9 m 55.98 17.27 2.52 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.938 0.895 . . . . 0.0 112.222 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.96 139.2 3.32 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 67.9 m 54.24 -177.16 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.691 0.796 . . . . 0.0 111.804 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m 51.07 33.79 9.77 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.002 -0.436 . . . . 0.0 111.183 -174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.2 m -59.89 142.95 52.66 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 122.821 0.448 . . . . 0.0 110.043 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 56.1 mt -103.53 157.33 17.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.259 0.552 . . . . 0.0 112.232 -174.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -144.36 134.68 24.42 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.421 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 88.0 mt -127.96 148.96 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.306 0.574 . . . . 0.0 111.543 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.08 171.37 20.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.969 1.308 . . . . 0.0 108.374 172.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -84.14 144.35 29.07 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.943 -0.473 . . . . 0.0 110.775 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.06 168.43 11.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.345 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -84.26 -27.35 0.4 Allowed Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -176.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 44.9 Cg_endo -81.91 167.38 16.39 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 CA-C-N 121.752 1.661 . . . . 0.0 110.4 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 45.3 p -96.68 -9.11 29.83 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.28 0.232 . . . . 0.0 111.286 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 170.29 22.31 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.711 0.804 . . . . 0.0 109.617 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 91.6 mt -124.23 167.93 13.63 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.924 0.49 . . . . 0.0 110.758 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -123.58 158.55 31.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.434 HG11 ' C ' ' A' ' 280' ' ' TRP . 5.6 t -131.87 -24.78 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 122.309 0.244 . . . . 0.0 111.518 -171.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 62.89 -37.05 0.14 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.185 1.794 . . . . 0.0 115.055 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -164.64 177.87 7.74 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.787 0.835 . . . . 0.0 110.446 -174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -118.85 113.14 20.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -155.2 -174.66 5.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.699 1.199 . . . . 0.0 109.87 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -70.94 -3.82 21.32 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -113.17 -16.88 12.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.619 0.645 . . . . 0.0 111.438 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 14.6 t -156.98 132.42 9.23 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' TRP . . . . . 0.434 ' C ' HG11 ' A' ' 272' ' ' VAL . 12.6 t-105 -147.01 149.82 33.89 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 122.071 -0.393 . . . . 0.0 111.299 -175.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -126.22 137.65 53.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.3 0.64 . . . . 0.0 109.677 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -115.87 4.28 13.87 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.619 0.768 . . . . 0.0 112.464 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 11.8 t -119.22 -12.2 9.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.013 0.525 . . . . 0.0 111.707 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -71.72 158.09 88.48 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.119 0.568 . . . . 0.0 110.538 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -61.37 -11.34 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.158 3.238 . . . . 0.0 113.426 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -88.74 3.19 51.75 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.643 0.377 . . . . 0.0 111.937 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -140.36 -44.61 0.41 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.8 p 43.82 39.11 2.39 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.695 1.198 . . . . 0.0 113.028 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.33 -2.23 18.79 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.362 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -137.88 13.74 2.9 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.808 0.804 . . . . 0.0 111.493 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 117.387 -1.785 . . . . 0.0 111.675 -179.316 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 120.535 0.207 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -146.19 -63.4 0.31 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 122.85 0.46 . . . . 0.0 110.298 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 178' ' ' ARG . 19.4 tt -160.66 158.21 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.508 0.723 . . . . 0.0 109.173 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 80.9 p -83.81 -6.64 59.47 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.421 ' H ' HG12 ' A' ' 176' ' ' ILE . 55.8 ttm-85 -150.05 73.39 9.37 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 122.933 0.493 . . . . 0.0 110.117 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.44 -11.36 24.53 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.894 3.062 . . . . 0.0 111.526 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.2 178.1 49.79 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 183' ' ' ASP . 5.0 p-10 -143.13 157.08 44.84 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.653 0.381 . . . . 0.0 110.524 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.0 t 59.3 -9.64 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.147 1.379 . . . . 0.0 114.167 -177.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 181' ' ' ASP . 40.1 m-20 49.6 26.39 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.653 1.181 . . . . 0.0 112.999 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t70 53.04 26.18 4.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.84 0.856 . . . . 0.0 112.247 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 25.9 m 57.14 11.8 1.13 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.788 1.235 . . . . 0.0 113.421 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 59.08 147.22 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.095 1.758 . . . . 0.0 113.856 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 81.7 p -155.37 155.63 33.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.734 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.1 t -141.48 -75.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.458 -0.056 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -159.95 168.49 25.56 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.895 0.878 . . . . 0.0 110.082 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.4 p -89.16 13.3 13.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.431 0.693 . . . . 0.0 111.607 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 31.3 t -112.73 139.92 35.26 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 123.271 0.628 . . . . 0.0 110.962 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.0 mt -130.32 163.63 26.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.375 0.607 . . . . 0.0 111.279 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.2 tp -124.98 133.47 53.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.842 1.257 . . . . 0.0 107.962 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -119.37 142.95 47.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.743 0.817 . . . . 0.0 110.106 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 88.4 m -137.67 143.85 41.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.4 mp -108.51 137.99 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.8 mt -92.09 -35.46 13.89 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -133.0 68.73 78.81 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.801 0.84 . . . . 0.0 109.428 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.29 67.62 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.321 3.347 . . . . 0.0 112.109 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.1 pt -88.07 -4.34 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 122.079 -0.388 . . . . 0.0 111.128 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -128.18 169.27 14.32 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.02 0.928 . . . . 0.0 109.239 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 79.8 p -85.04 155.26 21.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.832 0.349 . . . . 0.0 111.487 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mm -135.66 138.18 48.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.3 p -143.27 174.39 10.76 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.956 0.502 . . . . 0.0 110.146 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 39.6 p -62.24 -25.2 67.69 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.415 0.286 . . . . 0.0 111.061 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -78.71 -24.36 45.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.349 0.26 . . . . 0.0 111.185 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.6 t -84.29 -38.34 13.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.83 -23.39 52.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.226 -0.296 . . . . 0.0 110.977 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -79.39 -33.85 42.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.271 0.487 . . . . 0.0 111.079 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -76.64 -20.92 56.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.219 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.3 pt -91.58 -22.35 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 118.251 0.478 . . . . 0.0 111.707 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.5 m -94.83 -19.53 20.24 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.39 0.541 . . . . 0.0 112.271 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.8 t-20 -59.8 -43.69 95.54 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 90.6 Cg_endo -71.56 -5.98 18.19 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.875 1.717 . . . . 0.0 112.22 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 86.1 m -96.13 -5.89 39.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.079 0.399 . . . . 0.0 111.134 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 137.44 174.24 13.26 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.8 119.25 6.26 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.711 2.941 . . . . 0.0 111.263 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.16 151.85 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -113.29 -36.46 5.0 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.101 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -165.3 160.24 18.08 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.198 0.453 . . . . 0.0 111.966 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 48.7 mt -143.0 147.54 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.971 0.908 . . . . 0.0 109.321 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.24 144.47 18.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 123.103 0.561 . . . . 0.0 109.795 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.51 150.9 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.797 0.839 . . . . 0.0 109.969 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -136.2 144.79 45.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.705 0.802 . . . . 0.0 109.073 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -146.13 20.46 1.41 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -68.78 -19.05 64.29 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.373 -0.205 . . . . 0.0 111.108 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -156.3 120.77 4.54 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 58.92 -145.98 42.95 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.3 t -132.59 132.3 59.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -145.48 168.5 20.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.633 0.773 . . . . 0.0 109.99 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -158.32 169.09 25.26 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.125 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.8 mtp -137.12 150.77 48.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.02 149.83 24.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -132.23 140.84 48.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -117.04 169.05 9.72 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.907 0.883 . . . . 0.0 110.849 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -77.81 -13.85 59.76 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.059 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 95.6 p -151.93 157.33 41.64 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.986 0.422 . . . . 0.0 110.839 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.72 -25.03 27.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.159 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -67.3 -29.99 69.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.124 -0.36 . . . . 0.0 110.344 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 50.2 m -79.41 -28.14 41.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.34 -26.68 42.09 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -70.05 -36.43 74.99 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -77.39 -27.47 52.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.457 -0.152 . . . . 0.0 110.631 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.02 -51.82 50.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.279 -0.263 . . . . 0.0 111.277 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.408 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.31 -13.93 60.13 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.516 179.531 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -86.78 -10.05 54.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.889 0.313 . . . . 0.0 111.495 176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.3 m -124.48 -2.05 8.0 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 88.1 mt -129.85 -5.22 4.56 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -77.35 130.69 37.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.975 0.807 . . . . 0.0 109.058 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.29 7.38 72.17 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.57 175.57 9.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.727 0.764 . . . . 0.0 111.568 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -137.3 144.88 42.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.96 0.904 . . . . 0.0 108.963 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.5 mt -109.34 -20.12 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 122.546 0.338 . . . . 0.0 111.603 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -127.37 28.52 5.69 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.973 -0.454 . . . . 0.0 111.43 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 96.2 p 49.79 22.66 0.86 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.046 1.338 . . . . 0.0 112.727 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 171.57 136.28 2.09 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 81.1 m 55.48 -172.62 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.924 0.89 . . . . 0.0 112.15 -176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.4 m 51.69 31.45 7.96 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.151 0.58 . . . . 0.0 112.003 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.6 m -59.12 140.49 55.79 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.852 0.461 . . . . 0.0 109.849 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.3 mt -94.31 154.79 17.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.202 0.525 . . . . 0.0 112.162 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -145.14 132.76 20.93 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 84.4 mt -132.7 147.94 31.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.247 0.546 . . . . 0.0 112.29 -172.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.36 172.87 15.8 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.869 1.268 . . . . 0.0 108.8 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -84.41 142.28 30.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.22 -0.3 . . . . 0.0 110.598 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.87 169.59 12.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.44 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -85.78 -26.97 0.37 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.0 Cg_endo -82.62 164.91 16.16 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.01 1.807 . . . . 0.0 110.261 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.5 p -94.1 -7.84 41.33 Favored 'General case' 0 CA--C 1.527 0.065 0 O-C-N 122.325 -0.234 . . . . 0.0 111.396 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.85 169.13 25.47 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.835 0.854 . . . . 0.0 109.809 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 85.9 mt -121.06 173.18 7.43 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.461 0.705 . . . . 0.0 110.08 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -129.42 157.37 42.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.601 0.36 . . . . 0.0 110.485 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.9 t -138.36 152.33 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 C-N-CA 124.118 0.967 . . . . 0.0 108.866 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -125.84 -14.8 6.09 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.394 0.278 . . . . 0.0 111.627 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -164.68 173.92 11.35 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.286 1.034 . . . . 0.0 109.885 -176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -119.95 98.24 6.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -150.58 -168.79 3.21 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.868 0.867 . . . . 0.0 110.311 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -71.77 -4.11 25.9 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -110.88 -24.65 10.28 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.673 0.67 . . . . 0.0 111.753 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.8 t -157.63 144.57 18.15 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 173.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -152.76 147.99 26.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.172 0.189 . . . . 0.0 110.522 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -122.17 134.84 54.72 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.73 8.53 17.51 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.702 0.801 . . . . 0.0 112.17 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.7 t -128.5 2.4 5.6 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.289 0.636 . . . . 0.0 110.532 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -66.2 129.04 94.18 Favored Pre-proline 0 N--CA 1.453 -0.312 0 C-N-CA 124.455 1.102 . . . . 0.0 109.455 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.04 -6.83 13.69 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.44 2.76 . . . . 0.0 112.853 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -89.55 1.41 55.97 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.824 0.45 . . . . 0.0 111.139 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 61.8 tp -138.48 -29.73 0.79 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.137 0.575 . . . . 0.0 111.041 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 48.7 m -82.21 166.13 19.87 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.896 0.479 . . . . 0.0 110.394 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.4 158.26 51.14 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -131.97 7.63 4.37 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.655 0.782 . . . . 0.0 110.781 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.325 -1.82 . . . . 0.0 110.763 -179.523 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.624 0.25 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -146.25 160.14 42.39 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.561 0.744 . . . . 0.0 109.489 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.3 tp -63.92 153.54 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.356 0.662 . . . . 0.0 110.598 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.3 p -80.36 4.8 16.75 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.616 0.767 . . . . 0.0 112.52 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -134.85 59.39 34.44 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 123.88 0.872 . . . . 0.0 109.523 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -76.2 -11.5 19.34 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.807 3.004 . . . . 0.0 112.252 -172.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.33 8.6 0.03 OUTLIER Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.509 -0.606 . . . . 0.0 113.207 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -71.09 140.69 50.74 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.488 1.144 . . . . 0.0 110.433 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.4 t 54.98 -173.43 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.288 1.035 . . . . 0.0 112.196 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 51.51 25.66 2.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.974 0.91 . . . . 0.0 112.778 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.5 t70 52.49 23.35 2.5 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.016 0.927 . . . . 0.0 112.032 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.8 t 57.79 9.16 0.81 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.728 1.211 . . . . 0.0 113.518 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -155.25 125.58 6.77 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.863 -0.523 . . . . 0.0 109.708 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 61.4 p -156.22 154.57 30.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.691 0.281 . . . . 0.0 111.453 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 6.9 p -151.43 -46.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.051 0.54 . . . . 0.0 109.942 173.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -164.01 164.07 23.2 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.035 0.934 . . . . 0.0 109.461 172.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.7 p -96.64 15.39 21.87 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.216 0.606 . . . . 0.0 112.082 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.34 143.53 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 123.038 0.535 . . . . 0.0 111.022 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.7 mt -129.13 166.13 19.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.182 0.593 . . . . 0.0 111.325 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.6 tp -124.95 133.95 52.83 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.823 1.249 . . . . 0.0 107.999 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -120.12 147.71 44.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.832 0.853 . . . . 0.0 109.889 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.8 m -136.82 139.11 41.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.5 mp -103.47 135.69 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 50.4 mt -102.5 -17.07 15.93 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -139.13 66.55 38.69 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 123.657 0.783 . . . . 0.0 109.362 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.24 40.58 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 124.903 3.735 . . . . 0.0 112.069 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 32.9 pt -77.66 -1.58 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 O-C-N 121.944 -0.473 . . . . 0.0 111.791 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -132.11 165.89 23.01 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.131 0.972 . . . . 0.0 109.216 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.9 m -73.98 149.6 41.22 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.758 0.313 . . . . 0.0 111.303 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.5 mm -136.54 137.98 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.7 p -145.33 175.33 10.38 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.287 0.635 . . . . 0.0 109.77 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.0 p -63.0 -23.1 67.3 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 122.423 0.289 . . . . 0.0 111.199 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.24 -26.68 35.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.311 -0.243 . . . . 0.0 111.205 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 89.8 t -81.86 -36.78 14.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.8 mt -76.9 -24.16 52.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 122.378 -0.201 . . . . 0.0 110.528 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -76.83 -36.15 57.06 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.851 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -77.52 -20.06 54.83 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.344 0.52 . . . . 0.0 111.544 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -93.27 -15.47 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 118.331 0.514 . . . . 0.0 111.653 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 67.5 m -98.52 -21.68 16.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.642 0.655 . . . . 0.0 111.924 176.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.47 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.9 t-20 -58.82 -43.4 97.69 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 96.6 Cg_endo -72.31 -8.83 23.39 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.004 1.803 . . . . 0.0 112.012 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 70.7 m -96.21 -21.0 18.15 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.912 0.324 . . . . 0.0 111.151 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.63 168.09 25.1 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.91 112.58 3.14 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.757 2.971 . . . . 0.0 110.895 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.99 151.48 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 123.286 0.634 . . . . 0.0 109.395 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -116.42 -36.05 4.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.0 0.52 . . . . 0.0 110.788 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -163.17 157.81 20.97 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 112.413 0.524 . . . . 0.0 112.413 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.7 mt -143.67 146.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.243 1.017 . . . . 0.0 109.443 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.0 p -146.4 143.59 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.307 0.643 . . . . 0.0 109.61 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.71 151.39 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.743 0.817 . . . . 0.0 110.016 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -136.5 149.36 48.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.724 0.81 . . . . 0.0 109.862 175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.4 18.37 2.05 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.31 -27.46 69.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.539 0.336 . . . . 0.0 110.396 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -151.11 121.84 7.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 58.24 -145.1 41.87 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.4 t -129.67 128.0 65.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -143.1 166.91 23.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.43 0.692 . . . . 0.0 110.396 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.98 169.5 24.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.865 0.466 . . . . 0.0 109.95 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.4 mtp -134.65 149.85 50.58 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.41 149.84 25.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -135.72 140.16 44.19 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.594 0.757 . . . . 0.0 109.434 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -118.58 167.97 11.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.897 0.879 . . . . 0.0 110.837 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -14.35 60.08 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.722 0.409 . . . . 0.0 111.493 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.1 t -149.97 150.39 31.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.061 0.544 . . . . 0.0 109.72 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.56 -25.93 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -66.77 -26.99 67.23 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.7 m -82.43 -25.49 33.59 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.82 -26.81 40.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -69.72 -36.46 75.9 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -79.14 -24.54 43.24 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.332 -0.23 . . . . 0.0 110.849 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.25 -53.38 30.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.305 -0.247 . . . . 0.0 111.06 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.15 -16.05 59.95 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.734 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.37 -9.89 58.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.032 0.378 . . . . 0.0 111.781 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 16.7 t -124.61 -5.38 7.61 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.6 mt -126.95 -4.96 6.27 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -176.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -76.88 131.25 38.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.94 4.76 78.26 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.15 -178.41 5.6 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.398 0.599 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -141.55 163.57 32.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.988 0.915 . . . . 0.0 109.145 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 39.1 mt -117.79 -20.5 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.214 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -138.32 80.69 1.81 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.843 -0.535 . . . . 0.0 111.183 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.8 m 50.74 42.05 26.99 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.522 0.729 . . . . 0.0 112.926 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 96.83 -4.61 63.44 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.743 -0.476 . . . . 0.0 112.934 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 58.8 m -97.03 167.58 10.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.834 0.817 . . . . 0.0 110.101 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 96.2 m 52.35 42.98 31.25 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.972 0.415 . . . . 0.0 110.66 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 8.7 m -55.62 138.2 47.54 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.396 0.679 . . . . 0.0 109.936 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 64.6 mt -102.65 154.0 19.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.073 0.549 . . . . 0.0 111.872 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -144.81 129.93 18.54 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 78.7 mt -128.87 147.08 33.31 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-O 121.347 0.594 . . . . 0.0 112.175 -170.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.51 173.41 15.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.891 1.277 . . . . 0.0 108.74 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -84.33 145.25 28.35 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 121.61 -0.681 . . . . 0.0 110.749 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.3 167.57 13.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.685 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 22.0 ptmt -82.38 -27.09 0.42 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 47.2 Cg_endo -84.31 -177.84 3.16 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.959 1.772 . . . . 0.0 110.065 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.9 p -111.36 -9.79 14.25 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.494 0.318 . . . . 0.0 111.337 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.401 ' HD3' ' N ' ' A' ' 270' ' ' LEU . 0.0 OUTLIER -156.36 137.35 13.56 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.401 ' N ' ' HD3' ' A' ' 269' ' ' ARG . 63.5 mt -88.02 172.79 9.29 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 123.088 0.555 . . . . 0.0 110.726 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -132.34 149.36 52.37 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.324 -0.235 . . . . 0.0 111.008 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 72.5 t -138.6 151.34 24.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 124.298 1.039 . . . . 0.0 108.484 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -124.44 -23.67 4.4 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 177.21 9.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.575 1.15 . . . . 0.0 108.834 176.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -110.76 110.16 20.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.651 0.381 . . . . 0.0 110.113 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -152.79 -175.02 5.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.237 1.015 . . . . 0.0 109.545 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -72.53 -1.72 17.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -117.38 -20.42 9.13 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 118.503 0.592 . . . . 0.0 111.775 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.9 t -154.13 137.87 16.14 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -159.25 146.67 17.26 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 122.381 -0.199 . . . . 0.0 110.517 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -129.79 139.23 51.3 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.628 0.728 . . . . 0.0 111.38 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -104.69 -6.94 19.94 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.741 0.816 . . . . 0.0 111.526 -173.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 12.3 t -88.13 7.52 31.25 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.217 0.607 . . . . 0.0 109.857 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -111.83 131.01 22.62 Favored Pre-proline 0 N--CA 1.452 -0.33 0 C-N-CA 125.103 1.361 . . . . 0.0 109.455 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.94 64.06 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.077 3.185 . . . . 0.0 111.471 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 53.52 23.0 3.22 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.711 1.204 . . . . 0.0 113.503 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 17.1 tp 54.93 23.36 4.97 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.052 0.941 . . . . 0.0 111.91 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.4 p -139.07 -4.51 1.52 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 76.81 4.47 82.23 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -88.53 2.04 53.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.629 0.714 . . . . 0.0 112.067 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 CA-C-O 117.271 -1.849 . . . . 0.0 111.349 178.525 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -144.52 172.93 12.28 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 123.238 0.615 . . . . 0.0 111.121 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.3 tt -64.78 154.59 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.345 0.658 . . . . 0.0 110.607 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.3 p -81.0 1.51 30.95 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.984 0.514 . . . . 0.0 112.383 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -136.81 64.43 49.87 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 123.747 0.819 . . . . 0.0 109.821 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.48 160.05 49.61 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.725 2.95 . . . . 0.0 111.219 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.68 -5.29 89.98 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.94 -0.367 . . . . 0.0 112.635 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -149.28 158.06 43.86 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.138 0.575 . . . . 0.0 110.163 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.0 t 56.43 -172.38 0.07 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.024 0.929 . . . . 0.0 111.868 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.8 t0 58.53 178.39 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.614 1.166 . . . . 0.0 112.369 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t70 62.37 162.98 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.038 1.335 . . . . 0.0 113.259 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 46.7 m 57.63 4.13 0.23 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.159 1.384 . . . . 0.0 114.093 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.536 ' HG2' ' H ' ' A' ' 187' ' ' SER . 50.9 ttt-85 45.49 -144.39 0.2 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.357 1.063 . . . . 0.0 111.06 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.536 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 57.8 p -151.75 150.38 30.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.515 1.126 . . . . 0.0 108.966 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 56.4 t -141.99 -63.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -161.34 164.99 29.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.235 0.614 . . . . 0.0 110.415 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.6 p -93.44 18.63 9.49 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.659 0.783 . . . . 0.0 112.048 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.17 145.09 30.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 122.939 0.496 . . . . 0.0 110.817 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.6 mt -131.08 163.24 28.08 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.305 0.574 . . . . 0.0 111.5 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 62.3 tp -122.73 132.36 54.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.663 1.185 . . . . 0.0 108.302 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -117.75 146.33 43.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.587 0.755 . . . . 0.0 109.685 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 97.0 m -138.2 143.34 40.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 196' ' ' ILE . 1.9 mp -106.67 137.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.22 -35.91 10.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -173.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -129.9 63.94 70.32 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.997 0.519 . . . . 0.0 110.346 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.47 100.41 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.167 2.578 . . . . 0.0 111.152 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.2 pt -122.17 3.11 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 122.874 0.469 . . . . 0.0 110.878 173.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -138.24 164.85 28.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.21 1.004 . . . . 0.0 109.097 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 80.3 p -79.21 156.6 28.09 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.902 0.382 . . . . 0.0 111.324 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.5 mm -135.86 137.95 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.1 p -144.44 175.41 10.14 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.137 0.575 . . . . 0.0 110.285 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.4 p -60.36 -26.45 66.63 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.973 0.509 . . . . 0.0 111.092 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.75 -21.3 44.63 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.506 0.322 . . . . 0.0 111.175 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.77 -37.86 10.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.21 -24.03 54.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.128 -0.357 . . . . 0.0 110.906 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -79.64 -33.06 41.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.95 -0.469 . . . . 0.0 111.111 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -77.09 -23.63 51.89 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-N 118.451 0.569 . . . . 0.0 111.369 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 39.1 pt -88.51 -22.25 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 118.258 0.481 . . . . 0.0 111.732 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 93.7 m -95.55 -21.94 17.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.546 0.612 . . . . 0.0 112.414 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.474 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.3 t-20 -60.33 -44.49 96.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 93.2 Cg_endo -72.89 -10.83 25.22 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.181 1.921 . . . . 0.0 111.727 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.7 m -94.04 -20.65 19.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.14 0.427 . . . . 0.0 110.931 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.67 168.36 27.7 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.08 105.84 1.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.659 2.906 . . . . 0.0 110.685 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.9 t -78.51 151.3 5.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -116.14 -37.66 3.77 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.705 0.402 . . . . 0.0 110.728 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -162.74 159.49 24.27 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 117.804 0.275 . . . . 0.0 111.474 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 50.5 mt -143.07 145.07 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 124.099 0.959 . . . . 0.0 110.319 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.4 m -137.83 149.69 25.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 123.587 0.755 . . . . 0.0 109.33 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.46 149.02 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.259 0.624 . . . . 0.0 109.789 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -130.4 122.85 28.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.3 ppt_? -144.77 17.77 1.63 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -84.74 -19.09 33.23 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -153.21 122.18 6.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 62.48 -159.37 34.22 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -172.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.4 p -149.04 116.68 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 121.421 0.629 . . . . 0.0 110.426 175.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -149.88 169.5 20.99 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.344 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.64 169.82 21.75 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.993 0.517 . . . . 0.0 110.446 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.1 mtp -140.09 150.46 44.34 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.9 t -137.88 150.97 25.21 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 122.64 0.376 . . . . 0.0 110.04 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -133.4 140.85 47.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.366 0.667 . . . . 0.0 109.572 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.11 171.29 8.38 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.873 0.869 . . . . 0.0 110.774 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.14 -16.56 61.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.763 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 60.0 p -154.02 163.31 40.29 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.219 0.533 . . . . 0.0 110.829 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.72 -25.52 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.354 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -71.1 -27.58 63.71 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.199 0.454 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 m -77.81 -28.98 50.51 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.76 -24.69 41.37 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.446 -0.159 . . . . 0.0 110.759 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -70.35 -36.51 74.25 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -80.24 -25.69 39.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.439 -0.163 . . . . 0.0 110.732 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.52 -50.32 63.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.038 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.409 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.27 -15.74 59.31 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.693 179.222 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.21 -10.42 58.59 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.905 0.32 . . . . 0.0 111.401 176.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.6 m -123.2 -3.22 8.51 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.58 -4.26 4.2 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -79.03 131.51 36.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.42 5.46 63.29 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.586 -0.605 . . . . 0.0 111.586 -176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.44 178.64 8.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.863 0.832 . . . . 0.0 111.093 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -141.17 160.05 40.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.613 0.765 . . . . 0.0 109.372 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.8 mt -111.66 -19.88 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -121.32 32.58 5.86 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.971 -0.455 . . . . 0.0 112.132 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 52.3 p 56.31 13.07 1.15 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.84 1.256 . . . . 0.0 112.766 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 169.85 150.15 6.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 79.4 m 55.06 -174.85 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.54 0.736 . . . . 0.0 111.927 -175.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.7 m 48.52 32.56 3.46 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.139 0.575 . . . . 0.0 111.307 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.9 m -58.44 140.41 53.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.321 0.648 . . . . 0.0 110.335 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 56.9 mt -98.0 155.17 17.23 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.115 0.566 . . . . 0.0 111.712 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -142.15 132.52 25.04 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.409 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 83.2 mt -129.38 145.67 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-O 121.17 0.51 . . . . 0.0 111.849 -174.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.27 168.21 26.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.94 1.296 . . . . 0.0 108.3 173.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -78.01 141.54 38.85 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.868 -0.52 . . . . 0.0 110.497 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -80.8 166.24 21.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.6 pttt -81.72 -27.42 0.44 Allowed Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 49.1 Cg_endo -81.33 178.48 6.7 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.891 1.727 . . . . 0.0 109.797 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 63.5 p -104.51 -7.65 19.62 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 122.109 0.164 . . . . 0.0 111.18 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 167.72 28.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.319 0.647 . . . . 0.0 110.449 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.59 170.18 12.33 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.942 0.897 . . . . 0.0 109.425 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -143.13 163.21 33.49 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.502 0.191 . . . . 0.0 110.788 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.6 156.42 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 124.214 1.006 . . . . 0.0 109.103 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -126.1 -18.88 4.9 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.775 0.43 . . . . 0.0 111.621 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -166.09 169.24 14.71 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.042 0.937 . . . . 0.0 109.297 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -117.56 109.36 16.61 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.055 0.455 . . . . 0.0 110.54 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -155.47 -167.21 2.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.718 1.207 . . . . 0.0 109.898 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -73.44 -5.72 41.74 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.47 -15.98 12.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.672 0.669 . . . . 0.0 111.54 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.0 t -159.08 139.44 12.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -154.07 148.03 25.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.139 -0.351 . . . . 0.0 110.792 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.86 135.39 54.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.903 0.481 . . . . 0.0 110.017 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -115.73 9.1 15.09 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.56 0.744 . . . . 0.0 112.132 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t -129.99 1.22 4.78 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.234 0.614 . . . . 0.0 110.765 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -66.13 125.36 90.02 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 124.096 0.958 . . . . 0.0 109.672 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -56.82 -17.64 24.24 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.505 2.803 . . . . 0.0 113.57 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -81.85 -1.22 46.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.023 0.374 . . . . 0.0 111.807 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 60.0 tp -135.29 -25.0 1.37 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.597 0.359 . . . . 0.0 110.666 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 42.4 m -75.15 -12.48 60.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.987 -0.446 . . . . 0.0 111.055 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -77.94 -5.92 87.03 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -82.0 -14.76 55.52 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.484 0.642 . . . . 0.0 110.912 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 117.392 -1.782 . . . . 0.0 111.262 -179.174 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -113.8 -55.86 2.46 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.374 0.67 . . . . 0.0 111.469 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.564 HG23 ' H ' ' A' ' 178' ' ' ARG . 17.9 tt -157.35 3.37 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.318 0.247 . . . . 0.0 111.001 -178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 20.4 m 56.92 8.66 0.52 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.62 1.168 . . . . 0.0 113.795 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.564 ' H ' HG23 ' A' ' 176' ' ' ILE . 14.4 tpt180 -155.13 52.69 0.74 Allowed Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.239 0.615 . . . . 0.0 110.951 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.52 -14.44 30.61 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.941 2.427 . . . . 0.0 111.06 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 168.74 165.06 25.5 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -153.32 166.02 33.93 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 122.958 0.503 . . . . 0.0 110.829 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.5 m 60.57 151.25 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.343 1.457 . . . . 0.0 113.776 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.6 t70 50.43 23.43 1.27 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.213 1.005 . . . . 0.0 112.814 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 53.75 19.7 1.96 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.186 0.994 . . . . 0.0 112.846 -176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 84.1 p 55.15 -57.83 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.527 2.731 . . . . 0.0 114.835 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 58.26 171.4 0.06 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.697 1.599 . . . . 0.0 112.862 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.3 m 57.9 168.37 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.803 1.241 . . . . 0.0 113.615 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.46 -42.81 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.819 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -164.85 166.1 19.94 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.314 0.646 . . . . 0.0 110.506 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -91.51 10.09 29.3 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.222 0.609 . . . . 0.0 111.587 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.5 t -106.04 137.94 33.78 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 C-N-CA 123.248 0.619 . . . . 0.0 110.589 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.3 mt -126.47 159.96 31.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.623 0.725 . . . . 0.0 111.572 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.0 tp -118.7 132.39 56.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.037 1.335 . . . . 0.0 108.15 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -118.37 141.66 48.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.302 0.641 . . . . 0.0 109.713 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 92.5 m -137.21 141.1 42.1 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.6 mp -104.26 136.21 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.46 -34.61 12.66 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -130.4 62.27 63.62 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.492 0.717 . . . . 0.0 110.041 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.33 101.79 0.89 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.781 2.32 . . . . 0.0 111.021 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.4 pt -127.0 2.31 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 122.878 0.471 . . . . 0.0 111.227 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -132.11 166.58 21.46 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.879 0.872 . . . . 0.0 109.405 177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.9 m -75.11 150.6 38.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.367 0.267 . . . . 0.0 111.346 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.6 mm -138.37 136.67 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 80.7 p -144.94 174.27 11.16 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.435 0.694 . . . . 0.0 109.853 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.7 p -62.17 -24.85 67.44 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.191 0.196 . . . . 0.0 111.142 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.16 -24.9 47.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.789 0.268 . . . . 0.0 111.154 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.77 -37.48 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.92 -23.45 52.48 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.381 -0.199 . . . . 0.0 110.753 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -79.87 -33.96 39.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.887 0.312 . . . . 0.0 110.957 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 t -75.54 -22.47 57.04 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 118.467 0.576 . . . . 0.0 110.935 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.9 pt -89.7 -22.09 6.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.157 0.435 . . . . 0.0 111.899 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.4 m -95.72 -20.13 19.14 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.403 0.547 . . . . 0.0 112.355 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.8 t-20 -60.88 -42.76 88.83 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 84.4 Cg_endo -72.1 -10.71 26.33 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.876 1.717 . . . . 0.0 111.795 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.8 m -91.22 -20.68 21.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.933 0.333 . . . . 0.0 110.888 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.52 171.35 25.25 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.74 111.95 2.94 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.676 2.917 . . . . 0.0 110.948 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.8 t -84.41 150.6 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -113.89 -37.3 4.54 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.119 0.567 . . . . 0.0 111.125 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -164.08 158.37 19.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.723 0.692 . . . . 0.0 112.351 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.2 mt -144.32 147.28 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.956 0.902 . . . . 0.0 109.529 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.04 144.02 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.262 0.625 . . . . 0.0 109.503 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.8 151.43 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.861 0.864 . . . . 0.0 109.907 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -136.65 143.05 43.26 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.984 0.913 . . . . 0.0 108.939 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.98 16.0 1.38 Allowed 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -174.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.49 -18.79 65.56 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.006 -0.433 . . . . 0.0 111.137 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -154.88 124.23 6.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 57.26 -147.31 35.31 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.6 t -133.96 129.51 54.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -146.24 167.18 24.13 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.242 0.617 . . . . 0.0 110.276 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.44 173.24 17.2 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.669 0.388 . . . . 0.0 110.278 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.5 mtp -137.51 150.25 47.4 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.92 151.34 25.44 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -138.73 141.75 38.89 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.195 0.598 . . . . 0.0 109.407 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -118.26 168.15 10.87 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.808 0.843 . . . . 0.0 110.805 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -76.67 -11.12 59.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.94 0.496 . . . . 0.0 111.527 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.0 t -151.67 150.18 29.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.157 0.583 . . . . 0.0 109.745 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.03 -23.64 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.05 -25.23 62.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 38.2 m -80.59 -26.31 37.94 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.09 -26.99 35.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.168 0.187 . . . . 0.0 110.521 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -68.06 -36.89 80.6 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.3 ttt-85 -78.62 -25.98 45.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.406 -0.184 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -68.4 -48.42 64.71 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.419 -0.324 . . . . 0.0 111.262 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.39 -13.26 59.92 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.534 0.606 . . . . 0.0 111.532 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.42 -9.67 54.05 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.543 -0.265 . . . . 0.0 111.6 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -123.87 -3.46 8.17 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.7 mt -129.99 -4.31 4.52 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -76.52 133.17 39.83 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 119.072 0.851 . . . . 0.0 109.134 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.59 5.89 69.65 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.803 -0.443 . . . . 0.0 112.327 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.31 174.74 11.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.689 0.744 . . . . 0.0 111.134 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -132.67 144.32 50.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.9 mt -92.43 -20.22 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 O-C-N 122.293 -0.254 . . . . 0.0 111.052 -177.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -122.11 25.56 8.97 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.177 0.591 . . . . 0.0 111.226 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.1 m 56.78 16.01 2.49 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.204 1.002 . . . . 0.0 112.416 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.78 142.57 4.26 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 64.6 m 55.19 -179.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.859 0.864 . . . . 0.0 112.008 -174.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.7 m 50.17 34.98 9.33 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.068 -0.395 . . . . 0.0 111.071 -173.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.8 m -59.82 142.58 53.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.939 0.495 . . . . 0.0 110.117 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 55.0 mt -100.58 154.56 18.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.365 0.602 . . . . 0.0 112.608 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -139.02 137.56 36.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 74.8 mt -134.5 142.68 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 111.382 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.07 167.83 28.49 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.468 1.107 . . . . 0.0 108.526 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.0 144.0 37.07 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.883 -0.511 . . . . 0.0 110.613 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.95 169.79 10.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.659 0.384 . . . . 0.0 110.926 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.1 pttt -84.55 -26.97 0.39 Allowed Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -176.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 52.2 Cg_endo -80.25 166.47 20.44 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 CA-C-N 121.82 1.686 . . . . 0.0 109.784 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.6 p -100.58 -10.88 20.55 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 122.314 -0.241 . . . . 0.0 111.154 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.65 137.07 11.96 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 85.7 mt -85.42 169.77 13.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.728 0.411 . . . . 0.0 110.74 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -132.3 151.14 51.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 93.8 t -138.3 154.01 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 124.072 0.949 . . . . 0.0 108.65 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.81 -23.75 4.99 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -173.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.2 171.07 12.63 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.542 1.137 . . . . 0.0 109.082 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -107.79 117.92 35.37 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.91 0.386 . . . . 0.0 110.593 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -157.99 -172.45 3.92 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.69 1.196 . . . . 0.0 109.309 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -73.59 -5.07 38.01 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -112.15 -20.0 12.07 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.801 0.728 . . . . 0.0 111.671 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.1 t -156.33 139.99 16.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 173.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -149.88 147.78 28.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 110.696 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -123.7 113.03 18.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -91.09 3.25 55.25 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.898 0.879 . . . . 0.0 111.709 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.3 t -124.85 20.04 8.46 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.555 0.742 . . . . 0.0 109.904 177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -69.85 143.33 91.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.227 0.611 . . . . 0.0 110.922 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.05 -16.92 35.26 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.237 2.625 . . . . 0.0 113.283 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -99.93 4.08 44.77 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.816 0.447 . . . . 0.0 111.731 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 40.2 tp -128.39 -14.89 4.69 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.862 0.465 . . . . 0.0 110.955 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 49.3 m -125.6 7.27 7.56 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.307 0.643 . . . . 0.0 111.55 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -77.17 177.04 52.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -139.87 10.51 2.41 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.002 0.521 . . . . 0.0 111.657 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.568 -1.684 . . . . 0.0 111.04 -179.782 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -139.16 167.89 21.05 Favored 'General case' 0 C--N 1.338 0.066 0 C-N-CA 123.699 0.8 . . . . 0.0 110.892 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.4 tt -142.91 163.91 16.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 124.152 0.981 . . . . 0.0 109.175 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 m -63.17 -14.02 44.02 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -148.48 94.47 4.17 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.4 -14.78 25.21 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.064 2.509 . . . . 0.0 111.823 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.53 155.53 21.32 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -147.18 159.17 43.94 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.002 0.521 . . . . 0.0 110.087 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.1 m 56.63 177.34 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.824 1.25 . . . . 0.0 113.036 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 52.04 24.99 2.91 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.003 0.921 . . . . 0.0 113.073 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.5 t70 54.91 25.19 6.51 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.947 0.899 . . . . 0.0 112.529 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.6 t 59.51 178.99 0.08 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.446 1.099 . . . . 0.0 112.734 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -68.11 150.75 47.99 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.903 0.481 . . . . 0.0 111.468 -176.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.9 t -157.79 170.63 21.93 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.982 0.913 . . . . 0.0 109.471 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.13 -96.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -157.46 163.49 38.43 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.273 0.629 . . . . 0.0 110.353 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.8 p -94.96 16.15 16.9 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.29 0.636 . . . . 0.0 111.953 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.59 146.13 25.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 123.042 0.537 . . . . 0.0 111.108 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.55 164.0 25.85 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.682 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.4 tp -122.98 133.29 54.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.874 1.27 . . . . 0.0 108.099 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -120.74 144.47 48.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.657 0.783 . . . . 0.0 110.168 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 96.4 m -136.61 141.01 43.25 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.3 mp -107.65 136.77 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.09 -26.95 13.51 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -134.22 62.51 56.68 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 123.618 0.767 . . . . 0.0 109.812 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.72 59.7 5.03 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 124.241 3.294 . . . . 0.0 111.477 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 43.8 pt -82.22 -0.83 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 O-C-N 121.884 -0.51 . . . . 0.0 111.565 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -134.79 167.97 19.89 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.061 0.944 . . . . 0.0 109.382 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.2 m -79.72 151.17 30.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.6 mm -133.64 138.66 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.1 p -141.81 174.78 10.26 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.101 0.56 . . . . 0.0 109.598 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.9 p -63.26 -21.69 66.4 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.48 0.312 . . . . 0.0 110.959 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.17 -24.53 40.28 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.488 0.315 . . . . 0.0 110.798 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 87.3 t -82.99 -37.4 13.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.4 mt -76.82 -22.75 53.16 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.155 -0.341 . . . . 0.0 110.75 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -79.17 -34.89 42.73 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.905 -0.497 . . . . 0.0 110.788 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.3 t -75.43 -23.1 56.91 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.114 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.0 pt -90.48 -20.89 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.53 0.605 . . . . 0.0 112.28 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.1 m -98.43 -19.87 17.45 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.866 0.757 . . . . 0.0 112.975 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.486 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 47.6 t30 -64.47 -40.49 51.05 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 90.5 Cg_endo -71.68 -3.36 12.96 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.576 1.517 . . . . 0.0 111.932 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 73.1 m -99.96 -4.5 29.99 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.702 0.401 . . . . 0.0 111.295 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 142.11 174.44 14.76 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.06 109.34 2.15 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.765 2.976 . . . . 0.0 110.981 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.2 t -80.98 149.71 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -115.67 -39.99 3.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.927 0.491 . . . . 0.0 111.337 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -161.27 158.15 26.71 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.1 mt -141.42 145.71 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.269 1.028 . . . . 0.0 109.582 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.68 147.91 20.41 Favored 'Isoleucine or valine' 0 C--O 1.23 0.052 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.92 149.24 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.05 0.54 . . . . 0.0 110.515 -173.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -128.78 123.66 33.48 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -145.27 28.47 1.21 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -76.38 -18.0 59.09 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -156.73 -54.65 0.08 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.36 -164.68 39.96 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.3 t -138.72 108.03 4.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -145.26 164.9 29.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.352 0.661 . . . . 0.0 109.952 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -153.63 171.49 18.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.694 0.398 . . . . 0.0 110.478 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 81.3 mtp -141.32 150.13 42.1 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 52.0 t -137.97 152.7 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.036 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -137.02 140.99 42.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.406 0.682 . . . . 0.0 109.755 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.66 168.39 10.76 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.006 0.922 . . . . 0.0 110.816 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.49 -10.38 59.69 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.213 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 40.7 t -153.21 151.66 30.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.034 0.534 . . . . 0.0 110.067 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.55 -22.67 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -66.67 -28.5 68.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.993 0.36 . . . . 0.0 110.642 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 75.4 m -87.21 -23.97 24.58 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.358 -0.214 . . . . 0.0 110.757 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.53 -28.86 59.25 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -70.72 -36.91 73.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 40.3 ttm105 -74.89 -32.79 61.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.341 0.256 . . . . 0.0 111.041 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.82 66.04 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.189 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.423 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.5 -11.83 59.94 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.972 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.43 -12.4 46.28 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.603 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 58.7 m -127.57 2.57 6.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 91.1 mt -130.86 -4.99 4.02 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.642 0.655 . . . . 0.0 112.488 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -79.05 131.14 36.17 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.75 7.54 70.03 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.32 177.99 8.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.428 0.691 . . . . 0.0 111.467 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.23 143.99 50.32 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.259 1.023 . . . . 0.0 108.357 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 59.7 mt -90.55 -22.45 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 O-C-N 122.403 -0.186 . . . . 0.0 111.272 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -122.7 30.43 6.46 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.838 0.455 . . . . 0.0 111.333 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.2 m 56.2 19.53 3.92 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.351 0.66 . . . . 0.0 111.828 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 172.07 155.53 11.18 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 6.7 p 48.97 -175.52 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.916 1.286 . . . . 0.0 113.112 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 76.4 m 47.38 37.77 6.51 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.132 0.573 . . . . 0.0 111.162 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 8.9 m -58.12 139.18 55.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.114 0.565 . . . . 0.0 110.105 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 51.1 mt -102.11 155.73 18.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.219 0.533 . . . . 0.0 112.212 -175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -143.4 134.74 26.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 74.2 mt -129.24 149.87 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 121.135 0.493 . . . . 0.0 111.436 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.75 170.27 22.44 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.984 1.314 . . . . 0.0 108.029 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -79.69 144.45 33.69 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 121.865 -0.522 . . . . 0.0 110.337 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.23 164.91 19.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.141 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 40.0 ttpt -72.27 -45.76 10.71 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 79.6 Cg_endo -75.59 176.79 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.605 2.203 . . . . 0.0 110.503 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 63.6 p -106.56 -8.66 16.91 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 122.595 0.358 . . . . 0.0 111.61 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.34 137.42 15.56 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 58.5 mt -90.18 177.64 6.38 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.105 0.562 . . . . 0.0 110.608 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -137.37 154.17 50.06 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.156 -0.34 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.2 t -138.29 153.07 26.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.948 0.899 . . . . 0.0 109.166 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.22 -15.24 4.72 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.617 0.367 . . . . 0.0 111.777 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -166.65 175.82 7.66 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.031 0.933 . . . . 0.0 109.911 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -119.6 101.19 7.75 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -150.47 -169.63 3.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.946 0.898 . . . . 0.0 110.341 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -71.13 -1.38 12.18 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -116.1 -21.25 9.52 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.917 0.781 . . . . 0.0 111.856 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.8 t -157.95 145.69 18.51 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 118.296 0.498 . . . . 0.0 109.999 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -153.15 151.05 29.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.657 0.265 . . . . 0.0 110.697 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.54 139.56 53.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.6 15.72 12.82 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.354 0.661 . . . . 0.0 112.171 -174.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.1 t -131.27 -3.39 3.88 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.1 -0.375 . . . . 0.0 111.863 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -81.9 154.73 70.46 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.175 0.59 . . . . 0.0 110.613 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.23 -6.34 18.27 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.447 2.765 . . . . 0.0 111.697 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -78.87 -4.42 49.58 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.769 0.428 . . . . 0.0 111.892 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 36.6 tp -94.97 -10.22 31.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.898 0.479 . . . . 0.0 110.909 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 50.5 m -134.84 11.49 3.66 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.006 0.522 . . . . 0.0 111.448 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 179.67 -169.11 39.92 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -90.0 -0.46 57.59 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.548 -0.384 . . . . 0.0 111.007 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.089 0 CA-C-O 117.361 -1.8 . . . . 0.0 111.087 -179.641 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -146.72 163.51 35.7 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.176 0.591 . . . . 0.0 109.763 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.83 154.34 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.587 0.355 . . . . 0.0 110.546 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 78.5 p -78.55 0.57 25.68 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.261 0.624 . . . . 0.0 112.285 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -139.37 68.54 39.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.601 0.761 . . . . 0.0 109.394 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.98 162.33 39.32 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.497 2.798 . . . . 0.0 110.96 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.89 175.18 53.94 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 183' ' ' ASP . 26.6 t70 -144.39 142.83 30.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.625 -0.338 . . . . 0.0 110.346 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.0 m 58.54 -19.28 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.77 2.028 . . . . 0.0 115.151 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 184' ' ' ASP . 38.2 t0 52.67 -171.69 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.757 1.223 . . . . 0.0 112.518 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.444 ' H ' ' CG ' ' A' ' 183' ' ' ASP . 8.6 t70 53.94 -158.42 0.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.139 0.975 . . . . 0.0 111.628 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.43 ' H ' ' CG ' ' A' ' 184' ' ' ASP . 19.4 t 60.5 -67.67 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.114 1.765 . . . . 0.0 113.781 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 54.54 -171.56 0.05 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.18 0.992 . . . . 0.0 111.711 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 60.6 m -145.32 152.26 39.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.945 0.498 . . . . 0.0 110.483 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.19 -50.19 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 122.246 0.218 . . . . 0.0 110.79 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -164.04 168.24 19.42 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.296 0.638 . . . . 0.0 110.069 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 81.2 p -101.18 16.73 24.52 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.536 0.734 . . . . 0.0 111.845 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.6 m -119.7 144.38 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 C-N-CA 123.008 0.523 . . . . 0.0 111.083 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.1 mt -130.94 164.64 24.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.168 0.508 . . . . 0.0 111.384 -174.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 62.8 tp -123.28 134.03 54.12 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.824 1.249 . . . . 0.0 108.316 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -120.52 146.71 46.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.678 0.791 . . . . 0.0 109.816 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 87.3 m -136.53 144.36 44.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.3 mp -110.42 136.43 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.5 mt -98.93 -32.79 11.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -172.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -133.42 69.38 77.22 Favored Pre-proline 0 CA--C 1.532 0.25 0 C-N-CA 123.572 0.749 . . . . 0.0 109.507 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.57 55.7 3.79 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 125.007 3.805 . . . . 0.0 112.26 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.1 -3.68 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 121.753 -0.592 . . . . 0.0 111.38 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -129.86 168.16 17.04 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.703 0.801 . . . . 0.0 109.378 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 82.0 p -80.87 153.01 27.86 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.947 0.403 . . . . 0.0 111.504 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.0 mm -138.68 139.48 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.9 p -144.04 173.14 11.98 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.528 0.731 . . . . 0.0 109.56 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.1 p -63.63 -19.13 64.62 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.355 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -83.24 -26.06 31.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 117.805 0.275 . . . . 0.0 110.591 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.2 t -81.51 -36.24 14.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.37 -25.19 57.47 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.275 -0.266 . . . . 0.0 110.333 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -77.05 -36.32 56.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.086 -0.384 . . . . 0.0 110.966 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -76.46 -20.27 57.19 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.471 0.578 . . . . 0.0 111.336 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.16 -16.69 7.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-N 118.244 0.474 . . . . 0.0 111.78 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.3 m -97.31 -20.92 17.53 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.761 0.71 . . . . 0.0 112.155 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.2 t-20 -61.41 -43.73 90.26 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 98.7 Cg_endo -72.43 -10.59 25.65 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.633 1.555 . . . . 0.0 111.633 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 74.7 m -94.42 -21.59 18.83 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.797 0.271 . . . . 0.0 111.397 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 167.8 168.54 30.09 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.98 99.47 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.297 3.331 . . . . 0.0 110.902 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.3 t -75.52 144.21 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -113.02 -33.65 5.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.456 0.302 . . . . 0.0 111.075 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -163.73 157.87 19.6 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 117.966 0.348 . . . . 0.0 111.574 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.0 mt -143.37 142.74 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.289 1.036 . . . . 0.0 109.715 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.1 m -138.43 156.61 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.055 0.542 . . . . 0.0 109.588 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 66.0 mt -132.14 149.87 33.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 122.89 0.476 . . . . 0.0 110.403 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -138.14 143.36 40.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.566 0.746 . . . . 0.0 109.599 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.96 14.96 1.72 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.708 0.403 . . . . 0.0 112.058 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -82.3 -2.27 52.17 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -145.74 11.1 1.24 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.127 0.571 . . . . 0.0 111.448 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 152.14 -134.26 4.48 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -173.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.52 116.36 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -149.3 165.7 31.15 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.556 0.742 . . . . 0.0 110.582 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.44 169.64 20.4 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.139 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 78.2 mtp -138.86 148.98 44.37 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.7 t -136.37 151.42 28.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 122.878 0.471 . . . . 0.0 109.842 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -137.08 138.58 40.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.25 0.62 . . . . 0.0 109.745 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.07 170.36 8.92 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.141 0.976 . . . . 0.0 110.497 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.05 -16.24 59.97 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.565 0.346 . . . . 0.0 111.528 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.7 t -150.99 154.46 37.12 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.729 0.412 . . . . 0.0 110.579 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.24 -26.94 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.022 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -67.08 -29.9 69.79 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.059 -0.401 . . . . 0.0 110.079 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.2 m -79.29 -26.68 42.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.411 0.285 . . . . 0.0 110.501 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.52 -26.29 38.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.396 -0.19 . . . . 0.0 110.685 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -69.54 -36.62 76.53 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -77.82 -26.6 49.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.307 0.243 . . . . 0.0 110.798 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.5 -53.82 30.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.141 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.61 -14.42 60.38 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.814 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.53 -10.65 55.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.096 -0.378 . . . . 0.0 111.45 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.6 m -123.78 -0.35 8.55 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 94.0 mt -131.1 -6.2 3.89 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -76.35 131.24 39.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.917 0.78 . . . . 0.0 109.274 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.42 7.51 73.21 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.121 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.99 174.05 12.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.864 0.832 . . . . 0.0 111.337 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -132.62 145.65 51.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.8 mt -95.68 -17.37 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 122.097 0.159 . . . . 0.0 111.124 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.23 27.07 7.21 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.04 0.536 . . . . 0.0 111.137 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.7 m 56.49 17.64 3.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.953 0.901 . . . . 0.0 112.244 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 172.54 143.36 4.12 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 84.7 m 54.91 -178.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.89 0.876 . . . . 0.0 112.04 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.8 m 50.82 33.7 9.0 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.916 0.486 . . . . 0.0 110.936 -173.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.8 m -59.21 140.57 55.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.978 0.511 . . . . 0.0 110.09 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 47.4 mt -98.9 153.62 18.67 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.126 0.571 . . . . 0.0 111.94 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -140.43 134.8 31.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 171.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.424 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 81.6 mt -129.19 149.34 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.209 0.528 . . . . 0.0 111.286 -175.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.74 169.16 24.99 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.865 1.266 . . . . 0.0 108.199 173.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -79.57 142.01 36.08 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.756 -0.59 . . . . 0.0 110.542 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.43 164.11 20.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -81.78 -26.12 0.41 Allowed Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -175.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 44.0 Cg_endo -81.51 177.69 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 121.767 1.667 . . . . 0.0 109.876 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 68.5 p -106.53 -5.56 18.71 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.611 0.364 . . . . 0.0 110.902 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.9 mmm-85 -153.81 154.81 34.67 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.901 0.88 . . . . 0.0 110.295 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.68 168.56 10.32 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.644 0.778 . . . . 0.0 109.47 173.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -140.16 166.63 24.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.935 0.398 . . . . 0.0 111.494 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.5 t -138.09 155.27 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.144 0.978 . . . . 0.0 108.723 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.81 -26.3 4.87 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.299 0.24 . . . . 0.0 111.392 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.76 168.87 17.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.451 1.101 . . . . 0.0 109.08 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -106.44 117.34 33.78 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.931 0.396 . . . . 0.0 110.963 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -157.41 -175.17 5.25 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.713 1.205 . . . . 0.0 109.496 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -71.24 -3.42 20.23 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -173.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -118.08 -14.3 9.94 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.711 0.687 . . . . 0.0 111.968 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.9 t -155.98 135.2 12.18 Favored 'General case' 0 C--O 1.228 -0.043 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -153.2 147.75 26.09 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.872 0.368 . . . . 0.0 111.359 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.68 135.57 55.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.452 0.701 . . . . 0.0 109.509 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -116.9 13.66 14.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.4 0.68 . . . . 0.0 112.503 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.1 t -135.98 -5.53 2.15 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.315 0.507 . . . . 0.0 112.342 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -80.33 160.79 67.0 Favored Pre-proline 0 CA--C 1.535 0.374 0 O-C-N 121.834 -0.542 . . . . 0.0 111.36 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -61.66 -10.07 15.64 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.203 3.268 . . . . 0.0 113.37 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -81.75 -5.66 58.35 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.738 0.415 . . . . 0.0 111.72 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 23.3 tp -138.19 0.72 2.15 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.82 0.448 . . . . 0.0 111.093 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 26.3 m 55.66 31.3 17.06 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.699 0.799 . . . . 0.0 112.822 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 84.53 -164.93 40.16 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 112.308 -0.317 . . . . 0.0 112.308 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -73.78 -13.13 60.9 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.43 -0.453 . . . . 0.0 110.81 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 CA-C-O 117.346 -1.808 . . . . 0.0 110.744 -179.861 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -143.42 155.87 44.51 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.096 0.559 . . . . 0.0 110.004 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 17.9 tt -69.11 156.17 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 122.861 0.464 . . . . 0.0 110.415 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 78.4 p -81.09 -1.64 45.07 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -140.46 62.15 18.38 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 123.607 0.763 . . . . 0.0 110.764 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.07 -9.31 23.34 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.08 3.187 . . . . 0.0 112.291 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.21 153.81 51.28 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -152.95 158.19 41.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.587 0.355 . . . . 0.0 110.943 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 58.1 p 53.19 175.11 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.659 1.984 . . . . 0.0 114.759 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.7 t0 53.32 17.79 1.13 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.898 1.279 . . . . 0.0 113.363 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.9 t0 51.57 29.59 5.65 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.021 0.928 . . . . 0.0 112.488 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 26.1 m 57.8 9.52 0.89 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.103 0.961 . . . . 0.0 112.952 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 59.32 140.86 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.111 2.165 . . . . 0.0 114.899 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.0 m 58.55 144.61 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.438 1.895 . . . . 0.0 114.983 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.5 p -156.06 -40.72 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.304 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -163.92 165.78 22.36 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.881 0.872 . . . . 0.0 109.935 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.6 p -96.51 12.25 32.15 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.138 0.575 . . . . 0.0 111.826 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.72 142.46 25.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 122.874 0.469 . . . . 0.0 111.194 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.3 mt -129.19 164.0 24.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.113 0.565 . . . . 0.0 111.454 -175.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.7 tp -123.89 132.69 53.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.716 1.206 . . . . 0.0 108.171 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -119.43 144.25 47.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.729 0.811 . . . . 0.0 109.805 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 91.7 m -139.06 144.3 38.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.9 mp -106.85 134.36 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.66 -36.55 15.18 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -173.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -131.54 63.5 69.72 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 123.606 0.762 . . . . 0.0 109.948 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.84 103.24 1.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.849 2.366 . . . . 0.0 110.88 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.9 pt -128.65 0.94 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 122.879 0.472 . . . . 0.0 111.384 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -130.1 166.52 20.02 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.954 0.902 . . . . 0.0 109.191 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.2 m -74.98 147.8 40.5 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.719 0.295 . . . . 0.0 111.56 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.1 mm -137.55 132.88 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.3 p -142.87 176.36 9.13 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 122.896 0.479 . . . . 0.0 110.299 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 41.5 p -63.31 -22.8 67.1 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.193 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -80.5 -26.14 38.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.295 0.238 . . . . 0.0 110.821 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 87.6 t -84.41 -37.59 12.9 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.17 -24.93 54.81 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.294 -0.254 . . . . 0.0 111.093 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -77.62 -37.26 50.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.815 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.4 t -75.74 -19.58 58.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.219 0.463 . . . . 0.0 111.374 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -94.92 -15.67 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.339 0.518 . . . . 0.0 111.858 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.5 m -97.41 -22.78 16.4 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.697 0.68 . . . . 0.0 111.864 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 26.9 t-20 -59.82 -43.04 94.07 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 93.9 Cg_endo -72.22 -9.19 24.05 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.985 1.79 . . . . 0.0 111.928 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.4 m -96.09 -20.75 18.41 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 122.063 -0.398 . . . . 0.0 111.317 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 162.94 169.75 26.82 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.84 115.76 3.76 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.571 2.847 . . . . 0.0 111.039 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.96 147.34 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -111.63 -39.56 4.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.986 0.514 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -160.83 159.08 29.46 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.56 0.618 . . . . 0.0 112.177 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.6 mt -142.53 146.96 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.623 0.769 . . . . 0.0 110.377 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.61 144.25 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 123.372 0.669 . . . . 0.0 109.587 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp -109.12 150.95 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.493 0.717 . . . . 0.0 109.727 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -136.9 149.2 47.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.741 0.816 . . . . 0.0 109.959 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.53 16.75 2.37 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.51 -26.84 68.76 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.441 0.296 . . . . 0.0 110.794 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -151.19 120.05 6.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 57.78 -141.38 44.89 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.5 t -129.12 131.44 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -145.23 166.97 23.95 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.3 0.64 . . . . 0.0 110.067 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.13 171.04 21.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.796 0.439 . . . . 0.0 110.071 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.2 mtp -138.24 151.29 47.51 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.1 t -141.13 151.93 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 122.847 0.459 . . . . 0.0 109.846 -175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -136.94 141.45 42.65 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -115.8 168.32 10.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.471 0.709 . . . . 0.0 110.802 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -74.51 -13.83 60.73 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.761 0.425 . . . . 0.0 111.341 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 37.7 t -152.31 153.82 34.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.839 0.456 . . . . 0.0 109.938 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.8 -25.19 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -65.39 -27.59 68.66 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.908 -0.495 . . . . 0.0 109.742 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 40.4 m -82.51 -26.85 32.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.2 0.2 . . . . 0.0 110.712 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.76 -25.4 41.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -70.73 -37.53 73.51 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -77.88 -24.83 48.35 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 122.076 0.15 . . . . 0.0 110.779 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.43 -54.6 18.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.325 -0.234 . . . . 0.0 110.935 -178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.68 -15.82 60.26 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.708 -179.383 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.14 -11.11 58.24 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.115 -0.366 . . . . 0.0 111.563 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.0 m -124.45 -0.71 8.14 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 87.2 mt -130.17 -4.82 4.4 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -77.0 130.24 37.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.461 -0.774 . . . . 0.0 109.176 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.68 6.2 76.51 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.805 -0.442 . . . . 0.0 112.052 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.26 176.29 7.52 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.673 0.737 . . . . 0.0 111.488 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -140.11 150.96 44.93 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.57 0.748 . . . . 0.0 109.364 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.3 mt -114.58 -18.01 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 122.407 0.283 . . . . 0.0 111.442 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.18 22.01 8.72 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.045 -0.409 . . . . 0.0 111.231 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.8 m 55.77 21.03 4.4 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.524 0.73 . . . . 0.0 112.096 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 168.95 137.65 2.3 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 85.5 m 55.69 -178.73 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.132 0.973 . . . . 0.0 112.243 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 79.6 m 51.81 30.53 7.1 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.062 -0.399 . . . . 0.0 111.878 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.68 140.72 56.21 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.962 0.505 . . . . 0.0 109.777 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 62.2 mt -93.52 155.2 17.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.206 0.527 . . . . 0.0 111.786 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -144.3 135.6 25.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 172.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 85.2 mt -130.17 149.7 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 121.0 0.428 . . . . 0.0 111.174 -175.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.35 168.77 26.0 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.934 1.294 . . . . 0.0 108.211 173.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -80.39 144.05 33.0 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.679 -0.638 . . . . 0.0 110.578 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.66 165.46 16.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.669 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -83.18 -25.79 0.38 Allowed Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 43.7 Cg_endo -81.43 179.46 5.79 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.836 1.691 . . . . 0.0 109.858 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 65.1 p -108.57 -4.65 17.0 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.734 0.414 . . . . 0.0 110.728 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.3 mmm-85 -153.8 153.94 33.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.039 0.936 . . . . 0.0 110.099 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 83.9 mt -115.21 168.91 9.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.298 0.639 . . . . 0.0 109.514 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -141.13 158.49 43.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.286 0.234 . . . . 0.0 110.813 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.37 156.22 29.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 124.215 1.006 . . . . 0.0 109.097 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -124.61 -15.73 6.47 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -173.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -162.49 175.16 11.77 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.698 0.799 . . . . 0.0 110.293 -176.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -121.09 95.88 4.87 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.38 0.672 . . . . 0.0 109.577 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -149.42 -170.69 3.7 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.726 0.81 . . . . 0.0 110.649 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -70.91 -5.04 27.73 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -109.0 -24.21 11.32 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.649 0.658 . . . . 0.0 111.392 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.2 t -159.26 143.33 15.11 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -150.91 150.23 30.6 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.25 137.57 52.06 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -113.81 5.17 16.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.379 0.671 . . . . 0.0 112.519 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t -128.25 -5.22 5.47 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.755 0.422 . . . . 0.0 110.921 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -79.91 126.54 79.72 Favored Pre-proline 0 N--CA 1.453 -0.312 0 C-N-CA 124.167 0.987 . . . . 0.0 109.907 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.16 -16.3 32.93 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.615 2.877 . . . . 0.0 113.782 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -67.11 121.65 16.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.417 ' N ' HD22 ' A' ' 287' ' ' LEU . 3.2 mm? 56.93 23.9 8.77 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.109 0.964 . . . . 0.0 111.123 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 10.2 t 52.29 15.52 0.47 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.792 1.237 . . . . 0.0 112.846 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 67.92 11.84 61.42 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.658 -0.523 . . . . 0.0 112.693 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -139.56 -4.37 1.44 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.125 0.962 . . . . 0.0 113.022 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.132 -1.927 . . . . 0.0 111.434 179.706 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.737 0.303 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.0 p -94.87 10.75 34.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.173 0.589 . . . . 0.0 111.258 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.35 139.47 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.683 0.793 . . . . 0.0 110.664 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 99.1 mt -128.52 160.35 32.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.386 0.612 . . . . 0.0 111.255 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.4 tp -120.65 133.36 55.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.99 1.316 . . . . 0.0 108.042 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -119.75 144.71 47.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.652 0.781 . . . . 0.0 109.912 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 99.0 m -139.52 142.83 37.24 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.4 mp -105.38 135.78 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.86 -35.79 12.54 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -130.79 62.84 67.58 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.429 0.692 . . . . 0.0 110.329 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.45 103.25 1.08 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.795 2.33 . . . . 0.0 110.989 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.8 pt -128.83 2.71 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.742 0.417 . . . . 0.0 111.614 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -132.31 167.47 19.81 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.737 0.815 . . . . 0.0 109.628 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.5 m -74.68 146.73 42.08 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.65 0.262 . . . . 0.0 111.133 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mm -138.11 136.02 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.5 p -144.05 174.21 11.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.463 0.705 . . . . 0.0 109.538 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.2 p -63.51 -19.16 64.54 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.507 0.323 . . . . 0.0 111.153 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -83.4 -25.96 30.84 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.745 0.248 . . . . 0.0 111.042 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.4 t -81.67 -36.58 14.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.76 -26.32 57.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.217 -0.302 . . . . 0.0 110.295 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -75.63 -36.64 60.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.868 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.1 t -77.13 -17.69 58.45 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.312 0.505 . . . . 0.0 111.647 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.77 -13.9 7.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.148 0.431 . . . . 0.0 111.877 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 83.6 m -99.31 -24.97 14.64 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.765 0.711 . . . . 0.0 112.139 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.471 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 47.9 t30 -63.93 -39.16 42.75 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 95.1 Cg_endo -72.89 -5.81 17.87 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.437 1.425 . . . . 0.0 111.729 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 73.0 m -102.54 -10.52 19.25 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.806 0.442 . . . . 0.0 111.105 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 156.89 166.01 15.81 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.71 112.75 2.97 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.61 2.873 . . . . 0.0 110.658 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.25 152.33 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -117.18 -37.82 3.48 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.617 0.367 . . . . 0.0 110.95 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -163.16 157.32 20.37 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.2 0.455 . . . . 0.0 112.186 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.6 mt -143.67 146.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.315 1.046 . . . . 0.0 109.913 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.17 150.9 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--O 1.231 0.116 0 C-N-CA 122.966 0.506 . . . . 0.0 110.742 -173.806 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.808 0.337 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -154.24 171.6 18.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.556 0.342 . . . . 0.0 110.418 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.4 mtp -138.45 147.73 43.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.2 t -137.81 151.75 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 123.149 0.58 . . . . 0.0 109.786 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -141.2 141.49 34.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.297 0.639 . . . . 0.0 109.88 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -118.0 168.73 10.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.95 0.9 . . . . 0.0 110.981 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.01 -14.41 60.22 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.979 0.512 . . . . 0.0 111.357 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.4 t -150.75 152.15 33.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.939 0.496 . . . . 0.0 109.998 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.52 -23.68 30.22 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.85 -29.09 70.03 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 27.3 m -83.87 -28.0 28.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.573 0.349 . . . . 0.0 110.391 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.23 -27.02 47.61 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -69.96 -38.92 76.25 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -76.55 -27.95 56.1 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.15 -53.83 39.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.399 -0.188 . . . . 0.0 110.968 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.433 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.57 -14.38 60.01 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.999 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.05 -12.58 57.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.014 0.37 . . . . 0.0 111.947 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -128.75 2.31 5.44 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 76.5 mt -128.45 -4.94 5.37 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.472 0.578 . . . . 0.0 112.363 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.4 132.85 37.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.97 7.94 72.08 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.69 174.17 11.62 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.574 0.687 . . . . 0.0 111.018 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -132.15 148.62 52.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 49.9 mt . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -178.479 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.605 0.24 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.94 140.53 56.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.28 0.632 . . . . 0.0 110.051 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.2 154.86 16.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.007 0.523 . . . . 0.0 111.661 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -143.24 124.9 14.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.433 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 71.6 mt -126.44 146.2 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.147 0.499 . . . . 0.0 111.715 -173.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -156.35 170.73 21.63 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.952 1.301 . . . . 0.0 108.656 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.48 145.74 33.09 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 121.798 -0.564 . . . . 0.0 110.427 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -89.68 166.41 13.61 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.2 pttt -79.02 -28.32 0.55 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.4 Cg_endo -82.01 163.2 18.05 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 121.95 1.732 . . . . 0.0 110.442 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.5 p -97.24 -7.48 32.16 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 122.275 0.23 . . . . 0.0 110.992 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -152.82 148.88 27.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.818 0.847 . . . . 0.0 110.187 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 67.9 mt -107.48 172.26 6.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.586 0.754 . . . . 0.0 109.638 173.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -141.36 157.0 45.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.711 0.404 . . . . 0.0 110.22 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 79.9 t -135.59 152.36 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -119.93 -22.85 6.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.386 0.274 . . . . 0.0 111.148 -174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -165.38 173.52 11.05 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.712 0.805 . . . . 0.0 109.971 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -117.16 111.45 19.49 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.764 0.316 . . . . 0.0 110.463 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -156.24 -171.69 3.81 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.98 1.312 . . . . 0.0 109.56 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -73.95 -0.49 16.33 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -109.69 -27.35 9.39 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.45 0.568 . . . . 0.0 111.05 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.9 t -156.09 144.33 19.9 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.155 0.582 . . . . 0.0 109.584 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -150.31 150.73 31.88 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.657 0.265 . . . . 0.0 110.634 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -126.5 137.55 53.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.071 0.549 . . . . 0.0 109.765 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.96 11.76 13.51 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.594 0.758 . . . . 0.0 112.351 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.533 0.296 0 CA-C-N 117.983 0.356 . . . . 0.0 111.942 -179.031 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 32.7 p30 . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.4 p -92.77 15.79 13.83 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.595 0.758 . . . . 0.0 112.472 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.47 145.9 24.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 122.884 0.474 . . . . 0.0 110.893 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.64 165.02 23.71 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.29 0.567 . . . . 0.0 111.29 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.1 tp -127.69 131.26 49.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -117.0 144.31 44.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.826 0.851 . . . . 0.0 109.443 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.1 m -135.91 141.72 44.59 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 196' ' ' ILE . 1.9 mp -103.91 136.19 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.6 mt -92.86 -36.55 12.76 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -131.67 64.87 74.39 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.467 0.707 . . . . 0.0 110.096 -177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.85 104.2 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.571 2.181 . . . . 0.0 111.075 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.2 pt -130.13 1.44 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.073 0.549 . . . . 0.0 111.457 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -131.5 167.32 19.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.849 0.86 . . . . 0.0 109.197 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 27.0 t -76.53 149.48 36.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.416 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.3 mm -138.8 133.3 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.6 p -145.07 176.17 9.7 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 123.388 0.675 . . . . 0.0 110.136 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 35.5 p -61.33 -28.15 69.01 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.383 -0.198 . . . . 0.0 110.936 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.08 -22.35 58.36 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.699 0.399 . . . . 0.0 111.631 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.0 t -89.62 -38.0 10.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 84.3 mt -77.76 -23.39 49.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.96 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -78.3 -34.54 48.71 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.017 -0.427 . . . . 0.0 110.711 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.9 t -75.59 -23.23 56.45 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.217 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.1 pt -88.91 -22.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.203 0.456 . . . . 0.0 111.755 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.9 m -96.21 -20.12 18.81 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.779 0.718 . . . . 0.0 112.507 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.482 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.84 -43.5 87.54 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 95.8 Cg_endo -72.13 -11.04 26.74 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.874 1.716 . . . . 0.0 111.594 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.1 m -90.56 -23.04 21.0 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.232 0.469 . . . . 0.0 111.121 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.26 170.97 28.91 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -68.38 111.03 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.766 2.978 . . . . 0.0 110.71 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -83.49 152.37 3.86 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -115.52 -35.53 4.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.815 0.446 . . . . 0.0 110.693 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -164.31 160.35 20.85 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.129 0.422 . . . . 0.0 111.772 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.1 mt -144.35 146.89 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.074 0.95 . . . . 0.0 109.986 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.1 144.61 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 123.528 0.731 . . . . 0.0 109.408 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.527 0.084 0 C-N-CA 123.767 0.827 . . . . 0.0 110.386 -176.502 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 . . . . . 0 N--CA 1.457 -0.087 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.15 168.65 26.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.418 0.287 . . . . 0.0 110.416 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 87.8 mtp -138.43 151.43 47.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.31 150.15 21.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 122.829 0.452 . . . . 0.0 109.898 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -132.44 141.78 48.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.746 0.818 . . . . 0.0 108.794 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -118.02 167.98 10.96 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.907 0.883 . . . . 0.0 110.916 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.24 -15.5 60.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.738 0.415 . . . . 0.0 111.135 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 93.4 p -152.08 158.34 42.87 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.039 0.447 . . . . 0.0 110.459 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.94 -26.68 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.388 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -72.63 -22.2 60.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.335 0.516 . . . . 0.0 110.534 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.8 m -80.56 -28.3 37.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.02 -26.19 39.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.354 0.262 . . . . 0.0 110.469 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -69.71 -36.91 76.32 Favored 'General case' 0 N--CA 1.458 -0.05 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -79.67 -24.94 41.46 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.16 0.184 . . . . 0.0 110.762 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.68 -52.79 33.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.975 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.412 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.92 -16.08 60.08 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.795 0.725 . . . . 0.0 111.662 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.8 58.74 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.702 0.228 . . . . 0.0 111.6 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.8 t -126.73 0.52 6.75 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.0 mt -130.68 -4.27 4.14 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -78.14 130.91 36.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.884 0.765 . . . . 0.0 109.083 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.38 8.66 76.02 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.25 175.38 9.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.666 0.733 . . . . 0.0 111.284 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -139.8 149.14 43.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.569 0.748 . . . . 0.0 109.01 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.4 mt . . . . . 0 CA--C 1.532 0.253 0 C-N-CA 122.491 0.317 . . . . 0.0 111.243 -176.051 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.39 142.69 51.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.385 0.674 . . . . 0.0 109.987 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 53.9 mt -97.76 154.99 17.24 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.15 0.5 . . . . 0.0 111.87 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -146.25 132.55 19.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.412 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 76.6 mt -129.58 149.12 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 121.338 0.589 . . . . 0.0 112.012 -172.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.74 172.3 16.89 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.356 1.462 . . . . 0.0 108.428 174.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -83.75 143.92 29.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.948 -0.47 . . . . 0.0 110.445 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.68 170.29 12.65 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.41 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.441 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -84.82 -26.35 0.37 Allowed Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 49.4 Cg_endo -82.5 -177.84 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.023 1.815 . . . . 0.0 110.033 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.0 p -108.23 -7.43 15.98 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 122.196 -0.315 . . . . 0.0 111.422 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.75 168.47 27.07 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.138 0.975 . . . . 0.0 109.665 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 90.4 mt -124.73 174.37 7.94 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.475 0.71 . . . . 0.0 109.739 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -140.79 159.77 41.49 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.835 0.35 . . . . 0.0 110.929 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.8 t -135.69 153.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 124.277 1.031 . . . . 0.0 108.744 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -120.58 -26.38 5.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.614 0.366 . . . . 0.0 111.493 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.12 169.89 18.71 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.729 1.212 . . . . 0.0 108.865 176.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -107.08 117.43 34.04 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.782 0.325 . . . . 0.0 110.616 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -158.25 -172.57 3.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.624 1.169 . . . . 0.0 109.755 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -71.49 -4.94 29.46 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -114.16 -18.9 11.53 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.664 0.665 . . . . 0.0 111.728 -178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.0 t -156.63 139.38 15.14 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -152.49 149.56 28.67 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.703 0.287 . . . . 0.0 110.666 -176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -124.95 138.2 54.24 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.176 0.59 . . . . 0.0 109.479 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -118.37 11.17 12.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.3 0.64 . . . . 0.0 112.253 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 CA--C 1.53 0.178 0 CA-C-N 118.231 0.469 . . . . 0.0 112.22 -178.006 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.5 p30 . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.659 0.266 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.5 p -100.3 15.59 27.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.686 0.795 . . . . 0.0 111.788 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.11 143.94 27.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.011 0.524 . . . . 0.0 110.858 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.3 mt -128.79 164.92 21.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.212 0.53 . . . . 0.0 111.783 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.1 tp -123.87 134.43 53.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.783 1.233 . . . . 0.0 107.939 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -121.75 150.85 41.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.029 0.932 . . . . 0.0 109.618 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 94.6 m -142.63 146.71 34.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 42.9 mt -119.26 136.99 54.65 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.05 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 50.2 mt -102.91 -23.69 13.72 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -173.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -131.7 62.19 62.91 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.39 0.676 . . . . 0.0 110.102 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.31 40.27 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 125.073 3.849 . . . . 0.0 112.632 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 38.0 pt -77.08 -0.7 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.887 -0.508 . . . . 0.0 111.888 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -130.16 166.05 21.05 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.729 0.812 . . . . 0.0 109.655 176.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.2 m -70.57 146.56 50.04 Favored 'General case' 0 C--N 1.335 -0.048 0 CA-C-O 120.73 0.3 . . . . 0.0 111.526 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.8 mm -137.33 134.6 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.9 p -146.87 173.88 12.01 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.368 0.667 . . . . 0.0 109.236 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.3 p -63.74 -19.56 65.06 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 122.333 0.253 . . . . 0.0 111.529 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.15 -24.37 37.65 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.843 0.292 . . . . 0.0 110.849 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.0 t -82.48 -37.62 14.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.58 -24.25 58.88 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.212 -0.305 . . . . 0.0 110.614 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -78.31 -36.23 46.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.229 -0.294 . . . . 0.0 111.177 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.7 t -74.97 -21.32 59.23 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.145 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 39.5 pt -91.73 -21.9 6.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 CA-C-N 118.136 0.425 . . . . 0.0 112.058 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.2 m -95.67 -24.2 16.66 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 50.4 t30 -63.88 -40.57 56.49 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 89.4 Cg_endo -73.14 -4.5 15.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.754 1.636 . . . . 0.0 111.821 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.5 m -101.67 -10.42 20.03 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.868 0.467 . . . . 0.0 111.199 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 155.53 164.66 13.38 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.86 109.59 1.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.729 2.953 . . . . 0.0 111.016 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.96 151.88 4.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -117.39 -38.37 3.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.612 0.365 . . . . 0.0 111.086 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -162.98 157.95 21.62 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.01 0.368 . . . . 0.0 111.424 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 54.1 mt -143.15 141.93 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.762 0.825 . . . . 0.0 109.419 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 20.3 m -136.2 151.66 29.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 56.3 mt . . . . . 0 N--CA 1.455 -0.182 0 C-N-CA 122.796 0.438 . . . . 0.0 110.138 -175.435 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 N--CA 1.457 -0.125 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.83 171.4 18.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.843 0.457 . . . . 0.0 109.985 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.0 mtp -141.47 150.53 42.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.2 t -136.71 152.41 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 C-N-CA 122.928 0.491 . . . . 0.0 109.829 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -137.42 140.84 41.55 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.461 0.704 . . . . 0.0 109.577 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -120.97 169.24 10.66 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 123.879 0.871 . . . . 0.0 111.079 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.04 -16.07 61.06 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.852 0.461 . . . . 0.0 111.362 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 90.7 p -153.02 159.71 42.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.974 0.416 . . . . 0.0 110.664 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.38 -26.62 31.84 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 O-C-N 122.269 -0.269 . . . . 0.0 110.365 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -65.49 -29.33 69.97 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 122.077 -0.39 . . . . 0.0 110.083 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.7 m -80.14 -27.33 39.08 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.704 0.402 . . . . 0.0 110.641 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.14 -25.27 37.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.276 -0.265 . . . . 0.0 110.527 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -70.89 -35.99 72.56 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -77.05 -27.79 54.54 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.335 -0.228 . . . . 0.0 110.487 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.12 -51.5 57.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.361 -0.212 . . . . 0.0 111.056 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -13.32 59.92 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.863 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -84.89 -10.79 56.76 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.924 0.329 . . . . 0.0 111.591 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.6 m -124.73 -2.47 7.84 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.51 -7.4 4.67 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -78.34 133.02 37.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.889 0.768 . . . . 0.0 109.099 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.16 4.78 64.3 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.79 179.67 7.41 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 117.641 0.72 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.48 161.45 37.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.723 0.809 . . . . 0.0 108.995 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.9 mt . . . . . 0 CA--C 1.531 0.226 0 CA-C-O 119.783 -0.151 . . . . 0.0 111.337 -177.718 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.5 m . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.703 0.287 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.9 m -56.27 138.17 50.95 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.919 0.487 . . . . 0.0 109.901 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.3 mt -105.21 153.44 21.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.043 0.537 . . . . 0.0 112.069 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -141.59 125.12 16.72 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 77.4 mt -124.25 147.6 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-O 121.136 0.494 . . . . 0.0 111.498 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -155.89 170.55 21.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.054 1.342 . . . . 0.0 108.427 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -80.39 146.35 31.54 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.861 -0.524 . . . . 0.0 110.51 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.26 165.92 15.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.489 0.316 . . . . 0.0 110.272 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -82.9 -26.55 0.4 Allowed Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 43.2 Cg_endo -81.7 177.74 7.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.848 1.696 . . . . 0.0 109.593 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 59.2 p -106.38 -5.17 19.2 Favored 'General case' 0 CA--C 1.527 0.084 0 O-C-N 122.285 -0.26 . . . . 0.0 110.985 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.0 mmm-85 -154.48 155.86 35.66 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.118 0.967 . . . . 0.0 110.235 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -118.47 168.64 10.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.173 0.989 . . . . 0.0 109.716 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -140.79 161.38 37.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.329 0.252 . . . . 0.0 110.878 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.15 153.92 36.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 124.164 0.986 . . . . 0.0 109.111 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -123.83 -21.28 5.19 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.453 ' HE3' ' CG2' ' A' ' 279' ' ' THR . 0.3 OUTLIER -164.95 173.08 12.0 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.678 1.191 . . . . 0.0 109.021 176.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -113.05 113.64 25.73 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -154.93 -172.13 4.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.944 1.297 . . . . 0.0 109.387 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -71.65 -4.97 30.24 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -115.86 -14.5 11.32 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.649 0.659 . . . . 0.0 111.899 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . 0.453 ' CG2' ' HE3' ' A' ' 274' ' ' LYS . 5.0 t -157.09 138.58 13.94 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -152.91 150.24 29.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.252 -0.28 . . . . 0.0 110.894 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -125.43 137.52 54.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.133 0.573 . . . . 0.0 109.556 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -117.15 7.27 12.97 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.312 0.645 . . . . 0.0 112.084 -175.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.533 0.297 0 C-N-CA 122.569 0.348 . . . . 0.0 111.837 179.215 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.701 0.286 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.1 p -87.17 15.44 6.21 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.248 0.619 . . . . 0.0 111.606 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.71 137.92 45.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 123.158 0.583 . . . . 0.0 111.073 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.06 163.31 24.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.376 0.607 . . . . 0.0 111.266 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.1 tp -125.09 132.41 53.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.871 1.268 . . . . 0.0 108.191 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -117.84 146.96 43.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.667 0.787 . . . . 0.0 109.845 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 72.9 m -136.59 144.39 44.1 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.6 mp -109.43 136.62 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 63.3 mt -99.71 -26.42 14.06 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -174.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -135.88 66.77 62.93 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 123.67 0.788 . . . . 0.0 109.687 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -75.11 52.64 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 125.133 3.889 . . . . 0.0 112.398 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.4 pt -78.79 -1.75 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 121.724 -0.61 . . . . 0.0 111.641 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -136.54 168.85 18.7 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.268 1.027 . . . . 0.0 109.36 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.9 m -79.12 150.5 31.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.853 0.359 . . . . 0.0 111.483 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.4 mm -134.31 138.73 49.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.4 p -142.18 174.53 10.52 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 122.934 0.493 . . . . 0.0 110.018 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 38.5 p -63.19 -21.45 66.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.203 0.201 . . . . 0.0 111.109 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.81 -27.91 33.4 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.38 0.272 . . . . 0.0 111.222 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.9 t -78.96 -37.8 20.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 89.2 mt -76.79 -22.49 53.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.274 -0.266 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -77.88 -34.32 51.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.973 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -76.88 -21.71 54.53 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.386 0.539 . . . . 0.0 111.294 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 44.8 pt -90.62 -21.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.969 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.7 m -96.58 -21.66 17.53 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.507 0.594 . . . . 0.0 112.257 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.476 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.1 t-20 -60.26 -44.3 95.79 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.434 -0.793 . . . . 0.0 113.111 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 97.8 Cg_endo -72.39 -9.43 24.2 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.039 1.826 . . . . 0.0 112.103 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 76.9 m -94.67 -20.5 19.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.99 0.359 . . . . 0.0 111.217 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.54 167.32 23.82 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.44 113.27 3.07 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.799 2.999 . . . . 0.0 110.886 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.7 t -87.21 150.45 3.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -112.35 -36.73 5.2 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.159 0.584 . . . . 0.0 110.796 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -164.35 159.17 19.46 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 117.993 0.36 . . . . 0.0 111.882 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 42.4 mt -144.34 142.35 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.01 0.924 . . . . 0.0 109.354 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 m -138.4 154.63 27.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 122.72 0.408 . . . . 0.0 110.239 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 CA--C 1.528 0.122 0 C-N-CA 123.604 0.762 . . . . 0.0 111.062 -175.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.995 0.426 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.57 166.47 31.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.409 0.683 . . . . 0.0 109.339 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 87.4 mtp -135.94 150.26 49.22 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.05 148.23 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 122.918 0.487 . . . . 0.0 109.881 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.9 138.91 48.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -115.24 169.33 9.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.922 0.889 . . . . 0.0 111.065 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.79 -16.64 61.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.574 0.35 . . . . 0.0 111.549 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.5 p -152.57 159.9 43.24 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.612 0.365 . . . . 0.0 110.684 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.39 -25.75 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -70.72 -25.2 62.83 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.305 -0.247 . . . . 0.0 110.405 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.9 m -80.37 -28.53 37.97 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.64 -25.78 41.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.381 -0.2 . . . . 0.0 110.528 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -69.68 -37.02 76.5 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 48.4 ttt-85 -78.92 -26.66 43.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 121.897 0.079 . . . . 0.0 110.936 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.25 -48.89 66.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.036 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -14.41 59.27 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 118.57 0.623 . . . . 0.0 111.663 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -84.67 -9.92 57.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.653 -0.213 . . . . 0.0 111.191 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -124.71 -1.44 7.94 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.0 mt -132.07 -5.52 3.49 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -77.21 131.24 38.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.021 0.828 . . . . 0.0 109.244 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.25 5.76 67.45 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.29 179.28 7.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.609 0.704 . . . . 0.0 111.281 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -139.43 157.98 44.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.853 0.861 . . . . 0.0 108.807 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 57.1 mt . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -174.044 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.783 0.325 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.4 m -60.38 137.93 58.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.692 0.397 . . . . 0.0 109.955 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.3 mt -98.85 156.17 17.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.206 0.602 . . . . 0.0 112.314 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -144.09 134.11 24.1 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 81.2 mt -128.53 148.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-O 121.217 0.532 . . . . 0.0 111.562 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -154.3 169.49 23.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.075 1.35 . . . . 0.0 108.488 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -83.37 143.08 30.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.831 -0.543 . . . . 0.0 110.449 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.84 169.38 11.65 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -85.07 -26.51 0.37 Allowed Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.6 Cg_endo -82.03 165.26 17.31 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 CA-C-N 122.069 1.775 . . . . 0.0 109.927 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.9 p -94.3 -7.79 40.86 Favored 'General case' 0 CA--C 1.527 0.073 0 O-C-N 122.245 -0.284 . . . . 0.0 111.419 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.88 169.53 24.57 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.806 0.842 . . . . 0.0 109.939 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 84.1 mt -121.05 167.75 12.28 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.501 0.72 . . . . 0.0 109.565 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -129.85 154.13 47.59 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.681 0.277 . . . . 0.0 110.374 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 87.6 t -136.86 151.14 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.221 1.008 . . . . 0.0 108.866 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -123.43 -19.99 5.73 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.856 0.463 . . . . 0.0 111.324 -174.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -164.7 168.29 18.15 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.891 1.276 . . . . 0.0 108.7 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -116.96 109.27 16.81 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 121.016 0.436 . . . . 0.0 110.648 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -154.51 -172.14 4.1 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.789 1.236 . . . . 0.0 109.506 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -69.88 -4.85 22.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -114.1 -15.46 12.25 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 118.732 0.696 . . . . 0.0 111.826 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.2 t -159.43 134.75 8.32 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -152.23 148.31 27.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.121 -0.362 . . . . 0.0 111.153 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -125.64 132.5 52.45 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.44 0.696 . . . . 0.0 109.436 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -109.38 2.19 20.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.628 0.771 . . . . 0.0 112.137 -173.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.532 0.269 0 C-N-CA 122.947 0.499 . . . . 0.0 110.499 177.367 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.774 0.321 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.8 p -89.68 13.68 13.59 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.194 0.597 . . . . 0.0 112.127 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.56 145.62 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 122.6 0.36 . . . . 0.0 110.721 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.3 mt -130.34 165.06 23.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.266 0.626 . . . . 0.0 111.586 -174.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 63.8 tp -123.89 133.01 53.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.565 1.146 . . . . 0.0 108.432 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -119.95 144.98 47.18 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.76 0.824 . . . . 0.0 109.994 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.1 m -138.1 142.93 40.21 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.2 mp -106.54 136.53 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.9 mt -92.4 -34.58 14.1 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -134.35 67.42 72.4 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 123.634 0.773 . . . . 0.0 109.34 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.13 64.59 4.26 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.666 3.577 . . . . 0.0 112.113 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 45.6 pt -83.84 -4.5 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.993 -0.442 . . . . 0.0 111.202 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -129.38 166.24 19.93 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 109.379 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 77.9 p -80.54 156.61 26.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.642 0.258 . . . . 0.0 111.121 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mm -136.21 139.96 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 70.7 p -143.25 172.36 12.85 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.066 0.546 . . . . 0.0 110.007 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.6 p -62.04 -24.97 67.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.24 0.216 . . . . 0.0 110.991 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -78.92 -27.57 43.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.346 0.258 . . . . 0.0 111.352 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.15 -38.58 18.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.878 0.37 . . . . 0.0 110.025 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.35 -22.97 54.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.218 -0.301 . . . . 0.0 110.561 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -78.65 -35.22 45.69 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.914 0.324 . . . . 0.0 110.879 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.2 t -74.73 -23.56 58.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.242 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 pt -89.05 -21.41 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 118.379 0.536 . . . . 0.0 111.955 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 87.6 m -95.74 -19.3 19.78 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.302 0.501 . . . . 0.0 112.182 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.458 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.6 t-20 -60.39 -44.08 94.87 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 92.7 Cg_endo -73.06 -10.81 24.89 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.706 1.604 . . . . 0.0 111.995 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 77.5 m -89.4 -23.7 22.1 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.161 0.437 . . . . 0.0 111.249 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.86 171.78 30.52 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.1 111.43 2.68 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.553 2.835 . . . . 0.0 110.556 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.47 151.45 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -116.06 -39.1 3.49 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.064 0.546 . . . . 0.0 110.907 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -161.67 158.48 26.08 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.402 0.546 . . . . 0.0 112.062 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 41.2 mt -144.89 143.93 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 124.364 1.066 . . . . 0.0 109.721 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.427 ' C ' HD12 ' A' ' 223' ' ' ILE . 22.4 m -141.69 149.52 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 123.288 0.635 . . . . 0.0 109.857 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.427 HD12 ' C ' ' A' ' 222' ' ' VAL . 1.8 mp . . . . . 0 CA--C 1.529 0.17 0 C-N-CA 123.765 0.826 . . . . 0.0 109.81 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 N--CA 1.455 -0.183 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.05 171.64 20.1 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.528 0.331 . . . . 0.0 110.218 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.8 mtp -138.78 149.95 45.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.28 151.37 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -135.5 140.74 45.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.564 0.746 . . . . 0.0 109.818 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -120.03 167.74 11.87 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.851 0.861 . . . . 0.0 110.854 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.51 -11.21 59.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.616 0.366 . . . . 0.0 111.349 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 42.9 t -152.18 151.45 31.03 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.151 0.581 . . . . 0.0 110.088 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.11 -25.71 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.54 -24.38 62.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.009 -0.432 . . . . 0.0 110.14 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 41.2 m -80.35 -27.2 38.35 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.75 -26.42 37.32 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.243 0.217 . . . . 0.0 110.424 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -68.46 -37.64 80.36 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -78.68 -24.79 44.86 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.99 -50.63 54.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.319 -0.238 . . . . 0.0 111.197 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.404 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.06 -14.57 59.45 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.626 179.07 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.22 -8.54 58.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.835 0.289 . . . . 0.0 111.555 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.8 t -125.6 -6.79 6.88 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.3 mt -124.49 -5.33 7.67 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -77.71 131.36 37.66 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.82 5.05 73.41 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.563 -0.576 . . . . 0.0 111.827 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.86 177.57 8.95 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.833 0.816 . . . . 0.0 111.093 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -138.64 160.38 39.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.758 0.823 . . . . 0.0 109.371 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.4 mt . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.294 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.3 m . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.49 0.186 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.0 m -60.56 139.59 57.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.937 0.495 . . . . 0.0 110.041 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.0 mt -95.24 154.51 17.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.372 0.669 . . . . 0.0 111.756 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -145.56 129.15 17.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.404 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 81.0 mt -129.29 147.69 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 CA-C-O 121.171 0.51 . . . . 0.0 112.216 -171.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.36 173.56 15.47 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.679 1.191 . . . . 0.0 108.547 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -83.23 143.56 30.36 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.976 -0.452 . . . . 0.0 110.675 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.18 167.33 17.84 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.068 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 39.7 ttpt -74.64 -46.88 5.43 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 118.298 -0.858 . . . . 0.0 113.273 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 74.8 Cg_endo -74.9 177.53 8.43 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.353 2.035 . . . . 0.0 110.539 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.2 p -108.49 -7.79 15.69 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.592 0.357 . . . . 0.0 111.534 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.77 136.49 14.4 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 56.4 mt -88.05 171.09 10.53 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 122.731 0.412 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -131.93 151.7 51.55 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.549 0.34 . . . . 0.0 110.369 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.3 153.69 24.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 124.171 0.988 . . . . 0.0 108.786 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -126.94 -19.62 4.39 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.57 0.348 . . . . 0.0 111.437 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -165.56 170.46 14.27 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 124.505 1.122 . . . . 0.0 109.011 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -117.06 109.42 16.94 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.619 0.368 . . . . 0.0 110.411 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -154.93 -172.13 4.08 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.585 1.154 . . . . 0.0 109.627 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -69.75 -4.86 21.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -115.2 -17.29 11.41 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.121 0.873 . . . . 0.0 111.779 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.6 t -156.68 134.81 11.2 Favored 'General case' 0 N--CA 1.458 -0.055 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -152.61 147.36 26.06 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.758 0.314 . . . . 0.0 111.212 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -124.43 119.76 30.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -95.66 -4.68 43.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.281 0.632 . . . . 0.0 111.568 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 121.335 0.588 . . . . 0.0 110.124 176.698 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.3 p30 . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 120.988 0.423 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.0 p -82.96 10.13 8.59 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.5 t -109.43 136.56 44.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 122.815 0.446 . . . . 0.0 110.611 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.5 mt -125.1 161.43 26.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.754 0.788 . . . . 0.0 111.373 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.0 tp -126.17 131.44 52.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.035 1.334 . . . . 0.0 107.51 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -118.09 145.16 45.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.69 0.796 . . . . 0.0 109.406 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.3 m -139.49 141.54 37.34 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.2 mp -105.7 135.3 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.4 mt -94.02 -36.55 12.08 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -173.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -129.87 62.78 65.68 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 123.368 0.667 . . . . 0.0 110.082 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.45 101.96 0.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.947 2.431 . . . . 0.0 110.717 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.0 pt -128.26 3.07 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.788 0.435 . . . . 0.0 111.402 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -131.67 166.47 21.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.855 0.862 . . . . 0.0 109.457 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.5 m -73.91 145.8 44.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.787 0.327 . . . . 0.0 111.32 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.5 mm -137.49 136.79 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.6 p -145.04 172.27 13.3 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.529 0.732 . . . . 0.0 109.636 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.9 p -63.77 -20.76 66.02 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 122.327 -0.233 . . . . 0.0 110.931 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -79.7 -27.37 40.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.326 0.25 . . . . 0.0 110.888 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.2 t -81.51 -37.64 15.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.66 -28.54 62.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.185 -0.322 . . . . 0.0 110.599 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -74.28 -37.96 63.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.991 -0.443 . . . . 0.0 111.044 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.7 t -74.11 -20.99 60.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.555 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.3 pt -88.85 -23.55 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.184 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 16.6 p -109.69 -6.83 15.2 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.16 -42.79 87.82 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.562 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 94.4 Cg_endo -72.85 -7.02 20.07 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.805 1.67 . . . . 0.0 112.089 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 65.7 m -86.02 -21.86 27.57 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.062 0.392 . . . . 0.0 111.213 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.8 176.7 32.17 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.77 107.83 1.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.975 3.117 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.09 149.47 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -112.61 -39.05 4.44 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.474 0.31 . . . . 0.0 111.003 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -167.18 161.75 14.72 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 117.967 0.349 . . . . 0.0 111.911 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.4 mt -143.07 139.76 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.205 1.002 . . . . 0.0 109.145 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.17 157.8 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.8 mt . . . . . 0 C--N 1.335 -0.053 0 C-N-CA 122.875 0.47 . . . . 0.0 111.014 -175.274 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.785 0.326 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.55 172.14 17.04 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.418 0.287 . . . . 0.0 110.58 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 85.0 mtp -141.39 152.41 44.31 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 46.5 t -139.73 149.86 22.36 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.032 0 C-N-CA 123.02 0.528 . . . . 0.0 109.607 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -132.91 140.48 47.89 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -117.33 169.07 9.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.045 0.938 . . . . 0.0 110.974 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.56 -11.15 59.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.061 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.9 t -150.59 149.65 30.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.211 0.604 . . . . 0.0 110.111 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.45 -26.37 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -70.94 -23.63 62.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.961 -0.462 . . . . 0.0 110.316 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.9 m -80.11 -28.31 39.02 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.22 -27.86 42.5 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.519 0.199 . . . . 0.0 110.793 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -67.26 -36.02 80.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -82.47 -27.09 32.06 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.73 0.412 . . . . 0.0 111.698 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.16 -44.16 72.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.06 -0.4 . . . . 0.0 110.399 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -27.94 64.81 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -77.66 -8.53 58.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.819 -0.551 . . . . 0.0 111.712 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.6 m -121.07 -5.5 9.51 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.45 -8.75 2.53 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -74.57 131.15 40.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.735 1.152 . . . . 0.0 108.845 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 71.88 6.17 63.05 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.386 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.33 -179.06 7.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.83 0.815 . . . . 0.0 111.387 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -140.28 163.15 33.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.897 0.879 . . . . 0.0 109.456 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.0 mt . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -175.519 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 79.8 m . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.638 0.256 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.7 m -59.94 139.22 57.54 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.044 0.538 . . . . 0.0 109.896 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 64.9 mt -93.71 154.64 17.68 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.433 0.693 . . . . 0.0 111.799 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -144.06 123.1 12.83 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.6 mt -123.82 145.53 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-O 120.98 0.419 . . . . 0.0 111.575 -173.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -155.02 172.68 17.71 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.818 1.247 . . . . 0.0 108.498 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -85.81 147.25 26.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.11 -0.369 . . . . 0.0 110.858 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -95.7 165.74 12.16 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.657 0.383 . . . . 0.0 110.816 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -80.72 -27.17 0.45 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 47.6 Cg_endo -80.66 160.44 21.91 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 CA-C-N 121.965 1.738 . . . . 0.0 110.047 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 43.0 p -89.87 -10.44 45.29 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.6 0.36 . . . . 0.0 111.257 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 168.73 26.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.612 0.765 . . . . 0.0 110.074 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -119.93 172.69 7.55 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.093 0.957 . . . . 0.0 109.691 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -134.28 154.64 51.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.292 -0.255 . . . . 0.0 110.404 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 70.7 t -136.77 150.52 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.747 0.819 . . . . 0.0 108.885 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -122.75 -20.56 5.87 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.482 0.313 . . . . 0.0 111.358 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -165.23 169.98 15.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.176 0.99 . . . . 0.0 109.414 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -116.47 116.37 27.54 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.023 0.44 . . . . 0.0 110.519 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -159.87 -172.54 3.69 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.338 1.455 . . . . 0.0 109.384 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.75 -1.32 11.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.46 -19.93 8.64 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.622 0.646 . . . . 0.0 111.944 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 2.8 t -153.68 137.11 15.84 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -153.84 149.44 27.37 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.221 -0.299 . . . . 0.0 111.394 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -128.34 138.07 52.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.275 0.63 . . . . 0.0 109.62 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -115.9 6.93 14.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.582 0.753 . . . . 0.0 112.461 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.532 0.264 0 C-N-CA 122.843 0.457 . . . . 0.0 111.163 179.051 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.2 p30 . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.628 0.251 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.2 p -99.61 18.87 16.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.483 0.713 . . . . 0.0 111.955 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.6 143.92 33.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 C-N-CA 123.003 0.521 . . . . 0.0 110.696 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.5 mt -129.68 163.24 26.55 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.149 0.58 . . . . 0.0 111.365 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.3 tp -121.2 133.68 55.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.989 1.316 . . . . 0.0 108.054 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -119.61 145.58 46.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.521 0.728 . . . . 0.0 109.738 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.6 m -140.62 144.49 35.8 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.5 mp -107.68 135.25 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.1 mt -91.77 -35.67 13.99 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -130.79 61.71 61.0 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 123.575 0.75 . . . . 0.0 110.184 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.98 101.79 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.78 2.32 . . . . 0.0 110.784 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.0 pt -125.72 0.22 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.95 0.5 . . . . 0.0 111.339 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.13 166.47 21.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.711 0.804 . . . . 0.0 109.264 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.5 m -73.53 151.68 40.9 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.81 0.338 . . . . 0.0 111.563 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.5 mm -138.71 135.24 43.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 68.4 p -146.46 176.35 9.87 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.149 0.58 . . . . 0.0 110.1 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.2 p -62.38 -25.55 67.98 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 122.435 0.294 . . . . 0.0 111.209 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -80.54 -20.61 43.08 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.545 0.338 . . . . 0.0 111.461 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 88.6 t -90.56 -37.82 9.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.4 mt -77.31 -22.53 51.81 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.254 -0.279 . . . . 0.0 110.715 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -78.8 -36.1 43.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.924 0.329 . . . . 0.0 110.903 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.9 t -77.0 -17.31 58.93 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.996 -0.44 . . . . 0.0 111.395 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.41 -17.57 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.913 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 88.8 m -95.7 -25.3 16.16 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.91 0.777 . . . . 0.0 111.859 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.487 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.2 t-20 -59.71 -42.2 90.1 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 83.6 Cg_endo -71.1 -4.54 15.1 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.962 1.775 . . . . 0.0 112.1 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 72.4 m -107.52 -11.68 15.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.223 0.465 . . . . 0.0 111.335 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.7 165.05 15.87 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.42 114.39 3.79 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.897 3.064 . . . . 0.0 110.67 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.2 t -86.56 151.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -113.34 -36.39 5.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.162 0.585 . . . . 0.0 110.554 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -164.04 159.88 21.08 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.8 mt -144.49 145.79 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.361 1.064 . . . . 0.0 109.92 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.37 150.39 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 C-N-CA 123.265 0.626 . . . . 0.0 109.45 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.231 0.104 0 C-N-CA 123.077 0.551 . . . . 0.0 110.872 -175.785 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.77 170.15 23.11 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.9 mtp -138.49 151.52 47.45 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 43.7 t -138.4 149.49 24.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 C-N-CA 122.645 0.378 . . . . 0.0 110.424 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -132.43 138.88 47.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.728 0.811 . . . . 0.0 109.147 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -117.04 167.85 10.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.445 0.698 . . . . 0.0 110.797 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -75.99 -15.37 60.16 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.237 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.6 t -152.23 153.49 33.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.241 0.616 . . . . 0.0 110.057 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.89 -27.08 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -68.17 -24.13 64.94 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.926 -0.484 . . . . 0.0 109.854 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.9 m -81.47 -27.9 34.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.424 0.29 . . . . 0.0 110.395 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.15 -25.21 37.03 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -70.02 -37.5 75.64 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -77.49 -26.6 51.41 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 122.277 -0.265 . . . . 0.0 110.494 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.55 -53.59 39.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.951 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.26 -14.34 60.13 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.622 0.647 . . . . 0.0 111.976 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.85 -12.67 55.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.1 -0.375 . . . . 0.0 111.855 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.0 m -129.67 1.72 4.95 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 77.0 mt -128.46 -4.27 5.41 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.65 0.659 . . . . 0.0 112.717 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -78.78 132.04 36.75 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.6 4.51 70.51 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.016 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.74 177.59 8.54 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.634 0.717 . . . . 0.0 110.866 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -140.39 161.18 38.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.466 0.706 . . . . 0.0 109.287 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.8 mt . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.851 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.4 m . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.471 0.177 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 16.7 m -59.55 138.22 57.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.78 0.432 . . . . 0.0 110.081 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 62.6 mt -91.68 156.78 17.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.322 0.649 . . . . 0.0 112.053 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -140.76 137.91 33.75 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 77.7 mt -133.82 141.62 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.135 0.493 . . . . 0.0 111.489 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.75 167.94 27.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.782 1.233 . . . . 0.0 108.232 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -78.41 144.55 35.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.808 -0.558 . . . . 0.0 110.812 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.87 165.68 17.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.508 0.323 . . . . 0.0 110.265 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -81.06 -27.24 0.45 Allowed Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -176.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 46.2 Cg_endo -81.67 178.34 6.67 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.838 1.692 . . . . 0.0 109.913 177.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 69.2 p -105.09 -9.0 18.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.432 0.293 . . . . 0.0 111.089 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.92 168.03 27.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.835 0.854 . . . . 0.0 109.976 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 94.4 mt -127.11 170.43 12.36 Favored 'General case' 0 N--CA 1.459 0.014 0 C-N-CA 123.659 0.784 . . . . 0.0 109.817 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -138.76 163.85 31.1 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.397 0.618 . . . . 0.0 111.673 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 38.7 t -140.51 156.2 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 124.695 1.198 . . . . 0.0 108.555 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -125.61 -21.92 4.37 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.504 0.322 . . . . 0.0 111.678 -174.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -163.6 169.1 19.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.381 1.072 . . . . 0.0 108.91 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -115.71 110.01 18.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.121 0.486 . . . . 0.0 110.438 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -155.32 -170.24 3.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.009 1.323 . . . . 0.0 109.335 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -72.67 -2.51 20.44 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -119.6 -15.82 8.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.893 0.77 . . . . 0.0 112.006 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.7 t -154.76 135.01 13.2 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -157.96 145.25 18.18 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.266 -0.271 . . . . 0.0 110.871 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -129.19 141.14 51.24 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.575 0.703 . . . . 0.0 111.311 171.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -108.58 -9.81 15.29 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.558 0.743 . . . . 0.0 111.816 -174.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 CA--C 1.532 0.26 0 C-N-CA 123.089 0.556 . . . . 0.0 110.23 176.026 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.6 p30 . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 121.112 0.482 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.7 p -97.76 15.89 22.3 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.809 0.843 . . . . 0.0 111.021 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.08 138.74 38.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 C-N-CA 123.615 0.766 . . . . 0.0 110.703 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.0 mt -127.35 159.91 32.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.298 0.57 . . . . 0.0 111.54 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.9 tp -124.2 130.51 52.66 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.017 1.327 . . . . 0.0 107.764 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -115.1 145.03 42.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.401 0.68 . . . . 0.0 109.684 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.9 m -139.44 144.38 38.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.4 mp -107.17 136.94 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 75.4 mt -93.77 -34.87 13.03 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -130.09 63.15 67.83 Favored Pre-proline 0 CA--C 1.528 0.114 0 C-N-CA 123.162 0.585 . . . . 0.0 109.951 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.58 101.71 0.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.766 2.31 . . . . 0.0 110.881 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.58 2.5 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 122.774 0.429 . . . . 0.0 111.29 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -134.98 166.89 21.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.814 0.845 . . . . 0.0 109.314 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 33.1 t -78.54 151.44 32.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.794 0.331 . . . . 0.0 110.975 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.1 mm -136.83 137.16 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.6 p -143.52 176.72 8.97 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 123.148 0.579 . . . . 0.0 110.053 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.1 p -62.34 -23.25 66.66 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.696 0.399 . . . . 0.0 111.195 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -82.2 -23.75 35.27 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.84 0.291 . . . . 0.0 111.274 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 83.6 t -83.97 -37.64 13.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.84 -21.52 47.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.039 -0.413 . . . . 0.0 110.848 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -77.6 -34.39 53.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.171 0.441 . . . . 0.0 110.848 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.3 t -76.91 -22.34 53.51 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.268 0.485 . . . . 0.0 111.354 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.2 pt -90.18 -22.44 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.491 0.587 . . . . 0.0 111.791 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.4 m -94.66 -23.07 17.76 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.439 0.563 . . . . 0.0 112.013 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.3 t-20 -59.75 -44.57 97.54 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 97.2 Cg_endo -72.77 -10.11 24.59 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.863 1.708 . . . . 0.0 111.803 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 74.6 m -93.73 -20.92 19.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.32 0.509 . . . . 0.0 110.95 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 166.35 167.38 26.91 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.12 104.77 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.93 3.087 . . . . 0.0 110.763 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.4 t -78.42 152.0 5.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -115.0 -40.85 3.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.011 0.525 . . . . 0.0 110.828 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.412 HH22 ' CG1' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -163.96 159.51 20.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.53 0.605 . . . . 0.0 112.495 177.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 42.0 mt -142.07 150.64 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 124.104 0.962 . . . . 0.0 110.45 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.412 ' CG1' HH22 ' A' ' 220' ' ' ARG . 7.3 p -141.53 148.62 20.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 C-N-CA 123.739 0.816 . . . . 0.0 109.202 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 38.6 mm . . . . . 0 N--CA 1.456 -0.148 0 C-N-CA 124.035 0.934 . . . . 0.0 110.418 -174.587 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.83 0.348 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.8 167.73 29.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.026 0.531 . . . . 0.0 109.957 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.2 mtp -134.98 142.69 46.53 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.64 151.25 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.16 0.584 . . . . 0.0 110.237 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -135.17 140.79 45.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.44 0.696 . . . . 0.0 109.225 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -118.73 168.02 11.12 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.722 0.809 . . . . 0.0 110.996 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.47 -17.85 61.73 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.88 0.472 . . . . 0.0 111.564 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.0 p -152.37 160.08 43.34 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.626 0.371 . . . . 0.0 110.422 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.74 -28.26 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -64.83 -30.07 71.06 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.925 -0.485 . . . . 0.0 109.877 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 45.0 m -78.24 -28.77 47.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.211 0.204 . . . . 0.0 110.571 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.49 -26.03 38.45 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.212 -0.305 . . . . 0.0 110.639 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -70.56 -36.13 73.46 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -79.77 -24.98 41.15 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.278 -0.264 . . . . 0.0 110.497 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.84 -52.66 40.97 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.162 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -15.49 59.68 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.755 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -80.72 -13.95 58.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.912 0.324 . . . . 0.0 111.721 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.7 m -125.05 1.44 7.95 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.0 mt -129.18 -4.82 4.94 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -77.74 132.73 38.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.8 5.55 64.88 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.218 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.15 179.56 7.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.679 0.74 . . . . 0.0 111.007 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -139.64 163.08 33.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.278 0.631 . . . . 0.0 109.515 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.6 mt . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -176.485 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.927 0.394 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 14.6 m -59.67 138.81 57.63 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.746 0.418 . . . . 0.0 109.917 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 58.4 mt -92.62 155.47 17.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.276 0.631 . . . . 0.0 112.179 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -143.63 123.62 13.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 74.1 mt -123.78 146.3 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.248 0.547 . . . . 0.0 111.682 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.44 169.27 24.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.677 1.191 . . . . 0.0 108.732 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -78.44 145.53 35.01 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.008 -0.433 . . . . 0.0 110.599 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.86 167.85 15.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.328 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -80.06 -29.27 0.55 Allowed Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.8 Cg_endo -82.68 169.44 13.56 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 121.73 1.653 . . . . 0.0 110.093 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.0 p -99.57 -5.93 28.28 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 122.388 -0.195 . . . . 0.0 110.998 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -152.85 157.04 40.13 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 123.836 0.854 . . . . 0.0 110.634 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 80.2 mt -121.99 175.37 6.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.186 0.994 . . . . 0.0 109.308 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -143.95 165.14 28.57 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.483 0.313 . . . . 0.0 110.926 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.2 t -137.6 157.98 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 124.398 1.079 . . . . 0.0 108.925 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -125.03 -31.36 3.12 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 122.263 -0.273 . . . . 0.0 110.923 -174.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.09 167.78 28.34 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.264 1.025 . . . . 0.0 109.291 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -107.66 118.59 37.15 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.121 0.486 . . . . 0.0 111.148 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.97 -171.64 3.47 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.063 1.345 . . . . 0.0 109.251 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -74.5 -3.69 32.3 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -107.67 -23.68 12.02 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.409 0.55 . . . . 0.0 111.115 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.1 t -158.07 141.08 14.95 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -150.71 151.26 32.16 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.304 -0.248 . . . . 0.0 110.873 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -129.18 135.99 49.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.222 0.609 . . . . 0.0 109.403 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.2 6.03 14.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.549 0.74 . . . . 0.0 112.211 -174.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.531 0.224 0 C-N-CA 122.993 0.517 . . . . 0.0 111.211 179.23 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.7 p -88.58 7.6 32.46 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.835 0.454 . . . . 0.0 111.415 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -104.54 138.51 28.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.552 0.741 . . . . 0.0 111.297 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.09 160.64 32.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.544 0.737 . . . . 0.0 111.507 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 64.4 tp -119.71 133.89 55.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.036 1.334 . . . . 0.0 107.862 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -120.12 147.33 45.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.492 0.717 . . . . 0.0 109.861 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 81.5 m -142.09 145.36 34.2 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.4 mp -109.51 135.91 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 64.8 mt -94.85 -28.73 15.07 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -136.15 68.17 62.62 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 123.911 0.884 . . . . 0.0 109.587 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.55 57.41 4.26 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.704 3.603 . . . . 0.0 112.425 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.87 -3.12 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 O-C-N 121.958 -0.464 . . . . 0.0 111.616 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -130.13 166.59 19.91 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.924 0.89 . . . . 0.0 109.442 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 m -74.8 148.52 40.26 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.939 0.399 . . . . 0.0 111.604 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.9 mm -137.73 138.3 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.3 p -145.47 174.98 10.67 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.208 0.603 . . . . 0.0 109.893 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 38.0 p -63.14 -21.24 66.06 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 122.314 -0.241 . . . . 0.0 111.099 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -81.94 -26.18 34.25 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.024 0.375 . . . . 0.0 111.048 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.06 -38.59 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 86.3 mt -76.95 -22.92 52.52 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.921 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -76.3 -36.14 58.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 117.96 0.346 . . . . 0.0 110.785 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.1 t -78.11 -18.68 55.36 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.14 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -95.84 -14.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 118.348 0.522 . . . . 0.0 112.028 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 78.3 m -98.21 -24.36 15.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.869 0.758 . . . . 0.0 112.25 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.469 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 48.6 t30 -64.18 -38.87 38.34 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 86.1 Cg_endo -73.66 -0.05 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.635 1.557 . . . . 0.0 112.159 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 80.6 m -112.62 -5.69 13.97 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.609 0.364 . . . . 0.0 111.625 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 158.8 164.39 14.26 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.98 106.39 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.852 3.035 . . . . 0.0 110.638 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.7 t -78.49 150.63 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -117.03 -36.5 3.79 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.643 0.377 . . . . 0.0 111.279 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -164.12 156.43 17.05 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.101 0.41 . . . . 0.0 111.792 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 40.5 mt -144.77 143.75 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.751 0.821 . . . . 0.0 109.761 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.7 m -138.76 155.97 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 123.359 0.663 . . . . 0.0 109.756 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.7 mm . . . . . 0 C--O 1.231 0.101 0 C-N-CA 123.569 0.747 . . . . 0.0 111.096 -176.293 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.01 171.18 20.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.388 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.6 mtp -135.77 149.38 49.13 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 55.2 t -136.63 150.77 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -139.85 141.33 36.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -118.27 170.47 8.87 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.834 0.853 . . . . 0.0 110.849 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.63 -13.16 59.98 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.549 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 46.1 t -150.53 153.56 36.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.677 0.391 . . . . 0.0 110.416 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.17 -26.5 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -71.04 -24.04 62.27 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 22.5 m -81.34 -27.43 34.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.22 -25.1 36.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.416 0.286 . . . . 0.0 110.457 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -70.56 -37.49 74.01 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -74.93 -29.33 60.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.315 0.246 . . . . 0.0 110.689 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.49 -52.44 45.97 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 119.733 -0.175 . . . . 0.0 111.268 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.41 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.76 -12.6 59.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.845 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.52 -10.22 52.32 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.822 0.283 . . . . 0.0 111.601 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 21.4 m -126.33 -1.78 6.93 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.7 mt -130.62 -5.36 4.14 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -78.14 132.71 37.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.38 6.9 71.39 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.46 174.94 11.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.672 0.736 . . . . 0.0 111.061 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -132.65 149.75 52.26 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.1 0.96 . . . . 0.0 108.763 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.4 mt . . . . . 0 CA--C 1.533 0.3 0 CA-C-N 117.433 0.106 . . . . 0.0 111.219 -177.942 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.601 0.239 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.7 m -60.13 139.8 57.29 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.991 0.516 . . . . 0.0 110.223 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 54.3 mt -96.79 156.9 16.15 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.111 0.564 . . . . 0.0 112.282 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -140.52 137.71 34.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 171.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 71.7 mt -136.0 142.33 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.082 0.467 . . . . 0.0 111.308 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.72 167.3 30.07 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.563 1.145 . . . . 0.0 108.54 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -79.01 141.49 37.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.803 -0.561 . . . . 0.0 110.684 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.67 167.9 14.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.423 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -81.26 -27.89 0.46 Allowed Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.2 Cg_endo -82.15 166.86 16.26 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 CA-C-N 121.913 1.719 . . . . 0.0 110.138 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.1 p -99.87 -5.32 28.62 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 122.332 0.253 . . . . 0.0 111.025 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -154.76 151.95 29.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.088 0.955 . . . . 0.0 109.92 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.46 171.41 7.53 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.779 0.832 . . . . 0.0 109.398 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -138.92 159.3 42.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.961 0.504 . . . . 0.0 109.893 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.94 154.02 35.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.912 0.885 . . . . 0.0 109.006 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -123.15 -21.71 5.35 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.672 0.389 . . . . 0.0 111.771 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -166.93 173.11 9.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.311 1.044 . . . . 0.0 109.695 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -116.48 113.51 22.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.073 0.463 . . . . 0.0 110.473 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -157.53 -174.38 4.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.204 1.401 . . . . 0.0 109.243 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -69.79 -4.15 18.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -117.24 -11.76 10.61 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.713 0.688 . . . . 0.0 112.031 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.2 t -158.55 134.25 8.88 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -152.65 150.73 29.79 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 122.087 -0.383 . . . . 0.0 111.055 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -123.24 137.45 54.87 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.247 0.619 . . . . 0.0 109.743 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -119.33 15.95 13.05 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.487 0.715 . . . . 0.0 112.091 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.669 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.8 p30 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.992 0.425 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -90.12 18.08 6.29 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.565 0.746 . . . . 0.0 111.243 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.1 t -116.62 139.62 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.423 0.689 . . . . 0.0 110.325 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.2 mt -128.59 161.86 28.62 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.353 0.597 . . . . 0.0 110.621 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 tt -129.68 136.35 49.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -117.02 148.49 41.44 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.191 0.996 . . . . 0.0 109.903 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 89.8 m -133.28 141.16 47.86 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.4 mp -107.21 138.84 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 53.3 mt -108.06 -22.59 12.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -131.47 63.27 69.01 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 123.499 0.719 . . . . 0.0 109.777 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.92 40.04 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 125.104 3.869 . . . . 0.0 112.87 -173.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.4 pt -75.95 -2.91 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.6 -0.688 . . . . 0.0 111.531 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -130.4 165.22 23.02 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.987 0.915 . . . . 0.0 109.516 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 32.4 t -74.74 148.77 40.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.623 0.249 . . . . 0.0 111.487 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.7 mm -137.28 136.48 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 124.462 1.105 . . . . 0.0 108.175 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.0 p -143.97 176.88 8.95 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.138 0.575 . . . . 0.0 109.967 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.2 p -61.92 -22.68 65.8 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.569 0.348 . . . . 0.0 111.011 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.95 -24.61 35.45 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.48 0.312 . . . . 0.0 110.793 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.5 t -83.99 -37.6 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.95 -22.55 53.1 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.656 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -75.8 -36.92 59.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.196 0.453 . . . . 0.0 110.675 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 t -77.93 -18.7 55.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.396 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.94 -15.15 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.894 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.6 m -96.91 -25.42 15.43 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.741 0.701 . . . . 0.0 111.826 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.499 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 25.5 t-20 -58.75 -42.57 94.95 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 79.9 Cg_endo -71.26 -2.42 11.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.183 1.922 . . . . 0.0 112.379 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 83.7 m -115.03 -4.75 12.5 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.153 0.433 . . . . 0.0 111.642 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 158.86 158.68 9.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.76 114.59 3.75 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.674 2.916 . . . . 0.0 110.634 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.7 t -85.68 149.39 4.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -112.58 -34.74 5.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.893 0.477 . . . . 0.0 110.943 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -165.36 160.41 18.11 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 111.945 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 41.6 mt -143.48 147.43 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 124.256 1.023 . . . . 0.0 109.487 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.98 145.04 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.062 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.5 mm . . . . . 0 N--CA 1.455 -0.194 0 C-N-CA 123.754 0.822 . . . . 0.0 110.291 -174.137 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.826 0.346 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.65 168.56 26.76 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.62 0.768 . . . . 0.0 109.914 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 85.2 mtp -136.89 151.65 49.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.74 150.27 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.048 0.539 . . . . 0.0 110.062 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -133.08 139.53 47.19 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -114.04 167.38 10.71 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.777 0.831 . . . . 0.0 111.299 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -75.2 -14.13 60.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.9 t -152.06 151.49 31.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.017 0.527 . . . . 0.0 110.08 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.4 p -69.12 -24.05 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.41 -24.81 62.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 26.3 m -81.54 -25.38 35.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.738 0.415 . . . . 0.0 110.612 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.46 -26.4 35.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.64 -36.9 76.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -77.64 -29.33 51.66 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.31 -52.24 55.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 119.647 -0.216 . . . . 0.0 110.97 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.422 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.99 -15.07 59.75 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.628 0.649 . . . . 0.0 112.209 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -82.53 -12.7 57.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.986 0.357 . . . . 0.0 111.814 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -128.51 2.53 5.59 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 73.2 mt -129.59 -3.61 4.78 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.791 0.723 . . . . 0.0 112.491 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -78.5 131.53 36.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.24 3.63 76.85 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.75 179.95 5.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.762 0.781 . . . . 0.0 110.7 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.78 162.34 35.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.434 0.694 . . . . 0.0 109.181 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 38.3 mt . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 111.227 0.084 . . . . 0.0 111.227 -176.74 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.512 0.196 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.1 m -55.35 142.12 33.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.41 0.684 . . . . 0.0 109.795 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.0 mt -108.62 153.76 22.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.374 0.669 . . . . 0.0 112.022 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -140.26 135.0 31.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 171.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.422 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 79.4 mt -125.81 148.99 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.048 0.451 . . . . 0.0 111.435 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.86 165.97 34.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.034 1.333 . . . . 0.0 108.421 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.73 139.95 38.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.834 -0.541 . . . . 0.0 110.231 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -75.36 167.18 22.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.897 0.479 . . . . 0.0 111.427 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -71.72 -54.78 6.09 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.164 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.66 164.59 31.88 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.336 2.024 . . . . 0.0 111.123 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.0 p -91.74 -6.47 51.86 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.712 0.405 . . . . 0.0 111.576 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.62 167.06 30.81 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.732 0.813 . . . . 0.0 109.878 176.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 86.2 mt -123.54 173.15 8.23 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.517 0.727 . . . . 0.0 109.863 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -136.19 154.53 50.92 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 91.9 t -136.37 153.12 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.876 0.871 . . . . 0.0 108.65 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.72 -18.78 5.09 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -166.06 172.56 11.24 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.931 1.292 . . . . 0.0 109.296 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -119.06 110.63 17.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.01 0.434 . . . . 0.0 110.46 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -154.62 -169.85 3.34 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.796 1.238 . . . . 0.0 109.773 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -70.18 -6.66 35.93 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -114.42 -15.25 12.1 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.782 0.719 . . . . 0.0 112.209 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.2 t -159.02 140.17 12.97 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -154.88 148.32 25.14 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.997 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -128.03 135.7 50.23 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -112.87 5.12 17.26 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.612 0.765 . . . . 0.0 112.031 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 CA--C 1.53 0.19 0 C-N-CA 122.907 0.483 . . . . 0.0 111.55 -179.503 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.846 0.355 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 82.3 p -87.12 13.59 9.13 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.245 0.618 . . . . 0.0 111.842 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.4 t -109.01 138.63 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 122.91 0.484 . . . . 0.0 110.885 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.67 160.83 31.24 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 121.427 0.632 . . . . 0.0 111.459 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.7 tp -125.7 130.29 51.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.94 1.296 . . . . 0.0 108.222 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -115.56 146.91 41.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.566 0.746 . . . . 0.0 109.985 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.4 m -138.43 142.63 39.52 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.7 mp -106.8 136.46 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 73.1 mt -92.4 -34.46 14.14 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -134.02 68.25 74.35 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 123.406 0.682 . . . . 0.0 109.543 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -74.41 62.92 5.4 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.555 3.503 . . . . 0.0 112.427 -174.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 44.8 pt -84.66 -4.85 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 122.024 -0.422 . . . . 0.0 111.289 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -126.85 167.88 15.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.945 0.898 . . . . 0.0 109.27 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 78.1 p -83.26 154.15 24.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.015 0.436 . . . . 0.0 111.21 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.0 mm -136.91 138.3 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.1 p -143.97 176.1 9.54 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.044 0.538 . . . . 0.0 110.018 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.9 p -62.12 -27.47 68.95 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 122.542 0.337 . . . . 0.0 110.966 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -78.03 -20.34 52.65 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.431 0.292 . . . . 0.0 111.495 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.42 -40.68 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 88.5 mt -73.56 -30.67 63.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.175 -0.328 . . . . 0.0 110.924 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -68.87 -37.82 79.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.217 0.462 . . . . 0.0 110.921 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 t -78.58 -17.43 56.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.481 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.35 -9.73 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 18.2 p -119.69 -6.23 10.16 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.347 0.976 . . . . 0.0 113.136 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.498 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.6 t-20 -63.06 -41.12 68.24 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.496 -0.764 . . . . 0.0 113.054 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 96.3 Cg_endo -71.7 -3.03 12.32 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.794 1.663 . . . . 0.0 111.982 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.2 m -93.58 -8.47 41.11 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.096 0.407 . . . . 0.0 111.41 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 144.91 174.58 17.29 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.38 114.91 3.42 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.672 2.915 . . . . 0.0 110.953 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 96.9 t -87.06 150.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -113.9 -37.61 4.45 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -165.17 159.16 17.29 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.518 0.599 . . . . 0.0 112.287 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 48.7 mt -142.83 144.36 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.081 0.953 . . . . 0.0 109.677 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.408 ' C ' HD12 ' A' ' 223' ' ' ILE . 6.4 p -143.85 142.71 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 123.486 0.714 . . . . 0.0 109.487 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 222' ' ' VAL . 1.8 mp . . . . . 0 CA--C 1.529 0.143 0 C-N-CA 123.799 0.84 . . . . 0.0 109.649 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.913 0.387 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.35 169.28 24.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.024 0.53 . . . . 0.0 109.731 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.0 mtp -137.96 151.71 48.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.1 t -139.3 151.1 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 C-N-CA 122.904 0.482 . . . . 0.0 109.884 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -135.41 141.65 45.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.457 0.703 . . . . 0.0 109.192 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -117.37 168.45 10.34 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.087 0.955 . . . . 0.0 110.761 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.88 -9.98 59.77 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.791 0.437 . . . . 0.0 110.889 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.1 t -150.17 147.67 28.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.103 0.561 . . . . 0.0 109.935 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 -23.3 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -73.2 -23.23 60.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.082 -0.386 . . . . 0.0 110.235 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 42.2 m -80.85 -28.12 36.2 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.82 -25.43 44.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -70.92 -37.96 72.93 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -74.96 -27.61 60.24 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.247 0.619 . . . . 0.0 110.965 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.32 -54.98 10.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.125 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -14.77 60.35 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.356 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -81.52 -16.62 51.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.118 0.417 . . . . 0.0 111.568 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -123.44 4.38 9.04 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.7 mt -121.65 -5.69 9.19 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.856 0.753 . . . . 0.0 112.559 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -74.79 129.93 38.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.943 0.792 . . . . 0.0 109.149 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.43 8.78 76.56 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.13 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.93 174.15 10.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.85 0.825 . . . . 0.0 111.333 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -137.71 145.26 42.33 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.66 0.784 . . . . 0.0 109.185 -177.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 51.8 mt . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -176.534 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 26.9 m -58.61 140.61 54.14 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.738 0.415 . . . . 0.0 109.948 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.4 mt -95.07 154.99 16.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.023 0.44 . . . . 0.0 112.014 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -145.65 134.7 22.67 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.34 150.42 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-O 120.993 0.425 . . . . 0.0 111.247 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -153.75 168.05 27.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.194 1.398 . . . . 0.0 108.364 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.85 144.0 32.33 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 121.74 -0.6 . . . . 0.0 110.994 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.03 170.3 10.46 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.413 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.7 pttt -86.0 -26.21 0.36 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -177.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.4 Cg_endo -82.23 164.63 17.11 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 121.881 1.707 . . . . 0.0 110.406 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 58.4 p -93.45 -9.04 39.88 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 122.265 -0.272 . . . . 0.0 111.564 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.39 168.48 27.21 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.746 0.818 . . . . 0.0 109.711 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 87.7 mt -120.6 170.74 9.13 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.369 0.668 . . . . 0.0 109.685 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -131.1 157.47 43.02 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.449 0.166 . . . . 0.0 110.667 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 87.0 t -137.85 153.93 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 124.08 0.952 . . . . 0.0 108.958 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -128.06 -14.66 4.91 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.294 0.238 . . . . 0.0 111.627 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -163.54 170.32 17.43 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.048 0.939 . . . . 0.0 109.237 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.33 99.65 6.83 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -152.96 -169.14 3.25 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.103 0.961 . . . . 0.0 110.102 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -72.27 -1.81 16.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.53 -31.39 8.54 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.183 0.593 . . . . 0.0 110.8 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.3 t -159.28 147.02 17.43 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -152.48 146.68 25.46 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.721 0.296 . . . . 0.0 110.705 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -121.28 134.3 55.16 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.956 0.502 . . . . 0.0 109.646 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.99 6.48 19.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.554 0.742 . . . . 0.0 112.449 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 123.15 0.58 . . . . 0.0 110.552 177.691 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.5 p30 . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.9 p -97.46 8.62 44.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.372 0.669 . . . . 0.0 111.975 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.96 143.37 18.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 123.055 0.542 . . . . 0.0 110.86 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.0 mt -129.0 163.54 25.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.073 0.549 . . . . 0.0 111.663 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.7 tp -123.24 133.38 54.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.654 1.182 . . . . 0.0 108.179 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -120.24 143.62 48.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.675 0.79 . . . . 0.0 109.383 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 97.4 m -139.51 143.55 37.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.0 mp -106.35 135.38 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.8 mt -90.39 -36.52 14.56 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -131.93 64.27 71.84 Favored Pre-proline 0 CA--C 1.529 0.135 0 C-N-CA 123.379 0.672 . . . . 0.0 109.922 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.6 102.91 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.608 2.205 . . . . 0.0 111.135 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.4 pt -129.58 2.7 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 122.996 0.518 . . . . 0.0 111.401 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -130.6 169.58 15.42 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.791 0.836 . . . . 0.0 109.492 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.5 m -77.58 145.86 36.58 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.5 mm -137.18 133.89 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 61.7 p -142.58 175.55 9.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.8 p -64.37 -20.48 66.15 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 122.296 0.239 . . . . 0.0 111.206 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.7 -25.34 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 122.283 0.233 . . . . 0.0 110.587 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.7 t -82.42 -36.87 13.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.7 -25.43 53.59 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.122 -0.362 . . . . 0.0 110.781 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -78.39 -34.5 48.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.023 -0.423 . . . . 0.0 111.057 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -74.9 -23.46 58.37 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.563 0.62 . . . . 0.0 111.389 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.6 pt -88.73 -23.17 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.176 0.444 . . . . 0.0 111.723 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.9 m -95.58 -20.15 19.22 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.618 0.645 . . . . 0.0 112.483 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.459 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.41 -43.79 90.48 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 87.8 Cg_endo -73.94 -9.63 22.4 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.887 1.724 . . . . 0.0 111.651 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 82.3 m -91.98 -21.56 20.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.023 0.374 . . . . 0.0 111.207 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.15 172.45 30.65 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.57 105.14 1.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 124.122 3.215 . . . . 0.0 110.549 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 94.0 t -78.32 150.14 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -113.53 -41.09 3.69 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.778 0.431 . . . . 0.0 110.876 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.73 163.34 32.4 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.177 0.444 . . . . 0.0 111.472 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.43 146.9 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.534 0.734 . . . . 0.0 109.903 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.24 147.6 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 54.3 mt . . . . . 0 N--CA 1.456 -0.172 0 C-N-CA 123.348 0.659 . . . . 0.0 110.085 -174.208 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--O 1.23 0.061 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.4 171.9 19.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.552 0.215 . . . . 0.0 110.876 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.1 mtp -142.28 150.38 40.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 49.0 t -139.25 151.37 23.04 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.987 0.515 . . . . 0.0 109.719 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -136.2 141.32 44.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.144 0.577 . . . . 0.0 109.497 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -116.31 168.84 9.78 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.905 0.882 . . . . 0.0 110.983 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.55 -14.16 60.76 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.831 0.452 . . . . 0.0 111.22 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 48.4 t -152.7 153.54 33.47 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.878 0.471 . . . . 0.0 110.378 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.09 -25.71 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.57 -29.4 68.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.012 0.369 . . . . 0.0 110.056 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 20.8 m -79.24 -27.58 42.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.541 0.336 . . . . 0.0 110.65 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.4 -27.45 38.1 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -68.01 -37.24 81.2 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -78.46 -25.68 45.9 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.344 0.257 . . . . 0.0 110.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.93 -55.39 17.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.343 0.257 . . . . 0.0 110.807 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -16.36 60.51 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.566 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -78.43 -14.65 59.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.189 0.45 . . . . 0.0 111.643 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 55.6 m -125.07 1.56 7.94 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.56 -5.17 4.72 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -78.22 132.79 37.7 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.917 0.781 . . . . 0.0 109.124 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.33 6.66 70.42 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.48 176.6 7.39 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.715 0.758 . . . . 0.0 111.343 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -139.6 151.07 45.72 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.707 0.803 . . . . 0.0 109.13 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.1 mt . . . . . 0 CA--C 1.535 0.368 0 C-N-CA 122.405 0.282 . . . . 0.0 111.296 -175.688 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.7 m -60.27 141.68 55.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.244 0.618 . . . . 0.0 109.87 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.42 155.41 16.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -144.51 124.78 13.76 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.41 147.38 28.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 CA-C-O 121.163 0.506 . . . . 0.0 111.542 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.56 171.01 20.66 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.718 1.207 . . . . 0.0 108.762 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -80.99 143.98 32.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 122.051 -0.405 . . . . 0.0 110.45 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.3 167.2 15.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.319 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.44 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -83.46 -26.56 0.4 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -176.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 48.2 Cg_endo -80.95 -176.7 3.29 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.952 1.768 . . . . 0.0 109.9 176.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 67.2 p -117.77 -0.75 11.71 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.749 0.42 . . . . 0.0 110.89 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -155.16 146.05 22.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.912 0.885 . . . . 0.0 109.255 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.9 mt -112.35 167.55 10.34 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.246 0.619 . . . . 0.0 110.01 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -129.62 166.74 19.15 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.49 0.316 . . . . 0.0 110.813 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.73 155.71 22.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.223 1.009 . . . . 0.0 109.023 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -130.47 -16.74 3.41 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.368 0.267 . . . . 0.0 111.563 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -165.84 174.38 9.66 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.182 0.993 . . . . 0.0 109.516 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -120.35 96.69 5.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -148.35 -166.01 2.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.929 0.892 . . . . 0.0 110.126 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -73.36 -3.0 24.51 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -112.48 -21.88 11.11 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.813 0.733 . . . . 0.0 111.749 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.2 t -159.9 144.97 15.17 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -151.86 153.3 33.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.91 138.75 51.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 110.393 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -116.4 7.19 13.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.556 0.742 . . . . 0.0 112.331 -174.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 CA--C 1.531 0.225 0 C-N-CA 122.875 0.47 . . . . 0.0 110.517 176.393 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.877 0.37 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 85.8 p -86.31 13.97 7.29 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.147 0.579 . . . . 0.0 112.264 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.75 138.91 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 123.002 0.521 . . . . 0.0 110.712 -176.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.8 mt -129.56 162.45 28.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.416 0.627 . . . . 0.0 111.246 -177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.1 tp -122.43 133.09 54.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.935 1.294 . . . . 0.0 107.994 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -118.8 145.42 45.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.677 0.791 . . . . 0.0 109.827 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 96.2 m -136.19 141.75 44.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.9 mp -107.27 133.23 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 66.3 mt -92.69 -29.51 16.04 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -137.89 69.35 50.7 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 123.557 0.743 . . . . 0.0 109.586 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.4 56.16 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.529 3.486 . . . . 0.0 112.047 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.8 pt -81.04 -1.53 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 122.03 -0.419 . . . . 0.0 111.603 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -128.85 167.24 17.64 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.683 0.793 . . . . 0.0 109.685 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.1 m -75.84 149.78 37.8 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 111.539 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.4 mm -137.49 137.57 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 81.0 p -145.27 175.49 10.24 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.385 0.674 . . . . 0.0 109.782 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.2 p -63.64 -22.82 67.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 119.673 -0.203 . . . . 0.0 111.049 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -79.0 -23.87 44.09 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.298 0.239 . . . . 0.0 111.129 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 88.1 t -86.33 -39.11 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.92 -22.8 58.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.11 -0.369 . . . . 0.0 110.94 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -78.89 -36.11 42.6 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.885 0.311 . . . . 0.0 111.144 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.9 t -74.94 -20.47 59.67 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.89 -0.506 . . . . 0.0 111.327 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.2 pt -92.04 -21.54 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.7 m -97.85 -23.67 15.76 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.798 0.726 . . . . 0.0 112.899 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.48 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 51.1 t30 -65.21 -40.78 47.5 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 98.3 Cg_endo -72.91 -8.96 23.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.424 1.416 . . . . 0.0 111.684 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 77.5 m -97.81 -12.69 21.91 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.707 0.403 . . . . 0.0 111.17 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 161.65 162.06 12.57 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.28 110.73 2.09 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.654 2.903 . . . . 0.0 110.581 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.7 149.79 4.37 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -115.0 -34.75 4.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.847 0.459 . . . . 0.0 110.901 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -164.32 159.49 19.9 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.3 144.65 23.42 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 124.098 0.959 . . . . 0.0 109.644 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.02 142.96 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.288 0.635 . . . . 0.0 109.472 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.53 0.205 0 C-N-CA 123.905 0.882 . . . . 0.0 109.756 -179.372 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.957 0.408 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.53 167.05 31.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.6 mtp -134.38 150.94 50.94 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.35 149.36 22.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.643 0.377 . . . . 0.0 110.194 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -131.52 140.73 49.58 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -116.27 167.91 10.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.872 0.869 . . . . 0.0 110.648 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -72.31 -18.84 61.75 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.686 0.394 . . . . 0.0 111.611 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 85.1 p -151.64 159.86 43.87 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.913 0.485 . . . . 0.0 110.473 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.7 -28.78 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 O-C-N 122.18 -0.325 . . . . 0.0 110.386 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -69.3 -25.07 64.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.035 0.38 . . . . 0.0 110.394 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 59.6 m -78.37 -29.39 47.39 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.45 -24.5 42.38 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.396 -0.19 . . . . 0.0 110.941 176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -70.86 -36.63 72.93 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -78.51 -27.16 46.04 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 122.153 -0.342 . . . . 0.0 110.578 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.39 -52.71 51.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.174 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.421 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.66 -17.37 60.0 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.838 0.744 . . . . 0.0 111.74 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -82.46 -9.61 59.36 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.934 0.334 . . . . 0.0 111.547 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.2 m -124.93 -2.3 7.75 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 79.9 mt -131.11 -4.58 3.91 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.697 0.68 . . . . 0.0 112.823 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -75.76 132.81 40.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 118.953 0.797 . . . . 0.0 109.13 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.78 5.24 68.68 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 119.794 -0.448 . . . . 0.0 112.331 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.93 175.44 10.04 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.712 0.756 . . . . 0.0 111.506 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -132.64 145.07 50.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.2 mt . . . . . 0 CA--C 1.531 0.221 0 O-C-N 122.491 -0.131 . . . . 0.0 111.348 -177.166 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.534 0.207 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.2 m -59.89 142.95 52.66 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 122.821 0.448 . . . . 0.0 110.043 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 56.1 mt -103.53 157.33 17.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.259 0.552 . . . . 0.0 112.232 -174.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -144.36 134.68 24.42 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.421 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 88.0 mt -127.96 148.96 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.306 0.574 . . . . 0.0 111.543 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.08 171.37 20.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.969 1.308 . . . . 0.0 108.374 172.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -84.14 144.35 29.07 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.943 -0.473 . . . . 0.0 110.775 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.06 168.43 11.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.345 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -84.26 -27.35 0.4 Allowed Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -176.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 44.9 Cg_endo -81.91 167.38 16.39 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 CA-C-N 121.752 1.661 . . . . 0.0 110.4 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 45.3 p -96.68 -9.11 29.83 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.28 0.232 . . . . 0.0 111.286 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 170.29 22.31 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.711 0.804 . . . . 0.0 109.617 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 91.6 mt -124.23 167.93 13.63 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.924 0.49 . . . . 0.0 110.758 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -123.58 158.55 31.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.434 HG11 ' C ' ' A' ' 280' ' ' TRP . 5.6 t -131.87 -24.78 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 122.309 0.244 . . . . 0.0 111.518 -171.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 62.89 -37.05 0.14 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.185 1.794 . . . . 0.0 115.055 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -164.64 177.87 7.74 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.787 0.835 . . . . 0.0 110.446 -174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -118.85 113.14 20.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -155.2 -174.66 5.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.699 1.199 . . . . 0.0 109.87 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -70.94 -3.82 21.32 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -113.17 -16.88 12.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.619 0.645 . . . . 0.0 111.438 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 14.6 t -156.98 132.42 9.23 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . 0.434 ' C ' HG11 ' A' ' 272' ' ' VAL . 12.6 t-105 -147.01 149.82 33.89 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 122.071 -0.393 . . . . 0.0 111.299 -175.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -126.22 137.65 53.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.3 0.64 . . . . 0.0 109.677 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -115.87 4.28 13.87 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.619 0.768 . . . . 0.0 112.464 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 CA--C 1.531 0.239 0 C-N-CA 123.013 0.525 . . . . 0.0 111.707 -179.092 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.4 p -89.16 13.3 13.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.431 0.693 . . . . 0.0 111.607 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 31.3 t -112.73 139.92 35.26 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 123.271 0.628 . . . . 0.0 110.962 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.0 mt -130.32 163.63 26.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.375 0.607 . . . . 0.0 111.279 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.2 tp -124.98 133.47 53.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.842 1.257 . . . . 0.0 107.962 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -119.37 142.95 47.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.743 0.817 . . . . 0.0 110.106 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 88.4 m -137.67 143.85 41.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.4 mp -108.51 137.99 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.8 mt -92.09 -35.46 13.89 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -133.0 68.73 78.81 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.801 0.84 . . . . 0.0 109.428 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.29 67.62 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.321 3.347 . . . . 0.0 112.109 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.1 pt -88.07 -4.34 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 122.079 -0.388 . . . . 0.0 111.128 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -128.18 169.27 14.32 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.02 0.928 . . . . 0.0 109.239 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 79.8 p -85.04 155.26 21.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.832 0.349 . . . . 0.0 111.487 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mm -135.66 138.18 48.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.3 p -143.27 174.39 10.76 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.956 0.502 . . . . 0.0 110.146 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 39.6 p -62.24 -25.2 67.69 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.415 0.286 . . . . 0.0 111.061 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -78.71 -24.36 45.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.349 0.26 . . . . 0.0 111.185 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.6 t -84.29 -38.34 13.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.83 -23.39 52.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.226 -0.296 . . . . 0.0 110.977 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -79.39 -33.85 42.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.271 0.487 . . . . 0.0 111.079 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -76.64 -20.92 56.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.219 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.3 pt -91.58 -22.35 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 118.251 0.478 . . . . 0.0 111.707 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.5 m -94.83 -19.53 20.24 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.39 0.541 . . . . 0.0 112.271 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.8 t-20 -59.8 -43.69 95.54 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 90.6 Cg_endo -71.56 -5.98 18.19 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.875 1.717 . . . . 0.0 112.22 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 86.1 m -96.13 -5.89 39.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.079 0.399 . . . . 0.0 111.134 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 137.44 174.24 13.26 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.8 119.25 6.26 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.711 2.941 . . . . 0.0 111.263 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.16 151.85 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -113.29 -36.46 5.0 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.101 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -165.3 160.24 18.08 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.198 0.453 . . . . 0.0 111.966 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 48.7 mt -143.0 147.54 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.971 0.908 . . . . 0.0 109.321 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.24 144.47 18.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 123.103 0.561 . . . . 0.0 109.795 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.53 0.209 0 C-N-CA 123.797 0.839 . . . . 0.0 109.969 -178.24 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.955 0.407 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -158.32 169.09 25.26 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.125 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.8 mtp -137.12 150.77 48.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.02 149.83 24.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -132.23 140.84 48.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -117.04 169.05 9.72 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.907 0.883 . . . . 0.0 110.849 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -77.81 -13.85 59.76 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.059 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 95.6 p -151.93 157.33 41.64 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.986 0.422 . . . . 0.0 110.839 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.72 -25.03 27.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.159 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -67.3 -29.99 69.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.124 -0.36 . . . . 0.0 110.344 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 50.2 m -79.41 -28.14 41.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.34 -26.68 42.09 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -70.05 -36.43 74.99 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -77.39 -27.47 52.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.457 -0.152 . . . . 0.0 110.631 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.02 -51.82 50.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.279 -0.263 . . . . 0.0 111.277 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.408 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.31 -13.93 60.13 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.516 179.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -86.78 -10.05 54.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.889 0.313 . . . . 0.0 111.495 176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.3 m -124.48 -2.05 8.0 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 88.1 mt -129.85 -5.22 4.56 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -77.35 130.69 37.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.975 0.807 . . . . 0.0 109.058 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.29 7.38 72.17 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.57 175.57 9.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.727 0.764 . . . . 0.0 111.568 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -137.3 144.88 42.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.96 0.904 . . . . 0.0 108.963 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.5 mt . . . . . 0 CA--C 1.534 0.329 0 C-N-CA 122.546 0.338 . . . . 0.0 111.603 -175.814 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.6 m -59.12 140.49 55.79 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.852 0.461 . . . . 0.0 109.849 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.3 mt -94.31 154.79 17.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.202 0.525 . . . . 0.0 112.162 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -145.14 132.76 20.93 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 84.4 mt -132.7 147.94 31.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.247 0.546 . . . . 0.0 112.29 -172.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.36 172.87 15.8 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.869 1.268 . . . . 0.0 108.8 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -84.41 142.28 30.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.22 -0.3 . . . . 0.0 110.598 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.87 169.59 12.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.44 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -85.78 -26.97 0.37 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.0 Cg_endo -82.62 164.91 16.16 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.01 1.807 . . . . 0.0 110.261 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.5 p -94.1 -7.84 41.33 Favored 'General case' 0 CA--C 1.527 0.065 0 O-C-N 122.325 -0.234 . . . . 0.0 111.396 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.85 169.13 25.47 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.835 0.854 . . . . 0.0 109.809 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 85.9 mt -121.06 173.18 7.43 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.461 0.705 . . . . 0.0 110.08 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -129.42 157.37 42.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.601 0.36 . . . . 0.0 110.485 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.9 t -138.36 152.33 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 C-N-CA 124.118 0.967 . . . . 0.0 108.866 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -125.84 -14.8 6.09 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.394 0.278 . . . . 0.0 111.627 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -164.68 173.92 11.35 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.286 1.034 . . . . 0.0 109.885 -176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -119.95 98.24 6.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -150.58 -168.79 3.21 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.868 0.867 . . . . 0.0 110.311 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -71.77 -4.11 25.9 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -110.88 -24.65 10.28 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.673 0.67 . . . . 0.0 111.753 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.8 t -157.63 144.57 18.15 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 173.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -152.76 147.99 26.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.172 0.189 . . . . 0.0 110.522 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -122.17 134.84 54.72 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.73 8.53 17.51 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.702 0.801 . . . . 0.0 112.17 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 123.289 0.636 . . . . 0.0 110.532 178.001 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 44.3 p30 . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.7 p -96.64 15.39 21.87 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.216 0.606 . . . . 0.0 112.082 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.34 143.53 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 123.038 0.535 . . . . 0.0 111.022 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.7 mt -129.13 166.13 19.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.182 0.593 . . . . 0.0 111.325 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.6 tp -124.95 133.95 52.83 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.823 1.249 . . . . 0.0 107.999 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -120.12 147.71 44.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.832 0.853 . . . . 0.0 109.889 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.8 m -136.82 139.11 41.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.5 mp -103.47 135.69 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 50.4 mt -102.5 -17.07 15.93 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -139.13 66.55 38.69 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 123.657 0.783 . . . . 0.0 109.362 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.24 40.58 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 124.903 3.735 . . . . 0.0 112.069 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 32.9 pt -77.66 -1.58 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 O-C-N 121.944 -0.473 . . . . 0.0 111.791 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -132.11 165.89 23.01 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.131 0.972 . . . . 0.0 109.216 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.9 m -73.98 149.6 41.22 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.758 0.313 . . . . 0.0 111.303 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.5 mm -136.54 137.98 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.7 p -145.33 175.33 10.38 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.287 0.635 . . . . 0.0 109.77 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.0 p -63.0 -23.1 67.3 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 122.423 0.289 . . . . 0.0 111.199 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.24 -26.68 35.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.311 -0.243 . . . . 0.0 111.205 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 89.8 t -81.86 -36.78 14.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.8 mt -76.9 -24.16 52.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 122.378 -0.201 . . . . 0.0 110.528 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -76.83 -36.15 57.06 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.851 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -77.52 -20.06 54.83 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.344 0.52 . . . . 0.0 111.544 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -93.27 -15.47 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 118.331 0.514 . . . . 0.0 111.653 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 67.5 m -98.52 -21.68 16.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.642 0.655 . . . . 0.0 111.924 176.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.47 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.9 t-20 -58.82 -43.4 97.69 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 96.6 Cg_endo -72.31 -8.83 23.39 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.004 1.803 . . . . 0.0 112.012 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 70.7 m -96.21 -21.0 18.15 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.912 0.324 . . . . 0.0 111.151 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.63 168.09 25.1 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.91 112.58 3.14 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.757 2.971 . . . . 0.0 110.895 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.99 151.48 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 123.286 0.634 . . . . 0.0 109.395 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -116.42 -36.05 4.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.0 0.52 . . . . 0.0 110.788 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -163.17 157.81 20.97 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 112.413 0.524 . . . . 0.0 112.413 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.7 mt -143.67 146.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.243 1.017 . . . . 0.0 109.443 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.0 p -146.4 143.59 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.307 0.643 . . . . 0.0 109.61 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.529 0.166 0 C-N-CA 123.743 0.817 . . . . 0.0 110.016 -178.286 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.805 0.336 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.98 169.5 24.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.865 0.466 . . . . 0.0 109.95 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.4 mtp -134.65 149.85 50.58 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.41 149.84 25.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -135.72 140.16 44.19 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.594 0.757 . . . . 0.0 109.434 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -118.58 167.97 11.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.897 0.879 . . . . 0.0 110.837 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -14.35 60.08 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.722 0.409 . . . . 0.0 111.493 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.1 t -149.97 150.39 31.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.061 0.544 . . . . 0.0 109.72 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.56 -25.93 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -66.77 -26.99 67.23 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.7 m -82.43 -25.49 33.59 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.82 -26.81 40.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -69.72 -36.46 75.9 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -79.14 -24.54 43.24 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.332 -0.23 . . . . 0.0 110.849 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.25 -53.38 30.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.305 -0.247 . . . . 0.0 111.06 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.15 -16.05 59.95 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.734 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.37 -9.89 58.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.032 0.378 . . . . 0.0 111.781 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 16.7 t -124.61 -5.38 7.61 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.6 mt -126.95 -4.96 6.27 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -176.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -76.88 131.25 38.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.94 4.76 78.26 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.15 -178.41 5.6 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.398 0.599 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -141.55 163.57 32.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.988 0.915 . . . . 0.0 109.145 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 39.1 mt . . . . . 0 CA--C 1.532 0.28 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.214 -178.877 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 96.2 m . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.972 0.415 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 8.7 m -55.62 138.2 47.54 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.396 0.679 . . . . 0.0 109.936 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 64.6 mt -102.65 154.0 19.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.073 0.549 . . . . 0.0 111.872 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -144.81 129.93 18.54 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 78.7 mt -128.87 147.08 33.31 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-O 121.347 0.594 . . . . 0.0 112.175 -170.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.51 173.41 15.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.891 1.277 . . . . 0.0 108.74 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -84.33 145.25 28.35 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 121.61 -0.681 . . . . 0.0 110.749 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.3 167.57 13.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.685 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 22.0 ptmt -82.38 -27.09 0.42 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 47.2 Cg_endo -84.31 -177.84 3.16 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.959 1.772 . . . . 0.0 110.065 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.9 p -111.36 -9.79 14.25 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.494 0.318 . . . . 0.0 111.337 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.401 ' HD3' ' N ' ' A' ' 270' ' ' LEU . 0.0 OUTLIER -156.36 137.35 13.56 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.401 ' N ' ' HD3' ' A' ' 269' ' ' ARG . 63.5 mt -88.02 172.79 9.29 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 123.088 0.555 . . . . 0.0 110.726 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -132.34 149.36 52.37 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.324 -0.235 . . . . 0.0 111.008 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 72.5 t -138.6 151.34 24.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 124.298 1.039 . . . . 0.0 108.484 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -124.44 -23.67 4.4 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 177.21 9.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.575 1.15 . . . . 0.0 108.834 176.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -110.76 110.16 20.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.651 0.381 . . . . 0.0 110.113 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -152.79 -175.02 5.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.237 1.015 . . . . 0.0 109.545 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -72.53 -1.72 17.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -117.38 -20.42 9.13 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 118.503 0.592 . . . . 0.0 111.775 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.9 t -154.13 137.87 16.14 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -159.25 146.67 17.26 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 122.381 -0.199 . . . . 0.0 110.517 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -129.79 139.23 51.3 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.628 0.728 . . . . 0.0 111.38 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -104.69 -6.94 19.94 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.741 0.816 . . . . 0.0 111.526 -173.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 123.217 0.607 . . . . 0.0 109.857 173.207 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 35.6 p30 . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.6 p -93.44 18.63 9.49 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.659 0.783 . . . . 0.0 112.048 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.17 145.09 30.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 122.939 0.496 . . . . 0.0 110.817 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.6 mt -131.08 163.24 28.08 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.305 0.574 . . . . 0.0 111.5 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 62.3 tp -122.73 132.36 54.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.663 1.185 . . . . 0.0 108.302 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -117.75 146.33 43.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.587 0.755 . . . . 0.0 109.685 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 97.0 m -138.2 143.34 40.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 196' ' ' ILE . 1.9 mp -106.67 137.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.22 -35.91 10.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -173.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -129.9 63.94 70.32 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.997 0.519 . . . . 0.0 110.346 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.47 100.41 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.167 2.578 . . . . 0.0 111.152 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.2 pt -122.17 3.11 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 122.874 0.469 . . . . 0.0 110.878 173.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -138.24 164.85 28.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.21 1.004 . . . . 0.0 109.097 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 80.3 p -79.21 156.6 28.09 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.902 0.382 . . . . 0.0 111.324 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.5 mm -135.86 137.95 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.1 p -144.44 175.41 10.14 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.137 0.575 . . . . 0.0 110.285 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.4 p -60.36 -26.45 66.63 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.973 0.509 . . . . 0.0 111.092 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.75 -21.3 44.63 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.506 0.322 . . . . 0.0 111.175 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.77 -37.86 10.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.21 -24.03 54.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.128 -0.357 . . . . 0.0 110.906 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -79.64 -33.06 41.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.95 -0.469 . . . . 0.0 111.111 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -77.09 -23.63 51.89 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-N 118.451 0.569 . . . . 0.0 111.369 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 39.1 pt -88.51 -22.25 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 118.258 0.481 . . . . 0.0 111.732 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 93.7 m -95.55 -21.94 17.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.546 0.612 . . . . 0.0 112.414 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.474 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.3 t-20 -60.33 -44.49 96.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 93.2 Cg_endo -72.89 -10.83 25.22 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.181 1.921 . . . . 0.0 111.727 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.7 m -94.04 -20.65 19.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.14 0.427 . . . . 0.0 110.931 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.67 168.36 27.7 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.08 105.84 1.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.659 2.906 . . . . 0.0 110.685 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.9 t -78.51 151.3 5.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -116.14 -37.66 3.77 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.705 0.402 . . . . 0.0 110.728 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -162.74 159.49 24.27 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 117.804 0.275 . . . . 0.0 111.474 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 50.5 mt -143.07 145.07 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 124.099 0.959 . . . . 0.0 110.319 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.4 m -137.83 149.69 25.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 123.587 0.755 . . . . 0.0 109.33 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 123.259 0.624 . . . . 0.0 109.789 -178.227 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 . . . . . 0 N--CA 1.458 -0.041 0 CA-C-O 120.678 0.275 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.64 169.82 21.75 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.993 0.517 . . . . 0.0 110.446 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.1 mtp -140.09 150.46 44.34 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.9 t -137.88 150.97 25.21 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 122.64 0.376 . . . . 0.0 110.04 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -133.4 140.85 47.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.366 0.667 . . . . 0.0 109.572 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.11 171.29 8.38 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.873 0.869 . . . . 0.0 110.774 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.14 -16.56 61.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.763 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 60.0 p -154.02 163.31 40.29 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.219 0.533 . . . . 0.0 110.829 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.72 -25.52 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.354 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -71.1 -27.58 63.71 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.199 0.454 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 m -77.81 -28.98 50.51 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.76 -24.69 41.37 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.446 -0.159 . . . . 0.0 110.759 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -70.35 -36.51 74.25 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -80.24 -25.69 39.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.439 -0.163 . . . . 0.0 110.732 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.52 -50.32 63.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.038 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.409 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.27 -15.74 59.31 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.693 179.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.21 -10.42 58.59 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.905 0.32 . . . . 0.0 111.401 176.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.6 m -123.2 -3.22 8.51 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.58 -4.26 4.2 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -79.03 131.51 36.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.42 5.46 63.29 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.586 -0.605 . . . . 0.0 111.586 -176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.44 178.64 8.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.863 0.832 . . . . 0.0 111.093 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -141.17 160.05 40.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.613 0.765 . . . . 0.0 109.372 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.8 mt . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.071 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.362 0.125 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.9 m -58.44 140.41 53.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.321 0.648 . . . . 0.0 110.335 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 56.9 mt -98.0 155.17 17.23 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.115 0.566 . . . . 0.0 111.712 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -142.15 132.52 25.04 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.409 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 83.2 mt -129.38 145.67 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-O 121.17 0.51 . . . . 0.0 111.849 -174.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.27 168.21 26.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.94 1.296 . . . . 0.0 108.3 173.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -78.01 141.54 38.85 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.868 -0.52 . . . . 0.0 110.497 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -80.8 166.24 21.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.6 pttt -81.72 -27.42 0.44 Allowed Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 49.1 Cg_endo -81.33 178.48 6.7 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.891 1.727 . . . . 0.0 109.797 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 63.5 p -104.51 -7.65 19.62 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 122.109 0.164 . . . . 0.0 111.18 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 167.72 28.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.319 0.647 . . . . 0.0 110.449 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.59 170.18 12.33 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.942 0.897 . . . . 0.0 109.425 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -143.13 163.21 33.49 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.502 0.191 . . . . 0.0 110.788 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.6 156.42 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 124.214 1.006 . . . . 0.0 109.103 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -126.1 -18.88 4.9 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.775 0.43 . . . . 0.0 111.621 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -166.09 169.24 14.71 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.042 0.937 . . . . 0.0 109.297 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -117.56 109.36 16.61 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.055 0.455 . . . . 0.0 110.54 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -155.47 -167.21 2.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.718 1.207 . . . . 0.0 109.898 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -73.44 -5.72 41.74 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.47 -15.98 12.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.672 0.669 . . . . 0.0 111.54 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.0 t -159.08 139.44 12.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -154.07 148.03 25.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.139 -0.351 . . . . 0.0 110.792 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.86 135.39 54.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.903 0.481 . . . . 0.0 110.017 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -115.73 9.1 15.09 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.56 0.744 . . . . 0.0 112.132 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.533 0.319 0 C-N-CA 123.234 0.614 . . . . 0.0 110.765 177.721 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.7 p30 . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.545 0.212 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -91.51 10.09 29.3 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.222 0.609 . . . . 0.0 111.587 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.5 t -106.04 137.94 33.78 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 C-N-CA 123.248 0.619 . . . . 0.0 110.589 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.3 mt -126.47 159.96 31.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.623 0.725 . . . . 0.0 111.572 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.0 tp -118.7 132.39 56.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.037 1.335 . . . . 0.0 108.15 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -118.37 141.66 48.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.302 0.641 . . . . 0.0 109.713 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 92.5 m -137.21 141.1 42.1 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.6 mp -104.26 136.21 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.46 -34.61 12.66 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -130.4 62.27 63.62 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.492 0.717 . . . . 0.0 110.041 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.33 101.79 0.89 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.781 2.32 . . . . 0.0 111.021 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.4 pt -127.0 2.31 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 122.878 0.471 . . . . 0.0 111.227 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -132.11 166.58 21.46 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.879 0.872 . . . . 0.0 109.405 177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.9 m -75.11 150.6 38.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.367 0.267 . . . . 0.0 111.346 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.6 mm -138.37 136.67 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 80.7 p -144.94 174.27 11.16 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.435 0.694 . . . . 0.0 109.853 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.7 p -62.17 -24.85 67.44 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.191 0.196 . . . . 0.0 111.142 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.16 -24.9 47.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.789 0.268 . . . . 0.0 111.154 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.77 -37.48 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.92 -23.45 52.48 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.381 -0.199 . . . . 0.0 110.753 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -79.87 -33.96 39.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.887 0.312 . . . . 0.0 110.957 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 t -75.54 -22.47 57.04 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 118.467 0.576 . . . . 0.0 110.935 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.9 pt -89.7 -22.09 6.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.157 0.435 . . . . 0.0 111.899 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.4 m -95.72 -20.13 19.14 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.403 0.547 . . . . 0.0 112.355 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.8 t-20 -60.88 -42.76 88.83 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 84.4 Cg_endo -72.1 -10.71 26.33 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.876 1.717 . . . . 0.0 111.795 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.8 m -91.22 -20.68 21.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.933 0.333 . . . . 0.0 110.888 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.52 171.35 25.25 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.74 111.95 2.94 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.676 2.917 . . . . 0.0 110.948 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.8 t -84.41 150.6 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -113.89 -37.3 4.54 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.119 0.567 . . . . 0.0 111.125 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -164.08 158.37 19.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.723 0.692 . . . . 0.0 112.351 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.2 mt -144.32 147.28 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.956 0.902 . . . . 0.0 109.529 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.04 144.02 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.262 0.625 . . . . 0.0 109.503 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.529 0.159 0 C-N-CA 123.861 0.864 . . . . 0.0 109.907 -178.05 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.872 0.368 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.44 173.24 17.2 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.669 0.388 . . . . 0.0 110.278 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.5 mtp -137.51 150.25 47.4 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.92 151.34 25.44 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -138.73 141.75 38.89 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.195 0.598 . . . . 0.0 109.407 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -118.26 168.15 10.87 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.808 0.843 . . . . 0.0 110.805 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -76.67 -11.12 59.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.94 0.496 . . . . 0.0 111.527 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.0 t -151.67 150.18 29.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.157 0.583 . . . . 0.0 109.745 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.03 -23.64 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.05 -25.23 62.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 38.2 m -80.59 -26.31 37.94 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.09 -26.99 35.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.168 0.187 . . . . 0.0 110.521 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -68.06 -36.89 80.6 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.3 ttt-85 -78.62 -25.98 45.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.406 -0.184 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -68.4 -48.42 64.71 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.419 -0.324 . . . . 0.0 111.262 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.39 -13.26 59.92 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.534 0.606 . . . . 0.0 111.532 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.42 -9.67 54.05 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.543 -0.265 . . . . 0.0 111.6 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -123.87 -3.46 8.17 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.7 mt -129.99 -4.31 4.52 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -76.52 133.17 39.83 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 119.072 0.851 . . . . 0.0 109.134 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.59 5.89 69.65 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.803 -0.443 . . . . 0.0 112.327 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.31 174.74 11.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.689 0.744 . . . . 0.0 111.134 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -132.67 144.32 50.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.9 mt . . . . . 0 CA--C 1.53 0.208 0 O-C-N 122.293 -0.254 . . . . 0.0 111.052 -177.269 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.543 0.211 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.8 m -59.82 142.58 53.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.939 0.495 . . . . 0.0 110.117 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 55.0 mt -100.58 154.56 18.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.365 0.602 . . . . 0.0 112.608 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -139.02 137.56 36.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 74.8 mt -134.5 142.68 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 111.382 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.07 167.83 28.49 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.468 1.107 . . . . 0.0 108.526 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.0 144.0 37.07 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.883 -0.511 . . . . 0.0 110.613 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.95 169.79 10.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.659 0.384 . . . . 0.0 110.926 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.1 pttt -84.55 -26.97 0.39 Allowed Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -176.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 52.2 Cg_endo -80.25 166.47 20.44 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 CA-C-N 121.82 1.686 . . . . 0.0 109.784 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.6 p -100.58 -10.88 20.55 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 122.314 -0.241 . . . . 0.0 111.154 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.65 137.07 11.96 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 85.7 mt -85.42 169.77 13.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.728 0.411 . . . . 0.0 110.74 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -132.3 151.14 51.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 93.8 t -138.3 154.01 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 124.072 0.949 . . . . 0.0 108.65 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.81 -23.75 4.99 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -173.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.2 171.07 12.63 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.542 1.137 . . . . 0.0 109.082 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -107.79 117.92 35.37 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.91 0.386 . . . . 0.0 110.593 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -157.99 -172.45 3.92 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.69 1.196 . . . . 0.0 109.309 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -73.59 -5.07 38.01 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -112.15 -20.0 12.07 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.801 0.728 . . . . 0.0 111.671 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.1 t -156.33 139.99 16.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 173.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -149.88 147.78 28.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 110.696 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -123.7 113.03 18.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -91.09 3.25 55.25 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.898 0.879 . . . . 0.0 111.709 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.3 t . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 123.555 0.742 . . . . 0.0 109.904 177.202 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 43.0 p30 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.696 0.284 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.8 p -94.96 16.15 16.9 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.29 0.636 . . . . 0.0 111.953 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.59 146.13 25.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 123.042 0.537 . . . . 0.0 111.108 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.55 164.0 25.85 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.682 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.4 tp -122.98 133.29 54.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.874 1.27 . . . . 0.0 108.099 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -120.74 144.47 48.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.657 0.783 . . . . 0.0 110.168 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 96.4 m -136.61 141.01 43.25 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.3 mp -107.65 136.77 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.09 -26.95 13.51 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -134.22 62.51 56.68 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 123.618 0.767 . . . . 0.0 109.812 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.72 59.7 5.03 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 124.241 3.294 . . . . 0.0 111.477 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 43.8 pt -82.22 -0.83 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 O-C-N 121.884 -0.51 . . . . 0.0 111.565 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -134.79 167.97 19.89 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.061 0.944 . . . . 0.0 109.382 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.2 m -79.72 151.17 30.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.6 mm -133.64 138.66 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.1 p -141.81 174.78 10.26 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.101 0.56 . . . . 0.0 109.598 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.9 p -63.26 -21.69 66.4 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.48 0.312 . . . . 0.0 110.959 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.17 -24.53 40.28 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.488 0.315 . . . . 0.0 110.798 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 87.3 t -82.99 -37.4 13.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.4 mt -76.82 -22.75 53.16 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.155 -0.341 . . . . 0.0 110.75 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -79.17 -34.89 42.73 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.905 -0.497 . . . . 0.0 110.788 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.3 t -75.43 -23.1 56.91 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.114 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.0 pt -90.48 -20.89 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.53 0.605 . . . . 0.0 112.28 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.1 m -98.43 -19.87 17.45 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.866 0.757 . . . . 0.0 112.975 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.486 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 47.6 t30 -64.47 -40.49 51.05 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 90.5 Cg_endo -71.68 -3.36 12.96 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.576 1.517 . . . . 0.0 111.932 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 73.1 m -99.96 -4.5 29.99 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.702 0.401 . . . . 0.0 111.295 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 142.11 174.44 14.76 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.06 109.34 2.15 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.765 2.976 . . . . 0.0 110.981 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.2 t -80.98 149.71 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -115.67 -39.99 3.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.927 0.491 . . . . 0.0 111.337 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -161.27 158.15 26.71 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.1 mt -141.42 145.71 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.269 1.028 . . . . 0.0 109.582 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.68 147.91 20.41 Favored 'Isoleucine or valine' 0 C--O 1.23 0.052 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.0 mt . . . . . 0 N--CA 1.456 -0.14 0 C-N-CA 123.05 0.54 . . . . 0.0 110.515 -173.591 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -153.63 171.49 18.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.694 0.398 . . . . 0.0 110.478 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 81.3 mtp -141.32 150.13 42.1 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 52.0 t -137.97 152.7 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.036 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -137.02 140.99 42.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.406 0.682 . . . . 0.0 109.755 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.66 168.39 10.76 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.006 0.922 . . . . 0.0 110.816 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.49 -10.38 59.69 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.213 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 40.7 t -153.21 151.66 30.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.034 0.534 . . . . 0.0 110.067 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.55 -22.67 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -66.67 -28.5 68.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.993 0.36 . . . . 0.0 110.642 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 75.4 m -87.21 -23.97 24.58 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.358 -0.214 . . . . 0.0 110.757 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.53 -28.86 59.25 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -70.72 -36.91 73.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 40.3 ttm105 -74.89 -32.79 61.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.341 0.256 . . . . 0.0 111.041 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.82 66.04 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.189 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.423 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.5 -11.83 59.94 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.972 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.43 -12.4 46.28 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.603 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 58.7 m -127.57 2.57 6.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 91.1 mt -130.86 -4.99 4.02 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.642 0.655 . . . . 0.0 112.488 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -79.05 131.14 36.17 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.75 7.54 70.03 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.32 177.99 8.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.428 0.691 . . . . 0.0 111.467 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.23 143.99 50.32 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.259 1.023 . . . . 0.0 108.357 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 59.7 mt . . . . . 0 CA--C 1.53 0.196 0 O-C-N 122.403 -0.186 . . . . 0.0 111.272 -177.627 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 76.4 m . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.565 0.222 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 8.9 m -58.12 139.18 55.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.114 0.565 . . . . 0.0 110.105 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 51.1 mt -102.11 155.73 18.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.219 0.533 . . . . 0.0 112.212 -175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -143.4 134.74 26.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 74.2 mt -129.24 149.87 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 121.135 0.493 . . . . 0.0 111.436 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.75 170.27 22.44 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.984 1.314 . . . . 0.0 108.029 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -79.69 144.45 33.69 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 121.865 -0.522 . . . . 0.0 110.337 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.23 164.91 19.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.141 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 40.0 ttpt -72.27 -45.76 10.71 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 79.6 Cg_endo -75.59 176.79 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.605 2.203 . . . . 0.0 110.503 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 63.6 p -106.56 -8.66 16.91 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 122.595 0.358 . . . . 0.0 111.61 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.34 137.42 15.56 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 58.5 mt -90.18 177.64 6.38 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.105 0.562 . . . . 0.0 110.608 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -137.37 154.17 50.06 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.156 -0.34 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.2 t -138.29 153.07 26.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.948 0.899 . . . . 0.0 109.166 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.22 -15.24 4.72 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.617 0.367 . . . . 0.0 111.777 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -166.65 175.82 7.66 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.031 0.933 . . . . 0.0 109.911 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -119.6 101.19 7.75 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -150.47 -169.63 3.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.946 0.898 . . . . 0.0 110.341 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -71.13 -1.38 12.18 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -116.1 -21.25 9.52 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.917 0.781 . . . . 0.0 111.856 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.8 t -157.95 145.69 18.51 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 118.296 0.498 . . . . 0.0 109.999 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -153.15 151.05 29.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.657 0.265 . . . . 0.0 110.697 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.54 139.56 53.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.6 15.72 12.82 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.354 0.661 . . . . 0.0 112.171 -174.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 CA--C 1.533 0.289 0 O-C-N 122.1 -0.375 . . . . 0.0 111.863 -178.737 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 45.9 p30 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 81.2 p -101.18 16.73 24.52 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.536 0.734 . . . . 0.0 111.845 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.6 m -119.7 144.38 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 C-N-CA 123.008 0.523 . . . . 0.0 111.083 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.1 mt -130.94 164.64 24.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.168 0.508 . . . . 0.0 111.384 -174.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 62.8 tp -123.28 134.03 54.12 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.824 1.249 . . . . 0.0 108.316 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -120.52 146.71 46.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.678 0.791 . . . . 0.0 109.816 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 87.3 m -136.53 144.36 44.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.3 mp -110.42 136.43 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.5 mt -98.93 -32.79 11.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -172.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -133.42 69.38 77.22 Favored Pre-proline 0 CA--C 1.532 0.25 0 C-N-CA 123.572 0.749 . . . . 0.0 109.507 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.57 55.7 3.79 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 125.007 3.805 . . . . 0.0 112.26 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.1 -3.68 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 121.753 -0.592 . . . . 0.0 111.38 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -129.86 168.16 17.04 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.703 0.801 . . . . 0.0 109.378 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 82.0 p -80.87 153.01 27.86 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.947 0.403 . . . . 0.0 111.504 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.0 mm -138.68 139.48 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.9 p -144.04 173.14 11.98 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.528 0.731 . . . . 0.0 109.56 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.1 p -63.63 -19.13 64.62 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.355 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -83.24 -26.06 31.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 117.805 0.275 . . . . 0.0 110.591 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.2 t -81.51 -36.24 14.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.37 -25.19 57.47 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.275 -0.266 . . . . 0.0 110.333 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -77.05 -36.32 56.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.086 -0.384 . . . . 0.0 110.966 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -76.46 -20.27 57.19 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.471 0.578 . . . . 0.0 111.336 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.16 -16.69 7.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-N 118.244 0.474 . . . . 0.0 111.78 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.3 m -97.31 -20.92 17.53 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.761 0.71 . . . . 0.0 112.155 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.2 t-20 -61.41 -43.73 90.26 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 98.7 Cg_endo -72.43 -10.59 25.65 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.633 1.555 . . . . 0.0 111.633 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 74.7 m -94.42 -21.59 18.83 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.797 0.271 . . . . 0.0 111.397 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 167.8 168.54 30.09 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.98 99.47 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.297 3.331 . . . . 0.0 110.902 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.3 t -75.52 144.21 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -113.02 -33.65 5.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.456 0.302 . . . . 0.0 111.075 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -163.73 157.87 19.6 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 117.966 0.348 . . . . 0.0 111.574 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.0 mt -143.37 142.74 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.289 1.036 . . . . 0.0 109.715 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.1 m -138.43 156.61 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.055 0.542 . . . . 0.0 109.588 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 66.0 mt . . . . . 0 C--O 1.231 0.098 0 C-N-CA 122.89 0.476 . . . . 0.0 110.403 -175.739 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.996 0.427 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.44 169.64 20.4 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.139 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 78.2 mtp -138.86 148.98 44.37 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.7 t -136.37 151.42 28.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 122.878 0.471 . . . . 0.0 109.842 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -137.08 138.58 40.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.25 0.62 . . . . 0.0 109.745 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.07 170.36 8.92 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.141 0.976 . . . . 0.0 110.497 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.05 -16.24 59.97 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.565 0.346 . . . . 0.0 111.528 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.7 t -150.99 154.46 37.12 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.729 0.412 . . . . 0.0 110.579 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.24 -26.94 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.022 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -67.08 -29.9 69.79 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.059 -0.401 . . . . 0.0 110.079 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.2 m -79.29 -26.68 42.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.411 0.285 . . . . 0.0 110.501 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.52 -26.29 38.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.396 -0.19 . . . . 0.0 110.685 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -69.54 -36.62 76.53 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -77.82 -26.6 49.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.307 0.243 . . . . 0.0 110.798 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.5 -53.82 30.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.141 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.61 -14.42 60.38 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.814 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.53 -10.65 55.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.096 -0.378 . . . . 0.0 111.45 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.6 m -123.78 -0.35 8.55 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 94.0 mt -131.1 -6.2 3.89 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -76.35 131.24 39.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.917 0.78 . . . . 0.0 109.274 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.42 7.51 73.21 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.121 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.99 174.05 12.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.864 0.832 . . . . 0.0 111.337 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -132.62 145.65 51.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.8 mt . . . . . 0 CA--C 1.531 0.244 0 C-N-CA 122.097 0.159 . . . . 0.0 111.124 -177.246 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 120.586 0.232 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.8 m -59.21 140.57 55.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.978 0.511 . . . . 0.0 110.09 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 47.4 mt -98.9 153.62 18.67 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.126 0.571 . . . . 0.0 111.94 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -140.43 134.8 31.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 171.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.424 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 81.6 mt -129.19 149.34 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.209 0.528 . . . . 0.0 111.286 -175.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.74 169.16 24.99 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.865 1.266 . . . . 0.0 108.199 173.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -79.57 142.01 36.08 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.756 -0.59 . . . . 0.0 110.542 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.43 164.11 20.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -81.78 -26.12 0.41 Allowed Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -175.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 44.0 Cg_endo -81.51 177.69 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 121.767 1.667 . . . . 0.0 109.876 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 68.5 p -106.53 -5.56 18.71 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.611 0.364 . . . . 0.0 110.902 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.9 mmm-85 -153.81 154.81 34.67 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.901 0.88 . . . . 0.0 110.295 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.68 168.56 10.32 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.644 0.778 . . . . 0.0 109.47 173.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -140.16 166.63 24.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.935 0.398 . . . . 0.0 111.494 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.5 t -138.09 155.27 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.144 0.978 . . . . 0.0 108.723 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.81 -26.3 4.87 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.299 0.24 . . . . 0.0 111.392 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.76 168.87 17.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.451 1.101 . . . . 0.0 109.08 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -106.44 117.34 33.78 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.931 0.396 . . . . 0.0 110.963 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -157.41 -175.17 5.25 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.713 1.205 . . . . 0.0 109.496 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -71.24 -3.42 20.23 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -173.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -118.08 -14.3 9.94 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.711 0.687 . . . . 0.0 111.968 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.9 t -155.98 135.2 12.18 Favored 'General case' 0 C--O 1.228 -0.043 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -153.2 147.75 26.09 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.872 0.368 . . . . 0.0 111.359 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.68 135.57 55.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.452 0.701 . . . . 0.0 109.509 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -116.9 13.66 14.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.4 0.68 . . . . 0.0 112.503 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.53 0.2 0 CA-C-N 118.315 0.507 . . . . 0.0 112.342 -177.544 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.2 p30 . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.6 p -96.51 12.25 32.15 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.138 0.575 . . . . 0.0 111.826 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.72 142.46 25.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 122.874 0.469 . . . . 0.0 111.194 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.3 mt -129.19 164.0 24.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.113 0.565 . . . . 0.0 111.454 -175.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.7 tp -123.89 132.69 53.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.716 1.206 . . . . 0.0 108.171 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -119.43 144.25 47.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.729 0.811 . . . . 0.0 109.805 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 91.7 m -139.06 144.3 38.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.9 mp -106.85 134.36 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.66 -36.55 15.18 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -173.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -131.54 63.5 69.72 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 123.606 0.762 . . . . 0.0 109.948 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.84 103.24 1.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.849 2.366 . . . . 0.0 110.88 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.9 pt -128.65 0.94 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 122.879 0.472 . . . . 0.0 111.384 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -130.1 166.52 20.02 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.954 0.902 . . . . 0.0 109.191 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.2 m -74.98 147.8 40.5 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.719 0.295 . . . . 0.0 111.56 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.1 mm -137.55 132.88 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.3 p -142.87 176.36 9.13 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 122.896 0.479 . . . . 0.0 110.299 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 41.5 p -63.31 -22.8 67.1 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.193 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -80.5 -26.14 38.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.295 0.238 . . . . 0.0 110.821 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 87.6 t -84.41 -37.59 12.9 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.17 -24.93 54.81 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.294 -0.254 . . . . 0.0 111.093 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -77.62 -37.26 50.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.815 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.4 t -75.74 -19.58 58.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.219 0.463 . . . . 0.0 111.374 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -94.92 -15.67 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.339 0.518 . . . . 0.0 111.858 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.5 m -97.41 -22.78 16.4 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.697 0.68 . . . . 0.0 111.864 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 26.9 t-20 -59.82 -43.04 94.07 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 93.9 Cg_endo -72.22 -9.19 24.05 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.985 1.79 . . . . 0.0 111.928 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.4 m -96.09 -20.75 18.41 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 122.063 -0.398 . . . . 0.0 111.317 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 162.94 169.75 26.82 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.84 115.76 3.76 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.571 2.847 . . . . 0.0 111.039 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.96 147.34 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -111.63 -39.56 4.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.986 0.514 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -160.83 159.08 29.46 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.56 0.618 . . . . 0.0 112.177 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.6 mt -142.53 146.96 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.623 0.769 . . . . 0.0 110.377 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.61 144.25 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 123.372 0.669 . . . . 0.0 109.587 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 123.493 0.717 . . . . 0.0 109.727 -178.967 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 . . . . . 0 CA--C 1.528 0.134 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.13 171.04 21.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.796 0.439 . . . . 0.0 110.071 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.2 mtp -138.24 151.29 47.51 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.1 t -141.13 151.93 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 122.847 0.459 . . . . 0.0 109.846 -175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -136.94 141.45 42.65 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -115.8 168.32 10.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.471 0.709 . . . . 0.0 110.802 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -74.51 -13.83 60.73 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.761 0.425 . . . . 0.0 111.341 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 37.7 t -152.31 153.82 34.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.839 0.456 . . . . 0.0 109.938 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.8 -25.19 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -65.39 -27.59 68.66 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.908 -0.495 . . . . 0.0 109.742 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 40.4 m -82.51 -26.85 32.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.2 0.2 . . . . 0.0 110.712 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.76 -25.4 41.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -70.73 -37.53 73.51 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -77.88 -24.83 48.35 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 122.076 0.15 . . . . 0.0 110.779 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.43 -54.6 18.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.325 -0.234 . . . . 0.0 110.935 -178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.68 -15.82 60.26 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.708 -179.383 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.14 -11.11 58.24 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.115 -0.366 . . . . 0.0 111.563 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.0 m -124.45 -0.71 8.14 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 87.2 mt -130.17 -4.82 4.4 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -77.0 130.24 37.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.461 -0.774 . . . . 0.0 109.176 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.68 6.2 76.51 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.805 -0.442 . . . . 0.0 112.052 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.26 176.29 7.52 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.673 0.737 . . . . 0.0 111.488 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -140.11 150.96 44.93 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.57 0.748 . . . . 0.0 109.364 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.3 mt . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 122.407 0.283 . . . . 0.0 111.442 -176.106 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 79.6 m . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.68 140.72 56.21 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.962 0.505 . . . . 0.0 109.777 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 62.2 mt -93.52 155.2 17.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.206 0.527 . . . . 0.0 111.786 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -144.3 135.6 25.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 172.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 85.2 mt -130.17 149.7 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 121.0 0.428 . . . . 0.0 111.174 -175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.35 168.77 26.0 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.934 1.294 . . . . 0.0 108.211 173.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -80.39 144.05 33.0 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.679 -0.638 . . . . 0.0 110.578 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.66 165.46 16.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.669 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -83.18 -25.79 0.38 Allowed Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 43.7 Cg_endo -81.43 179.46 5.79 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.836 1.691 . . . . 0.0 109.858 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 65.1 p -108.57 -4.65 17.0 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.734 0.414 . . . . 0.0 110.728 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.3 mmm-85 -153.8 153.94 33.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.039 0.936 . . . . 0.0 110.099 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 83.9 mt -115.21 168.91 9.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.298 0.639 . . . . 0.0 109.514 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -141.13 158.49 43.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.286 0.234 . . . . 0.0 110.813 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.37 156.22 29.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 124.215 1.006 . . . . 0.0 109.097 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -124.61 -15.73 6.47 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -173.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -162.49 175.16 11.77 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.698 0.799 . . . . 0.0 110.293 -176.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -121.09 95.88 4.87 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.38 0.672 . . . . 0.0 109.577 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -149.42 -170.69 3.7 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.726 0.81 . . . . 0.0 110.649 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -70.91 -5.04 27.73 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -109.0 -24.21 11.32 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.649 0.658 . . . . 0.0 111.392 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.2 t -159.26 143.33 15.11 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -150.91 150.23 30.6 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.25 137.57 52.06 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -113.81 5.17 16.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.379 0.671 . . . . 0.0 112.519 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.531 0.235 0 C-N-CA 122.755 0.422 . . . . 0.0 110.921 178.693 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 119.901 -0.095 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -148.01 159.44 43.89 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.28 153.19 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 122.991 0.516 . . . . 0.0 110.584 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.5 p -78.39 1.84 20.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.016 0.526 . . . . 0.0 112.21 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -139.2 68.73 40.83 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 123.8 0.84 . . . . 0.0 109.02 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.1 171.39 17.67 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.108 3.205 . . . . 0.0 111.127 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -70.45 173.97 39.29 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 112.363 -0.295 . . . . 0.0 112.363 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -146.39 170.23 17.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.195 0.598 . . . . 0.0 109.727 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 29.2 m 54.95 21.45 3.72 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.658 0.783 . . . . 0.0 112.819 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.0 t0 50.68 32.2 6.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.921 0.888 . . . . 0.0 111.983 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 26.3 t70 53.38 23.93 3.62 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.389 1.076 . . . . 0.0 112.825 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 38.5 m 56.46 13.74 1.42 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.451 1.1 . . . . 0.0 113.184 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 54.16 -173.32 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.861 1.264 . . . . 0.0 113.037 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 47.3 t -147.76 158.35 43.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.459 0.704 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.1 p -147.16 -54.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.542 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -166.21 166.13 17.09 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.395 0.678 . . . . 0.0 110.447 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.0 p -94.87 10.75 34.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.173 0.589 . . . . 0.0 111.258 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.35 139.47 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.683 0.793 . . . . 0.0 110.664 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 99.1 mt -128.52 160.35 32.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.386 0.612 . . . . 0.0 111.255 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.4 tp -120.65 133.36 55.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.99 1.316 . . . . 0.0 108.042 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -119.75 144.71 47.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.652 0.781 . . . . 0.0 109.912 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 99.0 m -139.52 142.83 37.24 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.4 mp -105.38 135.78 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.86 -35.79 12.54 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -130.79 62.84 67.58 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.429 0.692 . . . . 0.0 110.329 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.45 103.25 1.08 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.795 2.33 . . . . 0.0 110.989 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.8 pt -128.83 2.71 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.742 0.417 . . . . 0.0 111.614 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -132.31 167.47 19.81 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.737 0.815 . . . . 0.0 109.628 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.5 m -74.68 146.73 42.08 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.65 0.262 . . . . 0.0 111.133 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mm -138.11 136.02 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.5 p -144.05 174.21 11.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.463 0.705 . . . . 0.0 109.538 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.2 p -63.51 -19.16 64.54 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.507 0.323 . . . . 0.0 111.153 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -83.4 -25.96 30.84 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.745 0.248 . . . . 0.0 111.042 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.4 t -81.67 -36.58 14.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.76 -26.32 57.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.217 -0.302 . . . . 0.0 110.295 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -75.63 -36.64 60.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.868 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.1 t -77.13 -17.69 58.45 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.312 0.505 . . . . 0.0 111.647 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.77 -13.9 7.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.148 0.431 . . . . 0.0 111.877 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 83.6 m -99.31 -24.97 14.64 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.765 0.711 . . . . 0.0 112.139 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.471 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 47.9 t30 -63.93 -39.16 42.75 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 95.1 Cg_endo -72.89 -5.81 17.87 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.437 1.425 . . . . 0.0 111.729 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 73.0 m -102.54 -10.52 19.25 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.806 0.442 . . . . 0.0 111.105 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 156.89 166.01 15.81 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.71 112.75 2.97 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.61 2.873 . . . . 0.0 110.658 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.25 152.33 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -117.18 -37.82 3.48 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.617 0.367 . . . . 0.0 110.95 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -163.16 157.32 20.37 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.2 0.455 . . . . 0.0 112.186 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.6 mt -143.67 146.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.315 1.046 . . . . 0.0 109.913 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.17 150.9 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.2 mt -130.55 149.35 33.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.966 0.506 . . . . 0.0 110.742 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -138.51 134.57 34.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.737 0.815 . . . . 0.0 109.441 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.25 24.95 1.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.29 -20.13 63.9 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -152.18 120.63 6.4 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 61.96 -154.67 39.69 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.0 t -139.16 125.99 24.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -145.85 164.44 31.92 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.324 0.649 . . . . 0.0 110.236 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -154.24 171.6 18.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.556 0.342 . . . . 0.0 110.418 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.4 mtp -138.45 147.73 43.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.2 t -137.81 151.75 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 123.149 0.58 . . . . 0.0 109.786 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -141.2 141.49 34.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.297 0.639 . . . . 0.0 109.88 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -118.0 168.73 10.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.95 0.9 . . . . 0.0 110.981 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.01 -14.41 60.22 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.979 0.512 . . . . 0.0 111.357 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.4 t -150.75 152.15 33.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.939 0.496 . . . . 0.0 109.998 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.52 -23.68 30.22 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.85 -29.09 70.03 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 27.3 m -83.87 -28.0 28.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.573 0.349 . . . . 0.0 110.391 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.23 -27.02 47.61 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -69.96 -38.92 76.25 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -76.55 -27.95 56.1 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.15 -53.83 39.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.399 -0.188 . . . . 0.0 110.968 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.433 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.57 -14.38 60.01 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.999 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.05 -12.58 57.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.014 0.37 . . . . 0.0 111.947 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -128.75 2.31 5.44 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 76.5 mt -128.45 -4.94 5.37 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.472 0.578 . . . . 0.0 112.363 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.4 132.85 37.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.97 7.94 72.08 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.69 174.17 11.62 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.574 0.687 . . . . 0.0 111.018 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -132.15 148.62 52.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 49.9 mt -100.62 -16.05 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.91 24.32 9.05 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.998 0.519 . . . . 0.0 111.551 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 24.7 m 57.52 15.23 2.66 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.077 0.951 . . . . 0.0 112.209 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 173.38 143.67 4.36 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 68.3 m 56.19 179.38 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.736 0.814 . . . . 0.0 111.906 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.0 m 49.94 33.85 7.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.85 0.46 . . . . 0.0 110.971 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.94 140.53 56.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.28 0.632 . . . . 0.0 110.051 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.2 154.86 16.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.007 0.523 . . . . 0.0 111.661 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -143.24 124.9 14.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.433 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 71.6 mt -126.44 146.2 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.147 0.499 . . . . 0.0 111.715 -173.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -156.35 170.73 21.63 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.952 1.301 . . . . 0.0 108.656 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.48 145.74 33.09 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 121.798 -0.564 . . . . 0.0 110.427 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -89.68 166.41 13.61 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.2 pttt -79.02 -28.32 0.55 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.4 Cg_endo -82.01 163.2 18.05 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 121.95 1.732 . . . . 0.0 110.442 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.5 p -97.24 -7.48 32.16 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 122.275 0.23 . . . . 0.0 110.992 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -152.82 148.88 27.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.818 0.847 . . . . 0.0 110.187 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 67.9 mt -107.48 172.26 6.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.586 0.754 . . . . 0.0 109.638 173.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -141.36 157.0 45.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.711 0.404 . . . . 0.0 110.22 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 79.9 t -135.59 152.36 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -119.93 -22.85 6.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.386 0.274 . . . . 0.0 111.148 -174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -165.38 173.52 11.05 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.712 0.805 . . . . 0.0 109.971 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -117.16 111.45 19.49 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.764 0.316 . . . . 0.0 110.463 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -156.24 -171.69 3.81 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.98 1.312 . . . . 0.0 109.56 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -73.95 -0.49 16.33 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -109.69 -27.35 9.39 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.45 0.568 . . . . 0.0 111.05 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.9 t -156.09 144.33 19.9 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.155 0.582 . . . . 0.0 109.584 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -150.31 150.73 31.88 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.657 0.265 . . . . 0.0 110.634 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -126.5 137.55 53.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.071 0.549 . . . . 0.0 109.765 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.96 11.76 13.51 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.594 0.758 . . . . 0.0 112.351 -174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.0 t -130.87 -7.32 3.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.983 0.356 . . . . 0.0 111.942 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -64.87 150.79 94.33 Favored Pre-proline 0 CA--C 1.532 0.265 0 O-C-N 121.685 -0.634 . . . . 0.0 109.926 174.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.2 0.36 10.08 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.916 3.077 . . . . 0.0 111.3 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -137.79 39.38 2.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.059 0.944 . . . . 0.0 110.127 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -73.68 0.36 13.13 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 26.8 p 56.82 178.23 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.539 1.536 . . . . 0.0 113.559 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -177.89 -174.92 44.64 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -137.24 8.61 2.93 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.861 0.464 . . . . 0.0 111.772 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 117.476 -1.736 . . . . 0.0 110.861 -179.797 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -137.76 164.27 29.3 Favored 'General case' 0 C--N 1.338 0.066 0 C-N-CA 123.466 0.706 . . . . 0.0 111.032 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 19.3 tt -130.43 10.64 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.268 1.027 . . . . 0.0 110.848 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.3 m 59.53 9.64 1.61 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.007 1.323 . . . . 0.0 114.2 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' ' 179' ' ' PRO . 33.6 ptt-85 -149.77 43.54 0.28 Allowed Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 123.462 0.705 . . . . 0.0 112.027 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 178' ' ' ARG . 90.0 Cg_endo -72.02 -17.31 28.52 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.93 2.42 . . . . 0.0 111.588 -176.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 151.25 -164.72 30.19 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -81.37 160.45 24.1 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.572 0.349 . . . . 0.0 110.551 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 t 57.35 -166.49 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.607 0.763 . . . . 0.0 112.095 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 185' ' ' SER . 27.1 t0 62.62 163.96 0.1 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.48 1.512 . . . . 0.0 112.653 -175.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 61.08 -22.35 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.334 1.854 . . . . 0.0 114.003 -173.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.446 ' H ' ' C ' ' A' ' 183' ' ' ASP . 26.5 m 48.38 23.99 0.66 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.859 1.263 . . . . 0.0 113.801 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 50.76 27.11 2.87 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.981 0.912 . . . . 0.0 112.218 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.3 t -66.95 149.51 50.52 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.573 0.749 . . . . 0.0 112.029 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 65.3 t -140.98 -67.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -162.1 164.36 28.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.857 0.863 . . . . 0.0 110.12 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.4 p -92.77 15.79 13.83 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.595 0.758 . . . . 0.0 112.472 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.47 145.9 24.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 122.884 0.474 . . . . 0.0 110.893 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.64 165.02 23.71 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.29 0.567 . . . . 0.0 111.29 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.1 tp -127.69 131.26 49.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -117.0 144.31 44.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.826 0.851 . . . . 0.0 109.443 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.1 m -135.91 141.72 44.59 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 196' ' ' ILE . 1.9 mp -103.91 136.19 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.6 mt -92.86 -36.55 12.76 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -131.67 64.87 74.39 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.467 0.707 . . . . 0.0 110.096 -177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.85 104.2 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.571 2.181 . . . . 0.0 111.075 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.2 pt -130.13 1.44 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.073 0.549 . . . . 0.0 111.457 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -131.5 167.32 19.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.849 0.86 . . . . 0.0 109.197 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 27.0 t -76.53 149.48 36.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.416 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.3 mm -138.8 133.3 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.6 p -145.07 176.17 9.7 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 123.388 0.675 . . . . 0.0 110.136 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 35.5 p -61.33 -28.15 69.01 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.383 -0.198 . . . . 0.0 110.936 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.08 -22.35 58.36 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.699 0.399 . . . . 0.0 111.631 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.0 t -89.62 -38.0 10.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 84.3 mt -77.76 -23.39 49.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.96 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -78.3 -34.54 48.71 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.017 -0.427 . . . . 0.0 110.711 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.9 t -75.59 -23.23 56.45 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.217 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.1 pt -88.91 -22.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.203 0.456 . . . . 0.0 111.755 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.9 m -96.21 -20.12 18.81 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.779 0.718 . . . . 0.0 112.507 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.482 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.84 -43.5 87.54 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 95.8 Cg_endo -72.13 -11.04 26.74 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.874 1.716 . . . . 0.0 111.594 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.1 m -90.56 -23.04 21.0 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.232 0.469 . . . . 0.0 111.121 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.26 170.97 28.91 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.396 -0.681 . . . . 0.0 111.396 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -68.38 111.03 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.766 2.978 . . . . 0.0 110.71 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -83.49 152.37 3.86 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -115.52 -35.53 4.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.815 0.446 . . . . 0.0 110.693 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -164.31 160.35 20.85 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.129 0.422 . . . . 0.0 111.772 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.1 mt -144.35 146.89 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.074 0.95 . . . . 0.0 109.986 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.1 144.61 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 123.528 0.731 . . . . 0.0 109.408 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.0 mp -120.91 151.01 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 C-N-CA 123.767 0.827 . . . . 0.0 110.386 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.65 138.56 51.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 173.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -140.86 21.9 2.29 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -115.84 140.56 49.11 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 53.98 18.68 1.74 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.014 0.926 . . . . 0.0 112.266 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 149.51 -173.36 29.33 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.2 t -135.45 124.59 40.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 CA-C-N 117.505 0.652 . . . . 0.0 109.605 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -148.31 168.96 21.21 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 124.026 0.931 . . . . 0.0 109.463 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.15 168.65 26.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.418 0.287 . . . . 0.0 110.416 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 87.8 mtp -138.43 151.43 47.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.31 150.15 21.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 122.829 0.452 . . . . 0.0 109.898 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -132.44 141.78 48.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.746 0.818 . . . . 0.0 108.794 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -118.02 167.98 10.96 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.907 0.883 . . . . 0.0 110.916 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.24 -15.5 60.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.738 0.415 . . . . 0.0 111.135 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 93.4 p -152.08 158.34 42.87 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.039 0.447 . . . . 0.0 110.459 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.94 -26.68 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.388 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -72.63 -22.2 60.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.335 0.516 . . . . 0.0 110.534 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.8 m -80.56 -28.3 37.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.02 -26.19 39.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.354 0.262 . . . . 0.0 110.469 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -69.71 -36.91 76.32 Favored 'General case' 0 N--CA 1.458 -0.05 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -79.67 -24.94 41.46 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.16 0.184 . . . . 0.0 110.762 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.68 -52.79 33.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.975 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.412 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.92 -16.08 60.08 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.795 0.725 . . . . 0.0 111.662 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.8 58.74 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.702 0.228 . . . . 0.0 111.6 176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.8 t -126.73 0.52 6.75 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.0 mt -130.68 -4.27 4.14 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -78.14 130.91 36.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.884 0.765 . . . . 0.0 109.083 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.38 8.66 76.02 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.25 175.38 9.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.666 0.733 . . . . 0.0 111.284 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -139.8 149.14 43.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.569 0.748 . . . . 0.0 109.01 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.4 mt -111.13 -19.02 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 122.491 0.317 . . . . 0.0 111.243 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -125.91 23.14 7.28 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.72 0.408 . . . . 0.0 111.66 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.2 m 55.38 20.12 3.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.618 0.767 . . . . 0.0 112.41 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 169.17 136.57 2.09 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 71.9 m 57.27 178.81 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.865 0.866 . . . . 0.0 111.941 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.8 m 53.02 29.8 8.53 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.924 0.489 . . . . 0.0 111.639 -174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.39 142.69 51.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.385 0.674 . . . . 0.0 109.987 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 53.9 mt -97.76 154.99 17.24 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.15 0.5 . . . . 0.0 111.87 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -146.25 132.55 19.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.412 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 76.6 mt -129.58 149.12 33.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 121.338 0.589 . . . . 0.0 112.012 -172.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.74 172.3 16.89 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.356 1.462 . . . . 0.0 108.428 174.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -83.75 143.92 29.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.948 -0.47 . . . . 0.0 110.445 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.68 170.29 12.65 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.41 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.441 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -84.82 -26.35 0.37 Allowed Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 49.4 Cg_endo -82.5 -177.84 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.023 1.815 . . . . 0.0 110.033 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.0 p -108.23 -7.43 15.98 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 122.196 -0.315 . . . . 0.0 111.422 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.75 168.47 27.07 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.138 0.975 . . . . 0.0 109.665 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 90.4 mt -124.73 174.37 7.94 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.475 0.71 . . . . 0.0 109.739 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -140.79 159.77 41.49 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.835 0.35 . . . . 0.0 110.929 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.8 t -135.69 153.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 124.277 1.031 . . . . 0.0 108.744 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -120.58 -26.38 5.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.614 0.366 . . . . 0.0 111.493 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.12 169.89 18.71 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.729 1.212 . . . . 0.0 108.865 176.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -107.08 117.43 34.04 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.782 0.325 . . . . 0.0 110.616 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -158.25 -172.57 3.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.624 1.169 . . . . 0.0 109.755 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -71.49 -4.94 29.46 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -114.16 -18.9 11.53 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.664 0.665 . . . . 0.0 111.728 -178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.0 t -156.63 139.38 15.14 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -152.49 149.56 28.67 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.703 0.287 . . . . 0.0 110.666 -176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -124.95 138.2 54.24 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.176 0.59 . . . . 0.0 109.479 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -118.37 11.17 12.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.3 0.64 . . . . 0.0 112.253 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.7 t -132.41 -7.82 3.31 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.231 0.469 . . . . 0.0 112.22 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -79.79 155.68 75.47 Favored Pre-proline 0 CA--C 1.533 0.315 0 O-C-N 121.8 -0.563 . . . . 0.0 110.792 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.84 -5.13 16.63 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.213 2.609 . . . . 0.0 112.201 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -77.82 -10.22 59.45 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.106 -0.371 . . . . 0.0 111.239 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 44.0 tp -90.67 -12.34 37.06 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.509 0.324 . . . . 0.0 110.688 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 35.1 m -67.57 -9.78 45.87 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.94 -0.475 . . . . 0.0 111.686 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -80.62 -5.18 90.08 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -134.99 -14.81 2.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.493 0.646 . . . . 0.0 111.445 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.368 -1.795 . . . . 0.0 111.017 179.489 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -141.1 172.75 12.25 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 123.555 0.742 . . . . 0.0 110.79 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.423 HG23 ' H ' ' A' ' 178' ' ' ARG . 8.6 tp -78.9 6.58 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.626 1.17 . . . . 0.0 111.271 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.5 m 59.1 7.99 0.95 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.887 1.275 . . . . 0.0 113.49 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.423 ' H ' HG23 ' A' ' 176' ' ' ILE . 43.3 ttt85 -152.91 61.91 4.01 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 123.407 0.683 . . . . 0.0 109.202 174.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -69.56 170.05 17.24 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.826 3.017 . . . . 0.0 111.336 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 100.3 -164.23 19.14 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -124.05 157.85 33.55 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.144 0.578 . . . . 0.0 110.881 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 20.3 m 56.63 -174.79 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.491 1.117 . . . . 0.0 113.251 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 29.9 t70 61.91 137.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.071 1.748 . . . . 0.0 114.15 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 t70 51.13 16.94 0.41 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.949 1.299 . . . . 0.0 113.359 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 54.0 m 53.81 14.16 0.62 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.121 0.968 . . . . 0.0 112.831 -175.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 48.6 -156.25 0.07 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.352 1.061 . . . . 0.0 111.776 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.6 t -147.43 151.76 36.99 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.063 0.545 . . . . 0.0 109.58 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.8 p -152.69 -51.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.294 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -165.87 170.23 14.04 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.012 0.525 . . . . 0.0 110.598 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.5 p -100.3 15.59 27.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.686 0.795 . . . . 0.0 111.788 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.11 143.94 27.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.011 0.524 . . . . 0.0 110.858 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.3 mt -128.79 164.92 21.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.212 0.53 . . . . 0.0 111.783 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.1 tp -123.87 134.43 53.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.783 1.233 . . . . 0.0 107.939 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -121.75 150.85 41.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.029 0.932 . . . . 0.0 109.618 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 94.6 m -142.63 146.71 34.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 42.9 mt -119.26 136.99 54.65 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.05 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 50.2 mt -102.91 -23.69 13.72 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -173.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -131.7 62.19 62.91 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.39 0.676 . . . . 0.0 110.102 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.31 40.27 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 125.073 3.849 . . . . 0.0 112.632 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 38.0 pt -77.08 -0.7 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.887 -0.508 . . . . 0.0 111.888 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -130.16 166.05 21.05 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.729 0.812 . . . . 0.0 109.655 176.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.2 m -70.57 146.56 50.04 Favored 'General case' 0 C--N 1.335 -0.048 0 CA-C-O 120.73 0.3 . . . . 0.0 111.526 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.8 mm -137.33 134.6 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.9 p -146.87 173.88 12.01 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.368 0.667 . . . . 0.0 109.236 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.3 p -63.74 -19.56 65.06 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 122.333 0.253 . . . . 0.0 111.529 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.15 -24.37 37.65 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.843 0.292 . . . . 0.0 110.849 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.0 t -82.48 -37.62 14.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.58 -24.25 58.88 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.212 -0.305 . . . . 0.0 110.614 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -78.31 -36.23 46.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.229 -0.294 . . . . 0.0 111.177 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.7 t -74.97 -21.32 59.23 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.145 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 39.5 pt -91.73 -21.9 6.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 CA-C-N 118.136 0.425 . . . . 0.0 112.058 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.2 m -95.67 -24.2 16.66 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 50.4 t30 -63.88 -40.57 56.49 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 89.4 Cg_endo -73.14 -4.5 15.54 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.754 1.636 . . . . 0.0 111.821 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.5 m -101.67 -10.42 20.03 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.868 0.467 . . . . 0.0 111.199 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 155.53 164.66 13.38 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.86 109.59 1.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.729 2.953 . . . . 0.0 111.016 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.96 151.88 4.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -117.39 -38.37 3.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.612 0.365 . . . . 0.0 111.086 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -162.98 157.95 21.62 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.01 0.368 . . . . 0.0 111.424 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 54.1 mt -143.15 141.93 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.762 0.825 . . . . 0.0 109.419 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 20.3 m -136.2 151.66 29.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 56.3 mt -133.91 150.24 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 122.796 0.438 . . . . 0.0 110.138 -175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.2 121.72 22.93 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -142.63 18.3 2.01 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 122.798 0.439 . . . . 0.0 111.984 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.644 ' HE2' ' HA ' ' A' ' 226' ' ' LYS . 0.7 OUTLIER -76.84 -24.2 52.71 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -150.97 125.56 9.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 61.61 -157.43 33.85 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.94 118.85 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 117.475 0.637 . . . . 0.0 110.674 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -148.4 165.15 31.98 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 123.395 0.678 . . . . 0.0 110.188 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.83 171.4 18.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.843 0.457 . . . . 0.0 109.985 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.0 mtp -141.47 150.53 42.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.2 t -136.71 152.41 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 C-N-CA 122.928 0.491 . . . . 0.0 109.829 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -137.42 140.84 41.55 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.461 0.704 . . . . 0.0 109.577 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -120.97 169.24 10.66 Favored 'General case' 0 C--O 1.23 0.069 0 C-N-CA 123.879 0.871 . . . . 0.0 111.079 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.04 -16.07 61.06 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.852 0.461 . . . . 0.0 111.362 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 90.7 p -153.02 159.71 42.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.974 0.416 . . . . 0.0 110.664 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.38 -26.62 31.84 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 O-C-N 122.269 -0.269 . . . . 0.0 110.365 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -65.49 -29.33 69.97 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 122.077 -0.39 . . . . 0.0 110.083 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.7 m -80.14 -27.33 39.08 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.704 0.402 . . . . 0.0 110.641 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.14 -25.27 37.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.276 -0.265 . . . . 0.0 110.527 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -70.89 -35.99 72.56 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -77.05 -27.79 54.54 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.335 -0.228 . . . . 0.0 110.487 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.12 -51.5 57.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.361 -0.212 . . . . 0.0 111.056 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -13.32 59.92 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.863 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -84.89 -10.79 56.76 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.924 0.329 . . . . 0.0 111.591 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.6 m -124.73 -2.47 7.84 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.51 -7.4 4.67 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -78.34 133.02 37.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.889 0.768 . . . . 0.0 109.099 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.16 4.78 64.3 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.79 179.67 7.41 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 117.641 0.72 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.48 161.45 37.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.723 0.809 . . . . 0.0 108.995 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.9 mt -113.01 -23.28 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 119.783 -0.151 . . . . 0.0 111.337 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -137.75 82.55 1.93 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.191 0.45 . . . . 0.0 111.674 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.9 m 49.26 45.71 23.29 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 94.19 -0.64 66.54 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.591 -0.561 . . . . 0.0 112.464 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 60.9 m -102.66 166.81 10.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.802 0.801 . . . . 0.0 109.802 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.5 m 52.55 43.13 31.44 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.558 0.343 . . . . 0.0 110.778 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 23.9 m -56.27 138.17 50.95 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.919 0.487 . . . . 0.0 109.901 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.3 mt -105.21 153.44 21.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.043 0.537 . . . . 0.0 112.069 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -141.59 125.12 16.72 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 77.4 mt -124.25 147.6 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-O 121.136 0.494 . . . . 0.0 111.498 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -155.89 170.55 21.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.054 1.342 . . . . 0.0 108.427 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -80.39 146.35 31.54 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.861 -0.524 . . . . 0.0 110.51 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.26 165.92 15.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.489 0.316 . . . . 0.0 110.272 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -82.9 -26.55 0.4 Allowed Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 43.2 Cg_endo -81.7 177.74 7.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.848 1.696 . . . . 0.0 109.593 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 59.2 p -106.38 -5.17 19.2 Favored 'General case' 0 CA--C 1.527 0.084 0 O-C-N 122.285 -0.26 . . . . 0.0 110.985 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.0 mmm-85 -154.48 155.86 35.66 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.118 0.967 . . . . 0.0 110.235 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -118.47 168.64 10.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.173 0.989 . . . . 0.0 109.716 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -140.79 161.38 37.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.329 0.252 . . . . 0.0 110.878 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.15 153.92 36.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 124.164 0.986 . . . . 0.0 109.111 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -123.83 -21.28 5.19 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.453 ' HE3' ' CG2' ' A' ' 279' ' ' THR . 0.3 OUTLIER -164.95 173.08 12.0 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.678 1.191 . . . . 0.0 109.021 176.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -113.05 113.64 25.73 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -154.93 -172.13 4.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.944 1.297 . . . . 0.0 109.387 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -71.65 -4.97 30.24 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -115.86 -14.5 11.32 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.649 0.659 . . . . 0.0 111.899 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . 0.453 ' CG2' ' HE3' ' A' ' 274' ' ' LYS . 5.0 t -157.09 138.58 13.94 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -152.91 150.24 29.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.252 -0.28 . . . . 0.0 110.894 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -125.43 137.52 54.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.133 0.573 . . . . 0.0 109.556 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -117.15 7.27 12.97 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.312 0.645 . . . . 0.0 112.084 -175.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t -132.1 -7.13 3.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.569 0.348 . . . . 0.0 111.837 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -68.9 121.6 82.08 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.06 -11.27 28.88 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.226 2.617 . . . . 0.0 112.163 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -99.44 5.09 46.36 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.087 0.555 . . . . 0.0 110.955 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 16.4 tp 51.49 25.19 2.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.951 0.9 . . . . 0.0 111.935 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 17.1 m 54.47 18.44 1.96 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.72 1.208 . . . . 0.0 113.449 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 68.77 -169.71 41.39 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 122.879 0.276 . . . . 0.0 112.418 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -140.81 9.92 2.19 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.98 0.512 . . . . 0.0 111.6 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.325 -1.819 . . . . 0.0 111.087 -178.177 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -148.18 -61.46 0.25 Allowed 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.563 0.345 . . . . 0.0 110.241 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.2 tp -159.76 167.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 108.279 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 78.6 p -88.78 2.04 54.19 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -136.34 45.63 1.33 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.502 0.721 . . . . 0.0 112.507 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.75 -15.24 30.12 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.607 2.205 . . . . 0.0 111.576 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.9 7.92 80.94 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.781 -0.527 . . . . 0.0 111.781 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -140.62 167.91 21.05 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.511 0.725 . . . . 0.0 110.366 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.7 t 57.99 -172.65 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.678 0.791 . . . . 0.0 112.015 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.9 t0 52.97 30.52 9.49 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.026 0.93 . . . . 0.0 111.845 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.98 24.76 3.58 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.436 1.094 . . . . 0.0 112.52 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 33.3 m 54.11 15.14 0.83 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.391 1.077 . . . . 0.0 113.118 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 50.81 25.61 2.22 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.616 1.166 . . . . 0.0 113.101 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 80.7 p -79.82 152.46 29.71 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.616 0.367 . . . . 0.0 110.831 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 61.1 t -140.31 -64.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -161.26 163.62 30.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.604 0.762 . . . . 0.0 110.279 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.1 p -87.17 15.44 6.21 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.248 0.619 . . . . 0.0 111.606 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.71 137.92 45.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 123.158 0.583 . . . . 0.0 111.073 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.06 163.31 24.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.376 0.607 . . . . 0.0 111.266 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.1 tp -125.09 132.41 53.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.871 1.268 . . . . 0.0 108.191 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -117.84 146.96 43.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.667 0.787 . . . . 0.0 109.845 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 72.9 m -136.59 144.39 44.1 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.6 mp -109.43 136.62 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 63.3 mt -99.71 -26.42 14.06 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -174.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -135.88 66.77 62.93 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 123.67 0.788 . . . . 0.0 109.687 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -75.11 52.64 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 125.133 3.889 . . . . 0.0 112.398 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.4 pt -78.79 -1.75 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 121.724 -0.61 . . . . 0.0 111.641 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -136.54 168.85 18.7 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.268 1.027 . . . . 0.0 109.36 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 50.9 m -79.12 150.5 31.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.853 0.359 . . . . 0.0 111.483 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.4 mm -134.31 138.73 49.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.4 p -142.18 174.53 10.52 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 122.934 0.493 . . . . 0.0 110.018 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 38.5 p -63.19 -21.45 66.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.203 0.201 . . . . 0.0 111.109 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.81 -27.91 33.4 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.38 0.272 . . . . 0.0 111.222 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.9 t -78.96 -37.8 20.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 89.2 mt -76.79 -22.49 53.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.274 -0.266 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -77.88 -34.32 51.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.973 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -76.88 -21.71 54.53 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.386 0.539 . . . . 0.0 111.294 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 44.8 pt -90.62 -21.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.969 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.7 m -96.58 -21.66 17.53 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.507 0.594 . . . . 0.0 112.257 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.476 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.1 t-20 -60.26 -44.3 95.79 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.434 -0.793 . . . . 0.0 113.111 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 97.8 Cg_endo -72.39 -9.43 24.2 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.039 1.826 . . . . 0.0 112.103 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 76.9 m -94.67 -20.5 19.5 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.99 0.359 . . . . 0.0 111.217 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.54 167.32 23.82 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.44 113.27 3.07 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.799 2.999 . . . . 0.0 110.886 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 69.7 t -87.21 150.45 3.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -112.35 -36.73 5.2 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.159 0.584 . . . . 0.0 110.796 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -164.35 159.17 19.46 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 117.993 0.36 . . . . 0.0 111.882 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 42.4 mt -144.34 142.35 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.01 0.924 . . . . 0.0 109.354 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 m -138.4 154.63 27.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 122.72 0.408 . . . . 0.0 110.239 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.4 mm -114.27 152.07 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.604 0.762 . . . . 0.0 111.062 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -136.01 140.96 44.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.973 0.909 . . . . 0.0 108.775 173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -142.85 23.43 1.9 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -108.47 139.54 43.07 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.18 0.592 . . . . 0.0 109.804 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 62.1 t30 51.04 22.29 1.2 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.459 1.104 . . . . 0.0 112.6 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 149.57 -161.47 28.82 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.0 p -141.47 126.48 17.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.292 0.568 . . . . 0.0 109.768 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -150.74 171.91 16.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.071 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.57 166.47 31.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.409 0.683 . . . . 0.0 109.339 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 87.4 mtp -135.94 150.26 49.22 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.05 148.23 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 122.918 0.487 . . . . 0.0 109.881 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.9 138.91 48.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -115.24 169.33 9.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.922 0.889 . . . . 0.0 111.065 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.79 -16.64 61.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.574 0.35 . . . . 0.0 111.549 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.5 p -152.57 159.9 43.24 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.612 0.365 . . . . 0.0 110.684 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.39 -25.75 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -70.72 -25.2 62.83 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.305 -0.247 . . . . 0.0 110.405 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.9 m -80.37 -28.53 37.97 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.64 -25.78 41.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.381 -0.2 . . . . 0.0 110.528 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -69.68 -37.02 76.5 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 48.4 ttt-85 -78.92 -26.66 43.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 121.897 0.079 . . . . 0.0 110.936 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.25 -48.89 66.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.036 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -14.41 59.27 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 118.57 0.623 . . . . 0.0 111.663 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -84.67 -9.92 57.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.653 -0.213 . . . . 0.0 111.191 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -124.71 -1.44 7.94 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.0 mt -132.07 -5.52 3.49 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -77.21 131.24 38.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.021 0.828 . . . . 0.0 109.244 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.25 5.76 67.45 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.29 179.28 7.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.609 0.704 . . . . 0.0 111.281 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -139.43 157.98 44.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.853 0.861 . . . . 0.0 108.807 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 57.1 mt -106.46 -21.92 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -122.35 35.07 4.97 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.192 0.451 . . . . 0.0 112.057 -174.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.5 m 57.41 19.11 4.89 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.799 0.84 . . . . 0.0 111.637 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 163.89 162.03 14.09 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 9.1 p 47.61 -172.99 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.333 1.453 . . . . 0.0 113.092 -176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.0 m 46.68 36.09 3.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.109 0.564 . . . . 0.0 111.384 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.4 m -60.38 137.93 58.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.692 0.397 . . . . 0.0 109.955 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.3 mt -98.85 156.17 17.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.206 0.602 . . . . 0.0 112.314 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -144.09 134.11 24.1 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 81.2 mt -128.53 148.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-O 121.217 0.532 . . . . 0.0 111.562 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -154.3 169.49 23.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.075 1.35 . . . . 0.0 108.488 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -83.37 143.08 30.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.831 -0.543 . . . . 0.0 110.449 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.84 169.38 11.65 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -85.07 -26.51 0.37 Allowed Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.6 Cg_endo -82.03 165.26 17.31 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 CA-C-N 122.069 1.775 . . . . 0.0 109.927 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.9 p -94.3 -7.79 40.86 Favored 'General case' 0 CA--C 1.527 0.073 0 O-C-N 122.245 -0.284 . . . . 0.0 111.419 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.88 169.53 24.57 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.806 0.842 . . . . 0.0 109.939 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 84.1 mt -121.05 167.75 12.28 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.501 0.72 . . . . 0.0 109.565 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -129.85 154.13 47.59 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.681 0.277 . . . . 0.0 110.374 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 87.6 t -136.86 151.14 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.221 1.008 . . . . 0.0 108.866 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -123.43 -19.99 5.73 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.856 0.463 . . . . 0.0 111.324 -174.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -164.7 168.29 18.15 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.891 1.276 . . . . 0.0 108.7 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -116.96 109.27 16.81 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 121.016 0.436 . . . . 0.0 110.648 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -154.51 -172.14 4.1 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.789 1.236 . . . . 0.0 109.506 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -69.88 -4.85 22.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -114.1 -15.46 12.25 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 118.732 0.696 . . . . 0.0 111.826 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.2 t -159.43 134.75 8.32 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -152.23 148.31 27.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.121 -0.362 . . . . 0.0 111.153 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -125.64 132.5 52.45 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.44 0.696 . . . . 0.0 109.436 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -109.38 2.19 20.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.628 0.771 . . . . 0.0 112.137 -173.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t -117.84 -2.79 11.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.947 0.499 . . . . 0.0 110.499 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -67.61 123.5 86.96 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.626 1.17 . . . . 0.0 109.585 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.67 -16.67 25.6 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.816 3.011 . . . . 0.0 113.875 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -93.81 -28.89 15.63 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.159 0.436 . . . . 0.0 111.172 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 21.3 tp 55.35 -2.86 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.803 1.641 . . . . 0.0 114.882 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 89.5 p -152.46 11.83 0.53 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.943 0.792 . . . . 0.0 112.36 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -168.33 -176.05 38.41 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.43 5.64 3.22 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.222 0.609 . . . . 0.0 112.156 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 117.433 -1.76 . . . . 0.0 110.751 -179.899 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -148.87 174.8 11.85 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.177 0.591 . . . . 0.0 110.399 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.35 156.32 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.332 0.653 . . . . 0.0 110.117 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 81.0 p -80.1 1.01 29.6 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -139.37 62.08 22.98 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.9 0.88 . . . . 0.0 110.413 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.88 141.78 66.45 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.823 2.349 . . . . 0.0 110.677 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.77 8.5 72.77 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.499 -0.611 . . . . 0.0 112.826 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -144.7 153.4 41.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.251 1.026 . . . . 0.0 111.468 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.9 t -158.64 177.77 10.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.636 0.374 . . . . 0.0 110.916 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 61.1 165.42 0.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.898 1.679 . . . . 0.0 114.265 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 57.74 -3.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.262 1.825 . . . . 0.0 114.623 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 37.3 m 55.35 -0.53 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.759 1.624 . . . . 0.0 114.294 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 52.11 -173.47 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.315 1.446 . . . . 0.0 113.206 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.4 m -71.86 158.24 36.42 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.332 0.653 . . . . 0.0 111.023 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.01 -65.88 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.337 0.065 0 C-N-CA 122.57 0.348 . . . . 0.0 110.542 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -158.78 160.46 36.31 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.124 0.57 . . . . 0.0 110.482 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.8 p -89.68 13.68 13.59 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.194 0.597 . . . . 0.0 112.127 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.56 145.62 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 122.6 0.36 . . . . 0.0 110.721 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.3 mt -130.34 165.06 23.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.266 0.626 . . . . 0.0 111.586 -174.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 63.8 tp -123.89 133.01 53.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.565 1.146 . . . . 0.0 108.432 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -119.95 144.98 47.18 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.76 0.824 . . . . 0.0 109.994 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.1 m -138.1 142.93 40.21 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.2 mp -106.54 136.53 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.9 mt -92.4 -34.58 14.1 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -134.35 67.42 72.4 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 123.634 0.773 . . . . 0.0 109.34 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.13 64.59 4.26 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.666 3.577 . . . . 0.0 112.113 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 45.6 pt -83.84 -4.5 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.993 -0.442 . . . . 0.0 111.202 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -129.38 166.24 19.93 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 109.379 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 77.9 p -80.54 156.61 26.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.642 0.258 . . . . 0.0 111.121 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mm -136.21 139.96 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 70.7 p -143.25 172.36 12.85 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.066 0.546 . . . . 0.0 110.007 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.6 p -62.04 -24.97 67.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.24 0.216 . . . . 0.0 110.991 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -78.92 -27.57 43.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.346 0.258 . . . . 0.0 111.352 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.15 -38.58 18.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.878 0.37 . . . . 0.0 110.025 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.35 -22.97 54.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.218 -0.301 . . . . 0.0 110.561 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -78.65 -35.22 45.69 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.914 0.324 . . . . 0.0 110.879 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.2 t -74.73 -23.56 58.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.242 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 pt -89.05 -21.41 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 118.379 0.536 . . . . 0.0 111.955 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 87.6 m -95.74 -19.3 19.78 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.302 0.501 . . . . 0.0 112.182 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.458 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.6 t-20 -60.39 -44.08 94.87 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 92.7 Cg_endo -73.06 -10.81 24.89 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.706 1.604 . . . . 0.0 111.995 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 77.5 m -89.4 -23.7 22.1 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.161 0.437 . . . . 0.0 111.249 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.86 171.78 30.52 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.1 111.43 2.68 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.553 2.835 . . . . 0.0 110.556 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.47 151.45 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -116.06 -39.1 3.49 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.064 0.546 . . . . 0.0 110.907 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -161.67 158.48 26.08 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.402 0.546 . . . . 0.0 112.062 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 41.2 mt -144.89 143.93 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 124.364 1.066 . . . . 0.0 109.721 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.427 ' C ' HD12 ' A' ' 223' ' ' ILE . 22.4 m -141.69 149.52 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 123.288 0.635 . . . . 0.0 109.857 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.427 HD12 ' C ' ' A' ' 222' ' ' VAL . 1.8 mp -113.41 151.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.765 0.826 . . . . 0.0 109.81 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -137.07 150.47 48.06 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.977 0.911 . . . . 0.0 109.9 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.34 16.24 1.86 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.0 -29.46 68.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.623 0.369 . . . . 0.0 110.497 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -151.8 123.94 8.18 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 58.13 -143.25 43.65 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.3 t -131.39 130.86 63.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -143.69 166.08 25.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.346 0.658 . . . . 0.0 109.891 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.05 171.64 20.1 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.528 0.331 . . . . 0.0 110.218 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.8 mtp -138.78 149.95 45.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.28 151.37 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -135.5 140.74 45.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.564 0.746 . . . . 0.0 109.818 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -120.03 167.74 11.87 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.851 0.861 . . . . 0.0 110.854 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.51 -11.21 59.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.616 0.366 . . . . 0.0 111.349 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 42.9 t -152.18 151.45 31.03 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.151 0.581 . . . . 0.0 110.088 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.11 -25.71 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.54 -24.38 62.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.009 -0.432 . . . . 0.0 110.14 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 41.2 m -80.35 -27.2 38.35 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.75 -26.42 37.32 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.243 0.217 . . . . 0.0 110.424 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -68.46 -37.64 80.36 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -78.68 -24.79 44.86 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.99 -50.63 54.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.319 -0.238 . . . . 0.0 111.197 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.404 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.06 -14.57 59.45 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.626 179.07 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.22 -8.54 58.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.835 0.289 . . . . 0.0 111.555 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.8 t -125.6 -6.79 6.88 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.3 mt -124.49 -5.33 7.67 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -77.71 131.36 37.66 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.82 5.05 73.41 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.563 -0.576 . . . . 0.0 111.827 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.86 177.57 8.95 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.833 0.816 . . . . 0.0 111.093 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -138.64 160.38 39.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.758 0.823 . . . . 0.0 109.371 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.4 mt -112.37 -20.89 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -120.95 28.82 7.69 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.6 t 58.14 15.44 3.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.973 0.909 . . . . 0.0 112.05 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 170.4 145.48 4.75 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 75.2 m 53.83 -172.58 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.754 0.822 . . . . 0.0 111.852 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.3 m 50.3 33.48 7.5 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.198 0.599 . . . . 0.0 111.222 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.0 m -60.56 139.59 57.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.937 0.495 . . . . 0.0 110.041 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.0 mt -95.24 154.51 17.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.372 0.669 . . . . 0.0 111.756 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -145.56 129.15 17.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.404 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 81.0 mt -129.29 147.69 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 CA-C-O 121.171 0.51 . . . . 0.0 112.216 -171.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.36 173.56 15.47 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.679 1.191 . . . . 0.0 108.547 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -83.23 143.56 30.36 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.976 -0.452 . . . . 0.0 110.675 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.18 167.33 17.84 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.068 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 39.7 ttpt -74.64 -46.88 5.43 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 118.298 -0.858 . . . . 0.0 113.273 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 74.8 Cg_endo -74.9 177.53 8.43 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.353 2.035 . . . . 0.0 110.539 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.2 p -108.49 -7.79 15.69 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.592 0.357 . . . . 0.0 111.534 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.77 136.49 14.4 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 56.4 mt -88.05 171.09 10.53 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 122.731 0.412 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -131.93 151.7 51.55 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.549 0.34 . . . . 0.0 110.369 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.3 153.69 24.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 124.171 0.988 . . . . 0.0 108.786 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -126.94 -19.62 4.39 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.57 0.348 . . . . 0.0 111.437 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -165.56 170.46 14.27 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 124.505 1.122 . . . . 0.0 109.011 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -117.06 109.42 16.94 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 122.619 0.368 . . . . 0.0 110.411 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -154.93 -172.13 4.08 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.585 1.154 . . . . 0.0 109.627 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -69.75 -4.86 21.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -115.2 -17.29 11.41 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.121 0.873 . . . . 0.0 111.779 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.6 t -156.68 134.81 11.2 Favored 'General case' 0 N--CA 1.458 -0.055 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -152.61 147.36 26.06 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.758 0.314 . . . . 0.0 111.212 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -124.43 119.76 30.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -95.66 -4.68 43.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.281 0.632 . . . . 0.0 111.568 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.5 t -111.89 15.51 20.76 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.335 0.588 . . . . 0.0 110.124 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -68.89 124.81 91.09 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 123.765 0.826 . . . . 0.0 109.755 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.08 -17.89 26.76 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.272 2.648 . . . . 0.0 113.197 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -89.12 -0.29 57.31 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.538 0.335 . . . . 0.0 111.591 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 56.9 tp -117.34 -19.56 9.51 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.366 0.666 . . . . 0.0 110.515 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.6 p -96.73 -4.14 41.21 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.016 0.526 . . . . 0.0 111.441 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.41 171.07 54.88 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -141.32 10.04 2.09 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.065 0.546 . . . . 0.0 111.927 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.305 -1.831 . . . . 0.0 110.824 -179.189 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -143.47 159.44 42.4 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.007 0.523 . . . . 0.0 110.229 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.3 tp -64.31 155.81 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.324 0.65 . . . . 0.0 110.659 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.0 p -68.88 159.25 32.92 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.695 0.398 . . . . 0.0 111.001 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 45.69 55.21 14.74 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.606 0.762 . . . . 0.0 110.843 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.0 164.8 34.5 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.335 2.69 . . . . 0.0 111.46 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.69 5.35 0.02 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.743 -0.476 . . . . 0.0 112.286 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -148.0 153.94 39.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.891 0.845 . . . . 0.0 110.467 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.1 t 61.97 151.31 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.658 1.583 . . . . 0.0 113.409 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.4 p30 45.64 22.88 0.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.818 1.647 . . . . 0.0 113.764 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.4 t70 57.05 13.05 1.41 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.472 1.109 . . . . 0.0 113.251 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 50.0 m 53.24 20.27 1.81 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.902 1.281 . . . . 0.0 114.078 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.31 164.63 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.021 1.329 . . . . 0.0 113.668 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 57.42 -178.29 0.06 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.758 1.223 . . . . 0.0 112.582 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.7 t -136.68 -93.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 122.621 0.368 . . . . 0.0 110.518 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -154.65 169.82 22.98 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.293 0.637 . . . . 0.0 110.76 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.0 p -82.96 10.13 8.59 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.5 t -109.43 136.56 44.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 122.815 0.446 . . . . 0.0 110.611 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.5 mt -125.1 161.43 26.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.754 0.788 . . . . 0.0 111.373 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.0 tp -126.17 131.44 52.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.035 1.334 . . . . 0.0 107.51 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -118.09 145.16 45.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.69 0.796 . . . . 0.0 109.406 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.3 m -139.49 141.54 37.34 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.2 mp -105.7 135.3 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.4 mt -94.02 -36.55 12.08 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -173.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -129.87 62.78 65.68 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 123.368 0.667 . . . . 0.0 110.082 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.45 101.96 0.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.947 2.431 . . . . 0.0 110.717 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.0 pt -128.26 3.07 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.788 0.435 . . . . 0.0 111.402 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -131.67 166.47 21.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.855 0.862 . . . . 0.0 109.457 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.5 m -73.91 145.8 44.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.787 0.327 . . . . 0.0 111.32 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.5 mm -137.49 136.79 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.6 p -145.04 172.27 13.3 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.529 0.732 . . . . 0.0 109.636 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.9 p -63.77 -20.76 66.02 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 122.327 -0.233 . . . . 0.0 110.931 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -79.7 -27.37 40.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.326 0.25 . . . . 0.0 110.888 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.2 t -81.51 -37.64 15.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.66 -28.54 62.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.185 -0.322 . . . . 0.0 110.599 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -74.28 -37.96 63.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.991 -0.443 . . . . 0.0 111.044 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.7 t -74.11 -20.99 60.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.555 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.3 pt -88.85 -23.55 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.184 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 16.6 p -109.69 -6.83 15.2 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.16 -42.79 87.82 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.483 -0.77 . . . . 0.0 112.562 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 94.4 Cg_endo -72.85 -7.02 20.07 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.805 1.67 . . . . 0.0 112.089 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 65.7 m -86.02 -21.86 27.57 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.062 0.392 . . . . 0.0 111.213 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.8 176.7 32.17 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.77 107.83 1.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.975 3.117 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.09 149.47 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -112.61 -39.05 4.44 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.474 0.31 . . . . 0.0 111.003 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -167.18 161.75 14.72 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 117.967 0.349 . . . . 0.0 111.911 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.4 mt -143.07 139.76 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.205 1.002 . . . . 0.0 109.145 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.17 157.8 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.8 mt -128.92 151.78 36.17 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.053 0 C-N-CA 122.875 0.47 . . . . 0.0 111.014 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -138.97 145.1 39.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.781 0.833 . . . . 0.0 109.574 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.85 15.48 2.3 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -79.22 -9.21 59.51 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.067 0.547 . . . . 0.0 111.613 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -135.06 12.75 3.6 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.219 0.608 . . . . 0.0 112.125 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 137.71 -128.99 4.47 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 108.926 -1.669 . . . . 0.0 108.926 -174.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.5 t -133.87 112.79 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -144.84 163.69 33.32 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 122.832 0.453 . . . . 0.0 110.303 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.55 172.14 17.04 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.418 0.287 . . . . 0.0 110.58 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 85.0 mtp -141.39 152.41 44.31 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 46.5 t -139.73 149.86 22.36 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.032 0 C-N-CA 123.02 0.528 . . . . 0.0 109.607 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -132.91 140.48 47.89 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -117.33 169.07 9.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.045 0.938 . . . . 0.0 110.974 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.56 -11.15 59.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.061 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.9 t -150.59 149.65 30.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.211 0.604 . . . . 0.0 110.111 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.45 -26.37 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -70.94 -23.63 62.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.961 -0.462 . . . . 0.0 110.316 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.9 m -80.11 -28.31 39.02 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.22 -27.86 42.5 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.519 0.199 . . . . 0.0 110.793 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -67.26 -36.02 80.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -82.47 -27.09 32.06 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.73 0.412 . . . . 0.0 111.698 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.16 -44.16 72.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.06 -0.4 . . . . 0.0 110.399 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -27.94 64.81 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -77.66 -8.53 58.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.819 -0.551 . . . . 0.0 111.712 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.6 m -121.07 -5.5 9.51 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.45 -8.75 2.53 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -74.57 131.15 40.72 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.735 1.152 . . . . 0.0 108.845 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 71.88 6.17 63.05 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.386 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.33 -179.06 7.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.83 0.815 . . . . 0.0 111.387 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -140.28 163.15 33.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.897 0.879 . . . . 0.0 109.456 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.0 mt -114.89 -17.4 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -125.24 31.14 5.65 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.022 -0.424 . . . . 0.0 112.051 -175.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.0 m 56.69 16.66 2.73 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.808 0.843 . . . . 0.0 112.346 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 165.77 148.77 5.64 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 82.7 m 54.72 -177.42 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.922 0.889 . . . . 0.0 111.922 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 79.8 m 49.36 32.71 4.73 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.094 0.558 . . . . 0.0 111.182 -174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.7 m -59.94 139.22 57.54 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.044 0.538 . . . . 0.0 109.896 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 64.9 mt -93.71 154.64 17.68 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.433 0.693 . . . . 0.0 111.799 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -144.06 123.1 12.83 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.6 mt -123.82 145.53 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-O 120.98 0.419 . . . . 0.0 111.575 -173.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -155.02 172.68 17.71 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.818 1.247 . . . . 0.0 108.498 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -85.81 147.25 26.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.11 -0.369 . . . . 0.0 110.858 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -95.7 165.74 12.16 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.657 0.383 . . . . 0.0 110.816 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -80.72 -27.17 0.45 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 47.6 Cg_endo -80.66 160.44 21.91 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 CA-C-N 121.965 1.738 . . . . 0.0 110.047 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 43.0 p -89.87 -10.44 45.29 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.6 0.36 . . . . 0.0 111.257 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 168.73 26.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.612 0.765 . . . . 0.0 110.074 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -119.93 172.69 7.55 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.093 0.957 . . . . 0.0 109.691 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -134.28 154.64 51.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.292 -0.255 . . . . 0.0 110.404 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 70.7 t -136.77 150.52 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.747 0.819 . . . . 0.0 108.885 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -122.75 -20.56 5.87 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.482 0.313 . . . . 0.0 111.358 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -165.23 169.98 15.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.176 0.99 . . . . 0.0 109.414 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -116.47 116.37 27.54 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.023 0.44 . . . . 0.0 110.519 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -159.87 -172.54 3.69 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.338 1.455 . . . . 0.0 109.384 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.75 -1.32 11.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.46 -19.93 8.64 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.622 0.646 . . . . 0.0 111.944 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 2.8 t -153.68 137.11 15.84 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -153.84 149.44 27.37 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.221 -0.299 . . . . 0.0 111.394 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -128.34 138.07 52.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.275 0.63 . . . . 0.0 109.62 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -115.9 6.93 14.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.582 0.753 . . . . 0.0 112.461 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t -122.7 -9.55 8.38 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.843 0.457 . . . . 0.0 111.163 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -70.13 126.14 92.27 Favored Pre-proline 0 N--CA 1.452 -0.336 0 C-N-CA 123.895 0.878 . . . . 0.0 109.089 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.99 -6.09 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.859 3.04 . . . . 0.0 113.578 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -114.4 19.92 15.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.704 0.802 . . . . 0.0 111.567 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -63.82 -6.27 5.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -134.67 17.18 3.6 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.589 0.756 . . . . 0.0 110.961 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 78.07 -170.38 54.88 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -129.06 6.48 5.42 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.596 0.758 . . . . 0.0 111.14 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.21 0 CA-C-O 117.372 -1.793 . . . . 0.0 110.883 -179.721 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 120.392 0.139 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -85.23 162.16 19.28 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.755 0.422 . . . . 0.0 109.98 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.25 151.61 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 122.396 0.278 . . . . 0.0 110.61 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.3 m -76.62 -2.35 32.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.003 0.521 . . . . 0.0 112.396 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -139.74 76.26 29.63 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.92 -5.3 16.62 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.733 2.955 . . . . 0.0 112.041 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.52 -5.9 86.29 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -148.85 150.15 32.52 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.697 0.749 . . . . 0.0 110.045 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 42.3 m 53.78 -167.94 0.07 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.451 0.701 . . . . 0.0 112.326 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.5 t0 59.64 172.4 0.08 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.275 1.03 . . . . 0.0 112.253 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 27.4 t70 51.75 35.34 14.99 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.07 0.548 . . . . 0.0 111.422 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 66.7 p 53.06 20.81 1.86 Allowed 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.937 1.295 . . . . 0.0 113.214 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 53.03 29.96 8.79 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.409 1.083 . . . . 0.0 111.652 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 44.9 t -63.33 143.89 57.42 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.136 0.574 . . . . 0.0 111.349 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.07 -45.81 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.783 0.433 . . . . 0.0 110.329 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -164.49 166.21 20.65 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.429 0.692 . . . . 0.0 110.486 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.2 p -99.61 18.87 16.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.483 0.713 . . . . 0.0 111.955 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.6 143.92 33.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 C-N-CA 123.003 0.521 . . . . 0.0 110.696 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.5 mt -129.68 163.24 26.55 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.149 0.58 . . . . 0.0 111.365 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.3 tp -121.2 133.68 55.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.989 1.316 . . . . 0.0 108.054 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -119.61 145.58 46.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.521 0.728 . . . . 0.0 109.738 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.6 m -140.62 144.49 35.8 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.5 mp -107.68 135.25 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 70.1 mt -91.77 -35.67 13.99 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -130.79 61.71 61.0 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 123.575 0.75 . . . . 0.0 110.184 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.98 101.79 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.78 2.32 . . . . 0.0 110.784 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.0 pt -125.72 0.22 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.95 0.5 . . . . 0.0 111.339 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.13 166.47 21.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.711 0.804 . . . . 0.0 109.264 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.5 m -73.53 151.68 40.9 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.81 0.338 . . . . 0.0 111.563 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.5 mm -138.71 135.24 43.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 68.4 p -146.46 176.35 9.87 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.149 0.58 . . . . 0.0 110.1 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.2 p -62.38 -25.55 67.98 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 122.435 0.294 . . . . 0.0 111.209 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -80.54 -20.61 43.08 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.545 0.338 . . . . 0.0 111.461 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 88.6 t -90.56 -37.82 9.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.4 mt -77.31 -22.53 51.81 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.254 -0.279 . . . . 0.0 110.715 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -78.8 -36.1 43.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.924 0.329 . . . . 0.0 110.903 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.9 t -77.0 -17.31 58.93 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.996 -0.44 . . . . 0.0 111.395 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.41 -17.57 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.913 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 88.8 m -95.7 -25.3 16.16 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.91 0.777 . . . . 0.0 111.859 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.487 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.2 t-20 -59.71 -42.2 90.1 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 83.6 Cg_endo -71.1 -4.54 15.1 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.962 1.775 . . . . 0.0 112.1 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 72.4 m -107.52 -11.68 15.43 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.223 0.465 . . . . 0.0 111.335 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.7 165.05 15.87 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.42 114.39 3.79 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.897 3.064 . . . . 0.0 110.67 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.2 t -86.56 151.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -113.34 -36.39 5.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.162 0.585 . . . . 0.0 110.554 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.2 ptp85 -164.04 159.88 21.08 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 49.8 mt -144.49 145.79 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.361 1.064 . . . . 0.0 109.92 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.37 150.39 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 C-N-CA 123.265 0.626 . . . . 0.0 109.45 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.28 151.06 32.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 C-N-CA 123.077 0.551 . . . . 0.0 110.872 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -128.93 137.65 51.53 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -140.05 23.41 2.4 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -118.77 142.32 47.81 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 35.7 m120 53.05 20.29 1.67 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.924 0.89 . . . . 0.0 112.474 -174.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 145.89 -171.88 26.72 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.45 125.06 42.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 117.348 0.574 . . . . 0.0 109.517 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -148.58 168.97 21.38 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.932 0.893 . . . . 0.0 109.529 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.77 170.15 23.11 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.9 mtp -138.49 151.52 47.45 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 43.7 t -138.4 149.49 24.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 C-N-CA 122.645 0.378 . . . . 0.0 110.424 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -132.43 138.88 47.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.728 0.811 . . . . 0.0 109.147 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -117.04 167.85 10.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.445 0.698 . . . . 0.0 110.797 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -75.99 -15.37 60.16 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.237 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.6 t -152.23 153.49 33.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.241 0.616 . . . . 0.0 110.057 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.89 -27.08 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -68.17 -24.13 64.94 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.926 -0.484 . . . . 0.0 109.854 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.9 m -81.47 -27.9 34.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.424 0.29 . . . . 0.0 110.395 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.15 -25.21 37.03 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -70.02 -37.5 75.64 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -77.49 -26.6 51.41 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 122.277 -0.265 . . . . 0.0 110.494 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.55 -53.59 39.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.951 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.26 -14.34 60.13 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.622 0.647 . . . . 0.0 111.976 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.85 -12.67 55.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.1 -0.375 . . . . 0.0 111.855 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.0 m -129.67 1.72 4.95 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 77.0 mt -128.46 -4.27 5.41 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.65 0.659 . . . . 0.0 112.717 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -78.78 132.04 36.75 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.6 4.51 70.51 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.016 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.74 177.59 8.54 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.634 0.717 . . . . 0.0 110.866 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -140.39 161.18 38.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.466 0.706 . . . . 0.0 109.287 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.8 mt -115.81 -15.57 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -122.24 28.32 7.53 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.898 -0.501 . . . . 0.0 112.222 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 25.5 m 57.64 14.75 2.52 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.043 0.937 . . . . 0.0 112.247 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 168.44 148.79 5.87 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 65.0 m 54.63 -176.31 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.665 0.786 . . . . 0.0 111.862 -176.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.4 m 50.09 31.74 5.22 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.915 0.486 . . . . 0.0 111.438 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 16.7 m -59.55 138.22 57.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.78 0.432 . . . . 0.0 110.081 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 62.6 mt -91.68 156.78 17.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.322 0.649 . . . . 0.0 112.053 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -140.76 137.91 33.75 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 77.7 mt -133.82 141.62 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.135 0.493 . . . . 0.0 111.489 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.75 167.94 27.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.782 1.233 . . . . 0.0 108.232 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -78.41 144.55 35.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.808 -0.558 . . . . 0.0 110.812 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.87 165.68 17.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.508 0.323 . . . . 0.0 110.265 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -81.06 -27.24 0.45 Allowed Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -176.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 46.2 Cg_endo -81.67 178.34 6.67 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.838 1.692 . . . . 0.0 109.913 177.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 69.2 p -105.09 -9.0 18.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.432 0.293 . . . . 0.0 111.089 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.92 168.03 27.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.835 0.854 . . . . 0.0 109.976 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 94.4 mt -127.11 170.43 12.36 Favored 'General case' 0 N--CA 1.459 0.014 0 C-N-CA 123.659 0.784 . . . . 0.0 109.817 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -138.76 163.85 31.1 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.397 0.618 . . . . 0.0 111.673 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 38.7 t -140.51 156.2 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 124.695 1.198 . . . . 0.0 108.555 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -125.61 -21.92 4.37 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.504 0.322 . . . . 0.0 111.678 -174.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -163.6 169.1 19.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.381 1.072 . . . . 0.0 108.91 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -115.71 110.01 18.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.121 0.486 . . . . 0.0 110.438 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -155.32 -170.24 3.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.009 1.323 . . . . 0.0 109.335 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -72.67 -2.51 20.44 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -119.6 -15.82 8.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.893 0.77 . . . . 0.0 112.006 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.7 t -154.76 135.01 13.2 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -157.96 145.25 18.18 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.266 -0.271 . . . . 0.0 110.871 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -129.19 141.14 51.24 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.575 0.703 . . . . 0.0 111.311 171.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -108.58 -9.81 15.29 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.558 0.743 . . . . 0.0 111.816 -174.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.3 t -89.82 1.9 55.59 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.089 0.556 . . . . 0.0 110.23 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -78.99 123.03 85.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.57 1.148 . . . . 0.0 110.083 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.67 -14.56 24.53 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.486 2.791 . . . . 0.0 112.27 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -107.82 -8.86 15.88 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.815 0.446 . . . . 0.0 110.99 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 14.8 tp 49.12 26.94 1.58 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.459 1.104 . . . . 0.0 111.979 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.6 m -138.63 162.72 33.92 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.526 0.73 . . . . 0.0 110.898 -176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.07 175.88 47.51 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 116.609 -0.269 . . . . 0.0 112.554 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -87.04 1.44 52.9 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.824 0.449 . . . . 0.0 112.09 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 CA-C-O 117.195 -1.892 . . . . 0.0 110.617 -179.223 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -147.29 165.02 31.37 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.2 tp -60.57 153.63 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.317 0.647 . . . . 0.0 110.412 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 76.9 p -71.97 -7.32 48.01 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.428 0.691 . . . . 0.0 112.701 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -144.07 85.38 9.0 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.557 0.743 . . . . 0.0 109.477 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.49 -13.38 18.42 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.485 2.79 . . . . 0.0 111.219 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.78 178.65 53.91 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.336 -0.705 . . . . 0.0 111.336 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -148.0 155.49 41.59 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 122.851 0.46 . . . . 0.0 110.31 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.3 p 54.9 -178.57 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.668 1.587 . . . . 0.0 113.564 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.6 t70 62.92 -23.07 0.05 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.197 1.799 . . . . 0.0 114.775 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.0 t0 48.8 27.65 1.64 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.576 1.15 . . . . 0.0 113.125 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 31.7 m 56.55 11.93 0.97 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.478 1.111 . . . . 0.0 113.299 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 54.66 -177.42 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 125.207 1.403 . . . . 0.0 113.361 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 47.5 t -151.97 149.63 29.12 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 123.944 0.898 . . . . 0.0 108.963 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.83 -44.93 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -164.25 169.65 17.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.392 0.542 . . . . 0.0 111.214 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.7 p -97.76 15.89 22.3 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.809 0.843 . . . . 0.0 111.021 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.08 138.74 38.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 C-N-CA 123.615 0.766 . . . . 0.0 110.703 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.0 mt -127.35 159.91 32.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.298 0.57 . . . . 0.0 111.54 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.9 tp -124.2 130.51 52.66 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.017 1.327 . . . . 0.0 107.764 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -115.1 145.03 42.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.401 0.68 . . . . 0.0 109.684 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 98.9 m -139.44 144.38 38.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.4 mp -107.17 136.94 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 75.4 mt -93.77 -34.87 13.03 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -130.09 63.15 67.83 Favored Pre-proline 0 CA--C 1.528 0.114 0 C-N-CA 123.162 0.585 . . . . 0.0 109.951 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.58 101.71 0.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.766 2.31 . . . . 0.0 110.881 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.58 2.5 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 122.774 0.429 . . . . 0.0 111.29 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -134.98 166.89 21.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.814 0.845 . . . . 0.0 109.314 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 33.1 t -78.54 151.44 32.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.794 0.331 . . . . 0.0 110.975 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.1 mm -136.83 137.16 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.6 p -143.52 176.72 8.97 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 123.148 0.579 . . . . 0.0 110.053 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.1 p -62.34 -23.25 66.66 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.696 0.399 . . . . 0.0 111.195 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -82.2 -23.75 35.27 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.84 0.291 . . . . 0.0 111.274 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 83.6 t -83.97 -37.64 13.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.84 -21.52 47.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.039 -0.413 . . . . 0.0 110.848 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -77.6 -34.39 53.51 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.171 0.441 . . . . 0.0 110.848 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.3 t -76.91 -22.34 53.51 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.268 0.485 . . . . 0.0 111.354 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.2 pt -90.18 -22.44 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.491 0.587 . . . . 0.0 111.791 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.4 m -94.66 -23.07 17.76 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.439 0.563 . . . . 0.0 112.013 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.3 t-20 -59.75 -44.57 97.54 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 97.2 Cg_endo -72.77 -10.11 24.59 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.863 1.708 . . . . 0.0 111.803 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 74.6 m -93.73 -20.92 19.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.32 0.509 . . . . 0.0 110.95 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 166.35 167.38 26.91 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.12 104.77 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.93 3.087 . . . . 0.0 110.763 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.4 t -78.42 152.0 5.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -115.0 -40.85 3.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.011 0.525 . . . . 0.0 110.828 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.412 HH22 ' CG1' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -163.96 159.51 20.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.53 0.605 . . . . 0.0 112.495 177.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 42.0 mt -142.07 150.64 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 124.104 0.962 . . . . 0.0 110.45 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.412 ' CG1' HH22 ' A' ' 220' ' ' ARG . 7.3 p -141.53 148.62 20.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 C-N-CA 123.739 0.816 . . . . 0.0 109.202 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 38.6 mm -115.54 148.67 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 124.035 0.934 . . . . 0.0 110.418 -174.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -139.09 132.39 29.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.46 21.92 0.93 Allowed 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -68.77 -20.11 64.35 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.186 -0.321 . . . . 0.0 110.607 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -154.81 121.57 5.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 61.73 -154.15 39.68 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 27.6 t -140.28 127.86 24.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -149.0 168.57 22.76 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.779 0.831 . . . . 0.0 110.094 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.8 167.73 29.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.026 0.531 . . . . 0.0 109.957 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.2 mtp -134.98 142.69 46.53 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.64 151.25 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.16 0.584 . . . . 0.0 110.237 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -135.17 140.79 45.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.44 0.696 . . . . 0.0 109.225 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -118.73 168.02 11.12 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.722 0.809 . . . . 0.0 110.996 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.47 -17.85 61.73 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.88 0.472 . . . . 0.0 111.564 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.0 p -152.37 160.08 43.34 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.626 0.371 . . . . 0.0 110.422 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.74 -28.26 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -64.83 -30.07 71.06 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.925 -0.485 . . . . 0.0 109.877 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 45.0 m -78.24 -28.77 47.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.211 0.204 . . . . 0.0 110.571 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.49 -26.03 38.45 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.212 -0.305 . . . . 0.0 110.639 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -70.56 -36.13 73.46 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -79.77 -24.98 41.15 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.278 -0.264 . . . . 0.0 110.497 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.84 -52.66 40.97 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.162 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -15.49 59.68 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.755 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -80.72 -13.95 58.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.912 0.324 . . . . 0.0 111.721 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.7 m -125.05 1.44 7.95 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.0 mt -129.18 -4.82 4.94 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -77.74 132.73 38.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.8 5.55 64.88 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.218 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.15 179.56 7.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.679 0.74 . . . . 0.0 111.007 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -139.64 163.08 33.53 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.278 0.631 . . . . 0.0 109.515 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.6 mt -115.69 -18.81 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -120.92 30.96 6.61 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 122.03 -0.419 . . . . 0.0 111.716 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.4 m 57.41 15.73 2.84 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.802 0.841 . . . . 0.0 112.139 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 165.58 150.0 6.09 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 81.9 m 55.02 -176.97 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.61 0.764 . . . . 0.0 111.854 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.8 m 49.93 32.75 5.83 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.973 0.509 . . . . 0.0 111.663 -175.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 14.6 m -59.67 138.81 57.63 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.746 0.418 . . . . 0.0 109.917 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 58.4 mt -92.62 155.47 17.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.276 0.631 . . . . 0.0 112.179 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -143.63 123.62 13.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 74.1 mt -123.78 146.3 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.248 0.547 . . . . 0.0 111.682 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.44 169.27 24.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.677 1.191 . . . . 0.0 108.732 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -78.44 145.53 35.01 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.008 -0.433 . . . . 0.0 110.599 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.86 167.85 15.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.328 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -80.06 -29.27 0.55 Allowed Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.8 Cg_endo -82.68 169.44 13.56 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 121.73 1.653 . . . . 0.0 110.093 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.0 p -99.57 -5.93 28.28 Favored 'General case' 0 C--O 1.23 0.062 0 O-C-N 122.388 -0.195 . . . . 0.0 110.998 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -152.85 157.04 40.13 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 123.836 0.854 . . . . 0.0 110.634 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 80.2 mt -121.99 175.37 6.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.186 0.994 . . . . 0.0 109.308 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -143.95 165.14 28.57 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.483 0.313 . . . . 0.0 110.926 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.2 t -137.6 157.98 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 124.398 1.079 . . . . 0.0 108.925 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -125.03 -31.36 3.12 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 122.263 -0.273 . . . . 0.0 110.923 -174.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.09 167.78 28.34 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.264 1.025 . . . . 0.0 109.291 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -107.66 118.59 37.15 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.121 0.486 . . . . 0.0 111.148 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.97 -171.64 3.47 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.063 1.345 . . . . 0.0 109.251 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -74.5 -3.69 32.3 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -107.67 -23.68 12.02 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.409 0.55 . . . . 0.0 111.115 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.1 t -158.07 141.08 14.95 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -150.71 151.26 32.16 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.304 -0.248 . . . . 0.0 110.873 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -129.18 135.99 49.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.222 0.609 . . . . 0.0 109.403 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.2 6.03 14.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.549 0.74 . . . . 0.0 112.211 -174.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.0 t -124.42 -9.44 7.47 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.993 0.517 . . . . 0.0 111.211 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 285' ' ' PRO . 56.0 t-20 -66.87 123.79 86.97 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 123.92 0.888 . . . . 0.0 109.445 176.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 284' ' ' ASN . 54.0 Cg_exo -57.3 -19.51 35.24 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.733 2.955 . . . . 0.0 113.424 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -84.95 -22.92 29.01 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.985 0.357 . . . . 0.0 111.01 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 17.0 tp 50.11 23.27 1.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.482 1.113 . . . . 0.0 112.517 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.1 p -146.02 -22.52 0.45 Allowed 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.616 -0.677 . . . . 0.0 112.568 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 154.85 176.68 27.36 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.255 0.479 . . . . 0.0 112.252 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -151.36 5.51 0.47 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.903 0.481 . . . . 0.0 112.007 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 CA-C-O 117.575 -1.68 . . . . 0.0 111.326 -179.873 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 179' ' ' PRO . 76.2 tttt -145.97 159.42 43.28 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.364 0.666 . . . . 0.0 109.412 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 tt -69.01 153.12 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.1 m -75.95 -1.14 24.17 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -136.5 65.76 56.15 Favored Pre-proline 0 C--N 1.339 0.123 0 C-N-CA 123.944 0.898 . . . . 0.0 109.479 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.457 ' HB3' ' HE2' ' A' ' 175' ' ' LYS . 87.4 Cg_endo -72.29 -18.44 26.63 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.763 2.975 . . . . 0.0 111.658 -175.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 75.13 -18.81 2.43 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.799 0.714 . . . . 0.0 113.051 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -155.27 159.69 40.22 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.002 0.901 . . . . 0.0 110.477 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 t 59.41 167.83 0.06 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.866 1.267 . . . . 0.0 113.696 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.6 p30 47.99 16.0 0.08 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.236 1.815 . . . . 0.0 114.463 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 186' ' ' ARG . 51.5 m-20 51.33 25.3 2.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.298 1.039 . . . . 0.0 112.513 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.0 m 61.87 -19.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.949 1.699 . . . . 0.0 113.993 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.408 ' H ' ' C ' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -162.58 145.55 11.15 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.706 0.684 . . . . 0.0 110.073 173.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 83.4 p -159.52 153.12 22.69 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.615 0.366 . . . . 0.0 110.301 176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 55.0 t -142.72 -67.45 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -163.99 165.0 22.97 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.11 0.964 . . . . 0.0 109.934 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.7 p -88.58 7.6 32.46 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.835 0.454 . . . . 0.0 111.415 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -104.54 138.51 28.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.552 0.741 . . . . 0.0 111.297 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.09 160.64 32.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.544 0.737 . . . . 0.0 111.507 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 64.4 tp -119.71 133.89 55.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.036 1.334 . . . . 0.0 107.862 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -120.12 147.33 45.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.492 0.717 . . . . 0.0 109.861 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 81.5 m -142.09 145.36 34.2 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.4 mp -109.51 135.91 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 64.8 mt -94.85 -28.73 15.07 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -136.15 68.17 62.62 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 123.911 0.884 . . . . 0.0 109.587 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.55 57.41 4.26 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.704 3.603 . . . . 0.0 112.425 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.87 -3.12 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 O-C-N 121.958 -0.464 . . . . 0.0 111.616 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -130.13 166.59 19.91 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.924 0.89 . . . . 0.0 109.442 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 m -74.8 148.52 40.26 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.939 0.399 . . . . 0.0 111.604 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.9 mm -137.73 138.3 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.3 p -145.47 174.98 10.67 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.208 0.603 . . . . 0.0 109.893 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 38.0 p -63.14 -21.24 66.06 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 122.314 -0.241 . . . . 0.0 111.099 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -81.94 -26.18 34.25 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.024 0.375 . . . . 0.0 111.048 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.06 -38.59 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 86.3 mt -76.95 -22.92 52.52 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.921 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -76.3 -36.14 58.5 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 117.96 0.346 . . . . 0.0 110.785 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.1 t -78.11 -18.68 55.36 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.14 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -95.84 -14.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 118.348 0.522 . . . . 0.0 112.028 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 78.3 m -98.21 -24.36 15.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.869 0.758 . . . . 0.0 112.25 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.469 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 48.6 t30 -64.18 -38.87 38.34 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 86.1 Cg_endo -73.66 -0.05 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.635 1.557 . . . . 0.0 112.159 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 80.6 m -112.62 -5.69 13.97 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.609 0.364 . . . . 0.0 111.625 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 158.8 164.39 14.26 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.98 106.39 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.852 3.035 . . . . 0.0 110.638 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.7 t -78.49 150.63 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -117.03 -36.5 3.79 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.643 0.377 . . . . 0.0 111.279 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -164.12 156.43 17.05 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.101 0.41 . . . . 0.0 111.792 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 40.5 mt -144.77 143.75 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.751 0.821 . . . . 0.0 109.761 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.7 m -138.76 155.97 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 123.359 0.663 . . . . 0.0 109.756 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.7 mm -116.55 153.28 18.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 123.569 0.747 . . . . 0.0 111.096 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -138.8 145.81 40.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.009 0.924 . . . . 0.0 109.533 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 19.07 1.84 Allowed 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -177.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -64.44 -27.05 68.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.485 0.314 . . . . 0.0 110.446 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -153.44 123.86 7.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 58.44 -144.9 42.71 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.0 t -130.74 129.32 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -142.91 166.62 24.15 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.374 0.67 . . . . 0.0 109.878 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.01 171.18 20.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.388 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.6 mtp -135.77 149.38 49.13 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 55.2 t -136.63 150.77 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -139.85 141.33 36.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -118.27 170.47 8.87 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.834 0.853 . . . . 0.0 110.849 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.63 -13.16 59.98 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.549 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 46.1 t -150.53 153.56 36.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.677 0.391 . . . . 0.0 110.416 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.17 -26.5 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -71.04 -24.04 62.27 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 22.5 m -81.34 -27.43 34.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.22 -25.1 36.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.416 0.286 . . . . 0.0 110.457 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -70.56 -37.49 74.01 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -74.93 -29.33 60.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.315 0.246 . . . . 0.0 110.689 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.49 -52.44 45.97 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 119.733 -0.175 . . . . 0.0 111.268 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.41 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.76 -12.6 59.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.845 -179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.52 -10.22 52.32 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.822 0.283 . . . . 0.0 111.601 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 21.4 m -126.33 -1.78 6.93 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.7 mt -130.62 -5.36 4.14 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -78.14 132.71 37.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.38 6.9 71.39 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.46 174.94 11.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.672 0.736 . . . . 0.0 111.061 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -132.65 149.75 52.26 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.1 0.96 . . . . 0.0 108.763 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.4 mt -102.0 -17.63 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 117.433 0.106 . . . . 0.0 111.219 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.74 25.63 8.01 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.025 -0.422 . . . . 0.0 111.447 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 31.8 m 56.0 16.51 2.2 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.095 0.958 . . . . 0.0 112.476 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.98 141.56 3.88 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 85.2 m 54.13 -176.56 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.914 0.885 . . . . 0.0 112.014 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.1 m 51.01 33.08 8.37 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.977 0.511 . . . . 0.0 111.133 -174.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 18.7 m -60.13 139.8 57.29 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.991 0.516 . . . . 0.0 110.223 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 54.3 mt -96.79 156.9 16.15 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.111 0.564 . . . . 0.0 112.282 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -140.52 137.71 34.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 171.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 71.7 mt -136.0 142.33 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.082 0.467 . . . . 0.0 111.308 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.72 167.3 30.07 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.563 1.145 . . . . 0.0 108.54 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -79.01 141.49 37.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.803 -0.561 . . . . 0.0 110.684 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.67 167.9 14.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.423 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -81.26 -27.89 0.46 Allowed Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.2 Cg_endo -82.15 166.86 16.26 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 CA-C-N 121.913 1.719 . . . . 0.0 110.138 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.1 p -99.87 -5.32 28.62 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 122.332 0.253 . . . . 0.0 111.025 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -154.76 151.95 29.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.088 0.955 . . . . 0.0 109.92 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.46 171.41 7.53 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.779 0.832 . . . . 0.0 109.398 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -138.92 159.3 42.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.961 0.504 . . . . 0.0 109.893 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.94 154.02 35.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.912 0.885 . . . . 0.0 109.006 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -123.15 -21.71 5.35 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.672 0.389 . . . . 0.0 111.771 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -166.93 173.11 9.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.311 1.044 . . . . 0.0 109.695 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -116.48 113.51 22.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.073 0.463 . . . . 0.0 110.473 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -157.53 -174.38 4.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.204 1.401 . . . . 0.0 109.243 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -69.79 -4.15 18.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -117.24 -11.76 10.61 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.713 0.688 . . . . 0.0 112.031 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.2 t -158.55 134.25 8.88 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -152.65 150.73 29.79 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 122.087 -0.383 . . . . 0.0 111.055 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -123.24 137.45 54.87 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.247 0.619 . . . . 0.0 109.743 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -119.33 15.95 13.05 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.487 0.715 . . . . 0.0 112.091 -174.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t -135.6 -10.69 2.12 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -77.45 162.0 70.36 Favored Pre-proline 0 CA--C 1.535 0.369 0 O-C-N 121.803 -0.561 . . . . 0.0 110.36 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.37 -7.32 10.15 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.58 2.853 . . . . 0.0 113.714 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -115.92 23.9 11.89 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.755 0.822 . . . . 0.0 111.451 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.08 -4.9 5.36 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 45.4 m -118.13 13.09 13.75 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.628 0.771 . . . . 0.0 110.716 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -135.53 -164.47 10.38 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -76.46 2.24 14.26 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 116.991 -2.005 . . . . 0.0 111.473 -179.764 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 110.71 -0.107 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -142.0 166.76 23.82 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.484 0.714 . . . . 0.0 111.078 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 19.5 tt -141.83 165.89 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.865 1.266 . . . . 0.0 108.86 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 80.8 p -75.91 -1.28 24.72 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -142.57 64.87 16.41 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.355 0.662 . . . . 0.0 109.762 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.96 -15.39 18.72 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.683 2.922 . . . . 0.0 111.893 -174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.58 -155.46 26.78 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -75.77 176.36 7.84 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.296 0.638 . . . . 0.0 110.932 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.0 m 61.07 178.26 0.11 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.174 0.989 . . . . 0.0 112.828 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 55.74 15.52 1.64 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.401 1.08 . . . . 0.0 112.907 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.2 t70 54.35 12.11 0.47 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.13 1.372 . . . . 0.0 113.722 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 93.8 p 40.97 -127.85 0.47 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.401 1.08 . . . . 0.0 111.977 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -139.99 138.21 35.3 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.5 0.72 . . . . 0.0 109.419 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 63.6 m 57.86 169.71 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.808 1.243 . . . . 0.0 113.521 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.31 -41.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 119.251 -0.404 . . . . 0.0 111.527 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -164.21 163.15 22.91 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.565 0.62 . . . . 0.0 111.194 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -90.12 18.08 6.29 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.565 0.746 . . . . 0.0 111.243 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.1 t -116.62 139.62 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.423 0.689 . . . . 0.0 110.325 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.2 mt -128.59 161.86 28.62 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.353 0.597 . . . . 0.0 110.621 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 tt -129.68 136.35 49.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -117.02 148.49 41.44 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.191 0.996 . . . . 0.0 109.903 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 89.8 m -133.28 141.16 47.86 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.4 mp -107.21 138.84 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 53.3 mt -108.06 -22.59 12.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -131.47 63.27 69.01 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 123.499 0.719 . . . . 0.0 109.777 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.92 40.04 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 125.104 3.869 . . . . 0.0 112.87 -173.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.4 pt -75.95 -2.91 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.6 -0.688 . . . . 0.0 111.531 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -130.4 165.22 23.02 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.987 0.915 . . . . 0.0 109.516 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 32.4 t -74.74 148.77 40.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.623 0.249 . . . . 0.0 111.487 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.7 mm -137.28 136.48 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 124.462 1.105 . . . . 0.0 108.175 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.0 p -143.97 176.88 8.95 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.138 0.575 . . . . 0.0 109.967 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.2 p -61.92 -22.68 65.8 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.569 0.348 . . . . 0.0 111.011 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.95 -24.61 35.45 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.48 0.312 . . . . 0.0 110.793 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.5 t -83.99 -37.6 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.95 -22.55 53.1 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.656 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -75.8 -36.92 59.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.196 0.453 . . . . 0.0 110.675 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 t -77.93 -18.7 55.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.396 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.94 -15.15 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.894 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.6 m -96.91 -25.42 15.43 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.741 0.701 . . . . 0.0 111.826 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.499 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 25.5 t-20 -58.75 -42.57 94.95 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 79.9 Cg_endo -71.26 -2.42 11.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.183 1.922 . . . . 0.0 112.379 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 83.7 m -115.03 -4.75 12.5 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.153 0.433 . . . . 0.0 111.642 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 158.86 158.68 9.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.76 114.59 3.75 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.674 2.916 . . . . 0.0 110.634 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.7 t -85.68 149.39 4.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -112.58 -34.74 5.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.893 0.477 . . . . 0.0 110.943 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -165.36 160.41 18.11 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 111.945 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 41.6 mt -143.48 147.43 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 124.256 1.023 . . . . 0.0 109.487 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.98 145.04 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.062 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.5 mm -112.76 151.61 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 123.754 0.822 . . . . 0.0 110.291 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -133.58 109.65 9.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -139.78 16.8 2.5 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.1 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -76.47 -27.78 56.27 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -150.68 136.81 18.47 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 59.61 -157.99 24.25 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.58 114.83 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 O-C-N 122.172 -0.605 . . . . 0.0 110.172 175.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -149.67 172.6 14.8 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.264 0.626 . . . . 0.0 110.611 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.65 168.56 26.76 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.62 0.768 . . . . 0.0 109.914 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 85.2 mtp -136.89 151.65 49.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.74 150.27 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.048 0.539 . . . . 0.0 110.062 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -133.08 139.53 47.19 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -114.04 167.38 10.71 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.777 0.831 . . . . 0.0 111.299 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -75.2 -14.13 60.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.9 t -152.06 151.49 31.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.017 0.527 . . . . 0.0 110.08 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.4 p -69.12 -24.05 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -70.41 -24.81 62.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 26.3 m -81.54 -25.38 35.92 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.738 0.415 . . . . 0.0 110.612 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.46 -26.4 35.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.64 -36.9 76.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -77.64 -29.33 51.66 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.31 -52.24 55.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 119.647 -0.216 . . . . 0.0 110.97 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.422 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.99 -15.07 59.75 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.628 0.649 . . . . 0.0 112.209 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -82.53 -12.7 57.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.986 0.357 . . . . 0.0 111.814 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -128.51 2.53 5.59 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 73.2 mt -129.59 -3.61 4.78 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.791 0.723 . . . . 0.0 112.491 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -78.5 131.53 36.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.24 3.63 76.85 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.75 179.95 5.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 117.762 0.781 . . . . 0.0 110.7 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.78 162.34 35.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.434 0.694 . . . . 0.0 109.181 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 38.3 mt -114.77 -20.09 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 111.227 0.084 . . . . 0.0 111.227 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -137.6 73.99 1.46 Allowed 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.048 -0.407 . . . . 0.0 111.498 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 25.0 m 49.2 48.37 21.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 95.28 0.07 63.47 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.257 0.456 . . . . 0.0 112.497 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 58.5 m -106.44 163.53 12.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 117.388 0.594 . . . . 0.0 109.67 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.8 m 51.94 41.45 29.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.022 0.529 . . . . 0.0 110.688 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.1 m -55.35 142.12 33.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.41 0.684 . . . . 0.0 109.795 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 61.0 mt -108.62 153.76 22.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.374 0.669 . . . . 0.0 112.022 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -140.26 135.0 31.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 171.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.422 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 79.4 mt -125.81 148.99 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 121.048 0.451 . . . . 0.0 111.435 -175.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.86 165.97 34.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.034 1.333 . . . . 0.0 108.421 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.73 139.95 38.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.834 -0.541 . . . . 0.0 110.231 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -75.36 167.18 22.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.897 0.479 . . . . 0.0 111.427 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -71.72 -54.78 6.09 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.164 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.66 164.59 31.88 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.336 2.024 . . . . 0.0 111.123 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.0 p -91.74 -6.47 51.86 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.712 0.405 . . . . 0.0 111.576 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.62 167.06 30.81 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.732 0.813 . . . . 0.0 109.878 176.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 86.2 mt -123.54 173.15 8.23 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.517 0.727 . . . . 0.0 109.863 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -136.19 154.53 50.92 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 91.9 t -136.37 153.12 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.876 0.871 . . . . 0.0 108.65 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -125.72 -18.78 5.09 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -166.06 172.56 11.24 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.931 1.292 . . . . 0.0 109.296 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -119.06 110.63 17.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.01 0.434 . . . . 0.0 110.46 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -154.62 -169.85 3.34 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.796 1.238 . . . . 0.0 109.773 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -70.18 -6.66 35.93 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -114.42 -15.25 12.1 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.782 0.719 . . . . 0.0 112.209 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.2 t -159.02 140.17 12.97 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -154.88 148.32 25.14 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.997 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -128.03 135.7 50.23 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -112.87 5.12 17.26 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.612 0.765 . . . . 0.0 112.031 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.0 t -125.63 -4.64 7.1 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.907 0.483 . . . . 0.0 111.55 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -65.92 120.56 70.13 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.613 0.765 . . . . 0.0 109.467 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.15 -17.34 38.23 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.583 2.855 . . . . 0.0 113.682 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -104.54 3.52 31.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.085 0.554 . . . . 0.0 111.573 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 18.4 tp 50.98 28.62 3.93 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.774 0.83 . . . . 0.0 111.339 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 17.3 m 54.98 20.03 2.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.208 1.003 . . . . 0.0 113.21 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -77.31 174.93 54.43 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -82.14 -15.19 54.21 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.499 -0.412 . . . . 0.0 110.688 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-O 117.139 -1.923 . . . . 0.0 111.695 179.676 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -145.9 162.11 38.49 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.131 0.573 . . . . 0.0 109.658 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.9 tp -61.7 157.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.049 0.54 . . . . 0.0 110.595 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 78.5 p -82.85 1.27 40.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.392 0.677 . . . . 0.0 112.753 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -133.37 56.98 23.58 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 123.496 0.718 . . . . 0.0 111.063 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.01 159.14 45.1 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.628 2.886 . . . . 0.0 110.582 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.29 1.01 84.11 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.858 -0.412 . . . . 0.0 112.133 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -153.53 176.6 11.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.646 0.723 . . . . 0.0 110.721 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 39.5 m 58.61 18.78 6.1 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.591 1.157 . . . . 0.0 114.079 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 47.04 79.14 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.593 1.157 . . . . 0.0 112.867 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 60.97 -0.74 0.29 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 51.0 m 48.82 -154.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.049 0.94 . . . . 0.0 112.342 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 60.48 -175.95 0.11 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.45 1.1 . . . . 0.0 112.177 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 83.4 p -141.49 173.53 11.41 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.799 0.839 . . . . 0.0 110.177 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.0 t -118.66 -77.44 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 O-C-N 122.143 -0.348 . . . . 0.0 111.314 -176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -156.33 163.48 39.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.126 0.57 . . . . 0.0 110.685 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 82.3 p -87.12 13.59 9.13 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.245 0.618 . . . . 0.0 111.842 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.4 t -109.01 138.63 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 122.91 0.484 . . . . 0.0 110.885 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.67 160.83 31.24 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 121.427 0.632 . . . . 0.0 111.459 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.7 tp -125.7 130.29 51.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.94 1.296 . . . . 0.0 108.222 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -115.56 146.91 41.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.566 0.746 . . . . 0.0 109.985 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.4 m -138.43 142.63 39.52 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.7 mp -106.8 136.46 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 73.1 mt -92.4 -34.46 14.14 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -134.02 68.25 74.35 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 123.406 0.682 . . . . 0.0 109.543 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -74.41 62.92 5.4 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.555 3.503 . . . . 0.0 112.427 -174.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 44.8 pt -84.66 -4.85 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 122.024 -0.422 . . . . 0.0 111.289 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -126.85 167.88 15.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.945 0.898 . . . . 0.0 109.27 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 78.1 p -83.26 154.15 24.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.015 0.436 . . . . 0.0 111.21 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.0 mm -136.91 138.3 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.1 p -143.97 176.1 9.54 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.044 0.538 . . . . 0.0 110.018 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.9 p -62.12 -27.47 68.95 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 122.542 0.337 . . . . 0.0 110.966 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -78.03 -20.34 52.65 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.431 0.292 . . . . 0.0 111.495 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.42 -40.68 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 88.5 mt -73.56 -30.67 63.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.175 -0.328 . . . . 0.0 110.924 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -68.87 -37.82 79.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.217 0.462 . . . . 0.0 110.921 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.8 t -78.58 -17.43 56.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.481 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.35 -9.73 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 18.2 p -119.69 -6.23 10.16 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.347 0.976 . . . . 0.0 113.136 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.498 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.6 t-20 -63.06 -41.12 68.24 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.496 -0.764 . . . . 0.0 113.054 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 96.3 Cg_endo -71.7 -3.03 12.32 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.794 1.663 . . . . 0.0 111.982 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.2 m -93.58 -8.47 41.11 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.096 0.407 . . . . 0.0 111.41 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 144.91 174.58 17.29 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.38 114.91 3.42 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.672 2.915 . . . . 0.0 110.953 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 96.9 t -87.06 150.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -113.9 -37.61 4.45 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -165.17 159.16 17.29 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.518 0.599 . . . . 0.0 112.287 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 48.7 mt -142.83 144.36 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.081 0.953 . . . . 0.0 109.677 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.408 ' C ' HD12 ' A' ' 223' ' ' ILE . 6.4 p -143.85 142.71 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 123.486 0.714 . . . . 0.0 109.487 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 222' ' ' VAL . 1.8 mp -109.83 150.37 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 123.799 0.84 . . . . 0.0 109.649 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -136.35 138.79 42.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.619 0.767 . . . . 0.0 109.905 176.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.25 22.76 0.84 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -73.66 -20.13 60.64 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.997 -0.439 . . . . 0.0 110.281 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -154.56 122.09 5.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 60.43 -153.7 35.61 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -173.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.0 t -138.08 124.38 26.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -147.23 169.79 18.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.473 0.709 . . . . 0.0 110.636 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.35 169.28 24.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.024 0.53 . . . . 0.0 109.731 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.0 mtp -137.96 151.71 48.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.1 t -139.3 151.1 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.075 0 C-N-CA 122.904 0.482 . . . . 0.0 109.884 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -135.41 141.65 45.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.457 0.703 . . . . 0.0 109.192 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -117.37 168.45 10.34 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.087 0.955 . . . . 0.0 110.761 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.88 -9.98 59.77 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.791 0.437 . . . . 0.0 110.889 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.1 t -150.17 147.67 28.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.103 0.561 . . . . 0.0 109.935 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 -23.3 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -73.2 -23.23 60.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.082 -0.386 . . . . 0.0 110.235 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 42.2 m -80.85 -28.12 36.2 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.82 -25.43 44.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -70.92 -37.96 72.93 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -74.96 -27.61 60.24 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.247 0.619 . . . . 0.0 110.965 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.32 -54.98 10.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.125 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -14.77 60.35 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.356 -177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -81.52 -16.62 51.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.118 0.417 . . . . 0.0 111.568 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -123.44 4.38 9.04 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 92.7 mt -121.65 -5.69 9.19 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.856 0.753 . . . . 0.0 112.559 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -74.79 129.93 38.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.943 0.792 . . . . 0.0 109.149 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.43 8.78 76.56 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.13 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.93 174.15 10.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.85 0.825 . . . . 0.0 111.333 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -137.71 145.26 42.33 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.66 0.784 . . . . 0.0 109.185 -177.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 51.8 mt -108.29 -19.11 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -126.11 22.34 7.28 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.91 -0.494 . . . . 0.0 111.776 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 25.6 m 55.95 20.88 4.52 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.509 0.724 . . . . 0.0 111.91 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 173.44 135.07 1.93 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 76.6 m 54.73 -173.36 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.232 1.013 . . . . 0.0 112.129 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m 52.58 31.62 10.35 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.815 0.446 . . . . 0.0 111.673 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 26.9 m -58.61 140.61 54.14 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.738 0.415 . . . . 0.0 109.948 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.4 mt -95.07 154.99 16.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.023 0.44 . . . . 0.0 112.014 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -145.65 134.7 22.67 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.34 150.42 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-O 120.993 0.425 . . . . 0.0 111.247 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -153.75 168.05 27.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.194 1.398 . . . . 0.0 108.364 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.85 144.0 32.33 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 121.74 -0.6 . . . . 0.0 110.994 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.03 170.3 10.46 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.413 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.7 pttt -86.0 -26.21 0.36 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -177.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 40.4 Cg_endo -82.23 164.63 17.11 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 121.881 1.707 . . . . 0.0 110.406 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 58.4 p -93.45 -9.04 39.88 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 122.265 -0.272 . . . . 0.0 111.564 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.39 168.48 27.21 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.746 0.818 . . . . 0.0 109.711 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 87.7 mt -120.6 170.74 9.13 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.369 0.668 . . . . 0.0 109.685 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -131.1 157.47 43.02 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.449 0.166 . . . . 0.0 110.667 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 87.0 t -137.85 153.93 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 124.08 0.952 . . . . 0.0 108.958 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -128.06 -14.66 4.91 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.294 0.238 . . . . 0.0 111.627 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -163.54 170.32 17.43 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.048 0.939 . . . . 0.0 109.237 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -119.33 99.65 6.83 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -152.96 -169.14 3.25 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.103 0.961 . . . . 0.0 110.102 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -72.27 -1.81 16.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.53 -31.39 8.54 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.183 0.593 . . . . 0.0 110.8 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.3 t -159.28 147.02 17.43 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -152.48 146.68 25.46 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.721 0.296 . . . . 0.0 110.705 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -121.28 134.3 55.16 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.956 0.502 . . . . 0.0 109.646 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.99 6.48 19.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.554 0.742 . . . . 0.0 112.449 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.9 t -125.8 0.27 7.38 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.15 0.58 . . . . 0.0 110.552 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 285' ' ' PRO . 60.8 t-20 -66.89 123.63 86.59 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.146 0.978 . . . . 0.0 109.661 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 284' ' ' ASN . 51.9 Cg_exo -58.69 -13.97 19.84 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.411 2.741 . . . . 0.0 113.727 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -87.67 0.15 56.08 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.0 tp -79.68 -22.7 43.14 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.929 0.331 . . . . 0.0 111.052 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.2 p -148.09 3.88 0.71 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.651 0.38 . . . . 0.0 111.992 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 78.81 170.36 38.03 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -142.82 8.17 1.69 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.758 0.423 . . . . 0.0 111.887 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 117.308 -1.829 . . . . 0.0 111.217 -179.51 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -138.07 168.9 18.75 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.274 0.63 . . . . 0.0 110.521 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 tt -69.27 162.12 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.396 0.678 . . . . 0.0 109.98 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.8 m -70.77 -1.52 11.81 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.0 ttp-105 -147.17 70.59 11.97 Favored Pre-proline 0 CA--C 1.53 0.184 0 C-N-CA 123.595 0.758 . . . . 0.0 109.05 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.13 -16.98 15.42 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.664 2.909 . . . . 0.0 112.301 -172.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.78 -5.33 24.61 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.887 -0.396 . . . . 0.0 112.958 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -152.29 150.31 29.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 117.749 0.774 . . . . 0.0 109.692 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.2 t 58.55 166.45 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.363 1.065 . . . . 0.0 111.974 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 48.97 37.13 9.64 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.288 0.635 . . . . 0.0 111.903 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 54.43 28.85 10.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.654 0.782 . . . . 0.0 112.246 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 55.5 p 57.41 11.84 1.29 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.858 1.663 . . . . 0.0 113.944 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 55.83 -177.92 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.976 1.31 . . . . 0.0 112.886 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 43.0 t -147.14 159.69 43.31 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.414 0.685 . . . . 0.0 109.881 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.54 -72.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.5 p30 -162.62 166.17 24.92 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.338 0.655 . . . . 0.0 110.28 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.9 p -97.46 8.62 44.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.372 0.669 . . . . 0.0 111.975 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.96 143.37 18.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 123.055 0.542 . . . . 0.0 110.86 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.0 mt -129.0 163.54 25.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.073 0.549 . . . . 0.0 111.663 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.7 tp -123.24 133.38 54.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.654 1.182 . . . . 0.0 108.179 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -120.24 143.62 48.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.675 0.79 . . . . 0.0 109.383 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 97.4 m -139.51 143.55 37.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.0 mp -106.35 135.38 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.8 mt -90.39 -36.52 14.56 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -131.93 64.27 71.84 Favored Pre-proline 0 CA--C 1.529 0.135 0 C-N-CA 123.379 0.672 . . . . 0.0 109.922 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.6 102.91 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.608 2.205 . . . . 0.0 111.135 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.4 pt -129.58 2.7 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 122.996 0.518 . . . . 0.0 111.401 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -130.6 169.58 15.42 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.791 0.836 . . . . 0.0 109.492 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.5 m -77.58 145.86 36.58 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.961 0.41 . . . . 0.0 111.063 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.5 mm -137.18 133.89 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 61.7 p -142.58 175.55 9.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.8 p -64.37 -20.48 66.15 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 122.296 0.239 . . . . 0.0 111.206 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.7 -25.34 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 122.283 0.233 . . . . 0.0 110.587 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.7 t -82.42 -36.87 13.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.7 -25.43 53.59 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.122 -0.362 . . . . 0.0 110.781 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -78.39 -34.5 48.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.023 -0.423 . . . . 0.0 111.057 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -74.9 -23.46 58.37 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.563 0.62 . . . . 0.0 111.389 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.6 pt -88.73 -23.17 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.176 0.444 . . . . 0.0 111.723 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.9 m -95.58 -20.15 19.22 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.618 0.645 . . . . 0.0 112.483 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.459 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.0 t-20 -61.41 -43.79 90.48 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 87.8 Cg_endo -73.94 -9.63 22.4 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.887 1.724 . . . . 0.0 111.651 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 82.3 m -91.98 -21.56 20.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.023 0.374 . . . . 0.0 111.207 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.15 172.45 30.65 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.57 105.14 1.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 124.122 3.215 . . . . 0.0 110.549 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 94.0 t -78.32 150.14 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -113.53 -41.09 3.69 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.778 0.431 . . . . 0.0 110.876 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.73 163.34 32.4 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.177 0.444 . . . . 0.0 111.472 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.43 146.9 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.534 0.734 . . . . 0.0 109.903 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.24 147.6 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 54.3 mt -133.15 151.44 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 123.348 0.659 . . . . 0.0 110.085 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -131.77 128.92 39.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -146.14 23.78 1.33 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -72.91 -29.36 63.08 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -151.62 127.97 10.62 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 60.57 -159.67 25.56 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -172.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.1 t -140.81 128.42 22.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.304 0.552 . . . . 0.0 109.627 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -146.38 163.26 36.16 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 123.608 0.763 . . . . 0.0 109.424 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.4 171.9 19.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.552 0.215 . . . . 0.0 110.876 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.1 mtp -142.28 150.38 40.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 49.0 t -139.25 151.37 23.04 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.987 0.515 . . . . 0.0 109.719 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -136.2 141.32 44.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.144 0.577 . . . . 0.0 109.497 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -116.31 168.84 9.78 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.905 0.882 . . . . 0.0 110.983 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.55 -14.16 60.76 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.831 0.452 . . . . 0.0 111.22 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 48.4 t -152.7 153.54 33.47 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.878 0.471 . . . . 0.0 110.378 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.09 -25.71 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.57 -29.4 68.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.012 0.369 . . . . 0.0 110.056 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 20.8 m -79.24 -27.58 42.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.541 0.336 . . . . 0.0 110.65 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.4 -27.45 38.1 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -68.01 -37.24 81.2 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -78.46 -25.68 45.9 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.344 0.257 . . . . 0.0 110.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.93 -55.39 17.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.343 0.257 . . . . 0.0 110.807 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -16.36 60.51 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.566 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -78.43 -14.65 59.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.189 0.45 . . . . 0.0 111.643 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 55.6 m -125.07 1.56 7.94 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.56 -5.17 4.72 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -78.22 132.79 37.7 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.917 0.781 . . . . 0.0 109.124 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.33 6.66 70.42 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.48 176.6 7.39 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.715 0.758 . . . . 0.0 111.343 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -139.6 151.07 45.72 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.707 0.803 . . . . 0.0 109.13 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.1 mt -114.63 -17.8 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 122.405 0.282 . . . . 0.0 111.296 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -127.96 25.1 5.96 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.059 -0.401 . . . . 0.0 111.567 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.3 p 53.3 19.41 1.55 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.119 1.368 . . . . 0.0 112.592 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 170.9 138.78 2.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 69.6 m 56.91 179.6 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.26 1.024 . . . . 0.0 112.107 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 72.3 m 52.94 30.36 9.18 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.772 0.429 . . . . 0.0 111.735 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 19.7 m -60.27 141.68 55.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.244 0.618 . . . . 0.0 109.87 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 52.9 mt -94.42 155.41 16.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -144.51 124.78 13.76 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.41 147.38 28.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 CA-C-O 121.163 0.506 . . . . 0.0 111.542 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.56 171.01 20.66 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.718 1.207 . . . . 0.0 108.762 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -80.99 143.98 32.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 122.051 -0.405 . . . . 0.0 110.45 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.3 167.2 15.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.319 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.44 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -83.46 -26.56 0.4 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -176.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 48.2 Cg_endo -80.95 -176.7 3.29 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.952 1.768 . . . . 0.0 109.9 176.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 67.2 p -117.77 -0.75 11.71 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.749 0.42 . . . . 0.0 110.89 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -155.16 146.05 22.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.912 0.885 . . . . 0.0 109.255 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.9 mt -112.35 167.55 10.34 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.246 0.619 . . . . 0.0 110.01 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -129.62 166.74 19.15 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.49 0.316 . . . . 0.0 110.813 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.73 155.71 22.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.223 1.009 . . . . 0.0 109.023 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -130.47 -16.74 3.41 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.368 0.267 . . . . 0.0 111.563 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -165.84 174.38 9.66 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.182 0.993 . . . . 0.0 109.516 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -120.35 96.69 5.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -148.35 -166.01 2.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.929 0.892 . . . . 0.0 110.126 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -73.36 -3.0 24.51 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -112.48 -21.88 11.11 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.813 0.733 . . . . 0.0 111.749 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.2 t -159.9 144.97 15.17 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -151.86 153.3 33.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.91 138.75 51.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 110.393 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -116.4 7.19 13.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.556 0.742 . . . . 0.0 112.331 -174.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.4 t -125.61 -4.04 7.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.875 0.47 . . . . 0.0 110.517 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -57.75 135.15 82.96 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 124.862 1.265 . . . . 0.0 108.878 174.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -62.15 -9.38 14.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.767 2.978 . . . . 0.0 114.289 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.93 11.03 30.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.151 0.887 . . . . 0.0 111.486 175.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.88 14.36 2.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.883 0.873 . . . . 0.0 110.204 178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 32.7 t -150.59 160.55 43.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.118 0.567 . . . . 0.0 110.082 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 67.83 -155.9 52.83 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.39 -13.97 60.43 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.863 0.465 . . . . 0.0 111.318 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.454 -1.748 . . . . 0.0 111.325 -179.51 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -83.88 -60.61 2.05 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.398 0.279 . . . . 0.0 110.509 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 32.6 pt -150.47 -177.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.416 1.486 . . . . 0.0 108.724 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 39.7 m -84.51 -3.13 58.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -149.45 52.2 1.07 Allowed Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.35 168.59 23.03 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.348 2.699 . . . . 0.0 111.074 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.35 -173.77 30.36 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -131.5 157.18 44.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.079 0.552 . . . . 0.0 110.734 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.9 p 58.85 159.26 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.043 1.737 . . . . 0.0 113.656 -175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.0 t70 48.92 -152.13 0.13 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.032 0.933 . . . . 0.0 110.938 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.6 t0 59.56 172.34 0.08 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.722 1.209 . . . . 0.0 113.655 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 94.1 p 48.62 28.48 1.81 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.466 1.506 . . . . 0.0 113.609 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -141.03 151.69 44.27 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.793 0.437 . . . . 0.0 110.962 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 40.7 t -155.08 149.52 26.22 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.153 0.581 . . . . 0.0 110.21 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 52.3 t -142.14 -75.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.048 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 -161.07 166.09 28.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.19 0.996 . . . . 0.0 110.081 176.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 85.8 p -86.31 13.97 7.29 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.147 0.579 . . . . 0.0 112.264 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.75 138.91 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 123.002 0.521 . . . . 0.0 110.712 -176.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.8 mt -129.56 162.45 28.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.416 0.627 . . . . 0.0 111.246 -177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.1 tp -122.43 133.09 54.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.935 1.294 . . . . 0.0 107.994 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -118.8 145.42 45.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.677 0.791 . . . . 0.0 109.827 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 96.2 m -136.19 141.75 44.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.9 mp -107.27 133.23 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 66.3 mt -92.69 -29.51 16.04 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -137.89 69.35 50.7 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 123.557 0.743 . . . . 0.0 109.586 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.4 56.16 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.529 3.486 . . . . 0.0 112.047 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.8 pt -81.04 -1.53 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 122.03 -0.419 . . . . 0.0 111.603 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -128.85 167.24 17.64 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.683 0.793 . . . . 0.0 109.685 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.1 m -75.84 149.78 37.8 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 111.539 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.4 mm -137.49 137.57 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 81.0 p -145.27 175.49 10.24 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.385 0.674 . . . . 0.0 109.782 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.2 p -63.64 -22.82 67.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 119.673 -0.203 . . . . 0.0 111.049 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -79.0 -23.87 44.09 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.298 0.239 . . . . 0.0 111.129 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 88.1 t -86.33 -39.11 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.92 -22.8 58.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.11 -0.369 . . . . 0.0 110.94 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -78.89 -36.11 42.6 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.885 0.311 . . . . 0.0 111.144 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.9 t -74.94 -20.47 59.67 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.89 -0.506 . . . . 0.0 111.327 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.2 pt -92.04 -21.54 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.7 m -97.85 -23.67 15.76 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.798 0.726 . . . . 0.0 112.899 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.48 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 51.1 t30 -65.21 -40.78 47.5 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 98.3 Cg_endo -72.91 -8.96 23.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.424 1.416 . . . . 0.0 111.684 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 77.5 m -97.81 -12.69 21.91 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.707 0.403 . . . . 0.0 111.17 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 161.65 162.06 12.57 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.28 110.73 2.09 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.654 2.903 . . . . 0.0 110.581 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.7 149.79 4.37 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -115.0 -34.75 4.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.847 0.459 . . . . 0.0 110.901 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -164.32 159.49 19.9 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.3 144.65 23.42 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 124.098 0.959 . . . . 0.0 109.644 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.02 142.96 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.288 0.635 . . . . 0.0 109.472 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.03 150.58 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.905 0.882 . . . . 0.0 109.756 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -136.64 147.88 47.14 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.019 0.928 . . . . 0.0 109.878 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.78 17.94 1.98 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.997 0.519 . . . . 0.0 112.28 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.62 -24.45 67.05 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 122.232 -0.292 . . . . 0.0 110.825 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -154.47 123.73 6.44 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 59.4 -144.1 45.82 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.7 t -134.31 127.32 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -145.81 168.23 21.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.99 0.516 . . . . 0.0 110.547 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.53 167.05 31.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.6 mtp -134.38 150.94 50.94 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.35 149.36 22.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.643 0.377 . . . . 0.0 110.194 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -131.52 140.73 49.58 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -116.27 167.91 10.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.872 0.869 . . . . 0.0 110.648 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -72.31 -18.84 61.75 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.686 0.394 . . . . 0.0 111.611 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 85.1 p -151.64 159.86 43.87 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.913 0.485 . . . . 0.0 110.473 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.7 -28.78 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 O-C-N 122.18 -0.325 . . . . 0.0 110.386 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -69.3 -25.07 64.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.035 0.38 . . . . 0.0 110.394 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 59.6 m -78.37 -29.39 47.39 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.45 -24.5 42.38 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.396 -0.19 . . . . 0.0 110.941 176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -70.86 -36.63 72.93 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -78.51 -27.16 46.04 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 122.153 -0.342 . . . . 0.0 110.578 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.39 -52.71 51.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.174 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.421 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.66 -17.37 60.0 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.838 0.744 . . . . 0.0 111.74 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -82.46 -9.61 59.36 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.934 0.334 . . . . 0.0 111.547 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.2 m -124.93 -2.3 7.75 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 79.9 mt -131.11 -4.58 3.91 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.697 0.68 . . . . 0.0 112.823 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -75.76 132.81 40.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 118.953 0.797 . . . . 0.0 109.13 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.78 5.24 68.68 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 119.794 -0.448 . . . . 0.0 112.331 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.93 175.44 10.04 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.712 0.756 . . . . 0.0 111.506 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -132.64 145.07 50.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.2 mt -92.12 -22.17 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 O-C-N 122.491 -0.131 . . . . 0.0 111.348 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -123.64 25.49 8.13 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.729 0.412 . . . . 0.0 111.591 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 37.9 m 55.98 17.27 2.52 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.938 0.895 . . . . 0.0 112.222 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.96 139.2 3.32 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 67.9 m 54.24 -177.16 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.691 0.796 . . . . 0.0 111.804 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m 51.07 33.79 9.77 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.002 -0.436 . . . . 0.0 111.183 -174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 25.2 m -59.89 142.95 52.66 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 122.821 0.448 . . . . 0.0 110.043 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 56.1 mt -103.53 157.33 17.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.259 0.552 . . . . 0.0 112.232 -174.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -144.36 134.68 24.42 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.421 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 88.0 mt -127.96 148.96 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.306 0.574 . . . . 0.0 111.543 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.08 171.37 20.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.969 1.308 . . . . 0.0 108.374 172.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -84.14 144.35 29.07 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.943 -0.473 . . . . 0.0 110.775 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.06 168.43 11.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.345 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -84.26 -27.35 0.4 Allowed Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -176.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 44.9 Cg_endo -81.91 167.38 16.39 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 CA-C-N 121.752 1.661 . . . . 0.0 110.4 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 45.3 p -96.68 -9.11 29.83 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.28 0.232 . . . . 0.0 111.286 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 170.29 22.31 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.711 0.804 . . . . 0.0 109.617 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 91.6 mt -124.23 167.93 13.63 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.924 0.49 . . . . 0.0 110.758 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -123.58 158.55 31.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.434 HG11 ' C ' ' A' ' 280' ' ' TRP . 5.6 t -131.87 -24.78 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 122.309 0.244 . . . . 0.0 111.518 -171.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 62.89 -37.05 0.14 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.185 1.794 . . . . 0.0 115.055 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -164.64 177.87 7.74 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.787 0.835 . . . . 0.0 110.446 -174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -118.85 113.14 20.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -155.2 -174.66 5.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.699 1.199 . . . . 0.0 109.87 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -70.94 -3.82 21.32 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -113.17 -16.88 12.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.619 0.645 . . . . 0.0 111.438 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 14.6 t -156.98 132.42 9.23 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . 0.434 ' C ' HG11 ' A' ' 272' ' ' VAL . 12.6 t-105 -147.01 149.82 33.89 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 122.071 -0.393 . . . . 0.0 111.299 -175.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -126.22 137.65 53.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.3 0.64 . . . . 0.0 109.677 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -115.87 4.28 13.87 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.619 0.768 . . . . 0.0 112.464 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 11.8 t -119.22 -12.2 9.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.013 0.525 . . . . 0.0 111.707 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -71.72 158.09 88.48 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.119 0.568 . . . . 0.0 110.538 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -61.37 -11.34 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.158 3.238 . . . . 0.0 113.426 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -88.74 3.19 51.75 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.643 0.377 . . . . 0.0 111.937 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -140.36 -44.61 0.41 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.8 p 43.82 39.11 2.39 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.695 1.198 . . . . 0.0 113.028 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.33 -2.23 18.79 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.362 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -137.88 13.74 2.9 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.808 0.804 . . . . 0.0 111.493 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 117.387 -1.785 . . . . 0.0 111.675 -179.316 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 120.535 0.207 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -146.19 -63.4 0.31 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 122.85 0.46 . . . . 0.0 110.298 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 178' ' ' ARG . 19.4 tt -160.66 158.21 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.508 0.723 . . . . 0.0 109.173 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 80.9 p -83.81 -6.64 59.47 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.421 ' H ' HG12 ' A' ' 176' ' ' ILE . 55.8 ttm-85 -150.05 73.39 9.37 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 122.933 0.493 . . . . 0.0 110.117 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.44 -11.36 24.53 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.894 3.062 . . . . 0.0 111.526 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.2 178.1 49.79 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 183' ' ' ASP . 5.0 p-10 -143.13 157.08 44.84 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.653 0.381 . . . . 0.0 110.524 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.0 t 59.3 -9.64 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.147 1.379 . . . . 0.0 114.167 -177.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 181' ' ' ASP . 40.1 m-20 49.6 26.39 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.653 1.181 . . . . 0.0 112.999 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t70 53.04 26.18 4.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.84 0.856 . . . . 0.0 112.247 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 25.9 m 57.14 11.8 1.13 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.788 1.235 . . . . 0.0 113.421 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 59.08 147.22 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.095 1.758 . . . . 0.0 113.856 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 81.7 p -155.37 155.63 33.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.734 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.1 t -141.48 -75.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.458 -0.056 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -159.95 168.49 25.56 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.895 0.878 . . . . 0.0 110.082 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.4 p -89.16 13.3 13.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.431 0.693 . . . . 0.0 111.607 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 31.3 t -112.73 139.92 35.26 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 123.271 0.628 . . . . 0.0 110.962 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 95.0 mt -130.32 163.63 26.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.375 0.607 . . . . 0.0 111.279 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.2 tp -124.98 133.47 53.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.842 1.257 . . . . 0.0 107.962 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -119.37 142.95 47.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.743 0.817 . . . . 0.0 110.106 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 88.4 m -137.67 143.85 41.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.4 mp -108.51 137.99 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.8 mt -92.09 -35.46 13.89 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -133.0 68.73 78.81 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.801 0.84 . . . . 0.0 109.428 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.29 67.62 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.321 3.347 . . . . 0.0 112.109 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.1 pt -88.07 -4.34 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 122.079 -0.388 . . . . 0.0 111.128 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -128.18 169.27 14.32 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.02 0.928 . . . . 0.0 109.239 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 79.8 p -85.04 155.26 21.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.832 0.349 . . . . 0.0 111.487 -176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mm -135.66 138.18 48.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.3 p -143.27 174.39 10.76 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.956 0.502 . . . . 0.0 110.146 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 39.6 p -62.24 -25.2 67.69 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.415 0.286 . . . . 0.0 111.061 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -78.71 -24.36 45.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.349 0.26 . . . . 0.0 111.185 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.6 t -84.29 -38.34 13.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.83 -23.39 52.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.226 -0.296 . . . . 0.0 110.977 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -79.39 -33.85 42.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.271 0.487 . . . . 0.0 111.079 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -76.64 -20.92 56.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.219 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.3 pt -91.58 -22.35 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 118.251 0.478 . . . . 0.0 111.707 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.5 m -94.83 -19.53 20.24 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.39 0.541 . . . . 0.0 112.271 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.8 t-20 -59.8 -43.69 95.54 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 90.6 Cg_endo -71.56 -5.98 18.19 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.875 1.717 . . . . 0.0 112.22 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 86.1 m -96.13 -5.89 39.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.079 0.399 . . . . 0.0 111.134 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 137.44 174.24 13.26 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.8 119.25 6.26 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.711 2.941 . . . . 0.0 111.263 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.16 151.85 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -113.29 -36.46 5.0 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.101 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -165.3 160.24 18.08 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.198 0.453 . . . . 0.0 111.966 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 48.7 mt -143.0 147.54 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.971 0.908 . . . . 0.0 109.321 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.24 144.47 18.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 123.103 0.561 . . . . 0.0 109.795 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.51 150.9 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.797 0.839 . . . . 0.0 109.969 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -136.2 144.79 45.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.705 0.802 . . . . 0.0 109.073 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -146.13 20.46 1.41 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -68.78 -19.05 64.29 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.373 -0.205 . . . . 0.0 111.108 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -156.3 120.77 4.54 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 58.92 -145.98 42.95 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.3 t -132.59 132.3 59.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -145.48 168.5 20.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.633 0.773 . . . . 0.0 109.99 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -158.32 169.09 25.26 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.125 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 82.8 mtp -137.12 150.77 48.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.02 149.83 24.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -132.23 140.84 48.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -117.04 169.05 9.72 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.907 0.883 . . . . 0.0 110.849 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -77.81 -13.85 59.76 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.059 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 95.6 p -151.93 157.33 41.64 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.986 0.422 . . . . 0.0 110.839 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.72 -25.03 27.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.159 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -67.3 -29.99 69.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.124 -0.36 . . . . 0.0 110.344 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 50.2 m -79.41 -28.14 41.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.34 -26.68 42.09 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -70.05 -36.43 74.99 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -77.39 -27.47 52.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.457 -0.152 . . . . 0.0 110.631 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.02 -51.82 50.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.279 -0.263 . . . . 0.0 111.277 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.408 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.31 -13.93 60.13 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.516 179.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -86.78 -10.05 54.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.889 0.313 . . . . 0.0 111.495 176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.3 m -124.48 -2.05 8.0 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 88.1 mt -129.85 -5.22 4.56 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -77.35 130.69 37.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.975 0.807 . . . . 0.0 109.058 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.29 7.38 72.17 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.57 175.57 9.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.727 0.764 . . . . 0.0 111.568 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -137.3 144.88 42.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.96 0.904 . . . . 0.0 108.963 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.5 mt -109.34 -20.12 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 122.546 0.338 . . . . 0.0 111.603 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -127.37 28.52 5.69 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.973 -0.454 . . . . 0.0 111.43 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 96.2 p 49.79 22.66 0.86 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.046 1.338 . . . . 0.0 112.727 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 171.57 136.28 2.09 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 81.1 m 55.48 -172.62 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.924 0.89 . . . . 0.0 112.15 -176.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 74.4 m 51.69 31.45 7.96 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.151 0.58 . . . . 0.0 112.003 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.6 m -59.12 140.49 55.79 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.852 0.461 . . . . 0.0 109.849 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 59.3 mt -94.31 154.79 17.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.202 0.525 . . . . 0.0 112.162 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -145.14 132.76 20.93 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 84.4 mt -132.7 147.94 31.72 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.247 0.546 . . . . 0.0 112.29 -172.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.36 172.87 15.8 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.869 1.268 . . . . 0.0 108.8 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -84.41 142.28 30.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.22 -0.3 . . . . 0.0 110.598 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.87 169.59 12.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.44 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.4 pttt -85.78 -26.97 0.37 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 41.0 Cg_endo -82.62 164.91 16.16 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.01 1.807 . . . . 0.0 110.261 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.5 p -94.1 -7.84 41.33 Favored 'General case' 0 CA--C 1.527 0.065 0 O-C-N 122.325 -0.234 . . . . 0.0 111.396 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.85 169.13 25.47 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.835 0.854 . . . . 0.0 109.809 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 85.9 mt -121.06 173.18 7.43 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.461 0.705 . . . . 0.0 110.08 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -129.42 157.37 42.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.601 0.36 . . . . 0.0 110.485 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.9 t -138.36 152.33 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.06 0 C-N-CA 124.118 0.967 . . . . 0.0 108.866 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -125.84 -14.8 6.09 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.394 0.278 . . . . 0.0 111.627 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -164.68 173.92 11.35 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.286 1.034 . . . . 0.0 109.885 -176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -119.95 98.24 6.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -150.58 -168.79 3.21 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.868 0.867 . . . . 0.0 110.311 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -71.77 -4.11 25.9 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -110.88 -24.65 10.28 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.673 0.67 . . . . 0.0 111.753 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.8 t -157.63 144.57 18.15 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 173.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -152.76 147.99 26.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.172 0.189 . . . . 0.0 110.522 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -122.17 134.84 54.72 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.73 8.53 17.51 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.702 0.801 . . . . 0.0 112.17 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.7 t -128.5 2.4 5.6 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.289 0.636 . . . . 0.0 110.532 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -66.2 129.04 94.18 Favored Pre-proline 0 N--CA 1.453 -0.312 0 C-N-CA 124.455 1.102 . . . . 0.0 109.455 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.04 -6.83 13.69 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.44 2.76 . . . . 0.0 112.853 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -89.55 1.41 55.97 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.824 0.45 . . . . 0.0 111.139 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 61.8 tp -138.48 -29.73 0.79 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.137 0.575 . . . . 0.0 111.041 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 48.7 m -82.21 166.13 19.87 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.896 0.479 . . . . 0.0 110.394 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.4 158.26 51.14 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -131.97 7.63 4.37 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.655 0.782 . . . . 0.0 110.781 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.325 -1.82 . . . . 0.0 110.763 -179.523 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.624 0.25 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -146.25 160.14 42.39 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.561 0.744 . . . . 0.0 109.489 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.3 tp -63.92 153.54 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.356 0.662 . . . . 0.0 110.598 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.3 p -80.36 4.8 16.75 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.616 0.767 . . . . 0.0 112.52 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -134.85 59.39 34.44 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 123.88 0.872 . . . . 0.0 109.523 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -76.2 -11.5 19.34 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.807 3.004 . . . . 0.0 112.252 -172.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.33 8.6 0.03 OUTLIER Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.509 -0.606 . . . . 0.0 113.207 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -71.09 140.69 50.74 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.488 1.144 . . . . 0.0 110.433 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.4 t 54.98 -173.43 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.288 1.035 . . . . 0.0 112.196 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 51.51 25.66 2.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.974 0.91 . . . . 0.0 112.778 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.5 t70 52.49 23.35 2.5 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.016 0.927 . . . . 0.0 112.032 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.8 t 57.79 9.16 0.81 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.728 1.211 . . . . 0.0 113.518 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -155.25 125.58 6.77 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.863 -0.523 . . . . 0.0 109.708 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 61.4 p -156.22 154.57 30.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.691 0.281 . . . . 0.0 111.453 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 6.9 p -151.43 -46.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.051 0.54 . . . . 0.0 109.942 173.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -164.01 164.07 23.2 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.035 0.934 . . . . 0.0 109.461 172.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.7 p -96.64 15.39 21.87 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.216 0.606 . . . . 0.0 112.082 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.34 143.53 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 123.038 0.535 . . . . 0.0 111.022 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.7 mt -129.13 166.13 19.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.182 0.593 . . . . 0.0 111.325 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.6 tp -124.95 133.95 52.83 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.823 1.249 . . . . 0.0 107.999 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -120.12 147.71 44.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.832 0.853 . . . . 0.0 109.889 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 93.8 m -136.82 139.11 41.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.5 mp -103.47 135.69 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 50.4 mt -102.5 -17.07 15.93 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -139.13 66.55 38.69 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 123.657 0.783 . . . . 0.0 109.362 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.24 40.58 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 124.903 3.735 . . . . 0.0 112.069 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 32.9 pt -77.66 -1.58 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 O-C-N 121.944 -0.473 . . . . 0.0 111.791 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -132.11 165.89 23.01 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.131 0.972 . . . . 0.0 109.216 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.9 m -73.98 149.6 41.22 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.758 0.313 . . . . 0.0 111.303 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.5 mm -136.54 137.98 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.7 p -145.33 175.33 10.38 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.287 0.635 . . . . 0.0 109.77 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.0 p -63.0 -23.1 67.3 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 122.423 0.289 . . . . 0.0 111.199 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.24 -26.68 35.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.311 -0.243 . . . . 0.0 111.205 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 89.8 t -81.86 -36.78 14.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.8 mt -76.9 -24.16 52.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 122.378 -0.201 . . . . 0.0 110.528 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -76.83 -36.15 57.06 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.851 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -77.52 -20.06 54.83 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.344 0.52 . . . . 0.0 111.544 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -93.27 -15.47 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 118.331 0.514 . . . . 0.0 111.653 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 67.5 m -98.52 -21.68 16.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.642 0.655 . . . . 0.0 111.924 176.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.47 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.9 t-20 -58.82 -43.4 97.69 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 96.6 Cg_endo -72.31 -8.83 23.39 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.004 1.803 . . . . 0.0 112.012 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 70.7 m -96.21 -21.0 18.15 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.912 0.324 . . . . 0.0 111.151 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 163.63 168.09 25.1 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.91 112.58 3.14 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.757 2.971 . . . . 0.0 110.895 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.99 151.48 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 123.286 0.634 . . . . 0.0 109.395 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -116.42 -36.05 4.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.0 0.52 . . . . 0.0 110.788 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -163.17 157.81 20.97 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 112.413 0.524 . . . . 0.0 112.413 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.7 mt -143.67 146.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.243 1.017 . . . . 0.0 109.443 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.0 p -146.4 143.59 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.307 0.643 . . . . 0.0 109.61 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.71 151.39 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.743 0.817 . . . . 0.0 110.016 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -136.5 149.36 48.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.724 0.81 . . . . 0.0 109.862 175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.4 18.37 2.05 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.31 -27.46 69.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.539 0.336 . . . . 0.0 110.396 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -151.11 121.84 7.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 58.24 -145.1 41.87 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.4 t -129.67 128.0 65.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -143.1 166.91 23.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.43 0.692 . . . . 0.0 110.396 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -155.98 169.5 24.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.865 0.466 . . . . 0.0 109.95 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.4 mtp -134.65 149.85 50.58 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.41 149.84 25.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -135.72 140.16 44.19 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.594 0.757 . . . . 0.0 109.434 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -118.58 167.97 11.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.897 0.879 . . . . 0.0 110.837 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -14.35 60.08 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.722 0.409 . . . . 0.0 111.493 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.1 t -149.97 150.39 31.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.061 0.544 . . . . 0.0 109.72 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.56 -25.93 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -66.77 -26.99 67.23 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.7 m -82.43 -25.49 33.59 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.82 -26.81 40.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -69.72 -36.46 75.9 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -79.14 -24.54 43.24 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.332 -0.23 . . . . 0.0 110.849 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.25 -53.38 30.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.305 -0.247 . . . . 0.0 111.06 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.15 -16.05 59.95 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.734 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.37 -9.89 58.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.032 0.378 . . . . 0.0 111.781 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 16.7 t -124.61 -5.38 7.61 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 83.6 mt -126.95 -4.96 6.27 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -176.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -76.88 131.25 38.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.94 4.76 78.26 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.15 -178.41 5.6 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.398 0.599 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -141.55 163.57 32.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.988 0.915 . . . . 0.0 109.145 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 39.1 mt -117.79 -20.5 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.214 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -138.32 80.69 1.81 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.843 -0.535 . . . . 0.0 111.183 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.8 m 50.74 42.05 26.99 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.522 0.729 . . . . 0.0 112.926 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 96.83 -4.61 63.44 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 119.743 -0.476 . . . . 0.0 112.934 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 58.8 m -97.03 167.58 10.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.834 0.817 . . . . 0.0 110.101 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 96.2 m 52.35 42.98 31.25 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.972 0.415 . . . . 0.0 110.66 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 8.7 m -55.62 138.2 47.54 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.396 0.679 . . . . 0.0 109.936 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 64.6 mt -102.65 154.0 19.57 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.073 0.549 . . . . 0.0 111.872 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -144.81 129.93 18.54 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 174.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 78.7 mt -128.87 147.08 33.31 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-O 121.347 0.594 . . . . 0.0 112.175 -170.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.51 173.41 15.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.891 1.277 . . . . 0.0 108.74 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -84.33 145.25 28.35 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 121.61 -0.681 . . . . 0.0 110.749 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.3 167.57 13.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.685 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 22.0 ptmt -82.38 -27.09 0.42 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 47.2 Cg_endo -84.31 -177.84 3.16 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.959 1.772 . . . . 0.0 110.065 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 60.9 p -111.36 -9.79 14.25 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.494 0.318 . . . . 0.0 111.337 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.401 ' HD3' ' N ' ' A' ' 270' ' ' LEU . 0.0 OUTLIER -156.36 137.35 13.56 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.401 ' N ' ' HD3' ' A' ' 269' ' ' ARG . 63.5 mt -88.02 172.79 9.29 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 123.088 0.555 . . . . 0.0 110.726 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -132.34 149.36 52.37 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.324 -0.235 . . . . 0.0 111.008 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 72.5 t -138.6 151.34 24.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 124.298 1.039 . . . . 0.0 108.484 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -124.44 -23.67 4.4 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 177.21 9.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.575 1.15 . . . . 0.0 108.834 176.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -110.76 110.16 20.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.651 0.381 . . . . 0.0 110.113 177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -152.79 -175.02 5.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.237 1.015 . . . . 0.0 109.545 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -72.53 -1.72 17.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -117.38 -20.42 9.13 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 118.503 0.592 . . . . 0.0 111.775 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.9 t -154.13 137.87 16.14 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -159.25 146.67 17.26 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 122.381 -0.199 . . . . 0.0 110.517 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -129.79 139.23 51.3 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.628 0.728 . . . . 0.0 111.38 171.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -104.69 -6.94 19.94 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.741 0.816 . . . . 0.0 111.526 -173.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 12.3 t -88.13 7.52 31.25 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.217 0.607 . . . . 0.0 109.857 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -111.83 131.01 22.62 Favored Pre-proline 0 N--CA 1.452 -0.33 0 C-N-CA 125.103 1.361 . . . . 0.0 109.455 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.94 64.06 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.077 3.185 . . . . 0.0 111.471 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 53.52 23.0 3.22 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.711 1.204 . . . . 0.0 113.503 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 17.1 tp 54.93 23.36 4.97 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.052 0.941 . . . . 0.0 111.91 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.4 p -139.07 -4.51 1.52 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 76.81 4.47 82.23 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -88.53 2.04 53.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.629 0.714 . . . . 0.0 112.067 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 CA-C-O 117.271 -1.849 . . . . 0.0 111.349 178.525 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -144.52 172.93 12.28 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 123.238 0.615 . . . . 0.0 111.121 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.3 tt -64.78 154.59 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.345 0.658 . . . . 0.0 110.607 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.3 p -81.0 1.51 30.95 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.984 0.514 . . . . 0.0 112.383 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -136.81 64.43 49.87 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 123.747 0.819 . . . . 0.0 109.821 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.48 160.05 49.61 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.725 2.95 . . . . 0.0 111.219 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.68 -5.29 89.98 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.94 -0.367 . . . . 0.0 112.635 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -149.28 158.06 43.86 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.138 0.575 . . . . 0.0 110.163 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.0 t 56.43 -172.38 0.07 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.024 0.929 . . . . 0.0 111.868 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.8 t0 58.53 178.39 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.614 1.166 . . . . 0.0 112.369 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t70 62.37 162.98 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.038 1.335 . . . . 0.0 113.259 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 46.7 m 57.63 4.13 0.23 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.159 1.384 . . . . 0.0 114.093 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.536 ' HG2' ' H ' ' A' ' 187' ' ' SER . 50.9 ttt-85 45.49 -144.39 0.2 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.357 1.063 . . . . 0.0 111.06 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.536 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 57.8 p -151.75 150.38 30.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.515 1.126 . . . . 0.0 108.966 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 56.4 t -141.99 -63.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -161.34 164.99 29.71 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.235 0.614 . . . . 0.0 110.415 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.6 p -93.44 18.63 9.49 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.659 0.783 . . . . 0.0 112.048 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.17 145.09 30.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 122.939 0.496 . . . . 0.0 110.817 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.6 mt -131.08 163.24 28.08 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.305 0.574 . . . . 0.0 111.5 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 62.3 tp -122.73 132.36 54.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.663 1.185 . . . . 0.0 108.302 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -117.75 146.33 43.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.587 0.755 . . . . 0.0 109.685 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 97.0 m -138.2 143.34 40.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 196' ' ' ILE . 1.9 mp -106.67 137.08 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.22 -35.91 10.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -173.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -129.9 63.94 70.32 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.997 0.519 . . . . 0.0 110.346 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.47 100.41 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.167 2.578 . . . . 0.0 111.152 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.2 pt -122.17 3.11 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 122.874 0.469 . . . . 0.0 110.878 173.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -138.24 164.85 28.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.21 1.004 . . . . 0.0 109.097 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 80.3 p -79.21 156.6 28.09 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.902 0.382 . . . . 0.0 111.324 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.5 mm -135.86 137.95 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 73.1 p -144.44 175.41 10.14 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.137 0.575 . . . . 0.0 110.285 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 32.4 p -60.36 -26.45 66.63 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 122.973 0.509 . . . . 0.0 111.092 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.75 -21.3 44.63 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.506 0.322 . . . . 0.0 111.175 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.77 -37.86 10.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.21 -24.03 54.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.128 -0.357 . . . . 0.0 110.906 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -79.64 -33.06 41.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.95 -0.469 . . . . 0.0 111.111 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 t -77.09 -23.63 51.89 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-N 118.451 0.569 . . . . 0.0 111.369 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 39.1 pt -88.51 -22.25 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 118.258 0.481 . . . . 0.0 111.732 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 93.7 m -95.55 -21.94 17.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.546 0.612 . . . . 0.0 112.414 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.474 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 28.3 t-20 -60.33 -44.49 96.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 93.2 Cg_endo -72.89 -10.83 25.22 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.181 1.921 . . . . 0.0 111.727 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.7 m -94.04 -20.65 19.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.14 0.427 . . . . 0.0 110.931 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.67 168.36 27.7 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.08 105.84 1.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.659 2.906 . . . . 0.0 110.685 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.9 t -78.51 151.3 5.2 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -116.14 -37.66 3.77 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.705 0.402 . . . . 0.0 110.728 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -162.74 159.49 24.27 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 117.804 0.275 . . . . 0.0 111.474 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 50.5 mt -143.07 145.07 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 124.099 0.959 . . . . 0.0 110.319 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 33.4 m -137.83 149.69 25.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 123.587 0.755 . . . . 0.0 109.33 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.46 149.02 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.259 0.624 . . . . 0.0 109.789 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -130.4 122.85 28.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.3 ppt_? -144.77 17.77 1.63 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -84.74 -19.09 33.23 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -153.21 122.18 6.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 62.48 -159.37 34.22 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -172.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.4 p -149.04 116.68 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 121.421 0.629 . . . . 0.0 110.426 175.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -149.88 169.5 20.99 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.344 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.64 169.82 21.75 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.993 0.517 . . . . 0.0 110.446 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 83.1 mtp -140.09 150.46 44.34 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.9 t -137.88 150.97 25.21 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 122.64 0.376 . . . . 0.0 110.04 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -133.4 140.85 47.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.366 0.667 . . . . 0.0 109.572 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.11 171.29 8.38 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.873 0.869 . . . . 0.0 110.774 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.14 -16.56 61.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.763 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 60.0 p -154.02 163.31 40.29 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.219 0.533 . . . . 0.0 110.829 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.72 -25.52 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.354 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -71.1 -27.58 63.71 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.199 0.454 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 m -77.81 -28.98 50.51 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.76 -24.69 41.37 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.446 -0.159 . . . . 0.0 110.759 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -70.35 -36.51 74.25 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -80.24 -25.69 39.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.439 -0.163 . . . . 0.0 110.732 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.52 -50.32 63.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.038 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.409 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.27 -15.74 59.31 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.693 179.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.21 -10.42 58.59 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.905 0.32 . . . . 0.0 111.401 176.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.6 m -123.2 -3.22 8.51 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.58 -4.26 4.2 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -79.03 131.51 36.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.42 5.46 63.29 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.586 -0.605 . . . . 0.0 111.586 -176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.44 178.64 8.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.863 0.832 . . . . 0.0 111.093 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -141.17 160.05 40.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.613 0.765 . . . . 0.0 109.372 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.8 mt -111.66 -19.88 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -121.32 32.58 5.86 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.971 -0.455 . . . . 0.0 112.132 -175.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 52.3 p 56.31 13.07 1.15 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.84 1.256 . . . . 0.0 112.766 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 169.85 150.15 6.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 79.4 m 55.06 -174.85 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.54 0.736 . . . . 0.0 111.927 -175.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.7 m 48.52 32.56 3.46 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.139 0.575 . . . . 0.0 111.307 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 12.9 m -58.44 140.41 53.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.321 0.648 . . . . 0.0 110.335 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 56.9 mt -98.0 155.17 17.23 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.115 0.566 . . . . 0.0 111.712 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -142.15 132.52 25.04 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.409 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 83.2 mt -129.38 145.67 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-O 121.17 0.51 . . . . 0.0 111.849 -174.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.27 168.21 26.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.94 1.296 . . . . 0.0 108.3 173.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -78.01 141.54 38.85 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.868 -0.52 . . . . 0.0 110.497 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -80.8 166.24 21.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.6 pttt -81.72 -27.42 0.44 Allowed Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 49.1 Cg_endo -81.33 178.48 6.7 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.891 1.727 . . . . 0.0 109.797 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 63.5 p -104.51 -7.65 19.62 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 122.109 0.164 . . . . 0.0 111.18 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 167.72 28.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.319 0.647 . . . . 0.0 110.449 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.59 170.18 12.33 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.942 0.897 . . . . 0.0 109.425 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -143.13 163.21 33.49 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.502 0.191 . . . . 0.0 110.788 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.6 156.42 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 124.214 1.006 . . . . 0.0 109.103 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -126.1 -18.88 4.9 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.775 0.43 . . . . 0.0 111.621 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -166.09 169.24 14.71 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.042 0.937 . . . . 0.0 109.297 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -117.56 109.36 16.61 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.055 0.455 . . . . 0.0 110.54 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -155.47 -167.21 2.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.718 1.207 . . . . 0.0 109.898 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -73.44 -5.72 41.74 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.47 -15.98 12.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.672 0.669 . . . . 0.0 111.54 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.0 t -159.08 139.44 12.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -154.07 148.03 25.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.139 -0.351 . . . . 0.0 110.792 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.86 135.39 54.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.903 0.481 . . . . 0.0 110.017 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -115.73 9.1 15.09 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.56 0.744 . . . . 0.0 112.132 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.5 t -129.99 1.22 4.78 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.234 0.614 . . . . 0.0 110.765 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -66.13 125.36 90.02 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 124.096 0.958 . . . . 0.0 109.672 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -56.82 -17.64 24.24 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.505 2.803 . . . . 0.0 113.57 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -81.85 -1.22 46.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.023 0.374 . . . . 0.0 111.807 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 60.0 tp -135.29 -25.0 1.37 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.597 0.359 . . . . 0.0 110.666 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 42.4 m -75.15 -12.48 60.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.987 -0.446 . . . . 0.0 111.055 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -77.94 -5.92 87.03 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -82.0 -14.76 55.52 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.484 0.642 . . . . 0.0 110.912 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 117.392 -1.782 . . . . 0.0 111.262 -179.174 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -113.8 -55.86 2.46 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.374 0.67 . . . . 0.0 111.469 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.564 HG23 ' H ' ' A' ' 178' ' ' ARG . 17.9 tt -157.35 3.37 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.318 0.247 . . . . 0.0 111.001 -178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 20.4 m 56.92 8.66 0.52 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.62 1.168 . . . . 0.0 113.795 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.564 ' H ' HG23 ' A' ' 176' ' ' ILE . 14.4 tpt180 -155.13 52.69 0.74 Allowed Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.239 0.615 . . . . 0.0 110.951 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.52 -14.44 30.61 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.941 2.427 . . . . 0.0 111.06 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 168.74 165.06 25.5 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -153.32 166.02 33.93 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 122.958 0.503 . . . . 0.0 110.829 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.5 m 60.57 151.25 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.343 1.457 . . . . 0.0 113.776 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.6 t70 50.43 23.43 1.27 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.213 1.005 . . . . 0.0 112.814 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 53.75 19.7 1.96 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.186 0.994 . . . . 0.0 112.846 -176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 84.1 p 55.15 -57.83 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.527 2.731 . . . . 0.0 114.835 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 58.26 171.4 0.06 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.697 1.599 . . . . 0.0 112.862 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.3 m 57.9 168.37 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.803 1.241 . . . . 0.0 113.615 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.46 -42.81 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.819 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -164.85 166.1 19.94 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.314 0.646 . . . . 0.0 110.506 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -91.51 10.09 29.3 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.222 0.609 . . . . 0.0 111.587 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.5 t -106.04 137.94 33.78 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 C-N-CA 123.248 0.619 . . . . 0.0 110.589 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.3 mt -126.47 159.96 31.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.623 0.725 . . . . 0.0 111.572 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.0 tp -118.7 132.39 56.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.037 1.335 . . . . 0.0 108.15 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -118.37 141.66 48.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.302 0.641 . . . . 0.0 109.713 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 92.5 m -137.21 141.1 42.1 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.6 mp -104.26 136.21 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.46 -34.61 12.66 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -130.4 62.27 63.62 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.492 0.717 . . . . 0.0 110.041 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.33 101.79 0.89 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.781 2.32 . . . . 0.0 111.021 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.4 pt -127.0 2.31 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 122.878 0.471 . . . . 0.0 111.227 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -132.11 166.58 21.46 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.879 0.872 . . . . 0.0 109.405 177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.9 m -75.11 150.6 38.76 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.367 0.267 . . . . 0.0 111.346 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.6 mm -138.37 136.67 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 80.7 p -144.94 174.27 11.16 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.435 0.694 . . . . 0.0 109.853 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.7 p -62.17 -24.85 67.44 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.191 0.196 . . . . 0.0 111.142 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.16 -24.9 47.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.789 0.268 . . . . 0.0 111.154 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.77 -37.48 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.92 -23.45 52.48 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.381 -0.199 . . . . 0.0 110.753 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -79.87 -33.96 39.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.887 0.312 . . . . 0.0 110.957 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 t -75.54 -22.47 57.04 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 118.467 0.576 . . . . 0.0 110.935 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.9 pt -89.7 -22.09 6.56 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.157 0.435 . . . . 0.0 111.899 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.4 m -95.72 -20.13 19.14 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.403 0.547 . . . . 0.0 112.355 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.8 t-20 -60.88 -42.76 88.83 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 84.4 Cg_endo -72.1 -10.71 26.33 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.876 1.717 . . . . 0.0 111.795 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 79.8 m -91.22 -20.68 21.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.933 0.333 . . . . 0.0 110.888 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 159.52 171.35 25.25 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.74 111.95 2.94 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.676 2.917 . . . . 0.0 110.948 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.8 t -84.41 150.6 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -113.89 -37.3 4.54 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.119 0.567 . . . . 0.0 111.125 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -164.08 158.37 19.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.723 0.692 . . . . 0.0 112.351 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.2 mt -144.32 147.28 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.956 0.902 . . . . 0.0 109.529 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.04 144.02 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.262 0.625 . . . . 0.0 109.503 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.8 151.43 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.861 0.864 . . . . 0.0 109.907 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -136.65 143.05 43.26 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.984 0.913 . . . . 0.0 108.939 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.98 16.0 1.38 Allowed 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -174.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.49 -18.79 65.56 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.006 -0.433 . . . . 0.0 111.137 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -154.88 124.23 6.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 57.26 -147.31 35.31 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.6 t -133.96 129.51 54.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -146.24 167.18 24.13 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.242 0.617 . . . . 0.0 110.276 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.44 173.24 17.2 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.669 0.388 . . . . 0.0 110.278 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.5 mtp -137.51 150.25 47.4 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.92 151.34 25.44 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -138.73 141.75 38.89 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.195 0.598 . . . . 0.0 109.407 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -118.26 168.15 10.87 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.808 0.843 . . . . 0.0 110.805 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -76.67 -11.12 59.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.94 0.496 . . . . 0.0 111.527 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.0 t -151.67 150.18 29.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.157 0.583 . . . . 0.0 109.745 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.03 -23.64 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.05 -25.23 62.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 38.2 m -80.59 -26.31 37.94 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -81.09 -26.99 35.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.168 0.187 . . . . 0.0 110.521 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -68.06 -36.89 80.6 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.3 ttt-85 -78.62 -25.98 45.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.406 -0.184 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -68.4 -48.42 64.71 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.419 -0.324 . . . . 0.0 111.262 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.39 -13.26 59.92 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.534 0.606 . . . . 0.0 111.532 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.42 -9.67 54.05 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.543 -0.265 . . . . 0.0 111.6 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -123.87 -3.46 8.17 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.7 mt -129.99 -4.31 4.52 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -76.52 133.17 39.83 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 119.072 0.851 . . . . 0.0 109.134 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.59 5.89 69.65 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.803 -0.443 . . . . 0.0 112.327 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.31 174.74 11.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.689 0.744 . . . . 0.0 111.134 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -132.67 144.32 50.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 60.9 mt -92.43 -20.22 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 O-C-N 122.293 -0.254 . . . . 0.0 111.052 -177.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -122.11 25.56 8.97 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.177 0.591 . . . . 0.0 111.226 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.1 m 56.78 16.01 2.49 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.204 1.002 . . . . 0.0 112.416 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.78 142.57 4.26 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 64.6 m 55.19 -179.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.859 0.864 . . . . 0.0 112.008 -174.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 73.7 m 50.17 34.98 9.33 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.068 -0.395 . . . . 0.0 111.071 -173.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.8 m -59.82 142.58 53.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.939 0.495 . . . . 0.0 110.117 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 55.0 mt -100.58 154.56 18.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.365 0.602 . . . . 0.0 112.608 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -139.02 137.56 36.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 74.8 mt -134.5 142.68 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 111.382 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.07 167.83 28.49 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.468 1.107 . . . . 0.0 108.526 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.0 144.0 37.07 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.883 -0.511 . . . . 0.0 110.613 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -90.95 169.79 10.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.659 0.384 . . . . 0.0 110.926 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.1 pttt -84.55 -26.97 0.39 Allowed Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -176.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 52.2 Cg_endo -80.25 166.47 20.44 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 CA-C-N 121.82 1.686 . . . . 0.0 109.784 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.6 p -100.58 -10.88 20.55 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 122.314 -0.241 . . . . 0.0 111.154 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.65 137.07 11.96 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 85.7 mt -85.42 169.77 13.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.728 0.411 . . . . 0.0 110.74 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -132.3 151.14 51.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 93.8 t -138.3 154.01 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 124.072 0.949 . . . . 0.0 108.65 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.81 -23.75 4.99 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -173.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.2 171.07 12.63 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.542 1.137 . . . . 0.0 109.082 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -107.79 117.92 35.37 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.91 0.386 . . . . 0.0 110.593 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -157.99 -172.45 3.92 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.69 1.196 . . . . 0.0 109.309 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -73.59 -5.07 38.01 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -112.15 -20.0 12.07 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.801 0.728 . . . . 0.0 111.671 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.1 t -156.33 139.99 16.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 173.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -149.88 147.78 28.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 110.696 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -123.7 113.03 18.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -91.09 3.25 55.25 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.898 0.879 . . . . 0.0 111.709 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.3 t -124.85 20.04 8.46 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.555 0.742 . . . . 0.0 109.904 177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -69.85 143.33 91.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.227 0.611 . . . . 0.0 110.922 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.05 -16.92 35.26 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.237 2.625 . . . . 0.0 113.283 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -99.93 4.08 44.77 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.816 0.447 . . . . 0.0 111.731 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 40.2 tp -128.39 -14.89 4.69 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.862 0.465 . . . . 0.0 110.955 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 49.3 m -125.6 7.27 7.56 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.307 0.643 . . . . 0.0 111.55 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -77.17 177.04 52.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -139.87 10.51 2.41 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.002 0.521 . . . . 0.0 111.657 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.568 -1.684 . . . . 0.0 111.04 -179.782 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -139.16 167.89 21.05 Favored 'General case' 0 C--N 1.338 0.066 0 C-N-CA 123.699 0.8 . . . . 0.0 110.892 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.4 tt -142.91 163.91 16.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 124.152 0.981 . . . . 0.0 109.175 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 m -63.17 -14.02 44.02 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -148.48 94.47 4.17 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.4 -14.78 25.21 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.064 2.509 . . . . 0.0 111.823 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.53 155.53 21.32 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -147.18 159.17 43.94 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.002 0.521 . . . . 0.0 110.087 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.1 m 56.63 177.34 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.824 1.25 . . . . 0.0 113.036 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 52.04 24.99 2.91 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.003 0.921 . . . . 0.0 113.073 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.5 t70 54.91 25.19 6.51 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.947 0.899 . . . . 0.0 112.529 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.6 t 59.51 178.99 0.08 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.446 1.099 . . . . 0.0 112.734 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -68.11 150.75 47.99 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.903 0.481 . . . . 0.0 111.468 -176.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.9 t -157.79 170.63 21.93 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.982 0.913 . . . . 0.0 109.471 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.13 -96.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -157.46 163.49 38.43 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.273 0.629 . . . . 0.0 110.353 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.8 p -94.96 16.15 16.9 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.29 0.636 . . . . 0.0 111.953 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.59 146.13 25.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 123.042 0.537 . . . . 0.0 111.108 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.55 164.0 25.85 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.682 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 66.4 tp -122.98 133.29 54.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.874 1.27 . . . . 0.0 108.099 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -120.74 144.47 48.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.657 0.783 . . . . 0.0 110.168 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 96.4 m -136.61 141.01 43.25 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.3 mp -107.65 136.77 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.09 -26.95 13.51 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -134.22 62.51 56.68 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 123.618 0.767 . . . . 0.0 109.812 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.72 59.7 5.03 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 124.241 3.294 . . . . 0.0 111.477 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 43.8 pt -82.22 -0.83 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 O-C-N 121.884 -0.51 . . . . 0.0 111.565 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -134.79 167.97 19.89 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.061 0.944 . . . . 0.0 109.382 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.2 m -79.72 151.17 30.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.6 mm -133.64 138.66 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.1 p -141.81 174.78 10.26 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.101 0.56 . . . . 0.0 109.598 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.9 p -63.26 -21.69 66.4 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.48 0.312 . . . . 0.0 110.959 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.17 -24.53 40.28 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.488 0.315 . . . . 0.0 110.798 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 87.3 t -82.99 -37.4 13.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.4 mt -76.82 -22.75 53.16 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.155 -0.341 . . . . 0.0 110.75 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -79.17 -34.89 42.73 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.905 -0.497 . . . . 0.0 110.788 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.3 t -75.43 -23.1 56.91 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.114 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.0 pt -90.48 -20.89 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.53 0.605 . . . . 0.0 112.28 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.1 m -98.43 -19.87 17.45 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.866 0.757 . . . . 0.0 112.975 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.486 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 47.6 t30 -64.47 -40.49 51.05 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 90.5 Cg_endo -71.68 -3.36 12.96 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.576 1.517 . . . . 0.0 111.932 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 73.1 m -99.96 -4.5 29.99 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.702 0.401 . . . . 0.0 111.295 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 142.11 174.44 14.76 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.06 109.34 2.15 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.765 2.976 . . . . 0.0 110.981 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.2 t -80.98 149.71 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -115.67 -39.99 3.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.927 0.491 . . . . 0.0 111.337 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -161.27 158.15 26.71 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.1 mt -141.42 145.71 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.269 1.028 . . . . 0.0 109.582 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.68 147.91 20.41 Favored 'Isoleucine or valine' 0 C--O 1.23 0.052 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.92 149.24 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.05 0.54 . . . . 0.0 110.515 -173.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -128.78 123.66 33.48 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -145.27 28.47 1.21 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -76.38 -18.0 59.09 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -156.73 -54.65 0.08 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.36 -164.68 39.96 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.3 t -138.72 108.03 4.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -145.26 164.9 29.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.352 0.661 . . . . 0.0 109.952 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -153.63 171.49 18.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.694 0.398 . . . . 0.0 110.478 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 81.3 mtp -141.32 150.13 42.1 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 52.0 t -137.97 152.7 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.036 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -137.02 140.99 42.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.406 0.682 . . . . 0.0 109.755 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.66 168.39 10.76 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.006 0.922 . . . . 0.0 110.816 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.49 -10.38 59.69 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.213 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 40.7 t -153.21 151.66 30.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.034 0.534 . . . . 0.0 110.067 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.55 -22.67 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -66.67 -28.5 68.5 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.993 0.36 . . . . 0.0 110.642 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 75.4 m -87.21 -23.97 24.58 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.358 -0.214 . . . . 0.0 110.757 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.53 -28.86 59.25 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -70.72 -36.91 73.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 40.3 ttm105 -74.89 -32.79 61.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.341 0.256 . . . . 0.0 111.041 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.82 66.04 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.189 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.423 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -76.5 -11.83 59.94 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.972 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -87.43 -12.4 46.28 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.443 -0.313 . . . . 0.0 111.603 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 58.7 m -127.57 2.57 6.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 91.1 mt -130.86 -4.99 4.02 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.642 0.655 . . . . 0.0 112.488 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -79.05 131.14 36.17 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 72.75 7.54 70.03 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.32 177.99 8.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.428 0.691 . . . . 0.0 111.467 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.23 143.99 50.32 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.259 1.023 . . . . 0.0 108.357 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 59.7 mt -90.55 -22.45 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 O-C-N 122.403 -0.186 . . . . 0.0 111.272 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -122.7 30.43 6.46 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.838 0.455 . . . . 0.0 111.333 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.2 m 56.2 19.53 3.92 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.351 0.66 . . . . 0.0 111.828 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 172.07 155.53 11.18 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 6.7 p 48.97 -175.52 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.916 1.286 . . . . 0.0 113.112 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 76.4 m 47.38 37.77 6.51 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.132 0.573 . . . . 0.0 111.162 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 8.9 m -58.12 139.18 55.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.114 0.565 . . . . 0.0 110.105 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 51.1 mt -102.11 155.73 18.01 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.219 0.533 . . . . 0.0 112.212 -175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -143.4 134.74 26.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 74.2 mt -129.24 149.87 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 121.135 0.493 . . . . 0.0 111.436 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.75 170.27 22.44 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.984 1.314 . . . . 0.0 108.029 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -79.69 144.45 33.69 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 121.865 -0.522 . . . . 0.0 110.337 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.23 164.91 19.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.141 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 40.0 ttpt -72.27 -45.76 10.71 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 79.6 Cg_endo -75.59 176.79 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.605 2.203 . . . . 0.0 110.503 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 63.6 p -106.56 -8.66 16.91 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 122.595 0.358 . . . . 0.0 111.61 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.34 137.42 15.56 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 58.5 mt -90.18 177.64 6.38 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.105 0.562 . . . . 0.0 110.608 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -137.37 154.17 50.06 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.156 -0.34 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 96.2 t -138.29 153.07 26.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.948 0.899 . . . . 0.0 109.166 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.22 -15.24 4.72 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.617 0.367 . . . . 0.0 111.777 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -166.65 175.82 7.66 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.031 0.933 . . . . 0.0 109.911 -175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -119.6 101.19 7.75 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -150.47 -169.63 3.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.946 0.898 . . . . 0.0 110.341 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -71.13 -1.38 12.18 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -116.1 -21.25 9.52 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.917 0.781 . . . . 0.0 111.856 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.8 t -157.95 145.69 18.51 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 118.296 0.498 . . . . 0.0 109.999 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -153.15 151.05 29.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.657 0.265 . . . . 0.0 110.697 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.54 139.56 53.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.6 15.72 12.82 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.354 0.661 . . . . 0.0 112.171 -174.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 15.1 t -131.27 -3.39 3.88 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.1 -0.375 . . . . 0.0 111.863 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -81.9 154.73 70.46 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.175 0.59 . . . . 0.0 110.613 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.23 -6.34 18.27 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.447 2.765 . . . . 0.0 111.697 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -78.87 -4.42 49.58 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.769 0.428 . . . . 0.0 111.892 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 36.6 tp -94.97 -10.22 31.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.898 0.479 . . . . 0.0 110.909 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 50.5 m -134.84 11.49 3.66 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.006 0.522 . . . . 0.0 111.448 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 179.67 -169.11 39.92 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -90.0 -0.46 57.59 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.548 -0.384 . . . . 0.0 111.007 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.089 0 CA-C-O 117.361 -1.8 . . . . 0.0 111.087 -179.641 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -146.72 163.51 35.7 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.176 0.591 . . . . 0.0 109.763 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.83 154.34 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.587 0.355 . . . . 0.0 110.546 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 78.5 p -78.55 0.57 25.68 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.261 0.624 . . . . 0.0 112.285 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -139.37 68.54 39.47 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.601 0.761 . . . . 0.0 109.394 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.98 162.33 39.32 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.497 2.798 . . . . 0.0 110.96 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.89 175.18 53.94 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 183' ' ' ASP . 26.6 t70 -144.39 142.83 30.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.625 -0.338 . . . . 0.0 110.346 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.0 m 58.54 -19.28 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.77 2.028 . . . . 0.0 115.151 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 184' ' ' ASP . 38.2 t0 52.67 -171.69 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.757 1.223 . . . . 0.0 112.518 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.444 ' H ' ' CG ' ' A' ' 183' ' ' ASP . 8.6 t70 53.94 -158.42 0.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.139 0.975 . . . . 0.0 111.628 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.43 ' H ' ' CG ' ' A' ' 184' ' ' ASP . 19.4 t 60.5 -67.67 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.114 1.765 . . . . 0.0 113.781 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 54.54 -171.56 0.05 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.18 0.992 . . . . 0.0 111.711 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 60.6 m -145.32 152.26 39.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.945 0.498 . . . . 0.0 110.483 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.19 -50.19 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 122.246 0.218 . . . . 0.0 110.79 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -164.04 168.24 19.42 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.296 0.638 . . . . 0.0 110.069 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 81.2 p -101.18 16.73 24.52 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.536 0.734 . . . . 0.0 111.845 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.6 m -119.7 144.38 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.081 0 C-N-CA 123.008 0.523 . . . . 0.0 111.083 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.1 mt -130.94 164.64 24.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.168 0.508 . . . . 0.0 111.384 -174.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 62.8 tp -123.28 134.03 54.12 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.824 1.249 . . . . 0.0 108.316 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -120.52 146.71 46.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.678 0.791 . . . . 0.0 109.816 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 87.3 m -136.53 144.36 44.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 196' ' ' ILE . 3.3 mp -110.42 136.43 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.5 mt -98.93 -32.79 11.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -172.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -133.42 69.38 77.22 Favored Pre-proline 0 CA--C 1.532 0.25 0 C-N-CA 123.572 0.749 . . . . 0.0 109.507 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.57 55.7 3.79 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 125.007 3.805 . . . . 0.0 112.26 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.1 -3.68 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 121.753 -0.592 . . . . 0.0 111.38 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -129.86 168.16 17.04 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.703 0.801 . . . . 0.0 109.378 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 82.0 p -80.87 153.01 27.86 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.947 0.403 . . . . 0.0 111.504 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.0 mm -138.68 139.48 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.9 p -144.04 173.14 11.98 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.528 0.731 . . . . 0.0 109.56 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 34.1 p -63.63 -19.13 64.62 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.355 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -83.24 -26.06 31.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 117.805 0.275 . . . . 0.0 110.591 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.2 t -81.51 -36.24 14.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.37 -25.19 57.47 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.275 -0.266 . . . . 0.0 110.333 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -77.05 -36.32 56.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.086 -0.384 . . . . 0.0 110.966 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.7 t -76.46 -20.27 57.19 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.471 0.578 . . . . 0.0 111.336 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.16 -16.69 7.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-N 118.244 0.474 . . . . 0.0 111.78 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.3 m -97.31 -20.92 17.53 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.761 0.71 . . . . 0.0 112.155 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.2 t-20 -61.41 -43.73 90.26 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 98.7 Cg_endo -72.43 -10.59 25.65 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.633 1.555 . . . . 0.0 111.633 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 74.7 m -94.42 -21.59 18.83 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.797 0.271 . . . . 0.0 111.397 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 167.8 168.54 30.09 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.98 99.47 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.297 3.331 . . . . 0.0 110.902 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.3 t -75.52 144.21 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -113.02 -33.65 5.97 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.456 0.302 . . . . 0.0 111.075 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -163.73 157.87 19.6 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 117.966 0.348 . . . . 0.0 111.574 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.0 mt -143.37 142.74 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.289 1.036 . . . . 0.0 109.715 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.1 m -138.43 156.61 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.055 0.542 . . . . 0.0 109.588 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 66.0 mt -132.14 149.87 33.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 122.89 0.476 . . . . 0.0 110.403 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -138.14 143.36 40.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.566 0.746 . . . . 0.0 109.599 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.96 14.96 1.72 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.708 0.403 . . . . 0.0 112.058 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -82.3 -2.27 52.17 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -145.74 11.1 1.24 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.127 0.571 . . . . 0.0 111.448 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 152.14 -134.26 4.48 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -173.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.52 116.36 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -149.3 165.7 31.15 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.556 0.742 . . . . 0.0 110.582 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.44 169.64 20.4 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.139 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 78.2 mtp -138.86 148.98 44.37 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.7 t -136.37 151.42 28.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 122.878 0.471 . . . . 0.0 109.842 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -137.08 138.58 40.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.25 0.62 . . . . 0.0 109.745 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.07 170.36 8.92 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.141 0.976 . . . . 0.0 110.497 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.05 -16.24 59.97 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.565 0.346 . . . . 0.0 111.528 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.7 t -150.99 154.46 37.12 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.729 0.412 . . . . 0.0 110.579 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.24 -26.94 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.022 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -67.08 -29.9 69.79 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.059 -0.401 . . . . 0.0 110.079 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.2 m -79.29 -26.68 42.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.411 0.285 . . . . 0.0 110.501 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -80.52 -26.29 38.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.396 -0.19 . . . . 0.0 110.685 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -69.54 -36.62 76.53 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -77.82 -26.6 49.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.307 0.243 . . . . 0.0 110.798 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.5 -53.82 30.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.141 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.61 -14.42 60.38 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.814 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.53 -10.65 55.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.096 -0.378 . . . . 0.0 111.45 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.6 m -123.78 -0.35 8.55 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 94.0 mt -131.1 -6.2 3.89 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -76.35 131.24 39.05 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.917 0.78 . . . . 0.0 109.274 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.42 7.51 73.21 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.121 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.99 174.05 12.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.864 0.832 . . . . 0.0 111.337 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -132.62 145.65 51.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 52.8 mt -95.68 -17.37 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 122.097 0.159 . . . . 0.0 111.124 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.23 27.07 7.21 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.04 0.536 . . . . 0.0 111.137 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.7 m 56.49 17.64 3.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.953 0.901 . . . . 0.0 112.244 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 172.54 143.36 4.12 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 84.7 m 54.91 -178.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.89 0.876 . . . . 0.0 112.04 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 71.8 m 50.82 33.7 9.0 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.916 0.486 . . . . 0.0 110.936 -173.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 20.8 m -59.21 140.57 55.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.978 0.511 . . . . 0.0 110.09 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 47.4 mt -98.9 153.62 18.67 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.126 0.571 . . . . 0.0 111.94 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -140.43 134.8 31.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 171.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.424 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 81.6 mt -129.19 149.34 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.209 0.528 . . . . 0.0 111.286 -175.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.74 169.16 24.99 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.865 1.266 . . . . 0.0 108.199 173.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -79.57 142.01 36.08 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.756 -0.59 . . . . 0.0 110.542 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -83.43 164.11 20.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.3 pttt -81.78 -26.12 0.41 Allowed Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -175.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 44.0 Cg_endo -81.51 177.69 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 121.767 1.667 . . . . 0.0 109.876 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 68.5 p -106.53 -5.56 18.71 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.611 0.364 . . . . 0.0 110.902 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.9 mmm-85 -153.81 154.81 34.67 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.901 0.88 . . . . 0.0 110.295 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.68 168.56 10.32 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.644 0.778 . . . . 0.0 109.47 173.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -140.16 166.63 24.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.935 0.398 . . . . 0.0 111.494 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 99.5 t -138.09 155.27 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.144 0.978 . . . . 0.0 108.723 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.81 -26.3 4.87 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.299 0.24 . . . . 0.0 111.392 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.76 168.87 17.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.451 1.101 . . . . 0.0 109.08 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -106.44 117.34 33.78 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.931 0.396 . . . . 0.0 110.963 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -157.41 -175.17 5.25 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.713 1.205 . . . . 0.0 109.496 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -71.24 -3.42 20.23 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -173.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -118.08 -14.3 9.94 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.711 0.687 . . . . 0.0 111.968 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 4.9 t -155.98 135.2 12.18 Favored 'General case' 0 C--O 1.228 -0.043 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -153.2 147.75 26.09 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.872 0.368 . . . . 0.0 111.359 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.68 135.57 55.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.452 0.701 . . . . 0.0 109.509 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -116.9 13.66 14.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.4 0.68 . . . . 0.0 112.503 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 14.1 t -135.98 -5.53 2.15 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.315 0.507 . . . . 0.0 112.342 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -80.33 160.79 67.0 Favored Pre-proline 0 CA--C 1.535 0.374 0 O-C-N 121.834 -0.542 . . . . 0.0 111.36 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -61.66 -10.07 15.64 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.203 3.268 . . . . 0.0 113.37 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -81.75 -5.66 58.35 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.738 0.415 . . . . 0.0 111.72 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 23.3 tp -138.19 0.72 2.15 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.82 0.448 . . . . 0.0 111.093 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 26.3 m 55.66 31.3 17.06 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.699 0.799 . . . . 0.0 112.822 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 84.53 -164.93 40.16 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 112.308 -0.317 . . . . 0.0 112.308 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -73.78 -13.13 60.9 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.43 -0.453 . . . . 0.0 110.81 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 CA-C-O 117.346 -1.808 . . . . 0.0 110.744 -179.861 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -143.42 155.87 44.51 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.096 0.559 . . . . 0.0 110.004 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 17.9 tt -69.11 156.17 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 122.861 0.464 . . . . 0.0 110.415 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 78.4 p -81.09 -1.64 45.07 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -140.46 62.15 18.38 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 123.607 0.763 . . . . 0.0 110.764 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.07 -9.31 23.34 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.08 3.187 . . . . 0.0 112.291 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.21 153.81 51.28 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -152.95 158.19 41.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.587 0.355 . . . . 0.0 110.943 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 58.1 p 53.19 175.11 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.659 1.984 . . . . 0.0 114.759 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.7 t0 53.32 17.79 1.13 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.898 1.279 . . . . 0.0 113.363 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.9 t0 51.57 29.59 5.65 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.021 0.928 . . . . 0.0 112.488 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 26.1 m 57.8 9.52 0.89 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.103 0.961 . . . . 0.0 112.952 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 59.32 140.86 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.111 2.165 . . . . 0.0 114.899 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.0 m 58.55 144.61 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.438 1.895 . . . . 0.0 114.983 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.5 p -156.06 -40.72 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.304 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -163.92 165.78 22.36 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.881 0.872 . . . . 0.0 109.935 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.6 p -96.51 12.25 32.15 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.138 0.575 . . . . 0.0 111.826 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.72 142.46 25.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 122.874 0.469 . . . . 0.0 111.194 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.3 mt -129.19 164.0 24.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.113 0.565 . . . . 0.0 111.454 -175.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.7 tp -123.89 132.69 53.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.716 1.206 . . . . 0.0 108.171 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -119.43 144.25 47.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.729 0.811 . . . . 0.0 109.805 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 91.7 m -139.06 144.3 38.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 196' ' ' ILE . 2.9 mp -106.85 134.36 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.66 -36.55 15.18 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -173.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -131.54 63.5 69.72 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 123.606 0.762 . . . . 0.0 109.948 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.84 103.24 1.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.849 2.366 . . . . 0.0 110.88 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.9 pt -128.65 0.94 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 122.879 0.472 . . . . 0.0 111.384 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -130.1 166.52 20.02 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.954 0.902 . . . . 0.0 109.191 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.2 m -74.98 147.8 40.5 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.719 0.295 . . . . 0.0 111.56 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.1 mm -137.55 132.88 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 69.3 p -142.87 176.36 9.13 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 122.896 0.479 . . . . 0.0 110.299 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 41.5 p -63.31 -22.8 67.1 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.193 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -80.5 -26.14 38.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.295 0.238 . . . . 0.0 110.821 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 87.6 t -84.41 -37.59 12.9 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.17 -24.93 54.81 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.294 -0.254 . . . . 0.0 111.093 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -77.62 -37.26 50.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.815 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.4 t -75.74 -19.58 58.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.219 0.463 . . . . 0.0 111.374 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 pp -94.92 -15.67 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.339 0.518 . . . . 0.0 111.858 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.5 m -97.41 -22.78 16.4 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.697 0.68 . . . . 0.0 111.864 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 26.9 t-20 -59.82 -43.04 94.07 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 93.9 Cg_endo -72.22 -9.19 24.05 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.985 1.79 . . . . 0.0 111.928 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 75.4 m -96.09 -20.75 18.41 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 122.063 -0.398 . . . . 0.0 111.317 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 162.94 169.75 26.82 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.84 115.76 3.76 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.571 2.847 . . . . 0.0 111.039 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.96 147.34 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -111.63 -39.56 4.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.986 0.514 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -160.83 159.08 29.46 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.56 0.618 . . . . 0.0 112.177 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.6 mt -142.53 146.96 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.623 0.769 . . . . 0.0 110.377 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.61 144.25 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 123.372 0.669 . . . . 0.0 109.587 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.9 mp -109.12 150.95 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.493 0.717 . . . . 0.0 109.727 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -136.9 149.2 47.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.741 0.816 . . . . 0.0 109.959 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.53 16.75 2.37 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.51 -26.84 68.76 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.441 0.296 . . . . 0.0 110.794 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -151.19 120.05 6.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 57.78 -141.38 44.89 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.5 t -129.12 131.44 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -145.23 166.97 23.95 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.3 0.64 . . . . 0.0 110.067 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -157.13 171.04 21.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.796 0.439 . . . . 0.0 110.071 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 84.2 mtp -138.24 151.29 47.51 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.1 t -141.13 151.93 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 122.847 0.459 . . . . 0.0 109.846 -175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -136.94 141.45 42.65 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -115.8 168.32 10.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.471 0.709 . . . . 0.0 110.802 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -74.51 -13.83 60.73 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.761 0.425 . . . . 0.0 111.341 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 37.7 t -152.31 153.82 34.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.839 0.456 . . . . 0.0 109.938 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.8 -25.19 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -65.39 -27.59 68.66 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.908 -0.495 . . . . 0.0 109.742 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 40.4 m -82.51 -26.85 32.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.2 0.2 . . . . 0.0 110.712 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -79.76 -25.4 41.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -70.73 -37.53 73.51 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -77.88 -24.83 48.35 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 122.076 0.15 . . . . 0.0 110.779 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -67.43 -54.6 18.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.325 -0.234 . . . . 0.0 110.935 -178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -75.68 -15.82 60.26 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.708 -179.383 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -83.14 -11.11 58.24 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.115 -0.366 . . . . 0.0 111.563 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.0 m -124.45 -0.71 8.14 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 87.2 mt -130.17 -4.82 4.4 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -77.0 130.24 37.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.461 -0.774 . . . . 0.0 109.176 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.68 6.2 76.51 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.805 -0.442 . . . . 0.0 112.052 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -75.26 176.29 7.52 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.673 0.737 . . . . 0.0 111.488 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -140.11 150.96 44.93 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.57 0.748 . . . . 0.0 109.364 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.3 mt -114.58 -18.01 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 122.407 0.283 . . . . 0.0 111.442 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.18 22.01 8.72 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.045 -0.409 . . . . 0.0 111.231 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.8 m 55.77 21.03 4.4 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.524 0.73 . . . . 0.0 112.096 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 168.95 137.65 2.3 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 85.5 m 55.69 -178.73 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.132 0.973 . . . . 0.0 112.243 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 79.6 m 51.81 30.53 7.1 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.062 -0.399 . . . . 0.0 111.878 -174.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 21.6 m -59.68 140.72 56.21 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.962 0.505 . . . . 0.0 109.777 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 62.2 mt -93.52 155.2 17.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.206 0.527 . . . . 0.0 111.786 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -144.3 135.6 25.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 172.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 245' ' ' LYS . 85.2 mt -130.17 149.7 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 121.0 0.428 . . . . 0.0 111.174 -175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.35 168.77 26.0 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.934 1.294 . . . . 0.0 108.211 173.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -80.39 144.05 33.0 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.679 -0.638 . . . . 0.0 110.578 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.66 165.46 16.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.669 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 65.5 pttt -83.18 -25.79 0.38 Allowed Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -176.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 43.7 Cg_endo -81.43 179.46 5.79 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.836 1.691 . . . . 0.0 109.858 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 65.1 p -108.57 -4.65 17.0 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.734 0.414 . . . . 0.0 110.728 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 7.3 mmm-85 -153.8 153.94 33.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.039 0.936 . . . . 0.0 110.099 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 83.9 mt -115.21 168.91 9.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.298 0.639 . . . . 0.0 109.514 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -141.13 158.49 43.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.286 0.234 . . . . 0.0 110.813 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 72.0 t -138.37 156.22 29.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 124.215 1.006 . . . . 0.0 109.097 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -124.61 -15.73 6.47 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -173.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -162.49 175.16 11.77 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.698 0.799 . . . . 0.0 110.293 -176.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -121.09 95.88 4.87 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.38 0.672 . . . . 0.0 109.577 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -149.42 -170.69 3.7 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.726 0.81 . . . . 0.0 110.649 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -70.91 -5.04 27.73 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -109.0 -24.21 11.32 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.649 0.658 . . . . 0.0 111.392 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.2 t -159.26 143.33 15.11 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -150.91 150.23 30.6 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.25 137.57 52.06 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -113.81 5.17 16.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.379 0.671 . . . . 0.0 112.519 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 13.4 t -128.25 -5.22 5.47 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.755 0.422 . . . . 0.0 110.921 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -79.91 126.54 79.72 Favored Pre-proline 0 N--CA 1.453 -0.312 0 C-N-CA 124.167 0.987 . . . . 0.0 109.907 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.16 -16.3 32.93 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.615 2.877 . . . . 0.0 113.782 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -67.11 121.65 16.08 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.417 ' N ' HD22 ' A' ' 287' ' ' LEU . 3.2 mm? 56.93 23.9 8.77 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.109 0.964 . . . . 0.0 111.123 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 10.2 t 52.29 15.52 0.47 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.792 1.237 . . . . 0.0 112.846 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 67.92 11.84 61.42 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.658 -0.523 . . . . 0.0 112.693 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -139.56 -4.37 1.44 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.125 0.962 . . . . 0.0 113.022 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.132 -1.927 . . . . 0.0 111.434 179.706 . . . . . . . . 0 0 . 1 stop_ save_